




Analysis Type:	PANTHER Overrepresentation Test (Released 20200728)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4081749 Released 2020-10-09
Analyzed List:	upload_1 (Homo sapiens)
Reference List:	human_background.txt (Homo sapiens)
Test Type:	BINOMIAL
Correction:	NONE
GO biological process complete	human_background.txt - REFLIST (16250)	upload_1 (830)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)
ectoderm and mesoderm interaction (GO:0007499)	1	1	.05	+	19.58	4.98E-02
fluorene metabolic process (GO:0018917)	1	1	.05	+	19.58	4.98E-02
nerve maturation (GO:0021682)	1	1	.05	+	19.58	4.98E-02
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	1	1	.05	+	19.58	4.98E-02
positive regulation of testosterone secretion (GO:2000845)	1	1	.05	+	19.58	4.98E-02
regulation of testosterone secretion (GO:2000843)	1	1	.05	+	19.58	4.98E-02
biphenyl metabolic process (GO:0018879)	2	2	.10	+	19.58	4.87E-03
negative regulation of synaptic vesicle clustering (GO:2000808)	1	1	.05	+	19.58	4.98E-02
regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	1	.05	+	19.58	4.98E-02
suppression by symbiont of host defense-related programmed cell death (GO:0034054)	1	1	.05	+	19.58	4.98E-02
modulation by symbiont of host defense-related programmed cell death (GO:0034053)	1	1	.05	+	19.58	4.98E-02
multi-organism intercellular transport (GO:1902586)	1	1	.05	+	19.58	4.98E-02
negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	1	.05	+	19.58	4.98E-02
regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	1	.05	+	19.58	4.98E-02
ncRNA deadenylation (GO:0110008)	1	1	.05	+	19.58	4.98E-02
B cell cytokine production (GO:0002368)	1	1	.05	+	19.58	4.98E-02
glucocorticoid catabolic process (GO:0006713)	1	1	.05	+	19.58	4.98E-02
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	1	.05	+	19.58	4.98E-02
negative regulation of translation in response to oxidative stress (GO:0032938)	1	1	.05	+	19.58	4.98E-02
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	2	2	.10	+	19.58	4.87E-03
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	2	2	.10	+	19.58	4.87E-03
primary adaptive immune response involving T cells and B cells (GO:0090721)	1	1	.05	+	19.58	4.98E-02
primary adaptive immune response (GO:0090720)	1	1	.05	+	19.58	4.98E-02
positive regulation of endoribonuclease activity (GO:1902380)	1	1	.05	+	19.58	4.98E-02
prolactin signaling pathway (GO:0038161)	1	1	.05	+	19.58	4.98E-02
negative regulation of chromosome condensation (GO:1902340)	1	1	.05	+	19.58	4.98E-02
slow axonal transport (GO:1990832)	1	1	.05	+	19.58	4.98E-02
subtelomeric heterochromatin organization (GO:0140461)	1	1	.05	+	19.58	4.98E-02
negative regulation of eosinophil extravasation (GO:2000420)	1	1	.05	+	19.58	4.98E-02
regulation of eosinophil extravasation (GO:2000419)	1	1	.05	+	19.58	4.98E-02
cellular response to blue light (GO:0071483)	2	2	.10	+	19.58	4.87E-03
positive regulation of prolactin signaling pathway (GO:1902213)	1	1	.05	+	19.58	4.98E-02
regulation of prolactin signaling pathway (GO:1902211)	1	1	.05	+	19.58	4.98E-02
cellular response to non-ionic osmotic stress (GO:0071471)	1	1	.05	+	19.58	4.98E-02
cellular response to anoxia (GO:0071454)	1	1	.05	+	19.58	4.98E-02
mitotic spindle microtubule depolymerization (GO:1990755)	1	1	.05	+	19.58	4.98E-02
starch catabolic process (GO:0005983)	1	1	.05	+	19.58	4.98E-02
starch metabolic process (GO:0005982)	1	1	.05	+	19.58	4.98E-02
transcription elongation from mitochondrial promoter (GO:0006392)	1	1	.05	+	19.58	4.98E-02
cellular response to cortisol stimulus (GO:0071387)	1	1	.05	+	19.58	4.98E-02
regulation of acid-sensing ion channel activity (GO:1901585)	1	1	.05	+	19.58	4.98E-02
barbed-end actin filament uncapping (GO:0051638)	1	1	.05	+	19.58	4.98E-02
positive regulation of norepinephrine uptake (GO:0051623)	1	1	.05	+	19.58	4.98E-02
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	1	.05	+	19.58	4.98E-02
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	1	1	.05	+	19.58	4.98E-02
cytosol to ERGIC protein transport (GO:0106273)	1	1	.05	+	19.58	4.98E-02
protein localization to ERGIC (GO:0106272)	1	1	.05	+	19.58	4.98E-02
suppression of host defenses by symbiont (GO:0044414)	1	1	.05	+	19.58	4.98E-02
nonfunctional rRNA decay (GO:0070651)	1	1	.05	+	19.58	4.98E-02
DNA excision (GO:0044349)	1	1	.05	+	19.58	4.98E-02
nucleotide-excision repair, DNA damage removal (GO:0000718)	1	1	.05	+	19.58	4.98E-02
monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	1	1	.05	+	19.58	4.98E-02
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	1	1	.05	+	19.58	4.98E-02
response to cytochalasin B (GO:1901328)	1	1	.05	+	19.58	4.98E-02
positive regulation of sterol regulatory element binding protein cleavage (GO:1901310)	1	1	.05	+	19.58	4.98E-02
regulation of sterol regulatory element binding protein cleavage (GO:1901308)	1	1	.05	+	19.58	4.98E-02
positive regulation of spermidine biosynthetic process (GO:1901307)	1	1	.05	+	19.58	4.98E-02
regulation of spermidine biosynthetic process (GO:1901304)	1	1	.05	+	19.58	4.98E-02
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	1	1	.05	+	19.58	4.98E-02
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	2	2	.10	+	19.58	4.87E-03
negative regulation of telomere maintenance via recombination (GO:0032208)	1	1	.05	+	19.58	4.98E-02
regulation of telomere maintenance via recombination (GO:0032207)	1	1	.05	+	19.58	4.98E-02
RNA localization to chromatin (GO:1990280)	1	1	.05	+	19.58	4.98E-02
negative regulation of protein localization to endosome (GO:1905667)	1	1	.05	+	19.58	4.98E-02
negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	1	.05	+	19.58	4.98E-02
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	1	1	.05	+	19.58	4.98E-02
meiotic metaphase plate congression (GO:0051311)	1	1	.05	+	19.58	4.98E-02
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	1	.05	+	19.58	4.98E-02
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	1	.05	+	19.58	4.98E-02
maintenance of ciliary planar beating movement pattern (GO:0120221)	1	1	.05	+	19.58	4.98E-02
blue light signaling pathway (GO:0009785)	2	2	.10	+	19.58	4.87E-03
regulation of translation in response to oxidative stress (GO:0043556)	1	1	.05	+	19.58	4.98E-02
response to low light intensity stimulus (GO:0009645)	1	1	.05	+	19.58	4.98E-02
subtelomeric heterochromatin assembly (GO:0031509)	1	1	.05	+	19.58	4.98E-02
negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998)	1	1	.05	+	19.58	4.98E-02
oncosis (GO:0070267)	1	1	.05	+	19.58	4.98E-02
negative regulation of endosome organization (GO:1904979)	1	1	.05	+	19.58	4.98E-02
response to D-galactose (GO:1905377)	1	1	.05	+	19.58	4.98E-02
negative regulation of intralumenal vesicle formation (GO:1905366)	1	1	.05	+	19.58	4.98E-02
regulation of intralumenal vesicle formation (GO:1905365)	1	1	.05	+	19.58	4.98E-02
negative regulation of calcium-independent cell-cell adhesion (GO:0051042)	1	1	.05	+	19.58	4.98E-02
nucleologenesis (GO:0017126)	2	2	.10	+	19.58	4.87E-03
isotype switching to IgG isotypes (GO:0048291)	1	1	.05	+	19.58	4.98E-02
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	1	.05	+	19.58	4.98E-02
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	1	.05	+	19.58	4.98E-02
chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	1	.05	+	19.58	4.98E-02
regulation of protein localization to adherens junction (GO:1904702)	1	1	.05	+	19.58	4.98E-02
manchette disassembly (GO:1905199)	1	1	.05	+	19.58	4.98E-02
actin rod assembly (GO:0031247)	1	1	.05	+	19.58	4.98E-02
circadian sleep/wake cycle, REM sleep (GO:0042747)	2	2	.10	+	19.58	4.87E-03
response to curcumin (GO:1904643)	1	1	.05	+	19.58	4.98E-02
regulation of embryonic cell shape (GO:0016476)	1	1	.05	+	19.58	4.98E-02
negative regulation of astrocyte activation (GO:0061889)	1	1	.05	+	19.58	4.98E-02
cardiac jelly development (GO:1905072)	1	1	.05	+	19.58	4.98E-02
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	1	.05	+	19.58	4.98E-02
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	1	1	.05	+	19.58	4.98E-02
calcium-dependent cell-matrix adhesion (GO:0016340)	2	2	.10	+	19.58	4.87E-03
pantothenate transmembrane transport (GO:0015887)	1	1	.05	+	19.58	4.98E-02
meiotic metaphase I plate congression (GO:0043060)	1	1	.05	+	19.58	4.98E-02
tyrosine transport (GO:0015828)	1	1	.05	+	19.58	4.98E-02
regulation of polyamine biosynthetic process (GO:0010967)	1	1	.05	+	19.58	4.98E-02
muscle attachment (GO:0016203)	1	1	.05	+	19.58	4.98E-02
methionine catabolic process (GO:0009087)	1	1	.05	+	19.58	4.98E-02
regulation of microtubule anchoring at centrosome (GO:0150101)	1	1	.05	+	19.58	4.98E-02
execution phase of necroptosis (GO:0097528)	2	2	.10	+	19.58	4.87E-03
negative regulation of telomere single strand break repair (GO:1903824)	1	1	.05	+	19.58	4.98E-02
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	1	.05	+	19.58	4.98E-02
negative regulation of beta-galactosidase activity (GO:1903770)	1	1	.05	+	19.58	4.98E-02
cellular response to caloric restriction (GO:0061433)	1	1	.05	+	19.58	4.98E-02
response to tellurium ion (GO:0046690)	1	1	.05	+	19.58	4.98E-02
peptidyl-aspartic acid hydroxylation (GO:0042264)	1	1	.05	+	19.58	4.98E-02
positive regulation of otic vesicle morphogenesis (GO:1904120)	1	1	.05	+	19.58	4.98E-02
regulation of otic vesicle morphogenesis (GO:1904118)	1	1	.05	+	19.58	4.98E-02
positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395)	1	1	.05	+	19.58	4.98E-02
positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638)	1	1	.05	+	19.58	4.98E-02
regulation of protein insertion into mitochondrial outer membrane (GO:1903636)	1	1	.05	+	19.58	4.98E-02
venous endothelial cell differentiation (GO:0060843)	1	1	.05	+	19.58	4.98E-02
positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804)	1	1	.05	+	19.58	4.98E-02
negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	1	.05	+	19.58	4.98E-02
regulation of cystathionine beta-synthase activity (GO:1904041)	1	1	.05	+	19.58	4.98E-02
mitochondrial unfolded protein response (GO:0034514)	1	1	.05	+	19.58	4.98E-02
nitrogen utilization (GO:0019740)	1	1	.05	+	19.58	4.98E-02
negative regulation of single strand break repair (GO:1903517)	1	1	.05	+	19.58	4.98E-02
cellular response to cytochalasin B (GO:0072749)	1	1	.05	+	19.58	4.98E-02
cellular response to anisomycin (GO:0072740)	1	1	.05	+	19.58	4.98E-02
response to anisomycin (GO:0072739)	1	1	.05	+	19.58	4.98E-02
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	1	.05	+	19.58	4.98E-02
phosphatidylglycerol catabolic process (GO:0034478)	1	1	.05	+	19.58	4.98E-02
spongiotrophoblast layer development (GO:0060712)	1	1	.05	+	19.58	4.98E-02
epidermal cell division (GO:0010481)	1	1	.05	+	19.58	4.98E-02
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	1	1	.05	+	19.58	4.98E-02
ammonia assimilation cycle (GO:0019676)	1	1	.05	+	19.58	4.98E-02
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	1	.05	+	19.58	4.98E-02
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	2	2	.10	+	19.58	4.87E-03
phosphatidylserine exposure on blood platelet (GO:0097045)	1	1	.05	+	19.58	4.98E-02
response to non-ionic osmotic stress (GO:0010335)	1	1	.05	+	19.58	4.98E-02
coronary sinus valve morphogenesis (GO:0003182)	1	1	.05	+	19.58	4.98E-02
coronary sinus valve development (GO:0003178)	1	1	.05	+	19.58	4.98E-02
formaldehyde biosynthetic process (GO:0046293)	1	1	.05	+	19.58	4.98E-02
protein localization to spindle microtubule (GO:1902889)	1	1	.05	+	19.58	4.98E-02
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	5	.31	+	16.32	1.73E-05
circadian regulation of translation (GO:0097167)	4	3	.20	+	14.68	1.22E-03
pole plasm assembly (GO:0007315)	3	2	.15	+	13.05	1.06E-02
oocyte anterior/posterior axis specification (GO:0007314)	3	2	.15	+	13.05	1.06E-02
negative regulation of glucocorticoid secretion (GO:2000850)	3	2	.15	+	13.05	1.06E-02
oocyte axis specification (GO:0007309)	3	2	.15	+	13.05	1.06E-02
oocyte construction (GO:0007308)	3	2	.15	+	13.05	1.06E-02
negative regulation of corticosteroid hormone secretion (GO:2000847)	3	2	.15	+	13.05	1.06E-02
negative regulation of steroid hormone secretion (GO:2000832)	3	2	.15	+	13.05	1.06E-02
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	3	2	.15	+	13.05	1.06E-02
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	3	2	.15	+	13.05	1.06E-02
S-adenosylmethionine biosynthetic process (GO:0006556)	3	2	.15	+	13.05	1.06E-02
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	3	2	.15	+	13.05	1.06E-02
circadian sleep/wake cycle, sleep (GO:0050802)	3	2	.15	+	13.05	1.06E-02
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	3	2	.15	+	13.05	1.06E-02
positive regulation of transcription via serum response element binding (GO:0010735)	3	2	.15	+	13.05	1.06E-02
maternal determination of anterior/posterior axis, embryo (GO:0008358)	3	2	.15	+	13.05	1.06E-02
positive regulation of mitochondrial fusion (GO:0010636)	3	2	.15	+	13.05	1.06E-02
negative regulation of mitotic recombination (GO:0045950)	3	2	.15	+	13.05	1.06E-02
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	3	2	.15	+	13.05	1.06E-02
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	8	5	.41	+	12.24	6.70E-05
farnesyl diphosphate metabolic process (GO:0045338)	5	3	.26	+	11.75	2.29E-03
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	5	3	.26	+	11.75	2.29E-03
sulfur oxidation (GO:0019417)	2	1	.10	+	9.79	9.71E-02
dolichol biosynthetic process (GO:0019408)	2	1	.10	+	9.79	9.71E-02
response to intra-S DNA damage checkpoint signaling (GO:0072429)	2	1	.10	+	9.79	9.71E-02
isoprenoid biosynthetic process via mevalonate (GO:1902767)	2	1	.10	+	9.79	9.71E-02
phthalate metabolic process (GO:0018963)	2	1	.10	+	9.79	9.71E-02
activation of blood coagulation via clotting cascade (GO:0002543)	2	1	.10	+	9.79	9.71E-02
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	2	1	.10	+	9.79	9.71E-02
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	4	2	.20	+	9.79	1.82E-02
hypersensitivity (GO:0002524)	2	1	.10	+	9.79	9.71E-02
positive regulation of dipeptide transport (GO:2000880)	2	1	.10	+	9.79	9.71E-02
positive regulation of oligopeptide transport (GO:2000878)	2	1	.10	+	9.79	9.71E-02
negative regulation of leucine import (GO:0060358)	2	1	.10	+	9.79	9.71E-02
regulation of leucine import (GO:0060357)	2	1	.10	+	9.79	9.71E-02
inositol phosphorylation (GO:0052746)	2	1	.10	+	9.79	9.71E-02
arsonoacetate metabolic process (GO:0018872)	2	1	.10	+	9.79	9.71E-02
negative regulation of barbed-end actin filament capping (GO:2000813)	2	1	.10	+	9.79	9.71E-02
regulation of barbed-end actin filament capping (GO:2000812)	2	1	.10	+	9.79	9.71E-02
response to anoxia (GO:0034059)	2	1	.10	+	9.79	9.71E-02
malonyl-CoA biosynthetic process (GO:2001295)	2	1	.10	+	9.79	9.71E-02
protein glycosylation in Golgi (GO:0033578)	2	1	.10	+	9.79	9.71E-02
vitellogenesis (GO:0007296)	4	2	.20	+	9.79	1.82E-02
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	2	1	.10	+	9.79	9.71E-02
negative regulation of nuclear cell cycle DNA replication (GO:1902576)	2	1	.10	+	9.79	9.71E-02
cell-cell signaling involved in metanephros development (GO:0072204)	2	1	.10	+	9.79	9.71E-02
positive regulation of eosinophil activation (GO:1902568)	2	1	.10	+	9.79	9.71E-02
positive regulation of protein K48-linked ubiquitination (GO:1902524)	2	1	.10	+	9.79	9.71E-02
cap-independent translational initiation of linear mRNA (GO:0110017)	2	1	.10	+	9.79	9.71E-02
cholesterol biosynthetic process via lathosterol (GO:0033490)	4	2	.20	+	9.79	1.82E-02
cholesterol biosynthetic process via desmosterol (GO:0033489)	4	2	.20	+	9.79	1.82E-02
positive regulation of dipeptide transmembrane transport (GO:2001150)	2	1	.10	+	9.79	9.71E-02
regulation of dipeptide transmembrane transport (GO:2001148)	2	1	.10	+	9.79	9.71E-02
epidermal growth factor catabolic process (GO:0007174)	2	1	.10	+	9.79	9.71E-02
nephron tubule epithelial cell differentiation (GO:0072160)	2	1	.10	+	9.79	9.71E-02
type IV hypersensitivity (GO:0001806)	2	1	.10	+	9.79	9.71E-02
positive regulation of histone H4-K16 acetylation (GO:2000620)	2	1	.10	+	9.79	9.71E-02
corticotropin hormone secreting cell differentiation (GO:0060128)	2	1	.10	+	9.79	9.71E-02
positive regulation of male mating behavior (GO:1902437)	2	1	.10	+	9.79	9.71E-02
regulation of male mating behavior (GO:1902435)	2	1	.10	+	9.79	9.71E-02
sphinganine metabolic process (GO:0006667)	2	1	.10	+	9.79	9.71E-02
geranyl diphosphate biosynthetic process (GO:0033384)	2	1	.10	+	9.79	9.71E-02
geranyl diphosphate metabolic process (GO:0033383)	2	1	.10	+	9.79	9.71E-02
farnesyl diphosphate biosynthetic process (GO:0045337)	4	2	.20	+	9.79	1.82E-02
ethanolamine metabolic process (GO:0006580)	2	1	.10	+	9.79	9.71E-02
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	6	3	.31	+	9.79	3.81E-03
Kit signaling pathway (GO:0038109)	2	1	.10	+	9.79	9.71E-02
IRES-dependent translational initiation of linear mRNA (GO:0002192)	2	1	.10	+	9.79	9.71E-02
cap-independent translational initiation (GO:0002190)	2	1	.10	+	9.79	9.71E-02
glutamine biosynthetic process (GO:0006542)	2	1	.10	+	9.79	9.71E-02
negative regulation of hepatic stellate cell activation (GO:2000490)	2	1	.10	+	9.79	9.71E-02
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	1	.10	+	9.79	9.71E-02
DNA methylation on adenine (GO:0032775)	2	1	.10	+	9.79	9.71E-02
negative regulation of mast cell cytokine production (GO:0032764)	2	1	.10	+	9.79	9.71E-02
negative regulation of eosinophil migration (GO:2000417)	2	1	.10	+	9.79	9.71E-02
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	2	1	.10	+	9.79	9.71E-02
Wnt receptor catabolic process (GO:0038018)	2	1	.10	+	9.79	9.71E-02
cellular response to cell-matrix adhesion (GO:0071460)	2	1	.10	+	9.79	9.71E-02
positive regulation of timing of anagen (GO:0051885)	2	1	.10	+	9.79	9.71E-02
phenylalanyl-tRNA aminoacylation (GO:0006432)	2	1	.10	+	9.79	9.71E-02
leucyl-tRNA aminoacylation (GO:0006429)	2	1	.10	+	9.79	9.71E-02
glutaminyl-tRNA aminoacylation (GO:0006425)	2	1	.10	+	9.79	9.71E-02
rRNA export from nucleus (GO:0006407)	2	1	.10	+	9.79	9.71E-02
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	2	1	.10	+	9.79	9.71E-02
cellular response to cycloheximide (GO:0071409)	4	2	.20	+	9.79	1.82E-02
cellular response to high density lipoprotein particle stimulus (GO:0071403)	2	1	.10	+	9.79	9.71E-02
L-asparagine metabolic process (GO:0070982)	2	1	.10	+	9.79	9.71E-02
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	2	1	.10	+	9.79	9.71E-02
termination of mitochondrial transcription (GO:0006393)	2	1	.10	+	9.79	9.71E-02
interferon-beta production (GO:0032608)	2	1	.10	+	9.79	9.71E-02
positive regulation of presynaptic membrane organization (GO:1901631)	2	1	.10	+	9.79	9.71E-02
regulation of presynaptic membrane organization (GO:1901629)	2	1	.10	+	9.79	9.71E-02
positive regulation of postsynaptic membrane organization (GO:1901628)	2	1	.10	+	9.79	9.71E-02
positive regulation of bile acid biosynthetic process (GO:0070859)	2	1	.10	+	9.79	9.71E-02
dendritic cell proliferation (GO:0044565)	2	1	.10	+	9.79	9.71E-02
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	1	.10	+	9.79	9.71E-02
actin filament uncapping (GO:0051695)	2	1	.10	+	9.79	9.71E-02
regulation of norepinephrine uptake (GO:0051621)	2	1	.10	+	9.79	9.71E-02
positive regulation of platelet-derived growth factor production (GO:0090362)	2	1	.10	+	9.79	9.71E-02
positive regulation of acylglycerol transport (GO:1901508)	2	1	.10	+	9.79	9.71E-02
regulation of acylglycerol transport (GO:1901506)	2	1	.10	+	9.79	9.71E-02
regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	2	1	.10	+	9.79	9.71E-02
positive regulation of ubiquitin-specific protease activity (GO:2000158)	2	1	.10	+	9.79	9.71E-02
Golgi calcium ion transport (GO:0032472)	2	1	.10	+	9.79	9.71E-02
peptidyl-aspartic acid modification (GO:0018197)	2	1	.10	+	9.79	9.71E-02
Golgi calcium ion homeostasis (GO:0032468)	2	1	.10	+	9.79	9.71E-02
positive regulation of triglyceride transport (GO:1905885)	2	1	.10	+	9.79	9.71E-02
regulation of triglyceride transport (GO:1905883)	2	1	.10	+	9.79	9.71E-02
negative regulation of keratinocyte migration (GO:0051548)	2	1	.10	+	9.79	9.71E-02
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	1	.10	+	9.79	9.71E-02
regulation of telomeric D-loop disassembly (GO:1905838)	2	1	.10	+	9.79	9.71E-02
superior temporal gyrus development (GO:0071109)	2	1	.10	+	9.79	9.71E-02
negative regulation of lipid kinase activity (GO:0090219)	4	2	.20	+	9.79	1.82E-02
negative regulation of type B pancreatic cell development (GO:2000077)	2	1	.10	+	9.79	9.71E-02
N-acetylmannosamine metabolic process (GO:0006051)	2	1	.10	+	9.79	9.71E-02
mannosamine metabolic process (GO:0006050)	2	1	.10	+	9.79	9.71E-02
regulation of intraciliary retrograde transport (GO:1905799)	2	1	.10	+	9.79	9.71E-02
negative regulation of exonuclease activity (GO:1905778)	2	1	.10	+	9.79	9.71E-02
dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	2	1	.10	+	9.79	9.71E-02
dendritic transport of ribonucleoprotein complex (GO:0098961)	2	1	.10	+	9.79	9.71E-02
positive regulation of inhibitory synapse assembly (GO:1905704)	2	1	.10	+	9.79	9.71E-02
dimethylallyl diphosphate metabolic process (GO:0050993)	2	1	.10	+	9.79	9.71E-02
dimethylallyl diphosphate biosynthetic process (GO:0050992)	2	1	.10	+	9.79	9.71E-02
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	2	1	.10	+	9.79	9.71E-02
negative regulation of telomere maintenance via semi-conservative replication (GO:0032214)	2	1	.10	+	9.79	9.71E-02
regulation of telomere maintenance via semi-conservative replication (GO:0032213)	2	1	.10	+	9.79	9.71E-02
regulation of dipeptide transport (GO:0090089)	2	1	.10	+	9.79	9.71E-02
regulation of oligopeptide transport (GO:0090088)	2	1	.10	+	9.79	9.71E-02
meiotic spindle midzone assembly (GO:0051257)	2	1	.10	+	9.79	9.71E-02
negative regulation of leucine import across plasma membrane (GO:1905533)	2	1	.10	+	9.79	9.71E-02
regulation of leucine import across plasma membrane (GO:1905532)	2	1	.10	+	9.79	9.71E-02
telomeric loop formation (GO:0031627)	2	1	.10	+	9.79	9.71E-02
box H/ACA snoRNA 3'-end processing (GO:0000495)	2	1	.10	+	9.79	9.71E-02
negative regulation of autophagosome maturation (GO:1901097)	6	3	.31	+	9.79	3.81E-03
lymphatic endothelial cell migration (GO:1904977)	2	1	.10	+	9.79	9.71E-02
intestinal stem cell homeostasis (GO:0036335)	4	2	.20	+	9.79	1.82E-02
SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316)	2	1	.10	+	9.79	9.71E-02
mRNA 3'-splice site recognition (GO:0000389)	6	3	.31	+	9.79	3.81E-03
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	4	2	.20	+	9.79	1.82E-02
'de novo' cotranslational protein folding (GO:0051083)	2	1	.10	+	9.79	9.71E-02
retrograde transport, vesicle recycling within Golgi (GO:0000301)	2	1	.10	+	9.79	9.71E-02
regulation of calcium-independent cell-cell adhesion (GO:0051040)	2	1	.10	+	9.79	9.71E-02
microtubule sliding (GO:0051012)	2	1	.10	+	9.79	9.71E-02
polynucleotide 3' dephosphorylation (GO:0098506)	2	1	.10	+	9.79	9.71E-02
insecticide metabolic process (GO:0017143)	2	1	.10	+	9.79	9.71E-02
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	1	.10	+	9.79	9.71E-02
cellular response to stem cell factor stimulus (GO:0036216)	2	1	.10	+	9.79	9.71E-02
response to stem cell factor (GO:0036215)	2	1	.10	+	9.79	9.71E-02
atrioventricular canal morphogenesis (GO:1905222)	2	1	.10	+	9.79	9.71E-02
positive regulation of eosinophil degranulation (GO:0043311)	2	1	.10	+	9.79	9.71E-02
positive regulation of apoptotic process involved in development (GO:1904747)	6	3	.31	+	9.79	3.81E-03
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	2	1	.10	+	9.79	9.71E-02
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	2	1	.10	+	9.79	9.71E-02
regulation of protein localization to phagocytic vesicle (GO:1905169)	2	1	.10	+	9.79	9.71E-02
histidine biosynthetic process (GO:0000105)	2	1	.10	+	9.79	9.71E-02
biotin import across plasma membrane (GO:1905135)	2	1	.10	+	9.79	9.71E-02
positive regulation of somatic stem cell population maintenance (GO:1904674)	2	1	.10	+	9.79	9.71E-02
P granule organization (GO:0030719)	2	1	.10	+	9.79	9.71E-02
regulation of astrocyte activation (GO:0061888)	2	1	.10	+	9.79	9.71E-02
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	2	1	.10	+	9.79	9.71E-02
regulation of mini excitatory postsynaptic potential (GO:0061884)	2	1	.10	+	9.79	9.71E-02
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	2	1	.10	+	9.79	9.71E-02
maltose metabolic process (GO:0000023)	2	1	.10	+	9.79	9.71E-02
regulation of mitotic recombination (GO:0000019)	6	3	.31	+	9.79	3.81E-03
negative regulation of telomeric loop disassembly (GO:1904534)	2	1	.10	+	9.79	9.71E-02
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	2	1	.10	+	9.79	9.71E-02
response to caloric restriction (GO:0061771)	4	2	.20	+	9.79	1.82E-02
chaperone-mediated protein transport involved in chaperone-mediated autophagy (GO:0061741)	2	1	.10	+	9.79	9.71E-02
lipophagy (GO:0061724)	2	1	.10	+	9.79	9.71E-02
histone H3-T11 phosphorylation (GO:0035407)	2	1	.10	+	9.79	9.71E-02
radial spoke assembly (GO:0062177)	2	1	.10	+	9.79	9.71E-02
box H/ACA snoRNA processing (GO:0034964)	2	1	.10	+	9.79	9.71E-02
pyridoxine biosynthetic process (GO:0008615)	2	1	.10	+	9.79	9.71E-02
pyridoxine metabolic process (GO:0008614)	2	1	.10	+	9.79	9.71E-02
regulation of transepithelial transport (GO:0150111)	4	2	.20	+	9.79	1.82E-02
cellular response to L-phenylalanine derivative (GO:1904387)	2	1	.10	+	9.79	9.71E-02
synaptic vesicle to endosome fusion (GO:0016189)	2	1	.10	+	9.79	9.71E-02
cellular stress response to acid chemical (GO:0097533)	2	1	.10	+	9.79	9.71E-02
stress response to acid chemical (GO:0097532)	2	1	.10	+	9.79	9.71E-02
negative regulation of triglyceride biosynthetic process (GO:0010868)	2	1	.10	+	9.79	9.71E-02
positive regulation of aorta morphogenesis (GO:1903849)	2	1	.10	+	9.79	9.71E-02
regulation of aorta morphogenesis (GO:1903847)	2	1	.10	+	9.79	9.71E-02
modification by virus of host mRNA processing (GO:0046778)	2	1	.10	+	9.79	9.71E-02
positive regulation of bile acid metabolic process (GO:1904253)	2	1	.10	+	9.79	9.71E-02
regulation of ubiquinone biosynthetic process (GO:0010795)	2	1	.10	+	9.79	9.71E-02
cellular response to phosphate starvation (GO:0016036)	2	1	.10	+	9.79	9.71E-02
positive regulation of potassium ion export across plasma membrane (GO:1903766)	2	1	.10	+	9.79	9.71E-02
cell-cell signaling involved in kidney development (GO:0060995)	2	1	.10	+	9.79	9.71E-02
olfactory learning (GO:0008355)	2	1	.10	+	9.79	9.71E-02
positive regulation of protein O-linked glycosylation (GO:1904100)	2	1	.10	+	9.79	9.71E-02
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061394)	2	1	.10	+	9.79	9.71E-02
Wnt protein secretion (GO:0061355)	2	1	.10	+	9.79	9.71E-02
negative regulation of chaperone-mediated protein folding (GO:1903645)	2	1	.10	+	9.79	9.71E-02
regulation of protein O-linked glycosylation (GO:1904098)	2	1	.10	+	9.79	9.71E-02
inactivation of X chromosome by genetic imprinting (GO:0060819)	2	1	.10	+	9.79	9.71E-02
sphinganine biosynthetic process (GO:0046511)	2	1	.10	+	9.79	9.71E-02
negative regulation of vascular endothelial growth factor production (GO:1904046)	2	1	.10	+	9.79	9.71E-02
regulation of lung blood pressure (GO:0014916)	4	2	.20	+	9.79	1.82E-02
tRNA N1-guanine methylation (GO:0002939)	2	1	.10	+	9.79	9.71E-02
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	2	1	.10	+	9.79	9.71E-02
Wnt signaling pathway involved in kidney development (GO:0061289)	2	1	.10	+	9.79	9.71E-02
negative regulation of exosomal secretion (GO:1903542)	2	1	.10	+	9.79	9.71E-02
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	2	1	.10	+	9.79	9.71E-02
cellular response to rapamycin (GO:0072752)	2	1	.10	+	9.79	9.71E-02
negative regulation of extracellular matrix constituent secretion (GO:0003332)	4	2	.20	+	9.79	1.82E-02
mesenchymal cell apoptotic process (GO:0097152)	2	1	.10	+	9.79	9.71E-02
circadian sleep/wake cycle process (GO:0022410)	4	2	.20	+	9.79	1.82E-02
lung smooth muscle development (GO:0061145)	2	1	.10	+	9.79	9.71E-02
negative regulation of mitotic cell cycle DNA replication (GO:1903464)	2	1	.10	+	9.79	9.71E-02
regulation of endoribonuclease activity (GO:0060699)	4	2	.20	+	9.79	1.82E-02
cardiac right atrium morphogenesis (GO:0003213)	2	1	.10	+	9.79	9.71E-02
cardiac atrium formation (GO:0003210)	2	1	.10	+	9.79	9.71E-02
cellular response to thyroxine stimulus (GO:0097069)	2	1	.10	+	9.79	9.71E-02
negative regulation of muscle hyperplasia (GO:0014740)	2	1	.10	+	9.79	9.71E-02
lymphocyte migration into lymph node (GO:0097022)	2	1	.10	+	9.79	9.71E-02
coronary vein morphogenesis (GO:0003169)	2	1	.10	+	9.79	9.71E-02
formaldehyde metabolic process (GO:0046292)	4	2	.20	+	9.79	1.82E-02
bronchus cartilage development (GO:0060532)	2	1	.10	+	9.79	9.71E-02
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	2	1	.10	+	9.79	9.71E-02
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	4	2	.20	+	9.79	1.82E-02
spermine catabolic process (GO:0046208)	2	1	.10	+	9.79	9.71E-02
spermidine catabolic process (GO:0046203)	2	1	.10	+	9.79	9.71E-02
negative regulation of translation in response to stress (GO:0032055)	7	3	.36	+	8.39	5.82E-03
dolichol metabolic process (GO:0019348)	5	2	.26	+	7.83	2.75E-02
protein localization to adherens junction (GO:0071896)	5	2	.26	+	7.83	2.75E-02
cytoplasm organization (GO:0007028)	10	4	.51	+	7.83	1.88E-03
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	5	2	.26	+	7.83	2.75E-02
response to blue light (GO:0009637)	5	2	.26	+	7.83	2.75E-02
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	5	2	.26	+	7.83	2.75E-02
isopentenyl diphosphate biosynthetic process (GO:0009240)	5	2	.26	+	7.83	2.75E-02
positive regulation of lipophagy (GO:1904504)	5	2	.26	+	7.83	2.75E-02
regulation of lipophagy (GO:1904502)	5	2	.26	+	7.83	2.75E-02
response to fungicide (GO:0060992)	5	2	.26	+	7.83	2.75E-02
isopentenyl diphosphate metabolic process (GO:0046490)	5	2	.26	+	7.83	2.75E-02
maintenance of protein location in mitochondrion (GO:0072656)	5	2	.26	+	7.83	2.75E-02
protein hexamerization (GO:0034214)	8	3	.41	+	7.34	8.37E-03
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	8	3	.41	+	7.34	8.37E-03
regulation of type B pancreatic cell development (GO:2000074)	8	3	.41	+	7.34	8.37E-03
ribosomal large subunit export from nucleus (GO:0000055)	8	3	.41	+	7.34	8.37E-03
regulation of extracellular matrix constituent secretion (GO:0003330)	8	3	.41	+	7.34	8.37E-03
endothelial cell apoptotic process (GO:0072577)	8	3	.41	+	7.34	8.37E-03
secondary alcohol biosynthetic process (GO:1902653)	40	14	2.04	+	6.85	3.50E-08
cholesterol biosynthetic process (GO:0006695)	40	14	2.04	+	6.85	3.50E-08
sterol biosynthetic process (GO:0016126)	45	15	2.30	+	6.53	2.16E-08
positive regulation of intestinal cholesterol absorption (GO:0045797)	3	1	.15	+	6.53	1.42E-01
4-hydroxyproline metabolic process (GO:0019471)	3	1	.15	+	6.53	1.42E-01
4-hydroxyproline catabolic process (GO:0019470)	3	1	.15	+	6.53	1.42E-01
U2-type prespliceosome assembly (GO:1903241)	3	1	.15	+	6.53	1.42E-01
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	3	1	.15	+	6.53	1.42E-01
cochlear nucleus development (GO:0021747)	3	1	.15	+	6.53	1.42E-01
lung induction (GO:0060492)	3	1	.15	+	6.53	1.42E-01
negative regulation of pro-B cell differentiation (GO:2000974)	3	1	.15	+	6.53	1.42E-01
proline catabolic process to glutamate (GO:0010133)	3	1	.15	+	6.53	1.42E-01
negative regulation of integrin activation (GO:0033624)	3	1	.15	+	6.53	1.42E-01
dibenzo-p-dioxin metabolic process (GO:0018894)	3	1	.15	+	6.53	1.42E-01
odontoblast differentiation (GO:0071895)	3	1	.15	+	6.53	1.42E-01
malonyl-CoA metabolic process (GO:2001293)	3	1	.15	+	6.53	1.42E-01
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	3	1	.15	+	6.53	1.42E-01
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	3	1	.15	+	6.53	1.42E-01
N-acetylneuraminate catabolic process (GO:0019262)	6	2	.31	+	6.53	3.84E-02
lactate biosynthetic process (GO:0019249)	3	1	.15	+	6.53	1.42E-01
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	3	1	.15	+	6.53	1.42E-01
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	3	1	.15	+	6.53	1.42E-01
immunoglobulin biosynthetic process (GO:0002378)	3	1	.15	+	6.53	1.42E-01
eye pigment biosynthetic process (GO:0006726)	3	1	.15	+	6.53	1.42E-01
cloacal septation (GO:0060197)	3	1	.15	+	6.53	1.42E-01
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	3	1	.15	+	6.53	1.42E-01
negative regulation of SREBP signaling pathway (GO:2000639)	3	1	.15	+	6.53	1.42E-01
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	3	1	.15	+	6.53	1.42E-01
negative regulation of integrin-mediated signaling pathway (GO:2001045)	3	1	.15	+	6.53	1.42E-01
male meiosis chromosome segregation (GO:0007060)	3	1	.15	+	6.53	1.42E-01
positive regulation of T cell costimulation (GO:2000525)	3	1	.15	+	6.53	1.42E-01
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	1	.15	+	6.53	1.42E-01
translation reinitiation (GO:0002188)	3	1	.15	+	6.53	1.42E-01
cytoplasmic translational termination (GO:0002184)	3	1	.15	+	6.53	1.42E-01
negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895)	3	1	.15	+	6.53	1.42E-01
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	3	1	.15	+	6.53	1.42E-01
regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	3	1	.15	+	6.53	1.42E-01
regulation of mitochondrial DNA metabolic process (GO:1901858)	3	1	.15	+	6.53	1.42E-01
extracellular polysaccharide biosynthetic process (GO:0045226)	3	1	.15	+	6.53	1.42E-01
establishment of neuroblast polarity (GO:0045200)	3	1	.15	+	6.53	1.42E-01
HRI-mediated signaling (GO:0140468)	3	1	.15	+	6.53	1.42E-01
pericentric heterochromatin organization (GO:0140462)	3	1	.15	+	6.53	1.42E-01
negative regulation of glycogen (starch) synthase activity (GO:2000466)	3	1	.15	+	6.53	1.42E-01
regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	3	1	.15	+	6.53	1.42E-01
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	3	1	.15	+	6.53	1.42E-01
threonyl-tRNA aminoacylation (GO:0006435)	3	1	.15	+	6.53	1.42E-01
asparaginyl-tRNA aminoacylation (GO:0006421)	3	1	.15	+	6.53	1.42E-01
establishment or maintenance of neuroblast polarity (GO:0045196)	3	1	.15	+	6.53	1.42E-01
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	3	1	.15	+	6.53	1.42E-01
lactose biosynthetic process (GO:0005989)	3	1	.15	+	6.53	1.42E-01
lactose metabolic process (GO:0005988)	3	1	.15	+	6.53	1.42E-01
negative regulation of mesoderm development (GO:2000381)	3	1	.15	+	6.53	1.42E-01
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	6	2	.31	+	6.53	3.84E-02
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	6	2	.31	+	6.53	3.84E-02
serine import into mitochondrion (GO:0140300)	3	1	.15	+	6.53	1.42E-01
cellular response to luteinizing hormone stimulus (GO:0071373)	3	1	.15	+	6.53	1.42E-01
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	12	4	.61	+	6.53	3.60E-03
constitutive secretory pathway (GO:0045054)	3	1	.15	+	6.53	1.42E-01
protein import into mitochondrial intermembrane space (GO:0045041)	3	1	.15	+	6.53	1.42E-01
regulation of postsynaptic membrane organization (GO:1901626)	3	1	.15	+	6.53	1.42E-01
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	3	1	.15	+	6.53	1.42E-01
protein carboxylation (GO:0018214)	3	1	.15	+	6.53	1.42E-01
regulation of platelet-derived growth factor production (GO:0090361)	3	1	.15	+	6.53	1.42E-01
negative regulation of female gonad development (GO:2000195)	3	1	.15	+	6.53	1.42E-01
female genitalia morphogenesis (GO:0048807)	3	1	.15	+	6.53	1.42E-01
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	3	1	.15	+	6.53	1.42E-01
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	3	1	.15	+	6.53	1.42E-01
positive regulation of chromatin silencing (GO:0031937)	3	1	.15	+	6.53	1.42E-01
regulation of centromere complex assembly (GO:0090230)	3	1	.15	+	6.53	1.42E-01
protein localization to nuclear pore (GO:0090204)	3	1	.15	+	6.53	1.42E-01
UDP-glucuronate biosynthetic process (GO:0006065)	3	1	.15	+	6.53	1.42E-01
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	1	.15	+	6.53	1.42E-01
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	3	1	.15	+	6.53	1.42E-01
regulation of exonuclease activity (GO:1905777)	3	1	.15	+	6.53	1.42E-01
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	3	1	.15	+	6.53	1.42E-01
response to rapamycin (GO:1901355)	3	1	.15	+	6.53	1.42E-01
vitamin D receptor signaling pathway (GO:0070561)	3	1	.15	+	6.53	1.42E-01
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	3	1	.15	+	6.53	1.42E-01
tubulin deacetylation (GO:0090042)	3	1	.15	+	6.53	1.42E-01
regulation of blastocyst development (GO:0120222)	3	1	.15	+	6.53	1.42E-01
mucociliary clearance (GO:0120197)	3	1	.15	+	6.53	1.42E-01
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	3	1	.15	+	6.53	1.42E-01
positive regulation of autophagosome maturation (GO:1901098)	6	2	.31	+	6.53	3.84E-02
positive regulation of NK T cell differentiation (GO:0051138)	3	1	.15	+	6.53	1.42E-01
calcium ion import into sarcoplasmic reticulum (GO:1990036)	3	1	.15	+	6.53	1.42E-01
renal water absorption (GO:0070295)	3	1	.15	+	6.53	1.42E-01
pericentric heterochromatin assembly (GO:0031508)	3	1	.15	+	6.53	1.42E-01
regulation of endosome organization (GO:1904978)	3	1	.15	+	6.53	1.42E-01
regulation of activation-induced cell death of T cells (GO:0070235)	3	1	.15	+	6.53	1.42E-01
tRNA-type intron splice site recognition and cleavage (GO:0000379)	3	1	.15	+	6.53	1.42E-01
pigment metabolic process involved in pigmentation (GO:0043474)	3	1	.15	+	6.53	1.42E-01
peptidyl-glutamic acid carboxylation (GO:0017187)	3	1	.15	+	6.53	1.42E-01
homocysteine catabolic process (GO:0043418)	3	1	.15	+	6.53	1.42E-01
positive regulation of isotype switching to IgA isotypes (GO:0048298)	3	1	.15	+	6.53	1.42E-01
negative regulation of isotype switching to IgE isotypes (GO:0048294)	3	1	.15	+	6.53	1.42E-01
D-serine transport (GO:0042942)	3	1	.15	+	6.53	1.42E-01
protein unfolding (GO:0043335)	3	1	.15	+	6.53	1.42E-01
pigment metabolic process involved in developmental pigmentation (GO:0043324)	3	1	.15	+	6.53	1.42E-01
regulation of eosinophil degranulation (GO:0043309)	3	1	.15	+	6.53	1.42E-01
putrescine catabolic process (GO:0009447)	3	1	.15	+	6.53	1.42E-01
positive regulation of intestinal lipid absorption (GO:1904731)	3	1	.15	+	6.53	1.42E-01
vitamin B6 biosynthetic process (GO:0042819)	3	1	.15	+	6.53	1.42E-01
histone H3-K9 dimethylation (GO:0036123)	3	1	.15	+	6.53	1.42E-01
positive regulation of lysosomal protein catabolic process (GO:1905167)	3	1	.15	+	6.53	1.42E-01
bone mineralization involved in bone maturation (GO:0035630)	6	2	.31	+	6.53	3.84E-02
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	3	1	.15	+	6.53	1.42E-01
circadian sleep/wake cycle (GO:0042745)	6	2	.31	+	6.53	3.84E-02
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	3	1	.15	+	6.53	1.42E-01
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	6	2	.31	+	6.53	3.84E-02
long-chain fatty acid import across plasma membrane (GO:0015911)	3	1	.15	+	6.53	1.42E-01
positive regulation of oocyte maturation (GO:1900195)	3	1	.15	+	6.53	1.42E-01
regulation of telomeric loop disassembly (GO:1904533)	3	1	.15	+	6.53	1.42E-01
positive regulation of hyaluranon cable assembly (GO:1900106)	3	1	.15	+	6.53	1.42E-01
regulation of hyaluranon cable assembly (GO:1900104)	3	1	.15	+	6.53	1.42E-01
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	3	1	.15	+	6.53	1.42E-01
late endosomal microautophagy (GO:0061738)	3	1	.15	+	6.53	1.42E-01
biotin transport (GO:0015878)	3	1	.15	+	6.53	1.42E-01
positive regulation of intestinal absorption (GO:1904480)	3	1	.15	+	6.53	1.42E-01
Cajal body organization (GO:0030576)	3	1	.15	+	6.53	1.42E-01
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	3	1	.15	+	6.53	1.42E-01
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	3	1	.15	+	6.53	1.42E-01
negative regulation of t-circle formation (GO:1904430)	3	1	.15	+	6.53	1.42E-01
regulation of vitamin D 24-hydroxylase activity (GO:0010979)	3	1	.15	+	6.53	1.42E-01
lysosomal microautophagy (GO:0016237)	3	1	.15	+	6.53	1.42E-01
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	3	1	.15	+	6.53	1.42E-01
aromatic amino acid family biosynthetic process (GO:0009073)	3	1	.15	+	6.53	1.42E-01
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	3	1	.15	+	6.53	1.42E-01
response to cycloheximide (GO:0046898)	6	2	.31	+	6.53	3.84E-02
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	3	1	.15	+	6.53	1.42E-01
regulation of protein localization to cell-cell junction (GO:0150106)	3	1	.15	+	6.53	1.42E-01
eye pigment metabolic process (GO:0042441)	3	1	.15	+	6.53	1.42E-01
regulation of phosphatidylcholine catabolic process (GO:0010899)	3	1	.15	+	6.53	1.42E-01
negative regulation of dopaminergic neuron differentiation (GO:1904339)	3	1	.15	+	6.53	1.42E-01
negative regulation of protein ADP-ribosylation (GO:0010836)	3	1	.15	+	6.53	1.42E-01
modulation by virus of host gene expression (GO:0039656)	3	1	.15	+	6.53	1.42E-01
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	3	1	.15	+	6.53	1.42E-01
polyprenol catabolic process (GO:0016095)	3	1	.15	+	6.53	1.42E-01
polyprenol biosynthetic process (GO:0016094)	3	1	.15	+	6.53	1.42E-01
piecemeal microautophagy of the nucleus (GO:0034727)	3	1	.15	+	6.53	1.42E-01
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	3	1	.15	+	6.53	1.42E-01
cardiac vascular smooth muscle cell development (GO:0060948)	3	1	.15	+	6.53	1.42E-01
cardiac vascular smooth muscle cell differentiation (GO:0060947)	6	2	.31	+	6.53	3.84E-02
negative regulation of alkaline phosphatase activity (GO:0010693)	3	1	.15	+	6.53	1.42E-01
positive regulation of Wnt protein secretion (GO:0061357)	3	1	.15	+	6.53	1.42E-01
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	1	.15	+	6.53	1.42E-01
signal transduction by trans-phosphorylation (GO:0023016)	3	1	.15	+	6.53	1.42E-01
mitochondrial respiratory chain complex II assembly (GO:0034553)	3	1	.15	+	6.53	1.42E-01
respiratory chain complex II assembly (GO:0034552)	3	1	.15	+	6.53	1.42E-01
positive regulation of B cell apoptotic process (GO:0002904)	3	1	.15	+	6.53	1.42E-01
cell proliferation involved in mesonephros development (GO:0061209)	3	1	.15	+	6.53	1.42E-01
regulation of single strand break repair (GO:1903516)	3	1	.15	+	6.53	1.42E-01
cellular response to sorbitol (GO:0072709)	3	1	.15	+	6.53	1.42E-01
U5 snRNA 3'-end processing (GO:0034476)	3	1	.15	+	6.53	1.42E-01
U1 snRNA 3'-end processing (GO:0034473)	3	1	.15	+	6.53	1.42E-01
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	3	1	.15	+	6.53	1.42E-01
regulation of epidermal cell division (GO:0010482)	3	1	.15	+	6.53	1.42E-01
actin modification (GO:0030047)	3	1	.15	+	6.53	1.42E-01
negative regulation of growth rate (GO:0045967)	3	1	.15	+	6.53	1.42E-01
box H/ACA snoRNA metabolic process (GO:0033979)	3	1	.15	+	6.53	1.42E-01
extracellular polysaccharide metabolic process (GO:0046379)	3	1	.15	+	6.53	1.42E-01
phosphatidylethanolamine catabolic process (GO:0046338)	3	1	.15	+	6.53	1.42E-01
regulation of muscle hyperplasia (GO:0014738)	3	1	.15	+	6.53	1.42E-01
pyramidal neuron migration (GO:0021852)	3	1	.15	+	6.53	1.42E-01
mitral valve formation (GO:0003192)	3	1	.15	+	6.53	1.42E-01
primary sex determination (GO:0007538)	3	1	.15	+	6.53	1.42E-01
atrioventricular node development (GO:0003162)	3	1	.15	+	6.53	1.42E-01
formaldehyde catabolic process (GO:0046294)	3	1	.15	+	6.53	1.42E-01
mesodermal cell fate determination (GO:0007500)	3	1	.15	+	6.53	1.42E-01
endodermal-mesodermal cell signaling involved in heart induction (GO:0003134)	3	1	.15	+	6.53	1.42E-01
endodermal-mesodermal cell signaling (GO:0003133)	3	1	.15	+	6.53	1.42E-01
BMP signaling pathway involved in heart induction (GO:0003130)	3	1	.15	+	6.53	1.42E-01
positive regulation of necroptotic process (GO:0060545)	3	1	.15	+	6.53	1.42E-01
heart induction (GO:0003129)	3	1	.15	+	6.53	1.42E-01
negative regulation of non-motile cilium assembly (GO:1902856)	3	1	.15	+	6.53	1.42E-01
biotin metabolic process (GO:0006768)	9	3	.46	+	6.53	1.15E-02
SREBP signaling pathway (GO:0032933)	9	3	.46	+	6.53	1.15E-02
lipid import into cell (GO:0140354)	9	3	.46	+	6.53	1.15E-02
long-chain fatty acid import into cell (GO:0044539)	9	3	.46	+	6.53	1.15E-02
negative regulation of circadian rhythm (GO:0042754)	15	5	.77	+	6.53	1.16E-03
negative regulation of viral release from host cell (GO:1902187)	16	5	.82	+	6.12	1.54E-03
response to follicle-stimulating hormone (GO:0032354)	16	5	.82	+	6.12	1.54E-03
regulation of autophagosome maturation (GO:1901096)	13	4	.66	+	6.02	4.77E-03
cellular response to sterol depletion (GO:0071501)	10	3	.51	+	5.87	1.52E-02
negative regulation of inclusion body assembly (GO:0090084)	10	3	.51	+	5.87	1.52E-02
poly(A)+ mRNA export from nucleus (GO:0016973)	20	6	1.02	+	5.87	6.55E-04
intestinal cholesterol absorption (GO:0030299)	10	3	.51	+	5.87	1.52E-02
regulation of cholesterol biosynthetic process (GO:0045540)	44	13	2.25	+	5.78	7.05E-07
regulation of sterol biosynthetic process (GO:0106118)	44	13	2.25	+	5.78	7.05E-07
protein refolding (GO:0042026)	17	5	.87	+	5.76	1.99E-03
photoperiodism (GO:0009648)	31	9	1.58	+	5.68	4.07E-05
regulation of pro-B cell differentiation (GO:2000973)	7	2	.36	+	5.59	5.05E-02
negative regulation of neuroblast proliferation (GO:0007406)	7	2	.36	+	5.59	5.05E-02
triglyceride-rich lipoprotein particle clearance (GO:0071830)	7	2	.36	+	5.59	5.05E-02
regulation of entry of bacterium into host cell (GO:2000535)	7	2	.36	+	5.59	5.05E-02
glutamate catabolic process (GO:0006538)	7	2	.36	+	5.59	5.05E-02
cellular response to oxygen-glucose deprivation (GO:0090650)	7	2	.36	+	5.59	5.05E-02
ribosome disassembly (GO:0032790)	7	2	.36	+	5.59	5.05E-02
dolichyl diphosphate biosynthetic process (GO:0006489)	7	2	.36	+	5.59	5.05E-02
modulation by symbiont of host defense response (GO:0052031)	7	2	.36	+	5.59	5.05E-02
regulation of metaphase plate congression (GO:0090235)	7	2	.36	+	5.59	5.05E-02
entrainment of circadian clock by photoperiod (GO:0043153)	28	8	1.43	+	5.59	1.20E-04
pantothenate metabolic process (GO:0015939)	7	2	.36	+	5.59	5.05E-02
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	7	2	.36	+	5.59	5.05E-02
positive regulation of receptor clustering (GO:1903911)	7	2	.36	+	5.59	5.05E-02
positive regulation of RNA export from nucleus (GO:0046833)	7	2	.36	+	5.59	5.05E-02
amyloid-beta clearance by cellular catabolic process (GO:0150094)	7	2	.36	+	5.59	5.05E-02
hyaluronan biosynthetic process (GO:0030213)	7	2	.36	+	5.59	5.05E-02
dolichyl diphosphate metabolic process (GO:0046465)	7	2	.36	+	5.59	5.05E-02
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)	7	2	.36	+	5.59	5.05E-02
chylomicron remnant clearance (GO:0034382)	7	2	.36	+	5.59	5.05E-02
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	18	5	.92	+	5.44	2.55E-03
response to sterol depletion (GO:0006991)	11	3	.56	+	5.34	1.95E-02
cyclooxygenase pathway (GO:0019371)	11	3	.56	+	5.34	1.95E-02
Leydig cell differentiation (GO:0033327)	11	3	.56	+	5.34	1.95E-02
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	11	3	.56	+	5.34	1.95E-02
positive regulation of chromosome segregation (GO:0051984)	11	3	.56	+	5.34	1.95E-02
tRNA 5'-leader removal (GO:0001682)	11	3	.56	+	5.34	1.95E-02
histone H3-K9 demethylation (GO:0033169)	11	3	.56	+	5.34	1.95E-02
negative regulation by symbiont of host programmed cell death (GO:0052041)	11	3	.56	+	5.34	1.95E-02
positive regulation of synaptic plasticity (GO:0031915)	11	3	.56	+	5.34	1.95E-02
postsynaptic actin cytoskeleton organization (GO:0098974)	11	3	.56	+	5.34	1.95E-02
methionine biosynthetic process (GO:0009086)	11	3	.56	+	5.34	1.95E-02
negative regulation of sprouting angiogenesis (GO:1903671)	11	3	.56	+	5.34	1.95E-02
epithelial cell differentiation involved in prostate gland development (GO:0060742)	11	3	.56	+	5.34	1.95E-02
prostate glandular acinus development (GO:0060525)	11	3	.56	+	5.34	1.95E-02
circadian regulation of gene expression (GO:0032922)	63	17	3.22	+	5.28	5.22E-08
methionine metabolic process (GO:0006555)	15	4	.77	+	5.22	7.81E-03
response to redox state (GO:0051775)	15	4	.77	+	5.22	7.81E-03
inositol phosphate dephosphorylation (GO:0046855)	15	4	.77	+	5.22	7.81E-03
cellular response to fluid shear stress (GO:0071498)	19	5	.97	+	5.15	3.20E-03
histone H3 deacetylation (GO:0070932)	19	5	.97	+	5.15	3.20E-03
prostaglandin biosynthetic process (GO:0001516)	19	5	.97	+	5.15	3.20E-03
prostanoid biosynthetic process (GO:0046457)	19	5	.97	+	5.15	3.20E-03
regulation of cholesterol metabolic process (GO:0090181)	59	15	3.01	+	4.98	6.53E-07
heat acclimation (GO:0010286)	4	1	.20	+	4.89	1.85E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	8	2	.41	+	4.89	6.38E-02
negative regulation of inner ear receptor cell differentiation (GO:2000981)	4	1	.20	+	4.89	1.85E-01
negative regulation of chondrocyte proliferation (GO:1902731)	4	1	.20	+	4.89	1.85E-01
osteoblast proliferation (GO:0033687)	4	1	.20	+	4.89	1.85E-01
negative regulation of mechanoreceptor differentiation (GO:0045632)	4	1	.20	+	4.89	1.85E-01
negative regulation of T-helper 2 cell differentiation (GO:0045629)	4	1	.20	+	4.89	1.85E-01
negative regulation of inner ear auditory receptor cell differentiation (GO:0045608)	4	1	.20	+	4.89	1.85E-01
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	4	1	.20	+	4.89	1.85E-01
plus-end-directed vesicle transport along microtubule (GO:0072383)	8	2	.41	+	4.89	6.38E-02
UDP-galactose transmembrane transport (GO:0072334)	4	1	.20	+	4.89	1.85E-01
positive regulation of transcription by glucose (GO:0046016)	4	1	.20	+	4.89	1.85E-01
podosome assembly (GO:0071800)	4	1	.20	+	4.89	1.85E-01
spermatid nucleus elongation (GO:0007290)	4	1	.20	+	4.89	1.85E-01
neuron-neuron synaptic transmission (GO:0007270)	8	2	.41	+	4.89	6.38E-02
negative regulation of receptor recycling (GO:0001920)	4	1	.20	+	4.89	1.85E-01
cellular detoxification of aldehyde (GO:0110095)	8	2	.41	+	4.89	6.38E-02
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	4	1	.20	+	4.89	1.85E-01
regulation of eosinophil activation (GO:1902566)	4	1	.20	+	4.89	1.85E-01
lens induction in camera-type eye (GO:0060235)	4	1	.20	+	4.89	1.85E-01
androgen catabolic process (GO:0006710)	4	1	.20	+	4.89	1.85E-01
inner ear receptor cell fate commitment (GO:0060120)	4	1	.20	+	4.89	1.85E-01
platelet activating factor biosynthetic process (GO:0006663)	4	1	.20	+	4.89	1.85E-01
positive regulation of meiotic cell cycle phase transition (GO:1901995)	4	1	.20	+	4.89	1.85E-01
response to psychosocial stress (GO:1990911)	4	1	.20	+	4.89	1.85E-01
negative regulation of endothelial cell chemotaxis (GO:2001027)	4	1	.20	+	4.89	1.85E-01
traversing start control point of mitotic cell cycle (GO:0007089)	4	1	.20	+	4.89	1.85E-01
formation of translation preinitiation complex (GO:0001731)	8	2	.41	+	4.89	6.38E-02
nucleolus organization (GO:0007000)	8	2	.41	+	4.89	6.38E-02
positive regulation by host of viral genome replication (GO:0044829)	8	2	.41	+	4.89	6.38E-02
rhythmic synaptic transmission (GO:0060024)	4	1	.20	+	4.89	1.85E-01
late nucleophagy (GO:0044805)	4	1	.20	+	4.89	1.85E-01
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	4	1	.20	+	4.89	1.85E-01
proline catabolic process (GO:0006562)	4	1	.20	+	4.89	1.85E-01
gamma-aminobutyric acid import (GO:0051939)	4	1	.20	+	4.89	1.85E-01
cellular response to nitrosative stress (GO:0071500)	4	1	.20	+	4.89	1.85E-01
RNA localization to nucleus (GO:0090685)	4	1	.20	+	4.89	1.85E-01
RNA localization to Cajal body (GO:0090670)	4	1	.20	+	4.89	1.85E-01
telomerase RNA stabilization (GO:0090669)	4	1	.20	+	4.89	1.85E-01
scaRNA localization to Cajal body (GO:0090666)	4	1	.20	+	4.89	1.85E-01
response to human chorionic gonadotropin (GO:0044752)	4	1	.20	+	4.89	1.85E-01
p38MAPK cascade (GO:0038066)	8	2	.41	+	4.89	6.38E-02
N-terminal protein myristoylation (GO:0006499)	4	1	.20	+	4.89	1.85E-01
cellular response to laminar fluid shear stress (GO:0071499)	8	2	.41	+	4.89	6.38E-02
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	4	1	.20	+	4.89	1.85E-01
negative regulation of histone ubiquitination (GO:0033183)	4	1	.20	+	4.89	1.85E-01
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	4	1	.20	+	4.89	1.85E-01
luteinization (GO:0001553)	8	2	.41	+	4.89	6.38E-02
protein myristoylation (GO:0018377)	4	1	.20	+	4.89	1.85E-01
type I interferon production (GO:0032606)	8	2	.41	+	4.89	6.38E-02
cellular response to parathyroid hormone stimulus (GO:0071374)	8	2	.41	+	4.89	6.38E-02
response to prolactin (GO:1990637)	4	1	.20	+	4.89	1.85E-01
regulation of mitotic spindle assembly (GO:1901673)	16	4	.82	+	4.89	9.71E-03
protein insertion into mitochondrial outer membrane (GO:0045040)	4	1	.20	+	4.89	1.85E-01
oxidative stress-induced premature senescence (GO:0090403)	4	1	.20	+	4.89	1.85E-01
negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	1	.20	+	4.89	1.85E-01
protein O-linked glycosylation via threonine (GO:0018243)	8	2	.41	+	4.89	6.38E-02
lagging strand elongation (GO:0006273)	4	1	.20	+	4.89	1.85E-01
leading strand elongation (GO:0006272)	4	1	.20	+	4.89	1.85E-01
DNA replication, synthesis of RNA primer (GO:0006269)	4	1	.20	+	4.89	1.85E-01
mitochondrial DNA replication (GO:0006264)	8	2	.41	+	4.89	6.38E-02
cellular response to lead ion (GO:0071284)	4	1	.20	+	4.89	1.85E-01
negative regulation of gonad development (GO:1905940)	4	1	.20	+	4.89	1.85E-01
protein targeting to vacuole involved in autophagy (GO:0071211)	4	1	.20	+	4.89	1.85E-01
synaptic vesicle endosomal processing (GO:0099532)	8	2	.41	+	4.89	6.38E-02
regulation of sodium-dependent phosphate transport (GO:2000118)	4	1	.20	+	4.89	1.85E-01
keratinocyte migration (GO:0051546)	4	1	.20	+	4.89	1.85E-01
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	8	2	.41	+	4.89	6.38E-02
negative regulation of cortisol biosynthetic process (GO:2000065)	4	1	.20	+	4.89	1.85E-01
negative regulation of aldosterone biosynthetic process (GO:0032348)	4	1	.20	+	4.89	1.85E-01
negative regulation of aldosterone metabolic process (GO:0032345)	4	1	.20	+	4.89	1.85E-01
polyadenylation-dependent mRNA catabolic process (GO:0071047)	4	1	.20	+	4.89	1.85E-01
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	4	1	.20	+	4.89	1.85E-01
fructose 6-phosphate metabolic process (GO:0006002)	12	3	.61	+	4.89	2.44E-02
telomeric 3' overhang formation (GO:0031860)	4	1	.20	+	4.89	1.85E-01
regulation of inhibitory synapse assembly (GO:1905702)	4	1	.20	+	4.89	1.85E-01
response to nitrosative stress (GO:0051409)	8	2	.41	+	4.89	6.38E-02
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	4	1	.20	+	4.89	1.85E-01
auditory receptor cell fate commitment (GO:0009912)	4	1	.20	+	4.89	1.85E-01
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	4	1	.20	+	4.89	1.85E-01
central nervous system myelin maintenance (GO:0032286)	4	1	.20	+	4.89	1.85E-01
luteinizing hormone secretion (GO:0032275)	4	1	.20	+	4.89	1.85E-01
gonadotropin secretion (GO:0032274)	4	1	.20	+	4.89	1.85E-01
IMP salvage (GO:0032264)	4	1	.20	+	4.89	1.85E-01
positive regulation of nucleobase-containing compound transport (GO:0032241)	8	2	.41	+	4.89	6.38E-02
activation of store-operated calcium channel activity (GO:0032237)	4	1	.20	+	4.89	1.85E-01
telomere assembly (GO:0032202)	4	1	.20	+	4.89	1.85E-01
intestinal lipid absorption (GO:0098856)	12	3	.61	+	4.89	2.44E-02
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	4	1	.20	+	4.89	1.85E-01
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	4	1	.20	+	4.89	1.85E-01
germline stem cell asymmetric division (GO:0098728)	4	1	.20	+	4.89	1.85E-01
glucose import across plasma membrane (GO:0098708)	4	1	.20	+	4.89	1.85E-01
sequestering of calcium ion (GO:0051208)	4	1	.20	+	4.89	1.85E-01
cellular heat acclimation (GO:0070370)	4	1	.20	+	4.89	1.85E-01
negative regulation of translational initiation in response to stress (GO:0032057)	4	1	.20	+	4.89	1.85E-01
lens fiber cell apoptotic process (GO:1990086)	4	1	.20	+	4.89	1.85E-01
regulation of lymphoid progenitor cell differentiation (GO:1905456)	8	2	.41	+	4.89	6.38E-02
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	4	1	.20	+	4.89	1.85E-01
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	4	1	.20	+	4.89	1.85E-01
malate-aspartate shuttle (GO:0043490)	4	1	.20	+	4.89	1.85E-01
cloaca development (GO:0035844)	4	1	.20	+	4.89	1.85E-01
telomerase holoenzyme complex assembly (GO:1905323)	4	1	.20	+	4.89	1.85E-01
regulation of isotype switching to IgA isotypes (GO:0048296)	4	1	.20	+	4.89	1.85E-01
beta-catenin destruction complex assembly (GO:1904885)	4	1	.20	+	4.89	1.85E-01
T-helper 2 cell cytokine production (GO:0035745)	4	1	.20	+	4.89	1.85E-01
respiratory chain complex III assembly (GO:0017062)	8	2	.41	+	4.89	6.38E-02
putrescine biosynthetic process (GO:0009446)	4	1	.20	+	4.89	1.85E-01
positive regulation of protein localization to nucleolus (GO:1904751)	4	1	.20	+	4.89	1.85E-01
regulation of protein localization to nucleolus (GO:1904749)	8	2	.41	+	4.89	6.38E-02
male germ-line stem cell asymmetric division (GO:0048133)	4	1	.20	+	4.89	1.85E-01
vitamin B6 metabolic process (GO:0042816)	4	1	.20	+	4.89	1.85E-01
regulation of protein K48-linked ubiquitination (GO:0061945)	4	1	.20	+	4.89	1.85E-01
eye pigmentation (GO:0048069)	4	1	.20	+	4.89	1.85E-01
ribosomal small subunit export from nucleus (GO:0000056)	8	2	.41	+	4.89	6.38E-02
mitigation of host defenses by symbiont (GO:0030682)	4	1	.20	+	4.89	1.85E-01
membrane tubulation (GO:0097749)	4	1	.20	+	4.89	1.85E-01
adenine transport (GO:0015853)	4	1	.20	+	4.89	1.85E-01
extracellular matrix-cell signaling (GO:0035426)	4	1	.20	+	4.89	1.85E-01
positive regulation of hemoglobin biosynthetic process (GO:0046985)	4	1	.20	+	4.89	1.85E-01
cytosol to endoplasmic reticulum transport (GO:0046967)	4	1	.20	+	4.89	1.85E-01
peptidyl-lysine deacetylation (GO:0034983)	8	2	.41	+	4.89	6.38E-02
histone H3-K36 dimethylation (GO:0097676)	4	1	.20	+	4.89	1.85E-01
positive regulation of programmed necrotic cell death (GO:0062100)	4	1	.20	+	4.89	1.85E-01
regulation of t-circle formation (GO:1904429)	4	1	.20	+	4.89	1.85E-01
serine phosphorylation of STAT protein (GO:0042501)	4	1	.20	+	4.89	1.85E-01
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	16	4	.82	+	4.89	9.71E-03
chaperone-mediated autophagy (GO:0061684)	8	2	.41	+	4.89	6.38E-02
positive regulation of odontogenesis (GO:0042482)	4	1	.20	+	4.89	1.85E-01
negative regulation of telomere capping (GO:1904354)	8	2	.41	+	4.89	6.38E-02
regulation of Toll signaling pathway (GO:0008592)	4	1	.20	+	4.89	1.85E-01
necroptotic signaling pathway (GO:0097527)	8	2	.41	+	4.89	6.38E-02
calcium activated phosphatidylserine scrambling (GO:0061589)	4	1	.20	+	4.89	1.85E-01
positive regulation of neuron projection arborization (GO:0150012)	8	2	.41	+	4.89	6.38E-02
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	4	1	.20	+	4.89	1.85E-01
polyprenol metabolic process (GO:0016093)	8	2	.41	+	4.89	6.38E-02
tRNA catabolic process (GO:0016078)	8	2	.41	+	4.89	6.38E-02
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	4	1	.20	+	4.89	1.85E-01
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	1	.20	+	4.89	1.85E-01
post-embryonic hemopoiesis (GO:0035166)	4	1	.20	+	4.89	1.85E-01
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	4	1	.20	+	4.89	1.85E-01
lipid tube assembly (GO:0060988)	4	1	.20	+	4.89	1.85E-01
coronary artery morphogenesis (GO:0060982)	8	2	.41	+	4.89	6.38E-02
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	4	1	.20	+	4.89	1.85E-01
response to luteinizing hormone (GO:0034699)	4	1	.20	+	4.89	1.85E-01
protein to membrane docking (GO:0022615)	4	1	.20	+	4.89	1.85E-01
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	4	1	.20	+	4.89	1.85E-01
regulation of Wnt protein secretion (GO:0061356)	4	1	.20	+	4.89	1.85E-01
mitochondrial respiratory chain complex III assembly (GO:0034551)	8	2	.41	+	4.89	6.38E-02
positive regulation of platelet activation (GO:0010572)	4	1	.20	+	4.89	1.85E-01
response to Thyroglobulin triiodothyronine (GO:1904016)	4	1	.20	+	4.89	1.85E-01
positive regulation of extracellular exosome assembly (GO:1903553)	4	1	.20	+	4.89	1.85E-01
apical constriction (GO:0003383)	4	1	.20	+	4.89	1.85E-01
cellular response to camptothecin (GO:0072757)	4	1	.20	+	4.89	1.85E-01
positive regulation of extracellular matrix constituent secretion (GO:0003331)	4	1	.20	+	4.89	1.85E-01
response to sorbitol (GO:0072708)	4	1	.20	+	4.89	1.85E-01
germ-line stem cell division (GO:0042078)	4	1	.20	+	4.89	1.85E-01
glycoprotein transport (GO:0034436)	4	1	.20	+	4.89	1.85E-01
cholesterol esterification (GO:0034435)	4	1	.20	+	4.89	1.85E-01
sterol esterification (GO:0034434)	4	1	.20	+	4.89	1.85E-01
steroid esterification (GO:0034433)	4	1	.20	+	4.89	1.85E-01
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	4	1	.20	+	4.89	1.85E-01
regulation of mitotic cell cycle DNA replication (GO:1903463)	4	1	.20	+	4.89	1.85E-01
radial glia guided migration of Purkinje cell (GO:0021942)	4	1	.20	+	4.89	1.85E-01
cell migration involved in endocardial cushion formation (GO:0003273)	4	1	.20	+	4.89	1.85E-01
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003257)	4	1	.20	+	4.89	1.85E-01
UDP-glucuronate metabolic process (GO:0046398)	4	1	.20	+	4.89	1.85E-01
growth involved in heart morphogenesis (GO:0003241)	4	1	.20	+	4.89	1.85E-01
cardiac right ventricle formation (GO:0003219)	4	1	.20	+	4.89	1.85E-01
regulation of chromosome condensation (GO:0060623)	4	1	.20	+	4.89	1.85E-01
very-low-density lipoprotein particle assembly (GO:0034379)	12	3	.61	+	4.89	2.44E-02
response to thyroxine (GO:0097068)	4	1	.20	+	4.89	1.85E-01
iris morphogenesis (GO:0061072)	8	2	.41	+	4.89	6.38E-02
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	4	1	.20	+	4.89	1.85E-01
negative regulation of bicellular tight junction assembly (GO:1903347)	4	1	.20	+	4.89	1.85E-01
positive regulation of protein folding (GO:1903334)	4	1	.20	+	4.89	1.85E-01
prostatic bud formation (GO:0060513)	4	1	.20	+	4.89	1.85E-01
entrainment of circadian clock (GO:0009649)	33	8	1.69	+	4.75	3.59E-04
early endosome to late endosome transport (GO:0045022)	21	5	1.07	+	4.66	4.86E-03
inositol phosphate catabolic process (GO:0071545)	17	4	.87	+	4.61	1.19E-02
retrograde protein transport, ER to cytosol (GO:0030970)	17	4	.87	+	4.61	1.19E-02
phosphorylated carbohydrate dephosphorylation (GO:0046838)	17	4	.87	+	4.61	1.19E-02
endoplasmic reticulum to cytosol transport (GO:1903513)	17	4	.87	+	4.61	1.19E-02
tetrahydrobiopterin metabolic process (GO:0046146)	13	3	.66	+	4.52	2.98E-02
cellular response to epinephrine stimulus (GO:0071872)	13	3	.66	+	4.52	2.98E-02
regulation of apoptotic process involved in morphogenesis (GO:1902337)	13	3	.66	+	4.52	2.98E-02
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	13	3	.66	+	4.52	2.98E-02
hematopoietic stem cell proliferation (GO:0071425)	13	3	.66	+	4.52	2.98E-02
mitochondrial transcription (GO:0006390)	13	3	.66	+	4.52	2.98E-02
ossification involved in bone maturation (GO:0043931)	13	3	.66	+	4.52	2.98E-02
postsynaptic cytoskeleton organization (GO:0099188)	13	3	.66	+	4.52	2.98E-02
regulation of apoptotic process involved in development (GO:1904748)	13	3	.66	+	4.52	2.98E-02
viral RNA genome replication (GO:0039694)	13	3	.66	+	4.52	2.98E-02
P-body assembly (GO:0033962)	13	3	.66	+	4.52	2.98E-02
adherens junction assembly (GO:0034333)	13	3	.66	+	4.52	2.98E-02
circadian behavior (GO:0048512)	22	5	1.12	+	4.45	5.89E-03
regulation of germinal center formation (GO:0002634)	9	2	.46	+	4.35	7.82E-02
plus-end-directed organelle transport along microtubule (GO:0072386)	9	2	.46	+	4.35	7.82E-02
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	9	2	.46	+	4.35	7.82E-02
androgen biosynthetic process (GO:0006702)	9	2	.46	+	4.35	7.82E-02
positive regulation of stem cell population maintenance (GO:1902459)	9	2	.46	+	4.35	7.82E-02
TORC1 signaling (GO:0038202)	9	2	.46	+	4.35	7.82E-02
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	9	2	.46	+	4.35	7.82E-02
response to oxygen-glucose deprivation (GO:0090649)	9	2	.46	+	4.35	7.82E-02
cellular response to gonadotropin stimulus (GO:0071371)	18	4	.92	+	4.35	1.44E-02
protein localization to nuclear envelope (GO:0090435)	9	2	.46	+	4.35	7.82E-02
endoplasmic reticulum localization (GO:0051643)	9	2	.46	+	4.35	7.82E-02
trans-synaptic signaling by trans-synaptic complex (GO:0099545)	9	2	.46	+	4.35	7.82E-02
lipid droplet formation (GO:0140042)	9	2	.46	+	4.35	7.82E-02
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	9	2	.46	+	4.35	7.82E-02
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)	9	2	.46	+	4.35	7.82E-02
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	9	2	.46	+	4.35	7.82E-02
intracellular distribution of mitochondria (GO:0048312)	9	2	.46	+	4.35	7.82E-02
negative regulation of amyloid-beta clearance (GO:1900222)	9	2	.46	+	4.35	7.82E-02
surfactant homeostasis (GO:0043129)	9	2	.46	+	4.35	7.82E-02
positive regulation of isomerase activity (GO:0010912)	9	2	.46	+	4.35	7.82E-02
regulation of isomerase activity (GO:0010911)	9	2	.46	+	4.35	7.82E-02
regulation of phosphatidylcholine metabolic process (GO:0150172)	9	2	.46	+	4.35	7.82E-02
negative regulation of cholesterol storage (GO:0010887)	9	2	.46	+	4.35	7.82E-02
regulation of B cell apoptotic process (GO:0002902)	18	4	.92	+	4.35	1.44E-02
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	9	2	.46	+	4.35	7.82E-02
regulation of ribonuclease activity (GO:0060700)	9	2	.46	+	4.35	7.82E-02
olfactory behavior (GO:0042048)	9	2	.46	+	4.35	7.82E-02
positive regulation of cell maturation (GO:1903431)	9	2	.46	+	4.35	7.82E-02
T-helper 17 cell differentiation (GO:0072539)	9	2	.46	+	4.35	7.82E-02
regulation of non-motile cilium assembly (GO:1902855)	9	2	.46	+	4.35	7.82E-02
vesicle-mediated transport between endosomal compartments (GO:0098927)	23	5	1.17	+	4.26	7.06E-03
rhythmic behavior (GO:0007622)	23	5	1.17	+	4.26	7.06E-03
ribosome localization (GO:0033750)	14	3	.72	+	4.20	3.59E-02
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	14	3	.72	+	4.20	3.59E-02
epithelial cell-cell adhesion (GO:0090136)	14	3	.72	+	4.20	3.59E-02
lipid digestion (GO:0044241)	14	3	.72	+	4.20	3.59E-02
tRNA 5'-end processing (GO:0099116)	14	3	.72	+	4.20	3.59E-02
sulfur amino acid biosynthetic process (GO:0000097)	14	3	.72	+	4.20	3.59E-02
ribosomal subunit export from nucleus (GO:0000054)	14	3	.72	+	4.20	3.59E-02
nuclear body organization (GO:0030575)	14	3	.72	+	4.20	3.59E-02
negative regulation of keratinocyte proliferation (GO:0010839)	14	3	.72	+	4.20	3.59E-02
S-adenosylmethionine metabolic process (GO:0046500)	14	3	.72	+	4.20	3.59E-02
negative regulation of cellular senescence (GO:2000773)	19	4	.97	+	4.12	1.72E-02
negative regulation of telomere maintenance via telomerase (GO:0032211)	19	4	.97	+	4.12	1.72E-02
positive regulation of histone deacetylation (GO:0031065)	19	4	.97	+	4.12	1.72E-02
negative regulation of cell aging (GO:0090344)	24	5	1.23	+	4.08	8.38E-03
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	24	5	1.23	+	4.08	8.38E-03
ER-nucleus signaling pathway (GO:0006984)	39	8	1.99	+	4.02	1.05E-03
regulation of steroid biosynthetic process (GO:0050810)	88	18	4.49	+	4.00	1.15E-06
negative regulation of cell volume (GO:0045794)	5	1	.26	+	3.92	2.25E-01
renal water transport (GO:0003097)	5	1	.26	+	3.92	2.25E-01
response to DNA damage checkpoint signaling (GO:0072423)	5	1	.26	+	3.92	2.25E-01
response to DNA integrity checkpoint signaling (GO:0072402)	5	1	.26	+	3.92	2.25E-01
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	10	2	.51	+	3.92	9.34E-02
negative regulation by symbiont of host apoptotic process (GO:0033668)	10	2	.51	+	3.92	9.34E-02
compartment pattern specification (GO:0007386)	5	1	.26	+	3.92	2.25E-01
response to cell cycle checkpoint signaling (GO:0072396)	5	1	.26	+	3.92	2.25E-01
cardiac muscle cell myoblast differentiation (GO:0060379)	10	2	.51	+	3.92	9.34E-02
negative regulation of cell adhesion molecule production (GO:0060354)	5	1	.26	+	3.92	2.25E-01
intracellular sequestering of iron ion (GO:0006880)	5	1	.26	+	3.92	2.25E-01
regulation of transcription by glucose (GO:0046015)	5	1	.26	+	3.92	2.25E-01
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	5	1	.26	+	3.92	2.25E-01
regulation of apoptotic process in bone marrow cell (GO:0071865)	5	1	.26	+	3.92	2.25E-01
interkinetic nuclear migration (GO:0022027)	5	1	.26	+	3.92	2.25E-01
negative regulation of cholesterol biosynthetic process (GO:0045541)	5	1	.26	+	3.92	2.25E-01
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	5	1	.26	+	3.92	2.25E-01
regulation of water loss via skin (GO:0033561)	25	5	1.28	+	3.92	9.87E-03
Notch receptor processing (GO:0007220)	10	2	.51	+	3.92	9.34E-02
cellular response to aldehyde (GO:0110096)	10	2	.51	+	3.92	9.34E-02
regulation of basement membrane organization (GO:0110011)	5	1	.26	+	3.92	2.25E-01
locomotor rhythm (GO:0045475)	10	2	.51	+	3.92	9.34E-02
immature B cell differentiation (GO:0002327)	10	2	.51	+	3.92	9.34E-02
selenium compound metabolic process (GO:0001887)	5	1	.26	+	3.92	2.25E-01
glomerular mesangial cell development (GO:0072144)	5	1	.26	+	3.92	2.25E-01
regulation of protein autoubiquitination (GO:1902498)	5	1	.26	+	3.92	2.25E-01
cellular response to indole-3-methanol (GO:0071681)	5	1	.26	+	3.92	2.25E-01
response to indole-3-methanol (GO:0071680)	5	1	.26	+	3.92	2.25E-01
monoacylglycerol biosynthetic process (GO:0006640)	5	1	.26	+	3.92	2.25E-01
positive regulation of cellular pH reduction (GO:0032849)	5	1	.26	+	3.92	2.25E-01
soft palate development (GO:0060023)	5	1	.26	+	3.92	2.25E-01
polyamine catabolic process (GO:0006598)	5	1	.26	+	3.92	2.25E-01
positive regulation of natural killer cell chemotaxis (GO:2000503)	5	1	.26	+	3.92	2.25E-01
lymphocyte aggregation (GO:0071593)	5	1	.26	+	3.92	2.25E-01
nuclear cell cycle DNA replication initiation (GO:1902315)	5	1	.26	+	3.92	2.25E-01
glutamate biosynthetic process (GO:0006537)	5	1	.26	+	3.92	2.25E-01
asparagine metabolic process (GO:0006528)	5	1	.26	+	3.92	2.25E-01
regulation of hepatic stellate cell activation (GO:2000489)	5	1	.26	+	3.92	2.25E-01
cell cycle DNA replication initiation (GO:1902292)	5	1	.26	+	3.92	2.25E-01
regulation of mast cell cytokine production (GO:0032763)	5	1	.26	+	3.92	2.25E-01
N-terminal protein lipidation (GO:0006498)	5	1	.26	+	3.92	2.25E-01
regulation of T cell extravasation (GO:2000407)	5	1	.26	+	3.92	2.25E-01
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	5	1	.26	+	3.92	2.25E-01
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	5	1	.26	+	3.92	2.25E-01
cellular response to UV-C (GO:0071494)	5	1	.26	+	3.92	2.25E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	5	1	.26	+	3.92	2.25E-01
inhibition of neuroepithelial cell differentiation (GO:0002085)	5	1	.26	+	3.92	2.25E-01
positive regulation of neuron maturation (GO:0014042)	5	1	.26	+	3.92	2.25E-01
regulation of timing of anagen (GO:0051884)	5	1	.26	+	3.92	2.25E-01
disaccharide metabolic process (GO:0005984)	10	2	.51	+	3.92	9.34E-02
immunoglobulin V(D)J recombination (GO:0033152)	5	1	.26	+	3.92	2.25E-01
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	5	1	.26	+	3.92	2.25E-01
CRD-mediated mRNA stabilization (GO:0070934)	5	1	.26	+	3.92	2.25E-01
regulation of mesoderm development (GO:2000380)	5	1	.26	+	3.92	2.25E-01
peptidyl-glutamine methylation (GO:0018364)	5	1	.26	+	3.92	2.25E-01
response to host defenses (GO:0052200)	10	2	.51	+	3.92	9.34E-02
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	10	2	.51	+	3.92	9.34E-02
hexose import across plasma membrane (GO:0140271)	5	1	.26	+	3.92	2.25E-01
response to defenses of other organism (GO:0052173)	10	2	.51	+	3.92	9.34E-02
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	5	1	.26	+	3.92	2.25E-01
regulation of NADP metabolic process (GO:1902031)	5	1	.26	+	3.92	2.25E-01
response to camptothecin (GO:1901563)	5	1	.26	+	3.92	2.25E-01
exocyst localization (GO:0051601)	5	1	.26	+	3.92	2.25E-01
chemical homeostasis within a tissue (GO:0048875)	10	2	.51	+	3.92	9.34E-02
positive regulation of hair follicle maturation (GO:0048818)	5	1	.26	+	3.92	2.25E-01
regulation of ubiquitin-specific protease activity (GO:2000152)	5	1	.26	+	3.92	2.25E-01
IMP biosynthetic process (GO:0006188)	10	2	.51	+	3.92	9.34E-02
citrate metabolic process (GO:0006101)	5	1	.26	+	3.92	2.25E-01
response to parathyroid hormone (GO:0071107)	10	2	.51	+	3.92	9.34E-02
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	5	1	.26	+	3.92	2.25E-01
negative regulation of glucocorticoid metabolic process (GO:0031944)	5	1	.26	+	3.92	2.25E-01
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	10	2	.51	+	3.92	9.34E-02
positive regulation of fibroblast growth factor production (GO:0090271)	5	1	.26	+	3.92	2.25E-01
negative regulation of cholesterol metabolic process (GO:0090206)	5	1	.26	+	3.92	2.25E-01
negative regulation of sterol biosynthetic process (GO:0106119)	5	1	.26	+	3.92	2.25E-01
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	5	1	.26	+	3.92	2.25E-01
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	5	1	.26	+	3.92	2.25E-01
response to cortisol (GO:0051414)	5	1	.26	+	3.92	2.25E-01
positive regulation of store-operated calcium channel activity (GO:1901341)	5	1	.26	+	3.92	2.25E-01
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	10	2	.51	+	3.92	9.34E-02
myoblast fate commitment (GO:0048625)	5	1	.26	+	3.92	2.25E-01
polysaccharide digestion (GO:0044245)	5	1	.26	+	3.92	2.25E-01
positive regulation of artery morphogenesis (GO:1905653)	5	1	.26	+	3.92	2.25E-01
regulation of artery morphogenesis (GO:1905651)	5	1	.26	+	3.92	2.25E-01
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	5	1	.26	+	3.92	2.25E-01
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	10	2	.51	+	3.92	9.34E-02
negative regulation of ribosome biogenesis (GO:0090071)	5	1	.26	+	3.92	2.25E-01
regulation of ribosome biogenesis (GO:0090069)	5	1	.26	+	3.92	2.25E-01
positive regulation of microtubule nucleation (GO:0090063)	5	1	.26	+	3.92	2.25E-01
negative regulation of steroid hormone biosynthetic process (GO:0090032)	5	1	.26	+	3.92	2.25E-01
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	5	1	.26	+	3.92	2.25E-01
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	10	2	.51	+	3.92	9.34E-02
asymmetric stem cell division (GO:0098722)	10	2	.51	+	3.92	9.34E-02
heat generation (GO:0031649)	5	1	.26	+	3.92	2.25E-01
carbohydrate import across plasma membrane (GO:0098704)	5	1	.26	+	3.92	2.25E-01
activated T cell proliferation (GO:0050798)	5	1	.26	+	3.92	2.25E-01
negative regulation of fat cell proliferation (GO:0070345)	5	1	.26	+	3.92	2.25E-01
bleb assembly (GO:0032060)	10	2	.51	+	3.92	9.34E-02
response to host (GO:0075136)	10	2	.51	+	3.92	9.34E-02
skin morphogenesis (GO:0043589)	10	2	.51	+	3.92	9.34E-02
mitophagy (GO:0000423)	5	1	.26	+	3.92	2.25E-01
regulation of NK T cell differentiation (GO:0051136)	5	1	.26	+	3.92	2.25E-01
chaperone-mediated protein complex assembly (GO:0051131)	20	4	1.02	+	3.92	2.03E-02
synaptic growth at neuromuscular junction (GO:0051124)	5	1	.26	+	3.92	2.25E-01
positive regulation of DNA ligation (GO:0051106)	5	1	.26	+	3.92	2.25E-01
regulation of DNA ligation (GO:0051105)	5	1	.26	+	3.92	2.25E-01
N-acylethanolamine metabolic process (GO:0070291)	5	1	.26	+	3.92	2.25E-01
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	5	1	.26	+	3.92	2.25E-01
regulation of endosome size (GO:0051036)	5	1	.26	+	3.92	2.25E-01
rRNA transport (GO:0051029)	5	1	.26	+	3.92	2.25E-01
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	5	1	.26	+	3.92	2.25E-01
barbed-end actin filament capping (GO:0051016)	20	4	1.02	+	3.92	2.03E-02
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	5	1	.26	+	3.92	2.25E-01
negative regulation of defense response to bacterium (GO:1900425)	5	1	.26	+	3.92	2.25E-01
negative regulation of mitochondrial membrane permeability (GO:0035795)	5	1	.26	+	3.92	2.25E-01
cellular response to L-glutamate (GO:1905232)	5	1	.26	+	3.92	2.25E-01
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	5	1	.26	+	3.92	2.25E-01
histone H3-K9 trimethylation (GO:0036124)	5	1	.26	+	3.92	2.25E-01
rDNA heterochromatin assembly (GO:0000183)	10	2	.51	+	3.92	9.34E-02
rRNA transcription (GO:0009303)	20	4	1.02	+	3.92	2.03E-02
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	5	1	.26	+	3.92	2.25E-01
protein O-linked fucosylation (GO:0036066)	5	1	.26	+	3.92	2.25E-01
negative regulation of cardiac muscle contraction (GO:0055118)	5	1	.26	+	3.92	2.25E-01
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	5	1	.26	+	3.92	2.25E-01
10-formyltetrahydrofolate metabolic process (GO:0009256)	5	1	.26	+	3.92	2.25E-01
regulation of oocyte maturation (GO:1900193)	5	1	.26	+	3.92	2.25E-01
female meiosis chromosome segregation (GO:0016321)	5	1	.26	+	3.92	2.25E-01
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	5	1	.26	+	3.92	2.25E-01
positive regulation of vascular wound healing (GO:0035470)	5	1	.26	+	3.92	2.25E-01
regulation of hemoglobin biosynthetic process (GO:0046984)	5	1	.26	+	3.92	2.25E-01
negative regulation of SMAD protein complex assembly (GO:0010991)	5	1	.26	+	3.92	2.25E-01
cellular magnesium ion homeostasis (GO:0010961)	5	1	.26	+	3.92	2.25E-01
positive regulation of histone exchange (GO:1900051)	10	2	.51	+	3.92	9.34E-02
regulation of histone exchange (GO:1900049)	10	2	.51	+	3.92	9.34E-02
positive regulation of necrotic cell death (GO:0010940)	10	2	.51	+	3.92	9.34E-02
cellular response to sodium arsenite (GO:1903936)	5	1	.26	+	3.92	2.25E-01
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	5	1	.26	+	3.92	2.25E-01
response to L-phenylalanine derivative (GO:1904386)	5	1	.26	+	3.92	2.25E-01
positive regulation of protein catabolic process in the vacuole (GO:1904352)	5	1	.26	+	3.92	2.25E-01
calcium activated galactosylceramide scrambling (GO:0061591)	5	1	.26	+	3.92	2.25E-01
calcium activated phosphatidylcholine scrambling (GO:0061590)	5	1	.26	+	3.92	2.25E-01
calcium activated phospholipid scrambling (GO:0061588)	5	1	.26	+	3.92	2.25E-01
carbon dioxide transport (GO:0015670)	5	1	.26	+	3.92	2.25E-01
regulation of vesicle size (GO:0097494)	10	2	.51	+	3.92	9.34E-02
histone H4-K20 trimethylation (GO:0034773)	5	1	.26	+	3.92	2.25E-01
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	5	1	.26	+	3.92	2.25E-01
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	5	1	.26	+	3.92	2.25E-01
regulation of potassium ion export across plasma membrane (GO:1903764)	5	1	.26	+	3.92	2.25E-01
negative regulation of pyruvate dehydrogenase activity (GO:1904183)	5	1	.26	+	3.92	2.25E-01
establishment of Sertoli cell barrier (GO:0097368)	5	1	.26	+	3.92	2.25E-01
apoptotic chromosome condensation (GO:0030263)	5	1	.26	+	3.92	2.25E-01
negative regulation of Schwann cell proliferation (GO:0010626)	5	1	.26	+	3.92	2.25E-01
L-ascorbic acid metabolic process (GO:0019852)	10	2	.51	+	3.92	9.34E-02
regulation of chaperone-mediated protein folding (GO:1903644)	5	1	.26	+	3.92	2.25E-01
negative regulation of photoreceptor cell differentiation (GO:0046533)	5	1	.26	+	3.92	2.25E-01
tRNA dihydrouridine synthesis (GO:0002943)	5	1	.26	+	3.92	2.25E-01
cornified envelope assembly (GO:1903575)	5	1	.26	+	3.92	2.25E-01
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	5	1	.26	+	3.92	2.25E-01
positive regulation of mast cell chemotaxis (GO:0060754)	5	1	.26	+	3.92	2.25E-01
intestinal epithelial structure maintenance (GO:0060729)	5	1	.26	+	3.92	2.25E-01
type 2 immune response (GO:0042092)	10	2	.51	+	3.92	9.34E-02
response to denervation involved in regulation of muscle adaptation (GO:0014894)	10	2	.51	+	3.92	9.34E-02
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	10	2	.51	+	3.92	9.34E-02
response to muscle inactivity (GO:0014870)	10	2	.51	+	3.92	9.34E-02
carbon catabolite activation of transcription (GO:0045991)	5	1	.26	+	3.92	2.25E-01
carbon catabolite regulation of transcription (GO:0045990)	5	1	.26	+	3.92	2.25E-01
microspike assembly (GO:0030035)	5	1	.26	+	3.92	2.25E-01
regulation of T cell mediated immune response to tumor cell (GO:0002840)	5	1	.26	+	3.92	2.25E-01
mitotic DNA replication initiation (GO:1902975)	5	1	.26	+	3.92	2.25E-01
disaccharide biosynthetic process (GO:0046351)	5	1	.26	+	3.92	2.25E-01
anterior head development (GO:0097065)	5	1	.26	+	3.92	2.25E-01
negative regulation of isotype switching (GO:0045829)	5	1	.26	+	3.92	2.25E-01
positive regulation of dendritic spine morphogenesis (GO:0061003)	20	4	1.02	+	3.92	2.03E-02
tricuspid valve morphogenesis (GO:0003186)	5	1	.26	+	3.92	2.25E-01
mitral valve morphogenesis (GO:0003183)	10	2	.51	+	3.92	9.34E-02
T-helper 17 type immune response (GO:0072538)	10	2	.51	+	3.92	9.34E-02
positive regulation of non-motile cilium assembly (GO:1902857)	5	1	.26	+	3.92	2.25E-01
type I pneumocyte differentiation (GO:0060509)	5	1	.26	+	3.92	2.25E-01
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	15	3	.77	+	3.92	4.26E-02
RNA surveillance (GO:0071025)	15	3	.77	+	3.92	4.26E-02
alternative mRNA splicing, via spliceosome (GO:0000380)	15	3	.77	+	3.92	4.26E-02
negative regulation of myotube differentiation (GO:0010832)	15	3	.77	+	3.92	4.26E-02
asymmetric cell division (GO:0008356)	15	3	.77	+	3.92	4.26E-02
regulation of cell communication by electrical coupling (GO:0010649)	15	3	.77	+	3.92	4.26E-02
circadian rhythm (GO:0007623)	137	27	7.00	+	3.86	5.73E-09
regulation of alcohol biosynthetic process (GO:1902930)	72	14	3.68	+	3.81	2.98E-05
alcohol biosynthetic process (GO:0046165)	93	18	4.75	+	3.79	2.46E-06
myelination in peripheral nervous system (GO:0022011)	26	5	1.33	+	3.77	1.15E-02
peripheral nervous system axon ensheathment (GO:0032292)	26	5	1.33	+	3.77	1.15E-02
regulation of hair cycle (GO:0042634)	26	5	1.33	+	3.77	1.15E-02
cellular response to growth hormone stimulus (GO:0071378)	21	4	1.07	+	3.73	2.37E-02
response to epinephrine (GO:0071871)	16	3	.82	+	3.67	4.98E-02
bone maturation (GO:0070977)	16	3	.82	+	3.67	4.98E-02
cellular response to ATP (GO:0071318)	16	3	.82	+	3.67	4.98E-02
modulation by symbiont of host programmed cell death (GO:0052040)	16	3	.82	+	3.67	4.98E-02
intracellular cholesterol transport (GO:0032367)	16	3	.82	+	3.67	4.98E-02
negative regulation of telomere maintenance (GO:0032205)	32	6	1.63	+	3.67	6.61E-03
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	16	3	.82	+	3.67	4.98E-02
negative regulation of translational initiation (GO:0045947)	16	3	.82	+	3.67	4.98E-02
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894)	16	3	.82	+	3.67	4.98E-02
cholesterol metabolic process (GO:0008203)	118	22	6.03	+	3.65	3.62E-07
necrotic cell death (GO:0070265)	27	5	1.38	+	3.63	1.34E-02
response to gonadotropin (GO:0034698)	27	5	1.38	+	3.63	1.34E-02
steroid biosynthetic process (GO:0006694)	121	22	6.18	+	3.56	5.46E-07
cellular response to nitrogen starvation (GO:0006995)	11	2	.56	+	3.56	1.09E-01
regulation of glucocorticoid secretion (GO:2000849)	11	2	.56	+	3.56	1.09E-01
IMP metabolic process (GO:0046040)	11	2	.56	+	3.56	1.09E-01
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	11	2	.56	+	3.56	1.09E-01
negative regulation of extracellular matrix organization (GO:1903054)	11	2	.56	+	3.56	1.09E-01
lens morphogenesis in camera-type eye (GO:0002089)	22	4	1.12	+	3.56	2.74E-02
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	11	2	.56	+	3.56	1.09E-01
neural crest formation (GO:0014029)	11	2	.56	+	3.56	1.09E-01
response to ATP (GO:0033198)	33	6	1.69	+	3.56	7.62E-03
histone H4 deacetylation (GO:0070933)	11	2	.56	+	3.56	1.09E-01
depurination (GO:0045007)	11	2	.56	+	3.56	1.09E-01
axo-dendritic protein transport (GO:0099640)	11	2	.56	+	3.56	1.09E-01
negative regulation of translation, ncRNA-mediated (GO:0040033)	11	2	.56	+	3.56	1.09E-01
histone H3-K4 methylation (GO:0051568)	33	6	1.69	+	3.56	7.62E-03
regulation of skeletal muscle fiber development (GO:0048742)	11	2	.56	+	3.56	1.09E-01
positive regulation of astrocyte differentiation (GO:0048711)	11	2	.56	+	3.56	1.09E-01
N-acetylneuraminate metabolic process (GO:0006054)	11	2	.56	+	3.56	1.09E-01
regulation of spindle assembly (GO:0090169)	22	4	1.12	+	3.56	2.74E-02
leukocyte aggregation (GO:0070486)	11	2	.56	+	3.56	1.09E-01
cell death in response to oxidative stress (GO:0036473)	22	4	1.12	+	3.56	2.74E-02
modulation by symbiont of host cellular process (GO:0044068)	33	6	1.69	+	3.56	7.62E-03
cellular response to nitrogen levels (GO:0043562)	11	2	.56	+	3.56	1.09E-01
regulation of establishment of protein localization to chromosome (GO:0070202)	11	2	.56	+	3.56	1.09E-01
positive regulation of protein localization to Cajal body (GO:1904871)	11	2	.56	+	3.56	1.09E-01
regulation of protein localization to Cajal body (GO:1904869)	11	2	.56	+	3.56	1.09E-01
SNARE complex assembly (GO:0035493)	11	2	.56	+	3.56	1.09E-01
miRNA mediated inhibition of translation (GO:0035278)	11	2	.56	+	3.56	1.09E-01
dendrite extension (GO:0097484)	11	2	.56	+	3.56	1.09E-01
establishment of skin barrier (GO:0061436)	22	4	1.12	+	3.56	2.74E-02
bone trabecula morphogenesis (GO:0061430)	11	2	.56	+	3.56	1.09E-01
phosphatidylcholine catabolic process (GO:0034638)	11	2	.56	+	3.56	1.09E-01
inhibition of cysteine-type endopeptidase activity (GO:0097340)	11	2	.56	+	3.56	1.09E-01
Notch signaling involved in heart development (GO:0061314)	11	2	.56	+	3.56	1.09E-01
negative regulation of B cell apoptotic process (GO:0002903)	11	2	.56	+	3.56	1.09E-01
presynaptic membrane assembly (GO:0097105)	11	2	.56	+	3.56	1.09E-01
regulation of translation, ncRNA-mediated (GO:0045974)	11	2	.56	+	3.56	1.09E-01
telencephalon regionalization (GO:0021978)	11	2	.56	+	3.56	1.09E-01
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)	11	2	.56	+	3.56	1.09E-01
mitral valve development (GO:0003174)	11	2	.56	+	3.56	1.09E-01
regulation of steroid metabolic process (GO:0019218)	117	21	5.98	+	3.51	1.20E-06
isoprenoid biosynthetic process (GO:0008299)	28	5	1.43	+	3.50	1.54E-02
interleukin-7-mediated signaling pathway (GO:0038111)	17	3	.87	+	3.45	5.76E-02
cellular response to prostaglandin E stimulus (GO:0071380)	17	3	.87	+	3.45	5.76E-02
intracellular sterol transport (GO:0032366)	17	3	.87	+	3.45	5.76E-02
regulation of inclusion body assembly (GO:0090083)	17	3	.87	+	3.45	5.76E-02
mitochondrion distribution (GO:0048311)	17	3	.87	+	3.45	5.76E-02
lymph vessel morphogenesis (GO:0036303)	17	3	.87	+	3.45	5.76E-02
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	17	3	.87	+	3.45	5.76E-02
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	17	3	.87	+	3.45	5.76E-02
response to arsenic-containing substance (GO:0046685)	34	6	1.74	+	3.45	8.74E-03
regulation of sprouting angiogenesis (GO:1903670)	34	6	1.74	+	3.45	8.74E-03
sterol metabolic process (GO:0016125)	132	23	6.74	+	3.41	6.24E-07
cellular response to sterol (GO:0036315)	23	4	1.17	+	3.40	3.15E-02
axon regeneration (GO:0031103)	23	4	1.17	+	3.40	3.15E-02
carbohydrate phosphorylation (GO:0046835)	23	4	1.17	+	3.40	3.15E-02
secondary alcohol metabolic process (GO:1902652)	127	22	6.49	+	3.39	1.19E-06
Schwann cell development (GO:0014044)	29	5	1.48	+	3.38	1.76E-02
acetyl-CoA metabolic process (GO:0006084)	29	5	1.48	+	3.38	1.76E-02
cerebral cortex regionalization (GO:0021796)	6	1	.31	+	3.26	2.64E-01
branchiomotor neuron axon guidance (GO:0021785)	6	1	.31	+	3.26	2.64E-01
phospholipid efflux (GO:0033700)	12	2	.61	+	3.26	1.26E-01
positive regulation of behavioral fear response (GO:2000987)	6	1	.31	+	3.26	2.64E-01
positive regulation of cardiac muscle contraction (GO:0060452)	6	1	.31	+	3.26	2.64E-01
polyol catabolic process (GO:0046174)	24	4	1.23	+	3.26	3.59E-02
urea transmembrane transport (GO:0071918)	6	1	.31	+	3.26	2.64E-01
clathrin coat disassembly (GO:0072318)	6	1	.31	+	3.26	2.64E-01
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	6	1	.31	+	3.26	2.64E-01
cardioblast differentiation (GO:0010002)	12	2	.61	+	3.26	1.26E-01
lymphangiogenesis (GO:0001946)	12	2	.61	+	3.26	1.26E-01
positive regulation of protein deubiquitination (GO:1903003)	6	1	.31	+	3.26	2.64E-01
B cell lineage commitment (GO:0002326)	6	1	.31	+	3.26	2.64E-01
common-partner SMAD protein phosphorylation (GO:0007182)	6	1	.31	+	3.26	2.64E-01
mesangial cell development (GO:0072143)	6	1	.31	+	3.26	2.64E-01
mitotic centrosome separation (GO:0007100)	6	1	.31	+	3.26	2.64E-01
regulation of SREBP signaling pathway (GO:2000638)	6	1	.31	+	3.26	2.64E-01
maternal process involved in parturition (GO:0060137)	6	1	.31	+	3.26	2.64E-01
regulation of histone H4-K16 acetylation (GO:2000618)	6	1	.31	+	3.26	2.64E-01
sphingomyelin biosynthetic process (GO:0006686)	6	1	.31	+	3.26	2.64E-01
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	12	2	.61	+	3.26	1.26E-01
S-adenosylmethionine cycle (GO:0033353)	6	1	.31	+	3.26	2.64E-01
viral release from host cell (GO:0019076)	6	1	.31	+	3.26	2.64E-01
positive regulation of skeletal muscle cell differentiation (GO:2001016)	6	1	.31	+	3.26	2.64E-01
outer mitochondrial membrane organization (GO:0007008)	6	1	.31	+	3.26	2.64E-01
protein localization to bicellular tight junction (GO:1902396)	6	1	.31	+	3.26	2.64E-01
modulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052433)	12	2	.61	+	3.26	1.26E-01
glomerular mesangial cell differentiation (GO:0072008)	6	1	.31	+	3.26	2.64E-01
regulation of T cell costimulation (GO:2000523)	6	1	.31	+	3.26	2.64E-01
leucine catabolic process (GO:0006552)	6	1	.31	+	3.26	2.64E-01
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	6	1	.31	+	3.26	2.64E-01
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	6	1	.31	+	3.26	2.64E-01
negative regulation of CREB transcription factor activity (GO:0032792)	6	1	.31	+	3.26	2.64E-01
regulation of glycogen (starch) synthase activity (GO:2000465)	6	1	.31	+	3.26	2.64E-01
regulation of eosinophil migration (GO:2000416)	6	1	.31	+	3.26	2.64E-01
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	6	1	.31	+	3.26	2.64E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	6	1	.31	+	3.26	2.64E-01
regulation of L-glutamate import across plasma membrane (GO:0002036)	6	1	.31	+	3.26	2.64E-01
regulation of glycogen catabolic process (GO:0005981)	6	1	.31	+	3.26	2.64E-01
negative regulation of interferon-alpha production (GO:0032687)	6	1	.31	+	3.26	2.64E-01
modulation of programmed cell death in other organism involved in symbiotic interaction (GO:0052248)	12	2	.61	+	3.26	1.26E-01
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	6	1	.31	+	3.26	2.64E-01
mRNA splice site selection (GO:0006376)	24	4	1.23	+	3.26	3.59E-02
positive regulation of hair follicle development (GO:0051798)	12	2	.61	+	3.26	1.26E-01
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668)	6	1	.31	+	3.26	2.64E-01
dehydroascorbic acid transport (GO:0070837)	6	1	.31	+	3.26	2.64E-01
modulation by symbiont of host apoptotic process (GO:0052150)	12	2	.61	+	3.26	1.26E-01
protein-chromophore linkage (GO:0018298)	12	2	.61	+	3.26	1.26E-01
modulation of apoptotic process in other organism (GO:0044532)	12	2	.61	+	3.26	1.26E-01
modulation of programmed cell death in other organism (GO:0044531)	12	2	.61	+	3.26	1.26E-01
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	6	1	.31	+	3.26	2.64E-01
endosome to plasma membrane protein transport (GO:0099638)	6	1	.31	+	3.26	2.64E-01
protein exit from endoplasmic reticulum (GO:0032527)	24	4	1.23	+	3.26	3.59E-02
protein-DNA covalent cross-linking repair (GO:0106300)	6	1	.31	+	3.26	2.64E-01
negative regulation of amyloid fibril formation (GO:1905907)	6	1	.31	+	3.26	2.64E-01
positive regulation of protein deacetylation (GO:0090312)	24	4	1.23	+	3.26	3.59E-02
regulation of female gonad development (GO:2000194)	6	1	.31	+	3.26	2.64E-01
'de novo' IMP biosynthetic process (GO:0006189)	6	1	.31	+	3.26	2.64E-01
snRNA modification (GO:0040031)	6	1	.31	+	3.26	2.64E-01
negative regulation of multicellular organism growth (GO:0040015)	12	2	.61	+	3.26	1.26E-01
histone H4-K12 acetylation (GO:0043983)	6	1	.31	+	3.26	2.64E-01
negative regulation of histone H4 acetylation (GO:0090241)	6	1	.31	+	3.26	2.64E-01
positive regulation of histone H4 acetylation (GO:0090240)	6	1	.31	+	3.26	2.64E-01
regulation of histone H4 acetylation (GO:0090239)	12	2	.61	+	3.26	1.26E-01
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	6	1	.31	+	3.26	2.64E-01
regulation of glutamate receptor clustering (GO:0106104)	6	1	.31	+	3.26	2.64E-01
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	6	1	.31	+	3.26	2.64E-01
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	6	1	.31	+	3.26	2.64E-01
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	6	1	.31	+	3.26	2.64E-01
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	6	1	.31	+	3.26	2.64E-01
nuclear ncRNA surveillance (GO:0071029)	6	1	.31	+	3.26	2.64E-01
protection from non-homologous end joining at telomere (GO:0031848)	6	1	.31	+	3.26	2.64E-01
planar cell polarity pathway involved in neural tube closure (GO:0090179)	12	2	.61	+	3.26	1.26E-01
endoplasmic reticulum membrane organization (GO:0090158)	6	1	.31	+	3.26	2.64E-01
cholesterol import (GO:0070508)	6	1	.31	+	3.26	2.64E-01
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	6	1	.31	+	3.26	2.64E-01
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	6	1	.31	+	3.26	2.64E-01
positive regulation of miRNA mediated inhibition of translation (GO:1905618)	6	1	.31	+	3.26	2.64E-01
regulation of miRNA mediated inhibition of translation (GO:1905616)	6	1	.31	+	3.26	2.64E-01
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228)	6	1	.31	+	3.26	2.64E-01
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	6	1	.31	+	3.26	2.64E-01
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	12	2	.61	+	3.26	1.26E-01
primary amino compound metabolic process (GO:1901160)	12	2	.61	+	3.26	1.26E-01
synaptic vesicle recycling via endosome (GO:0036466)	6	1	.31	+	3.26	2.64E-01
lens fiber cell morphogenesis (GO:0070309)	6	1	.31	+	3.26	2.64E-01
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	6	1	.31	+	3.26	2.64E-01
calcium import into the mitochondrion (GO:0036444)	6	1	.31	+	3.26	2.64E-01
COPI-coated vesicle budding (GO:0035964)	6	1	.31	+	3.26	2.64E-01
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	6	1	.31	+	3.26	2.64E-01
ruffle organization (GO:0031529)	24	4	1.23	+	3.26	3.59E-02
exit from host cell (GO:0035891)	6	1	.31	+	3.26	2.64E-01
exit from host (GO:0035890)	6	1	.31	+	3.26	2.64E-01
amyloid precursor protein catabolic process (GO:0042987)	12	2	.61	+	3.26	1.26E-01
activation of Janus kinase activity (GO:0042976)	6	1	.31	+	3.26	2.64E-01
glucocorticoid receptor signaling pathway (GO:0042921)	6	1	.31	+	3.26	2.64E-01
alkanesulfonate transport (GO:0042918)	6	1	.31	+	3.26	2.64E-01
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	12	2	.61	+	3.26	1.26E-01
COPI coating of Golgi vesicle (GO:0048205)	6	1	.31	+	3.26	2.64E-01
Golgi transport vesicle coating (GO:0048200)	6	1	.31	+	3.26	2.64E-01
histone dephosphorylation (GO:0016576)	6	1	.31	+	3.26	2.64E-01
regulation of AMPA glutamate receptor clustering (GO:1904717)	6	1	.31	+	3.26	2.64E-01
5S class rRNA transcription by RNA polymerase III (GO:0042791)	6	1	.31	+	3.26	2.64E-01
cleavage furrow formation (GO:0036089)	6	1	.31	+	3.26	2.64E-01
hepatocyte growth factor receptor signaling pathway (GO:0048012)	12	2	.61	+	3.26	1.26E-01
cellular response to interleukin-3 (GO:0036016)	6	1	.31	+	3.26	2.64E-01
response to interleukin-3 (GO:0036015)	6	1	.31	+	3.26	2.64E-01
telomeric D-loop disassembly (GO:0061820)	6	1	.31	+	3.26	2.64E-01
asymmetric neuroblast division (GO:0055059)	6	1	.31	+	3.26	2.64E-01
histone-threonine phosphorylation (GO:0035405)	6	1	.31	+	3.26	2.64E-01
endothelin receptor signaling pathway (GO:0086100)	6	1	.31	+	3.26	2.64E-01
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	6	1	.31	+	3.26	2.64E-01
PML body organization (GO:0030578)	6	1	.31	+	3.26	2.64E-01
regulation of SMAD protein complex assembly (GO:0010990)	6	1	.31	+	3.26	2.64E-01
positive regulation of xenophagy (GO:1904417)	6	1	.31	+	3.26	2.64E-01
regulation of xenophagy (GO:1904415)	6	1	.31	+	3.26	2.64E-01
regulation of amino acid import across plasma membrane (GO:0010958)	12	2	.61	+	3.26	1.26E-01
regulation of protein K63-linked ubiquitination (GO:1900044)	12	2	.61	+	3.26	1.26E-01
negative regulation of microglial cell activation (GO:1903979)	6	1	.31	+	3.26	2.64E-01
sterol import (GO:0035376)	6	1	.31	+	3.26	2.64E-01
response to sodium arsenite (GO:1903935)	6	1	.31	+	3.26	2.64E-01
taurine transport (GO:0015734)	6	1	.31	+	3.26	2.64E-01
regulation of cardiac muscle cell membrane potential (GO:0086036)	6	1	.31	+	3.26	2.64E-01
sequestering of iron ion (GO:0097577)	6	1	.31	+	3.26	2.64E-01
negative regulation of centrosome duplication (GO:0010826)	12	2	.61	+	3.26	1.26E-01
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	6	1	.31	+	3.26	2.64E-01
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)	6	1	.31	+	3.26	2.64E-01
water-soluble vitamin biosynthetic process (GO:0042364)	6	1	.31	+	3.26	2.64E-01
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	6	1	.31	+	3.26	2.64E-01
regulation of amino acid transmembrane transport (GO:1903789)	12	2	.61	+	3.26	1.26E-01
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	6	1	.31	+	3.26	2.64E-01
RIG-I signaling pathway (GO:0039529)	6	1	.31	+	3.26	2.64E-01
endocardial cell differentiation (GO:0060956)	6	1	.31	+	3.26	2.64E-01
negative regulation of centrosome cycle (GO:0046606)	12	2	.61	+	3.26	1.26E-01
zymogen inhibition (GO:0097341)	12	2	.61	+	3.26	1.26E-01
growth hormone secretion (GO:0030252)	6	1	.31	+	3.26	2.64E-01
plasma membrane tubulation (GO:0097320)	12	2	.61	+	3.26	1.26E-01
regulation of mitochondrial fusion (GO:0010635)	12	2	.61	+	3.26	1.26E-01
regulation of Schwann cell proliferation (GO:0010624)	6	1	.31	+	3.26	2.64E-01
testosterone biosynthetic process (GO:0061370)	6	1	.31	+	3.26	2.64E-01
positive regulation of Rac protein signal transduction (GO:0035022)	6	1	.31	+	3.26	2.64E-01
arterial endothelial cell differentiation (GO:0060842)	6	1	.31	+	3.26	2.64E-01
miRNA catabolic process (GO:0010587)	6	1	.31	+	3.26	2.64E-01
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	12	2	.61	+	3.26	1.26E-01
spermine metabolic process (GO:0008215)	6	1	.31	+	3.26	2.64E-01
RNA secondary structure unwinding (GO:0010501)	6	1	.31	+	3.26	2.64E-01
regulation of extracellular exosome assembly (GO:1903551)	6	1	.31	+	3.26	2.64E-01
one-carbon compound transport (GO:0019755)	12	2	.61	+	3.26	1.26E-01
cardiac endothelial cell differentiation (GO:0003348)	6	1	.31	+	3.26	2.64E-01
mammary gland branching involved in pregnancy (GO:0060745)	6	1	.31	+	3.26	2.64E-01
chorio-allantoic fusion (GO:0060710)	6	1	.31	+	3.26	2.64E-01
transition between fast and slow fiber (GO:0014883)	6	1	.31	+	3.26	2.64E-01
regulation of somitogenesis (GO:0014807)	6	1	.31	+	3.26	2.64E-01
fungiform papilla development (GO:0061196)	6	1	.31	+	3.26	2.64E-01
negative regulation of vasoconstriction (GO:0045906)	6	1	.31	+	3.26	2.64E-01
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	6	1	.31	+	3.26	2.64E-01
cardiac chamber formation (GO:0003207)	12	2	.61	+	3.26	1.26E-01
presynaptic membrane organization (GO:0097090)	12	2	.61	+	3.26	1.26E-01
Toll signaling pathway (GO:0008063)	6	1	.31	+	3.26	2.64E-01
lymphocyte migration into lymphoid organs (GO:0097021)	6	1	.31	+	3.26	2.64E-01
regulation of branching involved in lung morphogenesis (GO:0061046)	6	1	.31	+	3.26	2.64E-01
positive regulation of fear response (GO:1903367)	6	1	.31	+	3.26	2.64E-01
negative regulation of protein folding (GO:1903333)	6	1	.31	+	3.26	2.64E-01
regulation of protein folding (GO:1903332)	12	2	.61	+	3.26	1.26E-01
tricuspid valve development (GO:0003175)	6	1	.31	+	3.26	2.64E-01
endocardium morphogenesis (GO:0003160)	6	1	.31	+	3.26	2.64E-01
adaptive thermogenesis (GO:1990845)	18	3	.92	+	3.26	6.60E-02
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	36	6	1.84	+	3.26	1.13E-02
cellular senescence (GO:0090398)	30	5	1.53	+	3.26	2.00E-02
TOR signaling (GO:0031929)	30	5	1.53	+	3.26	2.00E-02
cobalamin metabolic process (GO:0009235)	18	3	.92	+	3.26	6.60E-02
protein O-linked mannosylation (GO:0035269)	18	3	.92	+	3.26	6.60E-02
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	43	7	2.20	+	3.19	7.31E-03
response to growth hormone (GO:0060416)	31	5	1.58	+	3.16	2.27E-02
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	31	5	1.58	+	3.16	2.27E-02
regulation of viral release from host cell (GO:1902186)	31	5	1.58	+	3.16	2.27E-02
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	25	4	1.28	+	3.13	4.07E-02
regulation of telomere capping (GO:1904353)	25	4	1.28	+	3.13	4.07E-02
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	25	4	1.28	+	3.13	4.07E-02
growth hormone receptor signaling pathway (GO:0060396)	19	3	.97	+	3.09	7.48E-02
regulation of skeletal muscle cell differentiation (GO:2001014)	19	3	.97	+	3.09	7.48E-02
glutamine metabolic process (GO:0006541)	19	3	.97	+	3.09	7.48E-02
endoplasmic reticulum mannose trimming (GO:1904380)	19	3	.97	+	3.09	7.48E-02
protein localization to cell-cell junction (GO:0150105)	19	3	.97	+	3.09	7.48E-02
ncRNA 5'-end processing (GO:0034471)	19	3	.97	+	3.09	7.48E-02
regulation of telomere maintenance via telomerase (GO:0032210)	51	8	2.60	+	3.07	5.31E-03
positive regulation of telomerase activity (GO:0051973)	32	5	1.63	+	3.06	2.55E-02
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	32	5	1.63	+	3.06	2.55E-02
mitochondrial RNA metabolic process (GO:0000959)	39	6	1.99	+	3.01	1.61E-02
pteridine-containing compound metabolic process (GO:0042558)	39	6	1.99	+	3.01	1.61E-02
negative regulation of epidermis development (GO:0045683)	13	2	.66	+	3.01	1.43E-01
negative regulation of epidermal cell differentiation (GO:0045605)	13	2	.66	+	3.01	1.43E-01
tripartite regional subdivision (GO:0007351)	13	2	.66	+	3.01	1.43E-01
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	13	2	.66	+	3.01	1.43E-01
GMP metabolic process (GO:0046037)	13	2	.66	+	3.01	1.43E-01
negative regulation of glial cell proliferation (GO:0060253)	13	2	.66	+	3.01	1.43E-01
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	13	2	.66	+	3.01	1.43E-01
negative regulation of stem cell proliferation (GO:2000647)	13	2	.66	+	3.01	1.43E-01
viral genome replication (GO:0019079)	26	4	1.33	+	3.01	4.58E-02
auditory receptor cell stereocilium organization (GO:0060088)	13	2	.66	+	3.01	1.43E-01
glutamate metabolic process (GO:0006536)	26	4	1.33	+	3.01	4.58E-02
negative regulation of cilium assembly (GO:1902018)	13	2	.66	+	3.01	1.43E-01
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	26	4	1.33	+	3.01	4.58E-02
regulation of DNA damage checkpoint (GO:2000001)	13	2	.66	+	3.01	1.43E-01
acetyl-CoA biosynthetic process (GO:0006085)	13	2	.66	+	3.01	1.43E-01
telomere maintenance via recombination (GO:0000722)	13	2	.66	+	3.01	1.43E-01
nuclear mRNA surveillance (GO:0071028)	13	2	.66	+	3.01	1.43E-01
nuclear RNA surveillance (GO:0071027)	13	2	.66	+	3.01	1.43E-01
positive regulation of p38MAPK cascade (GO:1900745)	26	4	1.33	+	3.01	4.58E-02
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	13	2	.66	+	3.01	1.43E-01
PERK-mediated unfolded protein response (GO:0036499)	13	2	.66	+	3.01	1.43E-01
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	13	2	.66	+	3.01	1.43E-01
regulation of protein localization to chromosome, telomeric region (GO:1904814)	13	2	.66	+	3.01	1.43E-01
chromatin-mediated maintenance of transcription (GO:0048096)	13	2	.66	+	3.01	1.43E-01
maternal behavior (GO:0042711)	13	2	.66	+	3.01	1.43E-01
anterior/posterior axis specification, embryo (GO:0008595)	13	2	.66	+	3.01	1.43E-01
positive regulation of ERAD pathway (GO:1904294)	13	2	.66	+	3.01	1.43E-01
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	13	2	.66	+	3.01	1.43E-01
ncRNA catabolic process (GO:0034661)	26	4	1.33	+	3.01	4.58E-02
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	13	2	.66	+	3.01	1.43E-01
positive regulation of striated muscle cell apoptotic process (GO:0010663)	13	2	.66	+	3.01	1.43E-01
male sex determination (GO:0030238)	13	2	.66	+	3.01	1.43E-01
programmed necrotic cell death (GO:0097300)	26	4	1.33	+	3.01	4.58E-02
parental behavior (GO:0060746)	13	2	.66	+	3.01	1.43E-01
cardiac muscle hypertrophy in response to stress (GO:0014898)	13	2	.66	+	3.01	1.43E-01
cardiac muscle adaptation (GO:0014887)	13	2	.66	+	3.01	1.43E-01
response to inactivity (GO:0014854)	13	2	.66	+	3.01	1.43E-01
muscle hypertrophy in response to stress (GO:0003299)	13	2	.66	+	3.01	1.43E-01
amino sugar catabolic process (GO:0046348)	13	2	.66	+	3.01	1.43E-01
negative regulation of alcohol biosynthetic process (GO:1902931)	13	2	.66	+	3.01	1.43E-01
eyelid development in camera-type eye (GO:0061029)	13	2	.66	+	3.01	1.43E-01
peptidyl-proline hydroxylation (GO:0019511)	13	2	.66	+	3.01	1.43E-01
cellular response to alcohol (GO:0097306)	85	13	4.34	+	2.99	5.59E-04
negative regulation of striated muscle cell differentiation (GO:0051154)	33	5	1.69	+	2.97	2.86E-02
sulfur amino acid metabolic process (GO:0000096)	33	5	1.69	+	2.97	2.86E-02
ncRNA transcription (GO:0098781)	86	13	4.39	+	2.96	6.22E-04
negative regulation of systemic arterial blood pressure (GO:0003085)	20	3	1.02	+	2.94	8.42E-02
spermatid nucleus differentiation (GO:0007289)	20	3	1.02	+	2.94	8.42E-02
modulation by virus of host cellular process (GO:0019054)	20	3	1.02	+	2.94	8.42E-02
animal organ maturation (GO:0048799)	20	3	1.02	+	2.94	8.42E-02
regulation of translation in response to stress (GO:0043555)	20	3	1.02	+	2.94	8.42E-02
beta-catenin destruction complex disassembly (GO:1904886)	20	3	1.02	+	2.94	8.42E-02
pore complex assembly (GO:0046931)	20	3	1.02	+	2.94	8.42E-02
aspartate family amino acid biosynthetic process (GO:0009067)	20	3	1.02	+	2.94	8.42E-02
negative regulation of lipid storage (GO:0010888)	20	3	1.02	+	2.94	8.42E-02
positive regulation of cholesterol efflux (GO:0010875)	20	3	1.02	+	2.94	8.42E-02
histone deacetylation (GO:0016575)	47	7	2.40	+	2.92	1.15E-02
modulation by symbiont of host process (GO:0044003)	54	8	2.76	+	2.90	7.36E-03
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	54	8	2.76	+	2.90	7.36E-03
epithelial cell apoptotic process (GO:1904019)	27	4	1.38	+	2.90	5.12E-02
positive regulation of translational initiation (GO:0045948)	27	4	1.38	+	2.90	5.12E-02
regulation of circadian rhythm (GO:0042752)	115	17	5.87	+	2.89	1.27E-04
negative regulation of chromosome organization (GO:2001251)	68	10	3.47	+	2.88	3.07E-03
response to fluid shear stress (GO:0034405)	34	5	1.74	+	2.88	3.18E-02
organic hydroxy compound biosynthetic process (GO:1901617)	166	24	8.48	+	2.83	8.30E-06
positive regulation of potassium ion import across plasma membrane (GO:1903288)	7	1	.36	+	2.80	3.01E-01
negative regulation of gluconeogenesis (GO:0045721)	14	2	.72	+	2.80	1.61E-01
negative regulation of glycogen biosynthetic process (GO:0045719)	7	1	.36	+	2.80	3.01E-01
lung lobe morphogenesis (GO:0060463)	7	1	.36	+	2.80	3.01E-01
lung lobe development (GO:0060462)	7	1	.36	+	2.80	3.01E-01
nuclear pore organization (GO:0006999)	14	2	.72	+	2.80	1.61E-01
positive regulation of cell cycle G2/M phase transition (GO:1902751)	28	4	1.43	+	2.80	5.70E-02
positive regulation of keratinocyte differentiation (GO:0045618)	14	2	.72	+	2.80	1.61E-01
negative regulation of keratinocyte differentiation (GO:0045617)	7	1	.36	+	2.80	3.01E-01
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	14	2	.72	+	2.80	1.61E-01
tricarboxylic acid metabolic process (GO:0072350)	14	2	.72	+	2.80	1.61E-01
vesicle uncoating (GO:0072319)	7	1	.36	+	2.80	3.01E-01
germinal center formation (GO:0002467)	7	1	.36	+	2.80	3.01E-01
receptor signaling pathway via JAK-STAT (GO:0007259)	35	5	1.79	+	2.80	3.54E-02
cytoplasmic sequestering of NF-kappaB (GO:0007253)	7	1	.36	+	2.80	3.01E-01
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	7	1	.36	+	2.80	3.01E-01
negative regulation of T cell mediated cytotoxicity (GO:0001915)	7	1	.36	+	2.80	3.01E-01
negative regulation of cardiac muscle cell differentiation (GO:2000726)	7	1	.36	+	2.80	3.01E-01
tetrahydrobiopterin biosynthetic process (GO:0006729)	7	1	.36	+	2.80	3.01E-01
response to ether (GO:0045472)	14	2	.72	+	2.80	1.61E-01
female meiosis I (GO:0007144)	7	1	.36	+	2.80	3.01E-01
male mating behavior (GO:0060179)	7	1	.36	+	2.80	3.01E-01
collagen biosynthetic process (GO:0032964)	7	1	.36	+	2.80	3.01E-01
prostaglandin metabolic process (GO:0006693)	35	5	1.79	+	2.80	3.54E-02
prostanoid metabolic process (GO:0006692)	35	5	1.79	+	2.80	3.54E-02
TORC2 signaling (GO:0038203)	7	1	.36	+	2.80	3.01E-01
CDP-choline pathway (GO:0006657)	7	1	.36	+	2.80	3.01E-01
regulation of meiotic cell cycle phase transition (GO:1901993)	7	1	.36	+	2.80	3.01E-01
embryonic retina morphogenesis in camera-type eye (GO:0060059)	7	1	.36	+	2.80	3.01E-01
positive regulation of protein glycosylation (GO:0060050)	7	1	.36	+	2.80	3.01E-01
oncostatin-M-mediated signaling pathway (GO:0038165)	7	1	.36	+	2.80	3.01E-01
mesangial cell differentiation (GO:0072007)	7	1	.36	+	2.80	3.01E-01
regulation of cellular pH reduction (GO:0032847)	7	1	.36	+	2.80	3.01E-01
regulation of natural killer cell chemotaxis (GO:2000501)	7	1	.36	+	2.80	3.01E-01
L-serine biosynthetic process (GO:0006564)	7	1	.36	+	2.80	3.01E-01
death-inducing signaling complex assembly (GO:0071550)	7	1	.36	+	2.80	3.01E-01
T-tubule organization (GO:0033292)	7	1	.36	+	2.80	3.01E-01
regulation of high voltage-gated calcium channel activity (GO:1901841)	14	2	.72	+	2.80	1.61E-01
auditory receptor cell morphogenesis (GO:0002093)	14	2	.72	+	2.80	1.61E-01
Schwann cell differentiation (GO:0014037)	35	5	1.79	+	2.80	3.54E-02
clustering of voltage-gated sodium channels (GO:0045162)	7	1	.36	+	2.80	3.01E-01
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	28	4	1.43	+	2.80	5.70E-02
negative regulation of interferon-beta production (GO:0032688)	14	2	.72	+	2.80	1.61E-01
cellular response to prostaglandin stimulus (GO:0071379)	21	3	1.07	+	2.80	9.40E-02
negative regulation of glycogen metabolic process (GO:0070874)	7	1	.36	+	2.80	3.01E-01
regulation of mitochondrial mRNA stability (GO:0044528)	7	1	.36	+	2.80	3.01E-01
cellular response to salt (GO:1902075)	7	1	.36	+	2.80	3.01E-01
positive regulation of anoikis (GO:2000210)	7	1	.36	+	2.80	3.01E-01
protein O-linked glycosylation via serine (GO:0018242)	7	1	.36	+	2.80	3.01E-01
RNA 5'-end processing (GO:0000966)	21	3	1.07	+	2.80	9.40E-02
cellular response to antibiotic (GO:0071236)	14	2	.72	+	2.80	1.61E-01
positive regulation of gonad development (GO:1905941)	7	1	.36	+	2.80	3.01E-01
negative regulation of mitophagy (GO:1901525)	7	1	.36	+	2.80	3.01E-01
positive regulation of axon extension involved in axon guidance (GO:0048842)	7	1	.36	+	2.80	3.01E-01
locomotion involved in locomotory behavior (GO:0031987)	7	1	.36	+	2.80	3.01E-01
corticosteroid receptor signaling pathway (GO:0031958)	7	1	.36	+	2.80	3.01E-01
negative regulation of calcium ion import (GO:0090281)	7	1	.36	+	2.80	3.01E-01
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	7	1	.36	+	2.80	3.01E-01
positive regulation of spindle checkpoint (GO:0090232)	7	1	.36	+	2.80	3.01E-01
regulation of cortisol biosynthetic process (GO:2000064)	7	1	.36	+	2.80	3.01E-01
macropinocytosis (GO:0044351)	7	1	.36	+	2.80	3.01E-01
oxygen homeostasis (GO:0032364)	7	1	.36	+	2.80	3.01E-01
positive regulation of male gonad development (GO:2000020)	7	1	.36	+	2.80	3.01E-01
regulation of aldosterone biosynthetic process (GO:0032347)	7	1	.36	+	2.80	3.01E-01
regulation of aldosterone metabolic process (GO:0032344)	7	1	.36	+	2.80	3.01E-01
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	7	1	.36	+	2.80	3.01E-01
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	7	1	.36	+	2.80	3.01E-01
resolution of meiotic recombination intermediates (GO:0000712)	14	2	.72	+	2.80	1.61E-01
retrograde trans-synaptic signaling (GO:0098917)	7	1	.36	+	2.80	3.01E-01
negative regulation of membrane permeability (GO:1905709)	7	1	.36	+	2.80	3.01E-01
regulation of store-operated calcium channel activity (GO:1901339)	7	1	.36	+	2.80	3.01E-01
detection of calcium ion (GO:0005513)	14	2	.72	+	2.80	1.61E-01
diapedesis (GO:0050904)	7	1	.36	+	2.80	3.01E-01
purine nucleotide salvage (GO:0032261)	7	1	.36	+	2.80	3.01E-01
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	7	1	.36	+	2.80	3.01E-01
foam cell differentiation (GO:0090077)	7	1	.36	+	2.80	3.01E-01
rRNA base methylation (GO:0070475)	7	1	.36	+	2.80	3.01E-01
regulation of extracellular matrix assembly (GO:1901201)	14	2	.72	+	2.80	1.61E-01
white fat cell differentiation (GO:0050872)	14	2	.72	+	2.80	1.61E-01
protein desumoylation (GO:0016926)	7	1	.36	+	2.80	3.01E-01
positive regulation of sequestering of calcium ion (GO:0051284)	14	2	.72	+	2.80	1.61E-01
cellular response to interleukin-7 (GO:0098761)	28	4	1.43	+	2.80	5.70E-02
response to interleukin-7 (GO:0098760)	28	4	1.43	+	2.80	5.70E-02
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	7	1	.36	+	2.80	3.01E-01
negative regulation of myelination (GO:0031642)	7	1	.36	+	2.80	3.01E-01
positive regulation of fever generation (GO:0031622)	7	1	.36	+	2.80	3.01E-01
negative regulation of cytokine secretion (GO:0050710)	14	2	.72	+	2.80	1.61E-01
negative regulation of nuclease activity (GO:0032074)	7	1	.36	+	2.80	3.01E-01
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	7	1	.36	+	2.80	3.01E-01
response to herbicide (GO:0009635)	7	1	.36	+	2.80	3.01E-01
vascular associated smooth muscle cell differentiation (GO:0035886)	14	2	.72	+	2.80	1.61E-01
regulation of skeletal muscle tissue regeneration (GO:0043416)	7	1	.36	+	2.80	3.01E-01
regulation of isotype switching to IgE isotypes (GO:0048293)	7	1	.36	+	2.80	3.01E-01
D-amino acid transport (GO:0042940)	7	1	.36	+	2.80	3.01E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	21	3	1.07	+	2.80	9.40E-02
positive regulation of prostaglandin biosynthetic process (GO:0031394)	7	1	.36	+	2.80	3.01E-01
positive regulation of core promoter binding (GO:1904798)	7	1	.36	+	2.80	3.01E-01
positive regulation of protein localization to centrosome (GO:1904781)	7	1	.36	+	2.80	3.01E-01
protein autoprocessing (GO:0016540)	21	3	1.07	+	2.80	9.40E-02
tRNA transcription by RNA polymerase III (GO:0042797)	7	1	.36	+	2.80	3.01E-01
snRNA transcription by RNA polymerase III (GO:0042796)	7	1	.36	+	2.80	3.01E-01
positive regulation of ubiquitin protein ligase activity (GO:1904668)	14	2	.72	+	2.80	1.61E-01
sulfur amino acid catabolic process (GO:0000098)	14	2	.72	+	2.80	1.61E-01
calcineurin-mediated signaling (GO:0097720)	14	2	.72	+	2.80	1.61E-01
post-embryonic camera-type eye development (GO:0031077)	7	1	.36	+	2.80	3.01E-01
urea transport (GO:0015840)	7	1	.36	+	2.80	3.01E-01
L-serine transport (GO:0015825)	7	1	.36	+	2.80	3.01E-01
exocrine pancreas development (GO:0031017)	7	1	.36	+	2.80	3.01E-01
histone H3-K4 monomethylation (GO:0097692)	7	1	.36	+	2.80	3.01E-01
regulation of microtubule nucleation (GO:0010968)	7	1	.36	+	2.80	3.01E-01
regulation of phosphate transport (GO:0010966)	7	1	.36	+	2.80	3.01E-01
negative regulation of protein K63-linked ubiquitination (GO:1900045)	7	1	.36	+	2.80	3.01E-01
androgen receptor signaling pathway (GO:0030521)	21	3	1.07	+	2.80	9.40E-02
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	14	2	.72	+	2.80	1.61E-01
negative regulation of anion transmembrane transport (GO:1903960)	14	2	.72	+	2.80	1.61E-01
glycerol transport (GO:0015793)	7	1	.36	+	2.80	3.01E-01
regulation of receptor clustering (GO:1903909)	14	2	.72	+	2.80	1.61E-01
Notch receptor processing, ligand-dependent (GO:0035333)	7	1	.36	+	2.80	3.01E-01
regulation of RNA export from nucleus (GO:0046831)	14	2	.72	+	2.80	1.61E-01
production of siRNA involved in RNA interference (GO:0030422)	7	1	.36	+	2.80	3.01E-01
terpenoid biosynthetic process (GO:0016114)	14	2	.72	+	2.80	1.61E-01
arginine transmembrane transport (GO:1903826)	7	1	.36	+	2.80	3.01E-01
peptidyl-arginine omega-N-methylation (GO:0035247)	7	1	.36	+	2.80	3.01E-01
amyloid-beta clearance by transcytosis (GO:0150093)	7	1	.36	+	2.80	3.01E-01
histone H4-K20 methylation (GO:0034770)	7	1	.36	+	2.80	3.01E-01
regulation of neuron projection arborization (GO:0150011)	14	2	.72	+	2.80	1.61E-01
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	14	2	.72	+	2.80	1.61E-01
macrophage derived foam cell differentiation (GO:0010742)	7	1	.36	+	2.80	3.01E-01
negative regulation of centriole replication (GO:0046600)	7	1	.36	+	2.80	3.01E-01
BMP signaling pathway involved in heart development (GO:0061312)	7	1	.36	+	2.80	3.01E-01
lymphatic endothelial cell differentiation (GO:0060836)	7	1	.36	+	2.80	3.01E-01
regulation of photoreceptor cell differentiation (GO:0046532)	7	1	.36	+	2.80	3.01E-01
response to gonadotropin-releasing hormone (GO:0097210)	7	1	.36	+	2.80	3.01E-01
regulation of mast cell chemotaxis (GO:0060753)	7	1	.36	+	2.80	3.01E-01
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	7	1	.36	+	2.80	3.01E-01
chorion development (GO:0060717)	7	1	.36	+	2.80	3.01E-01
negative regulation of smooth muscle contraction (GO:0045986)	14	2	.72	+	2.80	1.61E-01
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	7	1	.36	+	2.80	3.01E-01
pulmonary artery morphogenesis (GO:0061156)	7	1	.36	+	2.80	3.01E-01
neuroendocrine cell differentiation (GO:0061101)	7	1	.36	+	2.80	3.01E-01
L-arginine transmembrane transport (GO:1903400)	7	1	.36	+	2.80	3.01E-01
regulation of phospholipid catabolic process (GO:0060696)	7	1	.36	+	2.80	3.01E-01
positive regulation of tau-protein kinase activity (GO:1902949)	7	1	.36	+	2.80	3.01E-01
adherens junction maintenance (GO:0034334)	7	1	.36	+	2.80	3.01E-01
negative regulation of autophagosome assembly (GO:1902902)	14	2	.72	+	2.80	1.61E-01
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	7	1	.36	+	2.80	3.01E-01
protein localization to basolateral plasma membrane (GO:1903361)	7	1	.36	+	2.80	3.01E-01
forebrain regionalization (GO:0021871)	21	3	1.07	+	2.80	9.40E-02
negative regulation of dendritic spine morphogenesis (GO:0061002)	7	1	.36	+	2.80	3.01E-01
sex determination (GO:0007530)	21	3	1.07	+	2.80	9.40E-02
T-helper 17 cell lineage commitment (GO:0072540)	7	1	.36	+	2.80	3.01E-01
morphogenesis of an epithelial bud (GO:0060572)	7	1	.36	+	2.80	3.01E-01
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	7	1	.36	+	2.80	3.01E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	57	8	2.91	+	2.75	9.96E-03
regulation of telomere maintenance via telomere lengthening (GO:1904356)	57	8	2.91	+	2.75	9.96E-03
protein deacetylation (GO:0006476)	50	7	2.55	+	2.74	1.56E-02
regulation of synaptic vesicle exocytosis (GO:2000300)	50	7	2.55	+	2.74	1.56E-02
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	43	6	2.20	+	2.73	2.46E-02
maintenance of protein localization in organelle (GO:0072595)	43	6	2.20	+	2.73	2.46E-02
activation of JUN kinase activity (GO:0007257)	36	5	1.84	+	2.72	3.91E-02
receptor signaling pathway via STAT (GO:0097696)	36	5	1.84	+	2.72	3.91E-02
snRNA transcription (GO:0009301)	65	9	3.32	+	2.71	7.05E-03
protein demethylation (GO:0006482)	29	4	1.48	+	2.70	6.31E-02
RNA-dependent DNA biosynthetic process (GO:0006278)	29	4	1.48	+	2.70	6.31E-02
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	29	4	1.48	+	2.70	6.31E-02
regulation of histone deacetylation (GO:0031063)	29	4	1.48	+	2.70	6.31E-02
chromatin remodeling at centromere (GO:0031055)	29	4	1.48	+	2.70	6.31E-02
phosphatidylinositol dephosphorylation (GO:0046856)	29	4	1.48	+	2.70	6.31E-02
protein dealkylation (GO:0008214)	29	4	1.48	+	2.70	6.31E-02
diol metabolic process (GO:0034311)	29	4	1.48	+	2.70	6.31E-02
regulation of translational initiation (GO:0006446)	73	10	3.73	+	2.68	5.00E-03
cyclic purine nucleotide metabolic process (GO:0052652)	22	3	1.12	+	2.67	1.04E-01
protein targeting to lysosome (GO:0006622)	22	3	1.12	+	2.67	1.04E-01
vacuolar acidification (GO:0007035)	22	3	1.12	+	2.67	1.04E-01
protein hydroxylation (GO:0018126)	22	3	1.12	+	2.67	1.04E-01
regulation of nuclease activity (GO:0032069)	22	3	1.12	+	2.67	1.04E-01
necroptotic process (GO:0070266)	22	3	1.12	+	2.67	1.04E-01
regulation of vascular associated smooth muscle cell migration (GO:1904752)	22	3	1.12	+	2.67	1.04E-01
defense response to protozoan (GO:0042832)	22	3	1.12	+	2.67	1.04E-01
somatic recombination of immunoglobulin gene segments (GO:0016447)	22	3	1.12	+	2.67	1.04E-01
cyclic nucleotide biosynthetic process (GO:0009190)	22	3	1.12	+	2.67	1.04E-01
negative regulation of steroid biosynthetic process (GO:0010894)	22	3	1.12	+	2.67	1.04E-01
amyloid-beta clearance (GO:0097242)	22	3	1.12	+	2.67	1.04E-01
negative regulation of muscle contraction (GO:0045932)	22	3	1.12	+	2.67	1.04E-01
rhythmic process (GO:0048511)	265	36	13.54	+	2.66	2.22E-07
myoblast differentiation (GO:0045445)	37	5	1.89	+	2.65	4.31E-02
negative regulation of DNA biosynthetic process (GO:2000279)	37	5	1.89	+	2.65	4.31E-02
steroid metabolic process (GO:0008202)	239	32	12.21	+	2.62	1.39E-06
negative regulation of fatty acid biosynthetic process (GO:0045717)	15	2	.77	+	2.61	1.79E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	30	4	1.53	+	2.61	6.96E-02
integrated stress response signaling (GO:0140467)	15	2	.77	+	2.61	1.79E-01
positive regulation by host of viral process (GO:0044794)	15	2	.77	+	2.61	1.79E-01
cellular response to lipoprotein particle stimulus (GO:0071402)	30	4	1.53	+	2.61	6.96E-02
protein palmitoylation (GO:0018345)	30	4	1.53	+	2.61	6.96E-02
positive regulation of brown fat cell differentiation (GO:0090336)	15	2	.77	+	2.61	1.79E-01
positive regulation of cholesterol transport (GO:0032376)	30	4	1.53	+	2.61	6.96E-02
positive regulation of sterol transport (GO:0032373)	30	4	1.53	+	2.61	6.96E-02
peptidyl-lysine dimethylation (GO:0018027)	15	2	.77	+	2.61	1.79E-01
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	15	2	.77	+	2.61	1.79E-01
cardiolipin metabolic process (GO:0032048)	15	2	.77	+	2.61	1.79E-01
regulation of retinoic acid receptor signaling pathway (GO:0048385)	15	2	.77	+	2.61	1.79E-01
pyroptosis (GO:0070269)	15	2	.77	+	2.61	1.79E-01
peptidyl-serine dephosphorylation (GO:0070262)	15	2	.77	+	2.61	1.79E-01
plasma membrane phospholipid scrambling (GO:0017121)	15	2	.77	+	2.61	1.79E-01
cytoplasmic sequestering of transcription factor (GO:0042994)	15	2	.77	+	2.61	1.79E-01
excitatory synapse assembly (GO:1904861)	15	2	.77	+	2.61	1.79E-01
cellular response to hepatocyte growth factor stimulus (GO:0035729)	15	2	.77	+	2.61	1.79E-01
toxin metabolic process (GO:0009404)	15	2	.77	+	2.61	1.79E-01
positive regulation of circadian rhythm (GO:0042753)	15	2	.77	+	2.61	1.79E-01
purine-containing compound salvage (GO:0043101)	15	2	.77	+	2.61	1.79E-01
neuron projection regeneration (GO:0031102)	30	4	1.53	+	2.61	6.96E-02
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	15	2	.77	+	2.61	1.79E-01
fatty-acyl-CoA biosynthetic process (GO:0046949)	30	4	1.53	+	2.61	6.96E-02
telomere capping (GO:0016233)	15	2	.77	+	2.61	1.79E-01
dosage compensation by inactivation of X chromosome (GO:0009048)	15	2	.77	+	2.61	1.79E-01
sleep (GO:0030431)	15	2	.77	+	2.61	1.79E-01
positive regulation of TORC1 signaling (GO:1904263)	15	2	.77	+	2.61	1.79E-01
vitamin D metabolic process (GO:0042359)	15	2	.77	+	2.61	1.79E-01
coronary vasculature morphogenesis (GO:0060977)	15	2	.77	+	2.61	1.79E-01
response to laminar fluid shear stress (GO:0034616)	15	2	.77	+	2.61	1.79E-01
venous blood vessel development (GO:0060841)	15	2	.77	+	2.61	1.79E-01
piRNA metabolic process (GO:0034587)	15	2	.77	+	2.61	1.79E-01
activation of cysteine-type endopeptidase activity (GO:0097202)	15	2	.77	+	2.61	1.79E-01
glucocorticoid metabolic process (GO:0008211)	15	2	.77	+	2.61	1.79E-01
positive regulation of exosomal secretion (GO:1903543)	15	2	.77	+	2.61	1.79E-01
regulation of exosomal secretion (GO:1903541)	15	2	.77	+	2.61	1.79E-01
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	15	2	.77	+	2.61	1.79E-01
mitochondrial fusion (GO:0008053)	15	2	.77	+	2.61	1.79E-01
dosage compensation (GO:0007549)	15	2	.77	+	2.61	1.79E-01
negative regulation of organelle assembly (GO:1902116)	38	5	1.94	+	2.58	4.73E-02
positive regulation of viral genome replication (GO:0045070)	38	5	1.94	+	2.58	4.73E-02
positive regulation of DNA-templated transcription, initiation (GO:2000144)	38	5	1.94	+	2.58	4.73E-02
regulation of p38MAPK cascade (GO:1900744)	38	5	1.94	+	2.58	4.73E-02
negative regulation of actin filament depolymerization (GO:0030835)	38	5	1.94	+	2.58	4.73E-02
embryo implantation (GO:0007566)	38	5	1.94	+	2.58	4.73E-02
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	122	16	6.23	+	2.57	7.14E-04
ribonucleoprotein complex export from nucleus (GO:0071426)	107	14	5.47	+	2.56	1.53E-03
cytokine production involved in immune response (GO:0002367)	23	3	1.17	+	2.55	1.15E-01
microtubule nucleation (GO:0007020)	23	3	1.17	+	2.55	1.15E-01
regulation of telomerase activity (GO:0051972)	46	6	2.35	+	2.55	3.25E-02
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	23	3	1.17	+	2.55	1.15E-01
regulation of cell aging (GO:0090342)	46	6	2.35	+	2.55	3.25E-02
negative regulation of neural precursor cell proliferation (GO:2000178)	23	3	1.17	+	2.55	1.15E-01
positive regulation of telomere maintenance (GO:0032206)	46	6	2.35	+	2.55	3.25E-02
protein alpha-1,2-demannosylation (GO:0036508)	23	3	1.17	+	2.55	1.15E-01
protein demannosylation (GO:0036507)	23	3	1.17	+	2.55	1.15E-01
negative regulation of cold-induced thermogenesis (GO:0120163)	46	6	2.35	+	2.55	3.25E-02
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	23	3	1.17	+	2.55	1.15E-01
protein mannosylation (GO:0035268)	23	3	1.17	+	2.55	1.15E-01
response to activity (GO:0014823)	69	9	3.52	+	2.55	1.01E-02
negative regulation of steroid metabolic process (GO:0045939)	23	3	1.17	+	2.55	1.15E-01
regulation of protein polyubiquitination (GO:1902914)	23	3	1.17	+	2.55	1.15E-01
atrioventricular valve morphogenesis (GO:0003181)	23	3	1.17	+	2.55	1.15E-01
neuroepithelial cell differentiation (GO:0060563)	46	6	2.35	+	2.55	3.25E-02
ribonucleoprotein complex localization (GO:0071166)	108	14	5.52	+	2.54	1.66E-03
phosphatidylinositol phosphorylation (GO:0046854)	54	7	2.76	+	2.54	2.25E-02
cellular response to heat (GO:0034605)	54	7	2.76	+	2.54	2.25E-02
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	85	11	4.34	+	2.53	5.04E-03
protein-lipid complex assembly (GO:0065005)	31	4	1.58	+	2.53	7.64E-02
intestinal absorption (GO:0050892)	31	4	1.58	+	2.53	7.64E-02
water-soluble vitamin metabolic process (GO:0006767)	78	10	3.98	+	2.51	7.77E-03
one-carbon metabolic process (GO:0006730)	39	5	1.99	+	2.51	5.17E-02
regulation of mitotic sister chromatid segregation (GO:0033047)	39	5	1.99	+	2.51	5.17E-02
peptidyl-threonine modification (GO:0018210)	78	10	3.98	+	2.51	7.77E-03
positive regulation of bone mineralization (GO:0030501)	39	5	1.99	+	2.51	5.17E-02
regulation of myotube differentiation (GO:0010830)	39	5	1.99	+	2.51	5.17E-02
negative regulation of lipid localization (GO:1905953)	47	6	2.40	+	2.50	3.55E-02
amyloid-beta formation (GO:0034205)	8	1	.41	+	2.45	3.35E-01
negative regulation of cell size (GO:0045792)	8	1	.41	+	2.45	3.35E-01
regulation of potassium ion import (GO:1903286)	8	1	.41	+	2.45	3.35E-01
DNA integration (GO:0015074)	8	1	.41	+	2.45	3.35E-01
positive regulation of AMPA receptor activity (GO:2000969)	8	1	.41	+	2.45	3.35E-01
aldehyde biosynthetic process (GO:0046184)	8	1	.41	+	2.45	3.35E-01
DNA damage induced protein phosphorylation (GO:0006975)	8	1	.41	+	2.45	3.35E-01
positive regulation of fat cell differentiation (GO:0045600)	64	8	3.27	+	2.45	1.86E-02
regulation of establishment of endothelial barrier (GO:1903140)	16	2	.82	+	2.45	1.97E-01
bone trabecula formation (GO:0060346)	8	1	.41	+	2.45	3.35E-01
purine nucleobase transport (GO:0006863)	8	1	.41	+	2.45	3.35E-01
positive regulation of cholesterol biosynthetic process (GO:0045542)	8	1	.41	+	2.45	3.35E-01
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	8	1	.41	+	2.45	3.35E-01
response to pheromone (GO:0019236)	8	1	.41	+	2.45	3.35E-01
tyrosine phosphorylation of STAT protein (GO:0007260)	8	1	.41	+	2.45	3.35E-01
metanephric nephron tubule morphogenesis (GO:0072282)	8	1	.41	+	2.45	3.35E-01
lymph vessel development (GO:0001945)	24	3	1.23	+	2.45	1.26E-01
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	64	8	3.27	+	2.45	1.86E-02
regulation of cellular senescence (GO:2000772)	40	5	2.04	+	2.45	5.64E-02
vitamin A metabolic process (GO:0006776)	8	1	.41	+	2.45	3.35E-01
positive regulation of receptor catabolic process (GO:2000646)	8	1	.41	+	2.45	3.35E-01
glomerular mesangium development (GO:0072109)	8	1	.41	+	2.45	3.35E-01
positive regulation of cell cycle checkpoint (GO:1901978)	8	1	.41	+	2.45	3.35E-01
B cell apoptotic process (GO:0001783)	8	1	.41	+	2.45	3.35E-01
modulation by virus of host process (GO:0019048)	32	4	1.63	+	2.45	8.34E-02
mitotic sister chromatid cohesion (GO:0007064)	16	2	.82	+	2.45	1.97E-01
organ induction (GO:0001759)	16	2	.82	+	2.45	1.97E-01
microtubule depolymerization (GO:0007019)	16	2	.82	+	2.45	1.97E-01
leucine metabolic process (GO:0006551)	8	1	.41	+	2.45	3.35E-01
histidine metabolic process (GO:0006547)	8	1	.41	+	2.45	3.35E-01
telomeric loop disassembly (GO:0090657)	8	1	.41	+	2.45	3.35E-01
acrosome assembly (GO:0001675)	16	2	.82	+	2.45	1.97E-01
sequestering of BMP from receptor via BMP binding (GO:0038098)	8	1	.41	+	2.45	3.35E-01
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	8	1	.41	+	2.45	3.35E-01
regulation of translational fidelity (GO:0006450)	16	2	.82	+	2.45	1.97E-01
response to protozoan (GO:0001562)	24	3	1.23	+	2.45	1.26E-01
small RNA loading onto RISC (GO:0070922)	8	1	.41	+	2.45	3.35E-01
global genome nucleotide-excision repair (GO:0070911)	24	3	1.23	+	2.45	1.26E-01
negative regulation of interleukin-1 beta production (GO:0032691)	24	3	1.23	+	2.45	1.26E-01
interleukin-1 production (GO:0032612)	16	2	.82	+	2.45	1.97E-01
cellular response to ether (GO:0071362)	8	1	.41	+	2.45	3.35E-01
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	8	1	.41	+	2.45	3.35E-01
depyrimidination (GO:0045008)	8	1	.41	+	2.45	3.35E-01
stress-induced premature senescence (GO:0090400)	8	1	.41	+	2.45	3.35E-01
positive regulation of fibroblast apoptotic process (GO:2000271)	8	1	.41	+	2.45	3.35E-01
regulation of long-chain fatty acid import into cell (GO:0140212)	8	1	.41	+	2.45	3.35E-01
anterograde axonal protein transport (GO:0099641)	8	1	.41	+	2.45	3.35E-01
regulation of hematopoietic stem cell proliferation (GO:1902033)	8	1	.41	+	2.45	3.35E-01
L-arginine transport (GO:1902023)	8	1	.41	+	2.45	3.35E-01
regulation of endothelial cell development (GO:1901550)	16	2	.82	+	2.45	1.97E-01
regulation of amyloid fibril formation (GO:1905906)	8	1	.41	+	2.45	3.35E-01
leukemia inhibitory factor signaling pathway (GO:0048861)	8	1	.41	+	2.45	3.35E-01
mitotic spindle assembly (GO:0090307)	40	5	2.04	+	2.45	5.64E-02
regulation of growth rate (GO:0040009)	8	1	.41	+	2.45	3.35E-01
histone H3-K9 methylation (GO:0051567)	16	2	.82	+	2.45	1.97E-01
malate metabolic process (GO:0006108)	8	1	.41	+	2.45	3.35E-01
oxaloacetate metabolic process (GO:0006107)	8	1	.41	+	2.45	3.35E-01
regulation of glucocorticoid biosynthetic process (GO:0031946)	8	1	.41	+	2.45	3.35E-01
regulation of fibroblast growth factor production (GO:0090270)	8	1	.41	+	2.45	3.35E-01
cell-cell adhesion mediated by cadherin (GO:0044331)	8	1	.41	+	2.45	3.35E-01
regulation of male gonad development (GO:2000018)	8	1	.41	+	2.45	3.35E-01
positive regulation of protein localization to cell surface (GO:2000010)	16	2	.82	+	2.45	1.97E-01
positive regulation of sterol biosynthetic process (GO:0106120)	8	1	.41	+	2.45	3.35E-01
cellular glucan metabolic process (GO:0006073)	48	6	2.45	+	2.45	3.86E-02
mannose metabolic process (GO:0006013)	8	1	.41	+	2.45	3.35E-01
maintenance of protein location in nucleus (GO:0051457)	24	3	1.23	+	2.45	1.26E-01
fucose metabolic process (GO:0006004)	16	2	.82	+	2.45	1.97E-01
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	8	1	.41	+	2.45	3.35E-01
dendrite self-avoidance (GO:0070593)	16	2	.82	+	2.45	1.97E-01
regulation of axon regeneration (GO:0048679)	24	3	1.23	+	2.45	1.26E-01
positive regulation of synapse maturation (GO:0090129)	8	1	.41	+	2.45	3.35E-01
platelet aggregation (GO:0070527)	40	5	2.04	+	2.45	5.64E-02
peripheral nervous system myelin maintenance (GO:0032287)	8	1	.41	+	2.45	3.35E-01
regulation of synaptic transmission, dopaminergic (GO:0032225)	8	1	.41	+	2.45	3.35E-01
positive regulation of ligase activity (GO:0051351)	8	1	.41	+	2.45	3.35E-01
centrosome separation (GO:0051299)	8	1	.41	+	2.45	3.35E-01
response to mitochondrial depolarisation (GO:0098780)	16	2	.82	+	2.45	1.97E-01
dicarboxylic acid catabolic process (GO:0043649)	16	2	.82	+	2.45	1.97E-01
polyadenylation-dependent RNA catabolic process (GO:0043633)	8	1	.41	+	2.45	3.35E-01
negative regulation of dendrite morphogenesis (GO:0050774)	8	1	.41	+	2.45	3.35E-01
glucan metabolic process (GO:0044042)	48	6	2.45	+	2.45	3.86E-02
positive regulation of nuclease activity (GO:0032075)	8	1	.41	+	2.45	3.35E-01
regulation of endodeoxyribonuclease activity (GO:0032071)	8	1	.41	+	2.45	3.35E-01
postsynaptic specialization assembly (GO:0098698)	8	1	.41	+	2.45	3.35E-01
cardiolipin acyl-chain remodeling (GO:0035965)	8	1	.41	+	2.45	3.35E-01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	56	7	2.86	+	2.45	2.67E-02
dorsal aorta morphogenesis (GO:0035912)	8	1	.41	+	2.45	3.35E-01
positive regulation of actin nucleation (GO:0051127)	16	2	.82	+	2.45	1.97E-01
positive regulation of JUN kinase activity (GO:0043507)	64	8	3.27	+	2.45	1.86E-02
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	8	1	.41	+	2.45	3.35E-01
negative regulation of thymocyte apoptotic process (GO:0070244)	8	1	.41	+	2.45	3.35E-01
protein poly-ADP-ribosylation (GO:0070212)	8	1	.41	+	2.45	3.35E-01
histone H2A-K119 monoubiquitination (GO:0036353)	8	1	.41	+	2.45	3.35E-01
protein localization to presynapse (GO:1905383)	8	1	.41	+	2.45	3.35E-01
protein localization to chromosome, telomeric region (GO:0070198)	16	2	.82	+	2.45	1.97E-01
vesicle fusion with Golgi apparatus (GO:0048280)	8	1	.41	+	2.45	3.35E-01
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	8	1	.41	+	2.45	3.35E-01
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	8	1	.41	+	2.45	3.35E-01
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	8	1	.41	+	2.45	3.35E-01
response to hepatocyte growth factor (GO:0035728)	16	2	.82	+	2.45	1.97E-01
putrescine metabolic process (GO:0009445)	8	1	.41	+	2.45	3.35E-01
cytochrome complex assembly (GO:0017004)	32	4	1.63	+	2.45	8.34E-02
nucleosome positioning (GO:0016584)	8	1	.41	+	2.45	3.35E-01
myelin maintenance (GO:0043217)	16	2	.82	+	2.45	1.97E-01
snRNA transcription by RNA polymerase II (GO:0042795)	64	8	3.27	+	2.45	1.86E-02
tRNA transcription (GO:0009304)	8	1	.41	+	2.45	3.35E-01
regulation of synaptic vesicle endocytosis (GO:1900242)	16	2	.82	+	2.45	1.97E-01
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	8	1	.41	+	2.45	3.35E-01
response to macrophage colony-stimulating factor (GO:0036005)	8	1	.41	+	2.45	3.35E-01
negative regulation of chromatin binding (GO:0035562)	8	1	.41	+	2.45	3.35E-01
stress fiber assembly (GO:0043149)	16	2	.82	+	2.45	1.97E-01
coenzyme A metabolic process (GO:0015936)	16	2	.82	+	2.45	1.97E-01
cellular chloride ion homeostasis (GO:0030644)	8	1	.41	+	2.45	3.35E-01
cellular phosphate ion homeostasis (GO:0030643)	8	1	.41	+	2.45	3.35E-01
nucleoside monophosphate phosphorylation (GO:0046940)	8	1	.41	+	2.45	3.35E-01
histone lysine methylation (GO:0034968)	64	8	3.27	+	2.45	1.86E-02
female genitalia development (GO:0030540)	16	2	.82	+	2.45	1.97E-01
gap junction assembly (GO:0016264)	8	1	.41	+	2.45	3.35E-01
positive regulation of phosphatase activity (GO:0010922)	32	4	1.63	+	2.45	8.34E-02
regulation of protein complex stability (GO:0061635)	8	1	.41	+	2.45	3.35E-01
pharyngeal arch artery morphogenesis (GO:0061626)	8	1	.41	+	2.45	3.35E-01
glutamine family amino acid biosynthetic process (GO:0009084)	16	2	.82	+	2.45	1.97E-01
glutamine family amino acid catabolic process (GO:0009065)	24	3	1.23	+	2.45	1.26E-01
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	8	1	.41	+	2.45	3.35E-01
positive regulation of telomere capping (GO:1904355)	16	2	.82	+	2.45	1.97E-01
ethanolamine-containing compound metabolic process (GO:0042439)	8	1	.41	+	2.45	3.35E-01
regulation of cholesterol storage (GO:0010885)	16	2	.82	+	2.45	1.97E-01
snRNA processing (GO:0016180)	24	3	1.23	+	2.45	1.26E-01
regulation of protein ADP-ribosylation (GO:0010835)	8	1	.41	+	2.45	3.35E-01
positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	8	1	.41	+	2.45	3.35E-01
pericyte cell differentiation (GO:1904238)	8	1	.41	+	2.45	3.35E-01
rRNA catabolic process (GO:0016075)	16	2	.82	+	2.45	1.97E-01
cellular monovalent inorganic anion homeostasis (GO:0030320)	16	2	.82	+	2.45	1.97E-01
positive regulation of dendritic spine development (GO:0060999)	40	5	2.04	+	2.45	5.64E-02
regulation of pyruvate dehydrogenase activity (GO:1904182)	8	1	.41	+	2.45	3.35E-01
regulation of alkaline phosphatase activity (GO:0010692)	8	1	.41	+	2.45	3.35E-01
isoprenoid catabolic process (GO:0008300)	8	1	.41	+	2.45	3.35E-01
regulation of wound healing, spreading of epidermal cells (GO:1903689)	8	1	.41	+	2.45	3.35E-01
cell surface receptor signaling pathway involved in heart development (GO:0061311)	24	3	1.23	+	2.45	1.26E-01
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	8	1	.41	+	2.45	3.35E-01
blood vessel endothelial cell differentiation (GO:0060837)	8	1	.41	+	2.45	3.35E-01
spermidine metabolic process (GO:0008216)	8	1	.41	+	2.45	3.35E-01
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	8	1	.41	+	2.45	3.35E-01
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	8	1	.41	+	2.45	3.35E-01
dynamin family protein polymerization involved in membrane fission (GO:0003373)	8	1	.41	+	2.45	3.35E-01
glycerophospholipid catabolic process (GO:0046475)	24	3	1.23	+	2.45	1.26E-01
platelet activating factor metabolic process (GO:0046469)	8	1	.41	+	2.45	3.35E-01
icosanoid biosynthetic process (GO:0046456)	40	5	2.04	+	2.45	5.64E-02
U4 snRNA 3'-end processing (GO:0034475)	8	1	.41	+	2.45	3.35E-01
contractile actin filament bundle assembly (GO:0030038)	16	2	.82	+	2.45	1.97E-01
postsynaptic density assembly (GO:0097107)	8	1	.41	+	2.45	3.35E-01
negative regulation of striated muscle contraction (GO:0045988)	8	1	.41	+	2.45	3.35E-01
cellular anion homeostasis (GO:0030002)	16	2	.82	+	2.45	1.97E-01
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	8	1	.41	+	2.45	3.35E-01
GDP-mannose metabolic process (GO:0019673)	8	1	.41	+	2.45	3.35E-01
chemosensory behavior (GO:0007635)	16	2	.82	+	2.45	1.97E-01
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	24	3	1.23	+	2.45	1.26E-01
mesenchymal-epithelial cell signaling (GO:0060638)	8	1	.41	+	2.45	3.35E-01
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	8	1	.41	+	2.45	3.35E-01
craniofacial suture morphogenesis (GO:0097094)	16	2	.82	+	2.45	1.97E-01
adipose tissue development (GO:0060612)	32	4	1.63	+	2.45	8.34E-02
lateral sprouting from an epithelium (GO:0060601)	8	1	.41	+	2.45	3.35E-01
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	32	4	1.63	+	2.45	8.34E-02
positive regulation of sister chromatid cohesion (GO:0045876)	8	1	.41	+	2.45	3.35E-01
atrioventricular valve formation (GO:0003190)	8	1	.41	+	2.45	3.35E-01
histone H3-K4 trimethylation (GO:0080182)	16	2	.82	+	2.45	1.97E-01
regulation of fertilization (GO:0080154)	8	1	.41	+	2.45	3.35E-01
cellular trivalent inorganic anion homeostasis (GO:0072502)	8	1	.41	+	2.45	3.35E-01
cellular divalent inorganic anion homeostasis (GO:0072501)	8	1	.41	+	2.45	3.35E-01
trachea cartilage development (GO:0060534)	8	1	.41	+	2.45	3.35E-01
RNA export from nucleus (GO:0006405)	113	14	5.77	+	2.43	2.49E-03
canonical Wnt signaling pathway (GO:0060070)	81	10	4.14	+	2.42	9.92E-03
peptidyl-lysine methylation (GO:0018022)	65	8	3.32	+	2.41	2.02E-02
mRNA transport (GO:0051028)	130	16	6.64	+	2.41	1.36E-03
cell aging (GO:0007569)	65	8	3.32	+	2.41	2.02E-02
positive regulation of ossification (GO:0045778)	49	6	2.50	+	2.40	4.20E-02
RNA stabilization (GO:0043489)	49	6	2.50	+	2.40	4.20E-02
regulation of actin filament depolymerization (GO:0030834)	49	6	2.50	+	2.40	4.20E-02
bone mineralization (GO:0030282)	49	6	2.50	+	2.40	4.20E-02
positive regulation of response to cytokine stimulus (GO:0060760)	49	6	2.50	+	2.40	4.20E-02
regulation of RNA splicing (GO:0043484)	131	16	6.69	+	2.39	1.47E-03
positive regulation of lamellipodium organization (GO:1902745)	33	4	1.69	+	2.37	9.08E-02
regulation of mitotic spindle organization (GO:0060236)	33	4	1.69	+	2.37	9.08E-02
positive regulation of telomere maintenance via telomerase (GO:0032212)	33	4	1.69	+	2.37	9.08E-02
response to sterol (GO:0036314)	33	4	1.69	+	2.37	9.08E-02
xenobiotic transport (GO:0042908)	33	4	1.69	+	2.37	9.08E-02
snRNA metabolic process (GO:0016073)	33	4	1.69	+	2.37	9.08E-02
central nervous system neuron axonogenesis (GO:0021955)	33	4	1.69	+	2.37	9.08E-02
alcohol metabolic process (GO:0006066)	306	37	15.63	+	2.37	2.26E-06
mRNA export from nucleus (GO:0006406)	91	11	4.65	+	2.37	8.17E-03
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	91	11	4.65	+	2.37	8.17E-03
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	25	3	1.28	+	2.35	1.37E-01
NADH regeneration (GO:0006735)	25	3	1.28	+	2.35	1.37E-01
intermediate filament organization (GO:0045109)	25	3	1.28	+	2.35	1.37E-01
positive regulation of protein autophosphorylation (GO:0031954)	25	3	1.28	+	2.35	1.37E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	100	12	5.11	+	2.35	6.23E-03
regulation of astrocyte differentiation (GO:0048710)	25	3	1.28	+	2.35	1.37E-01
regulation of membrane protein ectodomain proteolysis (GO:0051043)	25	3	1.28	+	2.35	1.37E-01
histone lysine demethylation (GO:0070076)	25	3	1.28	+	2.35	1.37E-01
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	25	3	1.28	+	2.35	1.37E-01
microtubule polymerization or depolymerization (GO:0031109)	50	6	2.55	+	2.35	4.54E-02
glucose catabolic process to pyruvate (GO:0061718)	25	3	1.28	+	2.35	1.37E-01
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	25	3	1.28	+	2.35	1.37E-01
canonical glycolysis (GO:0061621)	25	3	1.28	+	2.35	1.37E-01
response to prostaglandin E (GO:0034695)	25	3	1.28	+	2.35	1.37E-01
positive regulation of lamellipodium assembly (GO:0010592)	25	3	1.28	+	2.35	1.37E-01
atrioventricular valve development (GO:0003171)	25	3	1.28	+	2.35	1.37E-01
regulation of fat cell differentiation (GO:0045598)	125	15	6.38	+	2.35	2.40E-03
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	150	18	7.66	+	2.35	9.39E-04
regulation of telomere maintenance (GO:0032204)	75	9	3.83	+	2.35	1.65E-02
regulation of cellular response to heat (GO:1900034)	75	9	3.83	+	2.35	1.65E-02
lipid phosphorylation (GO:0046834)	67	8	3.42	+	2.34	2.36E-02
substantia nigra development (GO:0021762)	42	5	2.15	+	2.33	6.65E-02
acyl-CoA biosynthetic process (GO:0071616)	42	5	2.15	+	2.33	6.65E-02
mRNA stabilization (GO:0048255)	42	5	2.15	+	2.33	6.65E-02
thioester biosynthetic process (GO:0035384)	42	5	2.15	+	2.33	6.65E-02
regulation of peptidyl-threonine phosphorylation (GO:0010799)	42	5	2.15	+	2.33	6.65E-02
lactation (GO:0007595)	42	5	2.15	+	2.33	6.65E-02
peptidyl-proline modification (GO:0018208)	51	6	2.60	+	2.30	4.91E-02
intracellular steroid hormone receptor signaling pathway (GO:0030518)	51	6	2.60	+	2.30	4.91E-02
aspartate family amino acid metabolic process (GO:0009066)	51	6	2.60	+	2.30	4.91E-02
branching involved in salivary gland morphogenesis (GO:0060445)	17	2	.87	+	2.30	2.16E-01
regulation of endothelial cell differentiation (GO:0045601)	34	4	1.74	+	2.30	9.85E-02
blastoderm segmentation (GO:0007350)	17	2	.87	+	2.30	2.16E-01
regulation of corticosteroid hormone secretion (GO:2000846)	17	2	.87	+	2.30	2.16E-01
long-term synaptic depression (GO:0060292)	17	2	.87	+	2.30	2.16E-01
Wnt signaling pathway, calcium modulating pathway (GO:0007223)	34	4	1.74	+	2.30	9.85E-02
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	17	2	.87	+	2.30	2.16E-01
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	17	2	.87	+	2.30	2.16E-01
viral translation (GO:0019081)	17	2	.87	+	2.30	2.16E-01
angiogenesis involved in wound healing (GO:0060055)	17	2	.87	+	2.30	2.16E-01
modulation by host of viral genome replication (GO:0044827)	17	2	.87	+	2.30	2.16E-01
isotype switching (GO:0045190)	17	2	.87	+	2.30	2.16E-01
positive regulation of RNA splicing (GO:0033120)	34	4	1.74	+	2.30	9.85E-02
regulation of gene expression by genetic imprinting (GO:0006349)	17	2	.87	+	2.30	2.16E-01
fatty acid transmembrane transport (GO:1902001)	17	2	.87	+	2.30	2.16E-01
positive regulation of lymphocyte chemotaxis (GO:0140131)	17	2	.87	+	2.30	2.16E-01
positive regulation of histone H3-K4 methylation (GO:0051571)	17	2	.87	+	2.30	2.16E-01
intracellular lipid transport (GO:0032365)	34	4	1.74	+	2.30	9.85E-02
regulation of nucleobase-containing compound transport (GO:0032239)	17	2	.87	+	2.30	2.16E-01
vitamin transmembrane transport (GO:0035461)	17	2	.87	+	2.30	2.16E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167)	34	4	1.74	+	2.30	9.85E-02
regulation of triglyceride biosynthetic process (GO:0010866)	17	2	.87	+	2.30	2.16E-01
mannosylation (GO:0097502)	34	4	1.74	+	2.30	9.85E-02
regulation of keratinocyte proliferation (GO:0010837)	34	4	1.74	+	2.30	9.85E-02
microtubule polymerization (GO:0046785)	34	4	1.74	+	2.30	9.85E-02
regulation of fibroblast migration (GO:0010762)	34	4	1.74	+	2.30	9.85E-02
miRNA metabolic process (GO:0010586)	17	2	.87	+	2.30	2.16E-01
centromere complex assembly (GO:0034508)	34	4	1.74	+	2.30	9.85E-02
regulation of ketone biosynthetic process (GO:0010566)	17	2	.87	+	2.30	2.16E-01
maintenance of cell polarity (GO:0030011)	17	2	.87	+	2.30	2.16E-01
cellular response to thyroid hormone stimulus (GO:0097067)	17	2	.87	+	2.30	2.16E-01
cellular response to ketone (GO:1901655)	94	11	4.80	+	2.29	1.02E-02
cellular response to mechanical stimulus (GO:0071260)	77	9	3.93	+	2.29	1.92E-02
protein deacylation (GO:0035601)	60	7	3.06	+	2.28	3.66E-02
negative regulation of DNA repair (GO:0045738)	26	3	1.33	+	2.26	1.49E-01
positive regulation of epidermis development (GO:0045684)	26	3	1.33	+	2.26	1.49E-01
CENP-A containing nucleosome assembly (GO:0034080)	26	3	1.33	+	2.26	1.49E-01
cytoplasmic translational initiation (GO:0002183)	26	3	1.33	+	2.26	1.49E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	104	12	5.31	+	2.26	8.34E-03
chondrocyte development (GO:0002063)	26	3	1.33	+	2.26	1.49E-01
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	26	3	1.33	+	2.26	1.49E-01
phagosome acidification (GO:0090383)	26	3	1.33	+	2.26	1.49E-01
maturation of LSU-rRNA (GO:0000470)	26	3	1.33	+	2.26	1.49E-01
histone demethylation (GO:0016577)	26	3	1.33	+	2.26	1.49E-01
CENP-A containing chromatin organization (GO:0061641)	26	3	1.33	+	2.26	1.49E-01
glycolytic process through glucose-6-phosphate (GO:0061620)	26	3	1.33	+	2.26	1.49E-01
glycolytic process through fructose-6-phosphate (GO:0061615)	26	3	1.33	+	2.26	1.49E-01
decidualization (GO:0046697)	26	3	1.33	+	2.26	1.49E-01
regulation of lipid biosynthetic process (GO:0046890)	192	22	9.81	+	2.24	4.99E-04
protein export from nucleus (GO:0006611)	131	15	6.69	+	2.24	3.69E-03
DNA replication-independent nucleosome assembly (GO:0006336)	35	4	1.79	+	2.24	1.07E-01
actin filament capping (GO:0051693)	35	4	1.79	+	2.24	1.07E-01
peptidyl-threonine phosphorylation (GO:0018107)	70	8	3.58	+	2.24	2.94E-02
axon extension (GO:0048675)	35	4	1.79	+	2.24	1.07E-01
multicellular organismal water homeostasis (GO:0050891)	70	8	3.58	+	2.24	2.94E-02
maintenance of blood-brain barrier (GO:0035633)	35	4	1.79	+	2.24	1.07E-01
negative regulation of macroautophagy (GO:0016242)	35	4	1.79	+	2.24	1.07E-01
regulation of lamellipodium assembly (GO:0010591)	35	4	1.79	+	2.24	1.07E-01
vitamin metabolic process (GO:0006766)	114	13	5.82	+	2.23	6.80E-03
RNA transport (GO:0050658)	167	19	8.53	+	2.23	1.26E-03
nucleic acid transport (GO:0050657)	167	19	8.53	+	2.23	1.26E-03
unsaturated fatty acid biosynthetic process (GO:0006636)	44	5	2.25	+	2.22	7.75E-02
positive regulation of cellular protein catabolic process (GO:1903364)	141	16	7.20	+	2.22	3.02E-03
regulation of lymphocyte apoptotic process (GO:0070228)	53	6	2.71	+	2.22	5.70E-02
macromolecule deacylation (GO:0098732)	62	7	3.17	+	2.21	4.23E-02
nuclear export (GO:0051168)	142	16	7.25	+	2.21	3.23E-03
steroid hormone mediated signaling pathway (GO:0043401)	71	8	3.63	+	2.21	3.16E-02
insulin receptor signaling pathway (GO:0008286)	80	9	4.09	+	2.20	2.37E-02
establishment of RNA localization (GO:0051236)	169	19	8.63	+	2.20	1.45E-03
positive regulation of biomineralization (GO:0110151)	45	5	2.30	+	2.18	8.33E-02
fatty acid derivative biosynthetic process (GO:1901570)	81	9	4.14	+	2.18	2.54E-02
positive regulation of biomineral tissue development (GO:0070169)	45	5	2.30	+	2.18	8.33E-02
regulation of mRNA splicing, via spliceosome (GO:0048024)	90	10	4.60	+	2.18	1.91E-02
regulation of dendritic spine morphogenesis (GO:0061001)	45	5	2.30	+	2.18	8.33E-02
positive regulation of acute inflammatory response (GO:0002675)	27	3	1.38	+	2.18	1.61E-01
negative regulation of oxidative stress-induced neuron death (GO:1903204)	18	2	.92	+	2.18	2.35E-01
regulation of inner ear receptor cell differentiation (GO:2000980)	9	1	.46	+	2.18	3.69E-01
negative regulation of myoblast differentiation (GO:0045662)	27	3	1.38	+	2.18	1.61E-01
negative regulation of erythrocyte differentiation (GO:0045647)	9	1	.46	+	2.18	3.69E-01
regulation of mechanoreceptor differentiation (GO:0045631)	9	1	.46	+	2.18	3.69E-01
regulation of keratinocyte differentiation (GO:0045616)	36	4	1.84	+	2.18	1.15E-01
arachidonic acid metabolic process (GO:0019369)	54	6	2.76	+	2.18	6.12E-02
regulation of inner ear auditory receptor cell differentiation (GO:0045607)	9	1	.46	+	2.18	3.69E-01
negative regulation of endothelial cell differentiation (GO:0045602)	9	1	.46	+	2.18	3.69E-01
negative regulation of autophagy of mitochondrion (GO:1903147)	9	1	.46	+	2.18	3.69E-01
negative regulation of cell adhesion mediated by integrin (GO:0033629)	9	1	.46	+	2.18	3.69E-01
cranial suture morphogenesis (GO:0060363)	9	1	.46	+	2.18	3.69E-01
regulation of heart morphogenesis (GO:2000826)	9	1	.46	+	2.18	3.69E-01
regulation of behavioral fear response (GO:2000822)	9	1	.46	+	2.18	3.69E-01
regulation of synaptic vesicle clustering (GO:2000807)	9	1	.46	+	2.18	3.69E-01
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	9	1	.46	+	2.18	3.69E-01
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	9	1	.46	+	2.18	3.69E-01
regulation of autophagosome assembly (GO:2000785)	36	4	1.84	+	2.18	1.15E-01
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	9	1	.46	+	2.18	3.69E-01
detection of cell density (GO:0060245)	9	1	.46	+	2.18	3.69E-01
contact inhibition (GO:0060242)	9	1	.46	+	2.18	3.69E-01
receptor guanylyl cyclase signaling pathway (GO:0007168)	9	1	.46	+	2.18	3.69E-01
glomerulus morphogenesis (GO:0072102)	9	1	.46	+	2.18	3.69E-01
telomere maintenance via telomerase (GO:0007004)	27	3	1.38	+	2.18	1.61E-01
proline metabolic process (GO:0006560)	9	1	.46	+	2.18	3.69E-01
cysteine metabolic process (GO:0006534)	9	1	.46	+	2.18	3.69E-01
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	9	1	.46	+	2.18	3.69E-01
regulation of protein neddylation (GO:2000434)	9	1	.46	+	2.18	3.69E-01
'de novo' protein folding (GO:0006458)	36	4	1.84	+	2.18	1.15E-01
cellular hypotonic response (GO:0071476)	9	1	.46	+	2.18	3.69E-01
negative regulation of gliogenesis (GO:0014014)	36	4	1.84	+	2.18	1.15E-01
meiotic telomere clustering (GO:0045141)	9	1	.46	+	2.18	3.69E-01
regulation of glycogen biosynthetic process (GO:0005979)	27	3	1.38	+	2.18	1.61E-01
production of small RNA involved in gene silencing by RNA (GO:0070918)	27	3	1.38	+	2.18	1.61E-01
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	18	2	.92	+	2.18	2.35E-01
cellular response to reactive nitrogen species (GO:1902170)	18	2	.92	+	2.18	2.35E-01
interleukin-4 production (GO:0032633)	9	1	.46	+	2.18	3.69E-01
cellular response to cholesterol (GO:0071397)	18	2	.92	+	2.18	2.35E-01
chromatin silencing at telomere (GO:0006348)	9	1	.46	+	2.18	3.69E-01
regulation of hair follicle development (GO:0051797)	18	2	.92	+	2.18	2.35E-01
DNA replication-dependent nucleosome assembly (GO:0006335)	9	1	.46	+	2.18	3.69E-01
mitotic recombination (GO:0006312)	18	2	.92	+	2.18	2.35E-01
regulation of bile acid biosynthetic process (GO:0070857)	9	1	.46	+	2.18	3.69E-01
negative regulation of mast cell activation involved in immune response (GO:0033007)	9	1	.46	+	2.18	3.69E-01
positive regulation of myoblast proliferation (GO:2000288)	9	1	.46	+	2.18	3.69E-01
base-excision repair, AP site formation (GO:0006285)	18	2	.92	+	2.18	2.35E-01
cellular response to electrical stimulus (GO:0071257)	9	1	.46	+	2.18	3.69E-01
establishment of centrosome localization (GO:0051660)	9	1	.46	+	2.18	3.69E-01
actin filament network formation (GO:0051639)	9	1	.46	+	2.18	3.69E-01
venous blood vessel morphogenesis (GO:0048845)	9	1	.46	+	2.18	3.69E-01
erythrocyte development (GO:0048821)	36	4	1.84	+	2.18	1.15E-01
response to muramyl dipeptide (GO:0032495)	18	2	.92	+	2.18	2.35E-01
regulation of hair follicle maturation (GO:0048819)	9	1	.46	+	2.18	3.69E-01
Rap protein signal transduction (GO:0032486)	9	1	.46	+	2.18	3.69E-01
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	9	1	.46	+	2.18	3.69E-01
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	18	2	.92	+	2.18	2.35E-01
IRES-dependent viral translational initiation (GO:0075522)	9	1	.46	+	2.18	3.69E-01
regulation of spindle organization (GO:0090224)	36	4	1.84	+	2.18	1.15E-01
negative regulation of triglyceride metabolic process (GO:0090209)	9	1	.46	+	2.18	3.69E-01
type B pancreatic cell proliferation (GO:0044342)	9	1	.46	+	2.18	3.69E-01
excitatory chemical synaptic transmission (GO:0098976)	9	1	.46	+	2.18	3.69E-01
dendritic transport (GO:0098935)	9	1	.46	+	2.18	3.69E-01
microtubule nucleation by microtubule organizing center (GO:0051418)	9	1	.46	+	2.18	3.69E-01
cellular response to insulin-like growth factor stimulus (GO:1990314)	9	1	.46	+	2.18	3.69E-01
regulation of neuron projection regeneration (GO:0070570)	27	3	1.38	+	2.18	1.61E-01
protein K63-linked deubiquitination (GO:0070536)	27	3	1.38	+	2.18	1.61E-01
cellular response to leucine starvation (GO:1990253)	9	1	.46	+	2.18	3.69E-01
regulation of ligase activity (GO:0051340)	9	1	.46	+	2.18	3.69E-01
meiotic chromosome separation (GO:0051307)	18	2	.92	+	2.18	2.35E-01
brown fat cell differentiation (GO:0050873)	27	3	1.38	+	2.18	1.61E-01
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	9	1	.46	+	2.18	3.69E-01
Peyer's patch development (GO:0048541)	9	1	.46	+	2.18	3.69E-01
progesterone receptor signaling pathway (GO:0050847)	9	1	.46	+	2.18	3.69E-01
mucosa-associated lymphoid tissue development (GO:0048537)	9	1	.46	+	2.18	3.69E-01
lymph node development (GO:0048535)	18	2	.92	+	2.18	2.35E-01
cellular response to cold (GO:0070417)	9	1	.46	+	2.18	3.69E-01
hydrocarbon metabolic process (GO:0120252)	9	1	.46	+	2.18	3.69E-01
regulation of acyl-CoA biosynthetic process (GO:0050812)	9	1	.46	+	2.18	3.69E-01
ATF6-mediated unfolded protein response (GO:0036500)	9	1	.46	+	2.18	3.69E-01
nuclear pore complex assembly (GO:0051292)	9	1	.46	+	2.18	3.69E-01
protein depolymerization (GO:0051261)	36	4	1.84	+	2.18	1.15E-01
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	9	1	.46	+	2.18	3.69E-01
positive regulation of myelination (GO:0031643)	18	2	.92	+	2.18	2.35E-01
response to fructose (GO:0009750)	9	1	.46	+	2.18	3.69E-01
regulation of fever generation (GO:0031620)	9	1	.46	+	2.18	3.69E-01
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	9	1	.46	+	2.18	3.69E-01
cardiolipin biosynthetic process (GO:0032049)	9	1	.46	+	2.18	3.69E-01
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	9	1	.46	+	2.18	3.69E-01
exonucleolytic trimming involved in rRNA processing (GO:0000459)	9	1	.46	+	2.18	3.69E-01
dorsal aorta development (GO:0035907)	9	1	.46	+	2.18	3.69E-01
response to light intensity (GO:0009642)	9	1	.46	+	2.18	3.69E-01
postsynapse assembly (GO:0099068)	18	2	.92	+	2.18	2.35E-01
chaperone cofactor-dependent protein refolding (GO:0051085)	27	3	1.38	+	2.18	1.61E-01
amyloid precursor protein metabolic process (GO:0042982)	18	2	.92	+	2.18	2.35E-01
regulation of telomerase RNA localization to Cajal body (GO:1904872)	18	2	.92	+	2.18	2.35E-01
positive regulation of establishment of protein localization to telomere (GO:1904851)	9	1	.46	+	2.18	3.69E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	9	1	.46	+	2.18	3.69E-01
positive regulation of aspartic-type peptidase activity (GO:1905247)	9	1	.46	+	2.18	3.69E-01
regulation of core promoter binding (GO:1904796)	9	1	.46	+	2.18	3.69E-01
phosphatidylcholine acyl-chain remodeling (GO:0036151)	27	3	1.38	+	2.18	1.61E-01
somatic stem cell division (GO:0048103)	9	1	.46	+	2.18	3.69E-01
regulation of lysosomal protein catabolic process (GO:1905165)	9	1	.46	+	2.18	3.69E-01
telomere maintenance in response to DNA damage (GO:0043247)	9	1	.46	+	2.18	3.69E-01
regulation of somatic stem cell population maintenance (GO:1904672)	9	1	.46	+	2.18	3.69E-01
platelet-derived growth factor receptor signaling pathway (GO:0048008)	36	4	1.84	+	2.18	1.15E-01
single strand break repair (GO:0000012)	9	1	.46	+	2.18	3.69E-01
mRNA transcription (GO:0009299)	18	2	.92	+	2.18	2.35E-01
glucan catabolic process (GO:0009251)	18	2	.92	+	2.18	2.35E-01
rRNA 3'-end processing (GO:0031125)	9	1	.46	+	2.18	3.69E-01
positive regulation of execution phase of apoptosis (GO:1900119)	9	1	.46	+	2.18	3.69E-01
reticulophagy (GO:0061709)	9	1	.46	+	2.18	3.69E-01
heme transport (GO:0015886)	9	1	.46	+	2.18	3.69E-01
nucleobase transport (GO:0015851)	9	1	.46	+	2.18	3.69E-01
primary miRNA processing (GO:0031053)	9	1	.46	+	2.18	3.69E-01
dsRNA processing (GO:0031050)	27	3	1.38	+	2.18	1.61E-01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	18	2	.92	+	2.18	2.35E-01
aspartate transmembrane transport (GO:0015810)	9	1	.46	+	2.18	3.69E-01
arginine transport (GO:0015809)	9	1	.46	+	2.18	3.69E-01
regulation of glucan biosynthetic process (GO:0010962)	27	3	1.38	+	2.18	1.61E-01
positive regulation of BMP signaling pathway (GO:0030513)	36	4	1.84	+	2.18	1.15E-01
ether lipid biosynthetic process (GO:0008611)	9	1	.46	+	2.18	3.69E-01
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	18	2	.92	+	2.18	2.35E-01
regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	9	1	.46	+	2.18	3.69E-01
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	36	4	1.84	+	2.18	1.15E-01
hormone catabolic process (GO:0042447)	9	1	.46	+	2.18	3.69E-01
positive regulation of steroid biosynthetic process (GO:0010893)	18	2	.92	+	2.18	2.35E-01
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	27	3	1.38	+	2.18	1.61E-01
serotonin metabolic process (GO:0042428)	9	1	.46	+	2.18	3.69E-01
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	18	2	.92	+	2.18	2.35E-01
extraembryonic membrane development (GO:1903867)	9	1	.46	+	2.18	3.69E-01
peptidyl-arginine N-methylation (GO:0035246)	9	1	.46	+	2.18	3.69E-01
fructose 1,6-bisphosphate metabolic process (GO:0030388)	9	1	.46	+	2.18	3.69E-01
DNA replication-independent nucleosome organization (GO:0034724)	36	4	1.84	+	2.18	1.15E-01
DNA replication-dependent nucleosome organization (GO:0034723)	9	1	.46	+	2.18	3.69E-01
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	9	1	.46	+	2.18	3.69E-01
cellular lipid biosynthetic process (GO:0097384)	9	1	.46	+	2.18	3.69E-01
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	9	1	.46	+	2.18	3.69E-01
platelet formation (GO:0030220)	18	2	.92	+	2.18	2.35E-01
regulation of centriole replication (GO:0046599)	18	2	.92	+	2.18	2.35E-01
glycerol ether biosynthetic process (GO:0046504)	9	1	.46	+	2.18	3.69E-01
negative regulation of calcium ion transport into cytosol (GO:0010523)	18	2	.92	+	2.18	2.35E-01
pericardium morphogenesis (GO:0003344)	9	1	.46	+	2.18	3.69E-01
phosphatidylinositol metabolic process (GO:0046488)	171	19	8.73	+	2.18	1.65E-03
glyoxylate metabolic process (GO:0046487)	9	1	.46	+	2.18	3.69E-01
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	9	1	.46	+	2.18	3.69E-01
histone H3-K36 methylation (GO:0010452)	9	1	.46	+	2.18	3.69E-01
plasma lipoprotein particle assembly (GO:0034377)	27	3	1.38	+	2.18	1.61E-01
vascular associated smooth muscle cell development (GO:0097084)	9	1	.46	+	2.18	3.69E-01
ncRNA export from nucleus (GO:0097064)	36	4	1.84	+	2.18	1.15E-01
diol biosynthetic process (GO:0034312)	18	2	.92	+	2.18	2.35E-01
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	9	1	.46	+	2.18	3.69E-01
regulation of fear response (GO:1903365)	9	1	.46	+	2.18	3.69E-01
regulation of necroptotic process (GO:0060544)	27	3	1.38	+	2.18	1.61E-01
negative regulation of cellular extravasation (GO:0002692)	9	1	.46	+	2.18	3.69E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	91	10	4.65	+	2.15	2.05E-02
cellular response to insulin stimulus (GO:0032869)	164	18	8.38	+	2.15	2.45E-03
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	73	8	3.73	+	2.15	3.62E-02
negative regulation of protein-containing complex disassembly (GO:0043242)	73	8	3.73	+	2.15	3.62E-02
axo-dendritic transport (GO:0008088)	64	7	3.27	+	2.14	4.86E-02
positive regulation of stress fiber assembly (GO:0051496)	55	6	2.81	+	2.14	6.56E-02
inositol phosphate metabolic process (GO:0043647)	55	6	2.81	+	2.14	6.56E-02
regulation of multi-organism process (GO:0043900)	46	5	2.35	+	2.13	8.94E-02
negative regulation of smooth muscle cell proliferation (GO:0048662)	46	5	2.35	+	2.13	8.94E-02
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	46	5	2.35	+	2.13	8.94E-02
histone methylation (GO:0016571)	83	9	4.24	+	2.12	2.90E-02
maternal placenta development (GO:0001893)	37	4	1.89	+	2.12	1.23E-01
telomere maintenance via semi-conservative replication (GO:0032201)	37	4	1.89	+	2.12	1.23E-01
positive regulation of dendrite morphogenesis (GO:0050775)	37	4	1.89	+	2.12	1.23E-01
positive regulation of TOR signaling (GO:0032008)	37	4	1.89	+	2.12	1.23E-01
protein peptidyl-prolyl isomerization (GO:0000413)	37	4	1.89	+	2.12	1.23E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	37	4	1.89	+	2.12	1.23E-01
lipid storage (GO:0019915)	37	4	1.89	+	2.12	1.23E-01
regulation of amyloid precursor protein catabolic process (GO:1902991)	37	4	1.89	+	2.12	1.23E-01
cellular response to starvation (GO:0009267)	176	19	8.99	+	2.11	2.26E-03
regulation of dendrite morphogenesis (GO:0048814)	65	7	3.32	+	2.11	5.19E-02
regulation of lipid kinase activity (GO:0043550)	65	7	3.32	+	2.11	5.19E-02
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	121	13	6.18	+	2.10	1.08E-02
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	28	3	1.43	+	2.10	1.74E-01
regulation of cell cycle checkpoint (GO:1901976)	28	3	1.43	+	2.10	1.74E-01
response to vitamin D (GO:0033280)	28	3	1.43	+	2.10	1.74E-01
positive regulation of excitatory postsynaptic potential (GO:2000463)	28	3	1.43	+	2.10	1.74E-01
mismatch repair (GO:0006298)	28	3	1.43	+	2.10	1.74E-01
nucleotide-excision repair, preincision complex assembly (GO:0006294)	28	3	1.43	+	2.10	1.74E-01
glucose catabolic process (GO:0006007)	28	3	1.43	+	2.10	1.74E-01
dicarboxylic acid metabolic process (GO:0043648)	84	9	4.29	+	2.10	3.10E-02
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	28	3	1.43	+	2.10	1.74E-01
developmental induction (GO:0031128)	28	3	1.43	+	2.10	1.74E-01
long-chain fatty acid transport (GO:0015909)	56	6	2.86	+	2.10	7.02E-02
response to lipoprotein particle (GO:0055094)	28	3	1.43	+	2.10	1.74E-01
inner ear auditory receptor cell differentiation (GO:0042491)	28	3	1.43	+	2.10	1.74E-01
regulation of cholesterol efflux (GO:0010874)	28	3	1.43	+	2.10	1.74E-01
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	28	3	1.43	+	2.10	1.74E-01
androgen metabolic process (GO:0008209)	28	3	1.43	+	2.10	1.74E-01
T-helper cell differentiation (GO:0042093)	28	3	1.43	+	2.10	1.74E-01
RNA localization (GO:0006403)	187	20	9.55	+	2.09	1.95E-03
isoprenoid metabolic process (GO:0006720)	131	14	6.69	+	2.09	8.70E-03
retrograde transport, endosome to Golgi (GO:0042147)	75	8	3.83	+	2.09	4.13E-02
regulation of proteasomal protein catabolic process (GO:0061136)	169	18	8.63	+	2.09	3.33E-03
regulation of lamellipodium organization (GO:1902743)	47	5	2.40	+	2.08	9.57E-02
glycogen metabolic process (GO:0005977)	47	5	2.40	+	2.08	9.57E-02
regulation of protein-containing complex disassembly (GO:0043244)	113	12	5.77	+	2.08	1.51E-02
mRNA 3'-end processing (GO:0031124)	66	7	3.37	+	2.08	5.54E-02
protein localization to nucleus (GO:0034504)	151	16	7.71	+	2.07	5.71E-03
post-Golgi vesicle-mediated transport (GO:0006892)	123	13	6.28	+	2.07	1.22E-02
cellular carbohydrate metabolic process (GO:0044262)	161	17	8.22	+	2.07	4.63E-03
regulation of steroid hormone secretion (GO:2000831)	19	2	.97	+	2.06	2.53E-01
response to nitric oxide (GO:0071731)	19	2	.97	+	2.06	2.53E-01
activation of adenylate cyclase activity (GO:0007190)	38	4	1.94	+	2.06	1.32E-01
blastocyst growth (GO:0001832)	19	2	.97	+	2.06	2.53E-01
auditory receptor cell development (GO:0060117)	19	2	.97	+	2.06	2.53E-01
pericardium development (GO:0060039)	19	2	.97	+	2.06	2.53E-01
mRNA cis splicing, via spliceosome (GO:0045292)	19	2	.97	+	2.06	2.53E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	19	2	.97	+	2.06	2.53E-01
glandular epithelial cell differentiation (GO:0002067)	38	4	1.94	+	2.06	1.32E-01
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	19	2	.97	+	2.06	2.53E-01
negative regulation of multi-organism process (GO:0043901)	19	2	.97	+	2.06	2.53E-01
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	19	2	.97	+	2.06	2.53E-01
cellular polysaccharide catabolic process (GO:0044247)	19	2	.97	+	2.06	2.53E-01
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	19	2	.97	+	2.06	2.53E-01
platelet morphogenesis (GO:0036344)	19	2	.97	+	2.06	2.53E-01
prostate gland development (GO:0030850)	38	4	1.94	+	2.06	1.32E-01
phosphatidylserine acyl-chain remodeling (GO:0036150)	19	2	.97	+	2.06	2.53E-01
cellular response to amyloid-beta (GO:1904646)	38	4	1.94	+	2.06	1.32E-01
regulation of amyloid-beta clearance (GO:1900221)	19	2	.97	+	2.06	2.53E-01
vesicle cargo loading (GO:0035459)	19	2	.97	+	2.06	2.53E-01
regulation of necrotic cell death (GO:0010939)	38	4	1.94	+	2.06	1.32E-01
phospholipid dephosphorylation (GO:0046839)	38	4	1.94	+	2.06	1.32E-01
middle ear morphogenesis (GO:0042474)	19	2	.97	+	2.06	2.53E-01
regulation of ERAD pathway (GO:1904292)	19	2	.97	+	2.06	2.53E-01
folic acid metabolic process (GO:0046655)	19	2	.97	+	2.06	2.53E-01
positive regulation of insulin receptor signaling pathway (GO:0046628)	19	2	.97	+	2.06	2.53E-01
positive regulation of sprouting angiogenesis (GO:1903672)	19	2	.97	+	2.06	2.53E-01
positive regulation of smooth muscle cell migration (GO:0014911)	38	4	1.94	+	2.06	1.32E-01
regulation of protein modification by small protein conjugation or removal (GO:1903320)	219	23	11.19	+	2.06	1.19E-03
protein methylation (GO:0006479)	105	11	5.36	+	2.05	2.12E-02
regulation of DNA biosynthetic process (GO:2000278)	105	11	5.36	+	2.05	2.12E-02
glucose metabolic process (GO:0006006)	105	11	5.36	+	2.05	2.12E-02
protein alkylation (GO:0008213)	105	11	5.36	+	2.05	2.12E-02
plasma membrane organization (GO:0007009)	86	9	4.39	+	2.05	3.51E-02
double-strand break repair via homologous recombination (GO:0000724)	86	9	4.39	+	2.05	3.51E-02
cellular response to steroid hormone stimulus (GO:0071383)	134	14	6.84	+	2.05	1.04E-02
positive regulation of nucleocytoplasmic transport (GO:0046824)	67	7	3.42	+	2.05	5.91E-02
nucleocytoplasmic transport (GO:0006913)	230	24	11.75	+	2.04	1.02E-03
modulation by symbiont of entry into host (GO:0052372)	48	5	2.45	+	2.04	1.02E-01
spliceosomal complex assembly (GO:0000245)	48	5	2.45	+	2.04	1.02E-01
endosome to lysosome transport (GO:0008333)	48	5	2.45	+	2.04	1.02E-01
regulation of gene expression, epigenetic (GO:0040029)	135	14	6.90	+	2.03	1.11E-02
cellular response to nutrient levels (GO:0031669)	222	23	11.34	+	2.03	1.41E-03
alpha-beta T cell differentiation involved in immune response (GO:0002293)	29	3	1.48	+	2.03	1.86E-01
alpha-beta T cell activation involved in immune response (GO:0002287)	29	3	1.48	+	2.03	1.86E-01
negative regulation of calcium ion transport (GO:0051926)	58	6	2.96	+	2.03	7.98E-02
negative regulation of lymphocyte apoptotic process (GO:0070229)	29	3	1.48	+	2.03	1.86E-01
somatic diversification of immunoglobulins (GO:0016445)	29	3	1.48	+	2.03	1.86E-01
regulation of dendritic spine development (GO:0060998)	58	6	2.96	+	2.03	7.98E-02
embryonic hindlimb morphogenesis (GO:0035116)	29	3	1.48	+	2.03	1.86E-01
cardiac atrium morphogenesis (GO:0003209)	29	3	1.48	+	2.03	1.86E-01
organic hydroxy compound metabolic process (GO:1901615)	446	46	22.78	+	2.02	8.90E-06
peptidyl-tyrosine dephosphorylation (GO:0035335)	97	10	4.95	+	2.02	2.98E-02
nuclear transport (GO:0051169)	233	24	11.90	+	2.02	1.21E-03
interferon-gamma-mediated signaling pathway (GO:0060333)	68	7	3.47	+	2.02	6.28E-02
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	68	7	3.47	+	2.02	6.28E-02
protein targeting to vacuole (GO:0006623)	39	4	1.99	+	2.01	1.41E-01
regulation of JUN kinase activity (GO:0043506)	78	8	3.98	+	2.01	4.98E-02
regulation of mRNA processing (GO:0050684)	127	13	6.49	+	2.00	1.54E-02
cytosolic transport (GO:0016482)	127	13	6.49	+	2.00	1.54E-02
regulation of DNA-templated transcription, initiation (GO:2000142)	88	9	4.49	+	2.00	3.96E-02
recombinational repair (GO:0000725)	88	9	4.49	+	2.00	3.96E-02
alcohol catabolic process (GO:0046164)	49	5	2.50	+	2.00	1.09E-01
Golgi to plasma membrane transport (GO:0006893)	49	5	2.50	+	2.00	1.09E-01
negative regulation of fat cell differentiation (GO:0045599)	49	5	2.50	+	2.00	1.09E-01
regulation of cilium assembly (GO:1902017)	49	5	2.50	+	2.00	1.09E-01
phosphatidylinositol biosynthetic process (GO:0006661)	108	11	5.52	+	1.99	2.53E-02
negative regulation of RNA catabolic process (GO:1902369)	59	6	3.01	+	1.99	8.49E-02
alpha-amino acid biosynthetic process (GO:1901607)	59	6	3.01	+	1.99	8.49E-02
cell cycle G2/M phase transition (GO:0044839)	138	14	7.05	+	1.99	1.31E-02
sterol transport (GO:0015918)	69	7	3.52	+	1.99	6.68E-02
fatty acid transport (GO:0015908)	69	7	3.52	+	1.99	6.68E-02
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	79	8	4.04	+	1.98	5.28E-02
regulation of response to endoplasmic reticulum stress (GO:1905897)	79	8	4.04	+	1.98	5.28E-02
water homeostasis (GO:0030104)	79	8	4.04	+	1.98	5.28E-02
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	178	18	9.09	+	1.98	5.60E-03
purine nucleotide biosynthetic process (GO:0006164)	139	14	7.10	+	1.97	1.39E-02
intracellular receptor signaling pathway (GO:0030522)	189	19	9.65	+	1.97	4.79E-03
positive regulation of cell size (GO:0045793)	10	1	.51	+	1.96	4.00E-01
foregut morphogenesis (GO:0007440)	10	1	.51	+	1.96	4.00E-01
signal transduction involved in G2 DNA damage checkpoint (GO:0072425)	10	1	.51	+	1.96	4.00E-01
bronchus development (GO:0060433)	10	1	.51	+	1.96	4.00E-01
hypotonic response (GO:0006971)	10	1	.51	+	1.96	4.00E-01
positive regulation of osteoblast proliferation (GO:0033690)	10	1	.51	+	1.96	4.00E-01
positive regulation of endothelial cell differentiation (GO:0045603)	10	1	.51	+	1.96	4.00E-01
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	10	1	.51	+	1.96	4.00E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617)	20	2	1.02	+	1.96	2.72E-01
regulation of cell adhesion molecule production (GO:0060353)	10	1	.51	+	1.96	4.00E-01
carnitine shuttle (GO:0006853)	10	1	.51	+	1.96	4.00E-01
acute inflammatory response to antigenic stimulus (GO:0002438)	10	1	.51	+	1.96	4.00E-01
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	10	1	.51	+	1.96	4.00E-01
regulation of extracellular matrix organization (GO:1903053)	40	4	2.04	+	1.96	1.51E-01
activation of JNKK activity (GO:0007256)	10	1	.51	+	1.96	4.00E-01
metanephric glomerulus development (GO:0072224)	10	1	.51	+	1.96	4.00E-01
ER-associated misfolded protein catabolic process (GO:0071712)	10	1	.51	+	1.96	4.00E-01
gas homeostasis (GO:0033483)	10	1	.51	+	1.96	4.00E-01
cell proliferation involved in kidney development (GO:0072111)	10	1	.51	+	1.96	4.00E-01
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	10	1	.51	+	1.96	4.00E-01
T-helper cell lineage commitment (GO:0002295)	10	1	.51	+	1.96	4.00E-01
virion attachment to host cell (GO:0019062)	10	1	.51	+	1.96	4.00E-01
lysosomal transport (GO:0007041)	100	10	5.11	+	1.96	3.54E-02
L-serine metabolic process (GO:0006563)	10	1	.51	+	1.96	4.00E-01
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	10	1	.51	+	1.96	4.00E-01
membrane protein ectodomain proteolysis (GO:0006509)	20	2	1.02	+	1.96	2.72E-01
negative regulation of fibrinolysis (GO:0051918)	10	1	.51	+	1.96	4.00E-01
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	10	1	.51	+	1.96	4.00E-01
positive regulation of cellular amine metabolic process (GO:0033240)	10	1	.51	+	1.96	4.00E-01
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	20	2	1.02	+	1.96	2.72E-01
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	20	2	1.02	+	1.96	2.72E-01
opioid receptor signaling pathway (GO:0038003)	10	1	.51	+	1.96	4.00E-01
regulation of translational termination (GO:0006449)	10	1	.51	+	1.96	4.00E-01
regulation of neuron maturation (GO:0014041)	10	1	.51	+	1.96	4.00E-01
maintenance of epithelial cell apical/basal polarity (GO:0045199)	10	1	.51	+	1.96	4.00E-01
cell migration involved in sprouting angiogenesis (GO:0002042)	20	2	1.02	+	1.96	2.72E-01
manganese ion transmembrane transport (GO:0071421)	10	1	.51	+	1.96	4.00E-01
response to vitamin E (GO:0033197)	10	1	.51	+	1.96	4.00E-01
glycogen biosynthetic process (GO:0005978)	20	2	1.02	+	1.96	2.72E-01
cellular response to testosterone stimulus (GO:0071394)	10	1	.51	+	1.96	4.00E-01
DNA dealkylation involved in DNA repair (GO:0006307)	10	1	.51	+	1.96	4.00E-01
response to L-glutamate (GO:1902065)	10	1	.51	+	1.96	4.00E-01
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	20	2	1.02	+	1.96	2.72E-01
cellular response to leucine (GO:0071233)	10	1	.51	+	1.96	4.00E-01
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	10	1	.51	+	1.96	4.00E-01
ether biosynthetic process (GO:1901503)	10	1	.51	+	1.96	4.00E-01
negative regulation of fatty acid transport (GO:2000192)	10	1	.51	+	1.96	4.00E-01
vesicle fusion to plasma membrane (GO:0099500)	10	1	.51	+	1.96	4.00E-01
cAMP biosynthetic process (GO:0006171)	10	1	.51	+	1.96	4.00E-01
regulation of glucocorticoid metabolic process (GO:0031943)	10	1	.51	+	1.96	4.00E-01
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	10	1	.51	+	1.96	4.00E-01
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	10	1	.51	+	1.96	4.00E-01
positive regulation of cholesterol metabolic process (GO:0090205)	10	1	.51	+	1.96	4.00E-01
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	20	2	1.02	+	1.96	2.72E-01
negative regulation of hormone biosynthetic process (GO:0032353)	10	1	.51	+	1.96	4.00E-01
serine transport (GO:0032329)	10	1	.51	+	1.96	4.00E-01
DNA double-strand break processing (GO:0000729)	20	2	1.02	+	1.96	2.72E-01
inositol metabolic process (GO:0006020)	10	1	.51	+	1.96	4.00E-01
aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074)	10	1	.51	+	1.96	4.00E-01
regulation of cellular response to osmotic stress (GO:0106049)	10	1	.51	+	1.96	4.00E-01
positive regulation of extracellular matrix assembly (GO:1901203)	10	1	.51	+	1.96	4.00E-01
primitive streak formation (GO:0090009)	10	1	.51	+	1.96	4.00E-01
spindle midzone assembly (GO:0051255)	10	1	.51	+	1.96	4.00E-01
sequestering of metal ion (GO:0051238)	10	1	.51	+	1.96	4.00E-01
positive regulation of heat generation (GO:0031652)	10	1	.51	+	1.96	4.00E-01
keratinocyte proliferation (GO:0043616)	10	1	.51	+	1.96	4.00E-01
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	10	1	.51	+	1.96	4.00E-01
regulation of fat cell proliferation (GO:0070344)	10	1	.51	+	1.96	4.00E-01
regulation of deoxyribonuclease activity (GO:0032070)	10	1	.51	+	1.96	4.00E-01
tetrahydrofolate interconversion (GO:0035999)	10	1	.51	+	1.96	4.00E-01
positive regulation of fatty acid beta-oxidation (GO:0032000)	10	1	.51	+	1.96	4.00E-01
regulation of translational initiation in response to stress (GO:0043558)	10	1	.51	+	1.96	4.00E-01
homocysteine metabolic process (GO:0050667)	10	1	.51	+	1.96	4.00E-01
regulation of establishment of protein localization to telomere (GO:0070203)	10	1	.51	+	1.96	4.00E-01
positive regulation of isotype switching to IgG isotypes (GO:0048304)	10	1	.51	+	1.96	4.00E-01
ESCRT III complex disassembly (GO:1904903)	10	1	.51	+	1.96	4.00E-01
positive regulation of lipoprotein lipase activity (GO:0051006)	10	1	.51	+	1.96	4.00E-01
regulation of Golgi to plasma membrane protein transport (GO:0042996)	10	1	.51	+	1.96	4.00E-01
ESCRT complex disassembly (GO:1904896)	10	1	.51	+	1.96	4.00E-01
regulation of memory T cell differentiation (GO:0043380)	10	1	.51	+	1.96	4.00E-01
mitotic prometaphase (GO:0000236)	160	16	8.17	+	1.96	9.56E-03
regulation of prostaglandin biosynthetic process (GO:0031392)	10	1	.51	+	1.96	4.00E-01
regulation of protein localization to centrosome (GO:1904779)	10	1	.51	+	1.96	4.00E-01
regulation of intestinal lipid absorption (GO:1904729)	10	1	.51	+	1.96	4.00E-01
ceramide transport (GO:0035627)	10	1	.51	+	1.96	4.00E-01
long-chain fatty acid catabolic process (GO:0042758)	10	1	.51	+	1.96	4.00E-01
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	10	1	.51	+	1.96	4.00E-01
glucan biosynthetic process (GO:0009250)	20	2	1.02	+	1.96	2.72E-01
DNA methylation involved in gamete generation (GO:0043046)	20	2	1.02	+	1.96	2.72E-01
pre-miRNA processing (GO:0031054)	10	1	.51	+	1.96	4.00E-01
neutral amino acid transport (GO:0015804)	40	4	2.04	+	1.96	1.51E-01
branched-chain amino acid transport (GO:0015803)	10	1	.51	+	1.96	4.00E-01
purine nucleoside monophosphate biosynthetic process (GO:0009127)	20	2	1.02	+	1.96	2.72E-01
protein folding in endoplasmic reticulum (GO:0034975)	10	1	.51	+	1.96	4.00E-01
histone arginine methylation (GO:0034969)	10	1	.51	+	1.96	4.00E-01
RNA interference (GO:0016246)	10	1	.51	+	1.96	4.00E-01
histone H3-K9 modification (GO:0061647)	20	2	1.02	+	1.96	2.72E-01
fatty-acyl-CoA metabolic process (GO:0035337)	40	4	2.04	+	1.96	1.51E-01
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	10	1	.51	+	1.96	4.00E-01
positive regulation of protein export from nucleus (GO:0046827)	20	2	1.02	+	1.96	2.72E-01
regulation of dopaminergic neuron differentiation (GO:1904338)	10	1	.51	+	1.96	4.00E-01
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	20	2	1.02	+	1.96	2.72E-01
norepinephrine metabolic process (GO:0042415)	10	1	.51	+	1.96	4.00E-01
GDP metabolic process (GO:0046710)	10	1	.51	+	1.96	4.00E-01
regulation of intestinal cholesterol absorption (GO:0030300)	10	1	.51	+	1.96	4.00E-01
error-prone translesion synthesis (GO:0042276)	20	2	1.02	+	1.96	2.72E-01
natural killer cell mediated cytotoxicity (GO:0042267)	20	2	1.02	+	1.96	2.72E-01
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	40	4	2.04	+	1.96	1.51E-01
maintenance of apical/basal cell polarity (GO:0035090)	10	1	.51	+	1.96	4.00E-01
negative regulation of viral entry into host cell (GO:0046597)	20	2	1.02	+	1.96	2.72E-01
intracellular mRNA localization (GO:0008298)	10	1	.51	+	1.96	4.00E-01
desmosome organization (GO:0002934)	10	1	.51	+	1.96	4.00E-01
monoacylglycerol metabolic process (GO:0046462)	10	1	.51	+	1.96	4.00E-01
snRNA 3'-end processing (GO:0034472)	20	2	1.02	+	1.96	2.72E-01
positive regulation of striated muscle contraction (GO:0045989)	10	1	.51	+	1.96	4.00E-01
positive regulation of transcription by RNA polymerase III (GO:0045945)	10	1	.51	+	1.96	4.00E-01
regulation of cell maturation (GO:1903429)	20	2	1.02	+	1.96	2.72E-01
hindbrain radial glia guided cell migration (GO:0021932)	10	1	.51	+	1.96	4.00E-01
endocardial cushion formation (GO:0003272)	20	2	1.02	+	1.96	2.72E-01
regulation of secondary heart field cardioblast proliferation (GO:0003266)	10	1	.51	+	1.96	4.00E-01
telomere localization (GO:0034397)	10	1	.51	+	1.96	4.00E-01
cardiac ventricle formation (GO:0003211)	10	1	.51	+	1.96	4.00E-01
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	10	1	.51	+	1.96	4.00E-01
high-density lipoprotein particle clearance (GO:0034384)	10	1	.51	+	1.96	4.00E-01
chylomicron assembly (GO:0034378)	10	1	.51	+	1.96	4.00E-01
dendritic spine maintenance (GO:0097062)	10	1	.51	+	1.96	4.00E-01
negative regulation of protein polyubiquitination (GO:1902915)	10	1	.51	+	1.96	4.00E-01
negative regulation of muscle adaptation (GO:0014745)	10	1	.51	+	1.96	4.00E-01
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	20	2	1.02	+	1.96	2.72E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	10	1	.51	+	1.96	4.00E-01
regulation of vascular wound healing (GO:0061043)	10	1	.51	+	1.96	4.00E-01
positive regulation of animal organ morphogenesis (GO:0110110)	30	3	1.53	+	1.96	1.99E-01
multi-organism localization (GO:1902579)	60	6	3.06	+	1.96	9.02E-02
inner ear receptor cell stereocilium organization (GO:0060122)	30	3	1.53	+	1.96	1.99E-01
cellular response to dexamethasone stimulus (GO:0071549)	30	3	1.53	+	1.96	1.99E-01
multi-organism transport (GO:0044766)	60	6	3.06	+	1.96	9.02E-02
negative regulation of interleukin-1 production (GO:0032692)	30	3	1.53	+	1.96	1.99E-01
regulation of interferon-alpha production (GO:0032647)	30	3	1.53	+	1.96	1.99E-01
cellular response to glucose stimulus (GO:0071333)	70	7	3.58	+	1.96	7.08E-02
epidermis morphogenesis (GO:0048730)	30	3	1.53	+	1.96	1.99E-01
protein sumoylation (GO:0016925)	60	6	3.06	+	1.96	9.02E-02
regulation of actin nucleation (GO:0051125)	30	3	1.53	+	1.96	1.99E-01
regulation of protein ubiquitination (GO:0031396)	190	19	9.70	+	1.96	5.06E-03
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	230	23	11.75	+	1.96	2.19E-03
regulation of programmed necrotic cell death (GO:0062098)	30	3	1.53	+	1.96	1.99E-01
negative regulation of cell-substrate adhesion (GO:0010812)	60	6	3.06	+	1.96	9.02E-02
response to prostaglandin (GO:0034694)	30	3	1.53	+	1.96	1.99E-01
positive regulation of cartilage development (GO:0061036)	30	3	1.53	+	1.96	1.99E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	201	20	10.27	+	1.95	4.32E-03
vacuolar transport (GO:0007034)	141	14	7.20	+	1.94	1.55E-02
nucleus organization (GO:0006997)	121	12	6.18	+	1.94	2.40E-02
regulation of cellular protein catabolic process (GO:1903362)	232	23	11.85	+	1.94	2.43E-03
cellular response to external stimulus (GO:0071496)	323	32	16.50	+	1.94	3.97E-04
stress-activated MAPK cascade (GO:0051403)	101	10	5.16	+	1.94	3.75E-02
cellular glucose homeostasis (GO:0001678)	91	9	4.65	+	1.94	4.70E-02
spindle assembly (GO:0051225)	81	8	4.14	+	1.93	5.93E-02
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	152	15	7.76	+	1.93	1.32E-02
response to amino acid starvation (GO:1990928)	71	7	3.63	+	1.93	7.50E-02
negative regulation of protein ubiquitination (GO:0031397)	71	7	3.63	+	1.93	7.50E-02
ATP-dependent chromatin remodeling (GO:0043044)	71	7	3.63	+	1.93	7.50E-02
neural nucleus development (GO:0048857)	61	6	3.12	+	1.93	9.56E-02
apical junction assembly (GO:0043297)	61	6	3.12	+	1.93	9.56E-02
protein-lipid complex subunit organization (GO:0071825)	51	5	2.60	+	1.92	1.23E-01
negative regulation of mRNA catabolic process (GO:1902373)	51	5	2.60	+	1.92	1.23E-01
positive regulation of interleukin-1 beta production (GO:0032731)	51	5	2.60	+	1.92	1.23E-01
intracellular transport of virus (GO:0075733)	51	5	2.60	+	1.92	1.23E-01
positive regulation of axon extension (GO:0045773)	41	4	2.09	+	1.91	1.60E-01
lung morphogenesis (GO:0060425)	41	4	2.09	+	1.91	1.60E-01
histone H3 acetylation (GO:0043966)	41	4	2.09	+	1.91	1.60E-01
protein K63-linked ubiquitination (GO:0070534)	41	4	2.09	+	1.91	1.60E-01
mRNA splicing, via spliceosome (GO:0000398)	267	26	13.64	+	1.91	1.68E-03
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	267	26	13.64	+	1.91	1.68E-03
negative regulation of DNA metabolic process (GO:0051053)	113	11	5.77	+	1.91	3.34E-02
regulation of double-strand break repair (GO:2000779)	72	7	3.68	+	1.90	7.94E-02
cellular response to hexose stimulus (GO:0071331)	72	7	3.68	+	1.90	7.94E-02
regulation of epidermis development (GO:0045682)	62	6	3.17	+	1.89	1.01E-01
regulation of neuroblast proliferation (GO:1902692)	31	3	1.58	+	1.89	2.12E-01
protein deglycosylation (GO:0006517)	31	3	1.58	+	1.89	2.12E-01
regulation of focal adhesion assembly (GO:0051893)	62	6	3.17	+	1.89	1.01E-01
regulation of isotype switching (GO:0045191)	31	3	1.58	+	1.89	2.12E-01
artery morphogenesis (GO:0048844)	62	6	3.17	+	1.89	1.01E-01
negative regulation of lipid transport (GO:0032369)	31	3	1.58	+	1.89	2.12E-01
regulation of cell-substrate junction assembly (GO:0090109)	62	6	3.17	+	1.89	1.01E-01
spleen development (GO:0048536)	31	3	1.58	+	1.89	2.12E-01
hormone-mediated signaling pathway (GO:0009755)	124	12	6.33	+	1.89	2.82E-02
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	31	3	1.58	+	1.89	2.12E-01
regulation of anion transmembrane transport (GO:1903959)	31	3	1.58	+	1.89	2.12E-01
negative regulation of insulin receptor signaling pathway (GO:0046627)	31	3	1.58	+	1.89	2.12E-01
regulation of smooth muscle cell migration (GO:0014910)	62	6	3.17	+	1.89	1.01E-01
positive regulation of autophagy (GO:0010508)	124	12	6.33	+	1.89	2.82E-02
adherens junction organization (GO:0034332)	62	6	3.17	+	1.89	1.01E-01
regulation of mRNA stability (GO:0043488)	176	17	8.99	+	1.89	1.06E-02
hexose metabolic process (GO:0019318)	145	14	7.41	+	1.89	1.92E-02
cellular response to carbohydrate stimulus (GO:0071322)	83	8	4.24	+	1.89	6.62E-02
RNA splicing, via transesterification reactions (GO:0000375)	270	26	13.79	+	1.89	1.96E-03
regulation of myoblast differentiation (GO:0045661)	52	5	2.66	+	1.88	1.30E-01
stem cell proliferation (GO:0072089)	52	5	2.66	+	1.88	1.30E-01
cellular response to glucocorticoid stimulus (GO:0071385)	52	5	2.66	+	1.88	1.30E-01
double-strand break repair via nonhomologous end joining (GO:0006303)	52	5	2.66	+	1.88	1.30E-01
regulation of cholesterol transport (GO:0032374)	52	5	2.66	+	1.88	1.30E-01
negative regulation of muscle cell differentiation (GO:0051148)	52	5	2.66	+	1.88	1.30E-01
chaperone-mediated protein folding (GO:0061077)	52	5	2.66	+	1.88	1.30E-01
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)	52	5	2.66	+	1.88	1.30E-01
cellular response to monosaccharide stimulus (GO:0071326)	73	7	3.73	+	1.88	8.39E-02
regulation of mitochondrial membrane permeability (GO:0046902)	73	7	3.73	+	1.88	8.39E-02
regulation of organelle assembly (GO:1902115)	167	16	8.53	+	1.88	1.38E-02
stress-activated protein kinase signaling cascade (GO:0031098)	115	11	5.87	+	1.87	3.71E-02
G2/M transition of mitotic cell cycle (GO:0000086)	136	13	6.95	+	1.87	2.51E-02
endosomal transport (GO:0016197)	199	19	10.16	+	1.87	8.05E-03
positive regulation of protein catabolic process (GO:0045732)	220	21	11.24	+	1.87	5.55E-03
hyperosmotic response (GO:0006972)	21	2	1.07	+	1.86	2.91E-01
positive regulation of myoblast differentiation (GO:0045663)	21	2	1.07	+	1.86	2.91E-01
positive regulation of extracellular matrix organization (GO:1903055)	21	2	1.07	+	1.86	2.91E-01
ensheathment of neurons (GO:0007272)	105	10	5.36	+	1.86	4.64E-02
regulation of receptor recycling (GO:0001919)	21	2	1.07	+	1.86	2.91E-01
negative regulation of stem cell differentiation (GO:2000737)	21	2	1.07	+	1.86	2.91E-01
negative regulation of transcription regulatory region DNA binding (GO:2000678)	21	2	1.07	+	1.86	2.91E-01
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	21	2	1.07	+	1.86	2.91E-01
regulation of endothelial cell chemotaxis (GO:2001026)	21	2	1.07	+	1.86	2.91E-01
mitotic spindle assembly checkpoint (GO:0007094)	21	2	1.07	+	1.86	2.91E-01
tRNA aminoacylation for protein translation (GO:0006418)	42	4	2.15	+	1.86	1.70E-01
error-free translesion synthesis (GO:0070987)	21	2	1.07	+	1.86	2.91E-01
regulation of lymphocyte chemotaxis (GO:1901623)	21	2	1.07	+	1.86	2.91E-01
cellular response to arsenic-containing substance (GO:0071243)	21	2	1.07	+	1.86	2.91E-01
regulation of brown fat cell differentiation (GO:0090335)	21	2	1.07	+	1.86	2.91E-01
mitotic spindle checkpoint (GO:0071174)	21	2	1.07	+	1.86	2.91E-01
spindle assembly checkpoint (GO:0071173)	21	2	1.07	+	1.86	2.91E-01
DNA catabolic process, endonucleolytic (GO:0000737)	21	2	1.07	+	1.86	2.91E-01
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	21	2	1.07	+	1.86	2.91E-01
nucleotide-excision repair, DNA damage recognition (GO:0000715)	21	2	1.07	+	1.86	2.91E-01
response to corticosterone (GO:0051412)	21	2	1.07	+	1.86	2.91E-01
mitochondrion morphogenesis (GO:0070584)	21	2	1.07	+	1.86	2.91E-01
positive regulation of actin filament bundle assembly (GO:0032233)	63	6	3.22	+	1.86	1.07E-01
G1 phase (GO:0051318)	21	2	1.07	+	1.86	2.91E-01
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	42	4	2.15	+	1.86	1.70E-01
cellular response to extracellular stimulus (GO:0031668)	252	24	12.87	+	1.86	3.27E-03
regulation of myelination (GO:0031641)	42	4	2.15	+	1.86	1.70E-01
import into nucleus (GO:0051170)	105	10	5.36	+	1.86	4.64E-02
spindle checkpoint (GO:0031577)	21	2	1.07	+	1.86	2.91E-01
polysaccharide catabolic process (GO:0000272)	21	2	1.07	+	1.86	2.91E-01
arachidonic acid secretion (GO:0050482)	21	2	1.07	+	1.86	2.91E-01
histone deubiquitination (GO:0016578)	21	2	1.07	+	1.86	2.91E-01
establishment of protein localization to plasma membrane (GO:0061951)	42	4	2.15	+	1.86	1.70E-01
exogenous drug catabolic process (GO:0042738)	21	2	1.07	+	1.86	2.91E-01
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	21	2	1.07	+	1.86	2.91E-01
mitotic G1 phase (GO:0000080)	21	2	1.07	+	1.86	2.91E-01
RNA 3'-end processing (GO:0031123)	105	10	5.36	+	1.86	4.64E-02
arachidonate transport (GO:1903963)	21	2	1.07	+	1.86	2.91E-01
regulation of centrosome duplication (GO:0010824)	42	4	2.15	+	1.86	1.70E-01
axon ensheathment (GO:0008366)	105	10	5.36	+	1.86	4.64E-02
prostate gland epithelium morphogenesis (GO:0060740)	21	2	1.07	+	1.86	2.91E-01
pulmonary valve development (GO:0003177)	21	2	1.07	+	1.86	2.91E-01
positive regulation of proteolysis (GO:0045862)	347	33	17.72	+	1.86	6.48E-04
lipid homeostasis (GO:0055088)	137	13	7.00	+	1.86	2.64E-02
response to heat (GO:0009408)	95	9	4.85	+	1.85	5.83E-02
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	53	5	2.71	+	1.85	1.38E-01
regulation of sterol transport (GO:0032371)	53	5	2.71	+	1.85	1.38E-01
regulation of phosphoprotein phosphatase activity (GO:0043666)	106	10	5.41	+	1.85	4.89E-02
response to ischemia (GO:0002931)	53	5	2.71	+	1.85	1.38E-01
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	53	5	2.71	+	1.85	1.38E-01
response to insulin (GO:0032868)	223	21	11.39	+	1.84	6.42E-03
regulation of cysteine-type endopeptidase activity (GO:2000116)	223	21	11.39	+	1.84	6.42E-03
protein-containing complex localization (GO:0031503)	223	21	11.39	+	1.84	6.42E-03
regulation of mRNA metabolic process (GO:1903311)	308	29	15.73	+	1.84	1.55E-03
regulation of cell-matrix adhesion (GO:0001952)	117	11	5.98	+	1.84	4.10E-02
purine-containing compound biosynthetic process (GO:0072522)	149	14	7.61	+	1.84	2.34E-02
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	32	3	1.63	+	1.84	2.25E-01
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	64	6	3.27	+	1.84	1.13E-01
T cell differentiation involved in immune response (GO:0002292)	32	3	1.63	+	1.84	2.25E-01
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)	64	6	3.27	+	1.84	1.13E-01
positive regulation of monooxygenase activity (GO:0032770)	32	3	1.63	+	1.84	2.25E-01
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	32	3	1.63	+	1.84	2.25E-01
tRNA export from nucleus (GO:0006409)	32	3	1.63	+	1.84	2.25E-01
regulation of glycogen metabolic process (GO:0070873)	32	3	1.63	+	1.84	2.25E-01
regulation of axon extension involved in axon guidance (GO:0048841)	32	3	1.63	+	1.84	2.25E-01
regulation of stem cell population maintenance (GO:2000036)	32	3	1.63	+	1.84	2.25E-01
maturation of 5.8S rRNA (GO:0000460)	32	3	1.63	+	1.84	2.25E-01
'de novo' posttranslational protein folding (GO:0051084)	32	3	1.63	+	1.84	2.25E-01
vesicle targeting, to, from or within Golgi (GO:0048199)	64	6	3.27	+	1.84	1.13E-01
positive regulation of protein-containing complex disassembly (GO:0043243)	32	3	1.63	+	1.84	2.25E-01
somatic cell DNA recombination (GO:0016444)	32	3	1.63	+	1.84	2.25E-01
telomere maintenance via telomere lengthening (GO:0010833)	32	3	1.63	+	1.84	2.25E-01
pyridine-containing compound biosynthetic process (GO:0072525)	32	3	1.63	+	1.84	2.25E-01
RNA splicing (GO:0008380)	352	33	17.98	+	1.84	8.20E-04
cellular response to interferon-gamma (GO:0071346)	150	14	7.66	+	1.83	2.46E-02
positive regulation of insulin secretion (GO:0032024)	75	7	3.83	+	1.83	9.33E-02
positive regulation of chromosome organization (GO:2001252)	161	15	8.22	+	1.82	2.08E-02
transcription by RNA polymerase II (GO:0006366)	365	34	18.64	+	1.82	7.67E-04
phospholipid biosynthetic process (GO:0008654)	247	23	12.62	+	1.82	5.11E-03
positive regulation of nitric oxide biosynthetic process (GO:0045429)	43	4	2.20	+	1.82	1.80E-01
protein import into nucleus (GO:0006606)	86	8	4.39	+	1.82	7.75E-02
intermembrane lipid transfer (GO:0120009)	43	4	2.20	+	1.82	1.80E-01
coronary vasculature development (GO:0060976)	43	4	2.20	+	1.82	1.80E-01
anterograde axonal transport (GO:0008089)	43	4	2.20	+	1.82	1.80E-01
axonal transport (GO:0098930)	54	5	2.76	+	1.81	1.46E-01
tight junction assembly (GO:0120192)	54	5	2.76	+	1.81	1.46E-01
cholesterol transport (GO:0030301)	54	5	2.76	+	1.81	1.46E-01
execution phase of apoptosis (GO:0097194)	54	5	2.76	+	1.81	1.46E-01
nucleobase-containing compound transport (GO:0015931)	227	21	11.59	+	1.81	7.75E-03
positive regulation of DNA biosynthetic process (GO:2000573)	65	6	3.32	+	1.81	1.19E-01
response to organophosphorus (GO:0046683)	130	12	6.64	+	1.81	3.81E-02
mitotic spindle organization (GO:0007052)	152	14	7.76	+	1.80	2.71E-02
cellular polysaccharide metabolic process (GO:0044264)	76	7	3.88	+	1.80	9.82E-02
regulation of striated muscle cell differentiation (GO:0051153)	76	7	3.88	+	1.80	9.82E-02
monosaccharide metabolic process (GO:0005996)	174	16	8.89	+	1.80	1.93E-02
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	87	8	4.44	+	1.80	8.15E-02
regulation of RNA stability (GO:0043487)	185	17	9.45	+	1.80	1.64E-02
mRNA processing (GO:0006397)	414	38	21.15	+	1.80	5.08E-04
macromolecule methylation (GO:0043414)	207	19	10.57	+	1.80	1.18E-02
response to starvation (GO:0042594)	218	20	11.13	+	1.80	9.99E-03
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	142	13	7.25	+	1.79	3.36E-02
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	153	14	7.81	+	1.79	2.84E-02
positive regulation of endopeptidase activity (GO:0010950)	164	15	8.38	+	1.79	2.40E-02
positive regulation of cellular catabolic process (GO:0031331)	372	34	19.00	+	1.79	1.05E-03
nucleotide biosynthetic process (GO:0009165)	197	18	10.06	+	1.79	1.45E-02
regulation of mRNA catabolic process (GO:0061013)	197	18	10.06	+	1.79	1.45E-02
homotypic cell-cell adhesion (GO:0034109)	55	5	2.81	+	1.78	1.53E-01
cellular response to corticosteroid stimulus (GO:0071384)	55	5	2.81	+	1.78	1.53E-01
regulation of DNA-templated transcription in response to stress (GO:0043620)	110	10	5.62	+	1.78	5.95E-02
gene silencing by RNA (GO:0031047)	77	7	3.93	+	1.78	1.03E-01
positive regulation of dephosphorylation (GO:0035306)	55	5	2.81	+	1.78	1.53E-01
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	55	5	2.81	+	1.78	1.53E-01
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	22	2	1.12	+	1.78	3.10E-01
aldehyde catabolic process (GO:0046185)	11	1	.56	+	1.78	4.30E-01
branching involved in mammary gland duct morphogenesis (GO:0060444)	22	2	1.12	+	1.78	3.10E-01
pinocytosis (GO:0006907)	11	1	.56	+	1.78	4.30E-01
positive regulation of monocyte differentiation (GO:0045657)	11	1	.56	+	1.78	4.30E-01
regulation of T-helper 2 cell differentiation (GO:0045628)	11	1	.56	+	1.78	4.30E-01
positive regulation of epidermal cell differentiation (GO:0045606)	22	2	1.12	+	1.78	3.10E-01
chaperone-mediated protein transport (GO:0072321)	11	1	.56	+	1.78	4.30E-01
trabecula formation (GO:0060343)	22	2	1.12	+	1.78	3.10E-01
DNA biosynthetic process (GO:0071897)	99	9	5.06	+	1.78	7.12E-02
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	11	1	.56	+	1.78	4.30E-01
regulation of chloride transport (GO:2001225)	11	1	.56	+	1.78	4.30E-01
pons development (GO:0021548)	11	1	.56	+	1.78	4.30E-01
T cell cytokine production (GO:0002369)	11	1	.56	+	1.78	4.30E-01
estrogen biosynthetic process (GO:0006703)	11	1	.56	+	1.78	4.30E-01
metanephric tubule morphogenesis (GO:0072173)	11	1	.56	+	1.78	4.30E-01
phosphatidylglycerol biosynthetic process (GO:0006655)	11	1	.56	+	1.78	4.30E-01
negative regulation of protein acetylation (GO:1901984)	22	2	1.12	+	1.78	3.10E-01
natural killer cell mediated immunity (GO:0002228)	22	2	1.12	+	1.78	3.10E-01
regulation of protein glycosylation (GO:0060049)	11	1	.56	+	1.78	4.30E-01
interleukin-2-mediated signaling pathway (GO:0038110)	11	1	.56	+	1.78	4.30E-01
L-phenylalanine catabolic process (GO:0006559)	11	1	.56	+	1.78	4.30E-01
L-phenylalanine metabolic process (GO:0006558)	11	1	.56	+	1.78	4.30E-01
negative regulation of telomerase activity (GO:0051974)	11	1	.56	+	1.78	4.30E-01
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	11	1	.56	+	1.78	4.30E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	11	1	.56	+	1.78	4.30E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	11	1	.56	+	1.78	4.30E-01
signal peptide processing (GO:0006465)	11	1	.56	+	1.78	4.30E-01
phosphatidylinositol 3-kinase signaling (GO:0014065)	33	3	1.69	+	1.78	2.39E-01
cellular hyperosmotic response (GO:0071474)	11	1	.56	+	1.78	4.30E-01
diet induced thermogenesis (GO:0002024)	11	1	.56	+	1.78	4.30E-01
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	11	1	.56	+	1.78	4.30E-01
adhesion of symbiont to host cell (GO:0044650)	11	1	.56	+	1.78	4.30E-01
termination of RNA polymerase II transcription (GO:0006369)	33	3	1.69	+	1.78	2.39E-01
positive thymic T cell selection (GO:0045059)	11	1	.56	+	1.78	4.30E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	11	1	.56	+	1.78	4.30E-01
maintenance of protein location in cell (GO:0032507)	66	6	3.37	+	1.78	1.25E-01
regulation of gonad development (GO:1905939)	11	1	.56	+	1.78	4.30E-01
negative regulation of excitatory postsynaptic potential (GO:0090394)	11	1	.56	+	1.78	4.30E-01
phagosome-lysosome fusion (GO:0090385)	11	1	.56	+	1.78	4.30E-01
L-aspartate transmembrane transport (GO:0070778)	11	1	.56	+	1.78	4.30E-01
regulation of protein deacetylation (GO:0090311)	44	4	2.25	+	1.78	1.90E-01
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	11	1	.56	+	1.78	4.30E-01
cGMP biosynthetic process (GO:0006182)	11	1	.56	+	1.78	4.30E-01
response to folic acid (GO:0051593)	11	1	.56	+	1.78	4.30E-01
negative regulation of histone H3-K9 methylation (GO:0051573)	11	1	.56	+	1.78	4.30E-01
regulation of chromatin silencing (GO:0031935)	11	1	.56	+	1.78	4.30E-01
negative regulation of astrocyte differentiation (GO:0048712)	11	1	.56	+	1.78	4.30E-01
response to leptin (GO:0044321)	22	2	1.12	+	1.78	3.10E-01
negative regulation of hormone metabolic process (GO:0032351)	11	1	.56	+	1.78	4.30E-01
gluconeogenesis (GO:0006094)	44	4	2.25	+	1.78	1.90E-01
positive regulation of prostaglandin secretion (GO:0032308)	11	1	.56	+	1.78	4.30E-01
positive regulation of phospholipid biosynthetic process (GO:0071073)	11	1	.56	+	1.78	4.30E-01
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	11	1	.56	+	1.78	4.30E-01
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	11	1	.56	+	1.78	4.30E-01
intracellular pH reduction (GO:0051452)	44	4	2.25	+	1.78	1.90E-01
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	22	2	1.12	+	1.78	3.10E-01
regulation of smooth muscle cell proliferation (GO:0048660)	132	12	6.74	+	1.78	4.19E-02
neurotransmitter receptor transport to plasma membrane (GO:0098877)	11	1	.56	+	1.78	4.30E-01
regulation of steroid hormone biosynthetic process (GO:0090030)	11	1	.56	+	1.78	4.30E-01
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	11	1	.56	+	1.78	4.30E-01
response to hexose (GO:0009746)	143	13	7.30	+	1.78	3.52E-02
negative regulation of phagocytosis (GO:0050765)	22	2	1.12	+	1.78	3.10E-01
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	22	2	1.12	+	1.78	3.10E-01
peptidyl-threonine dephosphorylation (GO:0035970)	22	2	1.12	+	1.78	3.10E-01
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	33	3	1.69	+	1.78	2.39E-01
protein auto-ADP-ribosylation (GO:0070213)	11	1	.56	+	1.78	4.30E-01
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	11	1	.56	+	1.78	4.30E-01
regulation of cellular carbohydrate catabolic process (GO:0043471)	11	1	.56	+	1.78	4.30E-01
positive regulation of immunoglobulin secretion (GO:0051024)	11	1	.56	+	1.78	4.30E-01
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	11	1	.56	+	1.78	4.30E-01
Rac protein signal transduction (GO:0016601)	22	2	1.12	+	1.78	3.10E-01
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	33	3	1.69	+	1.78	2.39E-01
response to insecticide (GO:0017085)	11	1	.56	+	1.78	4.30E-01
negative regulation of cardiocyte differentiation (GO:1905208)	11	1	.56	+	1.78	4.30E-01
positive regulation of actin filament depolymerization (GO:0030836)	11	1	.56	+	1.78	4.30E-01
mRNA transcription by RNA polymerase II (GO:0042789)	11	1	.56	+	1.78	4.30E-01
snoRNA 3'-end processing (GO:0031126)	11	1	.56	+	1.78	4.30E-01
nucleotide-sugar biosynthetic process (GO:0009226)	22	2	1.12	+	1.78	3.10E-01
negative regulation of protein localization to nucleus (GO:1900181)	33	3	1.69	+	1.78	2.39E-01
phosphate ion homeostasis (GO:0055062)	11	1	.56	+	1.78	4.30E-01
tRNA aminoacylation (GO:0043039)	44	4	2.25	+	1.78	1.90E-01
gamma-aminobutyric acid transport (GO:0015812)	11	1	.56	+	1.78	4.30E-01
positive regulation of cellular response to insulin stimulus (GO:1900078)	22	2	1.12	+	1.78	3.10E-01
negative regulation of cellular response to insulin stimulus (GO:1900077)	33	3	1.69	+	1.78	2.39E-01
magnesium ion homeostasis (GO:0010960)	11	1	.56	+	1.78	4.30E-01
positive regulation of nitric oxide metabolic process (GO:1904407)	44	4	2.25	+	1.78	1.90E-01
negative regulation of transcription by competitive promoter binding (GO:0010944)	11	1	.56	+	1.78	4.30E-01
negative regulation of hippo signaling (GO:0035331)	11	1	.56	+	1.78	4.30E-01
regulation of cell-substrate junction organization (GO:0150116)	66	6	3.37	+	1.78	1.25E-01
regulation of protein catabolic process in the vacuole (GO:1904350)	11	1	.56	+	1.78	4.30E-01
melanin biosynthetic process (GO:0042438)	11	1	.56	+	1.78	4.30E-01
regulation of cholesterol esterification (GO:0010872)	11	1	.56	+	1.78	4.30E-01
regulation of PERK-mediated unfolded protein response (GO:1903897)	11	1	.56	+	1.78	4.30E-01
negative regulation of neuroinflammatory response (GO:0150079)	11	1	.56	+	1.78	4.30E-01
muscle cell cellular homeostasis (GO:0046716)	22	2	1.12	+	1.78	3.10E-01
genitalia morphogenesis (GO:0035112)	11	1	.56	+	1.78	4.30E-01
endocrine hormone secretion (GO:0060986)	11	1	.56	+	1.78	4.30E-01
positive regulation of triglyceride lipase activity (GO:0061365)	11	1	.56	+	1.78	4.30E-01
cornea development in camera-type eye (GO:0061303)	11	1	.56	+	1.78	4.30E-01
sphingoid biosynthetic process (GO:0046520)	11	1	.56	+	1.78	4.30E-01
sphingosine biosynthetic process (GO:0046512)	11	1	.56	+	1.78	4.30E-01
regulation of vascular endothelial growth factor production (GO:0010574)	33	3	1.69	+	1.78	2.39E-01
negative regulation of smooth muscle cell migration (GO:0014912)	22	2	1.12	+	1.78	3.10E-01
establishment of protein localization to postsynaptic membrane (GO:1903540)	11	1	.56	+	1.78	4.30E-01
prostate gland growth (GO:0060736)	11	1	.56	+	1.78	4.30E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	11	1	.56	+	1.78	4.30E-01
negative regulation of heart rate (GO:0010459)	11	1	.56	+	1.78	4.30E-01
postsynaptic membrane assembly (GO:0097104)	11	1	.56	+	1.78	4.30E-01
positive regulation of transcription by RNA polymerase I (GO:0045943)	22	2	1.12	+	1.78	3.10E-01
regulation of cardioblast proliferation (GO:0003264)	11	1	.56	+	1.78	4.30E-01
positive regulation of protein polyubiquitination (GO:1902916)	11	1	.56	+	1.78	4.30E-01
regulation of skeletal muscle adaptation (GO:0014733)	11	1	.56	+	1.78	4.30E-01
negative regulation of striated muscle tissue development (GO:0045843)	11	1	.56	+	1.78	4.30E-01
pyramidal neuron development (GO:0021860)	11	1	.56	+	1.78	4.30E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	132	12	6.74	+	1.78	4.19E-02
aortic valve development (GO:0003176)	33	3	1.69	+	1.78	2.39E-01
endocardium development (GO:0003157)	11	1	.56	+	1.78	4.30E-01
trivalent inorganic anion homeostasis (GO:0072506)	11	1	.56	+	1.78	4.30E-01
divalent inorganic anion homeostasis (GO:0072505)	11	1	.56	+	1.78	4.30E-01
RNA biosynthetic process (GO:0032774)	508	46	25.95	+	1.77	1.85E-04
transcription, DNA-templated (GO:0006351)	498	45	25.44	+	1.77	2.26E-04
sulfur compound biosynthetic process (GO:0044272)	166	15	8.48	+	1.77	2.63E-02
negative regulation of organelle organization (GO:0010639)	310	28	15.83	+	1.77	3.27E-03
nucleic acid-templated transcription (GO:0097659)	499	45	25.49	+	1.77	2.36E-04
regulation of protein catabolic process (GO:0042176)	366	33	18.69	+	1.77	1.53E-03
modulation of process of other organism involved in symbiotic interaction (GO:0051817)	111	10	5.67	+	1.76	6.24E-02
nucleoside phosphate biosynthetic process (GO:1901293)	200	18	10.22	+	1.76	1.66E-02
JNK cascade (GO:0007254)	78	7	3.98	+	1.76	1.09E-01
cholesterol homeostasis (GO:0042632)	78	7	3.98	+	1.76	1.09E-01
chromatin organization (GO:0006325)	591	53	30.19	+	1.76	7.77E-05
response to purine-containing compound (GO:0014074)	145	13	7.41	+	1.76	3.86E-02
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	67	6	3.42	+	1.75	1.32E-01
Fc-gamma receptor signaling pathway (GO:0038094)	67	6	3.42	+	1.75	1.32E-01
chondrocyte differentiation (GO:0002062)	67	6	3.42	+	1.75	1.32E-01
positive regulation of protein localization to membrane (GO:1905477)	123	11	6.28	+	1.75	5.47E-02
phospholipid metabolic process (GO:0006644)	369	33	18.85	+	1.75	1.74E-03
regulation of epidermal cell differentiation (GO:0045604)	56	5	2.86	+	1.75	1.62E-01
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	56	5	2.86	+	1.75	1.62E-01
positive regulation of cell-matrix adhesion (GO:0001954)	56	5	2.86	+	1.75	1.62E-01
terpenoid metabolic process (GO:0006721)	112	10	5.72	+	1.75	6.54E-02
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	56	5	2.86	+	1.75	1.62E-01
non-recombinational repair (GO:0000726)	56	5	2.86	+	1.75	1.62E-01
tight junction organization (GO:0120193)	56	5	2.86	+	1.75	1.62E-01
embryonic digit morphogenesis (GO:0042733)	56	5	2.86	+	1.75	1.62E-01
regulation of cellular response to insulin stimulus (GO:1900076)	56	5	2.86	+	1.75	1.62E-01
polyol metabolic process (GO:0019751)	112	10	5.72	+	1.75	6.54E-02
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	202	18	10.32	+	1.74	1.81E-02
morphogenesis of a polarized epithelium (GO:0001738)	45	4	2.30	+	1.74	2.00E-01
DNA methylation (GO:0006306)	45	4	2.30	+	1.74	2.00E-01
DNA alkylation (GO:0006305)	45	4	2.30	+	1.74	2.00E-01
regulation of vacuole organization (GO:0044088)	45	4	2.30	+	1.74	2.00E-01
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	45	4	2.30	+	1.74	2.00E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	45	4	2.30	+	1.74	2.00E-01
amino acid activation (GO:0043038)	45	4	2.30	+	1.74	2.00E-01
cellular response to glucose starvation (GO:0042149)	45	4	2.30	+	1.74	2.00E-01
regulation of protein localization to nucleus (GO:1900180)	135	12	6.90	+	1.74	4.80E-02
cellular response to hormone stimulus (GO:0032870)	496	44	25.33	+	1.74	3.86E-04
cellular response to unfolded protein (GO:0034620)	124	11	6.33	+	1.74	5.73E-02
protein lipidation (GO:0006497)	79	7	4.04	+	1.73	1.14E-01
regulation of interleukin-1 beta production (GO:0032651)	79	7	4.04	+	1.73	1.14E-01
sterol homeostasis (GO:0055092)	79	7	4.04	+	1.73	1.14E-01
positive regulation of protein ubiquitination (GO:0031398)	113	10	5.77	+	1.73	6.84E-02
regulation of ossification (GO:0030278)	113	10	5.77	+	1.73	6.84E-02
long-chain fatty acid metabolic process (GO:0001676)	102	9	5.21	+	1.73	8.20E-02
cellular response to amino acid starvation (GO:0034198)	68	6	3.47	+	1.73	1.38E-01
regulation of type I interferon-mediated signaling pathway (GO:0060338)	34	3	1.74	+	1.73	2.52E-01
NADH metabolic process (GO:0006734)	34	3	1.74	+	1.73	2.52E-01
membrane assembly (GO:0071709)	34	3	1.74	+	1.73	2.52E-01
phosphatidylcholine biosynthetic process (GO:0006656)	34	3	1.74	+	1.73	2.52E-01
oocyte development (GO:0048599)	34	3	1.74	+	1.73	2.52E-01
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	68	6	3.47	+	1.73	1.38E-01
cellular response to hydrogen peroxide (GO:0070301)	68	6	3.47	+	1.73	1.38E-01
negative regulation of TOR signaling (GO:0032007)	34	3	1.74	+	1.73	2.52E-01
cardiac atrium development (GO:0003230)	34	3	1.74	+	1.73	2.52E-01
response to unfolded protein (GO:0006986)	159	14	8.12	+	1.72	3.71E-02
regulation of stress fiber assembly (GO:0051492)	91	8	4.65	+	1.72	9.87E-02
ciliary basal body-plasma membrane docking (GO:0097711)	91	8	4.65	+	1.72	9.87E-02
intrinsic apoptotic signaling pathway (GO:0097193)	148	13	7.56	+	1.72	4.41E-02
response to monosaccharide (GO:0034284)	148	13	7.56	+	1.72	4.41E-02
organic cyclic compound biosynthetic process (GO:1901362)	1094	96	55.88	+	1.72	2.37E-07
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	57	5	2.91	+	1.72	1.70E-01
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	57	5	2.91	+	1.72	1.70E-01
regulation of lymphocyte migration (GO:2000401)	57	5	2.91	+	1.72	1.70E-01
regulation of DNA repair (GO:0006282)	114	10	5.82	+	1.72	7.16E-02
positive regulation of wound healing (GO:0090303)	57	5	2.91	+	1.72	1.70E-01
negative regulation of actin filament polymerization (GO:0030837)	57	5	2.91	+	1.72	1.70E-01
negative regulation of protein dephosphorylation (GO:0035308)	57	5	2.91	+	1.72	1.70E-01
regulation of nucleocytoplasmic transport (GO:0046822)	114	10	5.82	+	1.72	7.16E-02
regulation of insulin receptor signaling pathway (GO:0046626)	57	5	2.91	+	1.72	1.70E-01
nucleoside bisphosphate biosynthetic process (GO:0033866)	57	5	2.91	+	1.72	1.70E-01
polysaccharide metabolic process (GO:0005976)	80	7	4.09	+	1.71	1.19E-01
regulation of cytokinesis (GO:0032465)	80	7	4.09	+	1.71	1.19E-01
regulation of phosphatase activity (GO:0010921)	160	14	8.17	+	1.71	3.88E-02
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	80	7	4.09	+	1.71	1.19E-01
myelination (GO:0042552)	103	9	5.26	+	1.71	8.58E-02
methylation (GO:0032259)	252	22	12.87	+	1.71	1.21E-02
regulation of protein dephosphorylation (GO:0035304)	126	11	6.44	+	1.71	6.26E-02
negative regulation of glial cell differentiation (GO:0045686)	23	2	1.17	+	1.70	3.28E-01
telencephalon glial cell migration (GO:0022030)	23	2	1.17	+	1.70	3.28E-01
late endosome to vacuole transport (GO:0045324)	23	2	1.17	+	1.70	3.28E-01
cholesterol efflux (GO:0033344)	23	2	1.17	+	1.70	3.28E-01
myeloid dendritic cell activation (GO:0001773)	23	2	1.17	+	1.70	3.28E-01
genetic imprinting (GO:0071514)	23	2	1.17	+	1.70	3.28E-01
cellular response to leukemia inhibitory factor (GO:1990830)	92	8	4.70	+	1.70	1.03E-01
regulation of protein sumoylation (GO:0033233)	23	2	1.17	+	1.70	3.28E-01
protein O-linked glycosylation (GO:0006493)	92	8	4.70	+	1.70	1.03E-01
negative regulation of protein kinase B signaling (GO:0051898)	46	4	2.35	+	1.70	2.11E-01
nucleotide-excision repair, DNA gap filling (GO:0006297)	23	2	1.17	+	1.70	3.28E-01
maintenance of location in cell (GO:0051651)	92	8	4.70	+	1.70	1.03E-01
regulation of protein autophosphorylation (GO:0031952)	46	4	2.35	+	1.70	2.11E-01
positive regulation of meiotic cell cycle (GO:0051446)	23	2	1.17	+	1.70	3.28E-01
negative regulation of potassium ion transmembrane transport (GO:1901380)	23	2	1.17	+	1.70	3.28E-01
cytoplasmic sequestering of protein (GO:0051220)	23	2	1.17	+	1.70	3.28E-01
heterochromatin assembly (GO:0031507)	23	2	1.17	+	1.70	3.28E-01
presynapse assembly (GO:0099054)	23	2	1.17	+	1.70	3.28E-01
centriole assembly (GO:0098534)	23	2	1.17	+	1.70	3.28E-01
positive regulation of nitric-oxide synthase activity (GO:0051000)	23	2	1.17	+	1.70	3.28E-01
drug catabolic process (GO:0042737)	23	2	1.17	+	1.70	3.28E-01
positive regulation of protein import (GO:1904591)	46	4	2.35	+	1.70	2.11E-01
positive regulation of macrophage activation (GO:0043032)	23	2	1.17	+	1.70	3.28E-01
benzene-containing compound metabolic process (GO:0042537)	23	2	1.17	+	1.70	3.28E-01
male genitalia development (GO:0030539)	23	2	1.17	+	1.70	3.28E-01
positive regulation of peptidase activity (GO:0010952)	184	16	9.40	+	1.70	3.01E-02
positive regulation of hemostasis (GO:1900048)	23	2	1.17	+	1.70	3.28E-01
respiratory chain complex IV assembly (GO:0008535)	23	2	1.17	+	1.70	3.28E-01
regulation of cell morphogenesis involved in differentiation (GO:0010769)	92	8	4.70	+	1.70	1.03E-01
regulation of centrosome cycle (GO:0046605)	46	4	2.35	+	1.70	2.11E-01
trabecula morphogenesis (GO:0061383)	46	4	2.35	+	1.70	2.11E-01
positive regulation of blood coagulation (GO:0030194)	23	2	1.17	+	1.70	3.28E-01
neuronal stem cell population maintenance (GO:0097150)	23	2	1.17	+	1.70	3.28E-01
response to muscle activity (GO:0014850)	23	2	1.17	+	1.70	3.28E-01
negative regulation of carbohydrate metabolic process (GO:0045912)	46	4	2.35	+	1.70	2.11E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	23	2	1.17	+	1.70	3.28E-01
negative regulation of heart contraction (GO:0045822)	23	2	1.17	+	1.70	3.28E-01
cerebral cortex radial glia guided migration (GO:0021801)	23	2	1.17	+	1.70	3.28E-01
prostate gland morphogenesis (GO:0060512)	23	2	1.17	+	1.70	3.28E-01
lipid biosynthetic process (GO:0008610)	552	48	28.19	+	1.70	3.31E-04
protein dephosphorylation (GO:0006470)	196	17	10.01	+	1.70	2.65E-02
regulation of macroautophagy (GO:0016241)	150	13	7.66	+	1.70	4.81E-02
organophosphate biosynthetic process (GO:0090407)	485	42	24.77	+	1.70	8.26E-04
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	104	9	5.31	+	1.69	8.97E-02
regulation of protein depolymerization (GO:1901879)	81	7	4.14	+	1.69	1.25E-01
regulation of neurotransmitter secretion (GO:0046928)	81	7	4.14	+	1.69	1.25E-01
regulation of peptidyl-serine phosphorylation (GO:0033135)	139	12	7.10	+	1.69	5.72E-02
COPII vesicle coating (GO:0048208)	58	5	2.96	+	1.69	1.78E-01
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	58	5	2.96	+	1.69	1.78E-01
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	58	5	2.96	+	1.69	1.78E-01
transport of virus (GO:0046794)	58	5	2.96	+	1.69	1.78E-01
regulation of lipid metabolic process (GO:0019216)	383	33	19.56	+	1.69	3.07E-03
response to leukemia inhibitory factor (GO:1990823)	93	8	4.75	+	1.68	1.08E-01
telomere organization (GO:0032200)	93	8	4.75	+	1.68	1.08E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	128	11	6.54	+	1.68	6.82E-02
transcription initiation from RNA polymerase II promoter (GO:0006367)	163	14	8.33	+	1.68	4.40E-02
negative regulation of cell-matrix adhesion (GO:0001953)	35	3	1.79	+	1.68	2.66E-01
positive regulation of double-strand break repair (GO:2000781)	35	3	1.79	+	1.68	2.66E-01
regulation of polysaccharide biosynthetic process (GO:0032885)	35	3	1.79	+	1.68	2.66E-01
positive regulation of cytokinesis (GO:0032467)	35	3	1.79	+	1.68	2.66E-01
vesicle-mediated transport to the plasma membrane (GO:0098876)	70	6	3.58	+	1.68	1.52E-01
regulation of cold-induced thermogenesis (GO:0120161)	140	12	7.15	+	1.68	5.96E-02
guanosine-containing compound metabolic process (GO:1901068)	35	3	1.79	+	1.68	2.66E-01
protein kinase B signaling (GO:0043491)	35	3	1.79	+	1.68	2.66E-01
tRNA transport (GO:0051031)	35	3	1.79	+	1.68	2.66E-01
stem cell division (GO:0017145)	35	3	1.79	+	1.68	2.66E-01
regulation of protein export from nucleus (GO:0046825)	35	3	1.79	+	1.68	2.66E-01
ubiquitin-dependent ERAD pathway (GO:0030433)	70	6	3.58	+	1.68	1.52E-01
protein localization to cell junction (GO:1902414)	82	7	4.19	+	1.67	1.31E-01
postsynapse organization (GO:0099173)	82	7	4.19	+	1.67	1.31E-01
erythrocyte differentiation (GO:0030218)	82	7	4.19	+	1.67	1.31E-01
negative regulation of autophagy (GO:0010507)	82	7	4.19	+	1.67	1.31E-01
regulation of chromosome organization (GO:0033044)	258	22	13.18	+	1.67	1.54E-02
purine ribonucleotide biosynthetic process (GO:0009152)	129	11	6.59	+	1.67	7.11E-02
protein stabilization (GO:0050821)	176	15	8.99	+	1.67	4.03E-02
hexose biosynthetic process (GO:0019319)	47	4	2.40	+	1.67	2.21E-01
plasma lipoprotein particle organization (GO:0071827)	47	4	2.40	+	1.67	2.21E-01
maintenance of protein location (GO:0045185)	94	8	4.80	+	1.67	1.13E-01
regulation of neurotransmitter transport (GO:0051588)	94	8	4.80	+	1.67	1.13E-01
anterior/posterior axis specification (GO:0009948)	47	4	2.40	+	1.67	2.21E-01
cellular response to topologically incorrect protein (GO:0035967)	141	12	7.20	+	1.67	6.22E-02
response to cold (GO:0009409)	47	4	2.40	+	1.67	2.21E-01
response to amyloid-beta (GO:1904645)	47	4	2.40	+	1.67	2.21E-01
ribonucleoside monophosphate metabolic process (GO:0009161)	47	4	2.40	+	1.67	2.21E-01
response to antibiotic (GO:0046677)	47	4	2.40	+	1.67	2.21E-01
pH reduction (GO:0045851)	47	4	2.40	+	1.67	2.21E-01
positive regulation of osteoblast differentiation (GO:0045669)	59	5	3.01	+	1.66	1.87E-01
positive regulation of macroautophagy (GO:0016239)	59	5	3.01	+	1.66	1.87E-01
cellular response to decreased oxygen levels (GO:0036294)	189	16	9.65	+	1.66	3.68E-02
cellular response to peptide hormone stimulus (GO:0071375)	260	22	13.28	+	1.66	1.66E-02
chromosome organization (GO:0051276)	910	77	46.48	+	1.66	1.41E-05
regulation of muscle cell differentiation (GO:0051147)	130	11	6.64	+	1.66	7.41E-02
negative regulation of protein polymerization (GO:0032272)	71	6	3.63	+	1.65	1.59E-01
ERAD pathway (GO:0036503)	83	7	4.24	+	1.65	1.37E-01
regulation of TOR signaling (GO:0032006)	83	7	4.24	+	1.65	1.37E-01
response to topologically incorrect protein (GO:0035966)	178	15	9.09	+	1.65	4.36E-02
small molecule biosynthetic process (GO:0044283)	535	45	27.33	+	1.65	9.76E-04
male gonad development (GO:0008584)	131	11	6.69	+	1.64	7.72E-02
double-strand break repair (GO:0006302)	167	14	8.53	+	1.64	5.17E-02
cellular response to peptide (GO:1901653)	323	27	16.50	+	1.64	1.00E-02
response to lead ion (GO:0010288)	24	2	1.23	+	1.63	3.47E-01
epithelial tube branching involved in lung morphogenesis (GO:0060441)	24	2	1.23	+	1.63	3.47E-01
imidazole-containing compound metabolic process (GO:0052803)	12	1	.61	+	1.63	4.58E-01
ER overload response (GO:0006983)	12	1	.61	+	1.63	4.58E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	84	7	4.29	+	1.63	1.43E-01
negative regulation of mitotic sister chromatid separation (GO:2000816)	24	2	1.23	+	1.63	3.47E-01
methylguanosine-cap decapping (GO:0110156)	12	1	.61	+	1.63	4.58E-01
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	12	1	.61	+	1.63	4.58E-01
suckling behavior (GO:0001967)	12	1	.61	+	1.63	4.58E-01
I-kappaB phosphorylation (GO:0007252)	12	1	.61	+	1.63	4.58E-01
negative regulation of double-strand break repair (GO:2000780)	24	2	1.23	+	1.63	3.47E-01
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	24	2	1.23	+	1.63	3.47E-01
ATP biosynthetic process (GO:0006754)	24	2	1.23	+	1.63	3.47E-01
regulation of receptor catabolic process (GO:2000644)	12	1	.61	+	1.63	4.58E-01
negative regulation of collagen biosynthetic process (GO:0032966)	12	1	.61	+	1.63	4.58E-01
sphingomyelin metabolic process (GO:0006684)	12	1	.61	+	1.63	4.58E-01
positive regulation of phagocytosis, engulfment (GO:0060100)	12	1	.61	+	1.63	4.58E-01
commissural neuron axon guidance (GO:0071679)	12	1	.61	+	1.63	4.58E-01
mesodermal cell fate commitment (GO:0001710)	12	1	.61	+	1.63	4.58E-01
synapse maturation (GO:0060074)	12	1	.61	+	1.63	4.58E-01
angiotensin-activated signaling pathway (GO:0038166)	12	1	.61	+	1.63	4.58E-01
distal tubule development (GO:0072017)	12	1	.61	+	1.63	4.58E-01
autophagy of nucleus (GO:0044804)	12	1	.61	+	1.63	4.58E-01
melanin metabolic process (GO:0006582)	12	1	.61	+	1.63	4.58E-01
negative regulation of muscle tissue development (GO:1901862)	12	1	.61	+	1.63	4.58E-01
basic amino acid transmembrane transport (GO:1990822)	12	1	.61	+	1.63	4.58E-01
mitochondrial tRNA processing (GO:0090646)	12	1	.61	+	1.63	4.58E-01
vascular endothelial growth factor signaling pathway (GO:0038084)	24	2	1.23	+	1.63	3.47E-01
positive regulation of interferon-alpha production (GO:0032727)	24	2	1.23	+	1.63	3.47E-01
neuronal ion channel clustering (GO:0045161)	12	1	.61	+	1.63	4.58E-01
regulation of histone ubiquitination (GO:0033182)	12	1	.61	+	1.63	4.58E-01
calcineurin-NFAT signaling cascade (GO:0033173)	12	1	.61	+	1.63	4.58E-01
regulation of histone phosphorylation (GO:0033127)	12	1	.61	+	1.63	4.58E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	24	2	1.23	+	1.63	3.47E-01
cellular response to interleukin-2 (GO:0071352)	12	1	.61	+	1.63	4.58E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048)	24	2	1.23	+	1.63	3.47E-01
negative regulation of sister chromatid segregation (GO:0033046)	24	2	1.23	+	1.63	3.47E-01
DNA replication initiation (GO:0006270)	24	2	1.23	+	1.63	3.47E-01
forebrain morphogenesis (GO:0048853)	12	1	.61	+	1.63	4.58E-01
response to peptidoglycan (GO:0032494)	12	1	.61	+	1.63	4.58E-01
motile cilium assembly (GO:0044458)	24	2	1.23	+	1.63	3.47E-01
adhesion of symbiont to host (GO:0044406)	12	1	.61	+	1.63	4.58E-01
histone H4-K8 acetylation (GO:0043982)	12	1	.61	+	1.63	4.58E-01
histone H4-K5 acetylation (GO:0043981)	12	1	.61	+	1.63	4.58E-01
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	12	1	.61	+	1.63	4.58E-01
response to interleukin-2 (GO:0070669)	12	1	.61	+	1.63	4.58E-01
lactate metabolic process (GO:0006089)	12	1	.61	+	1.63	4.58E-01
icosanoid secretion (GO:0032309)	24	2	1.23	+	1.63	3.47E-01
double-strand break repair via break-induced replication (GO:0000727)	12	1	.61	+	1.63	4.58E-01
proteoglycan metabolic process (GO:0006029)	84	7	4.29	+	1.63	1.43E-01
regulation of cardiac muscle cell action potential (GO:0098901)	24	2	1.23	+	1.63	3.47E-01
negative regulation of axon regeneration (GO:0048681)	12	1	.61	+	1.63	4.58E-01
positive regulation of collateral sprouting (GO:0048672)	12	1	.61	+	1.63	4.58E-01
positive regulation of smooth muscle cell proliferation (GO:0048661)	84	7	4.29	+	1.63	1.43E-01
negative regulation of muscle organ development (GO:0048635)	12	1	.61	+	1.63	4.58E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	12	1	.61	+	1.63	4.58E-01
regulation of protein deubiquitination (GO:0090085)	12	1	.61	+	1.63	4.58E-01
negative regulation of T cell receptor signaling pathway (GO:0050860)	24	2	1.23	+	1.63	3.47E-01
positive regulation of coagulation (GO:0050820)	24	2	1.23	+	1.63	3.47E-01
regulation of timing of cell differentiation (GO:0048505)	12	1	.61	+	1.63	4.58E-01
maintenance of location (GO:0051235)	156	13	7.97	+	1.63	6.13E-02
hepatocyte differentiation (GO:0070365)	12	1	.61	+	1.63	4.58E-01
regulation of dendrite development (GO:0050773)	96	8	4.90	+	1.63	1.23E-01
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	24	2	1.23	+	1.63	3.47E-01
glucose 6-phosphate metabolic process (GO:0051156)	24	2	1.23	+	1.63	3.47E-01
amyloid fibril formation (GO:1990000)	12	1	.61	+	1.63	4.58E-01
sarcoplasmic reticulum calcium ion transport (GO:0070296)	12	1	.61	+	1.63	4.58E-01
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	12	1	.61	+	1.63	4.58E-01
enamel mineralization (GO:0070166)	12	1	.61	+	1.63	4.58E-01
regulation of aspartic-type peptidase activity (GO:1905245)	12	1	.61	+	1.63	4.58E-01
intraciliary retrograde transport (GO:0035721)	12	1	.61	+	1.63	4.58E-01
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	48	4	2.45	+	1.63	2.32E-01
positive regulation of membrane invagination (GO:1905155)	12	1	.61	+	1.63	4.58E-01
proteasome assembly (GO:0043248)	12	1	.61	+	1.63	4.58E-01
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	12	1	.61	+	1.63	4.58E-01
regulation of response to osmotic stress (GO:0047484)	12	1	.61	+	1.63	4.58E-01
phospholipid homeostasis (GO:0055091)	12	1	.61	+	1.63	4.58E-01
cellular response to interferon-alpha (GO:0035457)	12	1	.61	+	1.63	4.58E-01
vitamin biosynthetic process (GO:0009110)	12	1	.61	+	1.63	4.58E-01
regulation of intestinal absorption (GO:1904478)	12	1	.61	+	1.63	4.58E-01
nucleotide-sugar transmembrane transport (GO:0015780)	12	1	.61	+	1.63	4.58E-01
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	24	2	1.23	+	1.63	3.47E-01
negative regulation of viral life cycle (GO:1903901)	24	2	1.23	+	1.63	3.47E-01
cellular response to forskolin (GO:1904322)	12	1	.61	+	1.63	4.58E-01
response to forskolin (GO:1904321)	12	1	.61	+	1.63	4.58E-01
positive regulation of triglyceride biosynthetic process (GO:0010867)	12	1	.61	+	1.63	4.58E-01
regulation of bile acid metabolic process (GO:1904251)	12	1	.61	+	1.63	4.58E-01
fibroblast migration (GO:0010761)	12	1	.61	+	1.63	4.58E-01
CDP-diacylglycerol biosynthetic process (GO:0016024)	12	1	.61	+	1.63	4.58E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	24	2	1.23	+	1.63	3.47E-01
DNA strand elongation (GO:0022616)	24	2	1.23	+	1.63	3.47E-01
dermatan sulfate biosynthetic process (GO:0030208)	12	1	.61	+	1.63	4.58E-01
negative regulation of cardiac muscle hypertrophy (GO:0010614)	24	2	1.23	+	1.63	3.47E-01
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	12	1	.61	+	1.63	4.58E-01
lipoprotein biosynthetic process (GO:0042158)	84	7	4.29	+	1.63	1.43E-01
regulation of cilium beat frequency (GO:0003356)	12	1	.61	+	1.63	4.58E-01
keratinocyte development (GO:0003334)	12	1	.61	+	1.63	4.58E-01
cellular response to hydroxyurea (GO:0072711)	12	1	.61	+	1.63	4.58E-01
response to hydroxyurea (GO:0072710)	12	1	.61	+	1.63	4.58E-01
ruffle assembly (GO:0097178)	12	1	.61	+	1.63	4.58E-01
negative regulation of immunoglobulin mediated immune response (GO:0002890)	12	1	.61	+	1.63	4.58E-01
actin filament depolymerization (GO:0030042)	12	1	.61	+	1.63	4.58E-01
adenohypophysis development (GO:0021984)	12	1	.61	+	1.63	4.58E-01
regulation of synaptic vesicle recycling (GO:1903421)	24	2	1.23	+	1.63	3.47E-01
mitotic DNA replication (GO:1902969)	12	1	.61	+	1.63	4.58E-01
low-density lipoprotein particle clearance (GO:0034383)	24	2	1.23	+	1.63	3.47E-01
response to thyroid hormone (GO:0097066)	24	2	1.23	+	1.63	3.47E-01
negative regulation of B cell mediated immunity (GO:0002713)	12	1	.61	+	1.63	4.58E-01
positive regulation of gene expression, epigenetic (GO:0045815)	48	4	2.45	+	1.63	2.32E-01
pyramidal neuron differentiation (GO:0021859)	12	1	.61	+	1.63	4.58E-01
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	12	1	.61	+	1.63	4.58E-01
heart valve formation (GO:0003188)	12	1	.61	+	1.63	4.58E-01
layer formation in cerebral cortex (GO:0021819)	12	1	.61	+	1.63	4.58E-01
regulation of immunoglobulin production (GO:0002637)	60	5	3.06	+	1.63	1.95E-01
ATP generation from ADP (GO:0006757)	36	3	1.84	+	1.63	2.80E-01
positive regulation of interleukin-10 production (GO:0032733)	36	3	1.84	+	1.63	2.80E-01
positive regulation of interleukin-1 production (GO:0032732)	60	5	3.06	+	1.63	1.95E-01
cellular response to osmotic stress (GO:0071470)	36	3	1.84	+	1.63	2.80E-01
demethylation (GO:0070988)	60	5	3.06	+	1.63	1.95E-01
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	36	3	1.84	+	1.63	2.80E-01
positive regulation of lipid transport (GO:0032370)	72	6	3.68	+	1.63	1.66E-01
glycolytic process (GO:0006096)	36	3	1.84	+	1.63	2.80E-01
steroid hormone biosynthetic process (GO:0120178)	36	3	1.84	+	1.63	2.80E-01
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	36	3	1.84	+	1.63	2.80E-01
positive regulation of morphogenesis of an epithelium (GO:1905332)	36	3	1.84	+	1.63	2.80E-01
regulation of cardiac muscle contraction (GO:0055117)	72	6	3.68	+	1.63	1.66E-01
hair cell differentiation (GO:0035315)	36	3	1.84	+	1.63	2.80E-01
tRNA methylation (GO:0030488)	36	3	1.84	+	1.63	2.80E-01
myeloid cell development (GO:0061515)	60	5	3.06	+	1.63	1.95E-01
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	72	6	3.68	+	1.63	1.66E-01
development of primary male sexual characteristics (GO:0046546)	132	11	6.74	+	1.63	8.04E-02
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	36	3	1.84	+	1.63	2.80E-01
pyridine-containing compound metabolic process (GO:0072524)	36	3	1.84	+	1.63	2.80E-01
cellular response to stress (GO:0033554)	1621	135	82.80	+	1.63	1.34E-08
apoptotic signaling pathway (GO:0097190)	277	23	14.15	+	1.63	1.77E-02
response to interferon-gamma (GO:0034341)	169	14	8.63	+	1.62	5.58E-02
regulation of mitochondrion organization (GO:0010821)	157	13	8.02	+	1.62	6.38E-02
regulation of lipid transport (GO:0032368)	121	10	6.18	+	1.62	9.61E-02
cellular response to oxygen levels (GO:0071453)	206	17	10.52	+	1.62	3.92E-02
RNA metabolic process (GO:0016070)	1394	115	71.20	+	1.62	3.07E-07
biomineralization (GO:0110148)	85	7	4.34	+	1.61	1.49E-01
acyl-CoA metabolic process (GO:0006637)	85	7	4.34	+	1.61	1.49E-01
regulation of membrane permeability (GO:0090559)	85	7	4.34	+	1.61	1.49E-01
biomineral tissue development (GO:0031214)	85	7	4.34	+	1.61	1.49E-01
thioester metabolic process (GO:0035383)	85	7	4.34	+	1.61	1.49E-01
positive regulation of catabolic process (GO:0009896)	438	36	22.37	+	1.61	4.30E-03
regulation of muscle adaptation (GO:0043502)	73	6	3.73	+	1.61	1.74E-01
phosphatidylinositol-mediated signaling (GO:0048015)	73	6	3.73	+	1.61	1.74E-01
regulation of plasma lipoprotein particle levels (GO:0097006)	73	6	3.73	+	1.61	1.74E-01
nucleobase-containing compound biosynthetic process (GO:0034654)	889	73	45.41	+	1.61	6.08E-05
regulation of regulated secretory pathway (GO:1903305)	134	11	6.84	+	1.61	8.70E-02
regulation of protein localization (GO:0032880)	902	74	46.07	+	1.61	5.57E-05
energy reserve metabolic process (GO:0006112)	61	5	3.12	+	1.60	2.04E-01
mRNA metabolic process (GO:0016071)	610	50	31.16	+	1.60	9.07E-04
membrane docking (GO:0022406)	171	14	8.73	+	1.60	6.02E-02
response to peptide (GO:1901652)	453	37	23.14	+	1.60	4.23E-03
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	49	4	2.50	+	1.60	2.43E-01
columnar/cuboidal epithelial cell differentiation (GO:0002065)	98	8	5.01	+	1.60	1.33E-01
post-transcriptional gene silencing by RNA (GO:0035194)	49	4	2.50	+	1.60	2.43E-01
negative regulation of neurogenesis (GO:0050768)	135	11	6.90	+	1.60	9.04E-02
regulation of small molecule metabolic process (GO:0062012)	418	34	21.35	+	1.59	6.30E-03
cellular response to radiation (GO:0071478)	160	13	8.17	+	1.59	7.15E-02
positive regulation of chromatin organization (GO:1905269)	111	9	5.67	+	1.59	1.20E-01
renal water homeostasis (GO:0003091)	37	3	1.89	+	1.59	2.94E-01
nucleotide-excision repair, DNA incision (GO:0033683)	37	3	1.89	+	1.59	2.94E-01
negative regulation of calcium ion transmembrane transport (GO:1903170)	37	3	1.89	+	1.59	2.94E-01
fat-soluble vitamin metabolic process (GO:0006775)	37	3	1.89	+	1.59	2.94E-01
lens development in camera-type eye (GO:0002088)	74	6	3.78	+	1.59	1.81E-01
regulation of triglyceride metabolic process (GO:0090207)	37	3	1.89	+	1.59	2.94E-01
neuron projection organization (GO:0106027)	37	3	1.89	+	1.59	2.94E-01
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	37	3	1.89	+	1.59	2.94E-01
ncRNA 3'-end processing (GO:0043628)	37	3	1.89	+	1.59	2.94E-01
phospholipid catabolic process (GO:0009395)	37	3	1.89	+	1.59	2.94E-01
nucleotide-sugar metabolic process (GO:0009225)	37	3	1.89	+	1.59	2.94E-01
protein localization to lysosome (GO:0061462)	37	3	1.89	+	1.59	2.94E-01
hindlimb morphogenesis (GO:0035137)	37	3	1.89	+	1.59	2.94E-01
lamellipodium assembly (GO:0030032)	37	3	1.89	+	1.59	2.94E-01
positive regulation of fatty acid metabolic process (GO:0045923)	37	3	1.89	+	1.59	2.94E-01
ribose phosphate biosynthetic process (GO:0046390)	148	12	7.56	+	1.59	8.18E-02
negative regulation of mRNA metabolic process (GO:1903312)	74	6	3.78	+	1.59	1.81E-01
cellular response to chemical stress (GO:0062197)	284	23	14.51	+	1.59	2.27E-02
spindle organization (GO:0007051)	210	17	10.73	+	1.58	4.54E-02
negative regulation of cell development (GO:0010721)	173	14	8.84	+	1.58	6.49E-02
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	173	14	8.84	+	1.58	6.49E-02
regulation of actomyosin structure organization (GO:0110020)	99	8	5.06	+	1.58	1.39E-01
negative regulation of angiogenesis (GO:0016525)	99	8	5.06	+	1.58	1.39E-01
positive regulation of protein secretion (GO:0050714)	161	13	8.22	+	1.58	7.41E-02
vesicle coating (GO:0006901)	62	5	3.17	+	1.58	2.13E-01
pyruvate metabolic process (GO:0006090)	62	5	3.17	+	1.58	2.13E-01
protein transport along microtubule (GO:0098840)	62	5	3.17	+	1.58	2.13E-01
microtubule-based protein transport (GO:0099118)	62	5	3.17	+	1.58	2.13E-01
chromatin organization involved in regulation of transcription (GO:0034401)	62	5	3.17	+	1.58	2.13E-01
protein localization to vacuole (GO:0072665)	62	5	3.17	+	1.58	2.13E-01
protein modification by small protein conjugation (GO:0032446)	720	58	36.78	+	1.58	5.50E-04
positive regulation of protein localization to nucleus (GO:1900182)	87	7	4.44	+	1.58	1.61E-01
regulation of cellular pH (GO:0030641)	87	7	4.44	+	1.58	1.61E-01
response to hydrogen peroxide (GO:0042542)	112	9	5.72	+	1.57	1.25E-01
response to ionizing radiation (GO:0010212)	137	11	7.00	+	1.57	9.74E-02
response to glucose (GO:0009749)	137	11	7.00	+	1.57	9.74E-02
organelle localization by membrane tethering (GO:0140056)	162	13	8.27	+	1.57	7.69E-02
protein ubiquitination (GO:0016567)	648	52	33.10	+	1.57	1.14E-03
positive regulation of DNA metabolic process (GO:0051054)	187	15	9.55	+	1.57	6.11E-02
regulation of cellular response to stress (GO:0080135)	636	51	32.48	+	1.57	1.28E-03
regulation of actin filament organization (GO:0110053)	262	21	13.38	+	1.57	3.13E-02
peptidyl-lysine modification (GO:0018205)	262	21	13.38	+	1.57	3.13E-02
glycerophospholipid metabolic process (GO:0006650)	312	25	15.94	+	1.57	2.03E-02
carbohydrate metabolic process (GO:0005975)	437	35	22.32	+	1.57	7.05E-03
regulation of heterotypic cell-cell adhesion (GO:0034114)	25	2	1.28	+	1.57	3.65E-01
immunoglobulin production involved in immunoglobulin mediated immune response (GO:0002381)	25	2	1.28	+	1.57	3.65E-01
regulation of transcription regulatory region DNA binding (GO:2000677)	50	4	2.55	+	1.57	2.54E-01
negative regulation of organic acid transport (GO:0032891)	25	2	1.28	+	1.57	3.65E-01
negative regulation of chromosome segregation (GO:0051985)	25	2	1.28	+	1.57	3.65E-01
regulation of oxidative phosphorylation (GO:0002082)	25	2	1.28	+	1.57	3.65E-01
regulation of anoikis (GO:2000209)	25	2	1.28	+	1.57	3.65E-01
negative regulation of blood vessel morphogenesis (GO:2000181)	100	8	5.11	+	1.57	1.44E-01
regulation of meiotic nuclear division (GO:0040020)	25	2	1.28	+	1.57	3.65E-01
negative regulation of chromosome separation (GO:1905819)	25	2	1.28	+	1.57	3.65E-01
peptidyl-lysine trimethylation (GO:0018023)	25	2	1.28	+	1.57	3.65E-01
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	25	2	1.28	+	1.57	3.65E-01
positive regulation of behavior (GO:0048520)	25	2	1.28	+	1.57	3.65E-01
olefinic compound metabolic process (GO:0120254)	100	8	5.11	+	1.57	1.44E-01
presynapse organization (GO:0099172)	25	2	1.28	+	1.57	3.65E-01
positive regulation of cytokine secretion (GO:0050715)	25	2	1.28	+	1.57	3.65E-01
negative regulation of lipid biosynthetic process (GO:0051055)	50	4	2.55	+	1.57	2.54E-01
interstrand cross-link repair (GO:0036297)	50	4	2.55	+	1.57	2.54E-01
regulation of mitochondrial translation (GO:0070129)	25	2	1.28	+	1.57	3.65E-01
NAD biosynthetic process (GO:0009435)	25	2	1.28	+	1.57	3.65E-01
regulation of ubiquitin protein ligase activity (GO:1904666)	25	2	1.28	+	1.57	3.65E-01
negative regulation of cardiac muscle tissue growth (GO:0055022)	25	2	1.28	+	1.57	3.65E-01
nucleotide phosphorylation (GO:0046939)	50	4	2.55	+	1.57	2.54E-01
negative regulation of blood circulation (GO:1903523)	25	2	1.28	+	1.57	3.65E-01
negative regulation of heart growth (GO:0061117)	25	2	1.28	+	1.57	3.65E-01
central nervous system projection neuron axonogenesis (GO:0021952)	25	2	1.28	+	1.57	3.65E-01
lipid droplet organization (GO:0034389)	25	2	1.28	+	1.57	3.65E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	25	2	1.28	+	1.57	3.65E-01
response to estrogen (GO:0043627)	75	6	3.83	+	1.57	1.89E-01
response to peptide hormone (GO:0043434)	375	30	19.15	+	1.57	1.21E-02
cellular amino acid biosynthetic process (GO:0008652)	75	6	3.83	+	1.57	1.89E-01
regulation of establishment of protein localization (GO:0070201)	613	49	31.31	+	1.56	1.69E-03
cellular response to oxidative stress (GO:0034599)	238	19	12.16	+	1.56	4.04E-02
regulation of actin filament polymerization (GO:0030833)	163	13	8.33	+	1.56	7.97E-02
positive regulation of canonical Wnt signaling pathway (GO:0090263)	138	11	7.05	+	1.56	1.01E-01
negative regulation of cellular component organization (GO:0051129)	653	52	33.35	+	1.56	1.34E-03
response to carbohydrate (GO:0009743)	176	14	8.99	+	1.56	7.22E-02
positive regulation of mitochondrion organization (GO:0010822)	88	7	4.49	+	1.56	1.68E-01
regulation of actin polymerization or depolymerization (GO:0008064)	176	14	8.99	+	1.56	7.22E-02
regulation of protein transport (GO:0051223)	591	47	30.19	+	1.56	2.29E-03
viral life cycle (GO:0019058)	214	17	10.93	+	1.56	5.22E-02
response to nutrient levels (GO:0031667)	466	37	23.80	+	1.55	6.51E-03
negative regulation of protein depolymerization (GO:1901880)	63	5	3.22	+	1.55	2.22E-01
regulation of sister chromatid segregation (GO:0033045)	63	5	3.22	+	1.55	2.22E-01
nucleoside monophosphate metabolic process (GO:0009123)	63	5	3.22	+	1.55	2.22E-01
glutamine family amino acid metabolic process (GO:0009064)	63	5	3.22	+	1.55	2.22E-01
regulation of cellular catabolic process (GO:0031329)	794	63	40.56	+	1.55	4.72E-04
protein modification by small protein conjugation or removal (GO:0070647)	895	71	45.71	+	1.55	2.09E-04
regulation of catabolic process (GO:0009894)	946	75	48.32	+	1.55	1.41E-04
regulation of response to cytokine stimulus (GO:0060759)	164	13	8.38	+	1.55	8.26E-02
negative regulation of vasculature development (GO:1901343)	101	8	5.16	+	1.55	1.50E-01
regulation of actin filament bundle assembly (GO:0032231)	101	8	5.16	+	1.55	1.50E-01
positive regulation of protein transport (GO:0051222)	341	27	17.42	+	1.55	1.87E-02
regulation of actin filament length (GO:0030832)	177	14	9.04	+	1.55	7.48E-02
RNA processing (GO:0006396)	797	63	40.71	+	1.55	5.18E-04
purine nucleotide metabolic process (GO:0006163)	291	23	14.86	+	1.55	2.88E-02
histone modification (GO:0016570)	329	26	16.80	+	1.55	2.12E-02
membrane protein proteolysis (GO:0033619)	38	3	1.94	+	1.55	3.07E-01
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	38	3	1.94	+	1.55	3.07E-01
negative regulation of transporter activity (GO:0032410)	76	6	3.88	+	1.55	1.96E-01
oocyte differentiation (GO:0009994)	38	3	1.94	+	1.55	3.07E-01
semi-lunar valve development (GO:1905314)	38	3	1.94	+	1.55	3.07E-01
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	38	3	1.94	+	1.55	3.07E-01
DNA damage response, detection of DNA damage (GO:0042769)	38	3	1.94	+	1.55	3.07E-01
positive regulation of muscle contraction (GO:0045933)	38	3	1.94	+	1.55	3.07E-01
plasma lipoprotein particle clearance (GO:0034381)	38	3	1.94	+	1.55	3.07E-01
positive regulation of establishment of protein localization (GO:1904951)	355	28	18.13	+	1.54	1.77E-02
carboxylic acid biosynthetic process (GO:0046394)	279	22	14.25	+	1.54	3.27E-02
cellular response to abiotic stimulus (GO:0071214)	292	23	14.91	+	1.54	2.98E-02
cellular response to environmental stimulus (GO:0104004)	292	23	14.91	+	1.54	2.98E-02
aromatic compound biosynthetic process (GO:0019438)	965	76	49.29	+	1.54	1.56E-04
modulation of process of other organism (GO:0035821)	127	10	6.49	+	1.54	1.21E-01
negative regulation of nervous system development (GO:0051961)	140	11	7.15	+	1.54	1.09E-01
organic acid biosynthetic process (GO:0016053)	280	22	14.30	+	1.54	3.38E-02
cellular response to organic cyclic compound (GO:0071407)	471	37	24.06	+	1.54	7.64E-03
heterocycle biosynthetic process (GO:0018130)	955	75	48.78	+	1.54	1.87E-04
negative regulation of phosphorylation (GO:0042326)	433	34	22.12	+	1.54	1.03E-02
response to axon injury (GO:0048678)	51	4	2.60	+	1.54	2.65E-01
posttranscriptional gene silencing (GO:0016441)	51	4	2.60	+	1.54	2.65E-01
negative regulation of mitochondrion organization (GO:0010823)	51	4	2.60	+	1.54	2.65E-01
establishment of protein localization to vacuole (GO:0072666)	51	4	2.60	+	1.54	2.65E-01
regulation of cell development (GO:0060284)	472	37	24.11	+	1.53	7.88E-03
purine ribonucleotide metabolic process (GO:0009150)	268	21	13.69	+	1.53	3.83E-02
regulation of cellular protein localization (GO:1903827)	536	42	27.38	+	1.53	4.89E-03
regulation of protein polymerization (GO:0032271)	217	17	11.08	+	1.53	5.78E-02
response to hormone (GO:0009725)	766	60	39.12	+	1.53	8.69E-04
purine nucleoside bisphosphate metabolic process (GO:0034032)	115	9	5.87	+	1.53	1.39E-01
fatty acid biosynthetic process (GO:0006633)	115	9	5.87	+	1.53	1.39E-01
ribonucleoside bisphosphate metabolic process (GO:0033875)	115	9	5.87	+	1.53	1.39E-01
nucleoside bisphosphate metabolic process (GO:0033865)	115	9	5.87	+	1.53	1.39E-01
regulation of insulin secretion (GO:0050796)	179	14	9.14	+	1.53	8.01E-02
regulation of synaptic plasticity (GO:0048167)	179	14	9.14	+	1.53	8.01E-02
mesoderm formation (GO:0001707)	64	5	3.27	+	1.53	2.32E-01
cellular response to ionizing radiation (GO:0071479)	64	5	3.27	+	1.53	2.32E-01
neuron projection extension (GO:1990138)	64	5	3.27	+	1.53	2.32E-01
regulation of dephosphorylation (GO:0035303)	192	15	9.81	+	1.53	7.26E-02
regulation of DNA metabolic process (GO:0051052)	333	26	17.01	+	1.53	2.41E-02
covalent chromatin modification (GO:0016569)	333	26	17.01	+	1.53	2.41E-02
regulation of neurogenesis (GO:0050767)	346	27	17.67	+	1.53	2.20E-02
ribonucleotide biosynthetic process (GO:0009260)	141	11	7.20	+	1.53	1.13E-01
regulation of cytokine-mediated signaling pathway (GO:0001959)	154	12	7.87	+	1.53	1.01E-01
regulation of chromosome segregation (GO:0051983)	77	6	3.93	+	1.53	2.04E-01
DNA-templated transcription, elongation (GO:0006354)	77	6	3.93	+	1.53	2.04E-01
inositol lipid-mediated signaling (GO:0048017)	77	6	3.93	+	1.53	2.04E-01
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	77	6	3.93	+	1.53	2.04E-01
male sex differentiation (GO:0046661)	154	12	7.87	+	1.53	1.01E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091)	257	20	13.13	+	1.52	4.49E-02
cellular response to hypoxia (GO:0071456)	180	14	9.19	+	1.52	8.29E-02
posttranscriptional regulation of gene expression (GO:0010608)	502	39	25.64	+	1.52	7.45E-03
response to decreased oxygen levels (GO:0036293)	335	26	17.11	+	1.52	2.57E-02
response to endoplasmic reticulum stress (GO:0034976)	245	19	12.51	+	1.52	5.10E-02
mitochondrial membrane organization (GO:0007006)	129	10	6.59	+	1.52	1.30E-01
dephosphorylation (GO:0016311)	284	22	14.51	+	1.52	3.84E-02
regulation of cell-substrate adhesion (GO:0010810)	207	16	10.57	+	1.51	7.03E-02
response to steroid hormone (GO:0048545)	272	21	13.89	+	1.51	4.35E-02
regulation of peptide transport (GO:0090087)	622	48	31.77	+	1.51	3.65E-03
erythrocyte homeostasis (GO:0034101)	91	7	4.65	+	1.51	1.88E-01
regulation of osteoblast differentiation (GO:0045667)	117	9	5.98	+	1.51	1.50E-01
toxin transport (GO:1901998)	39	3	1.99	+	1.51	3.21E-01
response to dexamethasone (GO:0071548)	39	3	1.99	+	1.51	3.21E-01
tRNA metabolic process (GO:0006399)	169	13	8.63	+	1.51	9.80E-02
telomere maintenance (GO:0000723)	91	7	4.65	+	1.51	1.88E-01
vitamin transport (GO:0051180)	39	3	1.99	+	1.51	3.21E-01
gene silencing (GO:0016458)	117	9	5.98	+	1.51	1.50E-01
cyclic nucleotide metabolic process (GO:0009187)	39	3	1.99	+	1.51	3.21E-01
chondroitin sulfate metabolic process (GO:0030204)	39	3	1.99	+	1.51	3.21E-01
regulation of oxidative stress-induced neuron death (GO:1903203)	26	2	1.33	+	1.51	3.83E-01
pathway-restricted SMAD protein phosphorylation (GO:0060389)	13	1	.66	+	1.51	4.85E-01
heart trabecula formation (GO:0060347)	13	1	.66	+	1.51	4.85E-01
regulation of axon guidance (GO:1902667)	13	1	.66	+	1.51	4.85E-01
cardiac epithelial to mesenchymal transition (GO:0060317)	26	2	1.33	+	1.51	3.83E-01
AMP metabolic process (GO:0046033)	13	1	.66	+	1.51	4.85E-01
RNA decapping (GO:0110154)	13	1	.66	+	1.51	4.85E-01
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	13	1	.66	+	1.51	4.85E-01
positive regulation of receptor recycling (GO:0001921)	13	1	.66	+	1.51	4.85E-01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	13	1	.66	+	1.51	4.85E-01
glutathione biosynthetic process (GO:0006750)	13	1	.66	+	1.51	4.85E-01
steroid catabolic process (GO:0006706)	26	2	1.33	+	1.51	3.83E-01
fat cell differentiation (GO:0045444)	104	8	5.31	+	1.51	1.67E-01
inositol phosphate biosynthetic process (GO:0032958)	13	1	.66	+	1.51	4.85E-01
regulation of stem cell proliferation (GO:0072091)	65	5	3.32	+	1.51	2.41E-01
endodermal cell fate commitment (GO:0001711)	13	1	.66	+	1.51	4.85E-01
cardiac muscle cell proliferation (GO:0060038)	13	1	.66	+	1.51	4.85E-01
polyamine biosynthetic process (GO:0006596)	13	1	.66	+	1.51	4.85E-01
receptor catabolic process (GO:0032801)	26	2	1.33	+	1.51	3.83E-01
negative regulation of amino acid transport (GO:0051956)	13	1	.66	+	1.51	4.85E-01
positive regulation of protein sumoylation (GO:0033235)	13	1	.66	+	1.51	4.85E-01
regulation of chromatin assembly or disassembly (GO:0001672)	26	2	1.33	+	1.51	3.83E-01
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	26	2	1.33	+	1.51	3.83E-01
cellular response to light stimulus (GO:0071482)	104	8	5.31	+	1.51	1.67E-01
negative regulation of receptor internalization (GO:0002091)	13	1	.66	+	1.51	4.85E-01
positive regulation of focal adhesion assembly (GO:0051894)	26	2	1.33	+	1.51	3.83E-01
apical protein localization (GO:0045176)	13	1	.66	+	1.51	4.85E-01
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	13	1	.66	+	1.51	4.85E-01
left/right axis specification (GO:0070986)	13	1	.66	+	1.51	4.85E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	13	1	.66	+	1.51	4.85E-01
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	13	1	.66	+	1.51	4.85E-01
cellular response to ethanol (GO:0071361)	13	1	.66	+	1.51	4.85E-01
cellular response to interleukin-15 (GO:0071350)	13	1	.66	+	1.51	4.85E-01
iron coordination entity transport (GO:1901678)	13	1	.66	+	1.51	4.85E-01
cellular response to vitamin D (GO:0071305)	13	1	.66	+	1.51	4.85E-01
regulation of protein exit from endoplasmic reticulum (GO:0070861)	26	2	1.33	+	1.51	3.83E-01
negative regulation of mast cell activation (GO:0033004)	13	1	.66	+	1.51	4.85E-01
bicellular tight junction assembly (GO:0070830)	52	4	2.66	+	1.51	2.76E-01
secondary metabolite biosynthetic process (GO:0044550)	13	1	.66	+	1.51	4.85E-01
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	13	1	.66	+	1.51	4.85E-01
peptidyl-arginine methylation (GO:0018216)	13	1	.66	+	1.51	4.85E-01
positive regulation of protein targeting to membrane (GO:0090314)	26	2	1.33	+	1.51	3.83E-01
negative regulation of axon extension involved in axon guidance (GO:0048843)	26	2	1.33	+	1.51	3.83E-01
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	260	20	13.28	+	1.51	4.94E-02
regulation of development, heterochronic (GO:0040034)	13	1	.66	+	1.51	4.85E-01
embryonic brain development (GO:1990403)	13	1	.66	+	1.51	4.85E-01
negative regulation of oligodendrocyte differentiation (GO:0048715)	13	1	.66	+	1.51	4.85E-01
regulation of prostaglandin secretion (GO:0032306)	13	1	.66	+	1.51	4.85E-01
galactose metabolic process (GO:0006012)	13	1	.66	+	1.51	4.85E-01
establishment of protein localization to mitochondrial membrane (GO:0090151)	26	2	1.33	+	1.51	3.83E-01
negative regulation of neuron projection regeneration (GO:0070571)	13	1	.66	+	1.51	4.85E-01
regulation of synapse maturation (GO:0090128)	13	1	.66	+	1.51	4.85E-01
COPII-coated vesicle budding (GO:0090114)	65	5	3.32	+	1.51	2.41E-01
COPII-coated vesicle cargo loading (GO:0090110)	13	1	.66	+	1.51	4.85E-01
positive regulation of synaptic transmission, GABAergic (GO:0032230)	13	1	.66	+	1.51	4.85E-01
kinetochore assembly (GO:0051382)	13	1	.66	+	1.51	4.85E-01
regulation of protein localization to endosome (GO:1905666)	13	1	.66	+	1.51	4.85E-01
metaphase plate congression (GO:0051310)	52	4	2.66	+	1.51	2.76E-01
dicarboxylic acid biosynthetic process (GO:0043650)	13	1	.66	+	1.51	4.85E-01
regulation of heat generation (GO:0031650)	13	1	.66	+	1.51	4.85E-01
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	13	1	.66	+	1.51	4.85E-01
regulation of relaxation of muscle (GO:1901077)	13	1	.66	+	1.51	4.85E-01
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	26	2	1.33	+	1.51	3.83E-01
actin filament bundle assembly (GO:0051017)	52	4	2.66	+	1.51	2.76E-01
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	13	1	.66	+	1.51	4.85E-01
interleukin-15-mediated signaling pathway (GO:0035723)	13	1	.66	+	1.51	4.85E-01
negative regulation of protein-containing complex assembly (GO:0031333)	130	10	6.64	+	1.51	1.34E-01
protein import (GO:0017038)	143	11	7.30	+	1.51	1.21E-01
regulation of long-term neuronal synaptic plasticity (GO:0048169)	26	2	1.33	+	1.51	3.83E-01
activation of MAPKKK activity (GO:0000185)	13	1	.66	+	1.51	4.85E-01
selective autophagy (GO:0061912)	52	4	2.66	+	1.51	2.76E-01
response to leucine (GO:0043201)	13	1	.66	+	1.51	4.85E-01
somatic hypermutation of immunoglobulin genes (GO:0016446)	13	1	.66	+	1.51	4.85E-01
sequestering of extracellular ligand from receptor (GO:0035581)	13	1	.66	+	1.51	4.85E-01
nucleotide salvage (GO:0043173)	13	1	.66	+	1.51	4.85E-01
snoRNA processing (GO:0043144)	13	1	.66	+	1.51	4.85E-01
deoxyribonucleotide biosynthetic process (GO:0009263)	13	1	.66	+	1.51	4.85E-01
negative regulation of microtubule polymerization (GO:0031115)	13	1	.66	+	1.51	4.85E-01
aromatic amino acid transport (GO:0015801)	13	1	.66	+	1.51	4.85E-01
protein localization to microtubule (GO:0035372)	13	1	.66	+	1.51	4.85E-01
polyol transport (GO:0015791)	13	1	.66	+	1.51	4.85E-01
progesterone metabolic process (GO:0042448)	13	1	.66	+	1.51	4.85E-01
positive regulation of T cell chemotaxis (GO:0010820)	13	1	.66	+	1.51	4.85E-01
regulation of IRE1-mediated unfolded protein response (GO:1903894)	13	1	.66	+	1.51	4.85E-01
positive regulation of protein kinase A signaling (GO:0010739)	13	1	.66	+	1.51	4.85E-01
negative regulation of collagen metabolic process (GO:0010713)	13	1	.66	+	1.51	4.85E-01
cell migration involved in heart development (GO:0060973)	13	1	.66	+	1.51	4.85E-01
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	13	1	.66	+	1.51	4.85E-01
positive regulation of muscle cell apoptotic process (GO:0010661)	26	2	1.33	+	1.51	3.83E-01
chondroitin sulfate biosynthetic process (GO:0030206)	26	2	1.33	+	1.51	3.83E-01
dermatan sulfate metabolic process (GO:0030205)	13	1	.66	+	1.51	4.85E-01
axonal transport of mitochondrion (GO:0019896)	13	1	.66	+	1.51	4.85E-01
striated muscle adaptation (GO:0014888)	26	2	1.33	+	1.51	3.83E-01
urate metabolic process (GO:0046415)	13	1	.66	+	1.51	4.85E-01
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	13	1	.66	+	1.51	4.85E-01
positive regulation of immune response to tumor cell (GO:0002839)	13	1	.66	+	1.51	4.85E-01
positive regulation of response to tumor cell (GO:0002836)	13	1	.66	+	1.51	4.85E-01
negative regulation of fatty acid metabolic process (GO:0045922)	26	2	1.33	+	1.51	3.83E-01
mechanosensory behavior (GO:0007638)	13	1	.66	+	1.51	4.85E-01
amino sugar biosynthetic process (GO:0046349)	13	1	.66	+	1.51	4.85E-01
CDP-diacylglycerol metabolic process (GO:0046341)	13	1	.66	+	1.51	4.85E-01
regulation of tau-protein kinase activity (GO:1902947)	13	1	.66	+	1.51	4.85E-01
negative regulation of muscle hypertrophy (GO:0014741)	26	2	1.33	+	1.51	3.83E-01
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	13	1	.66	+	1.51	4.85E-01
negative regulation of gene expression, epigenetic (GO:0045814)	52	4	2.66	+	1.51	2.76E-01
negative regulation of dendritic spine development (GO:0061000)	13	1	.66	+	1.51	4.85E-01
cardiac conduction system development (GO:0003161)	13	1	.66	+	1.51	4.85E-01
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	13	1	.66	+	1.51	4.85E-01
organic cyclic compound metabolic process (GO:1901360)	2802	215	143.12	+	1.50	2.56E-10
lipid localization (GO:0010876)	313	24	15.99	+	1.50	3.50E-02
positive regulation of cellular protein localization (GO:1903829)	287	22	14.66	+	1.50	4.22E-02
response to extracellular stimulus (GO:0009991)	497	38	25.39	+	1.50	1.03E-02
regulation of autophagy (GO:0010506)	314	24	16.04	+	1.50	3.60E-02
positive regulation of apoptotic signaling pathway (GO:2001235)	118	9	6.03	+	1.49	1.55E-01
regulation of translation (GO:0006417)	341	26	17.42	+	1.49	3.08E-02
cell-cell signaling by wnt (GO:0198738)	328	25	16.75	+	1.49	3.38E-02
Wnt signaling pathway (GO:0016055)	328	25	16.75	+	1.49	3.38E-02
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	105	8	5.36	+	1.49	1.73E-01
response to oxidative stress (GO:0006979)	381	29	19.46	+	1.49	2.41E-02
alpha-amino acid metabolic process (GO:1901605)	184	14	9.40	+	1.49	9.45E-02
negative regulation of ion transmembrane transport (GO:0034766)	92	7	4.70	+	1.49	1.95E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	79	6	4.04	+	1.49	2.20E-01
odontogenesis of dentin-containing tooth (GO:0042475)	79	6	4.04	+	1.49	2.20E-01
negative regulation of ion transport (GO:0043271)	145	11	7.41	+	1.49	1.29E-01
nucleosome assembly (GO:0006334)	66	5	3.37	+	1.48	2.50E-01
mesoderm morphogenesis (GO:0048332)	66	5	3.37	+	1.48	2.50E-01
body fluid secretion (GO:0007589)	66	5	3.37	+	1.48	2.50E-01
nucleic acid metabolic process (GO:0090304)	1929	146	98.53	+	1.48	9.47E-07
tRNA processing (GO:0008033)	119	9	6.08	+	1.48	1.60E-01
chromatin remodeling (GO:0006338)	159	12	8.12	+	1.48	1.20E-01
cellular response to cAMP (GO:0071320)	53	4	2.71	+	1.48	2.87E-01
cellular response to nerve growth factor stimulus (GO:1990090)	53	4	2.71	+	1.48	2.87E-01
positive regulation of blood vessel endothelial cell migration (GO:0043536)	53	4	2.71	+	1.48	2.87E-01
positive regulation of DNA binding (GO:0043388)	53	4	2.71	+	1.48	2.87E-01
actin filament bundle organization (GO:0061572)	53	4	2.71	+	1.48	2.87E-01
glycerolipid metabolic process (GO:0046486)	371	28	18.95	+	1.48	2.89E-02
monosaccharide biosynthetic process (GO:0046364)	53	4	2.71	+	1.48	2.87E-01
negative regulation of kinase activity (GO:0033673)	239	18	12.21	+	1.47	6.98E-02
nucleotide metabolic process (GO:0009117)	372	28	19.00	+	1.47	2.97E-02
lipid modification (GO:0030258)	213	16	10.88	+	1.47	8.49E-02
glycerophospholipid biosynthetic process (GO:0046474)	213	16	10.88	+	1.47	8.49E-02
ribose phosphate metabolic process (GO:0019693)	293	22	14.97	+	1.47	5.05E-02
response to oxygen levels (GO:0070482)	360	27	18.39	+	1.47	3.35E-02
production of molecular mediator of immune response (GO:0002440)	80	6	4.09	+	1.47	2.28E-01
positive regulation of stem cell proliferation (GO:2000648)	40	3	2.04	+	1.47	3.35E-01
somatic diversification of immune receptors (GO:0002200)	40	3	2.04	+	1.47	3.35E-01
sister chromatid cohesion (GO:0007062)	40	3	2.04	+	1.47	3.35E-01
regulation of polysaccharide metabolic process (GO:0032881)	40	3	2.04	+	1.47	3.35E-01
DNA-templated transcription, initiation (GO:0006352)	200	15	10.22	+	1.47	9.38E-02
membrane biogenesis (GO:0044091)	40	3	2.04	+	1.47	3.35E-01
regulation of postsynapse organization (GO:0099175)	80	6	4.09	+	1.47	2.28E-01
negative regulation of epithelial cell differentiation (GO:0030857)	40	3	2.04	+	1.47	3.35E-01
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)	40	3	2.04	+	1.47	3.35E-01
purine-containing compound metabolic process (GO:0072521)	320	24	16.34	+	1.47	4.31E-02
female gamete generation (GO:0007292)	120	9	6.13	+	1.47	1.66E-01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	120	9	6.13	+	1.47	1.66E-01
regulation of DNA binding (GO:0051101)	120	9	6.13	+	1.47	1.66E-01
nucleobase-containing compound metabolic process (GO:0006139)	2362	177	120.64	+	1.47	9.06E-08
negative regulation of transferase activity (GO:0051348)	267	20	13.64	+	1.47	6.11E-02
regulation of glucose metabolic process (GO:0010906)	107	8	5.47	+	1.46	1.86E-01
bone development (GO:0060348)	174	13	8.89	+	1.46	1.15E-01
positive regulation of DNA repair (GO:0045739)	67	5	3.42	+	1.46	2.60E-01
positive regulation of response to wounding (GO:1903036)	67	5	3.42	+	1.46	2.60E-01
epithelial to mesenchymal transition (GO:0001837)	67	5	3.42	+	1.46	2.60E-01
organic hydroxy compound catabolic process (GO:1901616)	67	5	3.42	+	1.46	2.60E-01
regulation of protein import (GO:1904589)	67	5	3.42	+	1.46	2.60E-01
digestive system process (GO:0022600)	67	5	3.42	+	1.46	2.60E-01
regulation of pH (GO:0006885)	94	7	4.80	+	1.46	2.09E-01
positive regulation of cell cycle phase transition (GO:1901989)	94	7	4.80	+	1.46	2.09E-01
regulation of interleukin-1 production (GO:0032652)	94	7	4.80	+	1.46	2.09E-01
DNA modification (GO:0006304)	94	7	4.80	+	1.46	2.09E-01
regulation of cellular localization (GO:0060341)	793	59	40.50	+	1.46	2.99E-03
cell-cell junction assembly (GO:0007043)	121	9	6.18	+	1.46	1.71E-01
regulation of protein secretion (GO:0050708)	323	24	16.50	+	1.45	4.69E-02
organophosphate metabolic process (GO:0019637)	808	60	41.27	+	1.45	2.88E-03
ribonucleotide metabolic process (GO:0009259)	283	21	14.45	+	1.45	6.05E-02
response to vitamin (GO:0033273)	81	6	4.14	+	1.45	2.36E-01
response to hypoxia (GO:0001666)	324	24	16.55	+	1.45	4.83E-02
regulation of intracellular pH (GO:0051453)	81	6	4.14	+	1.45	2.36E-01
cellular response to UV (GO:0034644)	81	6	4.14	+	1.45	2.36E-01
negative regulation of lipid metabolic process (GO:0045833)	81	6	4.14	+	1.45	2.36E-01
folic acid-containing compound metabolic process (GO:0006760)	27	2	1.38	+	1.45	4.01E-01
female meiotic nuclear division (GO:0007143)	27	2	1.38	+	1.45	4.01E-01
inner ear receptor cell differentiation (GO:0060113)	54	4	2.76	+	1.45	2.99E-01
gastrulation with mouth forming second (GO:0001702)	27	2	1.38	+	1.45	4.01E-01
nuclear DNA replication (GO:0033260)	54	4	2.76	+	1.45	2.99E-01
regulation of chromatin organization (GO:1902275)	189	14	9.65	+	1.45	1.10E-01
negative regulation of interleukin-2 production (GO:0032703)	27	2	1.38	+	1.45	4.01E-01
response to angiotensin (GO:1990776)	27	2	1.38	+	1.45	4.01E-01
negative regulation of signal transduction by p53 class mediator (GO:1901797)	27	2	1.38	+	1.45	4.01E-01
sprouting angiogenesis (GO:0002040)	54	4	2.76	+	1.45	2.99E-01
protein K48-linked ubiquitination (GO:0070936)	54	4	2.76	+	1.45	2.99E-01
cellular response to fatty acid (GO:0071398)	54	4	2.76	+	1.45	2.99E-01
cellular response to interleukin-4 (GO:0071353)	27	2	1.38	+	1.45	4.01E-01
positive regulation of oxidoreductase activity (GO:0051353)	54	4	2.76	+	1.45	2.99E-01
chromosome separation (GO:0051304)	27	2	1.38	+	1.45	4.01E-01
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	27	2	1.38	+	1.45	4.01E-01
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	27	2	1.38	+	1.45	4.01E-01
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	27	2	1.38	+	1.45	4.01E-01
hair follicle morphogenesis (GO:0031069)	27	2	1.38	+	1.45	4.01E-01
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	54	4	2.76	+	1.45	2.99E-01
epithelial structure maintenance (GO:0010669)	27	2	1.38	+	1.45	4.01E-01
cell fate commitment involved in formation of primary germ layer (GO:0060795)	27	2	1.38	+	1.45	4.01E-01
regulation of animal organ formation (GO:0003156)	27	2	1.38	+	1.45	4.01E-01
heterocycle metabolic process (GO:0046483)	2539	188	129.68	+	1.45	7.32E-08
regulation of cellular component biogenesis (GO:0044087)	893	66	45.61	+	1.45	2.03E-03
gene expression (GO:0010467)	1854	137	94.70	+	1.45	7.45E-06
cellular response to organonitrogen compound (GO:0071417)	555	41	28.35	+	1.45	1.34E-02
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1737	128	88.72	+	1.44	1.79E-05
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	95	7	4.85	+	1.44	2.16E-01
chromatin assembly (GO:0031497)	95	7	4.85	+	1.44	2.16E-01
regulation of exocytosis (GO:0017157)	190	14	9.70	+	1.44	1.14E-01
organelle fusion (GO:0048284)	95	7	4.85	+	1.44	2.16E-01
regulation of axon extension (GO:0030516)	95	7	4.85	+	1.44	2.16E-01
negative regulation of phosphatase activity (GO:0010923)	95	7	4.85	+	1.44	2.16E-01
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	95	7	4.85	+	1.44	2.16E-01
iron ion transport (GO:0006826)	68	5	3.47	+	1.44	2.69E-01
DNA-templated transcription, termination (GO:0006353)	68	5	3.47	+	1.44	2.69E-01
negative regulation of ion transmembrane transporter activity (GO:0032413)	68	5	3.47	+	1.44	2.69E-01
stem cell population maintenance (GO:0019827)	136	10	6.95	+	1.44	1.63E-01
positive regulation of transcription by RNA polymerase II (GO:0045944)	1131	83	57.77	+	1.44	6.82E-04
positive regulation of RNA biosynthetic process (GO:1902680)	1499	110	76.56	+	1.44	8.86E-05
cytokine production (GO:0001816)	150	11	7.66	+	1.44	1.51E-01
regulation of lipid localization (GO:1905952)	150	11	7.66	+	1.44	1.51E-01
regulation of viral life cycle (GO:1903900)	150	11	7.66	+	1.44	1.51E-01
lipid metabolic process (GO:0006629)	1105	81	56.44	+	1.44	8.17E-04
nucleoside phosphate metabolic process (GO:0006753)	382	28	19.51	+	1.44	3.92E-02
DNA recombination (GO:0006310)	191	14	9.76	+	1.44	1.17E-01
cellular aromatic compound metabolic process (GO:0006725)	2581	189	131.83	+	1.43	1.46E-07
positive regulation of glial cell differentiation (GO:0045687)	41	3	2.09	+	1.43	3.49E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	41	3	2.09	+	1.43	3.49E-01
negative regulation of type I interferon production (GO:0032480)	41	3	2.09	+	1.43	3.49E-01
regulation of leukocyte apoptotic process (GO:2000106)	82	6	4.19	+	1.43	2.45E-01
histone exchange (GO:0043486)	41	3	2.09	+	1.43	3.49E-01
calcium-ion regulated exocytosis (GO:0017156)	41	3	2.09	+	1.43	3.49E-01
ephrin receptor signaling pathway (GO:0048013)	82	6	4.19	+	1.43	2.45E-01
gene silencing by miRNA (GO:0035195)	41	3	2.09	+	1.43	3.49E-01
regulation of viral entry into host cell (GO:0046596)	41	3	2.09	+	1.43	3.49E-01
negative regulation of cation transmembrane transport (GO:1904063)	82	6	4.19	+	1.43	2.45E-01
positive regulation of RNA metabolic process (GO:0051254)	1587	116	81.06	+	1.43	6.53E-05
positive regulation of macromolecule biosynthetic process (GO:0010557)	1711	125	87.39	+	1.43	3.34E-05
regulation of cellular amide metabolic process (GO:0034248)	397	29	20.28	+	1.43	3.77E-02
peptidyl-serine phosphorylation (GO:0018105)	178	13	9.09	+	1.43	1.30E-01
mitotic cell cycle process (GO:1903047)	630	46	32.18	+	1.43	1.11E-02
positive regulation of nitrogen compound metabolic process (GO:0051173)	2945	215	150.42	+	1.43	1.74E-08
RNA phosphodiester bond hydrolysis (GO:0090501)	137	10	7.00	+	1.43	1.68E-01
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	96	7	4.90	+	1.43	2.23E-01
transforming growth factor beta receptor signaling pathway (GO:0007179)	96	7	4.90	+	1.43	2.23E-01
digestion (GO:0007586)	96	7	4.90	+	1.43	2.23E-01
positive regulation of cellular metabolic process (GO:0031325)	3115	227	159.10	+	1.43	6.60E-09
cellular response to nitrogen compound (GO:1901699)	604	44	30.85	+	1.43	1.33E-02
cellular macromolecule biosynthetic process (GO:0034645)	1456	106	74.37	+	1.43	1.62E-04
positive regulation of nucleic acid-templated transcription (GO:1903508)	1498	109	76.51	+	1.42	1.32E-04
cell cycle DNA replication (GO:0044786)	55	4	2.81	+	1.42	3.10E-01
interaction with host (GO:0051701)	165	12	8.43	+	1.42	1.44E-01
monocarboxylic acid biosynthetic process (GO:0072330)	179	13	9.14	+	1.42	1.34E-01
DNA-dependent DNA replication (GO:0006261)	124	9	6.33	+	1.42	1.88E-01
negative regulation of protein modification process (GO:0031400)	565	41	28.86	+	1.42	1.74E-02
hair follicle development (GO:0001942)	69	5	3.52	+	1.42	2.79E-01
retina homeostasis (GO:0001895)	69	5	3.52	+	1.42	2.79E-01
RNA methylation (GO:0001510)	69	5	3.52	+	1.42	2.79E-01
cellular response to acid chemical (GO:0071229)	69	5	3.52	+	1.42	2.79E-01
response to glucocorticoid (GO:0051384)	138	10	7.05	+	1.42	1.74E-01
maintenance of cell number (GO:0098727)	138	10	7.05	+	1.42	1.74E-01
positive regulation of inflammatory response (GO:0050729)	138	10	7.05	+	1.42	1.74E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	69	5	3.52	+	1.42	2.79E-01
response to organonitrogen compound (GO:0010243)	926	67	47.30	+	1.42	3.08E-03
vesicle targeting (GO:0006903)	83	6	4.24	+	1.42	2.53E-01
multicellular organism growth (GO:0035264)	83	6	4.24	+	1.42	2.53E-01
positive regulation of peptide hormone secretion (GO:0090277)	97	7	4.95	+	1.41	2.31E-01
cellular response to endogenous stimulus (GO:0071495)	1069	77	54.60	+	1.41	1.74E-03
macromolecule biosynthetic process (GO:0009059)	1500	108	76.62	+	1.41	2.10E-04
response to radiation (GO:0009314)	417	30	21.30	+	1.41	4.13E-02
regulation of supramolecular fiber organization (GO:1902903)	349	25	17.83	+	1.40	6.06E-02
positive regulation of cellular biosynthetic process (GO:0031328)	1815	130	92.70	+	1.40	5.51E-05
regulation of cellular component size (GO:0032535)	363	26	18.54	+	1.40	5.67E-02
regulation of actin filament-based process (GO:0032970)	377	27	19.26	+	1.40	5.30E-02
positive regulation of transcription, DNA-templated (GO:0045893)	1426	102	72.84	+	1.40	4.00E-04
lipid translocation (GO:0034204)	42	3	2.15	+	1.40	3.63E-01
negative regulation of immunoglobulin production (GO:0002638)	14	1	.72	+	1.40	5.11E-01
response to UV-C (GO:0010225)	14	1	.72	+	1.40	5.11E-01
thalamus development (GO:0021794)	14	1	.72	+	1.40	5.11E-01
positive regulation of glycogen biosynthetic process (GO:0045725)	14	1	.72	+	1.40	5.11E-01
atrial septum morphogenesis (GO:0060413)	14	1	.72	+	1.40	5.11E-01
somatic diversification of immune receptors via somatic mutation (GO:0002566)	14	1	.72	+	1.40	5.11E-01
leukotriene biosynthetic process (GO:0019370)	14	1	.72	+	1.40	5.11E-01
pyridine nucleotide biosynthetic process (GO:0019363)	28	2	1.43	+	1.40	4.19E-01
nicotinamide nucleotide biosynthetic process (GO:0019359)	28	2	1.43	+	1.40	4.19E-01
protein localization to Golgi apparatus (GO:0034067)	28	2	1.43	+	1.40	4.19E-01
regulation of apoptotic signaling pathway (GO:2001233)	336	24	17.16	+	1.40	6.66E-02
cell migration in hindbrain (GO:0021535)	14	1	.72	+	1.40	5.11E-01
hematopoietic stem cell differentiation (GO:0060218)	14	1	.72	+	1.40	5.11E-01
ubiquinone biosynthetic process (GO:0006744)	14	1	.72	+	1.40	5.11E-01
immunoglobulin production (GO:0002377)	56	4	2.86	+	1.40	3.21E-01
inner cell mass cell proliferation (GO:0001833)	14	1	.72	+	1.40	5.11E-01
epithelial cell fate commitment (GO:0072148)	14	1	.72	+	1.40	5.11E-01
prepulse inhibition (GO:0060134)	14	1	.72	+	1.40	5.11E-01
bile acid biosynthetic process (GO:0006699)	28	2	1.43	+	1.40	4.19E-01
regulation of phagocytosis, engulfment (GO:0060099)	14	1	.72	+	1.40	5.11E-01
collecting duct development (GO:0072044)	14	1	.72	+	1.40	5.11E-01
bile acid signaling pathway (GO:0038183)	14	1	.72	+	1.40	5.11E-01
Sertoli cell development (GO:0060009)	14	1	.72	+	1.40	5.11E-01
regulation of fibrinolysis (GO:0051917)	14	1	.72	+	1.40	5.11E-01
regulation of nuclear cell cycle DNA replication (GO:0033262)	14	1	.72	+	1.40	5.11E-01
cell-cell junction maintenance (GO:0045217)	14	1	.72	+	1.40	5.11E-01
positive regulation of interleukin-13 production (GO:0032736)	14	1	.72	+	1.40	5.11E-01
negative regulation of lymphocyte migration (GO:2000402)	14	1	.72	+	1.40	5.11E-01
protein N-linked glycosylation (GO:0006487)	70	5	3.58	+	1.40	2.89E-01
protein ADP-ribosylation (GO:0006471)	28	2	1.43	+	1.40	4.19E-01
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	14	1	.72	+	1.40	5.11E-01
interleukin-1 beta production (GO:0032611)	14	1	.72	+	1.40	5.11E-01
chromatin assembly or disassembly (GO:0006333)	112	8	5.72	+	1.40	2.18E-01
DNA catabolic process (GO:0006308)	28	2	1.43	+	1.40	4.19E-01
quinone biosynthetic process (GO:1901663)	14	1	.72	+	1.40	5.11E-01
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	14	1	.72	+	1.40	5.11E-01
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	14	1	.72	+	1.40	5.11E-01
regulation of myoblast proliferation (GO:2000291)	14	1	.72	+	1.40	5.11E-01
pyrimidine nucleotide catabolic process (GO:0006244)	14	1	.72	+	1.40	5.11E-01
response to cholesterol (GO:0070723)	28	2	1.43	+	1.40	4.19E-01
regulation of histone H3-K4 methylation (GO:0051569)	28	2	1.43	+	1.40	4.19E-01
regulation of keratinocyte migration (GO:0051547)	14	1	.72	+	1.40	5.11E-01
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	14	1	.72	+	1.40	5.11E-01
response to interleukin-15 (GO:0070672)	14	1	.72	+	1.40	5.11E-01
regulation of spindle checkpoint (GO:0090231)	14	1	.72	+	1.40	5.11E-01
regulation of meiotic cell cycle (GO:0051445)	42	3	2.15	+	1.40	3.63E-01
positive regulation of calcineurin-mediated signaling (GO:0106058)	14	1	.72	+	1.40	5.11E-01
negative regulation of calcineurin-mediated signaling (GO:0106057)	14	1	.72	+	1.40	5.11E-01
regulation of respiratory system process (GO:0044065)	14	1	.72	+	1.40	5.11E-01
lens fiber cell development (GO:0070307)	14	1	.72	+	1.40	5.11E-01
response to nerve growth factor (GO:1990089)	56	4	2.86	+	1.40	3.21E-01
regulation of thymocyte apoptotic process (GO:0070243)	14	1	.72	+	1.40	5.11E-01
regulation of isotype switching to IgG isotypes (GO:0048302)	14	1	.72	+	1.40	5.11E-01
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	168	12	8.58	+	1.40	1.57E-01
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	14	1	.72	+	1.40	5.11E-01
cellular response to increased oxygen levels (GO:0036295)	14	1	.72	+	1.40	5.11E-01
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	14	1	.72	+	1.40	5.11E-01
regulation of defense response to bacterium (GO:1900424)	14	1	.72	+	1.40	5.11E-01
positive T cell selection (GO:0043368)	28	2	1.43	+	1.40	4.19E-01
regulation of lysosomal lumen pH (GO:0035751)	14	1	.72	+	1.40	5.11E-01
meiotic spindle organization (GO:0000212)	14	1	.72	+	1.40	5.11E-01
positive regulation of B cell proliferation (GO:0030890)	42	3	2.15	+	1.40	3.63E-01
cytoskeleton-dependent intracellular transport (GO:0030705)	182	13	9.30	+	1.40	1.46E-01
hair cycle (GO:0042633)	84	6	4.29	+	1.40	2.61E-01
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	14	1	.72	+	1.40	5.11E-01
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	28	2	1.43	+	1.40	4.19E-01
monovalent inorganic anion homeostasis (GO:0055083)	28	2	1.43	+	1.40	4.19E-01
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	14	1	.72	+	1.40	5.11E-01
phosphate ion transmembrane transport (GO:0035435)	14	1	.72	+	1.40	5.11E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179)	56	4	2.86	+	1.40	3.21E-01
negative regulation of histone modification (GO:0031057)	42	3	2.15	+	1.40	3.63E-01
purine nucleoside diphosphate metabolic process (GO:0009135)	56	4	2.86	+	1.40	3.21E-01
pteridine-containing compound biosynthetic process (GO:0042559)	14	1	.72	+	1.40	5.11E-01
positive regulation of protein dephosphorylation (GO:0035307)	42	3	2.15	+	1.40	3.63E-01
positive regulation of keratinocyte proliferation (GO:0010838)	14	1	.72	+	1.40	5.11E-01
regulation of T cell chemotaxis (GO:0010819)	14	1	.72	+	1.40	5.11E-01
magnesium ion transmembrane transport (GO:1903830)	14	1	.72	+	1.40	5.11E-01
positive regulation of fibroblast migration (GO:0010763)	14	1	.72	+	1.40	5.11E-01
molting cycle (GO:0042303)	84	6	4.29	+	1.40	2.61E-01
heparan sulfate proteoglycan metabolic process (GO:0030201)	28	2	1.43	+	1.40	4.19E-01
ketone biosynthetic process (GO:0042181)	28	2	1.43	+	1.40	4.19E-01
secondary metabolic process (GO:0019748)	42	3	2.15	+	1.40	3.63E-01
regulation of mitotic spindle checkpoint (GO:1903504)	14	1	.72	+	1.40	5.11E-01
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	28	2	1.43	+	1.40	4.19E-01
cardiac muscle hypertrophy (GO:0003300)	28	2	1.43	+	1.40	4.19E-01
regulation of skeletal muscle cell proliferation (GO:0014857)	14	1	.72	+	1.40	5.11E-01
striated muscle cell proliferation (GO:0014855)	14	1	.72	+	1.40	5.11E-01
regulation of embryonic development (GO:0045995)	56	4	2.86	+	1.40	3.21E-01
positive regulation of smooth muscle contraction (GO:0045987)	28	2	1.43	+	1.40	4.19E-01
negative regulation of type 2 immune response (GO:0002829)	14	1	.72	+	1.40	5.11E-01
positive regulation of T-helper 1 type immune response (GO:0002827)	14	1	.72	+	1.40	5.11E-01
cardiac left ventricle morphogenesis (GO:0003214)	14	1	.72	+	1.40	5.11E-01
glucose import (GO:0046323)	14	1	.72	+	1.40	5.11E-01
positive regulation of peptide secretion (GO:0002793)	182	13	9.30	+	1.40	1.46E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314)	14	1	.72	+	1.40	5.11E-01
positive regulation of meiotic nuclear division (GO:0045836)	14	1	.72	+	1.40	5.11E-01
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	14	1	.72	+	1.40	5.11E-01
negative regulation of glycolytic process (GO:0045820)	14	1	.72	+	1.40	5.11E-01
apoptotic process involved in morphogenesis (GO:0060561)	14	1	.72	+	1.40	5.11E-01
positive regulation of response to DNA damage stimulus (GO:2001022)	98	7	5.01	+	1.40	2.38E-01
response to corticosteroid (GO:0031960)	154	11	7.87	+	1.40	1.70E-01
mitotic nuclear division (GO:0140014)	154	11	7.87	+	1.40	1.70E-01
positive regulation of cellular protein metabolic process (GO:0032270)	1512	108	77.23	+	1.40	2.81E-04
lipid transport (GO:0006869)	281	20	14.35	+	1.39	9.00E-02
cell cycle phase transition (GO:0044770)	281	20	14.35	+	1.39	9.00E-02
positive regulation of protein metabolic process (GO:0051247)	1588	113	81.11	+	1.39	2.31E-04
positive regulation of biosynthetic process (GO:0009891)	1843	131	94.13	+	1.39	7.19E-05
response to nitrogen compound (GO:1901698)	999	71	51.03	+	1.39	3.58E-03
negative regulation of protein phosphorylation (GO:0001933)	394	28	20.12	+	1.39	5.35E-02
peptidyl-serine modification (GO:0018209)	197	14	10.06	+	1.39	1.39E-01
negative regulation of phosphate metabolic process (GO:0045936)	535	38	27.33	+	1.39	2.84E-02
positive regulation of macromolecule metabolic process (GO:0010604)	3269	232	166.97	+	1.39	3.99E-08
negative regulation of phosphorus metabolic process (GO:0010563)	536	38	27.38	+	1.39	2.91E-02
organic substance biosynthetic process (GO:1901576)	2497	177	127.54	+	1.39	3.22E-06
cellular response to DNA damage stimulus (GO:0006974)	706	50	36.06	+	1.39	1.41E-02
regulation of response to DNA damage stimulus (GO:2001020)	198	14	10.11	+	1.38	1.43E-01
alpha-amino acid catabolic process (GO:1901606)	99	7	5.06	+	1.38	2.46E-01
actin cytoskeleton organization (GO:0030036)	495	35	25.28	+	1.38	3.62E-02
regulation of secretion by cell (GO:1903530)	595	42	30.39	+	1.38	2.41E-02
regulation of cell projection assembly (GO:0060491)	170	12	8.68	+	1.38	1.66E-01
biological phase (GO:0044848)	255	18	13.02	+	1.38	1.09E-01
mitochondrial respiratory chain complex assembly (GO:0033108)	85	6	4.34	+	1.38	2.70E-01
mitotic cell cycle phase (GO:0098763)	255	18	13.02	+	1.38	1.09E-01
midbrain development (GO:0030901)	85	6	4.34	+	1.38	2.70E-01
positive regulation of Wnt signaling pathway (GO:0030177)	170	12	8.68	+	1.38	1.66E-01
cell cycle phase (GO:0022403)	255	18	13.02	+	1.38	1.09E-01
sulfur compound metabolic process (GO:0006790)	326	23	16.65	+	1.38	7.88E-02
small molecule metabolic process (GO:0044281)	1560	110	79.68	+	1.38	3.91E-04
skin epidermis development (GO:0098773)	71	5	3.63	+	1.38	2.98E-01
oogenesis (GO:0048477)	71	5	3.63	+	1.38	2.98E-01
establishment of protein localization to mitochondrion (GO:0072655)	71	5	3.63	+	1.38	2.98E-01
negative regulation of epithelial cell proliferation (GO:0050680)	128	9	6.54	+	1.38	2.12E-01
response to alcohol (GO:0097305)	242	17	12.36	+	1.38	1.20E-01
regulation of monooxygenase activity (GO:0032768)	57	4	2.91	+	1.37	3.33E-01
dendrite morphogenesis (GO:0048813)	57	4	2.91	+	1.37	3.33E-01
positive regulation of calcium ion transport into cytosol (GO:0010524)	57	4	2.91	+	1.37	3.33E-01
regulation of intracellular transport (GO:0032386)	342	24	17.47	+	1.37	7.73E-02
biosynthetic process (GO:0009058)	2552	179	130.35	+	1.37	5.27E-06
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	499	35	25.49	+	1.37	3.98E-02
cellular nitrogen compound biosynthetic process (GO:0044271)	1383	97	70.64	+	1.37	1.04E-03
positive regulation of intracellular transport (GO:0032388)	214	15	10.93	+	1.37	1.39E-01
regulation of proteolysis (GO:0030162)	672	47	34.32	+	1.37	2.05E-02
regulation of protein localization to membrane (GO:1905475)	186	13	9.50	+	1.37	1.62E-01
glycerolipid biosynthetic process (GO:0045017)	229	16	11.70	+	1.37	1.33E-01
cellular protein modification process (GO:0006464)	2779	194	141.94	+	1.37	2.49E-06
protein modification process (GO:0036211)	2779	194	141.94	+	1.37	2.49E-06
regulation of striated muscle contraction (GO:0006942)	86	6	4.39	+	1.37	2.79E-01
inner ear receptor cell development (GO:0060119)	43	3	2.20	+	1.37	3.76E-01
activation of innate immune response (GO:0002218)	129	9	6.59	+	1.37	2.18E-01
phagosome maturation (GO:0090382)	43	3	2.20	+	1.37	3.76E-01
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	43	3	2.20	+	1.37	3.76E-01
modulation of excitatory postsynaptic potential (GO:0098815)	43	3	2.20	+	1.37	3.76E-01
vesicle transport along microtubule (GO:0047496)	43	3	2.20	+	1.37	3.76E-01
exocrine system development (GO:0035272)	43	3	2.20	+	1.37	3.76E-01
positive regulation of protein import into nucleus (GO:0042307)	43	3	2.20	+	1.37	3.76E-01
epithelial cell migration (GO:0010631)	86	6	4.39	+	1.37	2.79E-01
NAD metabolic process (GO:0019674)	43	3	2.20	+	1.37	3.76E-01
macromolecule modification (GO:0043412)	2973	207	151.85	+	1.36	1.19E-06
mitotic cell cycle phase transition (GO:0044772)	273	19	13.94	+	1.36	1.12E-01
glycoprotein metabolic process (GO:0009100)	345	24	17.62	+	1.36	8.31E-02
lipoprotein metabolic process (GO:0042157)	115	8	5.87	+	1.36	2.38E-01
regulation of protein-containing complex assembly (GO:0043254)	417	29	21.30	+	1.36	6.21E-02
response to reactive oxygen species (GO:0000302)	187	13	9.55	+	1.36	1.67E-01
glucose homeostasis (GO:0042593)	187	13	9.55	+	1.36	1.67E-01
acute inflammatory response (GO:0002526)	72	5	3.68	+	1.36	3.08E-01
cellular response to transforming growth factor beta stimulus (GO:0071560)	144	10	7.36	+	1.36	2.06E-01
regulation of bone mineralization (GO:0030500)	72	5	3.68	+	1.36	3.08E-01
hair cycle process (GO:0022405)	72	5	3.68	+	1.36	3.08E-01
molting cycle process (GO:0022404)	72	5	3.68	+	1.36	3.08E-01
response to endogenous stimulus (GO:0009719)	1326	92	67.73	+	1.36	1.92E-03
cell cycle (GO:0007049)	1240	86	63.34	+	1.36	2.72E-03
negative regulation of dephosphorylation (GO:0035305)	101	7	5.16	+	1.36	2.61E-01
enzyme linked receptor protein signaling pathway (GO:0007167)	693	48	35.40	+	1.36	2.25E-02
cell division (GO:0051301)	448	31	22.88	+	1.35	5.82E-02
response to temperature stimulus (GO:0009266)	159	11	8.12	+	1.35	1.95E-01
response to nutrient (GO:0007584)	159	11	8.12	+	1.35	1.95E-01
carbohydrate homeostasis (GO:0033500)	188	13	9.60	+	1.35	1.71E-01
regulation of organelle organization (GO:0033043)	1100	76	56.18	+	1.35	5.18E-03
regulation of protein stability (GO:0031647)	275	19	14.05	+	1.35	1.18E-01
ncRNA metabolic process (GO:0034660)	449	31	22.93	+	1.35	5.96E-02
positive regulation of neuron differentiation (GO:0045666)	87	6	4.44	+	1.35	2.87E-01
regulation of vasoconstriction (GO:0019229)	58	4	2.96	+	1.35	3.44E-01
regulation of glial cell proliferation (GO:0060251)	29	2	1.48	+	1.35	4.36E-01
icosanoid transport (GO:0071715)	29	2	1.48	+	1.35	4.36E-01
regulation of nitric oxide biosynthetic process (GO:0045428)	58	4	2.96	+	1.35	3.44E-01
reproductive behavior (GO:0019098)	29	2	1.48	+	1.35	4.36E-01
negative regulation of viral transcription (GO:0032897)	29	2	1.48	+	1.35	4.36E-01
modulation by host of viral process (GO:0044788)	29	2	1.48	+	1.35	4.36E-01
regulation of transcription by RNA polymerase I (GO:0006356)	29	2	1.48	+	1.35	4.36E-01
fatty acid derivative transport (GO:1901571)	29	2	1.48	+	1.35	4.36E-01
response to interleukin-4 (GO:0070670)	29	2	1.48	+	1.35	4.36E-01
positive regulation of protein polymerization (GO:0032273)	116	8	5.92	+	1.35	2.45E-01
G2 DNA damage checkpoint (GO:0031572)	29	2	1.48	+	1.35	4.36E-01
aorta morphogenesis (GO:0035909)	29	2	1.48	+	1.35	4.36E-01
regulation of defense response to virus by virus (GO:0050690)	29	2	1.48	+	1.35	4.36E-01
skeletal muscle tissue regeneration (GO:0043403)	29	2	1.48	+	1.35	4.36E-01
beta-catenin-TCF complex assembly (GO:1904837)	29	2	1.48	+	1.35	4.36E-01
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	29	2	1.48	+	1.35	4.36E-01
regulation of mitochondrial gene expression (GO:0062125)	29	2	1.48	+	1.35	4.36E-01
regulation of neuroinflammatory response (GO:0150077)	29	2	1.48	+	1.35	4.36E-01
regulation of gene silencing by miRNA (GO:0060964)	87	6	4.44	+	1.35	2.87E-01
artery development (GO:0060840)	87	6	4.44	+	1.35	2.87E-01
positive regulation of vascular endothelial growth factor production (GO:0010575)	29	2	1.48	+	1.35	4.36E-01
estrogen metabolic process (GO:0008210)	29	2	1.48	+	1.35	4.36E-01
striated muscle hypertrophy (GO:0014897)	29	2	1.48	+	1.35	4.36E-01
positive regulation of steroid metabolic process (GO:0045940)	29	2	1.48	+	1.35	4.36E-01
dendritic spine organization (GO:0097061)	29	2	1.48	+	1.35	4.36E-01
intracellular transport (GO:0046907)	1350	93	68.95	+	1.35	2.23E-03
negative regulation of cell population proliferation (GO:0008285)	654	45	33.40	+	1.35	2.91E-02
cellular amino acid metabolic process (GO:0006520)	262	18	13.38	+	1.35	1.30E-01
mitotic cell cycle (GO:0000278)	699	48	35.70	+	1.34	2.56E-02
positive regulation of metabolic process (GO:0009893)	3539	243	180.76	+	1.34	2.63E-07
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	102	7	5.21	+	1.34	2.69E-01
endoplasmic reticulum unfolded protein response (GO:0030968)	102	7	5.21	+	1.34	2.69E-01
mitotic sister chromatid segregation (GO:0000070)	102	7	5.21	+	1.34	2.69E-01
diterpenoid metabolic process (GO:0016101)	102	7	5.21	+	1.34	2.69E-01
regulation of gene silencing (GO:0060968)	102	7	5.21	+	1.34	2.69E-01
protein-containing complex subunit organization (GO:0043933)	1370	94	69.98	+	1.34	2.37E-03
microtubule-based transport (GO:0099111)	175	12	8.94	+	1.34	1.90E-01
negative regulation of apoptotic signaling pathway (GO:2001234)	219	15	11.19	+	1.34	1.58E-01
mitotic cell cycle checkpoint (GO:0007093)	146	10	7.46	+	1.34	2.18E-01
fatty acid derivative metabolic process (GO:1901568)	146	10	7.46	+	1.34	2.18E-01
Golgi vesicle budding (GO:0048194)	73	5	3.73	+	1.34	3.18E-01
transport along microtubule (GO:0010970)	146	10	7.46	+	1.34	2.18E-01
negative regulation of transport (GO:0051051)	424	29	21.66	+	1.34	7.28E-02
regulation of nucleobase-containing compound metabolic process (GO:0019219)	3554	243	181.53	+	1.34	3.71E-07
protein-containing complex assembly (GO:0065003)	1141	78	58.28	+	1.34	5.99E-03
regulation of canonical Wnt signaling pathway (GO:0060828)	278	19	14.20	+	1.34	1.27E-01
negative regulation of transcription, DNA-templated (GO:0045892)	1142	78	58.33	+	1.34	6.12E-03
regulation of intracellular protein transport (GO:0033157)	249	17	12.72	+	1.34	1.43E-01
response to light stimulus (GO:0009416)	293	20	14.97	+	1.34	1.21E-01
regulation of actin cytoskeleton organization (GO:0032956)	337	23	17.21	+	1.34	1.02E-01
negative regulation of oxidative stress-induced cell death (GO:1903202)	44	3	2.25	+	1.33	3.90E-01
polyol biosynthetic process (GO:0046173)	44	3	2.25	+	1.33	3.90E-01
ADP metabolic process (GO:0046031)	44	3	2.25	+	1.33	3.90E-01
mitotic metaphase plate congression (GO:0007080)	44	3	2.25	+	1.33	3.90E-01
regulation of sodium ion transport (GO:0002028)	88	6	4.49	+	1.33	2.96E-01
epithelium migration (GO:0090132)	88	6	4.49	+	1.33	2.96E-01
response to fatty acid (GO:0070542)	88	6	4.49	+	1.33	2.96E-01
calcium ion import (GO:0070509)	44	3	2.25	+	1.33	3.90E-01
developmental cell growth (GO:0048588)	88	6	4.49	+	1.33	2.96E-01
negative regulation of protein transport (GO:0051224)	132	9	6.74	+	1.33	2.37E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	44	3	2.25	+	1.33	3.90E-01
CD4-positive, alpha-beta T cell activation (GO:0035710)	44	3	2.25	+	1.33	3.90E-01
positive regulation of histone modification (GO:0031058)	88	6	4.49	+	1.33	2.96E-01
lamellipodium organization (GO:0097581)	44	3	2.25	+	1.33	3.90E-01
negative regulation of cell growth (GO:0030308)	176	12	8.99	+	1.33	1.95E-01
regulation of peptide secretion (GO:0002791)	352	24	17.98	+	1.33	9.78E-02
cell differentiation involved in kidney development (GO:0061005)	44	3	2.25	+	1.33	3.90E-01
endocardial cushion development (GO:0003197)	44	3	2.25	+	1.33	3.90E-01
microtubule cytoskeleton organization (GO:0000226)	515	35	26.30	+	1.33	5.69E-02
nucleosome organization (GO:0034728)	103	7	5.26	+	1.33	2.77E-01
positive regulation of endothelial cell migration (GO:0010595)	103	7	5.26	+	1.33	2.77E-01
Fc receptor signaling pathway (GO:0038093)	162	11	8.27	+	1.33	2.11E-01
regulation of endothelial cell migration (GO:0010594)	162	11	8.27	+	1.33	2.11E-01
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1356	92	69.26	+	1.33	3.60E-03
nucleobase-containing small molecule metabolic process (GO:0055086)	457	31	23.34	+	1.33	7.10E-02
regulation of secretion (GO:0051046)	649	44	33.15	+	1.33	3.76E-02
pattern recognition receptor signaling pathway (GO:0002221)	118	8	6.03	+	1.33	2.59E-01
regulation of interleukin-2 production (GO:0032663)	59	4	3.01	+	1.33	3.56E-01
positive regulation of intracellular protein transport (GO:0090316)	177	12	9.04	+	1.33	2.00E-01
ribonucleoside diphosphate metabolic process (GO:0009185)	59	4	3.01	+	1.33	3.56E-01
cellular nitrogen compound metabolic process (GO:0034641)	2950	200	150.68	+	1.33	1.10E-05
cellular carbohydrate biosynthetic process (GO:0034637)	59	4	3.01	+	1.33	3.56E-01
regulation of RNA metabolic process (GO:0051252)	3322	225	169.68	+	1.33	2.53E-06
oxidation-reduction process (GO:0055114)	857	58	43.77	+	1.33	1.97E-02
cellular macromolecule metabolic process (GO:0044260)	4483	303	228.98	+	1.32	1.38E-08
viral process (GO:0016032)	799	54	40.81	+	1.32	2.44E-02
cellular lipid metabolic process (GO:0044255)	873	59	44.59	+	1.32	1.92E-02
peripheral nervous system development (GO:0007422)	74	5	3.78	+	1.32	3.28E-01
response to osmotic stress (GO:0006970)	74	5	3.78	+	1.32	3.28E-01
vesicle fusion (GO:0006906)	74	5	3.78	+	1.32	3.28E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	148	10	7.56	+	1.32	2.30E-01
regulation of posttranscriptional gene silencing (GO:0060147)	89	6	4.55	+	1.32	3.05E-01
regulation of biomineral tissue development (GO:0070167)	89	6	4.55	+	1.32	3.05E-01
negative regulation of small molecule metabolic process (GO:0062014)	89	6	4.55	+	1.32	3.05E-01
positive regulation of gene expression (GO:0010628)	2123	143	108.44	+	1.32	3.59E-04
negative regulation of RNA metabolic process (GO:0051253)	1262	85	64.46	+	1.32	6.09E-03
cellular biosynthetic process (GO:0044249)	2406	162	122.89	+	1.32	1.36E-04
regulation of peptide hormone secretion (GO:0090276)	208	14	10.62	+	1.32	1.84E-01
negative regulation of cell cycle G1/S phase transition (GO:1902807)	104	7	5.31	+	1.32	2.84E-01
negative regulation of nucleic acid-templated transcription (GO:1903507)	1175	79	60.02	+	1.32	8.39E-03
positive regulation of apoptotic process (GO:0043065)	536	36	27.38	+	1.31	6.17E-02
regulation of cellular carbohydrate metabolic process (GO:0010675)	134	9	6.84	+	1.31	2.50E-01
positive regulation of organelle organization (GO:0010638)	551	37	28.14	+	1.31	5.90E-02
negative regulation of RNA biosynthetic process (GO:1902679)	1177	79	60.12	+	1.31	8.73E-03
regulation of body fluid levels (GO:0050878)	462	31	23.60	+	1.31	7.90E-02
cell population proliferation (GO:0008283)	462	31	23.60	+	1.31	7.90E-02
peptidyl-amino acid modification (GO:0018193)	790	53	40.35	+	1.31	2.87E-02
regulation of cell cycle G1/S phase transition (GO:1902806)	164	11	8.38	+	1.31	2.22E-01
protein-containing complex disassembly (GO:0032984)	209	14	10.68	+	1.31	1.88E-01
negative regulation of growth (GO:0045926)	239	16	12.21	+	1.31	1.69E-01
phosphate-containing compound metabolic process (GO:0006796)	1973	132	100.77	+	1.31	8.12E-04
organelle localization (GO:0051640)	569	38	29.06	+	1.31	6.00E-02
negative regulation of osteoblast differentiation (GO:0045668)	45	3	2.30	+	1.31	4.04E-01
cellular polysaccharide biosynthetic process (GO:0033692)	45	3	2.30	+	1.31	4.04E-01
regulation of biomineralization (GO:0110149)	90	6	4.60	+	1.31	3.14E-01
regulation of gliogenesis (GO:0014013)	90	6	4.60	+	1.31	3.14E-01
morphogenesis of an epithelial sheet (GO:0002011)	45	3	2.30	+	1.31	4.04E-01
genitalia development (GO:0048806)	45	3	2.30	+	1.31	4.04E-01
regulation of blood vessel endothelial cell migration (GO:0043535)	90	6	4.60	+	1.31	3.14E-01
polysaccharide biosynthetic process (GO:0000271)	45	3	2.30	+	1.31	4.04E-01
interleukin-12-mediated signaling pathway (GO:0035722)	45	3	2.30	+	1.31	4.04E-01
cell growth (GO:0016049)	90	6	4.60	+	1.31	3.14E-01
regulation of epithelial to mesenchymal transition (GO:0010717)	90	6	4.60	+	1.31	3.14E-01
regulation of gene silencing by RNA (GO:0060966)	90	6	4.60	+	1.31	3.14E-01
regulation of reactive oxygen species biosynthetic process (GO:1903426)	90	6	4.60	+	1.31	3.14E-01
negative regulation of endocytosis (GO:0045806)	45	3	2.30	+	1.31	4.04E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808)	45	3	2.30	+	1.31	4.04E-01
regulation of angiogenesis (GO:0045765)	270	18	13.79	+	1.31	1.56E-01
cerebral cortex radially oriented cell migration (GO:0021799)	30	2	1.53	+	1.31	4.53E-01
salivary gland morphogenesis (GO:0007435)	30	2	1.53	+	1.31	4.53E-01
positive regulation of digestive system process (GO:0060456)	15	1	.77	+	1.31	5.35E-01
respiratory system process (GO:0003016)	15	1	.77	+	1.31	5.35E-01
regulation of muscle contraction (GO:0006937)	150	10	7.66	+	1.31	2.42E-01
pyridine nucleotide metabolic process (GO:0019362)	30	2	1.53	+	1.31	4.53E-01
regulation of receptor localization to synapse (GO:1902683)	15	1	.77	+	1.31	5.35E-01
Golgi to endosome transport (GO:0006895)	15	1	.77	+	1.31	5.35E-01
intra-Golgi vesicle-mediated transport (GO:0006891)	30	2	1.53	+	1.31	4.53E-01
response to manganese ion (GO:0010042)	15	1	.77	+	1.31	5.35E-01
positive regulation of B cell differentiation (GO:0045579)	15	1	.77	+	1.31	5.35E-01
positive regulation of protein localization to plasma membrane (GO:1903078)	60	4	3.06	+	1.31	3.67E-01
metanephric nephron tubule development (GO:0072234)	15	1	.77	+	1.31	5.35E-01
mesenchymal to epithelial transition (GO:0060231)	15	1	.77	+	1.31	5.35E-01
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	15	1	.77	+	1.31	5.35E-01
alpha-beta T cell lineage commitment (GO:0002363)	15	1	.77	+	1.31	5.35E-01
cellular response to nitric oxide (GO:0071732)	15	1	.77	+	1.31	5.35E-01
nonribosomal peptide biosynthetic process (GO:0019184)	15	1	.77	+	1.31	5.35E-01
phagolysosome assembly (GO:0001845)	15	1	.77	+	1.31	5.35E-01
phosphatidylserine metabolic process (GO:0006658)	30	2	1.53	+	1.31	4.53E-01
regulation of integrin-mediated signaling pathway (GO:2001044)	15	1	.77	+	1.31	5.35E-01
positive regulation of endothelial cell chemotaxis (GO:2001028)	15	1	.77	+	1.31	5.35E-01
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	30	2	1.53	+	1.31	4.53E-01
GPI anchor biosynthetic process (GO:0006506)	30	2	1.53	+	1.31	4.53E-01
negative regulation of DNA-templated transcription, elongation (GO:0032785)	15	1	.77	+	1.31	5.35E-01
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	15	1	.77	+	1.31	5.35E-01
V(D)J recombination (GO:0033151)	15	1	.77	+	1.31	5.35E-01
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	15	1	.77	+	1.31	5.35E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	15	1	.77	+	1.31	5.35E-01
transcription by RNA polymerase III (GO:0006383)	30	2	1.53	+	1.31	4.53E-01
nucleosome disassembly (GO:0006337)	15	1	.77	+	1.31	5.35E-01
response to salt (GO:1902074)	15	1	.77	+	1.31	5.35E-01
protein N-linked glycosylation via asparagine (GO:0018279)	30	2	1.53	+	1.31	4.53E-01
DNA repair (GO:0006281)	465	31	23.75	+	1.31	8.40E-02
regulation of amyloid-beta formation (GO:1902003)	30	2	1.53	+	1.31	4.53E-01
peptidyl-asparagine modification (GO:0018196)	30	2	1.53	+	1.31	4.53E-01
synaptic vesicle transport along microtubule (GO:0099517)	15	1	.77	+	1.31	5.35E-01
synaptic vesicle cytoskeletal transport (GO:0099514)	15	1	.77	+	1.31	5.35E-01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	30	2	1.53	+	1.31	4.53E-01
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	30	2	1.53	+	1.31	4.53E-01
regulation of muscle system process (GO:0090257)	210	14	10.73	+	1.31	1.93E-01
alanine transport (GO:0032328)	15	1	.77	+	1.31	5.35E-01
membrane fission (GO:0090148)	15	1	.77	+	1.31	5.35E-01
induction of positive chemotaxis (GO:0050930)	15	1	.77	+	1.31	5.35E-01
positive regulation of vascular endothelial cell proliferation (GO:1905564)	15	1	.77	+	1.31	5.35E-01
cellular protein complex disassembly (GO:0043624)	135	9	6.90	+	1.31	2.57E-01
anterograde synaptic vesicle transport (GO:0048490)	15	1	.77	+	1.31	5.35E-01
intra-S DNA damage checkpoint (GO:0031573)	15	1	.77	+	1.31	5.35E-01
blood vessel endothelial cell migration (GO:0043534)	30	2	1.53	+	1.31	4.53E-01
cytokine secretion (GO:0050663)	15	1	.77	+	1.31	5.35E-01
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	15	1	.77	+	1.31	5.35E-01
protein homotrimerization (GO:0070207)	15	1	.77	+	1.31	5.35E-01
chromatin disassembly (GO:0031498)	15	1	.77	+	1.31	5.35E-01
actin filament severing (GO:0051014)	15	1	.77	+	1.31	5.35E-01
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	15	1	.77	+	1.31	5.35E-01
regulation of epithelial cell differentiation (GO:0030856)	135	9	6.90	+	1.31	2.57E-01
negative regulation of potassium ion transport (GO:0043267)	30	2	1.53	+	1.31	4.53E-01
regulation of membrane invagination (GO:1905153)	15	1	.77	+	1.31	5.35E-01
erythrocyte maturation (GO:0043249)	15	1	.77	+	1.31	5.35E-01
regulation of sulfur metabolic process (GO:0042762)	15	1	.77	+	1.31	5.35E-01
long-chain fatty acid biosynthetic process (GO:0042759)	30	2	1.53	+	1.31	4.53E-01
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	15	1	.77	+	1.31	5.35E-01
G1/S transition of mitotic cell cycle (GO:0000082)	120	8	6.13	+	1.31	2.74E-01
regulation of DNA recombination (GO:0000018)	105	7	5.36	+	1.31	2.92E-01
relaxation of cardiac muscle (GO:0055119)	15	1	.77	+	1.31	5.35E-01
cytoplasmic microtubule organization (GO:0031122)	60	4	3.06	+	1.31	3.67E-01
positive regulation of microtubule polymerization (GO:0031116)	30	2	1.53	+	1.31	4.53E-01
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	15	1	.77	+	1.31	5.35E-01
negative regulation of receptor binding (GO:1900121)	15	1	.77	+	1.31	5.35E-01
extracellular negative regulation of signal transduction (GO:1900116)	15	1	.77	+	1.31	5.35E-01
extracellular regulation of signal transduction (GO:1900115)	15	1	.77	+	1.31	5.35E-01
neuroblast division (GO:0055057)	15	1	.77	+	1.31	5.35E-01
Golgi to plasma membrane protein transport (GO:0043001)	30	2	1.53	+	1.31	4.53E-01
basic amino acid transport (GO:0015802)	15	1	.77	+	1.31	5.35E-01
negative regulation of protein processing (GO:0010955)	30	2	1.53	+	1.31	4.53E-01
regulation of microglial cell activation (GO:1903978)	15	1	.77	+	1.31	5.35E-01
serine family amino acid biosynthetic process (GO:0009070)	15	1	.77	+	1.31	5.35E-01
mechanoreceptor differentiation (GO:0042490)	60	4	3.06	+	1.31	3.67E-01
magnesium ion transport (GO:0015693)	15	1	.77	+	1.31	5.35E-01
snoRNA metabolic process (GO:0016074)	15	1	.77	+	1.31	5.35E-01
ribonucleoprotein complex assembly (GO:0022618)	165	11	8.43	+	1.31	2.28E-01
lipoprotein catabolic process (GO:0042159)	15	1	.77	+	1.31	5.35E-01
proteoglycan biosynthetic process (GO:0030166)	60	4	3.06	+	1.31	3.67E-01
tooth mineralization (GO:0034505)	15	1	.77	+	1.31	5.35E-01
C21-steroid hormone metabolic process (GO:0008207)	30	2	1.53	+	1.31	4.53E-01
nicotinamide nucleotide metabolic process (GO:0046496)	30	2	1.53	+	1.31	4.53E-01
regulation of gastrulation (GO:0010470)	15	1	.77	+	1.31	5.35E-01
mesenchymal cell proliferation (GO:0010463)	15	1	.77	+	1.31	5.35E-01
regulation of TORC1 signaling (GO:1903432)	30	2	1.53	+	1.31	4.53E-01
low-density lipoprotein particle remodeling (GO:0034374)	15	1	.77	+	1.31	5.35E-01
positive regulation of fatty acid oxidation (GO:0046321)	15	1	.77	+	1.31	5.35E-01
parturition (GO:0007567)	15	1	.77	+	1.31	5.35E-01
negative regulation of protein maturation (GO:1903318)	30	2	1.53	+	1.31	4.53E-01
connective tissue development (GO:0061448)	195	13	9.96	+	1.31	2.04E-01
regulation of biosynthetic process (GO:0009889)	3752	250	191.64	+	1.30	1.86E-06
phosphorus metabolic process (GO:0006793)	1999	133	102.10	+	1.30	9.57E-04
negative regulation of transcription by RNA polymerase II (GO:0000122)	857	57	43.77	+	1.30	2.76E-02
regulation of nervous system development (GO:0051960)	421	28	21.50	+	1.30	9.85E-02
response to abiotic stimulus (GO:0009628)	1083	72	55.32	+	1.30	1.46E-02
primary metabolic process (GO:0044238)	6575	437	335.83	+	1.30	9.29E-13
regulation of symbiotic process (GO:0043903)	226	15	11.54	+	1.30	1.87E-01
tissue homeostasis (GO:0001894)	211	14	10.78	+	1.30	1.97E-01
defense response to virus (GO:0051607)	196	13	10.01	+	1.30	2.08E-01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	1327	88	67.78	+	1.30	7.81E-03
macromolecule metabolic process (GO:0043170)	5505	365	281.18	+	1.30	1.02E-09
cell cycle checkpoint (GO:0000075)	181	12	9.24	+	1.30	2.20E-01
cellular response to oxygen-containing compound (GO:1901701)	996	66	50.87	+	1.30	2.01E-02
response to transforming growth factor beta (GO:0071559)	151	10	7.71	+	1.30	2.48E-01
positive regulation of secretion by cell (GO:1903532)	302	20	15.43	+	1.30	1.48E-01
negative regulation of secretion by cell (GO:1903531)	151	10	7.71	+	1.30	2.48E-01
negative regulation of programmed cell death (GO:0043069)	846	56	43.21	+	1.30	3.11E-02
negative regulation of establishment of protein localization (GO:1904950)	136	9	6.95	+	1.30	2.63E-01
positive regulation of programmed cell death (GO:0043068)	544	36	27.79	+	1.30	7.25E-02
monocarboxylic acid transport (GO:0015718)	136	9	6.95	+	1.30	2.63E-01
blood coagulation (GO:0007596)	272	18	13.89	+	1.30	1.63E-01
regulation of primary metabolic process (GO:0080090)	5371	355	274.33	+	1.29	3.32E-09
regulation of protein metabolic process (GO:0051246)	2573	170	131.42	+	1.29	2.28E-04
regulation of programmed cell death (GO:0043067)	1393	92	71.15	+	1.29	7.30E-03
DNA duplex unwinding (GO:0032508)	106	7	5.41	+	1.29	3.00E-01
positive regulation of viral process (GO:0048524)	106	7	5.41	+	1.29	3.00E-01
cellular monovalent inorganic cation homeostasis (GO:0030004)	106	7	5.41	+	1.29	3.00E-01
regulation of cellular protein metabolic process (GO:0032268)	2440	161	124.63	+	1.29	3.70E-04
regulation of fatty acid metabolic process (GO:0019217)	91	6	4.65	+	1.29	3.22E-01
microtubule-based process (GO:0007017)	728	48	37.18	+	1.29	4.58E-02
regulation of vasculature development (GO:1901342)	273	18	13.94	+	1.29	1.67E-01
coagulation (GO:0050817)	273	18	13.94	+	1.29	1.67E-01
protein phosphorylation (GO:0006468)	910	60	46.48	+	1.29	2.81E-02
regulation of cellular macromolecule biosynthetic process (GO:2000112)	3444	227	175.91	+	1.29	1.51E-05
limb development (GO:0060173)	167	11	8.53	+	1.29	2.39E-01
appendage development (GO:0048736)	167	11	8.53	+	1.29	2.39E-01
reproductive system development (GO:0061458)	410	27	20.94	+	1.29	1.12E-01
protein localization to mitochondrion (GO:0070585)	76	5	3.88	+	1.29	3.48E-01
positive regulation of B cell activation (GO:0050871)	76	5	3.88	+	1.29	3.48E-01
phosphatidylcholine metabolic process (GO:0046470)	76	5	3.88	+	1.29	3.48E-01
apoptotic process (GO:0006915)	852	56	43.52	+	1.29	3.47E-02
response to ketone (GO:1901654)	198	13	10.11	+	1.29	2.18E-01
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	396	26	20.23	+	1.29	1.20E-01
maternal process involved in female pregnancy (GO:0060135)	61	4	3.12	+	1.28	3.79E-01
cell cycle G1/S phase transition (GO:0044843)	122	8	6.23	+	1.28	2.88E-01
cellular response to amino acid stimulus (GO:0071230)	61	4	3.12	+	1.28	3.79E-01
negative regulation of synaptic transmission (GO:0050805)	61	4	3.12	+	1.28	3.79E-01
carbohydrate derivative biosynthetic process (GO:1901137)	549	36	28.04	+	1.28	7.98E-02
L-amino acid transport (GO:0015807)	61	4	3.12	+	1.28	3.79E-01
nitrogen compound metabolic process (GO:0006807)	6168	404	315.04	+	1.28	2.15E-10
regulation of macromolecule biosynthetic process (GO:0010556)	3529	231	180.25	+	1.28	1.96E-05
regulation of cellular metabolic process (GO:0031323)	5561	364	284.04	+	1.28	5.62E-09
organelle organization (GO:0006996)	3132	205	159.97	+	1.28	7.11E-05
regulation of RNA biosynthetic process (GO:2001141)	3087	202	157.67	+	1.28	8.34E-05
cellular response to lipid (GO:0071396)	474	31	24.21	+	1.28	1.00E-01
regulation of apoptotic process (GO:0042981)	1361	89	69.52	+	1.28	1.05E-02
regulation of transcription, DNA-templated (GO:0006355)	3028	198	154.66	+	1.28	1.05E-04
regulation of hormone secretion (GO:0046883)	260	17	13.28	+	1.28	1.84E-01
protein folding (GO:0006457)	199	13	10.16	+	1.28	2.23E-01
regulation of cytoskeleton organization (GO:0051493)	490	32	25.03	+	1.28	9.77E-02
negative regulation of apoptotic process (GO:0043066)	827	54	42.24	+	1.28	4.15E-02
cellular protein metabolic process (GO:0044267)	3340	218	170.60	+	1.28	4.51E-05
regulation of nucleic acid-templated transcription (GO:1903506)	3082	201	157.42	+	1.28	1.06E-04
negative regulation of blood pressure (GO:0045776)	46	3	2.35	+	1.28	4.17E-01
regulation of neuron differentiation (GO:0045664)	184	12	9.40	+	1.28	2.36E-01
long-term synaptic potentiation (GO:0060291)	46	3	2.35	+	1.28	4.17E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	184	12	9.40	+	1.28	2.36E-01
reciprocal meiotic recombination (GO:0007131)	46	3	2.35	+	1.28	4.17E-01
reciprocal homologous recombination (GO:0140527)	46	3	2.35	+	1.28	4.17E-01
DNA packaging (GO:0006323)	138	9	7.05	+	1.28	2.77E-01
base-excision repair (GO:0006284)	46	3	2.35	+	1.28	4.17E-01
negative regulation of leukocyte apoptotic process (GO:2000107)	46	3	2.35	+	1.28	4.17E-01
response to cAMP (GO:0051591)	92	6	4.70	+	1.28	3.31E-01
regulation of filopodium assembly (GO:0051489)	46	3	2.35	+	1.28	4.17E-01
regulation of release of cytochrome c from mitochondria (GO:0090199)	46	3	2.35	+	1.28	4.17E-01
regulation of nitric-oxide synthase activity (GO:0050999)	46	3	2.35	+	1.28	4.17E-01
skeletal muscle cell differentiation (GO:0035914)	46	3	2.35	+	1.28	4.17E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088)	46	3	2.35	+	1.28	4.17E-01
establishment or maintenance of bipolar cell polarity (GO:0061245)	46	3	2.35	+	1.28	4.17E-01
regulation of nitrogen compound metabolic process (GO:0051171)	5202	339	265.70	+	1.28	5.46E-08
positive regulation of translation (GO:0045727)	123	8	6.28	+	1.27	2.95E-01
organic substance metabolic process (GO:0071704)	6967	453	355.85	+	1.27	8.21E-12
regulation of cellular biosynthetic process (GO:0031326)	3676	239	187.76	+	1.27	2.08E-05
cytoskeleton organization (GO:0007010)	1108	72	56.59	+	1.27	2.29E-02
hemostasis (GO:0007599)	277	18	14.15	+	1.27	1.82E-01
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	77	5	3.93	+	1.27	3.58E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	1371	89	70.03	+	1.27	1.25E-02
regulation of anatomical structure size (GO:0090066)	493	32	25.18	+	1.27	1.03E-01
multicellular organismal homeostasis (GO:0048871)	339	22	17.32	+	1.27	1.54E-01
dendrite development (GO:0016358)	108	7	5.52	+	1.27	3.16E-01
negative regulation of protein catabolic process (GO:0042177)	108	7	5.52	+	1.27	3.16E-01
positive regulation of cell death (GO:0010942)	602	39	30.75	+	1.27	8.08E-02
regulation of cell cycle (GO:0051726)	1097	71	56.03	+	1.27	2.57E-02
ribonucleoprotein complex subunit organization (GO:0071826)	170	11	8.68	+	1.27	2.56E-01
regulation of transcription by RNA polymerase II (GO:0006357)	2335	151	119.26	+	1.27	1.34E-03
symbiotic process (GO:0044403)	882	57	45.05	+	1.27	4.34E-02
negative regulation of cellular biosynthetic process (GO:0031327)	1424	92	72.73	+	1.26	1.26E-02
bone morphogenesis (GO:0060349)	93	6	4.75	+	1.26	3.40E-01
face morphogenesis (GO:0060325)	31	2	1.58	+	1.26	4.70E-01
extracellular transport (GO:0006858)	31	2	1.58	+	1.26	4.70E-01
regulation of response to wounding (GO:1903034)	155	10	7.92	+	1.26	2.72E-01
GPI anchor metabolic process (GO:0006505)	31	2	1.58	+	1.26	4.70E-01
positive regulation of interleukin-2 production (GO:0032743)	31	2	1.58	+	1.26	4.70E-01
regulation of protein targeting to membrane (GO:0090313)	31	2	1.58	+	1.26	4.70E-01
sister chromatid segregation (GO:0000819)	124	8	6.33	+	1.26	3.03E-01
response to mineralocorticoid (GO:0051385)	31	2	1.58	+	1.26	4.70E-01
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	31	2	1.58	+	1.26	4.70E-01
smooth muscle cell differentiation (GO:0051145)	31	2	1.58	+	1.26	4.70E-01
muscle adaptation (GO:0043500)	31	2	1.58	+	1.26	4.70E-01
positive regulation of mRNA processing (GO:0050685)	31	2	1.58	+	1.26	4.70E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	31	2	1.58	+	1.26	4.70E-01
regulation of mast cell degranulation (GO:0043304)	31	2	1.58	+	1.26	4.70E-01
glucose transmembrane transport (GO:1904659)	31	2	1.58	+	1.26	4.70E-01
deoxyribonucleotide metabolic process (GO:0009262)	31	2	1.58	+	1.26	4.70E-01
cellular metabolic compound salvage (GO:0043094)	31	2	1.58	+	1.26	4.70E-01
ribonucleoside monophosphate biosynthetic process (GO:0009156)	31	2	1.58	+	1.26	4.70E-01
regulation of cell death (GO:0010941)	1519	98	77.59	+	1.26	1.05E-02
positive regulation of cell-substrate junction organization (GO:0150117)	31	2	1.58	+	1.26	4.70E-01
regulation of macrophage derived foam cell differentiation (GO:0010743)	31	2	1.58	+	1.26	4.70E-01
phosphatidylglycerol metabolic process (GO:0046471)	31	2	1.58	+	1.26	4.70E-01
muscle hypertrophy (GO:0014896)	31	2	1.58	+	1.26	4.70E-01
negative regulation of exocytosis (GO:0045920)	31	2	1.58	+	1.26	4.70E-01
mammary gland duct morphogenesis (GO:0060603)	31	2	1.58	+	1.26	4.70E-01
negative regulation of mitotic nuclear division (GO:0045839)	31	2	1.58	+	1.26	4.70E-01
response to stress (GO:0006950)	3229	208	164.93	+	1.26	1.56E-04
glycosylation (GO:0070085)	233	15	11.90	+	1.26	2.18E-01
negative regulation of cell death (GO:0060548)	932	60	47.60	+	1.26	4.15E-02
regulation of cellular component organization (GO:0051128)	2178	140	111.25	+	1.26	2.57E-03
modulation of chemical synaptic transmission (GO:0050804)	389	25	19.87	+	1.26	1.47E-01
cellular metabolic process (GO:0044237)	6769	435	345.74	+	1.26	2.83E-10
DNA conformation change (GO:0071103)	249	16	12.72	+	1.26	2.11E-01
negative regulation of intracellular signal transduction (GO:1902532)	467	30	23.85	+	1.26	1.22E-01
glial cell development (GO:0021782)	109	7	5.57	+	1.26	3.24E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	109	7	5.57	+	1.26	3.24E-01
regulation of extent of cell growth (GO:0061387)	109	7	5.57	+	1.26	3.24E-01
positive regulation of intracellular signal transduction (GO:1902533)	950	61	48.52	+	1.26	4.17E-02
hippocampus development (GO:0021766)	78	5	3.98	+	1.26	3.68E-01
cilium movement involved in cell motility (GO:0060294)	78	5	3.98	+	1.26	3.68E-01
regulation of trans-synaptic signaling (GO:0099177)	390	25	19.92	+	1.26	1.50E-01
Golgi vesicle transport (GO:0048193)	359	23	18.34	+	1.25	1.62E-01
negative regulation of catabolic process (GO:0009895)	281	18	14.35	+	1.25	1.97E-01
glycoprotein biosynthetic process (GO:0009101)	281	18	14.35	+	1.25	1.97E-01
DNA replication (GO:0006260)	203	13	10.37	+	1.25	2.44E-01
reproductive structure development (GO:0048608)	406	26	20.74	+	1.25	1.45E-01
neuron projection development (GO:0031175)	656	42	33.51	+	1.25	8.28E-02
negative regulation of biosynthetic process (GO:0009890)	1453	93	74.21	+	1.25	1.52E-02
ncRNA processing (GO:0034470)	375	24	19.15	+	1.25	1.57E-01
positive regulation of hormone secretion (GO:0046887)	125	8	6.38	+	1.25	3.10E-01
phosphorylation (GO:0016310)	1189	76	60.73	+	1.25	2.74E-02
hexose catabolic process (GO:0019320)	47	3	2.40	+	1.25	4.31E-01
intracellular protein transport (GO:0006886)	893	57	45.61	+	1.25	5.22E-02
cellular response to interleukin-12 (GO:0071349)	47	3	2.40	+	1.25	4.31E-01
regulation of viral genome replication (GO:0045069)	94	6	4.80	+	1.25	3.49E-01
mitochondrion localization (GO:0051646)	47	3	2.40	+	1.25	4.31E-01
positive regulation of cold-induced thermogenesis (GO:0120162)	94	6	4.80	+	1.25	3.49E-01
regulation of leukocyte degranulation (GO:0043300)	47	3	2.40	+	1.25	4.31E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205)	47	3	2.40	+	1.25	4.31E-01
microtubule organizing center organization (GO:0031023)	94	6	4.80	+	1.25	3.49E-01
regulation of fatty acid biosynthetic process (GO:0042304)	47	3	2.40	+	1.25	4.31E-01
carboxylic acid metabolic process (GO:0019752)	799	51	40.81	+	1.25	6.36E-02
regulation of microtubule-based movement (GO:0060632)	47	3	2.40	+	1.25	4.31E-01
positive regulation of secretion (GO:0051047)	329	21	16.80	+	1.25	1.79E-01
negative regulation of supramolecular fiber organization (GO:1902904)	141	9	7.20	+	1.25	2.97E-01
positive regulation of response to external stimulus (GO:0032103)	471	30	24.06	+	1.25	1.31E-01
protein acylation (GO:0043543)	157	10	8.02	+	1.25	2.85E-01
regulation of cell cycle phase transition (GO:1901987)	424	27	21.66	+	1.25	1.46E-01
mesoderm development (GO:0007498)	110	7	5.62	+	1.25	3.32E-01
myeloid cell homeostasis (GO:0002262)	110	7	5.62	+	1.25	3.32E-01
regulation of gene expression (GO:0010468)	4322	275	220.75	+	1.25	1.80E-05
actin filament-based process (GO:0030029)	566	36	28.91	+	1.25	1.09E-01
anatomical structure homeostasis (GO:0060249)	346	22	17.67	+	1.24	1.77E-01
response to organic cyclic compound (GO:0014070)	834	53	42.60	+	1.24	6.32E-02
DNA methylation or demethylation (GO:0044728)	63	4	3.22	+	1.24	4.02E-01
transcription elongation from RNA polymerase II promoter (GO:0006368)	63	4	3.22	+	1.24	4.02E-01
branching morphogenesis of an epithelial tube (GO:0048754)	126	8	6.44	+	1.24	3.18E-01
regulation of B cell proliferation (GO:0030888)	63	4	3.22	+	1.24	4.02E-01
negative regulation of BMP signaling pathway (GO:0030514)	63	4	3.22	+	1.24	4.02E-01
ribosomal small subunit biogenesis (GO:0042274)	63	4	3.22	+	1.24	4.02E-01
skeletal muscle organ development (GO:0060538)	126	8	6.44	+	1.24	3.18E-01
innate immune response (GO:0045087)	646	41	33.00	+	1.24	9.42E-02
regulation of metabolic process (GO:0019222)	6210	394	317.19	+	1.24	3.56E-08
metabolic process (GO:0008152)	7456	473	380.83	+	1.24	9.26E-11
homeostasis of number of cells (GO:0048872)	205	13	10.47	+	1.24	2.54E-01
positive regulation of neurogenesis (GO:0050769)	221	14	11.29	+	1.24	2.45E-01
positive regulation of mitotic cell cycle phase transition (GO:1901992)	79	5	4.04	+	1.24	3.78E-01
organelle membrane fusion (GO:0090174)	79	5	4.04	+	1.24	3.78E-01
positive regulation of response to stimulus (GO:0048584)	1992	126	101.75	+	1.24	7.14E-03
protein modification by small protein removal (GO:0070646)	253	16	12.92	+	1.24	2.28E-01
DNA metabolic process (GO:0006259)	665	42	33.97	+	1.24	9.63E-02
icosanoid metabolic process (GO:0006690)	95	6	4.85	+	1.24	3.58E-01
toll-like receptor signaling pathway (GO:0002224)	95	6	4.85	+	1.24	3.58E-01
positive regulation of lipid localization (GO:1905954)	95	6	4.85	+	1.24	3.58E-01
tissue migration (GO:0090130)	95	6	4.85	+	1.24	3.58E-01
regulation of Notch signaling pathway (GO:0008593)	95	6	4.85	+	1.24	3.58E-01
extrinsic apoptotic signaling pathway (GO:0097191)	95	6	4.85	+	1.24	3.58E-01
mitochondrial transport (GO:0006839)	206	13	10.52	+	1.24	2.59E-01
determination of left/right symmetry (GO:0007368)	111	7	5.67	+	1.23	3.41E-01
protein glycosylation (GO:0006486)	222	14	11.34	+	1.23	2.50E-01
macromolecule glycosylation (GO:0043413)	222	14	11.34	+	1.23	2.50E-01
positive regulation of defense response (GO:0031349)	333	21	17.01	+	1.23	1.93E-01
protein deubiquitination (GO:0016579)	238	15	12.16	+	1.23	2.41E-01
macromolecule localization (GO:0033036)	2285	144	116.71	+	1.23	4.55E-03
cellular response to reactive oxygen species (GO:0034614)	127	8	6.49	+	1.23	3.25E-01
regulation of protein modification process (GO:0031399)	1731	109	88.41	+	1.23	1.37E-02
organelle assembly (GO:0070925)	667	42	34.07	+	1.23	9.95E-02
regulation of DNA-binding transcription factor activity (GO:0051090)	413	26	21.09	+	1.23	1.65E-01
amide transport (GO:0042886)	1414	89	72.22	+	1.23	2.51E-02
regulation of cell division (GO:0051302)	159	10	8.12	+	1.23	2.98E-01
cell death (GO:0008219)	1002	63	51.18	+	1.23	5.45E-02
regulation of cell cycle process (GO:0010564)	700	44	35.75	+	1.23	9.55E-02
establishment of protein localization (GO:0045184)	1432	90	73.14	+	1.23	2.51E-02
protein metabolic process (GO:0019538)	3851	242	196.70	+	1.23	1.73E-04
ribonucleoprotein complex biogenesis (GO:0022613)	414	26	21.15	+	1.23	1.68E-01
regulation of epithelial cell migration (GO:0010632)	223	14	11.39	+	1.23	2.55E-01
regulation of macromolecule metabolic process (GO:0060255)	5728	359	292.57	+	1.23	1.15E-06
protein transport (GO:0015031)	1357	85	69.31	+	1.23	3.11E-02
cellular component assembly (GO:0022607)	2110	132	107.77	+	1.22	8.37E-03
regulation of acute inflammatory response (GO:0002673)	48	3	2.45	+	1.22	4.44E-01
multicellular organism aging (GO:0010259)	32	2	1.63	+	1.22	4.86E-01
regulation of oxidative stress-induced cell death (GO:1903201)	64	4	3.27	+	1.22	4.13E-01
lipoxygenase pathway (GO:0019372)	16	1	.82	+	1.22	5.59E-01
cGMP metabolic process (GO:0046068)	16	1	.82	+	1.22	5.59E-01
Golgi to vacuole transport (GO:0006896)	16	1	.82	+	1.22	5.59E-01
manganese ion transport (GO:0006828)	16	1	.82	+	1.22	5.59E-01
positive regulation of regulatory T cell differentiation (GO:0045591)	16	1	.82	+	1.22	5.59E-01
unsaturated fatty acid metabolic process (GO:0033559)	96	6	4.90	+	1.22	3.67E-01
dentate gyrus development (GO:0021542)	16	1	.82	+	1.22	5.59E-01
activation of NF-kappaB-inducing kinase activity (GO:0007250)	16	1	.82	+	1.22	5.59E-01
ubiquinone metabolic process (GO:0006743)	16	1	.82	+	1.22	5.59E-01
C21-steroid hormone biosynthetic process (GO:0006700)	16	1	.82	+	1.22	5.59E-01
trophectodermal cell differentiation (GO:0001829)	16	1	.82	+	1.22	5.59E-01
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	16	1	.82	+	1.22	5.59E-01
regulation of endopeptidase activity (GO:0052548)	384	24	19.61	+	1.22	1.85E-01
sphingosine metabolic process (GO:0006670)	16	1	.82	+	1.22	5.59E-01
mitotic chromosome condensation (GO:0007076)	16	1	.82	+	1.22	5.59E-01
negative regulation of cardiac muscle cell proliferation (GO:0060044)	16	1	.82	+	1.22	5.59E-01
negative regulation of cell junction assembly (GO:1901889)	32	2	1.63	+	1.22	4.86E-01
mesenchymal cell development (GO:0014031)	80	5	4.09	+	1.22	3.88E-01
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	16	1	.82	+	1.22	5.59E-01
3'-UTR-mediated mRNA stabilization (GO:0070935)	16	1	.82	+	1.22	5.59E-01
chromatin silencing (GO:0006342)	32	2	1.63	+	1.22	4.86E-01
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	16	1	.82	+	1.22	5.59E-01
postreplication repair (GO:0006301)	48	3	2.45	+	1.22	4.44E-01
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	32	2	1.63	+	1.22	4.86E-01
positive regulation of glycogen metabolic process (GO:0070875)	16	1	.82	+	1.22	5.59E-01
regulation of mast cell activation involved in immune response (GO:0033006)	32	2	1.63	+	1.22	4.86E-01
mitochondrial RNA processing (GO:0000963)	16	1	.82	+	1.22	5.59E-01
DNA unwinding involved in DNA replication (GO:0006268)	16	1	.82	+	1.22	5.59E-01
centrosome localization (GO:0051642)	32	2	1.63	+	1.22	4.86E-01
regulation of mitophagy (GO:1901524)	16	1	.82	+	1.22	5.59E-01
regulation of fatty acid transport (GO:2000191)	32	2	1.63	+	1.22	4.86E-01
negative regulation of DNA-dependent DNA replication (GO:2000104)	16	1	.82	+	1.22	5.59E-01
nucleoside diphosphate phosphorylation (GO:0006165)	48	3	2.45	+	1.22	4.44E-01
regulation of neurotransmitter uptake (GO:0051580)	16	1	.82	+	1.22	5.59E-01
histone H4 acetylation (GO:0043967)	48	3	2.45	+	1.22	4.44E-01
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	16	1	.82	+	1.22	5.59E-01
response to interleukin-12 (GO:0070671)	48	3	2.45	+	1.22	4.44E-01
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	16	1	.82	+	1.22	5.59E-01
DNA geometric change (GO:0032392)	112	7	5.72	+	1.22	3.49E-01
tricarboxylic acid cycle (GO:0006099)	32	2	1.63	+	1.22	4.86E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047)	16	1	.82	+	1.22	5.59E-01
negative regulation of voltage-gated calcium channel activity (GO:1901386)	16	1	.82	+	1.22	5.59E-01
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	32	2	1.63	+	1.22	4.86E-01
centrosome duplication (GO:0051298)	32	2	1.63	+	1.22	4.86E-01
cellular response to nutrient (GO:0031670)	32	2	1.63	+	1.22	4.86E-01
regulation of axonogenesis (GO:0050770)	160	10	8.17	+	1.22	3.04E-01
negative regulation of protein secretion (GO:0050709)	80	5	4.09	+	1.22	3.88E-01
regulation of cytokine secretion (GO:0050707)	48	3	2.45	+	1.22	4.44E-01
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	32	2	1.63	+	1.22	4.86E-01
actin cytoskeleton reorganization (GO:0031532)	64	4	3.27	+	1.22	4.13E-01
renal absorption (GO:0070293)	16	1	.82	+	1.22	5.59E-01
dermatan sulfate proteoglycan metabolic process (GO:0050655)	16	1	.82	+	1.22	5.59E-01
megakaryocyte development (GO:0035855)	16	1	.82	+	1.22	5.59E-01
homologous recombination (GO:0035825)	48	3	2.45	+	1.22	4.44E-01
positive regulation of mitochondrial translation (GO:0070131)	16	1	.82	+	1.22	5.59E-01
phosphatidylinositol acyl-chain remodeling (GO:0036149)	16	1	.82	+	1.22	5.59E-01
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	32	2	1.63	+	1.22	4.86E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	32	2	1.63	+	1.22	4.86E-01
negative regulation of macrophage activation (GO:0043031)	16	1	.82	+	1.22	5.59E-01
hexose transmembrane transport (GO:0008645)	32	2	1.63	+	1.22	4.86E-01
intracellular estrogen receptor signaling pathway (GO:0030520)	16	1	.82	+	1.22	5.59E-01
regulation of hippo signaling (GO:0035330)	16	1	.82	+	1.22	5.59E-01
negative regulation of programmed necrotic cell death (GO:0062099)	16	1	.82	+	1.22	5.59E-01
regulation of odontogenesis (GO:0042481)	16	1	.82	+	1.22	5.59E-01
hormone biosynthetic process (GO:0042446)	48	3	2.45	+	1.22	4.44E-01
cellular hormone metabolic process (GO:0034754)	112	7	5.72	+	1.22	3.49E-01
negative regulation of anion transport (GO:1903792)	32	2	1.63	+	1.22	4.86E-01
positive regulation of phospholipid metabolic process (GO:1903727)	16	1	.82	+	1.22	5.59E-01
mitochondrial outer membrane permeabilization (GO:0097345)	16	1	.82	+	1.22	5.59E-01
regulation of cell size (GO:0008361)	176	11	8.99	+	1.22	2.92E-01
hyaluronan metabolic process (GO:0030212)	32	2	1.63	+	1.22	4.86E-01
negative regulation of histone acetylation (GO:0035067)	16	1	.82	+	1.22	5.59E-01
adaptation of signaling pathway (GO:0023058)	16	1	.82	+	1.22	5.59E-01
regulation of cilium movement (GO:0003352)	32	2	1.63	+	1.22	4.86E-01
cilium movement (GO:0003341)	112	7	5.72	+	1.22	3.49E-01
ether lipid metabolic process (GO:0046485)	16	1	.82	+	1.22	5.59E-01
regulation of cytokine biosynthetic process (GO:0042035)	16	1	.82	+	1.22	5.59E-01
regulation of immune response to tumor cell (GO:0002837)	16	1	.82	+	1.22	5.59E-01
regulation of response to tumor cell (GO:0002834)	16	1	.82	+	1.22	5.59E-01
negative adaptation of signaling pathway (GO:0022401)	16	1	.82	+	1.22	5.59E-01
cerebral cortex development (GO:0021987)	112	7	5.72	+	1.22	3.49E-01
positive regulation of vasoconstriction (GO:0045907)	32	2	1.63	+	1.22	4.86E-01
central nervous system neuron development (GO:0021954)	80	5	4.09	+	1.22	3.88E-01
ventricular trabecula myocardium morphogenesis (GO:0003222)	16	1	.82	+	1.22	5.59E-01
regulation of membrane lipid distribution (GO:0097035)	48	3	2.45	+	1.22	4.44E-01
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	32	2	1.63	+	1.22	4.86E-01
female pregnancy (GO:0007565)	176	11	8.99	+	1.22	2.92E-01
negative regulation of nitrogen compound metabolic process (GO:0051172)	2179	136	111.30	+	1.22	8.01E-03
negative regulation of protein metabolic process (GO:0051248)	1010	63	51.59	+	1.22	6.16E-02
regulation of response to stress (GO:0080134)	1396	87	71.30	+	1.22	3.27E-02
cellular component biogenesis (GO:0044085)	2344	146	119.72	+	1.22	6.42E-03
cell morphogenesis involved in neuron differentiation (GO:0048667)	434	27	22.17	+	1.22	1.74E-01
meiotic cell cycle (GO:0051321)	193	12	9.86	+	1.22	2.86E-01
cell-cell junction organization (GO:0045216)	177	11	9.04	+	1.22	2.98E-01
peptide transport (GO:0015833)	1384	86	70.69	+	1.22	3.56E-02
microtubule-based movement (GO:0007018)	306	19	15.63	+	1.22	2.26E-01
negative regulation of cytoskeleton organization (GO:0051494)	145	9	7.41	+	1.22	3.25E-01
positive regulation of epithelial cell migration (GO:0010634)	145	9	7.41	+	1.22	3.25E-01
regulation of transferase activity (GO:0051338)	951	59	48.57	+	1.21	7.41E-02
mitochondrion organization (GO:0007005)	403	25	20.58	+	1.21	1.89E-01
negative regulation of translation (GO:0017148)	129	8	6.59	+	1.21	3.40E-01
regulation of wound healing (GO:0061041)	129	8	6.59	+	1.21	3.40E-01
negative regulation of transmembrane transport (GO:0034763)	113	7	5.77	+	1.21	3.57E-01
cellular response to organic substance (GO:0071310)	2199	136	112.32	+	1.21	1.07E-02
organonitrogen compound metabolic process (GO:1901564)	4770	295	243.64	+	1.21	6.90E-05
negative regulation of cellular metabolic process (GO:0031324)	2362	146	120.64	+	1.21	8.31E-03
axis specification (GO:0009798)	81	5	4.14	+	1.21	3.98E-01
positive regulation of actin filament polymerization (GO:0030838)	81	5	4.14	+	1.21	3.98E-01
phospholipid transport (GO:0015914)	81	5	4.14	+	1.21	3.98E-01
positive regulation of lipid biosynthetic process (GO:0046889)	81	5	4.14	+	1.21	3.98E-01
amino acid transmembrane transport (GO:0003333)	81	5	4.14	+	1.21	3.98E-01
regulation of response to oxidative stress (GO:1902882)	81	5	4.14	+	1.21	3.98E-01
plasma membrane bounded cell projection organization (GO:0120036)	1053	65	53.78	+	1.21	6.84E-02
negative regulation of cellular protein metabolic process (GO:0032269)	956	59	48.83	+	1.21	7.98E-02
regulation of viral process (GO:0050792)	211	13	10.78	+	1.21	2.86E-01
axon development (GO:0061564)	406	25	20.74	+	1.21	1.98E-01
organelle disassembly (GO:1903008)	65	4	3.32	+	1.20	4.24E-01
lysosome organization (GO:0007040)	65	4	3.32	+	1.20	4.24E-01
cytoplasmic translation (GO:0002181)	65	4	3.32	+	1.20	4.24E-01
regulation of carbohydrate metabolic process (GO:0006109)	195	12	9.96	+	1.20	2.98E-01
plasma membrane bounded cell projection assembly (GO:0120031)	390	24	19.92	+	1.20	2.05E-01
carboxylic acid transmembrane transport (GO:1905039)	130	8	6.64	+	1.20	3.48E-01
organophosphate catabolic process (GO:0046434)	130	8	6.64	+	1.20	3.48E-01
lytic vacuole organization (GO:0080171)	65	4	3.32	+	1.20	4.24E-01
regulation of phosphorylation (GO:0042325)	1529	94	78.10	+	1.20	3.62E-02
cell morphogenesis involved in differentiation (GO:0000904)	537	33	27.43	+	1.20	1.62E-01
cell projection assembly (GO:0030031)	407	25	20.79	+	1.20	2.01E-01
Notch signaling pathway (GO:0007219)	114	7	5.82	+	1.20	3.65E-01
carbohydrate derivative metabolic process (GO:1901135)	912	56	46.58	+	1.20	9.19E-02
odontogenesis (GO:0042476)	114	7	5.82	+	1.20	3.65E-01
negative regulation of cellular protein localization (GO:1903828)	114	7	5.82	+	1.20	3.65E-01
protein localization (GO:0008104)	1972	121	100.72	+	1.20	1.97E-02
regulation of mitotic cell cycle (GO:0007346)	555	34	28.35	+	1.20	1.62E-01
regulation of cell cycle G2/M phase transition (GO:1902749)	196	12	10.01	+	1.20	3.04E-01
face development (GO:0060324)	49	3	2.50	+	1.20	4.57E-01
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	49	3	2.50	+	1.20	4.57E-01
epidermal growth factor receptor signaling pathway (GO:0007173)	49	3	2.50	+	1.20	4.57E-01
intermediate filament cytoskeleton organization (GO:0045104)	49	3	2.50	+	1.20	4.57E-01
positive regulation of reactive oxygen species metabolic process (GO:2000379)	98	6	5.01	+	1.20	3.85E-01
DNA synthesis involved in DNA repair (GO:0000731)	49	3	2.50	+	1.20	4.57E-01
positive regulation of fibroblast proliferation (GO:0048146)	49	3	2.50	+	1.20	4.57E-01
autophagosome assembly (GO:0000045)	49	3	2.50	+	1.20	4.57E-01
regulation of microtubule polymerization (GO:0031113)	49	3	2.50	+	1.20	4.57E-01
regulation of immunoglobulin mediated immune response (GO:0002889)	49	3	2.50	+	1.20	4.57E-01
negative regulation of DNA recombination (GO:0045910)	49	3	2.50	+	1.20	4.57E-01
positive regulation of protein modification process (GO:0031401)	1160	71	59.25	+	1.20	6.75E-02
positive regulation of cellular process (GO:0048522)	5131	314	262.08	+	1.20	7.70E-05
cell cycle process (GO:0022402)	948	58	48.42	+	1.20	9.19E-02
negative regulation of cellular catabolic process (GO:0031330)	229	14	11.70	+	1.20	2.86E-01
regulation of kinase activity (GO:0043549)	851	52	43.47	+	1.20	1.07E-01
negative regulation of gene expression (GO:0010629)	1834	112	93.68	+	1.20	2.75E-02
regulation of phosphate metabolic process (GO:0019220)	1703	104	86.98	+	1.20	3.31E-02
nuclear division (GO:0000280)	262	16	13.38	+	1.20	2.70E-01
organic acid transmembrane transport (GO:1903825)	131	8	6.69	+	1.20	3.55E-01
regulation of phosphorus metabolic process (GO:0051174)	1704	104	87.04	+	1.19	3.35E-02
cell part morphogenesis (GO:0032990)	508	31	25.95	+	1.19	1.80E-01
pallium development (GO:0021543)	164	10	8.38	+	1.19	3.31E-01
positive regulation of cell division (GO:0051781)	82	5	4.19	+	1.19	4.08E-01
activation of protein kinase activity (GO:0032147)	312	19	15.94	+	1.19	2.51E-01
response to biotic stimulus (GO:0009607)	1199	73	61.24	+	1.19	7.02E-02
positive regulation of protein-containing complex assembly (GO:0031334)	230	14	11.75	+	1.19	2.91E-01
activation of MAPK activity (GO:0000187)	148	9	7.56	+	1.19	3.46E-01
regulation of mitotic cell cycle phase transition (GO:1901990)	395	24	20.18	+	1.19	2.22E-01
positive regulation of biological process (GO:0048518)	5614	341	286.75	+	1.19	5.29E-05
positive regulation of hydrolase activity (GO:0051345)	708	43	36.16	+	1.19	1.41E-01
cellular response to chemical stimulus (GO:0070887)	2718	165	138.83	+	1.19	9.56E-03
regulation of peptidase activity (GO:0052547)	412	25	21.04	+	1.19	2.18E-01
wound healing (GO:0042060)	412	25	21.04	+	1.19	2.18E-01
monocarboxylic acid metabolic process (GO:0032787)	478	29	24.41	+	1.19	1.98E-01
response to growth factor (GO:0070848)	511	31	26.10	+	1.19	1.89E-01
response to organic substance (GO:0010033)	2804	170	143.22	+	1.19	8.90E-03
regulation of protein localization to plasma membrane (GO:1903076)	99	6	5.06	+	1.19	3.94E-01
regulation of BMP signaling pathway (GO:0030510)	99	6	5.06	+	1.19	3.94E-01
gland morphogenesis (GO:0022612)	99	6	5.06	+	1.19	3.94E-01
salivary gland development (GO:0007431)	33	2	1.69	+	1.19	5.02E-01
negative regulation of toll-like receptor signaling pathway (GO:0034122)	33	2	1.69	+	1.19	5.02E-01
transferrin transport (GO:0033572)	33	2	1.69	+	1.19	5.02E-01
blood vessel remodeling (GO:0001974)	33	2	1.69	+	1.19	5.02E-01
secretory granule organization (GO:0033363)	33	2	1.69	+	1.19	5.02E-01
cellular response to alkaloid (GO:0071312)	33	2	1.69	+	1.19	5.02E-01
vesicle cytoskeletal trafficking (GO:0099518)	66	4	3.37	+	1.19	4.35E-01
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	33	2	1.69	+	1.19	5.02E-01
regulation of kidney development (GO:0090183)	33	2	1.69	+	1.19	5.02E-01
regulation of calcineurin-mediated signaling (GO:0106056)	33	2	1.69	+	1.19	5.02E-01
embryonic axis specification (GO:0000578)	33	2	1.69	+	1.19	5.02E-01
replication fork processing (GO:0031297)	33	2	1.69	+	1.19	5.02E-01
microtubule organizing center localization (GO:0061842)	33	2	1.69	+	1.19	5.02E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145)	33	2	1.69	+	1.19	5.02E-01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	33	2	1.69	+	1.19	5.02E-01
regulation of cardiac muscle cell contraction (GO:0086004)	33	2	1.69	+	1.19	5.02E-01
heart trabecula morphogenesis (GO:0061384)	33	2	1.69	+	1.19	5.02E-01
T cell proliferation (GO:0042098)	33	2	1.69	+	1.19	5.02E-01
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	66	4	3.37	+	1.19	4.35E-01
energy homeostasis (GO:0097009)	33	2	1.69	+	1.19	5.02E-01
positive regulation of heart contraction (GO:0045823)	33	2	1.69	+	1.19	5.02E-01
positive regulation of signaling (GO:0023056)	1618	98	82.64	+	1.19	4.51E-02
intracellular signal transduction (GO:0035556)	1571	95	80.24	+	1.18	4.96E-02
neuron projection morphogenesis (GO:0048812)	480	29	24.52	+	1.18	2.04E-01
anaphase (GO:0051322)	149	9	7.61	+	1.18	3.53E-01
mitotic anaphase (GO:0000090)	149	9	7.61	+	1.18	3.53E-01
positive regulation of signal transduction (GO:0009967)	1457	88	74.42	+	1.18	5.86E-02
regulation of binding (GO:0051098)	348	21	17.77	+	1.18	2.50E-01
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	116	7	5.92	+	1.18	3.82E-01
establishment of cell polarity (GO:0030010)	116	7	5.92	+	1.18	3.82E-01
skeletal muscle tissue development (GO:0007519)	116	7	5.92	+	1.18	3.82E-01
cell morphogenesis (GO:0000902)	680	41	34.73	+	1.18	1.58E-01
organonitrogen compound biosynthetic process (GO:1901566)	1245	75	63.59	+	1.18	7.98E-02
cellular response to catecholamine stimulus (GO:0071870)	83	5	4.24	+	1.18	4.18E-01
cellular response to monoamine stimulus (GO:0071868)	83	5	4.24	+	1.18	4.18E-01
centrosome cycle (GO:0007098)	83	5	4.24	+	1.18	4.18E-01
positive regulation of protein binding (GO:0032092)	83	5	4.24	+	1.18	4.18E-01
negative regulation of MAPK cascade (GO:0043409)	166	10	8.48	+	1.18	3.44E-01
cell projection organization (GO:0030030)	1096	66	55.98	+	1.18	9.60E-02
positive regulation of cell communication (GO:0010647)	1612	97	82.34	+	1.18	5.26E-02
positive regulation of chemotaxis (GO:0050921)	133	8	6.79	+	1.18	3.70E-01
cellular response to growth factor stimulus (GO:0071363)	483	29	24.67	+	1.18	2.13E-01
organic substance transport (GO:0071702)	1999	120	102.10	+	1.18	3.52E-02
regulation of megakaryocyte differentiation (GO:0045652)	50	3	2.55	+	1.17	4.70E-01
intermediate filament-based process (GO:0045103)	50	3	2.55	+	1.17	4.70E-01
nucleotide-excision repair (GO:0006289)	100	6	5.11	+	1.17	4.03E-01
glycosaminoglycan biosynthetic process (GO:0006024)	100	6	5.11	+	1.17	4.03E-01
chromatin organization involved in negative regulation of transcription (GO:0097549)	50	3	2.55	+	1.17	4.70E-01
negative regulation of endothelial cell migration (GO:0010596)	50	3	2.55	+	1.17	4.70E-01
intraciliary transport (GO:0042073)	50	3	2.55	+	1.17	4.70E-01
negative regulation of adaptive immune response (GO:0002820)	50	3	2.55	+	1.17	4.70E-01
regulation of B cell mediated immunity (GO:0002712)	50	3	2.55	+	1.17	4.70E-01
heart valve morphogenesis (GO:0003179)	50	3	2.55	+	1.17	4.70E-01
placenta development (GO:0001890)	150	9	7.66	+	1.17	3.60E-01
response to other organism (GO:0051707)	1167	70	59.61	+	1.17	9.39E-02
spermatogenesis (GO:0007283)	467	28	23.85	+	1.17	2.20E-01
oxoacid metabolic process (GO:0043436)	884	53	45.15	+	1.17	1.31E-01
negative regulation of macromolecule metabolic process (GO:0010605)	2603	156	132.95	+	1.17	1.79E-02
aging (GO:0007568)	267	16	13.64	+	1.17	2.94E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039)	484	29	24.72	+	1.17	2.16E-01
response to external biotic stimulus (GO:0043207)	1169	70	59.71	+	1.17	9.63E-02
regulation of cellular response to growth factor stimulus (GO:0090287)	284	17	14.51	+	1.17	2.88E-01
programmed cell death (GO:0012501)	969	58	49.49	+	1.17	1.22E-01
chromosome segregation (GO:0007059)	234	14	11.95	+	1.17	3.13E-01
determination of bilateral symmetry (GO:0009855)	117	7	5.98	+	1.17	3.90E-01
cellular amino acid catabolic process (GO:0009063)	117	7	5.98	+	1.17	3.90E-01
regulation of Wnt signaling pathway (GO:0030111)	351	21	17.93	+	1.17	2.62E-01
negative regulation of metabolic process (GO:0009892)	2826	169	144.34	+	1.17	1.48E-02
negative regulation of locomotion (GO:0040013)	301	18	15.37	+	1.17	2.82E-01
establishment of organelle localization (GO:0051656)	368	22	18.80	+	1.17	2.57E-01
organic acid metabolic process (GO:0006082)	904	54	46.17	+	1.17	1.34E-01
regulation of cellular component movement (GO:0051270)	971	58	49.60	+	1.17	1.25E-01
spermatid development (GO:0007286)	134	8	6.84	+	1.17	3.78E-01
negative regulation of response to DNA damage stimulus (GO:2001021)	67	4	3.42	+	1.17	4.47E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	134	8	6.84	+	1.17	3.78E-01
negative regulation of axonogenesis (GO:0050771)	67	4	3.42	+	1.17	4.47E-01
positive regulation of protein localization to cell periphery (GO:1904377)	67	4	3.42	+	1.17	4.47E-01
ribosomal large subunit biogenesis (GO:0042273)	67	4	3.42	+	1.17	4.47E-01
negative regulation of epithelial cell migration (GO:0010633)	67	4	3.42	+	1.17	4.47E-01
response to type I interferon (GO:0034340)	67	4	3.42	+	1.17	4.47E-01
cellular component morphogenesis (GO:0032989)	587	35	29.98	+	1.17	1.98E-01
regulation of localization (GO:0032879)	2600	155	132.80	+	1.17	2.16E-02
defense response to other organism (GO:0098542)	822	49	41.99	+	1.17	1.51E-01
regulation of generation of precursor metabolites and energy (GO:0043467)	151	9	7.71	+	1.17	3.67E-01
pattern specification process (GO:0007389)	403	24	20.58	+	1.17	2.51E-01
positive regulation of axonogenesis (GO:0050772)	84	5	4.29	+	1.17	4.28E-01
establishment or maintenance of cell polarity (GO:0007163)	185	11	9.45	+	1.16	3.48E-01
protein autophosphorylation (GO:0046777)	185	11	9.45	+	1.16	3.48E-01
positive regulation of supramolecular fiber organization (GO:1902905)	185	11	9.45	+	1.16	3.48E-01
positive regulation of transferase activity (GO:0051347)	656	39	33.51	+	1.16	1.87E-01
cell projection morphogenesis (GO:0048858)	488	29	24.93	+	1.16	2.29E-01
protein polyubiquitination (GO:0000209)	303	18	15.48	+	1.16	2.91E-01
regulation of transport (GO:0051049)	1701	101	86.88	+	1.16	6.36E-02
regulation of intracellular signal transduction (GO:1902531)	1651	98	84.33	+	1.16	6.74E-02
specification of symmetry (GO:0009799)	118	7	6.03	+	1.16	3.98E-01
negative regulation of cell motility (GO:2000146)	270	16	13.79	+	1.16	3.09E-01
mitochondrial gene expression (GO:0140053)	135	8	6.90	+	1.16	3.86E-01
B cell activation (GO:0042113)	152	9	7.76	+	1.16	3.74E-01
positive regulation of cellular amide metabolic process (GO:0034250)	152	9	7.76	+	1.16	3.74E-01
nitrogen compound transport (GO:0071705)	1674	99	85.50	+	1.16	7.11E-02
multi-multicellular organism process (GO:0044706)	203	12	10.37	+	1.16	3.45E-01
gonad development (GO:0008406)	203	12	10.37	+	1.16	3.45E-01
regulation of cell differentiation (GO:0045595)	1472	87	75.19	+	1.16	8.77E-02
cellular protein localization (GO:0034613)	1475	87	75.34	+	1.15	9.07E-02
positive regulation of cell migration (GO:0030335)	492	29	25.13	+	1.15	2.42E-01
response to lipid (GO:0033993)	798	47	40.76	+	1.15	1.77E-01
positive regulation of angiogenesis (GO:0045766)	153	9	7.81	+	1.15	3.81E-01
positive regulation of Notch signaling pathway (GO:0045747)	51	3	2.60	+	1.15	4.83E-01
axonogenesis (GO:0007409)	374	22	19.10	+	1.15	2.81E-01
L-alpha-amino acid transmembrane transport (GO:1902475)	51	3	2.60	+	1.15	4.83E-01
mitotic DNA integrity checkpoint (GO:0044774)	102	6	5.21	+	1.15	4.21E-01
regulation of neurotransmitter levels (GO:0001505)	204	12	10.42	+	1.15	3.51E-01
regulation of interferon-beta production (GO:0032648)	51	3	2.60	+	1.15	4.83E-01
IRE1-mediated unfolded protein response (GO:0036498)	51	3	2.60	+	1.15	4.83E-01
regulation of neuronal synaptic plasticity (GO:0048168)	51	3	2.60	+	1.15	4.83E-01
positive regulation of epithelial cell differentiation (GO:0030858)	51	3	2.60	+	1.15	4.83E-01
regulation of lipid storage (GO:0010883)	51	3	2.60	+	1.15	4.83E-01
positive regulation of vasculature development (GO:1904018)	153	9	7.81	+	1.15	3.81E-01
morphogenesis of a branching epithelium (GO:0061138)	153	9	7.81	+	1.15	3.81E-01
negative regulation of T-helper cell differentiation (GO:0045623)	17	1	.87	+	1.15	5.81E-01
regulation of integrin activation (GO:0033623)	17	1	.87	+	1.15	5.81E-01
mitochondrial calcium ion transmembrane transport (GO:0006851)	17	1	.87	+	1.15	5.81E-01
inflammatory response to antigenic stimulus (GO:0002437)	34	2	1.74	+	1.15	5.18E-01
dendritic cell chemotaxis (GO:0002407)	17	1	.87	+	1.15	5.81E-01
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	34	2	1.74	+	1.15	5.18E-01
positive regulation of transcription of Notch receptor target (GO:0007221)	17	1	.87	+	1.15	5.81E-01
metanephric nephron epithelium development (GO:0072243)	17	1	.87	+	1.15	5.81E-01
regulation of T cell mediated cytotoxicity (GO:0001914)	34	2	1.74	+	1.15	5.18E-01
leukocyte mediated cytotoxicity (GO:0001909)	34	2	1.74	+	1.15	5.18E-01
regulation of cardiac muscle cell differentiation (GO:2000725)	17	1	.87	+	1.15	5.81E-01
protein-DNA complex disassembly (GO:0032986)	17	1	.87	+	1.15	5.81E-01
positive regulation of protein depolymerization (GO:1901881)	17	1	.87	+	1.15	5.81E-01
osteoblast differentiation (GO:0001649)	119	7	6.08	+	1.15	4.06E-01
positive regulation of lymphocyte migration (GO:2000403)	34	2	1.74	+	1.15	5.18E-01
glycogen catabolic process (GO:0005980)	17	1	.87	+	1.15	5.81E-01
interferon-gamma production (GO:0032609)	17	1	.87	+	1.15	5.81E-01
muscle cell proliferation (GO:0033002)	17	1	.87	+	1.15	5.81E-01
regulation of fibroblast apoptotic process (GO:2000269)	17	1	.87	+	1.15	5.81E-01
cytokinetic process (GO:0032506)	34	2	1.74	+	1.15	5.18E-01
mitochondrial transmembrane transport (GO:1990542)	85	5	4.34	+	1.15	4.38E-01
positive regulation of potassium ion transmembrane transport (GO:1901381)	34	2	1.74	+	1.15	5.18E-01
regulation of synaptic transmission, GABAergic (GO:0032228)	34	2	1.74	+	1.15	5.18E-01
post-embryonic animal organ development (GO:0048569)	17	1	.87	+	1.15	5.81E-01
negative regulation of B cell activation (GO:0050869)	34	2	1.74	+	1.15	5.18E-01
reverse cholesterol transport (GO:0043691)	17	1	.87	+	1.15	5.81E-01
negative regulation of nervous system process (GO:0031645)	17	1	.87	+	1.15	5.81E-01
negative regulation of signal transduction in absence of ligand (GO:1901099)	34	2	1.74	+	1.15	5.18E-01
endothelial cell migration (GO:0043542)	68	4	3.47	+	1.15	4.58E-01
regulation of T cell apoptotic process (GO:0070232)	34	2	1.74	+	1.15	5.18E-01
positive regulation of lymphocyte apoptotic process (GO:0070230)	17	1	.87	+	1.15	5.81E-01
postsynaptic specialization organization (GO:0099084)	17	1	.87	+	1.15	5.81E-01
post-anal tail morphogenesis (GO:0036342)	17	1	.87	+	1.15	5.81E-01
epithelial cell differentiation involved in kidney development (GO:0035850)	34	2	1.74	+	1.15	5.18E-01
negative regulation of secretion (GO:0051048)	170	10	8.68	+	1.15	3.71E-01
regulation of immunoglobulin secretion (GO:0051023)	17	1	.87	+	1.15	5.81E-01
organelle fission (GO:0048285)	289	17	14.76	+	1.15	3.12E-01
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	17	1	.87	+	1.15	5.81E-01
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	17	1	.87	+	1.15	5.81E-01
midbody abscission (GO:0061952)	17	1	.87	+	1.15	5.81E-01
regulation of circadian sleep/wake cycle (GO:0042749)	17	1	.87	+	1.15	5.81E-01
fucosylation (GO:0036065)	17	1	.87	+	1.15	5.81E-01
histone H2A monoubiquitination (GO:0035518)	17	1	.87	+	1.15	5.81E-01
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	34	2	1.74	+	1.15	5.18E-01
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	17	1	.87	+	1.15	5.81E-01
regulation of execution phase of apoptosis (GO:1900117)	17	1	.87	+	1.15	5.81E-01
chloride ion homeostasis (GO:0055064)	17	1	.87	+	1.15	5.81E-01
T cell homeostasis (GO:0043029)	34	2	1.74	+	1.15	5.18E-01
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	34	2	1.74	+	1.15	5.18E-01
preassembly of GPI anchor in ER membrane (GO:0016254)	17	1	.87	+	1.15	5.81E-01
monosaccharide transmembrane transport (GO:0015749)	34	2	1.74	+	1.15	5.18E-01
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	119	7	6.08	+	1.15	4.06E-01
gas transport (GO:0015669)	17	1	.87	+	1.15	5.81E-01
negative regulation of epithelial to mesenchymal transition (GO:0010719)	34	2	1.74	+	1.15	5.18E-01
dendritic spine morphogenesis (GO:0060997)	17	1	.87	+	1.15	5.81E-01
negative regulation of organ growth (GO:0046621)	34	2	1.74	+	1.15	5.18E-01
regulation of cardiac muscle cell apoptotic process (GO:0010665)	34	2	1.74	+	1.15	5.18E-01
regulation of Rac protein signal transduction (GO:0035020)	17	1	.87	+	1.15	5.81E-01
sphingoid metabolic process (GO:0046519)	17	1	.87	+	1.15	5.81E-01
retina vasculature development in camera-type eye (GO:0061298)	17	1	.87	+	1.15	5.81E-01
postsynaptic density organization (GO:0097106)	17	1	.87	+	1.15	5.81E-01
endocardial cushion morphogenesis (GO:0003203)	34	2	1.74	+	1.15	5.18E-01
high-density lipoprotein particle remodeling (GO:0034375)	17	1	.87	+	1.15	5.81E-01
negative regulation of JNK cascade (GO:0046329)	34	2	1.74	+	1.15	5.18E-01
pulmonary valve morphogenesis (GO:0003184)	17	1	.87	+	1.15	5.81E-01
cellular macromolecule localization (GO:0070727)	1482	87	75.70	+	1.15	9.81E-02
positive regulation of cell development (GO:0010720)	290	17	14.81	+	1.15	3.17E-01
negative regulation of cytokine production (GO:0001818)	273	16	13.94	+	1.15	3.24E-01
positive regulation of cell cycle process (GO:0090068)	273	16	13.94	+	1.15	3.24E-01
cellular protein-containing complex assembly (GO:0034622)	683	40	34.89	+	1.15	2.10E-01
negative regulation of protein kinase activity (GO:0006469)	222	13	11.34	+	1.15	3.48E-01
cellular component organization (GO:0016043)	5005	293	255.64	+	1.15	3.05E-03
endocytosis (GO:0006897)	410	24	20.94	+	1.15	2.78E-01
establishment of vesicle localization (GO:0051650)	188	11	9.60	+	1.15	3.67E-01
response to interleukin-1 (GO:0070555)	188	11	9.60	+	1.15	3.67E-01
generation of precursor metabolites and energy (GO:0006091)	359	21	18.34	+	1.15	2.95E-01
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	154	9	7.87	+	1.14	3.89E-01
signal transduction by protein phosphorylation (GO:0023014)	394	23	20.12	+	1.14	2.87E-01
developmental growth (GO:0048589)	360	21	18.39	+	1.14	2.99E-01
regulation of B cell activation (GO:0050864)	120	7	6.13	+	1.14	4.15E-01
myeloid cell differentiation (GO:0030099)	223	13	11.39	+	1.14	3.54E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	103	6	5.26	+	1.14	4.30E-01
glycolipid metabolic process (GO:0006664)	103	6	5.26	+	1.14	4.30E-01
negative regulation of developmental growth (GO:0048640)	103	6	5.26	+	1.14	4.30E-01
regulation of oxidoreductase activity (GO:0051341)	103	6	5.26	+	1.14	4.30E-01
negative regulation of viral process (GO:0048525)	103	6	5.26	+	1.14	4.30E-01
positive regulation of molecular function (GO:0044093)	1685	98	86.06	+	1.14	9.81E-02
response to catecholamine (GO:0071869)	86	5	4.39	+	1.14	4.48E-01
response to monoamine (GO:0071867)	86	5	4.39	+	1.14	4.48E-01
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	86	5	4.39	+	1.14	4.48E-01
negative regulation of peptide secretion (GO:0002792)	86	5	4.39	+	1.14	4.48E-01
response to external stimulus (GO:0009605)	2203	128	112.52	+	1.14	6.63E-02
positive regulation of catalytic activity (GO:0043085)	1360	79	69.46	+	1.14	1.30E-01
cellular component organization or biogenesis (GO:0071840)	5201	302	265.65	+	1.14	4.12E-03
interspecies interaction between organisms (GO:0044419)	1826	106	93.27	+	1.14	9.11E-02
regulation of cell motility (GO:2000145)	897	52	45.82	+	1.13	1.92E-01
regulation of glial cell differentiation (GO:0045685)	69	4	3.52	+	1.13	4.69E-01
endosome organization (GO:0007032)	69	4	3.52	+	1.13	4.69E-01
ERBB signaling pathway (GO:0038127)	69	4	3.52	+	1.13	4.69E-01
establishment of chromosome localization (GO:0051303)	69	4	3.52	+	1.13	4.69E-01
DNA integrity checkpoint (GO:0031570)	138	8	7.05	+	1.13	4.09E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	69	4	3.52	+	1.13	4.69E-01
chromosome localization (GO:0050000)	69	4	3.52	+	1.13	4.69E-01
phagocytosis (GO:0006909)	190	11	9.70	+	1.13	3.80E-01
regulation of cell junction assembly (GO:1901888)	190	11	9.70	+	1.13	3.80E-01
gamete generation (GO:0007276)	605	35	30.90	+	1.13	2.50E-01
male gamete generation (GO:0048232)	484	28	24.72	+	1.13	2.78E-01
embryonic limb morphogenesis (GO:0030326)	121	7	6.18	+	1.13	4.23E-01
embryonic appendage morphogenesis (GO:0035113)	121	7	6.18	+	1.13	4.23E-01
negative regulation of cell-cell adhesion (GO:0022408)	173	10	8.84	+	1.13	3.91E-01
response to oxygen-containing compound (GO:1901700)	1488	86	76.00	+	1.13	1.27E-01
protein complex oligomerization (GO:0051259)	225	13	11.49	+	1.13	3.66E-01
response to virus (GO:0009615)	277	16	14.15	+	1.13	3.45E-01
lymphocyte homeostasis (GO:0002260)	52	3	2.66	+	1.13	4.96E-01
cellular aldehyde metabolic process (GO:0006081)	52	3	2.66	+	1.13	4.96E-01
negative regulation of DNA binding (GO:0043392)	52	3	2.66	+	1.13	4.96E-01
activation of MAPKK activity (GO:0000186)	52	3	2.66	+	1.13	4.96E-01
autophagosome organization (GO:1905037)	52	3	2.66	+	1.13	4.96E-01
ribonucleoside triphosphate metabolic process (GO:0009199)	52	3	2.66	+	1.13	4.96E-01
liposaccharide metabolic process (GO:1903509)	104	6	5.31	+	1.13	4.39E-01
neuron development (GO:0048666)	799	46	40.81	+	1.13	2.23E-01
negative regulation of cellular process (GO:0048523)	4465	257	228.06	+	1.13	1.42E-02
positive regulation of MAP kinase activity (GO:0043406)	226	13	11.54	+	1.13	3.72E-01
cilium-dependent cell motility (GO:0060285)	87	5	4.44	+	1.13	4.57E-01
neural tube closure (GO:0001843)	87	5	4.44	+	1.13	4.57E-01
cilium or flagellum-dependent cell motility (GO:0001539)	87	5	4.44	+	1.13	4.57E-01
positive regulation of cellular component movement (GO:0051272)	522	30	26.66	+	1.13	2.81E-01
regulation of carbohydrate catabolic process (GO:0043470)	87	5	4.44	+	1.13	4.57E-01
positive regulation of exocytosis (GO:0045921)	87	5	4.44	+	1.13	4.57E-01
membrane organization (GO:0061024)	766	44	39.12	+	1.12	2.33E-01
response to cytokine (GO:0034097)	1062	61	54.24	+	1.12	1.88E-01
development of primary sexual characteristics (GO:0045137)	209	12	10.68	+	1.12	3.82E-01
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	122	7	6.23	+	1.12	4.31E-01
growth (GO:0040007)	366	21	18.69	+	1.12	3.25E-01
mammary gland development (GO:0030879)	122	7	6.23	+	1.12	4.31E-01
negative regulation of cellular component movement (GO:0051271)	279	16	14.25	+	1.12	3.55E-01
cellular response to cytokine stimulus (GO:0071345)	978	56	49.95	+	1.12	2.07E-01
regulation of developmental process (GO:0050793)	2291	131	117.02	+	1.12	9.08E-02
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	35	2	1.79	+	1.12	5.34E-01
regulation of T-helper cell differentiation (GO:0045622)	35	2	1.79	+	1.12	5.34E-01
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	140	8	7.15	+	1.12	4.24E-01
regulation of protein acetylation (GO:1901983)	70	4	3.58	+	1.12	4.80E-01
regulation of amino acid transport (GO:0051955)	35	2	1.79	+	1.12	5.34E-01
heterochromatin organization (GO:0070828)	35	2	1.79	+	1.12	5.34E-01
cellular response to cadmium ion (GO:0071276)	35	2	1.79	+	1.12	5.34E-01
proximal/distal pattern formation (GO:0009954)	35	2	1.79	+	1.12	5.34E-01
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	105	6	5.36	+	1.12	4.48E-01
cellular carbohydrate catabolic process (GO:0044275)	35	2	1.79	+	1.12	5.34E-01
regulation of chemotaxis (GO:0050920)	210	12	10.73	+	1.12	3.88E-01
spermatid differentiation (GO:0048515)	140	8	7.15	+	1.12	4.24E-01
negative regulation of blood vessel endothelial cell migration (GO:0043537)	35	2	1.79	+	1.12	5.34E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	35	2	1.79	+	1.12	5.34E-01
cortical actin cytoskeleton organization (GO:0030866)	35	2	1.79	+	1.12	5.34E-01
amino acid import (GO:0043090)	35	2	1.79	+	1.12	5.34E-01
organic hydroxy compound transport (GO:0015850)	140	8	7.15	+	1.12	4.24E-01
positive regulation of calcium ion transmembrane transport (GO:1904427)	70	4	3.58	+	1.12	4.80E-01
carbohydrate transport (GO:0008643)	70	4	3.58	+	1.12	4.80E-01
serine family amino acid metabolic process (GO:0009069)	35	2	1.79	+	1.12	5.34E-01
positive regulation of blood circulation (GO:1903524)	35	2	1.79	+	1.12	5.34E-01
receptor localization to synapse (GO:0097120)	35	2	1.79	+	1.12	5.34E-01
long-term memory (GO:0007616)	35	2	1.79	+	1.12	5.34E-01
regulation of cellular extravasation (GO:0002691)	35	2	1.79	+	1.12	5.34E-01
positive regulation of protein kinase activity (GO:0045860)	508	29	25.95	+	1.12	2.97E-01
negative regulation of biological process (GO:0048519)	4998	285	255.28	+	1.12	1.46E-02
RNA catabolic process (GO:0006401)	228	13	11.65	+	1.12	3.83E-01
regulation of synapse organization (GO:0050807)	193	11	9.86	+	1.12	3.99E-01
negative regulation of catalytic activity (GO:0043086)	737	42	37.64	+	1.12	2.55E-01
negative regulation of binding (GO:0051100)	158	9	8.07	+	1.12	4.17E-01
immune system process (GO:0002376)	2318	132	118.40	+	1.11	9.80E-02
positive regulation of cell-substrate adhesion (GO:0010811)	123	7	6.28	+	1.11	4.39E-01
regulation of cell migration (GO:0030334)	844	48	43.11	+	1.11	2.42E-01
regulation of anatomical structure morphogenesis (GO:0022603)	932	53	47.60	+	1.11	2.29E-01
positive regulation of cell motility (GO:2000147)	510	29	26.05	+	1.11	3.05E-01
negative regulation of cell differentiation (GO:0045596)	598	34	30.54	+	1.11	2.86E-01
roof of mouth development (GO:0060021)	88	5	4.49	+	1.11	4.67E-01
regulation of NIK/NF-kappaB signaling (GO:1901222)	88	5	4.49	+	1.11	4.67E-01
epithelial cell proliferation (GO:0050673)	88	5	4.49	+	1.11	4.67E-01
tube closure (GO:0060606)	88	5	4.49	+	1.11	4.67E-01
negative regulation of developmental process (GO:0051093)	828	47	42.29	+	1.11	2.49E-01
positive regulation of cellular component organization (GO:0051130)	1075	61	54.91	+	1.11	2.15E-01
protein-DNA complex assembly (GO:0065004)	141	8	7.20	+	1.11	4.31E-01
regulation of histone modification (GO:0031056)	141	8	7.20	+	1.11	4.31E-01
negative regulation of cell cycle process (GO:0010948)	300	17	15.32	+	1.11	3.67E-01
regulation of locomotion (GO:0040012)	936	53	47.81	+	1.11	2.39E-01
regulation of multicellular organismal development (GO:2000026)	1254	71	64.05	+	1.11	1.99E-01
endochondral bone morphogenesis (GO:0060350)	53	3	2.71	+	1.11	5.08E-01
glomerulus development (GO:0032835)	53	3	2.71	+	1.11	5.08E-01
Fc-epsilon receptor signaling pathway (GO:0038095)	106	6	5.41	+	1.11	4.57E-01
positive regulation of ATPase activity (GO:0032781)	53	3	2.71	+	1.11	5.08E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288)	106	6	5.41	+	1.11	4.57E-01
negative regulation of chromatin organization (GO:1905268)	53	3	2.71	+	1.11	5.08E-01
regulation of macrophage activation (GO:0043030)	53	3	2.71	+	1.11	5.08E-01
actomyosin structure organization (GO:0031032)	106	6	5.41	+	1.11	4.57E-01
negative regulation of multicellular organismal process (GO:0051241)	973	55	49.70	+	1.11	2.38E-01
positive regulation of developmental process (GO:0051094)	1203	68	61.45	+	1.11	2.09E-01
cellular localization (GO:0051641)	2708	153	138.32	+	1.11	9.44E-02
activation of immune response (GO:0002253)	354	20	18.08	+	1.11	3.55E-01
positive regulation of cellular component biogenesis (GO:0044089)	496	28	25.33	+	1.11	3.22E-01
negative regulation of signal transduction (GO:0009968)	1205	68	61.55	+	1.10	2.13E-01
vesicle localization (GO:0051648)	195	11	9.96	+	1.10	4.12E-01
anterior/posterior pattern specification (GO:0009952)	195	11	9.96	+	1.10	4.12E-01
negative regulation of cell adhesion (GO:0007162)	266	15	13.59	+	1.10	3.85E-01
defense response (GO:0006952)	1189	67	60.73	+	1.10	2.19E-01
smoothened signaling pathway (GO:0007224)	71	4	3.63	+	1.10	4.91E-01
regulation of receptor signaling pathway via STAT (GO:1904892)	71	4	3.63	+	1.10	4.91E-01
limb morphogenesis (GO:0035108)	142	8	7.25	+	1.10	4.39E-01
appendage morphogenesis (GO:0035107)	142	8	7.25	+	1.10	4.39E-01
positive regulation of Ras protein signal transduction (GO:0046579)	71	4	3.63	+	1.10	4.91E-01
negative regulation of mitotic cell cycle (GO:0045930)	284	16	14.51	+	1.10	3.81E-01
outflow tract morphogenesis (GO:0003151)	71	4	3.63	+	1.10	4.91E-01
regulation of cell projection organization (GO:0031344)	604	34	30.85	+	1.10	3.06E-01
proteasomal protein catabolic process (GO:0010498)	320	18	16.34	+	1.10	3.73E-01
response to chemical (GO:0042221)	3773	212	192.71	+	1.10	6.24E-02
positive regulation of transport (GO:0051050)	890	50	45.46	+	1.10	2.64E-01
regulation of cell growth (GO:0001558)	392	22	20.02	+	1.10	3.57E-01
cilium assembly (GO:0060271)	303	17	15.48	+	1.10	3.82E-01
positive regulation of stress-activated MAPK cascade (GO:0032874)	107	6	5.47	+	1.10	4.65E-01
aminoglycan biosynthetic process (GO:0006023)	107	6	5.47	+	1.10	4.65E-01
B cell differentiation (GO:0030183)	107	6	5.47	+	1.10	4.65E-01
positive regulation of mitotic cell cycle (GO:0045931)	107	6	5.47	+	1.10	4.65E-01
cell development (GO:0048468)	1535	86	78.40	+	1.10	1.98E-01
multi-organism process (GO:0051704)	964	54	49.24	+	1.10	2.61E-01
cell junction assembly (GO:0034329)	268	15	13.69	+	1.10	3.96E-01
morphogenesis of a branching structure (GO:0001763)	161	9	8.22	+	1.09	4.39E-01
regulation of adaptive immune response (GO:0002819)	161	9	8.22	+	1.09	4.39E-01
vesicle-mediated transport (GO:0016192)	1684	94	86.01	+	1.09	1.96E-01
establishment of localization in cell (GO:0051649)	2151	120	109.87	+	1.09	1.62E-01
homeostatic process (GO:0042592)	1560	87	79.68	+	1.09	2.09E-01
secretion (GO:0046903)	1006	56	51.38	+	1.09	2.72E-01
multicellular organismal reproductive process (GO:0048609)	737	41	37.64	+	1.09	3.10E-01
protein-DNA complex subunit organization (GO:0071824)	180	10	9.19	+	1.09	4.38E-01
neurotransmitter secretion (GO:0007269)	90	5	4.60	+	1.09	4.86E-01
signal release from synapse (GO:0099643)	90	5	4.60	+	1.09	4.86E-01
protein polymerization (GO:0051258)	90	5	4.60	+	1.09	4.86E-01
regulation of carbohydrate biosynthetic process (GO:0043255)	90	5	4.60	+	1.09	4.86E-01
carbohydrate transmembrane transport (GO:0034219)	36	2	1.84	+	1.09	5.49E-01
response to glucagon (GO:0033762)	36	2	1.84	+	1.09	5.49E-01
positive regulation of cilium assembly (GO:0045724)	18	1	.92	+	1.09	6.01E-01
positive regulation of oxidative stress-induced cell death (GO:1903209)	18	1	.92	+	1.09	6.01E-01
activation of protein kinase A activity (GO:0034199)	18	1	.92	+	1.09	6.01E-01
purine ribonucleoside metabolic process (GO:0046128)	54	3	2.76	+	1.09	5.21E-01
epoxygenase P450 pathway (GO:0019373)	18	1	.92	+	1.09	6.01E-01
negative regulation of anoikis (GO:2000811)	18	1	.92	+	1.09	6.01E-01
head morphogenesis (GO:0060323)	36	2	1.84	+	1.09	5.49E-01
T cell mediated immunity (GO:0002456)	36	2	1.84	+	1.09	5.49E-01
regulation of protein phosphorylation (GO:0001932)	1368	76	69.87	+	1.09	2.38E-01
cell differentiation involved in metanephros development (GO:0072202)	18	1	.92	+	1.09	6.01E-01
definitive hemopoiesis (GO:0060216)	18	1	.92	+	1.09	6.01E-01
regulation of ATP biosynthetic process (GO:2001169)	18	1	.92	+	1.09	6.01E-01
metanephric tubule development (GO:0072170)	18	1	.92	+	1.09	6.01E-01
regulation of sodium ion transmembrane transporter activity (GO:2000649)	54	3	2.76	+	1.09	5.21E-01
glycerol ether metabolic process (GO:0006662)	18	1	.92	+	1.09	6.01E-01
positive regulation of transforming growth factor beta production (GO:0071636)	18	1	.92	+	1.09	6.01E-01
polyamine metabolic process (GO:0006595)	18	1	.92	+	1.09	6.01E-01
negative regulation of focal adhesion assembly (GO:0051895)	18	1	.92	+	1.09	6.01E-01
osteoblast development (GO:0002076)	18	1	.92	+	1.09	6.01E-01
oocyte maturation (GO:0001556)	18	1	.92	+	1.09	6.01E-01
negative regulation of reactive oxygen species metabolic process (GO:2000378)	54	3	2.76	+	1.09	5.21E-01
regulation of interleukin-10 production (GO:0032653)	54	3	2.76	+	1.09	5.21E-01
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	18	1	.92	+	1.09	6.01E-01
negative regulation of nuclear division (GO:0051784)	36	2	1.84	+	1.09	5.49E-01
movement in host environment (GO:0052126)	108	6	5.52	+	1.09	4.74E-01
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	36	2	1.84	+	1.09	5.49E-01
purine nucleobase metabolic process (GO:0006144)	18	1	.92	+	1.09	6.01E-01
regulation of calcium ion import (GO:0090279)	36	2	1.84	+	1.09	5.49E-01
positive regulation of icosanoid secretion (GO:0032305)	18	1	.92	+	1.09	6.01E-01
regulation of phospholipid biosynthetic process (GO:0071071)	18	1	.92	+	1.09	6.01E-01
regulation of voltage-gated calcium channel activity (GO:1901385)	36	2	1.84	+	1.09	5.49E-01
kinetochore organization (GO:0051383)	18	1	.92	+	1.09	6.01E-01
positive regulation of monocyte chemotaxis (GO:0090026)	18	1	.92	+	1.09	6.01E-01
negative regulation of calcium-mediated signaling (GO:0050849)	18	1	.92	+	1.09	6.01E-01
retrograde transport, endosome to plasma membrane (GO:1990126)	18	1	.92	+	1.09	6.01E-01
paraxial mesoderm development (GO:0048339)	18	1	.92	+	1.09	6.01E-01
protein trimerization (GO:0070206)	18	1	.92	+	1.09	6.01E-01
spliceosomal snRNP assembly (GO:0000387)	36	2	1.84	+	1.09	5.49E-01
interleukin-6-mediated signaling pathway (GO:0070102)	18	1	.92	+	1.09	6.01E-01
mitochondrial fission (GO:0000266)	18	1	.92	+	1.09	6.01E-01
negative regulation of B cell proliferation (GO:0030889)	18	1	.92	+	1.09	6.01E-01
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	18	1	.92	+	1.09	6.01E-01
mitochondrial genome maintenance (GO:0000002)	18	1	.92	+	1.09	6.01E-01
cardiac myofibril assembly (GO:0055003)	18	1	.92	+	1.09	6.01E-01
positive regulation of histone methylation (GO:0031062)	36	2	1.84	+	1.09	5.49E-01
myeloid dendritic cell differentiation (GO:0043011)	18	1	.92	+	1.09	6.01E-01
purine nucleoside triphosphate metabolic process (GO:0009144)	54	3	2.76	+	1.09	5.21E-01
nucleoside triphosphate metabolic process (GO:0009141)	72	4	3.68	+	1.09	5.01E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	18	1	.92	+	1.09	6.01E-01
regulation of striated muscle tissue development (GO:0016202)	36	2	1.84	+	1.09	5.49E-01
negative regulation of cell-substrate junction organization (GO:0150118)	18	1	.92	+	1.09	6.01E-01
female sex differentiation (GO:0046660)	108	6	5.52	+	1.09	4.74E-01
tetrahydrofolate metabolic process (GO:0046653)	18	1	.92	+	1.09	6.01E-01
alpha-beta T cell differentiation (GO:0046632)	54	3	2.76	+	1.09	5.21E-01
chromosome condensation (GO:0030261)	36	2	1.84	+	1.09	5.49E-01
glycerolipid catabolic process (GO:0046503)	54	3	2.76	+	1.09	5.21E-01
regulation of platelet activation (GO:0010543)	36	2	1.84	+	1.09	5.49E-01
positive regulation of autophagy of mitochondrion (GO:1903599)	18	1	.92	+	1.09	6.01E-01
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	36	2	1.84	+	1.09	5.49E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071)	54	3	2.76	+	1.09	5.21E-01
learning (GO:0007612)	144	8	7.36	+	1.09	4.54E-01
negative regulation of necrotic cell death (GO:0060547)	18	1	.92	+	1.09	6.01E-01
negative regulation of response to stimulus (GO:0048585)	1640	91	83.77	+	1.09	2.17E-01
regulation of signaling (GO:0023051)	3208	178	163.85	+	1.09	1.18E-01
regulation of cell communication (GO:0010646)	3173	176	162.07	+	1.09	1.20E-01
supramolecular fiber organization (GO:0097435)	469	26	23.96	+	1.09	3.63E-01
negative regulation of signaling (GO:0023057)	1299	72	66.35	+	1.09	2.52E-01
gland development (GO:0048732)	397	22	20.28	+	1.08	3.79E-01
regulation of cellular process (GO:0050794)	9638	534	492.28	+	1.08	1.69E-03
positive regulation of locomotion (GO:0040017)	524	29	26.76	+	1.08	3.56E-01
regulation of vesicle-mediated transport (GO:0060627)	488	27	24.93	+	1.08	3.64E-01
reproduction (GO:0000003)	1303	72	66.55	+	1.08	2.60E-01
translation (GO:0006412)	344	19	17.57	+	1.08	3.97E-01
response to wounding (GO:0009611)	507	28	25.90	+	1.08	3.64E-01
positive regulation of binding (GO:0051099)	163	9	8.33	+	1.08	4.53E-01
M phase (GO:0000279)	163	9	8.33	+	1.08	4.53E-01
mitotic M phase (GO:0000087)	163	9	8.33	+	1.08	4.53E-01
negative regulation of cellular amide metabolic process (GO:0034249)	145	8	7.41	+	1.08	4.62E-01
developmental process involved in reproduction (GO:0003006)	870	48	44.44	+	1.08	3.12E-01
positive regulation of synaptic transmission (GO:0050806)	127	7	6.49	+	1.08	4.72E-01
positive regulation of kinase activity (GO:0033674)	581	32	29.68	+	1.08	3.57E-01
cell surface receptor signaling pathway (GO:0007166)	2180	120	111.35	+	1.08	2.02E-01
regulation of anion transport (GO:0044070)	109	6	5.57	+	1.08	4.83E-01
mucopolysaccharide metabolic process (GO:1903510)	109	6	5.57	+	1.08	4.83E-01
positive regulation of cell differentiation (GO:0045597)	800	44	40.86	+	1.08	3.29E-01
regulation of protein binding (GO:0043393)	200	11	10.22	+	1.08	4.44E-01
energy derivation by oxidation of organic compounds (GO:0015980)	200	11	10.22	+	1.08	4.44E-01
nuclear chromosome segregation (GO:0098813)	182	10	9.30	+	1.08	4.52E-01
negative regulation of cell cycle (GO:0045786)	528	29	26.97	+	1.08	3.72E-01
regulation of biological process (GO:0050789)	10130	556	517.41	+	1.07	2.98E-03
regulation of signal transduction by p53 class mediator (GO:1901796)	164	9	8.38	+	1.07	4.60E-01
cellular response to interleukin-1 (GO:0071347)	164	9	8.38	+	1.07	4.60E-01
lung development (GO:0030324)	164	9	8.38	+	1.07	4.60E-01
regulation of response to stimulus (GO:0048583)	3795	208	193.84	+	1.07	1.32E-01
regulation of organic acid transport (GO:0032890)	73	4	3.73	+	1.07	5.12E-01
cartilage development (GO:0051216)	146	8	7.46	+	1.07	4.69E-01
peptide biosynthetic process (GO:0043043)	365	20	18.64	+	1.07	4.07E-01
nucleoside diphosphate metabolic process (GO:0009132)	73	4	3.73	+	1.07	5.12E-01
lymphocyte proliferation (GO:0046651)	73	4	3.73	+	1.07	5.12E-01
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	146	8	7.46	+	1.07	4.69E-01
negative regulation of cell communication (GO:0010648)	1296	71	66.20	+	1.07	2.86E-01
immune response (GO:0006955)	1479	81	75.54	+	1.07	2.71E-01
mRNA catabolic process (GO:0006402)	201	11	10.27	+	1.07	4.50E-01
regulation of endocytosis (GO:0030100)	201	11	10.27	+	1.07	4.50E-01
non-canonical Wnt signaling pathway (GO:0035567)	128	7	6.54	+	1.07	4.80E-01
sex differentiation (GO:0007548)	256	14	13.08	+	1.07	4.35E-01
inner ear development (GO:0048839)	183	10	9.35	+	1.07	4.58E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	183	10	9.35	+	1.07	4.58E-01
reproductive process (GO:0022414)	1301	71	66.45	+	1.07	2.98E-01
regulation of microtubule-based process (GO:0032886)	220	12	11.24	+	1.07	4.49E-01
positive regulation of blood vessel diameter (GO:0097755)	55	3	2.81	+	1.07	5.33E-01
purine nucleoside metabolic process (GO:0042278)	55	3	2.81	+	1.07	5.33E-01
monosaccharide catabolic process (GO:0046365)	55	3	2.81	+	1.07	5.33E-01
positive regulation of protein phosphorylation (GO:0001934)	954	52	48.73	+	1.07	3.35E-01
amide biosynthetic process (GO:0043604)	477	26	24.36	+	1.07	3.96E-01
exocytosis (GO:0006887)	734	40	37.49	+	1.07	3.60E-01
biological regulation (GO:0065007)	10703	583	546.68	+	1.07	4.05E-03
positive regulation of cytoskeleton organization (GO:0051495)	202	11	10.32	+	1.07	4.57E-01
regulation of catalytic activity (GO:0050790)	2167	118	110.68	+	1.07	2.41E-01
regulation of reproductive process (GO:2000241)	147	8	7.51	+	1.07	4.77E-01
regulation of hydrolase activity (GO:0051336)	1176	64	60.07	+	1.07	3.17E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035)	588	32	30.03	+	1.07	3.82E-01
regulation of response to external stimulus (GO:0032101)	1066	58	54.45	+	1.07	3.28E-01
meiosis I (GO:0007127)	92	5	4.70	+	1.06	5.06E-01
regulation of hormone levels (GO:0010817)	497	27	25.39	+	1.06	4.00E-01
cellular amide metabolic process (GO:0043603)	718	39	36.67	+	1.06	3.70E-01
response to molecule of bacterial origin (GO:0002237)	313	17	15.99	+	1.06	4.33E-01
multicellular organism reproduction (GO:0032504)	755	41	38.56	+	1.06	3.66E-01
endomembrane system organization (GO:0010256)	387	21	19.77	+	1.06	4.20E-01
DNA damage checkpoint (GO:0000077)	129	7	6.59	+	1.06	4.88E-01
negative regulation of cell migration (GO:0030336)	258	14	13.18	+	1.06	4.47E-01
platelet activation (GO:0030168)	129	7	6.59	+	1.06	4.88E-01
generation of neurons (GO:0048699)	1198	65	61.19	+	1.06	3.25E-01
cellular component disassembly (GO:0022411)	369	20	18.85	+	1.06	4.25E-01
negative regulation of neuron death (GO:1901215)	203	11	10.37	+	1.06	4.63E-01
organelle transport along microtubule (GO:0072384)	74	4	3.78	+	1.06	5.23E-01
formation of primary germ layer (GO:0001704)	111	6	5.67	+	1.06	5.00E-01
sarcomere organization (GO:0045214)	37	2	1.89	+	1.06	5.64E-01
transcription by RNA polymerase I (GO:0006360)	37	2	1.89	+	1.06	5.64E-01
positive regulation of ERBB signaling pathway (GO:1901186)	37	2	1.89	+	1.06	5.64E-01
positive regulation of nervous system process (GO:0031646)	37	2	1.89	+	1.06	5.64E-01
synaptic vesicle transport (GO:0048489)	37	2	1.89	+	1.06	5.64E-01
autophagy of mitochondrion (GO:0000422)	37	2	1.89	+	1.06	5.64E-01
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	37	2	1.89	+	1.06	5.64E-01
regulation of purine nucleotide metabolic process (GO:1900542)	111	6	5.67	+	1.06	5.00E-01
regulation of cellular response to oxidative stress (GO:1900407)	74	4	3.78	+	1.06	5.23E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201)	37	2	1.89	+	1.06	5.64E-01
mitochondrion disassembly (GO:0061726)	37	2	1.89	+	1.06	5.64E-01
regulation of phospholipid metabolic process (GO:1903725)	37	2	1.89	+	1.06	5.64E-01
regulation of striated muscle cell apoptotic process (GO:0010662)	37	2	1.89	+	1.06	5.64E-01
negative regulation of wound healing (GO:0061045)	74	4	3.78	+	1.06	5.23E-01
neurogenesis (GO:0022008)	1316	71	67.22	+	1.06	3.33E-01
regulation of synapse structure or activity (GO:0050803)	204	11	10.42	+	1.06	4.70E-01
regulation of epithelial cell proliferation (GO:0050678)	334	18	17.06	+	1.06	4.42E-01
peptide secretion (GO:0002790)	130	7	6.64	+	1.05	4.96E-01
transport (GO:0006810)	4013	216	204.97	+	1.05	1.98E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	186	10	9.50	+	1.05	4.79E-01
cytokinesis (GO:0000910)	93	5	4.75	+	1.05	5.15E-01
hemopoiesis (GO:0030097)	558	30	28.50	+	1.05	4.13E-01
cellular response to stimulus (GO:0051716)	5767	310	294.56	+	1.05	1.39E-01
establishment of localization (GO:0051234)	4136	222	211.25	+	1.05	2.07E-01
cellular response to biotic stimulus (GO:0071216)	205	11	10.47	+	1.05	4.76E-01
regulation of smooth muscle contraction (GO:0006940)	56	3	2.86	+	1.05	5.45E-01
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	168	9	8.58	+	1.05	4.88E-01
telencephalon cell migration (GO:0022029)	56	3	2.86	+	1.05	5.45E-01
protein transmembrane transport (GO:0071806)	56	3	2.86	+	1.05	5.45E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	56	3	2.86	+	1.05	5.45E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	56	3	2.86	+	1.05	5.45E-01
negative regulation of cell projection organization (GO:0031345)	168	9	8.58	+	1.05	4.88E-01
protein secretion (GO:0009306)	112	6	5.72	+	1.05	5.09E-01
cardiac cell development (GO:0055006)	56	3	2.86	+	1.05	5.45E-01
protein localization to synapse (GO:0035418)	56	3	2.86	+	1.05	5.45E-01
apoptotic mitochondrial changes (GO:0008637)	56	3	2.86	+	1.05	5.45E-01
respiratory tube development (GO:0030323)	168	9	8.58	+	1.05	4.88E-01
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	56	3	2.86	+	1.05	5.45E-01
protein localization to chromosome (GO:0034502)	56	3	2.86	+	1.05	5.45E-01
immune system development (GO:0002520)	635	34	32.43	+	1.05	4.14E-01
regulation of biological quality (GO:0065008)	3717	199	189.85	+	1.05	2.36E-01
ribosome biogenesis (GO:0042254)	299	16	15.27	+	1.05	4.60E-01
epithelial tube morphogenesis (GO:0060562)	299	16	15.27	+	1.05	4.60E-01
macromolecule catabolic process (GO:0009057)	954	51	48.73	+	1.05	3.89E-01
negative regulation of molecular function (GO:0044092)	1049	56	53.58	+	1.05	3.86E-01
multi-organism reproductive process (GO:0044703)	900	48	45.97	+	1.04	4.00E-01
positive regulation of response to biotic stimulus (GO:0002833)	225	12	11.49	+	1.04	4.80E-01
mononuclear cell proliferation (GO:0032943)	75	4	3.83	+	1.04	5.33E-01
positive regulation of reproductive process (GO:2000243)	75	4	3.83	+	1.04	5.33E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	300	16	15.32	+	1.04	4.65E-01
regulation of signal transduction (GO:0009966)	2833	151	144.70	+	1.04	2.95E-01
secretion by cell (GO:0032940)	902	48	46.07	+	1.04	4.06E-01
regulation of cell population proliferation (GO:0042127)	1541	82	78.71	+	1.04	3.65E-01
anatomical structure maturation (GO:0071695)	188	10	9.60	+	1.04	4.92E-01
translational termination (GO:0006415)	94	5	4.80	+	1.04	5.24E-01
primary neural tube formation (GO:0014020)	94	5	4.80	+	1.04	5.24E-01
meiosis I cell cycle process (GO:0061982)	94	5	4.80	+	1.04	5.24E-01
ear development (GO:0043583)	207	11	10.57	+	1.04	4.89E-01
germ cell development (GO:0007281)	226	12	11.54	+	1.04	4.86E-01
regulation of nucleotide metabolic process (GO:0006140)	113	6	5.77	+	1.04	5.17E-01
response to xenobiotic stimulus (GO:0009410)	113	6	5.77	+	1.04	5.17E-01
establishment of protein localization to extracellular region (GO:0035592)	113	6	5.77	+	1.04	5.17E-01
regulation of ATP metabolic process (GO:1903578)	113	6	5.77	+	1.04	5.17E-01
cellular process (GO:0009987)	13152	698	671.76	+	1.04	1.03E-02
carbohydrate biosynthetic process (GO:0016051)	132	7	6.74	+	1.04	5.12E-01
hematopoietic or lymphoid organ development (GO:0048534)	604	32	30.85	+	1.04	4.42E-01
glycosaminoglycan metabolic process (GO:0030203)	151	8	7.71	+	1.04	5.07E-01
modification-dependent macromolecule catabolic process (GO:0043632)	491	26	25.08	+	1.04	4.53E-01
chemical homeostasis (GO:0048878)	1060	56	54.14	+	1.03	4.17E-01
positive regulation of protein serine/threonine kinase activity (GO:0071902)	303	16	15.48	+	1.03	4.81E-01
cytokine-mediated signaling pathway (GO:0019221)	663	35	33.86	+	1.03	4.45E-01
neurotransmitter transport (GO:0006836)	133	7	6.79	+	1.03	5.20E-01
Rho protein signal transduction (GO:0007266)	57	3	2.91	+	1.03	5.57E-01
regulation of lipid catabolic process (GO:0050994)	57	3	2.91	+	1.03	5.57E-01
regulation of defense response (GO:0031347)	741	39	37.85	+	1.03	4.47E-01
regulation of mitotic sister chromatid separation (GO:0010965)	57	3	2.91	+	1.03	5.57E-01
regulation of myeloid leukocyte mediated immunity (GO:0002886)	57	3	2.91	+	1.03	5.57E-01
positive regulation of immunoglobulin production (GO:0002639)	38	2	1.94	+	1.03	5.78E-01
trachea development (GO:0060438)	19	1	.97	+	1.03	6.21E-01
regulation of autophagy of mitochondrion (GO:1903146)	38	2	1.94	+	1.03	5.78E-01
regulation of actin filament-based movement (GO:1903115)	38	2	1.94	+	1.03	5.78E-01
stress granule assembly (GO:0034063)	19	1	.97	+	1.03	6.21E-01
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	19	1	.97	+	1.03	6.21E-01
phosphate ion transport (GO:0006817)	19	1	.97	+	1.03	6.21E-01
centriole replication (GO:0007099)	19	1	.97	+	1.03	6.21E-01
regulation of exit from mitosis (GO:0007096)	19	1	.97	+	1.03	6.21E-01
nephron tubule development (GO:0072080)	76	4	3.88	+	1.03	5.44E-01
glomerulus vasculature development (GO:0072012)	19	1	.97	+	1.03	6.21E-01
Sertoli cell differentiation (GO:0060008)	19	1	.97	+	1.03	6.21E-01
regulation of muscle tissue development (GO:1901861)	38	2	1.94	+	1.03	5.78E-01
ameboidal-type cell migration (GO:0001667)	171	9	8.73	+	1.03	5.09E-01
cilium organization (GO:0044782)	323	17	16.50	+	1.03	4.84E-01
negative regulation of interleukin-8 production (GO:0032717)	19	1	.97	+	1.03	6.21E-01
neural crest cell development (GO:0014032)	76	4	3.88	+	1.03	5.44E-01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	38	2	1.94	+	1.03	5.78E-01
negative regulation of RNA splicing (GO:0033119)	19	1	.97	+	1.03	6.21E-01
mRNA cleavage (GO:0006379)	19	1	.97	+	1.03	6.21E-01
regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	19	1	.97	+	1.03	6.21E-01
glutathione derivative biosynthetic process (GO:1901687)	19	1	.97	+	1.03	6.21E-01
glutathione derivative metabolic process (GO:1901685)	19	1	.97	+	1.03	6.21E-01
DNA strand elongation involved in DNA replication (GO:0006271)	19	1	.97	+	1.03	6.21E-01
positive regulation of amyloid-beta formation (GO:1902004)	19	1	.97	+	1.03	6.21E-01
cellular response to misfolded protein (GO:0071218)	19	1	.97	+	1.03	6.21E-01
response to electrical stimulus (GO:0051602)	38	2	1.94	+	1.03	5.78E-01
endocytic recycling (GO:0032456)	38	2	1.94	+	1.03	5.78E-01
regulation of fatty acid beta-oxidation (GO:0031998)	19	1	.97	+	1.03	6.21E-01
positive regulation of multi-organism process (GO:0043902)	19	1	.97	+	1.03	6.21E-01
positive regulation of calcium ion import (GO:0090280)	19	1	.97	+	1.03	6.21E-01
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	19	1	.97	+	1.03	6.21E-01
cellular response to leptin stimulus (GO:0044320)	19	1	.97	+	1.03	6.21E-01
regulation of protein localization to cell surface (GO:2000008)	38	2	1.94	+	1.03	5.78E-01
N-acetylglucosamine metabolic process (GO:0006044)	19	1	.97	+	1.03	6.21E-01
regulation of potassium ion transmembrane transport (GO:1901379)	76	4	3.88	+	1.03	5.44E-01
small molecule catabolic process (GO:0044282)	399	21	20.38	+	1.03	4.75E-01
regulation of muscle organ development (GO:0048634)	38	2	1.94	+	1.03	5.78E-01
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	76	4	3.88	+	1.03	5.44E-01
regulation of endocrine process (GO:0044060)	38	2	1.94	+	1.03	5.78E-01
retinoic acid receptor signaling pathway (GO:0048384)	19	1	.97	+	1.03	6.21E-01
negative regulation of T cell apoptotic process (GO:0070233)	19	1	.97	+	1.03	6.21E-01
negative regulation of purine nucleotide metabolic process (GO:1900543)	19	1	.97	+	1.03	6.21E-01
intraciliary transport involved in cilium assembly (GO:0035735)	38	2	1.94	+	1.03	5.78E-01
amyloid-beta metabolic process (GO:0050435)	19	1	.97	+	1.03	6.21E-01
regulation of purine nucleotide biosynthetic process (GO:1900371)	38	2	1.94	+	1.03	5.78E-01
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	19	1	.97	+	1.03	6.21E-01
ovulation (GO:0030728)	19	1	.97	+	1.03	6.21E-01
rRNA methylation (GO:0031167)	19	1	.97	+	1.03	6.21E-01
nucleobase-containing small molecule interconversion (GO:0015949)	19	1	.97	+	1.03	6.21E-01
deoxyribonucleotide catabolic process (GO:0009264)	19	1	.97	+	1.03	6.21E-01
aromatic amino acid family metabolic process (GO:0009072)	38	2	1.94	+	1.03	5.78E-01
viral entry into host cell (GO:0046718)	95	5	4.85	+	1.03	5.34E-01
negative regulation of sodium ion transport (GO:0010766)	19	1	.97	+	1.03	6.21E-01
melanocyte differentiation (GO:0030318)	19	1	.97	+	1.03	6.21E-01
positive regulation of cell growth (GO:0030307)	152	8	7.76	+	1.03	5.14E-01
negative regulation of ossification (GO:0030279)	38	2	1.94	+	1.03	5.78E-01
negative regulation of platelet activation (GO:0010544)	19	1	.97	+	1.03	6.21E-01
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	19	1	.97	+	1.03	6.21E-01
vesicle transport along actin filament (GO:0030050)	19	1	.97	+	1.03	6.21E-01
cardiac right ventricle morphogenesis (GO:0003215)	19	1	.97	+	1.03	6.21E-01
morphogenesis of an epithelial fold (GO:0060571)	19	1	.97	+	1.03	6.21E-01
positive regulation of phosphorylation (GO:0042327)	1027	54	52.46	+	1.03	4.33E-01
MAPK cascade (GO:0000165)	381	20	19.46	+	1.03	4.82E-01
positive regulation of innate immune response (GO:0045089)	191	10	9.76	+	1.03	5.12E-01
regulation of multicellular organismal process (GO:0051239)	2522	132	128.82	+	1.02	3.95E-01
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	325	17	16.60	+	1.02	4.94E-01
ubiquitin-dependent protein catabolic process (GO:0006511)	478	25	24.41	+	1.02	4.80E-01
immune effector process (GO:0002252)	899	47	45.92	+	1.02	4.56E-01
sexual reproduction (GO:0019953)	746	39	38.10	+	1.02	4.64E-01
biological_process (GO:0008150)	14865	777	759.26	+	1.02	1.34E-02
vesicle organization (GO:0016050)	287	15	14.66	+	1.02	5.00E-01
positive regulation of nervous system development (GO:0051962)	268	14	13.69	+	1.02	5.03E-01
regulation of blood vessel diameter (GO:0097746)	134	7	6.84	+	1.02	5.27E-01
regulation of tube diameter (GO:0035296)	134	7	6.84	+	1.02	5.27E-01
regulation of molecular function (GO:0065009)	2779	145	141.94	+	1.02	4.03E-01
developmental growth involved in morphogenesis (GO:0060560)	115	6	5.87	+	1.02	5.34E-01
regulation of protein kinase activity (GO:0045859)	748	39	38.21	+	1.02	4.71E-01
response to stimulus (GO:0050896)	7154	373	365.40	+	1.02	3.10E-01
morphogenesis of an epithelium (GO:0002009)	422	22	21.55	+	1.02	4.91E-01
positive regulation of phosphorus metabolic process (GO:0010562)	1094	57	55.88	+	1.02	4.58E-01
positive regulation of phosphate metabolic process (GO:0045937)	1094	57	55.88	+	1.02	4.58E-01
vesicle budding from membrane (GO:0006900)	96	5	4.90	+	1.02	5.43E-01
mitotic DNA damage checkpoint (GO:0044773)	96	5	4.90	+	1.02	5.43E-01
retinoid metabolic process (GO:0001523)	96	5	4.90	+	1.02	5.43E-01
positive regulation of neuron death (GO:1901216)	96	5	4.90	+	1.02	5.43E-01
histone acetylation (GO:0016573)	96	5	4.90	+	1.02	5.43E-01
fatty acid metabolic process (GO:0006631)	288	15	14.71	+	1.02	5.05E-01
localization (GO:0051179)	5165	269	263.81	+	1.02	3.62E-01
proteolysis (GO:0006508)	1133	59	57.87	+	1.02	4.58E-01
axon guidance (GO:0007411)	269	14	13.74	+	1.02	5.08E-01
organic anion transport (GO:0015711)	442	23	22.58	+	1.02	4.93E-01
cellular macromolecule catabolic process (GO:0044265)	827	43	42.24	+	1.02	4.74E-01
regulation of glycolytic process (GO:0006110)	77	4	3.93	+	1.02	5.54E-01
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	77	4	3.93	+	1.02	5.54E-01
iron ion homeostasis (GO:0055072)	77	4	3.93	+	1.02	5.54E-01
associative learning (GO:0008306)	77	4	3.93	+	1.02	5.54E-01
neuron differentiation (GO:0030182)	982	51	50.16	+	1.02	4.72E-01
positive regulation of cell cycle (GO:0045787)	366	19	18.69	+	1.02	5.03E-01
modification-dependent protein catabolic process (GO:0019941)	482	25	24.62	+	1.02	4.97E-01
regulation of microtubule cytoskeleton organization (GO:0070507)	135	7	6.90	+	1.02	5.35E-01
neuron projection guidance (GO:0097485)	270	14	13.79	+	1.02	5.14E-01
regulation of tube size (GO:0035150)	135	7	6.90	+	1.02	5.35E-01
positive regulation of cation transmembrane transport (GO:1904064)	135	7	6.90	+	1.02	5.35E-01
immune response-regulating signaling pathway (GO:0002764)	328	17	16.75	+	1.01	5.09E-01
export from cell (GO:0140352)	946	49	48.32	+	1.01	4.81E-01
signal transduction by p53 class mediator (GO:0072331)	116	6	5.92	+	1.01	5.43E-01
transition metal ion transport (GO:0000041)	116	6	5.92	+	1.01	5.43E-01
regulation of cardiac muscle tissue growth (GO:0055021)	58	3	2.96	+	1.01	5.69E-01
forebrain cell migration (GO:0021885)	58	3	2.96	+	1.01	5.69E-01
regulation of metal ion transport (GO:0010959)	368	19	18.80	+	1.01	5.13E-01
ossification (GO:0001503)	252	13	12.87	+	1.01	5.23E-01
negative regulation of protein binding (GO:0032091)	97	5	4.95	+	1.01	5.52E-01
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	97	5	4.95	+	1.01	5.52E-01
antigen processing and presentation of exogenous antigen (GO:0019884)	175	9	8.94	+	1.01	5.37E-01
ventricular septum morphogenesis (GO:0060412)	39	2	1.99	+	1.00	5.92E-01
multivesicular body sorting pathway (GO:0071985)	39	2	1.99	+	1.00	5.92E-01
phospholipid translocation (GO:0045332)	39	2	1.99	+	1.00	5.92E-01
virion assembly (GO:0019068)	39	2	1.99	+	1.00	5.92E-01
semaphorin-plexin signaling pathway (GO:0071526)	39	2	1.99	+	1.00	5.92E-01
regulation of nucleotide biosynthetic process (GO:0030808)	39	2	1.99	+	1.00	5.92E-01
positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	39	2	1.99	+	1.00	5.92E-01
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	39	2	1.99	+	1.00	5.92E-01
regulation of protein localization to cell periphery (GO:1904375)	117	6	5.98	+	1.00	5.51E-01
translesion synthesis (GO:0019985)	39	2	1.99	+	1.00	5.92E-01
forelimb morphogenesis (GO:0035136)	39	2	1.99	+	1.00	5.92E-01
regulation of double-strand break repair via homologous recombination (GO:0010569)	39	2	1.99	+	1.00	5.92E-01
bile acid metabolic process (GO:0008206)	39	2	1.99	+	1.00	5.92E-01
vascular process in circulatory system (GO:0003018)	254	13	12.97	+	1.00	5.35E-01
response to UV (GO:0009411)	137	7	7.00	+	1.00	5.51E-01
lymphocyte differentiation (GO:0030098)	235	12	12.00	-	1.00	5.76E-01
cellular developmental process (GO:0048869)	3253	166	166.15	-	1.00	5.15E-01
regulation of calcium ion transport into cytosol (GO:0010522)	98	5	5.01	-	1.00	6.15E-01
organic substance catabolic process (GO:1901575)	1590	81	81.21	-	1.00	5.20E-01
cell differentiation (GO:0030154)	3201	163	163.50	-	1.00	5.04E-01
positive regulation of MAPK cascade (GO:0043410)	491	25	25.08	-	1.00	5.47E-01
regulation of cell adhesion (GO:0030155)	688	35	35.14	-	1.00	5.35E-01
SMAD protein signal transduction (GO:0060395)	59	3	3.01	-	1.00	6.44E-01
protein monoubiquitination (GO:0006513)	59	3	3.01	-	1.00	6.44E-01
negative regulation of chemotaxis (GO:0050922)	59	3	3.01	-	1.00	6.44E-01
embryonic pattern specification (GO:0009880)	59	3	3.01	-	1.00	6.44E-01
cell-substrate adhesion (GO:0031589)	177	9	9.04	-	1.00	5.82E-01
oligosaccharide metabolic process (GO:0009311)	59	3	3.01	-	1.00	6.44E-01
anion homeostasis (GO:0055081)	59	3	3.01	-	1.00	6.44E-01
tissue regeneration (GO:0042246)	59	3	3.01	-	1.00	6.44E-01
signal release (GO:0023061)	177	9	9.04	-	1.00	5.82E-01
regulation of cellular ketone metabolic process (GO:0010565)	177	9	9.04	-	1.00	5.82E-01
heart valve development (GO:0003170)	59	3	3.01	-	1.00	6.44E-01
monovalent inorganic cation homeostasis (GO:0055067)	138	7	7.05	-	.99	5.91E-01
calcium-mediated signaling (GO:0019722)	138	7	7.05	-	.99	5.91E-01
negative regulation of cell cycle phase transition (GO:1901988)	217	11	11.08	-	.99	5.69E-01
phenol-containing compound metabolic process (GO:0018958)	79	4	4.04	-	.99	6.22E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057)	79	4	4.04	-	.99	6.22E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433)	158	8	8.07	-	.99	5.83E-01
regulation of fibroblast proliferation (GO:0048145)	79	4	4.04	-	.99	6.22E-01
cardiac muscle cell differentiation (GO:0055007)	79	4	4.04	-	.99	6.22E-01
renal tubule development (GO:0061326)	79	4	4.04	-	.99	6.22E-01
positive regulation of mRNA metabolic process (GO:1903313)	79	4	4.04	-	.99	6.22E-01
positive regulation of multicellular organismal process (GO:0051240)	1343	68	68.60	-	.99	5.02E-01
cell communication (GO:0007154)	4706	238	240.37	-	.99	4.45E-01
protein catabolic process (GO:0030163)	614	31	31.36	-	.99	5.21E-01
signal transduction (GO:0007165)	4300	217	219.63	-	.99	4.36E-01
protein localization to extracellular region (GO:0071692)	119	6	6.08	-	.99	5.94E-01
proteolysis involved in cellular protein catabolic process (GO:0051603)	536	27	27.38	-	.99	5.22E-01
regulation of cytokine production (GO:0001817)	696	35	35.55	-	.98	5.07E-01
regulation of inflammatory response (GO:0050727)	458	23	23.39	-	.98	5.22E-01
response to lipopolysaccharide (GO:0032496)	299	15	15.27	-	.98	5.40E-01
developmental process (GO:0032502)	5215	261	266.37	-	.98	3.60E-01
receptor-mediated endocytosis (GO:0006898)	180	9	9.19	-	.98	5.62E-01
regulation of animal organ morphogenesis (GO:2000027)	180	9	9.19	-	.98	5.62E-01
positive regulation of bone resorption (GO:0045780)	20	1	1.02	-	.98	7.28E-01
lung epithelial cell differentiation (GO:0060487)	20	1	1.02	-	.98	7.28E-01
vesicle docking involved in exocytosis (GO:0006904)	40	2	2.04	-	.98	6.65E-01
regulation of monocyte differentiation (GO:0045655)	20	1	1.02	-	.98	7.28E-01
ectoderm development (GO:0007398)	20	1	1.02	-	.98	7.28E-01
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	20	1	1.02	-	.98	7.28E-01
water transport (GO:0006833)	20	1	1.02	-	.98	7.28E-01
central nervous system myelination (GO:0022010)	20	1	1.02	-	.98	7.28E-01
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	20	1	1.02	-	.98	7.28E-01
negative regulation of peptidyl-lysine acetylation (GO:2000757)	20	1	1.02	-	.98	7.28E-01
establishment of tissue polarity (GO:0007164)	20	1	1.02	-	.98	7.28E-01
mitotic G2 DNA damage checkpoint (GO:0007095)	20	1	1.02	-	.98	7.28E-01
regulation of sister chromatid cohesion (GO:0007063)	20	1	1.02	-	.98	7.28E-01
establishment of planar polarity (GO:0001736)	20	1	1.02	-	.98	7.28E-01
positive regulation of cell junction assembly (GO:1901890)	100	5	5.11	-	.98	5.97E-01
regulation of mitochondrial depolarization (GO:0051900)	20	1	1.02	-	.98	7.28E-01
regulation of cAMP-dependent protein kinase activity (GO:2000479)	20	1	1.02	-	.98	7.28E-01
regulation of T cell migration (GO:2000404)	40	2	2.04	-	.98	6.65E-01
tRNA modification (GO:0006400)	80	4	4.09	-	.98	6.12E-01
response to vitamin A (GO:0033189)	20	1	1.02	-	.98	7.28E-01
negative regulation of chemokine production (GO:0032682)	20	1	1.02	-	.98	7.28E-01
positive regulation of endothelial cell apoptotic process (GO:2000353)	20	1	1.02	-	.98	7.28E-01
internal peptidyl-lysine acetylation (GO:0018393)	100	5	5.11	-	.98	5.97E-01
cellular response to dsRNA (GO:0071359)	20	1	1.02	-	.98	7.28E-01
thymic T cell selection (GO:0045061)	20	1	1.02	-	.98	7.28E-01
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	20	1	1.02	-	.98	7.28E-01
nucleotide-excision repair, preincision complex stabilization (GO:0006293)	20	1	1.02	-	.98	7.28E-01
cellular response to vitamin (GO:0071295)	20	1	1.02	-	.98	7.28E-01
stem cell development (GO:0048864)	80	4	4.09	-	.98	6.12E-01
negative regulation of intracellular protein transport (GO:0090317)	40	2	2.04	-	.98	6.65E-01
positive regulation of chondrocyte differentiation (GO:0032332)	20	1	1.02	-	.98	7.28E-01
glycerol metabolic process (GO:0006071)	20	1	1.02	-	.98	7.28E-01
regulation of collateral sprouting (GO:0048670)	20	1	1.02	-	.98	7.28E-01
axon ensheathment in central nervous system (GO:0032291)	20	1	1.02	-	.98	7.28E-01
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	20	1	1.02	-	.98	7.28E-01
B cell receptor signaling pathway (GO:0050853)	40	2	2.04	-	.98	6.65E-01
regulation of vascular endothelial cell proliferation (GO:1905562)	20	1	1.02	-	.98	7.28E-01
linoleic acid metabolic process (GO:0043651)	20	1	1.02	-	.98	7.28E-01
sympathetic nervous system development (GO:0048485)	20	1	1.02	-	.98	7.28E-01
regulation of DNA methylation (GO:0044030)	20	1	1.02	-	.98	7.28E-01
regulation of lipoprotein lipase activity (GO:0051004)	20	1	1.02	-	.98	7.28E-01
positive regulation of receptor signaling pathway via STAT (GO:1904894)	40	2	2.04	-	.98	6.65E-01
positive regulation of potassium ion transport (GO:0043268)	40	2	2.04	-	.98	6.65E-01
membrane protein intracellular domain proteolysis (GO:0031293)	20	1	1.02	-	.98	7.28E-01
positive regulation of long-term synaptic potentiation (GO:1900273)	20	1	1.02	-	.98	7.28E-01
L-glutamate transmembrane transport (GO:0015813)	20	1	1.02	-	.98	7.28E-01
nucleoside monophosphate biosynthetic process (GO:0009124)	40	2	2.04	-	.98	6.65E-01
viral budding via host ESCRT complex (GO:0039702)	20	1	1.02	-	.98	7.28E-01
bicarbonate transport (GO:0015701)	40	2	2.04	-	.98	6.65E-01
maintenance of gastrointestinal epithelium (GO:0030277)	20	1	1.02	-	.98	7.28E-01
cellular protein-containing complex localization (GO:0034629)	20	1	1.02	-	.98	7.28E-01
glial cell migration (GO:0008347)	40	2	2.04	-	.98	6.65E-01
mammary gland lobule development (GO:0061377)	20	1	1.02	-	.98	7.28E-01
negative regulation of Rho protein signal transduction (GO:0035024)	20	1	1.02	-	.98	7.28E-01
mammary gland alveolus development (GO:0060749)	20	1	1.02	-	.98	7.28E-01
labyrinthine layer blood vessel development (GO:0060716)	20	1	1.02	-	.98	7.28E-01
labyrinthine layer morphogenesis (GO:0060713)	20	1	1.02	-	.98	7.28E-01
negative regulation of nucleotide metabolic process (GO:0045980)	20	1	1.02	-	.98	7.28E-01
atrial septum development (GO:0003283)	20	1	1.02	-	.98	7.28E-01
deoxyribose phosphate catabolic process (GO:0046386)	20	1	1.02	-	.98	7.28E-01
hypothalamus development (GO:0021854)	20	1	1.02	-	.98	7.28E-01
myoblast fusion (GO:0007520)	20	1	1.02	-	.98	7.28E-01
meiotic cell cycle process (GO:1903046)	140	7	7.15	-	.98	5.76E-01
heart looping (GO:0001947)	60	3	3.06	-	.98	6.33E-01
cell-matrix adhesion (GO:0007160)	120	6	6.13	-	.98	5.85E-01
T cell activation involved in immune response (GO:0002286)	60	3	3.06	-	.98	6.33E-01
positive regulation of gliogenesis (GO:0014015)	60	3	3.06	-	.98	6.33E-01
regulation of type I interferon production (GO:0032479)	120	6	6.13	-	.98	5.85E-01
exocytic process (GO:0140029)	60	3	3.06	-	.98	6.33E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	240	12	12.26	-	.98	5.46E-01
vesicle docking (GO:0048278)	60	3	3.06	-	.98	6.33E-01
rRNA metabolic process (GO:0016072)	240	12	12.26	-	.98	5.46E-01
regulation of growth (GO:0040008)	641	32	32.74	-	.98	4.94E-01
carboxylic acid transport (GO:0046942)	281	14	14.35	-	.98	5.33E-01
regulation of reactive oxygen species metabolic process (GO:2000377)	181	9	9.24	-	.97	5.55E-01
antigen processing and presentation of peptide antigen (GO:0048002)	181	9	9.24	-	.97	5.55E-01
hormone metabolic process (GO:0042445)	181	9	9.24	-	.97	5.55E-01
protein processing (GO:0016485)	161	8	8.22	-	.97	5.61E-01
organic acid transport (GO:0015849)	282	14	14.40	-	.97	5.27E-01
cell fate commitment (GO:0045165)	242	12	12.36	-	.97	5.34E-01
memory (GO:0007613)	121	6	6.18	-	.97	5.77E-01
positive regulation of GTPase activity (GO:0043547)	363	18	18.54	-	.97	5.11E-01
protein maturation (GO:0051604)	222	11	11.34	-	.97	5.39E-01
xenobiotic metabolic process (GO:0006805)	101	5	5.16	-	.97	5.88E-01
internal protein amino acid acetylation (GO:0006475)	101	5	5.16	-	.97	5.88E-01
cellular detoxification (GO:1990748)	101	5	5.16	-	.97	5.88E-01
response to mechanical stimulus (GO:0009612)	202	10	10.32	-	.97	5.43E-01
cellular protein catabolic process (GO:0044257)	566	28	28.91	-	.97	4.81E-01
regulation of calcium ion transmembrane transporter activity (GO:1901019)	81	4	4.14	-	.97	6.02E-01
developmental maturation (GO:0021700)	223	11	11.39	-	.97	5.32E-01
leukocyte activation (GO:0045321)	874	43	44.64	-	.96	4.39E-01
glycosphingolipid metabolic process (GO:0006687)	61	3	3.12	-	.96	6.21E-01
vacuole organization (GO:0007033)	122	6	6.23	-	.96	5.69E-01
positive regulation of synapse assembly (GO:0051965)	61	3	3.12	-	.96	6.21E-01
protein autoubiquitination (GO:0051865)	61	3	3.12	-	.96	6.21E-01
negative regulation of hormone secretion (GO:0046888)	61	3	3.12	-	.96	6.21E-01
neural tube formation (GO:0001841)	102	5	5.21	-	.96	5.79E-01
lymphocyte activation involved in immune response (GO:0002285)	102	5	5.21	-	.96	5.79E-01
signaling (GO:0023052)	4631	227	236.54	-	.96	2.44E-01
cellular response to molecule of bacterial origin (GO:0071219)	184	9	9.40	-	.96	5.35E-01
lymphocyte activation (GO:0046649)	368	18	18.80	-	.96	4.87E-01
regulation of neuron death (GO:1901214)	307	15	15.68	-	.96	4.98E-01
protein localization to organelle (GO:0033365)	717	35	36.62	-	.96	4.35E-01
photoreceptor cell maintenance (GO:0045494)	41	2	2.09	-	.96	6.51E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991)	205	10	10.47	-	.96	5.24E-01
regulation of DNA-templated transcription, elongation (GO:0032784)	41	2	2.09	-	.96	6.51E-01
negative regulation of proteasomal protein catabolic process (GO:1901799)	41	2	2.09	-	.96	6.51E-01
T cell selection (GO:0045058)	41	2	2.09	-	.96	6.51E-01
regulation of oligodendrocyte differentiation (GO:0048713)	41	2	2.09	-	.96	6.51E-01
amino sugar metabolic process (GO:0006040)	41	2	2.09	-	.96	6.51E-01
drug metabolic process (GO:0017144)	41	2	2.09	-	.96	6.51E-01
neutrophil degranulation (GO:0043312)	451	22	23.04	-	.96	4.68E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	82	4	4.19	-	.96	5.92E-01
synaptic vesicle localization (GO:0097479)	41	2	2.09	-	.96	6.51E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	82	4	4.19	-	.96	5.92E-01
regulation of GTPase activity (GO:0043087)	431	21	22.01	-	.95	4.69E-01
regulation of MAPK cascade (GO:0043408)	657	32	33.56	-	.95	4.36E-01
response to drug (GO:0042493)	370	18	18.90	-	.95	4.78E-01
telencephalon development (GO:0021537)	247	12	12.62	-	.95	5.05E-01
positive regulation of immune system process (GO:0002684)	844	41	43.11	-	.95	4.09E-01
regionalization (GO:0003002)	309	15	15.78	-	.95	4.88E-01
peptidyl-lysine acetylation (GO:0018394)	103	5	5.26	-	.95	5.70E-01
entry into host (GO:0044409)	103	5	5.26	-	.95	5.70E-01
lipid catabolic process (GO:0016042)	268	13	13.69	-	.95	4.97E-01
Ras protein signal transduction (GO:0007265)	165	8	8.43	-	.95	5.33E-01
cellular modified amino acid metabolic process (GO:0006575)	165	8	8.43	-	.95	5.33E-01
aminoglycan metabolic process (GO:0006022)	165	8	8.43	-	.95	5.33E-01
type I interferon signaling pathway (GO:0060337)	62	3	3.17	-	.95	6.10E-01
cellular response to type I interferon (GO:0071357)	62	3	3.17	-	.95	6.10E-01
tetrapyrrole metabolic process (GO:0033013)	62	3	3.17	-	.95	6.10E-01
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	62	3	3.17	-	.95	6.10E-01
glycolipid biosynthetic process (GO:0009247)	62	3	3.17	-	.95	6.10E-01
regulation of histone methylation (GO:0031060)	62	3	3.17	-	.95	6.10E-01
organic acid catabolic process (GO:0016054)	248	12	12.67	-	.95	5.00E-01
response to cadmium ion (GO:0046686)	62	3	3.17	-	.95	6.10E-01
regulation of alpha-beta T cell differentiation (GO:0046637)	62	3	3.17	-	.95	6.10E-01
carboxylic acid catabolic process (GO:0046395)	248	12	12.67	-	.95	5.00E-01
neutrophil activation involved in immune response (GO:0002283)	455	22	23.24	-	.95	4.51E-01
immune response-activating cell surface receptor signaling pathway (GO:0002429)	290	14	14.81	-	.95	4.84E-01
negative regulation of neuron apoptotic process (GO:0043524)	145	7	7.41	-	.95	5.38E-01
immune response-activating signal transduction (GO:0002757)	290	14	14.81	-	.95	4.84E-01
muscle cell differentiation (GO:0042692)	228	11	11.65	-	.94	5.02E-01
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	83	4	4.24	-	.94	5.82E-01
protein tetramerization (GO:0051262)	83	4	4.24	-	.94	5.82E-01
anatomical structure development (GO:0048856)	4804	231	245.37	-	.94	1.45E-01
in utero embryonic development (GO:0001701)	333	16	17.01	-	.94	4.66E-01
amino acid transport (GO:0006865)	125	6	6.38	-	.94	5.45E-01
RNA modification (GO:0009451)	146	7	7.46	-	.94	5.31E-01
positive regulation of cell projection organization (GO:0031346)	334	16	17.06	-	.94	4.61E-01
regulation of neuron projection development (GO:0010975)	418	20	21.35	-	.94	4.39E-01
regulated exocytosis (GO:0045055)	648	31	33.10	-	.94	3.98E-01
skeletal system development (GO:0001501)	460	22	23.50	-	.94	4.30E-01
multicellular organismal process (GO:0032501)	6025	288	307.74	-	.94	8.29E-02
multicellular organism development (GO:0007275)	4477	214	228.67	-	.94	1.35E-01
cellular homeostasis (GO:0019725)	838	40	42.80	-	.93	3.67E-01
neutrophil mediated immunity (GO:0002446)	461	22	23.55	-	.93	4.26E-01
nervous system development (GO:0007399)	2057	98	105.07	-	.93	2.49E-01
cerebral cortex cell migration (GO:0021795)	42	2	2.15	-	.93	6.37E-01
positive regulation of fatty acid biosynthetic process (GO:0045723)	21	1	1.07	-	.93	7.09E-01
limbic system development (GO:0021761)	105	5	5.36	-	.93	5.52E-01
lung cell differentiation (GO:0060479)	21	1	1.07	-	.93	7.09E-01
mammary gland morphogenesis (GO:0060443)	42	2	2.15	-	.93	6.37E-01
regulation of proton transport (GO:0010155)	21	1	1.07	-	.93	7.09E-01
regulation of erythrocyte differentiation (GO:0045646)	42	2	2.15	-	.93	6.37E-01
acrosome reaction (GO:0007340)	21	1	1.07	-	.93	7.09E-01
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	21	1	1.07	-	.93	7.09E-01
mast cell activation (GO:0045576)	21	1	1.07	-	.93	7.09E-01
negative regulation of cation channel activity (GO:2001258)	42	2	2.15	-	.93	6.37E-01
histone H2A ubiquitination (GO:0033522)	21	1	1.07	-	.93	7.09E-01
metanephric nephron morphogenesis (GO:0072273)	21	1	1.07	-	.93	7.09E-01
metanephric epithelium development (GO:0072207)	21	1	1.07	-	.93	7.09E-01
mitotic cytokinetic process (GO:1902410)	21	1	1.07	-	.93	7.09E-01
positive regulation of protein acetylation (GO:1901985)	42	2	2.15	-	.93	6.37E-01
nuclear migration (GO:0007097)	21	1	1.07	-	.93	7.09E-01
positive regulation of sodium ion transmembrane transport (GO:1902307)	21	1	1.07	-	.93	7.09E-01
regulation of interleukin-13 production (GO:0032656)	21	1	1.07	-	.93	7.09E-01
transcytosis (GO:0045056)	21	1	1.07	-	.93	7.09E-01
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	42	2	2.15	-	.93	6.37E-01
positive regulation of fatty acid transport (GO:2000193)	21	1	1.07	-	.93	7.09E-01
actin filament-based transport (GO:0099515)	21	1	1.07	-	.93	7.09E-01
regulation of gluconeogenesis (GO:0006111)	42	2	2.15	-	.93	6.37E-01
regulation of chromosome separation (GO:1905818)	63	3	3.22	-	.93	5.98E-01
positive regulation of triglyceride metabolic process (GO:0090208)	21	1	1.07	-	.93	7.09E-01
smooth muscle tissue development (GO:0048745)	21	1	1.07	-	.93	7.09E-01
olefinic compound biosynthetic process (GO:0120255)	21	1	1.07	-	.93	7.09E-01
regulation of behavior (GO:0050795)	63	3	3.22	-	.93	5.98E-01
tongue development (GO:0043586)	21	1	1.07	-	.93	7.09E-01
regulation of respiratory gaseous exchange (GO:0043576)	21	1	1.07	-	.93	7.09E-01
lymphocyte apoptotic process (GO:0070227)	21	1	1.07	-	.93	7.09E-01
regulation of calcium ion-dependent exocytosis (GO:0017158)	42	2	2.15	-	.93	6.37E-01
lung alveolus development (GO:0048286)	42	2	2.15	-	.93	6.37E-01
negative regulation of DNA recombination at telomere (GO:0048239)	21	1	1.07	-	.93	7.09E-01
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	21	1	1.07	-	.93	7.09E-01
polarized epithelial cell differentiation (GO:0030859)	21	1	1.07	-	.93	7.09E-01
response to platelet-derived growth factor (GO:0036119)	21	1	1.07	-	.93	7.09E-01
amine biosynthetic process (GO:0009309)	21	1	1.07	-	.93	7.09E-01
negative regulation of histone methylation (GO:0031061)	21	1	1.07	-	.93	7.09E-01
negative regulation of axon extension (GO:0030517)	42	2	2.15	-	.93	6.37E-01
C4-dicarboxylate transport (GO:0015740)	21	1	1.07	-	.93	7.09E-01
aspartate family amino acid catabolic process (GO:0009068)	21	1	1.07	-	.93	7.09E-01
bone remodeling (GO:0046849)	42	2	2.15	-	.93	6.37E-01
cellular biogenic amine biosynthetic process (GO:0042401)	21	1	1.07	-	.93	7.09E-01
regulation of protein import into nucleus (GO:0042306)	63	3	3.22	-	.93	5.98E-01
carbohydrate catabolic process (GO:0016052)	105	5	5.36	-	.93	5.52E-01
kidney vasculature development (GO:0061440)	21	1	1.07	-	.93	7.09E-01
renal system vasculature development (GO:0061437)	21	1	1.07	-	.93	7.09E-01
embryonic hemopoiesis (GO:0035162)	21	1	1.07	-	.93	7.09E-01
megakaryocyte differentiation (GO:0030219)	21	1	1.07	-	.93	7.09E-01
cardiocyte differentiation (GO:0035051)	105	5	5.36	-	.93	5.52E-01
somatic stem cell population maintenance (GO:0035019)	63	3	3.22	-	.93	5.98E-01
positive regulation of glycoprotein biosynthetic process (GO:0010560)	21	1	1.07	-	.93	7.09E-01
negative regulation of response to cytokine stimulus (GO:0060761)	63	3	3.22	-	.93	5.98E-01
amelogenesis (GO:0097186)	21	1	1.07	-	.93	7.09E-01
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	21	1	1.07	-	.93	7.09E-01
pituitary gland development (GO:0021983)	42	2	2.15	-	.93	6.37E-01
regulation of DNA recombination at telomere (GO:0072695)	21	1	1.07	-	.93	7.09E-01
mating behavior (GO:0007617)	21	1	1.07	-	.93	7.09E-01
negative regulation of T cell mediated immunity (GO:0002710)	21	1	1.07	-	.93	7.09E-01
positive regulation of isotype switching (GO:0045830)	21	1	1.07	-	.93	7.09E-01
neutrophil activation (GO:0042119)	462	22	23.60	-	.93	4.22E-01
regulation of response to biotic stimulus (GO:0002831)	378	18	19.31	-	.93	4.40E-01
respiratory system development (GO:0060541)	189	9	9.65	-	.93	5.01E-01
tissue morphogenesis (GO:0048729)	526	25	26.87	-	.93	4.05E-01
muscle structure development (GO:0061061)	442	21	22.58	-	.93	4.22E-01
establishment of protein localization to organelle (GO:0072594)	421	20	21.50	-	.93	4.26E-01
embryo development (GO:0009790)	927	44	47.35	-	.93	3.42E-01
organonitrogen compound catabolic process (GO:1901565)	971	46	49.60	-	.93	3.31E-01
epithelial cell development (GO:0002064)	190	9	9.70	-	.93	4.95E-01
myeloid leukocyte activation (GO:0002274)	549	26	28.04	-	.93	3.94E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	169	8	8.63	-	.93	5.05E-01
mesenchymal cell differentiation (GO:0048762)	148	7	7.56	-	.93	5.16E-01
meiotic nuclear division (GO:0140013)	127	6	6.49	-	.92	5.28E-01
rRNA processing (GO:0006364)	233	11	11.90	-	.92	4.72E-01
granulocyte activation (GO:0036230)	466	22	23.80	-	.92	4.05E-01
cellular response to xenobiotic stimulus (GO:0071466)	106	5	5.41	-	.92	5.43E-01
cellular response to fibroblast growth factor stimulus (GO:0044344)	106	5	5.41	-	.92	5.43E-01
embryonic placenta development (GO:0001892)	85	4	4.34	-	.92	5.62E-01
neural crest cell differentiation (GO:0014033)	85	4	4.34	-	.92	5.62E-01
transport across blood-brain barrier (GO:0150104)	85	4	4.34	-	.92	5.62E-01
regulation of immune system process (GO:0002682)	1445	68	73.81	-	.92	2.62E-01
cellular process involved in reproduction in multicellular organism (GO:0022412)	319	15	16.29	-	.92	4.37E-01
regeneration (GO:0031099)	149	7	7.61	-	.92	5.08E-01
catabolic process (GO:0009056)	1877	88	95.87	-	.92	2.13E-01
lymphocyte mediated immunity (GO:0002449)	128	6	6.54	-	.92	5.20E-01
mitotic G1/S transition checkpoint (GO:0044819)	64	3	3.27	-	.92	5.87E-01
regulation of sodium ion transmembrane transport (GO:1902305)	64	3	3.27	-	.92	5.87E-01
urogenital system development (GO:0001655)	320	15	16.34	-	.92	4.32E-01
regulation of protein processing (GO:0070613)	64	3	3.27	-	.92	5.87E-01
antigen receptor-mediated signaling pathway (GO:0050851)	192	9	9.81	-	.92	4.82E-01
mitotic G1 DNA damage checkpoint (GO:0031571)	64	3	3.27	-	.92	5.87E-01
positive regulation of epithelial cell proliferation (GO:0050679)	192	9	9.81	-	.92	4.82E-01
negative regulation of neuron projection development (GO:0010977)	128	6	6.54	-	.92	5.20E-01
organophosphate ester transport (GO:0015748)	128	6	6.54	-	.92	5.20E-01
system development (GO:0048731)	3952	185	201.86	-	.92	9.19E-02
leukocyte degranulation (GO:0043299)	470	22	24.01	-	.92	3.89E-01
cell-cell signaling (GO:0007267)	1048	49	53.53	-	.92	2.89E-01
cellular response to toxic substance (GO:0097237)	107	5	5.47	-	.91	5.35E-01
anion transport (GO:0006820)	557	26	28.45	-	.91	3.65E-01
anatomical structure morphogenesis (GO:0009653)	2036	95	103.99	-	.91	1.87E-01
negative regulation of cell activation (GO:0050866)	193	9	9.86	-	.91	4.75E-01
peptide metabolic process (GO:0006518)	473	22	24.16	-	.91	3.77E-01
vascular transport (GO:0010232)	86	4	4.39	-	.91	5.52E-01
ATP metabolic process (GO:0046034)	172	8	8.79	-	.91	4.84E-01
negative regulation of response to wounding (GO:1903035)	86	4	4.39	-	.91	5.52E-01
B cell activation involved in immune response (GO:0002312)	43	2	2.20	-	.91	6.24E-01
cell redox homeostasis (GO:0045454)	43	2	2.20	-	.91	6.24E-01
male meiotic nuclear division (GO:0007140)	43	2	2.20	-	.91	6.24E-01
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	43	2	2.20	-	.91	6.24E-01
regulation of mast cell activation (GO:0033003)	43	2	2.20	-	.91	6.24E-01
leukocyte proliferation (GO:0070661)	86	4	4.39	-	.91	5.52E-01
regulation of MAP kinase activity (GO:0043405)	301	14	15.37	-	.91	4.27E-01
regulation of long-term synaptic potentiation (GO:1900271)	43	2	2.20	-	.91	6.24E-01
ovulation cycle process (GO:0022602)	43	2	2.20	-	.91	6.24E-01
regulation of immune response (GO:0050776)	925	43	47.25	-	.91	2.93E-01
leukocyte activation involved in immune response (GO:0002366)	581	27	29.68	-	.91	3.51E-01
cell activation (GO:0001775)	1012	47	51.69	-	.91	2.78E-01
gastrulation (GO:0007369)	151	7	7.71	-	.91	4.93E-01
positive regulation of lipid metabolic process (GO:0045834)	151	7	7.71	-	.91	4.93E-01
glial cell differentiation (GO:0010001)	173	8	8.84	-	.91	4.77E-01
cell activation involved in immune response (GO:0002263)	585	27	29.88	-	.90	3.37E-01
regulation of heart growth (GO:0060420)	65	3	3.32	-	.90	5.76E-01
response to inorganic substance (GO:0010035)	520	24	26.56	-	.90	3.52E-01
G1 DNA damage checkpoint (GO:0044783)	65	3	3.32	-	.90	5.76E-01
determination of heart left/right asymmetry (GO:0061371)	65	3	3.32	-	.90	5.76E-01
anion transmembrane transport (GO:0098656)	282	13	14.40	-	.90	4.21E-01
electron transport chain (GO:0022900)	152	7	7.76	-	.90	4.86E-01
positive regulation of ion transmembrane transport (GO:0034767)	152	7	7.76	-	.90	4.86E-01
regulation of neural precursor cell proliferation (GO:2000177)	87	4	4.44	-	.90	5.43E-01
nucleobase-containing compound catabolic process (GO:0034655)	348	16	17.77	-	.90	3.93E-01
positive regulation of leukocyte chemotaxis (GO:0002690)	87	4	4.44	-	.90	5.43E-01
positive regulation of cell population proliferation (GO:0008284)	871	40	44.49	-	.90	2.74E-01
regulation of system process (GO:0044057)	545	25	27.84	-	.90	3.35E-01
myeloid leukocyte mediated immunity (GO:0002444)	480	22	24.52	-	.90	3.50E-01
sensory organ development (GO:0007423)	524	24	26.76	-	.90	3.37E-01
translational initiation (GO:0006413)	131	6	6.69	-	.90	4.96E-01
regulation of cell activation (GO:0050865)	546	25	27.89	-	.90	3.31E-01
positive regulation of immune response (GO:0050778)	546	25	27.89	-	.90	3.31E-01
stem cell differentiation (GO:0048863)	153	7	7.81	-	.90	4.79E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	175	8	8.94	-	.90	4.63E-01
embryonic morphogenesis (GO:0048598)	547	25	27.94	-	.89	3.28E-01
positive regulation of transmembrane transport (GO:0034764)	197	9	10.06	-	.89	4.49E-01
tissue development (GO:0009888)	1601	73	81.77	-	.89	1.68E-01
regulation of leukocyte activation (GO:0002694)	505	23	25.79	-	.89	3.32E-01
inflammatory response (GO:0006954)	484	22	24.72	-	.89	3.34E-01
regulation of establishment of planar polarity (GO:0090175)	110	5	5.62	-	.89	5.08E-01
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	44	2	2.25	-	.89	6.10E-01
body morphogenesis (GO:0010171)	44	2	2.25	-	.89	6.10E-01
cAMP metabolic process (GO:0046058)	22	1	1.12	-	.89	6.90E-01
GTP metabolic process (GO:0046039)	22	1	1.12	-	.89	6.90E-01
positive regulation of cation channel activity (GO:2001259)	66	3	3.37	-	.89	5.65E-01
regulation of cilium movement involved in cell motility (GO:0060295)	22	1	1.12	-	.89	6.90E-01
cell cycle arrest (GO:0007050)	132	6	6.74	-	.89	4.88E-01
negative regulation of stress-activated MAPK cascade (GO:0032873)	44	2	2.25	-	.89	6.10E-01
regulation of cardiac muscle cell proliferation (GO:0060043)	44	2	2.25	-	.89	6.10E-01
positive regulation of neuroblast proliferation (GO:0002052)	22	1	1.12	-	.89	6.90E-01
regulation of transcription by RNA polymerase III (GO:0006359)	22	1	1.12	-	.89	6.90E-01
response to misfolded protein (GO:0051788)	22	1	1.12	-	.89	6.90E-01
protein import into peroxisome membrane (GO:0045046)	22	1	1.12	-	.89	6.90E-01
regulation of cilium-dependent cell motility (GO:1902019)	22	1	1.12	-	.89	6.90E-01
negative regulation of cell cycle arrest (GO:0071157)	22	1	1.12	-	.89	6.90E-01
regulation of histone H3-K9 methylation (GO:0051570)	22	1	1.12	-	.89	6.90E-01
regulation of icosanoid secretion (GO:0032303)	22	1	1.12	-	.89	6.90E-01
cochlea morphogenesis (GO:0090103)	22	1	1.12	-	.89	6.90E-01
negative regulation of lyase activity (GO:0051350)	22	1	1.12	-	.89	6.90E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	176	8	8.99	-	.89	4.56E-01
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	22	1	1.12	-	.89	6.90E-01
regulation of T cell receptor signaling pathway (GO:0050856)	44	2	2.25	-	.89	6.10E-01
regulation of calcium-mediated signaling (GO:0050848)	66	3	3.37	-	.89	5.65E-01
protein heterooligomerization (GO:0051291)	22	1	1.12	-	.89	6.90E-01
zymogen activation (GO:0031638)	44	2	2.25	-	.89	6.10E-01
protein insertion into mitochondrial membrane (GO:0051204)	22	1	1.12	-	.89	6.90E-01
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	44	2	2.25	-	.89	6.10E-01
dendritic cell migration (GO:0036336)	22	1	1.12	-	.89	6.90E-01
negative regulation of receptor signaling pathway via STAT (GO:1904893)	22	1	1.12	-	.89	6.90E-01
cranial skeletal system development (GO:1904888)	66	3	3.37	-	.89	5.65E-01
N-terminal protein amino acid modification (GO:0031365)	22	1	1.12	-	.89	6.90E-01
amine catabolic process (GO:0009310)	22	1	1.12	-	.89	6.90E-01
purinergic nucleotide receptor signaling pathway (GO:0035590)	44	2	2.25	-	.89	6.10E-01
regulation of chromatin binding (GO:0035561)	22	1	1.12	-	.89	6.90E-01
mitochondrion transport along microtubule (GO:0047497)	22	1	1.12	-	.89	6.90E-01
cellular chemical homeostasis (GO:0055082)	704	32	35.96	-	.89	2.83E-01
response to interferon-alpha (GO:0035455)	22	1	1.12	-	.89	6.90E-01
retinol metabolic process (GO:0042572)	44	2	2.25	-	.89	6.10E-01
branched-chain amino acid catabolic process (GO:0009083)	22	1	1.12	-	.89	6.90E-01
regulation of hormone biosynthetic process (GO:0046885)	22	1	1.12	-	.89	6.90E-01
cellular response to angiotensin (GO:1904385)	22	1	1.12	-	.89	6.90E-01
maturation of SSU-rRNA (GO:0030490)	44	2	2.25	-	.89	6.10E-01
indole-containing compound metabolic process (GO:0042430)	22	1	1.12	-	.89	6.90E-01
cellular biogenic amine catabolic process (GO:0042402)	22	1	1.12	-	.89	6.90E-01
visual learning (GO:0008542)	44	2	2.25	-	.89	6.10E-01
retina layer formation (GO:0010842)	22	1	1.12	-	.89	6.90E-01
left/right pattern formation (GO:0060972)	22	1	1.12	-	.89	6.90E-01
alpha-beta T cell activation (GO:0046631)	66	3	3.37	-	.89	5.65E-01
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	22	1	1.12	-	.89	6.90E-01
cellular modified amino acid catabolic process (GO:0042219)	22	1	1.12	-	.89	6.90E-01
renal tubule morphogenesis (GO:0061333)	66	3	3.37	-	.89	5.65E-01
microtubule anchoring (GO:0034453)	22	1	1.12	-	.89	6.90E-01
negative regulation of lymphocyte mediated immunity (GO:0002707)	44	2	2.25	-	.89	6.10E-01
regulation of cartilage development (GO:0061035)	66	3	3.37	-	.89	5.65E-01
embryonic heart tube morphogenesis (GO:0003143)	66	3	3.37	-	.89	5.65E-01
striated muscle tissue development (GO:0014706)	265	12	13.54	-	.89	4.04E-01
myeloid cell activation involved in immune response (GO:0002275)	486	22	24.82	-	.89	3.27E-01
cellular response to lipopolysaccharide (GO:0071222)	177	8	9.04	-	.88	4.50E-01
cellular catabolic process (GO:0044248)	1639	74	83.72	-	.88	1.44E-01
regulation of transporter activity (GO:0032409)	266	12	13.59	-	.88	3.99E-01
negative regulation of response to external stimulus (GO:0032102)	466	21	23.80	-	.88	3.25E-01
renal system process (GO:0003014)	111	5	5.67	-	.88	5.00E-01
vesicle-mediated transport in synapse (GO:0099003)	111	5	5.67	-	.88	5.00E-01
regulation of leukocyte mediated immunity (GO:0002703)	200	9	10.22	-	.88	4.30E-01
acylglycerol metabolic process (GO:0006639)	89	4	4.55	-	.88	5.23E-01
regulation of ERBB signaling pathway (GO:1901184)	89	4	4.55	-	.88	5.23E-01
regulation of phagocytosis (GO:0050764)	89	4	4.55	-	.88	5.23E-01
regulation of pattern recognition receptor signaling pathway (GO:0062207)	89	4	4.55	-	.88	5.23E-01
organic cyclic compound catabolic process (GO:1901361)	445	20	22.73	-	.88	3.27E-01
gliogenesis (GO:0042063)	223	10	11.39	-	.88	4.13E-01
triglyceride metabolic process (GO:0006641)	67	3	3.42	-	.88	5.53E-01
vasculogenesis (GO:0001570)	67	3	3.42	-	.88	5.53E-01
positive regulation of muscle cell differentiation (GO:0051149)	67	3	3.42	-	.88	5.53E-01
mitotic cytokinesis (GO:0000281)	67	3	3.42	-	.88	5.53E-01
ribonucleoside metabolic process (GO:0009119)	67	3	3.42	-	.88	5.53E-01
negative regulation of cellular protein catabolic process (GO:1903363)	67	3	3.42	-	.88	5.53E-01
regulation of protein maturation (GO:1903317)	67	3	3.42	-	.88	5.53E-01
response to fibroblast growth factor (GO:0071774)	112	5	5.72	-	.87	4.91E-01
response to bacterium (GO:0009617)	560	25	28.60	-	.87	2.84E-01
neural tube development (GO:0021915)	157	7	8.02	-	.87	4.50E-01
positive regulation of growth (GO:0045927)	247	11	12.62	-	.87	3.92E-01
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	45	2	2.30	-	.87	5.96E-01
neutral lipid metabolic process (GO:0006638)	90	4	4.60	-	.87	5.14E-01
oligodendrocyte development (GO:0014003)	45	2	2.30	-	.87	5.96E-01
regulation of bone resorption (GO:0045124)	45	2	2.30	-	.87	5.96E-01
regulation of vascular permeability (GO:0043114)	45	2	2.30	-	.87	5.96E-01
female gonad development (GO:0008585)	90	4	4.60	-	.87	5.14E-01
negative regulation of response to biotic stimulus (GO:0002832)	90	4	4.60	-	.87	5.14E-01
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	45	2	2.30	-	.87	5.96E-01
protein localization to plasma membrane (GO:0072659)	180	8	9.19	-	.87	4.30E-01
mesenchyme development (GO:0060485)	203	9	10.37	-	.87	4.12E-01
animal organ development (GO:0048513)	2959	131	151.14	-	.87	3.69E-02
ear morphogenesis (GO:0042471)	113	5	5.77	-	.87	4.83E-01
regulation of cell morphogenesis (GO:0022604)	294	13	15.02	-	.87	3.60E-01
actin filament organization (GO:0007015)	249	11	12.72	-	.86	3.81E-01
negative regulation of neuron differentiation (GO:0045665)	68	3	3.47	-	.86	5.42E-01
regulation of synaptic transmission, glutamatergic (GO:0051966)	68	3	3.47	-	.86	5.42E-01
regulation of mitochondrial membrane potential (GO:0051881)	68	3	3.47	-	.86	5.42E-01
regulation of morphogenesis of an epithelium (GO:1905330)	68	3	3.47	-	.86	5.42E-01
regulation of establishment of protein localization to mitochondrion (GO:1903747)	68	3	3.47	-	.86	5.42E-01
positive regulation of endothelial cell proliferation (GO:0001938)	91	4	4.65	-	.86	5.04E-01
regulation of potassium ion transport (GO:0043266)	91	4	4.65	-	.86	5.04E-01
leukocyte mediated immunity (GO:0002443)	593	26	30.29	-	.86	2.46E-01
learning or memory (GO:0007611)	251	11	12.82	-	.86	3.70E-01
cellular respiration (GO:0045333)	137	6	7.00	-	.86	4.49E-01
muscle cell development (GO:0055001)	137	6	7.00	-	.86	4.49E-01
T cell receptor signaling pathway (GO:0050852)	160	7	8.17	-	.86	4.28E-01
head development (GO:0060322)	759	33	38.77	-	.85	1.95E-01
response to lithium ion (GO:0010226)	23	1	1.17	-	.85	6.72E-01
alditol metabolic process (GO:0019400)	23	1	1.17	-	.85	6.72E-01
ether metabolic process (GO:0018904)	23	1	1.17	-	.85	6.72E-01
regulation of osteoblast proliferation (GO:0033688)	23	1	1.17	-	.85	6.72E-01
adrenergic receptor signaling pathway (GO:0071875)	23	1	1.17	-	.85	6.72E-01
positive regulation of glycoprotein metabolic process (GO:1903020)	23	1	1.17	-	.85	6.72E-01
endothelial cell proliferation (GO:0001935)	23	1	1.17	-	.85	6.72E-01
T cell lineage commitment (GO:0002360)	23	1	1.17	-	.85	6.72E-01
bone resorption (GO:0045453)	23	1	1.17	-	.85	6.72E-01
positive regulation of transcription regulatory region DNA binding (GO:2000679)	23	1	1.17	-	.85	6.72E-01
homologous chromosome segregation (GO:0045143)	46	2	2.35	-	.85	5.83E-01
peptidyl-glutamic acid modification (GO:0018200)	23	1	1.17	-	.85	6.72E-01
peptidyl-arginine modification (GO:0018195)	23	1	1.17	-	.85	6.72E-01
skeletal muscle fiber development (GO:0048741)	23	1	1.17	-	.85	6.72E-01
positive regulation of oligodendrocyte differentiation (GO:0048714)	23	1	1.17	-	.85	6.72E-01
regulation of skeletal muscle tissue development (GO:0048641)	23	1	1.17	-	.85	6.72E-01
negative chemotaxis (GO:0050919)	46	2	2.35	-	.85	5.83E-01
cellular lipid catabolic process (GO:0044242)	184	8	9.40	-	.85	4.03E-01
relaxation of muscle (GO:0090075)	23	1	1.17	-	.85	6.72E-01
interleukin-1-mediated signaling pathway (GO:0070498)	92	4	4.70	-	.85	4.94E-01
digestive tract morphogenesis (GO:0048546)	46	2	2.35	-	.85	5.83E-01
bone cell development (GO:0098751)	23	1	1.17	-	.85	6.72E-01
regulation of neuron apoptotic process (GO:0043523)	207	9	10.57	-	.85	3.87E-01
positive regulation of mitochondrial membrane permeability (GO:0035794)	23	1	1.17	-	.85	6.72E-01
nucleoside triphosphate biosynthetic process (GO:0009142)	46	2	2.35	-	.85	5.83E-01
cellular component assembly involved in morphogenesis (GO:0010927)	92	4	4.70	-	.85	4.94E-01
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	46	2	2.35	-	.85	5.83E-01
apoptotic nuclear changes (GO:0030262)	23	1	1.17	-	.85	6.72E-01
histone mRNA metabolic process (GO:0008334)	23	1	1.17	-	.85	6.72E-01
labyrinthine layer development (GO:0060711)	46	2	2.35	-	.85	5.83E-01
positive regulation of heart rate (GO:0010460)	23	1	1.17	-	.85	6.72E-01
negative regulation of regulated secretory pathway (GO:1903306)	23	1	1.17	-	.85	6.72E-01
signal transduction involved in DNA damage checkpoint (GO:0072422)	69	3	3.52	-	.85	5.31E-01
signal transduction involved in DNA integrity checkpoint (GO:0072401)	69	3	3.52	-	.85	5.31E-01
leukocyte homeostasis (GO:0001776)	69	3	3.52	-	.85	5.31E-01
regulation of innate immune response (GO:0045088)	276	12	14.10	-	.85	3.47E-01
membrane fusion (GO:0061025)	138	6	7.05	-	.85	4.42E-01
antigen processing and presentation (GO:0019882)	208	9	10.62	-	.85	3.81E-01
negative regulation of Wnt signaling pathway (GO:0030178)	208	9	10.62	-	.85	3.81E-01
chordate embryonic development (GO:0043009)	578	25	29.52	-	.85	2.29E-01
muscle tissue development (GO:0060537)	278	12	14.20	-	.85	3.37E-01
negative regulation of hydrolase activity (GO:0051346)	417	18	21.30	-	.85	2.77E-01
regulation of transmembrane transporter activity (GO:0022898)	255	11	13.02	-	.84	3.49E-01
positive regulation of calcium ion transport (GO:0051928)	116	5	5.92	-	.84	4.57E-01
regulation of heart rate (GO:0002027)	93	4	4.75	-	.84	4.85E-01
tissue remodeling (GO:0048771)	93	4	4.75	-	.84	4.85E-01
regulation of protein serine/threonine kinase activity (GO:0071900)	466	20	23.80	-	.84	2.52E-01
regulation of lymphocyte activation (GO:0051249)	420	18	21.45	-	.84	2.66E-01
cardiac septum morphogenesis (GO:0060411)	70	3	3.58	-	.84	5.20E-01
signal transduction involved in cell cycle checkpoint (GO:0072395)	70	3	3.58	-	.84	5.20E-01
regulation of multicellular organism growth (GO:0040014)	70	3	3.58	-	.84	5.20E-01
regulation of glucose transmembrane transport (GO:0010827)	70	3	3.58	-	.84	5.20E-01
regulation of blood coagulation (GO:0030193)	70	3	3.58	-	.84	5.20E-01
muscle contraction (GO:0006936)	234	10	11.95	-	.84	3.51E-01
translational elongation (GO:0006414)	117	5	5.98	-	.84	4.49E-01
camera-type eye morphogenesis (GO:0048593)	117	5	5.98	-	.84	4.49E-01
regulation of cation transmembrane transport (GO:1904062)	328	14	16.75	-	.84	2.99E-01
heterocycle catabolic process (GO:0046700)	399	17	20.38	-	.83	2.66E-01
sulfur compound transport (GO:0072348)	47	2	2.40	-	.83	5.69E-01
phosphatidic acid biosynthetic process (GO:0006654)	47	2	2.40	-	.83	5.69E-01
thymus development (GO:0048538)	47	2	2.40	-	.83	5.69E-01
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	47	2	2.40	-	.83	5.69E-01
T cell differentiation (GO:0030217)	141	6	7.20	-	.83	4.19E-01
collagen fibril organization (GO:0030199)	47	2	2.40	-	.83	5.69E-01
negative regulation of leukocyte migration (GO:0002686)	47	2	2.40	-	.83	5.69E-01
tube morphogenesis (GO:0035239)	635	27	32.43	-	.83	1.90E-01
regulation of calcium ion transport (GO:0051924)	236	10	12.05	-	.83	3.40E-01
oligodendrocyte differentiation (GO:0048709)	71	3	3.63	-	.83	5.09E-01
regulation of hemostasis (GO:1900046)	71	3	3.63	-	.83	5.09E-01
regulation of production of molecular mediator of immune response (GO:0002700)	142	6	7.25	-	.83	4.12E-01
regulation of stress-activated MAPK cascade (GO:0032872)	166	7	8.48	-	.83	3.87E-01
blastocyst development (GO:0001824)	95	4	4.85	-	.82	4.66E-01
inner ear morphogenesis (GO:0042472)	95	4	4.85	-	.82	4.66E-01
development of primary female sexual characteristics (GO:0046545)	95	4	4.85	-	.82	4.66E-01
embryo development ending in birth or egg hatching (GO:0009792)	594	25	30.34	-	.82	1.87E-01
protein localization to cell periphery (GO:1990778)	214	9	10.93	-	.82	3.47E-01
brain development (GO:0007420)	715	30	36.52	-	.82	1.54E-01
morphogenesis of embryonic epithelium (GO:0016331)	143	6	7.30	-	.82	4.05E-01
regulation of leukocyte cell-cell adhesion (GO:1903037)	311	13	15.88	-	.82	2.82E-01
apoptotic process involved in development (GO:1902742)	24	1	1.23	-	.82	6.53E-01
regulation of bicellular tight junction assembly (GO:2000810)	24	1	1.23	-	.82	6.53E-01
negative regulation of protein localization to plasma membrane (GO:1903077)	24	1	1.23	-	.82	6.53E-01
startle response (GO:0001964)	24	1	1.23	-	.82	6.53E-01
regulation of protein localization to synapse (GO:1902473)	24	1	1.23	-	.82	6.53E-01
activin receptor signaling pathway (GO:0032924)	24	1	1.23	-	.82	6.53E-01
B cell homeostasis (GO:0001782)	24	1	1.23	-	.82	6.53E-01
pharyngeal system development (GO:0060037)	24	1	1.23	-	.82	6.53E-01
regulation of synapse assembly (GO:0051963)	96	4	4.90	-	.82	4.57E-01
positive regulation of interleukin-4 production (GO:0032753)	24	1	1.23	-	.82	6.53E-01
response to amine (GO:0014075)	48	2	2.45	-	.82	5.56E-01
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	24	1	1.23	-	.82	6.53E-01
regulation of mitochondrial fission (GO:0090140)	24	1	1.23	-	.82	6.53E-01
positive regulation of developmental growth (GO:0048639)	168	7	8.58	-	.82	3.74E-01
cleavage involved in rRNA processing (GO:0000469)	24	1	1.23	-	.82	6.53E-01
negative regulation of mRNA processing (GO:0050686)	24	1	1.23	-	.82	6.53E-01
negative regulation of defense response (GO:0031348)	312	13	15.94	-	.82	2.77E-01
negative regulation of cell killing (GO:0031342)	24	1	1.23	-	.82	6.53E-01
thyroid gland development (GO:0030878)	24	1	1.23	-	.82	6.53E-01
inositol phosphate-mediated signaling (GO:0048016)	24	1	1.23	-	.82	6.53E-01
receptor clustering (GO:0043113)	48	2	2.45	-	.82	5.56E-01
positive regulation of protein processing (GO:0010954)	24	1	1.23	-	.82	6.53E-01
secondary palate development (GO:0062009)	24	1	1.23	-	.82	6.53E-01
positive regulation of epithelial to mesenchymal transition (GO:0010718)	48	2	2.45	-	.82	5.56E-01
negative regulation of alpha-beta T cell differentiation (GO:0046639)	24	1	1.23	-	.82	6.53E-01
regulation of cardiac muscle hypertrophy (GO:0010611)	48	2	2.45	-	.82	5.56E-01
acylglycerol biosynthetic process (GO:0046463)	24	1	1.23	-	.82	6.53E-01
neutral lipid biosynthetic process (GO:0046460)	24	1	1.23	-	.82	6.53E-01
ammonium ion metabolic process (GO:0097164)	24	1	1.23	-	.82	6.53E-01
regulation of rhodopsin mediated signaling pathway (GO:0022400)	24	1	1.23	-	.82	6.53E-01
embryonic placenta morphogenesis (GO:0060669)	24	1	1.23	-	.82	6.53E-01
positive regulation of alcohol biosynthetic process (GO:1902932)	24	1	1.23	-	.82	6.53E-01
neuron recognition (GO:0008038)	48	2	2.45	-	.82	5.56E-01
protein acetylation (GO:0006473)	120	5	6.13	-	.82	4.24E-01
meiotic chromosome segregation (GO:0045132)	72	3	3.68	-	.82	4.99E-01
peptidyl-tyrosine phosphorylation (GO:0018108)	144	6	7.36	-	.82	3.97E-01
sperm motility (GO:0097722)	72	3	3.68	-	.82	4.99E-01
flagellated sperm motility (GO:0030317)	72	3	3.68	-	.82	4.99E-01
regulation of protein targeting (GO:1903533)	72	3	3.68	-	.82	4.99E-01
regulation of lymphocyte mediated immunity (GO:0002706)	144	6	7.36	-	.82	3.97E-01
muscle organ development (GO:0007517)	264	11	13.48	-	.82	3.04E-01
movement of cell or subcellular component (GO:0006928)	1420	59	72.53	-	.81	5.15E-02
negative regulation of inflammatory response (GO:0050728)	241	10	12.31	-	.81	3.14E-01
cell maturation (GO:0048469)	145	6	7.41	-	.81	3.90E-01
tube formation (GO:0035148)	145	6	7.41	-	.81	3.90E-01
detoxification (GO:0098754)	121	5	6.18	-	.81	4.16E-01
nephron epithelium development (GO:0072009)	97	4	4.95	-	.81	4.48E-01
nucleoside metabolic process (GO:0009116)	97	4	4.95	-	.81	4.48E-01
aromatic compound catabolic process (GO:0019439)	413	17	21.09	-	.81	2.18E-01
regulation of T cell mediated immunity (GO:0002709)	73	3	3.73	-	.80	4.88E-01
embryonic epithelial tube formation (GO:0001838)	122	5	6.23	-	.80	4.09E-01
regulation of developmental growth (GO:0048638)	318	13	16.24	-	.80	2.53E-01
synapse assembly (GO:0007416)	98	4	5.01	-	.80	4.39E-01
peptidyl-tyrosine modification (GO:0018212)	147	6	7.51	-	.80	3.76E-01
positive regulation of ion transmembrane transporter activity (GO:0032414)	98	4	5.01	-	.80	4.39E-01
regulation of action potential (GO:0098900)	49	2	2.50	-	.80	5.43E-01
cochlea development (GO:0090102)	49	2	2.50	-	.80	5.43E-01
sulfur compound catabolic process (GO:0044273)	49	2	2.50	-	.80	5.43E-01
synaptic vesicle exocytosis (GO:0016079)	49	2	2.50	-	.80	5.43E-01
positive regulation of mRNA catabolic process (GO:0061014)	49	2	2.50	-	.80	5.43E-01
response to toxic substance (GO:0009636)	221	9	11.29	-	.80	3.08E-01
negative regulation of leukocyte activation (GO:0002695)	172	7	8.79	-	.80	3.48E-01
regulation of ion transmembrane transporter activity (GO:0032412)	246	10	12.56	-	.80	2.89E-01
regulation of ERK1 and ERK2 cascade (GO:0070372)	271	11	13.84	-	.79	2.72E-01
endoderm development (GO:0007492)	74	3	3.78	-	.79	4.77E-01
NIK/NF-kappaB signaling (GO:0038061)	74	3	3.78	-	.79	4.77E-01
regulation of ATPase activity (GO:0043462)	74	3	3.78	-	.79	4.77E-01
embryonic heart tube development (GO:0035050)	74	3	3.78	-	.79	4.77E-01
cell junction organization (GO:0034330)	469	19	23.96	-	.79	1.79E-01
sensory organ morphogenesis (GO:0090596)	247	10	12.62	-	.79	2.84E-01
anatomical structure formation involved in morphogenesis (GO:0048646)	840	34	42.90	-	.79	9.05E-02
activation of GTPase activity (GO:0090630)	99	4	5.06	-	.79	4.30E-01
positive regulation of leukocyte activation (GO:0002696)	322	13	16.45	-	.79	2.37E-01
small GTPase mediated signal transduction (GO:0007264)	248	10	12.67	-	.79	2.79E-01
response to acid chemical (GO:0001101)	124	5	6.33	-	.79	3.93E-01
cardiac chamber morphogenesis (GO:0003206)	124	5	6.33	-	.79	3.93E-01
regulation of protein kinase B signaling (GO:0051896)	224	9	11.44	-	.79	2.93E-01
central nervous system development (GO:0007417)	947	38	48.37	-	.79	6.80E-02
cellular nitrogen compound catabolic process (GO:0044270)	399	16	20.38	-	.79	1.94E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	25	1	1.28	-	.78	6.35E-01
positive regulation of osteoclast differentiation (GO:0045672)	25	1	1.28	-	.78	6.35E-01
mesenchyme morphogenesis (GO:0072132)	50	2	2.55	-	.78	5.30E-01
positive regulation of mononuclear cell migration (GO:0071677)	25	1	1.28	-	.78	6.35E-01
positive regulation of mesenchymal cell proliferation (GO:0002053)	25	1	1.28	-	.78	6.35E-01
response to dietary excess (GO:0002021)	25	1	1.28	-	.78	6.35E-01
regulation of endothelial cell apoptotic process (GO:2000351)	50	2	2.55	-	.78	5.30E-01
intraspecies interaction between organisms (GO:0051703)	50	2	2.55	-	.78	5.30E-01
actin nucleation (GO:0045010)	25	1	1.28	-	.78	6.35E-01
positive regulation of positive chemotaxis (GO:0050927)	25	1	1.28	-	.78	6.35E-01
regulation of monocyte chemotaxis (GO:0090025)	25	1	1.28	-	.78	6.35E-01
lens fiber cell differentiation (GO:0070306)	25	1	1.28	-	.78	6.35E-01
mesodermal cell differentiation (GO:0048333)	25	1	1.28	-	.78	6.35E-01
positive regulation of leukocyte degranulation (GO:0043302)	25	1	1.28	-	.78	6.35E-01
signal transduction in response to DNA damage (GO:0042770)	100	4	5.11	-	.78	4.21E-01
focal adhesion assembly (GO:0048041)	25	1	1.28	-	.78	6.35E-01
DNA dealkylation (GO:0035510)	25	1	1.28	-	.78	6.35E-01
cardiac muscle tissue growth (GO:0055017)	25	1	1.28	-	.78	6.35E-01
branched-chain amino acid metabolic process (GO:0009081)	25	1	1.28	-	.78	6.35E-01
ionotropic glutamate receptor signaling pathway (GO:0035235)	25	1	1.28	-	.78	6.35E-01
viral budding (GO:0046755)	25	1	1.28	-	.78	6.35E-01
social behavior (GO:0035176)	50	2	2.55	-	.78	5.30E-01
regulation of androgen receptor signaling pathway (GO:0060765)	25	1	1.28	-	.78	6.35E-01
phosphatidic acid metabolic process (GO:0046473)	50	2	2.55	-	.78	5.30E-01
visual behavior (GO:0007632)	50	2	2.55	-	.78	5.30E-01
protein localization to cell surface (GO:0034394)	25	1	1.28	-	.78	6.35E-01
regulation of muscle hypertrophy (GO:0014743)	50	2	2.55	-	.78	5.30E-01
vasculature development (GO:0001944)	500	20	25.54	-	.78	1.55E-01
liver development (GO:0001889)	125	5	6.38	-	.78	3.85E-01
nephron development (GO:0072006)	125	5	6.38	-	.78	3.85E-01
mitotic interphase (GO:0051329)	75	3	3.83	-	.78	4.67E-01
interphase (GO:0051325)	75	3	3.83	-	.78	4.67E-01
response to tumor necrosis factor (GO:0034612)	250	10	12.77	-	.78	2.70E-01
cellular ketone metabolic process (GO:0042180)	75	3	3.83	-	.78	4.67E-01
regulation of blood circulation (GO:1903522)	275	11	14.05	-	.78	2.54E-01
epithelium development (GO:0060429)	1003	40	51.23	-	.78	5.69E-02
camera-type eye development (GO:0043010)	301	12	15.37	-	.78	2.35E-01
calcium ion transport (GO:0006816)	226	9	11.54	-	.78	2.83E-01
negative regulation of endopeptidase activity (GO:0010951)	226	9	11.54	-	.78	2.83E-01
forebrain development (GO:0030900)	378	15	19.31	-	.78	1.92E-01
cellular response to tumor necrosis factor (GO:0071356)	227	9	11.59	-	.78	2.78E-01
cell-cell adhesion (GO:0098609)	480	19	24.52	-	.77	1.51E-01
T cell activation (GO:0042110)	228	9	11.65	-	.77	2.73E-01
protein targeting to peroxisome (GO:0006625)	76	3	3.88	-	.77	4.56E-01
regulation of coagulation (GO:0050818)	76	3	3.88	-	.77	4.56E-01
establishment of protein localization to peroxisome (GO:0072663)	76	3	3.88	-	.77	4.56E-01
protein localization to peroxisome (GO:0072662)	76	3	3.88	-	.77	4.56E-01
kidney development (GO:0001822)	279	11	14.25	-	.77	2.37E-01
regulation of leukocyte migration (GO:0002685)	203	8	10.37	-	.77	2.91E-01
positive regulation of lymphocyte activation (GO:0051251)	280	11	14.30	-	.77	2.33E-01
positive regulation of lymphocyte differentiation (GO:0045621)	102	4	5.21	-	.77	4.04E-01
columnar/cuboidal epithelial cell development (GO:0002066)	51	2	2.60	-	.77	5.17E-01
T cell differentiation in thymus (GO:0033077)	51	2	2.60	-	.77	5.17E-01
negative regulation of reproductive process (GO:2000242)	51	2	2.60	-	.77	5.17E-01
cellular component maintenance (GO:0043954)	51	2	2.60	-	.77	5.17E-01
cardiac muscle tissue development (GO:0048738)	153	6	7.81	-	.77	3.35E-01
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	51	2	2.60	-	.77	5.17E-01
cardiac muscle cell development (GO:0055013)	51	2	2.60	-	.77	5.17E-01
negative regulation of blood coagulation (GO:0030195)	51	2	2.60	-	.77	5.17E-01
positive regulation of cell activation (GO:0050867)	332	13	16.96	-	.77	2.01E-01
muscle system process (GO:0003012)	281	11	14.35	-	.77	2.29E-01
hepaticobiliary system development (GO:0061008)	128	5	6.54	-	.76	3.63E-01
endothelial cell differentiation (GO:0045446)	77	3	3.93	-	.76	4.46E-01
positive regulation of leukocyte differentiation (GO:1902107)	154	6	7.87	-	.76	3.29E-01
peroxisomal transport (GO:0043574)	77	3	3.93	-	.76	4.46E-01
positive regulation of hemopoiesis (GO:1903708)	154	6	7.87	-	.76	3.29E-01
positive regulation of JNK cascade (GO:0046330)	77	3	3.93	-	.76	4.46E-01
primary alcohol metabolic process (GO:0034308)	77	3	3.93	-	.76	4.46E-01
response to amino acid (GO:0043200)	103	4	5.26	-	.76	3.95E-01
regulation of ion transport (GO:0043269)	670	26	34.22	-	.76	8.48E-02
regulation of endothelial cell proliferation (GO:0001936)	129	5	6.59	-	.76	3.55E-01
kidney epithelium development (GO:0072073)	129	5	6.59	-	.76	3.55E-01
leukocyte differentiation (GO:0002521)	336	13	17.16	-	.76	1.88E-01
regulation of cell-cell adhesion (GO:0022407)	414	16	21.15	-	.76	1.52E-01
cognition (GO:0050890)	285	11	14.56	-	.76	2.14E-01
negative regulation of proteolysis (GO:0045861)	311	12	15.88	-	.76	1.98E-01
negative regulation of lymphocyte proliferation (GO:0050672)	78	3	3.98	-	.75	4.36E-01
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	78	3	3.98	-	.75	4.36E-01
negative regulation of peptidase activity (GO:0010466)	234	9	11.95	-	.75	2.45E-01
heart growth (GO:0060419)	26	1	1.33	-	.75	6.17E-01
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	26	1	1.33	-	.75	6.17E-01
epithelial tube formation (GO:0072175)	130	5	6.64	-	.75	3.48E-01
positive regulation of gene silencing by miRNA (GO:2000637)	26	1	1.33	-	.75	6.17E-01
neural crest cell migration (GO:0001755)	52	2	2.66	-	.75	5.04E-01
positive regulation of cardiac muscle cell proliferation (GO:0060045)	26	1	1.33	-	.75	6.17E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	26	1	1.33	-	.75	6.17E-01
positive regulation of receptor internalization (GO:0002092)	26	1	1.33	-	.75	6.17E-01
branching involved in blood vessel morphogenesis (GO:0001569)	26	1	1.33	-	.75	6.17E-01
regulation of AMPA receptor activity (GO:2000311)	26	1	1.33	-	.75	6.17E-01
transcription elongation from RNA polymerase I promoter (GO:0006362)	26	1	1.33	-	.75	6.17E-01
cell-cell fusion (GO:0140253)	26	1	1.33	-	.75	6.17E-01
establishment of mitochondrion localization (GO:0051654)	26	1	1.33	-	.75	6.17E-01
regulation of non-canonical Wnt signaling pathway (GO:2000050)	26	1	1.33	-	.75	6.17E-01
syncytium formation by plasma membrane fusion (GO:0000768)	26	1	1.33	-	.75	6.17E-01
regulation of ubiquitin-protein transferase activity (GO:0051438)	52	2	2.66	-	.75	5.04E-01
regulation of positive chemotaxis (GO:0050926)	26	1	1.33	-	.75	6.17E-01
embryonic camera-type eye morphogenesis (GO:0048596)	26	1	1.33	-	.75	6.17E-01
aggrephagy (GO:0035973)	26	1	1.33	-	.75	6.17E-01
glucosamine-containing compound metabolic process (GO:1901071)	26	1	1.33	-	.75	6.17E-01
aorta development (GO:0035904)	52	2	2.66	-	.75	5.04E-01
regulation of potassium ion transmembrane transporter activity (GO:1901016)	52	2	2.66	-	.75	5.04E-01
negative regulation of receptor-mediated endocytosis (GO:0048261)	26	1	1.33	-	.75	6.17E-01
regulation of receptor binding (GO:1900120)	26	1	1.33	-	.75	6.17E-01
acidic amino acid transport (GO:0015800)	52	2	2.66	-	.75	5.04E-01
retinoic acid metabolic process (GO:0042573)	26	1	1.33	-	.75	6.17E-01
negative regulation of hemostasis (GO:1900047)	52	2	2.66	-	.75	5.04E-01
aromatic amino acid family catabolic process (GO:0009074)	26	1	1.33	-	.75	6.17E-01
regulation of bone remodeling (GO:0046850)	52	2	2.66	-	.75	5.04E-01
negative regulation of protein localization to cell periphery (GO:1904376)	26	1	1.33	-	.75	6.17E-01
adrenal gland development (GO:0030325)	26	1	1.33	-	.75	6.17E-01
protein localization to postsynaptic membrane (GO:1903539)	26	1	1.33	-	.75	6.17E-01
cell differentiation involved in embryonic placenta development (GO:0060706)	26	1	1.33	-	.75	6.17E-01
negative regulation of cytokine production involved in immune response (GO:0002719)	26	1	1.33	-	.75	6.17E-01
positive regulation of protein maturation (GO:1903319)	26	1	1.33	-	.75	6.17E-01
renal system development (GO:0072001)	287	11	14.66	-	.75	2.06E-01
Unclassified (UNCLASSIFIED)	1385	53	70.74	-	.75	1.34E-02
blood vessel morphogenesis (GO:0048514)	392	15	20.02	-	.75	1.52E-01
epidermis development (GO:0008544)	340	13	17.37	-	.75	1.75E-01
cell killing (GO:0001906)	105	4	5.36	-	.75	3.79E-01
positive regulation of transporter activity (GO:0032411)	105	4	5.36	-	.75	3.79E-01
response to alkaloid (GO:0043279)	105	4	5.36	-	.75	3.79E-01
membrane lipid metabolic process (GO:0006643)	184	7	9.40	-	.74	2.78E-01
negative regulation of mononuclear cell proliferation (GO:0032945)	79	3	4.04	-	.74	4.26E-01
anaphase-promoting complex-dependent catabolic process (GO:0031145)	79	3	4.04	-	.74	4.26E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	79	3	4.04	-	.74	4.26E-01
cellular ion homeostasis (GO:0006873)	606	23	30.95	-	.74	8.16E-02
ion homeostasis (GO:0050801)	738	28	37.69	-	.74	5.79E-02
regulation of T cell activation (GO:0050863)	317	12	16.19	-	.74	1.78E-01
circulatory system process (GO:0003013)	476	18	24.31	-	.74	1.12E-01
response to zinc ion (GO:0010043)	53	2	2.71	-	.74	4.92E-01
fatty acid beta-oxidation (GO:0006635)	53	2	2.71	-	.74	4.92E-01
protein targeting to mitochondrion (GO:0006626)	53	2	2.71	-	.74	4.92E-01
negative regulation of tumor necrosis factor production (GO:0032720)	53	2	2.71	-	.74	4.92E-01
regulation of receptor internalization (GO:0002090)	53	2	2.71	-	.74	4.92E-01
synaptic vesicle cycle (GO:0099504)	106	4	5.41	-	.74	3.70E-01
regulation of cell cycle arrest (GO:0071156)	106	4	5.41	-	.74	3.70E-01
T cell costimulation (GO:0031295)	53	2	2.71	-	.74	4.92E-01
regulation of cardiac conduction (GO:1903779)	53	2	2.71	-	.74	4.92E-01
regulation of histone acetylation (GO:0035065)	53	2	2.71	-	.74	4.92E-01
substrate adhesion-dependent cell spreading (GO:0034446)	53	2	2.71	-	.74	4.92E-01
eye development (GO:0001654)	345	13	17.62	-	.74	1.60E-01
ion transport (GO:0006811)	1222	46	62.42	-	.74	1.51E-02
transmembrane transport (GO:0055085)	1172	44	59.86	-	.74	1.65E-02
endoplasmic reticulum organization (GO:0007029)	80	3	4.09	-	.73	4.16E-01
divalent metal ion transport (GO:0070838)	267	10	13.64	-	.73	1.99E-01
mitochondrial translation (GO:0032543)	107	4	5.47	-	.73	3.62E-01
response to estradiol (GO:0032355)	134	5	6.84	-	.73	3.20E-01
regulation of nervous system process (GO:0031644)	134	5	6.84	-	.73	3.20E-01
positive regulation of cytokine production (GO:0001819)	429	16	21.91	-	.73	1.17E-01
inorganic ion homeostasis (GO:0098771)	671	25	34.27	-	.73	5.79E-02
visual system development (GO:0150063)	349	13	17.83	-	.73	1.49E-01
regulation of transmembrane transport (GO:0034762)	537	20	27.43	-	.73	8.46E-02
protein targeting (GO:0006605)	350	13	17.88	-	.73	1.46E-01
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	81	3	4.14	-	.73	4.07E-01
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	27	1	1.38	-	.73	5.99E-01
syncytium formation (GO:0006949)	27	1	1.38	-	.73	5.99E-01
positive regulation of erythrocyte differentiation (GO:0045648)	27	1	1.38	-	.73	5.99E-01
modified amino acid transport (GO:0072337)	27	1	1.38	-	.73	5.99E-01
leukocyte apoptotic process (GO:0071887)	27	1	1.38	-	.73	5.99E-01
endochondral ossification (GO:0001958)	27	1	1.38	-	.73	5.99E-01
regulation of stem cell differentiation (GO:2000736)	108	4	5.52	-	.73	3.54E-01
positive regulation of posttranscriptional gene silencing (GO:0060148)	27	1	1.38	-	.73	5.99E-01
leukotriene metabolic process (GO:0006691)	27	1	1.38	-	.73	5.99E-01
mitotic G2/M transition checkpoint (GO:0044818)	27	1	1.38	-	.73	5.99E-01
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	27	1	1.38	-	.73	5.99E-01
negative regulation of amine transport (GO:0051953)	27	1	1.38	-	.73	5.99E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	27	1	1.38	-	.73	5.99E-01
cellular response to gamma radiation (GO:0071480)	27	1	1.38	-	.73	5.99E-01
regulation of the force of heart contraction (GO:0002026)	27	1	1.38	-	.73	5.99E-01
ovarian follicle development (GO:0001541)	54	2	2.76	-	.73	4.79E-01
neurotransmitter uptake (GO:0001504)	27	1	1.38	-	.73	5.99E-01
mRNA polyadenylation (GO:0006378)	27	1	1.38	-	.73	5.99E-01
termination of RNA polymerase I transcription (GO:0006363)	27	1	1.38	-	.73	5.99E-01
nucleus localization (GO:0051647)	27	1	1.38	-	.73	5.99E-01
homeostasis of number of cells within a tissue (GO:0048873)	27	1	1.38	-	.73	5.99E-01
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	27	1	1.38	-	.73	5.99E-01
negative regulation of intracellular transport (GO:0032387)	54	2	2.76	-	.73	4.79E-01
positive regulation of membrane permeability (GO:1905710)	27	1	1.38	-	.73	5.99E-01
positive regulation of lipid catabolic process (GO:0050996)	27	1	1.38	-	.73	5.99E-01
ERK1 and ERK2 cascade (GO:0070371)	27	1	1.38	-	.73	5.99E-01
negative regulation of biomineral tissue development (GO:0070168)	27	1	1.38	-	.73	5.99E-01
replacement ossification (GO:0036075)	27	1	1.38	-	.73	5.99E-01
O-glycan processing (GO:0016266)	54	2	2.76	-	.73	4.79E-01
regulation of protein kinase A signaling (GO:0010738)	27	1	1.38	-	.73	5.99E-01
myotube cell development (GO:0014904)	27	1	1.38	-	.73	5.99E-01
negative regulation of ATP metabolic process (GO:1903579)	27	1	1.38	-	.73	5.99E-01
regulation of T-helper 1 type immune response (GO:0002825)	27	1	1.38	-	.73	5.99E-01
regulation of glucose import (GO:0046324)	54	2	2.76	-	.73	4.79E-01
response to gamma radiation (GO:0010332)	54	2	2.76	-	.73	4.79E-01
forebrain neuron development (GO:0021884)	27	1	1.38	-	.73	5.99E-01
cell proliferation in forebrain (GO:0021846)	27	1	1.38	-	.73	5.99E-01
outflow tract septum morphogenesis (GO:0003148)	27	1	1.38	-	.73	5.99E-01
animal organ morphogenesis (GO:0009887)	921	34	47.04	-	.72	2.57E-02
locomotion (GO:0040011)	1192	44	60.88	-	.72	1.18E-02
striated muscle cell differentiation (GO:0051146)	190	7	9.70	-	.72	2.46E-01
sensory system development (GO:0048880)	353	13	18.03	-	.72	1.38E-01
skeletal system morphogenesis (GO:0048705)	218	8	11.13	-	.72	2.18E-01
behavior (GO:0007610)	546	20	27.89	-	.72	7.22E-02
divalent inorganic cation transport (GO:0072511)	273	10	13.94	-	.72	1.77E-01
viral gene expression (GO:0019080)	164	6	8.38	-	.72	2.68E-01
interaction with symbiont (GO:0051702)	82	3	4.19	-	.72	3.97E-01
tube development (GO:0035295)	820	30	41.88	-	.72	3.09E-02
chemotaxis (GO:0006935)	520	19	26.56	-	.72	7.68E-02
regulation of myeloid cell differentiation (GO:0045637)	219	8	11.19	-	.72	2.14E-01
taxis (GO:0042330)	522	19	26.66	-	.71	7.40E-02
proton transmembrane transport (GO:1902600)	110	4	5.62	-	.71	3.39E-01
leukocyte cell-cell adhesion (GO:0007159)	55	2	2.81	-	.71	4.67E-01
protein homotetramerization (GO:0051289)	55	2	2.81	-	.71	4.67E-01
lymphocyte costimulation (GO:0031294)	55	2	2.81	-	.71	4.67E-01
axoneme assembly (GO:0035082)	55	2	2.81	-	.71	4.67E-01
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	55	2	2.81	-	.71	4.67E-01
blood circulation (GO:0008015)	385	14	19.66	-	.71	1.16E-01
negative regulation of leukocyte mediated immunity (GO:0002704)	55	2	2.81	-	.71	4.67E-01
peroxisome organization (GO:0007031)	83	3	4.24	-	.71	3.88E-01
BMP signaling pathway (GO:0030509)	83	3	4.24	-	.71	3.88E-01
negative regulation of T cell activation (GO:0050868)	111	4	5.67	-	.71	3.31E-01
autophagy (GO:0006914)	279	10	14.25	-	.70	1.57E-01
process utilizing autophagic mechanism (GO:0061919)	279	10	14.25	-	.70	1.57E-01
positive regulation of cell adhesion (GO:0045785)	420	15	21.45	-	.70	9.14E-02
skeletal muscle contraction (GO:0003009)	28	1	1.43	-	.70	5.81E-01
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	56	2	2.86	-	.70	4.55E-01
negative regulation of biomineralization (GO:0110150)	28	1	1.43	-	.70	5.81E-01
dopamine receptor signaling pathway (GO:0007212)	28	1	1.43	-	.70	5.81E-01
basement membrane organization (GO:0071711)	28	1	1.43	-	.70	5.81E-01
cellular biogenic amine metabolic process (GO:0006576)	56	2	2.86	-	.70	4.55E-01
behavioral fear response (GO:0001662)	28	1	1.43	-	.70	5.81E-01
temperature homeostasis (GO:0001659)	28	1	1.43	-	.70	5.81E-01
positive regulation of T cell migration (GO:2000406)	28	1	1.43	-	.70	5.81E-01
cellular response to glucagon stimulus (GO:0071377)	28	1	1.43	-	.70	5.81E-01
regulation of myeloid cell apoptotic process (GO:0033032)	28	1	1.43	-	.70	5.81E-01
localization within membrane (GO:0051668)	84	3	4.29	-	.70	3.78E-01
positive regulation of leukocyte apoptotic process (GO:2000108)	28	1	1.43	-	.70	5.81E-01
keratan sulfate biosynthetic process (GO:0018146)	28	1	1.43	-	.70	5.81E-01
pigment cell differentiation (GO:0050931)	28	1	1.43	-	.70	5.81E-01
negative regulation of coagulation (GO:0050819)	56	2	2.86	-	.70	4.55E-01
post-translational protein modification (GO:0043687)	336	12	17.16	-	.70	1.24E-01
regulation of sequestering of calcium ion (GO:0051282)	112	4	5.72	-	.70	3.23E-01
post-embryonic development (GO:0009791)	84	3	4.29	-	.70	3.78E-01
RNA polyadenylation (GO:0043631)	28	1	1.43	-	.70	5.81E-01
synaptic vesicle recycling (GO:0036465)	56	2	2.86	-	.70	4.55E-01
positive regulation of neuron apoptotic process (GO:0043525)	56	2	2.86	-	.70	4.55E-01
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	28	1	1.43	-	.70	5.81E-01
chromosome organization involved in meiotic cell cycle (GO:0070192)	56	2	2.86	-	.70	4.55E-01
regulation of cardiocyte differentiation (GO:1905207)	28	1	1.43	-	.70	5.81E-01
negative regulation of fibroblast proliferation (GO:0048147)	28	1	1.43	-	.70	5.81E-01
cortical cytoskeleton organization (GO:0030865)	56	2	2.86	-	.70	4.55E-01
granulocyte differentiation (GO:0030851)	28	1	1.43	-	.70	5.81E-01
2'-deoxyribonucleotide metabolic process (GO:0009394)	28	1	1.43	-	.70	5.81E-01
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	28	1	1.43	-	.70	5.81E-01
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	28	1	1.43	-	.70	5.81E-01
amino acid import across plasma membrane (GO:0089718)	28	1	1.43	-	.70	5.81E-01
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	28	1	1.43	-	.70	5.81E-01
myotube differentiation (GO:0014902)	56	2	2.86	-	.70	4.55E-01
metanephros morphogenesis (GO:0003338)	28	1	1.43	-	.70	5.81E-01
fluid transport (GO:0042044)	28	1	1.43	-	.70	5.81E-01
regulation of morphogenesis of a branching structure (GO:0060688)	56	2	2.86	-	.70	4.55E-01
aortic valve morphogenesis (GO:0003180)	28	1	1.43	-	.70	5.81E-01
blood vessel development (GO:0001568)	477	17	24.36	-	.70	7.35E-02
epithelial cell differentiation (GO:0030855)	590	21	30.14	-	.70	4.89E-02
cellular cation homeostasis (GO:0030003)	591	21	30.19	-	.70	4.79E-02
cell adhesion (GO:0007155)	876	31	44.74	-	.69	1.70E-02
positive regulation of interleukin-6 production (GO:0032755)	85	3	4.34	-	.69	3.69E-01
negative regulation of leukocyte proliferation (GO:0070664)	85	3	4.34	-	.69	3.69E-01
mitochondrial translational elongation (GO:0070125)	85	3	4.34	-	.69	3.69E-01
positive regulation of small molecule metabolic process (GO:0062013)	142	5	7.25	-	.69	2.68E-01
circulatory system development (GO:0072359)	824	29	42.09	-	.69	1.90E-02
biological adhesion (GO:0022610)	882	31	45.05	-	.69	1.52E-02
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)	57	2	2.91	-	.69	4.43E-01
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413)	57	2	2.91	-	.69	4.43E-01
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403)	57	2	2.91	-	.69	4.43E-01
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402)	57	2	2.91	-	.69	4.43E-01
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400)	57	2	2.91	-	.69	4.43E-01
cellular amine metabolic process (GO:0044106)	57	2	2.91	-	.69	4.43E-01
actin polymerization or depolymerization (GO:0008154)	57	2	2.91	-	.69	4.43E-01
positive regulation of myeloid leukocyte differentiation (GO:0002763)	57	2	2.91	-	.69	4.43E-01
regulation of leukocyte chemotaxis (GO:0002688)	114	4	5.82	-	.69	3.09E-01
regulation of calcium ion transmembrane transport (GO:1903169)	143	5	7.30	-	.68	2.62E-01
embryonic organ development (GO:0048568)	430	15	21.96	-	.68	7.52E-02
mitochondrial translational termination (GO:0070126)	86	3	4.39	-	.68	3.60E-01
regulation of ion transmembrane transport (GO:0034765)	459	16	23.44	-	.68	6.68E-02
cation homeostasis (GO:0055080)	660	23	33.71	-	.68	3.10E-02
system process (GO:0003008)	1607	56	82.08	-	.68	9.11E-04
membrane lipid biosynthetic process (GO:0046467)	115	4	5.87	-	.68	3.01E-01
cellular calcium ion homeostasis (GO:0006874)	403	14	20.58	-	.68	8.15E-02
eye morphogenesis (GO:0048592)	144	5	7.36	-	.68	2.56E-01
negative regulation of lymphocyte activation (GO:0051250)	144	5	7.36	-	.68	2.56E-01
positive regulation of neuron projection development (GO:0010976)	144	5	7.36	-	.68	2.56E-01
import into cell (GO:0098657)	173	6	8.84	-	.68	2.21E-01
cellular divalent inorganic cation homeostasis (GO:0072503)	433	15	22.12	-	.68	7.09E-02
response to X-ray (GO:0010165)	29	1	1.48	-	.68	5.64E-01
postsynaptic membrane organization (GO:0001941)	29	1	1.48	-	.68	5.64E-01
positive regulation of defense response to virus by host (GO:0002230)	29	1	1.48	-	.68	5.64E-01
behavioral defense response (GO:0002209)	29	1	1.48	-	.68	5.64E-01
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	58	2	2.96	-	.68	4.31E-01
neuron death (GO:0070997)	58	2	2.96	-	.68	4.31E-01
negative regulation of endothelial cell apoptotic process (GO:2000352)	29	1	1.48	-	.68	5.64E-01
protein K48-linked deubiquitination (GO:0071108)	29	1	1.48	-	.68	5.64E-01
negative regulation of oxidoreductase activity (GO:0051354)	29	1	1.48	-	.68	5.64E-01
positive regulation of calcium-mediated signaling (GO:0050850)	29	1	1.48	-	.68	5.64E-01
response to increased oxygen levels (GO:0036296)	29	1	1.48	-	.68	5.64E-01
histone phosphorylation (GO:0016572)	29	1	1.48	-	.68	5.64E-01
peroxisomal membrane transport (GO:0015919)	29	1	1.48	-	.68	5.64E-01
membrane depolarization during action potential (GO:0086010)	29	1	1.48	-	.68	5.64E-01
synaptic transmission, glutamatergic (GO:0035249)	29	1	1.48	-	.68	5.64E-01
dendritic spine development (GO:0060996)	29	1	1.48	-	.68	5.64E-01
ribosome assembly (GO:0042255)	58	2	2.96	-	.68	4.31E-01
mammary gland epithelium development (GO:0061180)	58	2	2.96	-	.68	4.31E-01
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	29	1	1.48	-	.68	5.64E-01
phosphatidylethanolamine metabolic process (GO:0046337)	29	1	1.48	-	.68	5.64E-01
histone monoubiquitination (GO:0010390)	29	1	1.48	-	.68	5.64E-01
negative regulation of protein tyrosine kinase activity (GO:0061099)	29	1	1.48	-	.68	5.64E-01
extracellular matrix assembly (GO:0085029)	29	1	1.48	-	.68	5.64E-01
clathrin-dependent endocytosis (GO:0072583)	29	1	1.48	-	.68	5.64E-01
negative regulation of immune system process (GO:0002683)	493	17	25.18	-	.68	5.38E-02
heart development (GO:0007507)	494	17	25.23	-	.67	5.28E-02
heart morphogenesis (GO:0003007)	233	8	11.90	-	.67	1.60E-01
protein homooligomerization (GO:0051260)	175	6	8.94	-	.67	2.11E-01
response to calcium ion (GO:0051592)	146	5	7.46	-	.67	2.45E-01
regulation of nuclear division (GO:0051783)	117	4	5.98	-	.67	2.87E-01
regulation of JNK cascade (GO:0046328)	117	4	5.98	-	.67	2.87E-01
positive regulation of T cell differentiation (GO:0045582)	88	3	4.49	-	.67	3.42E-01
calcium ion transmembrane transport (GO:0070588)	176	6	8.99	-	.67	2.06E-01
carbohydrate derivative transport (GO:1901264)	88	3	4.49	-	.67	3.42E-01
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	88	3	4.49	-	.67	3.42E-01
regulation of protein tyrosine kinase activity (GO:0061097)	88	3	4.49	-	.67	3.42E-01
second-messenger-mediated signaling (GO:0019932)	324	11	16.55	-	.66	9.97E-02
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	59	2	3.01	-	.66	4.20E-01
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	59	2	3.01	-	.66	4.20E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209)	118	4	6.03	-	.66	2.80E-01
modulation by host of symbiont process (GO:0051851)	59	2	3.01	-	.66	4.20E-01
positive regulation of organelle assembly (GO:1902117)	59	2	3.01	-	.66	4.20E-01
glycosyl compound metabolic process (GO:1901657)	118	4	6.03	-	.66	2.80E-01
myofibril assembly (GO:0030239)	59	2	3.01	-	.66	4.20E-01
response to metal ion (GO:0010038)	356	12	18.18	-	.66	8.28E-02
mesonephros development (GO:0001823)	89	3	4.55	-	.66	3.34E-01
cellular oxidant detoxification (GO:0098869)	89	3	4.55	-	.66	3.34E-01
defense response to Gram-positive bacterium (GO:0050830)	89	3	4.55	-	.66	3.34E-01
fatty acid catabolic process (GO:0009062)	89	3	4.55	-	.66	3.34E-01
regulation of immune effector process (GO:0002697)	387	13	19.77	-	.66	7.03E-02
positive regulation of ion transport (GO:0043270)	268	9	13.69	-	.66	1.23E-01
calcium ion homeostasis (GO:0055074)	417	14	21.30	-	.66	6.12E-02
lung epithelium development (GO:0060428)	30	1	1.53	-	.65	5.47E-01
regulation of regulatory T cell differentiation (GO:0045589)	30	1	1.53	-	.65	5.47E-01
regulation of peptidyl-lysine acetylation (GO:2000756)	60	2	3.06	-	.65	4.08E-01
cellular response to inorganic substance (GO:0071241)	210	7	10.73	-	.65	1.60E-01
multivesicular body assembly (GO:0036258)	30	1	1.53	-	.65	5.47E-01
rRNA modification (GO:0000154)	30	1	1.53	-	.65	5.47E-01
oligosaccharide biosynthetic process (GO:0009312)	30	1	1.53	-	.65	5.47E-01
very long-chain fatty acid metabolic process (GO:0000038)	30	1	1.53	-	.65	5.47E-01
ATP transport (GO:0015867)	30	1	1.53	-	.65	5.47E-01
positive regulation of protein targeting to mitochondrion (GO:1903955)	30	1	1.53	-	.65	5.47E-01
positive regulation of histone acetylation (GO:0035066)	30	1	1.53	-	.65	5.47E-01
deoxyribose phosphate metabolic process (GO:0019692)	30	1	1.53	-	.65	5.47E-01
plasma lipoprotein particle remodeling (GO:0034369)	30	1	1.53	-	.65	5.47E-01
protein-lipid complex remodeling (GO:0034368)	30	1	1.53	-	.65	5.47E-01
motor neuron axon guidance (GO:0008045)	30	1	1.53	-	.65	5.47E-01
divalent inorganic cation homeostasis (GO:0072507)	454	15	23.19	-	.65	4.59E-02
positive regulation of T cell activation (GO:0050870)	212	7	10.83	-	.65	1.53E-01
negative regulation of immune response (GO:0050777)	273	9	13.94	-	.65	1.10E-01
regulation of alpha-beta T cell activation (GO:0046634)	91	3	4.65	-	.65	3.17E-01
regulation of blood pressure (GO:0008217)	182	6	9.30	-	.65	1.80E-01
endothelium development (GO:0003158)	91	3	4.65	-	.65	3.17E-01
angiogenesis (GO:0001525)	304	10	15.53	-	.64	9.29E-02
cellular iron ion homeostasis (GO:0006879)	61	2	3.12	-	.64	3.97E-01
glycosaminoglycan catabolic process (GO:0006027)	61	2	3.12	-	.64	3.97E-01
cardiac muscle tissue morphogenesis (GO:0055008)	61	2	3.12	-	.64	3.97E-01
positive regulation of myeloid cell differentiation (GO:0045639)	92	3	4.70	-	.64	3.09E-01
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	92	3	4.70	-	.64	3.09E-01
regulation of organ growth (GO:0046620)	92	3	4.70	-	.64	3.09E-01
regulation of Ras protein signal transduction (GO:0046578)	184	6	9.40	-	.64	1.71E-01
skin development (GO:0043588)	307	10	15.68	-	.64	8.69E-02
regulation of lymphocyte proliferation (GO:0050670)	215	7	10.98	-	.64	1.43E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	123	4	6.28	-	.64	2.48E-01
transition metal ion homeostasis (GO:0055076)	123	4	6.28	-	.64	2.48E-01
trans-synaptic signaling (GO:0099537)	401	13	20.48	-	.63	5.20E-02
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	93	3	4.75	-	.63	3.01E-01
positive regulation of adaptive immune response (GO:0002821)	93	3	4.75	-	.63	3.01E-01
olfactory bulb development (GO:0021772)	31	1	1.58	-	.63	5.30E-01
neuroblast proliferation (GO:0007405)	31	1	1.58	-	.63	5.30E-01
cell volume homeostasis (GO:0006884)	31	1	1.58	-	.63	5.30E-01
regulation of B cell differentiation (GO:0045577)	31	1	1.58	-	.63	5.30E-01
regulation of mononuclear cell proliferation (GO:0032944)	217	7	11.08	-	.63	1.36E-01
ERBB2 signaling pathway (GO:0038128)	31	1	1.58	-	.63	5.30E-01
regulation of interleukin-4 production (GO:0032673)	31	1	1.58	-	.63	5.30E-01
quinone metabolic process (GO:1901661)	31	1	1.58	-	.63	5.30E-01
neurotransmitter receptor transport (GO:0099637)	31	1	1.58	-	.63	5.30E-01
positive regulation of filopodium assembly (GO:0051491)	31	1	1.58	-	.63	5.30E-01
establishment of epithelial cell polarity (GO:0090162)	31	1	1.58	-	.63	5.30E-01
positive regulation of phagocytosis (GO:0050766)	62	2	3.17	-	.63	3.86E-01
negative regulation of protein localization to membrane (GO:1905476)	31	1	1.58	-	.63	5.30E-01
regulation of smooth muscle cell differentiation (GO:0051150)	31	1	1.58	-	.63	5.30E-01
multivesicular body organization (GO:0036257)	31	1	1.58	-	.63	5.30E-01
protein localization to postsynapse (GO:0062237)	31	1	1.58	-	.63	5.30E-01
positive regulation of cardiac muscle tissue growth (GO:0055023)	31	1	1.58	-	.63	5.30E-01
nucleobase metabolic process (GO:0009112)	31	1	1.58	-	.63	5.30E-01
endocrine system development (GO:0035270)	124	4	6.33	-	.63	2.42E-01
regulation of muscle cell apoptotic process (GO:0010660)	62	2	3.17	-	.63	3.86E-01
negative regulation of T cell proliferation (GO:0042130)	62	2	3.17	-	.63	3.86E-01
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	31	1	1.58	-	.63	5.30E-01
negative regulation of DNA replication (GO:0008156)	31	1	1.58	-	.63	5.30E-01
regulation of type 2 immune response (GO:0002828)	31	1	1.58	-	.63	5.30E-01
reactive oxygen species biosynthetic process (GO:1903409)	31	1	1.58	-	.63	5.30E-01
placenta blood vessel development (GO:0060674)	31	1	1.58	-	.63	5.30E-01
localization of cell (GO:0051674)	962	31	49.14	-	.63	3.04E-03
cell motility (GO:0048870)	962	31	49.14	-	.63	3.04E-03
regulation of hemopoiesis (GO:1903706)	374	12	19.10	-	.63	5.59E-02
striated muscle cell development (GO:0055002)	125	4	6.38	-	.63	2.36E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029)	94	3	4.80	-	.62	2.93E-01
platelet degranulation (GO:0002576)	126	4	6.44	-	.62	2.30E-01
nephron tubule morphogenesis (GO:0072078)	63	2	3.22	-	.62	3.76E-01
amine metabolic process (GO:0009308)	63	2	3.22	-	.62	3.76E-01
regulation of mitotic nuclear division (GO:0007088)	95	3	4.85	-	.62	2.86E-01
positive regulation of production of molecular mediator of immune response (GO:0002702)	95	3	4.85	-	.62	2.86E-01
embryonic organ morphogenesis (GO:0048562)	287	9	14.66	-	.61	7.98E-02
phenol-containing compound biosynthetic process (GO:0046189)	32	1	1.63	-	.61	5.14E-01
negative regulation of protein serine/threonine kinase activity (GO:0071901)	128	4	6.54	-	.61	2.18E-01
metanephric nephron development (GO:0072210)	32	1	1.63	-	.61	5.14E-01
regulation of collagen biosynthetic process (GO:0032965)	32	1	1.63	-	.61	5.14E-01
leukocyte activation involved in inflammatory response (GO:0002269)	32	1	1.63	-	.61	5.14E-01
microglial cell activation (GO:0001774)	32	1	1.63	-	.61	5.14E-01
activation of protein kinase B activity (GO:0032148)	32	1	1.63	-	.61	5.14E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	192	6	9.81	-	.61	1.41E-01
fear response (GO:0042596)	32	1	1.63	-	.61	5.14E-01
regulation of viral transcription (GO:0046782)	64	2	3.27	-	.61	3.65E-01
vasodilation (GO:0042311)	32	1	1.63	-	.61	5.14E-01
embryonic forelimb morphogenesis (GO:0035115)	32	1	1.63	-	.61	5.14E-01
epithelial cell morphogenesis (GO:0003382)	32	1	1.63	-	.61	5.14E-01
positive regulation of immunoglobulin mediated immune response (GO:0002891)	32	1	1.63	-	.61	5.14E-01
protein-containing complex remodeling (GO:0034367)	32	1	1.63	-	.61	5.14E-01
regulation of fatty acid oxidation (GO:0046320)	32	1	1.63	-	.61	5.14E-01
cell junction maintenance (GO:0034331)	32	1	1.63	-	.61	5.14E-01
positive regulation of B cell mediated immunity (GO:0002714)	32	1	1.63	-	.61	5.14E-01
positive regulation of leukocyte migration (GO:0002687)	128	4	6.54	-	.61	2.18E-01
regulation of membrane potential (GO:0042391)	418	13	21.35	-	.61	3.54E-02
regulation of systemic arterial blood pressure (GO:0003073)	97	3	4.95	-	.61	2.71E-01
cellular response to BMP stimulus (GO:0071773)	97	3	4.95	-	.61	2.71E-01
response to BMP (GO:0071772)	97	3	4.95	-	.61	2.71E-01
synaptic signaling (GO:0099536)	421	13	21.50	-	.60	3.31E-02
cellular metal ion homeostasis (GO:0006875)	519	16	26.51	-	.60	1.85E-02
metal ion homeostasis (GO:0055065)	584	18	29.83	-	.60	1.27E-02
regulation of toll-like receptor signaling pathway (GO:0034121)	65	2	3.32	-	.60	3.55E-01
nephron epithelium morphogenesis (GO:0072088)	65	2	3.32	-	.60	3.55E-01
cellular response to drug (GO:0035690)	65	2	3.32	-	.60	3.55E-01
protein localization to membrane (GO:0072657)	488	15	24.93	-	.60	2.15E-02
fertilization (GO:0009566)	164	5	8.38	-	.60	1.58E-01
regulation of heart contraction (GO:0008016)	230	7	11.75	-	.60	9.95E-02
adaptive immune response (GO:0002250)	296	9	15.12	-	.60	6.44E-02
receptor metabolic process (GO:0043112)	99	3	5.06	-	.59	2.56E-01
positive regulation of peptidyl-lysine acetylation (GO:2000758)	33	1	1.69	-	.59	4.98E-01
nephron morphogenesis (GO:0072028)	66	2	3.37	-	.59	3.45E-01
protein transmembrane import into intracellular organelle (GO:0044743)	33	1	1.69	-	.59	4.98E-01
signal transduction in absence of ligand (GO:0038034)	33	1	1.69	-	.59	4.98E-01
positive regulation of interferon-beta production (GO:0032728)	33	1	1.69	-	.59	4.98E-01
transcription initiation from RNA polymerase I promoter (GO:0006361)	33	1	1.69	-	.59	4.98E-01
cellular response to retinoic acid (GO:0071300)	66	2	3.37	-	.59	3.45E-01
endosome transport via multivesicular body sorting pathway (GO:0032509)	33	1	1.69	-	.59	4.98E-01
synapse organization (GO:0050808)	264	8	13.48	-	.59	7.79E-02
digestive system development (GO:0055123)	132	4	6.74	-	.59	1.97E-01
aerobic respiration (GO:0009060)	66	2	3.37	-	.59	3.45E-01
keratan sulfate metabolic process (GO:0042339)	33	1	1.69	-	.59	4.98E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	33	1	1.69	-	.59	4.98E-01
regulation of mesenchymal cell proliferation (GO:0010464)	33	1	1.69	-	.59	4.98E-01
olfactory lobe development (GO:0021988)	33	1	1.69	-	.59	4.98E-01
dendritic cell differentiation (GO:0097028)	33	1	1.69	-	.59	4.98E-01
negative regulation of smoothened signaling pathway (GO:0045879)	33	1	1.69	-	.59	4.98E-01
establishment of endothelial barrier (GO:0061028)	33	1	1.69	-	.59	4.98E-01
metal ion transport (GO:0030001)	596	18	30.44	-	.59	9.58E-03
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	232	7	11.85	-	.59	9.47E-02
cardiac chamber development (GO:0003205)	166	5	8.48	-	.59	1.50E-01
regulation of leukocyte proliferation (GO:0070663)	233	7	11.90	-	.59	9.23E-02
positive regulation of protein kinase B signaling (GO:0051897)	167	5	8.53	-	.59	1.46E-01
ion transmembrane transport (GO:0034220)	837	25	42.75	-	.58	1.90E-03
single fertilization (GO:0007338)	134	4	6.84	-	.58	1.87E-01
response to ethanol (GO:0045471)	134	4	6.84	-	.58	1.87E-01
regulation of interleukin-6 production (GO:0032675)	134	4	6.84	-	.58	1.87E-01
aminoglycan catabolic process (GO:0006026)	67	2	3.42	-	.58	3.35E-01
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	67	2	3.42	-	.58	3.35E-01
ovulation cycle (GO:0042698)	67	2	3.42	-	.58	3.35E-01
cellular response to dopamine (GO:1903351)	67	2	3.42	-	.58	3.35E-01
response to dopamine (GO:1903350)	67	2	3.42	-	.58	3.35E-01
stimulatory C-type lectin receptor signaling pathway (GO:0002223)	101	3	5.16	-	.58	2.43E-01
positive regulation of endocytosis (GO:0045807)	101	3	5.16	-	.58	2.43E-01
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	135	4	6.90	-	.58	1.82E-01
regulation of cation channel activity (GO:2001257)	170	5	8.68	-	.58	1.35E-01
multicellular organismal response to stress (GO:0033555)	68	2	3.47	-	.58	3.25E-01
signaling receptor ligand precursor processing (GO:0140448)	34	1	1.74	-	.58	4.82E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	34	1	1.74	-	.58	4.82E-01
positive regulation of signaling receptor activity (GO:2000273)	34	1	1.74	-	.58	4.82E-01
establishment of protein localization to membrane (GO:0090150)	272	8	13.89	-	.58	6.38E-02
establishment of spindle orientation (GO:0051294)	34	1	1.74	-	.58	4.82E-01
lipopolysaccharide-mediated signaling pathway (GO:0031663)	34	1	1.74	-	.58	4.82E-01
detection of biotic stimulus (GO:0009595)	34	1	1.74	-	.58	4.82E-01
animal organ regeneration (GO:0031100)	68	2	3.47	-	.58	3.25E-01
negative regulation of blood vessel diameter (GO:0097756)	34	1	1.74	-	.58	4.82E-01
hormone secretion (GO:0046879)	68	2	3.47	-	.58	3.25E-01
positive regulation of sodium ion transport (GO:0010765)	34	1	1.74	-	.58	4.82E-01
ventricular septum development (GO:0003281)	68	2	3.47	-	.58	3.25E-01
mating (GO:0007618)	34	1	1.74	-	.58	4.82E-01
cell migration (GO:0016477)	851	25	43.47	-	.58	1.36E-03
positive regulation of immune effector process (GO:0002699)	205	6	10.47	-	.57	1.02E-01
retina development in camera-type eye (GO:0060041)	137	4	7.00	-	.57	1.72E-01
striated muscle contraction (GO:0006941)	104	3	5.31	-	.56	2.23E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	104	3	5.31	-	.56	2.23E-01
epidermal cell differentiation (GO:0009913)	243	7	12.41	-	.56	7.15E-02
sphingolipid metabolic process (GO:0006665)	139	4	7.10	-	.56	1.63E-01
regulation of lymphocyte differentiation (GO:0045619)	174	5	8.89	-	.56	1.21E-01
chemical synaptic transmission (GO:0007268)	384	11	19.61	-	.56	2.46E-02
anterograde trans-synaptic signaling (GO:0098916)	384	11	19.61	-	.56	2.46E-02
negative regulation of Notch signaling pathway (GO:0045746)	35	1	1.79	-	.56	4.66E-01
positive regulation of heart growth (GO:0060421)	35	1	1.79	-	.56	4.66E-01
muscle tissue morphogenesis (GO:0060415)	70	2	3.58	-	.56	3.07E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	70	2	3.58	-	.56	3.07E-01
response to amphetamine (GO:0001975)	35	1	1.79	-	.56	4.66E-01
cellular response to interleukin-6 (GO:0071354)	35	1	1.79	-	.56	4.66E-01
transcription-coupled nucleotide-excision repair (GO:0006283)	70	2	3.58	-	.56	3.07E-01
response to retinoic acid (GO:0032526)	105	3	5.36	-	.56	2.17E-01
adenine nucleotide transport (GO:0051503)	35	1	1.79	-	.56	4.66E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	35	1	1.79	-	.56	4.66E-01
embryonic eye morphogenesis (GO:0048048)	35	1	1.79	-	.56	4.66E-01
purine ribonucleotide transport (GO:0015868)	35	1	1.79	-	.56	4.66E-01
negative regulation of alpha-beta T cell activation (GO:0046636)	35	1	1.79	-	.56	4.66E-01
positive regulation of epithelial cell apoptotic process (GO:1904037)	35	1	1.79	-	.56	4.66E-01
cardiac septum development (GO:0003279)	105	3	5.36	-	.56	2.17E-01
innate immune response-activating signal transduction (GO:0002758)	105	3	5.36	-	.56	2.17E-01
positive regulation of smoothened signaling pathway (GO:0045880)	35	1	1.79	-	.56	4.66E-01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	248	7	12.67	-	.55	6.27E-02
regulation of T cell differentiation (GO:0045580)	143	4	7.30	-	.55	1.46E-01
cation transport (GO:0006812)	753	21	38.46	-	.55	1.27E-03
central nervous system neuron differentiation (GO:0021953)	180	5	9.19	-	.54	1.03E-01
positive regulation of DNA replication (GO:0045740)	36	1	1.84	-	.54	4.51E-01
Golgi organization (GO:0007030)	108	3	5.52	-	.54	1.99E-01
peptidyl-tyrosine autophosphorylation (GO:0038083)	36	1	1.84	-	.54	4.51E-01
cellular response to estradiol stimulus (GO:0071392)	36	1	1.84	-	.54	4.51E-01
regulation of hormone metabolic process (GO:0032350)	36	1	1.84	-	.54	4.51E-01
animal organ formation (GO:0048645)	36	1	1.84	-	.54	4.51E-01
triglyceride homeostasis (GO:0070328)	36	1	1.84	-	.54	4.51E-01
cellular response to virus (GO:0098586)	36	1	1.84	-	.54	4.51E-01
developmental pigmentation (GO:0048066)	36	1	1.84	-	.54	4.51E-01
acylglycerol homeostasis (GO:0055090)	36	1	1.84	-	.54	4.51E-01
purine nucleotide transport (GO:0015865)	36	1	1.84	-	.54	4.51E-01
regulation of collagen metabolic process (GO:0010712)	36	1	1.84	-	.54	4.51E-01
B cell proliferation (GO:0042100)	36	1	1.84	-	.54	4.51E-01
positive regulation of glucose import (GO:0046326)	36	1	1.84	-	.54	4.51E-01
regulation of leukocyte mediated cytotoxicity (GO:0001910)	73	2	3.73	-	.54	2.80E-01
positive regulation of lipase activity (GO:0060193)	73	2	3.73	-	.54	2.80E-01
cAMP-mediated signaling (GO:0019933)	146	4	7.46	-	.54	1.34E-01
cellular response to metal ion (GO:0071248)	183	5	9.35	-	.53	9.49E-02
carbohydrate derivative catabolic process (GO:1901136)	183	5	9.35	-	.53	9.49E-02
viral transcription (GO:0019083)	110	3	5.62	-	.53	1.88E-01
positive regulation of leukocyte mediated immunity (GO:0002705)	110	3	5.62	-	.53	1.88E-01
monocarboxylic acid catabolic process (GO:0072329)	111	3	5.67	-	.53	1.82E-01
homologous chromosome pairing at meiosis (GO:0007129)	37	1	1.89	-	.53	4.36E-01
cardiac muscle contraction (GO:0060048)	74	2	3.78	-	.53	2.72E-01
catecholamine metabolic process (GO:0006584)	37	1	1.89	-	.53	4.36E-01
actin-myosin filament sliding (GO:0033275)	37	1	1.89	-	.53	4.36E-01
brain morphogenesis (GO:0048854)	37	1	1.89	-	.53	4.36E-01
positive regulation of type I interferon production (GO:0032481)	74	2	3.78	-	.53	2.72E-01
muscle organ morphogenesis (GO:0048644)	74	2	3.78	-	.53	2.72E-01
killing of cells of other organism (GO:0031640)	74	2	3.78	-	.53	2.72E-01
catechol-containing compound metabolic process (GO:0009712)	37	1	1.89	-	.53	4.36E-01
negative regulation of MAP kinase activity (GO:0043407)	74	2	3.78	-	.53	2.72E-01
hindbrain development (GO:0030902)	148	4	7.56	-	.53	1.27E-01
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	37	1	1.89	-	.53	4.36E-01
positive regulation of glucose metabolic process (GO:0010907)	37	1	1.89	-	.53	4.36E-01
inorganic anion transport (GO:0015698)	148	4	7.56	-	.53	1.27E-01
immunoglobulin mediated immune response (GO:0016064)	74	2	3.78	-	.53	2.72E-01
negative regulation of insulin secretion (GO:0046676)	37	1	1.89	-	.53	4.36E-01
regulation of inflammatory response to antigenic stimulus (GO:0002861)	148	4	7.56	-	.53	1.27E-01
muscle filament sliding (GO:0030049)	37	1	1.89	-	.53	4.36E-01
protein localization to microtubule cytoskeleton (GO:0072698)	37	1	1.89	-	.53	4.36E-01
pyrimidine-containing compound catabolic process (GO:0072529)	37	1	1.89	-	.53	4.36E-01
diencephalon development (GO:0021536)	75	2	3.83	-	.52	2.63E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	150	4	7.66	-	.52	1.20E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	75	2	3.83	-	.52	2.63E-01
organ growth (GO:0035265)	75	2	3.83	-	.52	2.63E-01
inorganic anion transmembrane transport (GO:0098661)	113	3	5.77	-	.52	1.72E-01
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	114	3	5.82	-	.52	1.67E-01
regulation of tissue remodeling (GO:0034103)	76	2	3.88	-	.52	2.55E-01
blastocyst formation (GO:0001825)	38	1	1.94	-	.52	4.22E-01
ceramide metabolic process (GO:0006672)	76	2	3.88	-	.52	2.55E-01
regulation of transforming growth factor beta production (GO:0071634)	38	1	1.94	-	.52	4.22E-01
positive regulation of interleukin-12 production (GO:0032735)	38	1	1.94	-	.52	4.22E-01
regulation of interleukin-8 production (GO:0032677)	76	2	3.88	-	.52	2.55E-01
response to interleukin-6 (GO:0070741)	38	1	1.94	-	.52	4.22E-01
negative regulation of G0 to G1 transition (GO:0070317)	38	1	1.94	-	.52	4.22E-01
regulation of digestive system process (GO:0044058)	38	1	1.94	-	.52	4.22E-01
glial cell activation (GO:0061900)	38	1	1.94	-	.52	4.22E-01
embryonic camera-type eye development (GO:0031076)	38	1	1.94	-	.52	4.22E-01
neuron maturation (GO:0042551)	38	1	1.94	-	.52	4.22E-01
regulation of glycoprotein biosynthetic process (GO:0010559)	38	1	1.94	-	.52	4.22E-01
positive regulation of DNA recombination (GO:0045911)	38	1	1.94	-	.52	4.22E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	307	8	15.68	-	.51	2.51E-02
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	77	2	3.93	-	.51	2.47E-01
hormone transport (GO:0009914)	77	2	3.93	-	.51	2.47E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	77	2	3.93	-	.51	2.47E-01
B cell mediated immunity (GO:0019724)	77	2	3.93	-	.51	2.47E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204)	270	7	13.79	-	.51	3.44E-02
actin filament-based movement (GO:0030048)	116	3	5.92	-	.51	1.57E-01
fatty acid oxidation (GO:0019395)	78	2	3.98	-	.50	2.40E-01
binding of sperm to zona pellucida (GO:0007339)	39	1	1.99	-	.50	4.08E-01
regulation of activated T cell proliferation (GO:0046006)	39	1	1.99	-	.50	4.08E-01
response to testosterone (GO:0033574)	39	1	1.99	-	.50	4.08E-01
viral protein processing (GO:0019082)	39	1	1.99	-	.50	4.08E-01
regulation of defense response to virus by host (GO:0050691)	39	1	1.99	-	.50	4.08E-01
histone ubiquitination (GO:0016574)	39	1	1.99	-	.50	4.08E-01
negative regulation of production of molecular mediator of immune response (GO:0002701)	39	1	1.99	-	.50	4.08E-01
positive regulation of cell-cell adhesion (GO:0022409)	275	7	14.05	-	.50	2.98E-02
neuron migration (GO:0001764)	118	3	6.03	-	.50	1.48E-01
cytosolic calcium ion transport (GO:0060401)	79	2	4.04	-	.50	2.32E-01
negative regulation of myeloid cell differentiation (GO:0045638)	79	2	4.04	-	.50	2.32E-01
regulation of leukocyte differentiation (GO:1902105)	278	7	14.20	-	.49	2.74E-02
regulation of protein targeting to mitochondrion (GO:1903214)	40	1	2.04	-	.49	3.94E-01
nucleotide transport (GO:0006862)	40	1	2.04	-	.49	3.94E-01
positive regulation of organic acid transport (GO:0032892)	40	1	2.04	-	.49	3.94E-01
endodermal cell differentiation (GO:0035987)	40	1	2.04	-	.49	3.94E-01
phototransduction (GO:0007602)	40	1	2.04	-	.49	3.94E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	201	5	10.27	-	.49	5.66E-02
cell fate specification (GO:0001708)	81	2	4.14	-	.48	2.18E-01
positive regulation of cell cycle arrest (GO:0071158)	81	2	4.14	-	.48	2.18E-01
regulation of Rho protein signal transduction (GO:0035023)	81	2	4.14	-	.48	2.18E-01
digestive tract development (GO:0048565)	122	3	6.23	-	.48	1.31E-01
negative regulation of endothelial cell proliferation (GO:0001937)	41	1	2.09	-	.48	3.81E-01
cell-substrate junction assembly (GO:0007044)	41	1	2.09	-	.48	3.81E-01
inner mitochondrial membrane organization (GO:0007007)	41	1	2.09	-	.48	3.81E-01
negative regulation of signaling receptor activity (GO:2000272)	41	1	2.09	-	.48	3.81E-01
cellular response to calcium ion (GO:0071277)	82	2	4.19	-	.48	2.11E-01
protein localization to cytoskeleton (GO:0044380)	41	1	2.09	-	.48	3.81E-01
regulation of G0 to G1 transition (GO:0070316)	41	1	2.09	-	.48	3.81E-01
neuroinflammatory response (GO:0150076)	41	1	2.09	-	.48	3.81E-01
cellular modified amino acid biosynthetic process (GO:0042398)	41	1	2.09	-	.48	3.81E-01
kidney morphogenesis (GO:0060993)	82	2	4.19	-	.48	2.11E-01
response to nicotine (GO:0035094)	41	1	2.09	-	.48	3.81E-01
lipid oxidation (GO:0034440)	82	2	4.19	-	.48	2.11E-01
macroautophagy (GO:0016236)	166	4	8.48	-	.47	7.43E-02
cyclic-nucleotide-mediated signaling (GO:0019935)	166	4	8.48	-	.47	7.43E-02
regulation of epithelial cell apoptotic process (GO:1904035)	83	2	4.24	-	.47	2.04E-01
negative regulation of immune effector process (GO:0002698)	125	3	6.38	-	.47	1.19E-01
cell fate determination (GO:0001709)	42	1	2.15	-	.47	3.68E-01
branching involved in ureteric bud morphogenesis (GO:0001658)	42	1	2.15	-	.47	3.68E-01
ureteric bud development (GO:0001657)	84	2	4.29	-	.47	1.98E-01
pyrimidine nucleotide metabolic process (GO:0006220)	42	1	2.15	-	.47	3.68E-01
negative regulation of peptide hormone secretion (GO:0090278)	42	1	2.15	-	.47	3.68E-01
positive chemotaxis (GO:0050918)	42	1	2.15	-	.47	3.68E-01
musculoskeletal movement (GO:0050881)	42	1	2.15	-	.47	3.68E-01
multicellular organismal movement (GO:0050879)	42	1	2.15	-	.47	3.68E-01
import across plasma membrane (GO:0098739)	126	3	6.44	-	.47	1.15E-01
response to pH (GO:0009268)	42	1	2.15	-	.47	3.68E-01
cell-substrate junction organization (GO:0150115)	42	1	2.15	-	.47	3.68E-01
regulation of smoothened signaling pathway (GO:0008589)	84	2	4.29	-	.47	1.98E-01
positive regulation of glucose transmembrane transport (GO:0010828)	42	1	2.15	-	.47	3.68E-01
regulation of membrane depolarization (GO:0003254)	42	1	2.15	-	.47	3.68E-01
respiratory gaseous exchange by respiratory system (GO:0007585)	42	1	2.15	-	.47	3.68E-01
mesonephric tubule development (GO:0072164)	85	2	4.34	-	.46	1.91E-01
mesonephric epithelium development (GO:0072163)	85	2	4.34	-	.46	1.91E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	85	2	4.34	-	.46	1.91E-01
negative regulation of T cell differentiation (GO:0045581)	43	1	2.20	-	.46	3.55E-01
regulation of glycoprotein metabolic process (GO:1903018)	43	1	2.20	-	.46	3.55E-01
glutathione metabolic process (GO:0006749)	43	1	2.20	-	.46	3.55E-01
heart contraction (GO:0060047)	86	2	4.39	-	.46	1.85E-01
cellular extravasation (GO:0045123)	43	1	2.20	-	.46	3.55E-01
microtubule bundle formation (GO:0001578)	86	2	4.39	-	.46	1.85E-01
cellular response to epidermal growth factor stimulus (GO:0071364)	43	1	2.20	-	.46	3.55E-01
ceramide biosynthetic process (GO:0046513)	43	1	2.20	-	.46	3.55E-01
regulation of cytokine production involved in immune response (GO:0002718)	86	2	4.39	-	.46	1.85E-01
neuromuscular junction development (GO:0007528)	43	1	2.20	-	.46	3.55E-01
negative regulation of GTPase activity (GO:0034260)	43	1	2.20	-	.46	3.55E-01
actin-mediated cell contraction (GO:0070252)	87	2	4.44	-	.45	1.79E-01
defense response to bacterium (GO:0042742)	218	5	11.13	-	.45	3.38E-02
cation transmembrane transport (GO:0098655)	571	13	29.16	-	.45	5.60E-04
regulation of cytosolic calcium ion concentration (GO:0051480)	308	7	15.73	-	.44	1.12E-02
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	44	1	2.25	-	.44	3.43E-01
segmentation (GO:0035282)	88	2	4.49	-	.44	1.73E-01
negative regulation of epithelial cell apoptotic process (GO:1904036)	44	1	2.25	-	.44	3.43E-01
regulation of amine transport (GO:0051952)	89	2	4.55	-	.44	1.68E-01
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	224	5	11.44	-	.44	2.80E-02
regulation of cell adhesion mediated by integrin (GO:0033628)	45	1	2.30	-	.44	3.31E-01
glutamate receptor signaling pathway (GO:0007215)	45	1	2.30	-	.44	3.31E-01
negative regulation of interleukin-6 production (GO:0032715)	45	1	2.30	-	.44	3.31E-01
protein destabilization (GO:0031648)	45	1	2.30	-	.44	3.31E-01
autonomic nervous system development (GO:0048483)	45	1	2.30	-	.44	3.31E-01
plasma membrane invagination (GO:0099024)	45	1	2.30	-	.44	3.31E-01
positive regulation of alpha-beta T cell differentiation (GO:0046638)	45	1	2.30	-	.44	3.31E-01
positive regulation of organ growth (GO:0046622)	45	1	2.30	-	.44	3.31E-01
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	45	1	2.30	-	.44	3.31E-01
positive regulation of lymphocyte proliferation (GO:0050671)	136	3	6.95	-	.43	8.37E-02
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	136	3	6.95	-	.43	8.37E-02
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	91	2	4.65	-	.43	1.57E-01
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	91	2	4.65	-	.43	1.57E-01
positive regulation of mononuclear cell proliferation (GO:0032946)	137	3	7.00	-	.43	8.10E-02
negative regulation of cell cycle G2/M phase transition (GO:1902750)	92	2	4.70	-	.43	1.52E-01
response to dsRNA (GO:0043331)	46	1	2.35	-	.43	3.19E-01
positive regulation of lymphocyte mediated immunity (GO:0002708)	92	2	4.70	-	.43	1.52E-01
antimicrobial humoral response (GO:0019730)	138	3	7.05	-	.43	7.84E-02
inorganic ion transmembrane transport (GO:0098660)	600	13	30.65	-	.42	2.27E-04
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	185	4	9.45	-	.42	4.08E-02
nervous system process (GO:0050877)	976	21	49.85	-	.42	1.93E-06
integrin-mediated signaling pathway (GO:0007229)	93	2	4.75	-	.42	1.47E-01
regulation of lipase activity (GO:0060191)	93	2	4.75	-	.42	1.47E-01
action potential (GO:0001508)	93	2	4.75	-	.42	1.47E-01
inorganic cation transmembrane transport (GO:0098662)	512	11	26.15	-	.42	6.16E-04
regulation of tumor necrosis factor production (GO:0032680)	140	3	7.15	-	.42	7.34E-02
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	47	1	2.40	-	.42	3.08E-01
chloride transmembrane transport (GO:1902476)	94	2	4.80	-	.42	1.42E-01
response to epidermal growth factor (GO:0070849)	47	1	2.40	-	.42	3.08E-01
regulation of DNA-dependent DNA replication (GO:0090329)	47	1	2.40	-	.42	3.08E-01
regulation of lyase activity (GO:0051339)	47	1	2.40	-	.42	3.08E-01
response to cocaine (GO:0042220)	47	1	2.40	-	.42	3.08E-01
negative regulation of Ras protein signal transduction (GO:0046580)	47	1	2.40	-	.42	3.08E-01
cell recognition (GO:0008037)	142	3	7.25	-	.41	6.87E-02
humoral immune response (GO:0006959)	237	5	12.11	-	.41	1.84E-02
pigment biosynthetic process (GO:0046148)	48	1	2.45	-	.41	2.97E-01
cellular defense response (GO:0006968)	48	1	2.45	-	.41	2.97E-01
intracellular protein transmembrane transport (GO:0065002)	48	1	2.45	-	.41	2.97E-01
export across plasma membrane (GO:0140115)	48	1	2.45	-	.41	2.97E-01
neuron apoptotic process (GO:0051402)	48	1	2.45	-	.41	2.97E-01
endocrine process (GO:0050886)	48	1	2.45	-	.41	2.97E-01
establishment of spindle localization (GO:0051293)	48	1	2.45	-	.41	2.97E-01
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	48	1	2.45	-	.41	2.97E-01
positive regulation of T cell mediated immunity (GO:0002711)	48	1	2.45	-	.41	2.97E-01
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	144	3	7.36	-	.41	6.42E-02
neuromuscular process (GO:0050905)	97	2	4.95	-	.40	1.28E-01
smooth muscle contraction (GO:0006939)	49	1	2.50	-	.40	2.86E-01
endothelial cell development (GO:0001885)	49	1	2.50	-	.40	2.86E-01
regulation of postsynaptic membrane potential (GO:0060078)	98	2	5.01	-	.40	1.23E-01
membrane depolarization (GO:0051899)	49	1	2.50	-	.40	2.86E-01
positive regulation of nuclear division (GO:0051785)	49	1	2.50	-	.40	2.86E-01
presynaptic endocytosis (GO:0140238)	49	1	2.50	-	.40	2.86E-01
positive regulation of leukocyte proliferation (GO:0070665)	147	3	7.51	-	.40	5.80E-02
regulation of chondrocyte differentiation (GO:0032330)	49	1	2.50	-	.40	2.86E-01
synaptic vesicle endocytosis (GO:0048488)	49	1	2.50	-	.40	2.86E-01
forebrain neuron differentiation (GO:0021879)	49	1	2.50	-	.40	2.86E-01
heart process (GO:0003015)	99	2	5.06	-	.40	1.19E-01
regulation of cell killing (GO:0031341)	99	2	5.06	-	.40	1.19E-01
regulation of mononuclear cell migration (GO:0071675)	50	1	2.55	-	.39	2.76E-01
endoderm formation (GO:0001706)	50	1	2.55	-	.39	2.76E-01
regulation of DNA replication (GO:0006275)	100	2	5.11	-	.39	1.15E-01
muscle fiber development (GO:0048747)	50	1	2.55	-	.39	2.76E-01
negative regulation of ERBB signaling pathway (GO:1901185)	50	1	2.55	-	.39	2.76E-01
regulation of cytokine production involved in inflammatory response (GO:1900015)	50	1	2.55	-	.39	2.76E-01
keratinocyte differentiation (GO:0030216)	201	4	10.27	-	.39	2.40E-02
visual perception (GO:0007601)	201	4	10.27	-	.39	2.40E-02
chloride transport (GO:0006821)	101	2	5.16	-	.39	1.11E-01
sensory perception of light stimulus (GO:0050953)	202	4	10.32	-	.39	2.32E-02
regulation of receptor-mediated endocytosis (GO:0048259)	101	2	5.16	-	.39	1.11E-01
detection of stimulus (GO:0051606)	355	7	18.13	-	.39	2.46E-03
spinal cord development (GO:0021510)	102	2	5.21	-	.38	1.07E-01
cellular transition metal ion homeostasis (GO:0046916)	102	2	5.21	-	.38	1.07E-01
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	51	1	2.60	-	.38	2.66E-01
regulation of interferon-gamma production (GO:0032649)	104	2	5.31	-	.38	1.00E-01
positive regulation of neural precursor cell proliferation (GO:2000179)	52	1	2.66	-	.38	2.56E-01
protein insertion into membrane (GO:0051205)	52	1	2.66	-	.38	2.56E-01
ureteric bud morphogenesis (GO:0060675)	52	1	2.66	-	.38	2.56E-01
membrane invagination (GO:0010324)	52	1	2.66	-	.38	2.56E-01
positive regulation of regulated secretory pathway (GO:1903307)	52	1	2.66	-	.38	2.56E-01
negative regulation of lymphocyte differentiation (GO:0045620)	53	1	2.71	-	.37	2.47E-01
mesonephric tubule morphogenesis (GO:0072171)	53	1	2.71	-	.37	2.47E-01
spindle localization (GO:0051653)	53	1	2.71	-	.37	2.47E-01
monovalent inorganic cation transport (GO:0015672)	372	7	19.00	-	.37	1.38E-03
NADH dehydrogenase complex assembly (GO:0010257)	54	1	2.76	-	.36	2.38E-01
mitochondrial respiratory chain complex I assembly (GO:0032981)	54	1	2.76	-	.36	2.38E-01
collagen metabolic process (GO:0032963)	54	1	2.76	-	.36	2.38E-01
astrocyte differentiation (GO:0048708)	54	1	2.76	-	.36	2.38E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058)	54	1	2.76	-	.36	2.38E-01
positive regulation of receptor-mediated endocytosis (GO:0048260)	54	1	2.76	-	.36	2.38E-01
sodium ion transport (GO:0006814)	163	3	8.33	-	.36	3.33E-02
regulation of T cell proliferation (GO:0042129)	163	3	8.33	-	.36	3.33E-02
metencephalon development (GO:0022037)	109	2	5.57	-	.36	8.36E-02
cell differentiation in spinal cord (GO:0021515)	55	1	2.81	-	.36	2.29E-01
positive regulation of interleukin-8 production (GO:0032757)	55	1	2.81	-	.36	2.29E-01
negative regulation of viral genome replication (GO:0045071)	55	1	2.81	-	.36	2.29E-01
sperm-egg recognition (GO:0035036)	55	1	2.81	-	.36	2.29E-01
ventricular cardiac muscle tissue development (GO:0003229)	55	1	2.81	-	.36	2.29E-01
positive regulation of cytokine production involved in immune response (GO:0002720)	55	1	2.81	-	.36	2.29E-01
positive regulation of anion transport (GO:1903793)	56	1	2.86	-	.35	2.20E-01
macrophage activation (GO:0042116)	56	1	2.86	-	.35	2.20E-01
peptide hormone secretion (GO:0030072)	56	1	2.86	-	.35	2.20E-01
positive regulation of protein tyrosine kinase activity (GO:0061098)	56	1	2.86	-	.35	2.20E-01
retina morphogenesis in camera-type eye (GO:0060042)	57	1	2.91	-	.34	2.12E-01
sensory perception of taste (GO:0050909)	57	1	2.91	-	.34	2.12E-01
detection of light stimulus (GO:0009583)	57	1	2.91	-	.34	2.12E-01
regulation of interleukin-12 production (GO:0032655)	58	1	2.96	-	.34	2.04E-01
sodium ion transmembrane transport (GO:0035725)	116	2	5.92	-	.34	6.47E-02
extracellular matrix organization (GO:0030198)	348	6	17.77	-	.34	1.12E-03
negative regulation of innate immune response (GO:0045824)	58	1	2.96	-	.34	2.04E-01
extracellular structure organization (GO:0043062)	349	6	17.83	-	.34	1.08E-03
sensory perception (GO:0007600)	584	10	29.83	-	.34	1.96E-05
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	235	4	12.00	-	.33	7.28E-03
myeloid leukocyte differentiation (GO:0002573)	118	2	6.03	-	.33	6.01E-02
regulation of myeloid leukocyte differentiation (GO:0002761)	119	2	6.08	-	.33	5.79E-02
positive regulation of alpha-beta T cell activation (GO:0046635)	60	1	3.06	-	.33	1.89E-01
positive regulation of phospholipase activity (GO:0010518)	60	1	3.06	-	.33	1.89E-01
leukocyte migration (GO:0050900)	303	5	15.48	-	.32	1.87E-03
excitatory postsynaptic potential (GO:0060079)	61	1	3.12	-	.32	1.82E-01
neuron fate commitment (GO:0048663)	61	1	3.12	-	.32	1.82E-01
S phase (GO:0051320)	61	1	3.12	-	.32	1.82E-01
mitotic S phase (GO:0000084)	61	1	3.12	-	.32	1.82E-01
forebrain generation of neurons (GO:0021872)	61	1	3.12	-	.32	1.82E-01
sensory perception of chemical stimulus (GO:0007606)	186	3	9.50	-	.32	1.45E-02
sensory perception of smell (GO:0007608)	124	2	6.33	-	.32	4.80E-02
cardiac ventricle development (GO:0003231)	124	2	6.33	-	.32	4.80E-02
cell chemotaxis (GO:0060326)	188	3	9.60	-	.31	1.34E-02
locomotory behavior (GO:0007626)	188	3	9.60	-	.31	1.34E-02
nucleotide catabolic process (GO:0009166)	63	1	3.22	-	.31	1.68E-01
lymphocyte migration (GO:0072676)	63	1	3.22	-	.31	1.68E-01
pigment metabolic process (GO:0042440)	64	1	3.27	-	.31	1.62E-01
neural retina development (GO:0003407)	64	1	3.27	-	.31	1.62E-01
G protein-coupled receptor signaling pathway (GO:0007186)	907	14	46.33	-	.30	1.33E-08
receptor internalization (GO:0031623)	65	1	3.32	-	.30	1.56E-01
regulation of defense response to virus (GO:0050688)	65	1	3.32	-	.30	1.56E-01
regulation of osteoclast differentiation (GO:0045670)	66	1	3.37	-	.30	1.50E-01
chemical synaptic transmission, postsynaptic (GO:0099565)	66	1	3.37	-	.30	1.50E-01
positive regulation of interferon-gamma production (GO:0032729)	67	1	3.42	-	.29	1.44E-01
adult behavior (GO:0030534)	134	2	6.84	-	.29	3.28E-02
pancreas development (GO:0031016)	68	1	3.47	-	.29	1.38E-01
regulation of phospholipase activity (GO:0010517)	69	1	3.52	-	.28	1.33E-01
regulation of hematopoietic stem cell differentiation (GO:1902036)	70	1	3.58	-	.28	1.28E-01
sensory perception of sound (GO:0007605)	142	2	7.25	-	.28	2.40E-02
sensory perception of pain (GO:0019233)	72	1	3.68	-	.27	1.18E-01
cell-cell recognition (GO:0009988)	72	1	3.68	-	.27	1.18E-01
chemokine-mediated signaling pathway (GO:0070098)	72	1	3.68	-	.27	1.18E-01
cardiac ventricle morphogenesis (GO:0003208)	72	1	3.68	-	.27	1.18E-01
nerve development (GO:0021675)	73	1	3.73	-	.27	1.13E-01
nucleoside phosphate catabolic process (GO:1901292)	73	1	3.73	-	.27	1.13E-01
neural precursor cell proliferation (GO:0061351)	73	1	3.73	-	.27	1.13E-01
regulation of cell shape (GO:0008360)	148	2	7.56	-	.26	1.90E-02
somite development (GO:0061053)	74	1	3.78	-	.26	1.09E-01
regulation of signaling receptor activity (GO:0010469)	150	2	7.66	-	.26	1.75E-02
positive regulation of carbohydrate metabolic process (GO:0045913)	75	1	3.83	-	.26	1.04E-01
dicarboxylic acid transport (GO:0006835)	76	1	3.88	-	.26	1.00E-01
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	76	1	3.88	-	.26	1.00E-01
dorsal/ventral pattern formation (GO:0009953)	77	1	3.93	-	.25	9.61E-02
pyrimidine-containing compound metabolic process (GO:0072527)	77	1	3.93	-	.25	9.61E-02
regulation of neurotransmitter receptor activity (GO:0099601)	78	1	3.98	-	.25	9.22E-02
sphingolipid biosynthetic process (GO:0030148)	78	1	3.98	-	.25	9.22E-02
regulation of chemokine production (GO:0032642)	79	1	4.04	-	.25	8.85E-02
sensory perception of mechanical stimulus (GO:0050954)	159	2	8.12	-	.25	1.22E-02
cellular response to chemokine (GO:1990869)	81	1	4.14	-	.24	8.15E-02
response to chemokine (GO:1990868)	81	1	4.14	-	.24	8.15E-02
regulation of cellular amine metabolic process (GO:0033238)	81	1	4.14	-	.24	8.15E-02
metanephros development (GO:0001656)	81	1	4.14	-	.24	8.15E-02
feeding behavior (GO:0007631)	82	1	4.19	-	.24	7.82E-02
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	83	1	4.24	-	.24	7.50E-02
positive regulation of tumor necrosis factor production (GO:0032760)	84	1	4.29	-	.23	7.20E-02
protein targeting to membrane (GO:0006612)	170	2	8.68	-	.23	7.81E-03
pigmentation (GO:0043473)	85	1	4.34	-	.23	6.90E-02
detection of chemical stimulus (GO:0009593)	172	2	8.79	-	.23	7.19E-03
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	87	1	4.44	-	.23	6.35E-02
respiratory electron transport chain (GO:0022904)	90	1	4.60	-	.22	5.60E-02
hematopoietic progenitor cell differentiation (GO:0002244)	92	1	4.70	-	.21	5.14E-02
oxidative phosphorylation (GO:0006119)	93	1	4.75	-	.21	4.93E-02
cerebellum development (GO:0021549)	99	1	5.06	-	.20	3.82E-02
negative regulation of leukocyte differentiation (GO:1902106)	100	1	5.11	-	.20	3.66E-02
negative regulation of hemopoiesis (GO:1903707)	101	1	5.16	-	.19	3.50E-02
nucleobase-containing small molecule biosynthetic process (GO:0034404)	102	1	5.21	-	.19	3.35E-02
reactive oxygen species metabolic process (GO:0072593)	108	1	5.52	-	.18	2.59E-02
detection of external stimulus (GO:0009581)	123	1	6.28	-	.16	1.34E-02
detection of abiotic stimulus (GO:0009582)	125	1	6.38	-	.16	1.22E-02
leukocyte chemotaxis (GO:0030595)	132	1	6.74	-	.15	8.95E-03
protein localization to endoplasmic reticulum (GO:0070972)	136	1	6.95	-	.14	7.48E-03
keratinization (GO:0031424)	159	1	8.12	-	.12	2.63E-03
respiratory burst involved in defense response (GO:0002679)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of chronic inflammatory response (GO:0002678)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of chronic inflammatory response (GO:0002677)	5	0	.26	-	 < 0.01	7.75E-01
regulation of chronic inflammatory response (GO:0002676)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of acute inflammatory response (GO:0002674)	13	0	.66	-	 < 0.01	5.15E-01
quinolinate catabolic process (GO:0034213)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of T cell anergy (GO:0002669)	4	0	.20	-	 < 0.01	8.15E-01
regulation of T cell anergy (GO:0002667)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of T cell tolerance induction (GO:0002666)	8	0	.41	-	 < 0.01	6.65E-01
regulation of T cell tolerance induction (GO:0002664)	12	0	.61	-	 < 0.01	5.42E-01
detoxification of copper ion (GO:0010273)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of B cell tolerance induction (GO:0002663)	2	0	.10	-	 < 0.01	9.03E-01
response to silver ion (GO:0010272)	1	0	.05	-	 < 0.01	9.50E-01
regulation of B cell tolerance induction (GO:0002661)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of peripheral tolerance induction (GO:0002660)	2	0	.10	-	 < 0.01	9.03E-01
glycolipid translocation (GO:0034203)	1	0	.05	-	 < 0.01	9.50E-01
response to oleic acid (GO:0034201)	6	0	.31	-	 < 0.01	7.36E-01
response to selenium ion (GO:0010269)	10	0	.51	-	 < 0.01	6.00E-01
regulation of peripheral tolerance induction (GO:0002658)	2	0	.10	-	 < 0.01	9.03E-01
response to vitamin B1 (GO:0010266)	2	0	.10	-	 < 0.01	9.03E-01
SCF complex assembly (GO:0010265)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of tolerance induction dependent upon immune response (GO:0002654)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tolerance induction dependent upon immune response (GO:0002652)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of tolerance induction to self antigen (GO:0002651)	1	0	.05	-	 < 0.01	9.50E-01
animal organ senescence (GO:0010260)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of chromatin assembly or disassembly (GO:0045799)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of chromatin assembly or disassembly (GO:0045798)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of intestinal cholesterol absorption (GO:0045796)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell volume (GO:0045795)	1	0	.05	-	 < 0.01	9.50E-01
regulation of tolerance induction to self antigen (GO:0002649)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of central tolerance induction (GO:0002648)	1	0	.05	-	 < 0.01	9.50E-01
regulation of central tolerance induction (GO:0002646)	1	0	.05	-	 < 0.01	9.50E-01
glucose mediated signaling pathway (GO:0010255)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of tolerance induction (GO:0002645)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of tolerance induction (GO:0002644)	1	0	.05	-	 < 0.01	9.50E-01
regulation of tolerance induction (GO:0002643)	18	0	.92	-	 < 0.01	3.99E-01
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of germinal center formation (GO:0002636)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of germinal center formation (GO:0002635)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of bone resorption (GO:0045779)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of blood pressure (GO:0045777)	39	0	1.99	-	 < 0.01	1.36E-01
negative regulation of T cell antigen processing and presentation (GO:0002626)	1	0	.05	-	 < 0.01	9.50E-01
regulation of T cell antigen processing and presentation (GO:0002625)	2	0	.10	-	 < 0.01	9.03E-01
regulation of B cell antigen processing and presentation (GO:0002622)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of asymmetric cell division (GO:0045769)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular amino acid metabolic process (GO:0045764)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cellular amino acid metabolic process (GO:0045763)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of adenylate cyclase activity (GO:0045762)	10	0	.51	-	 < 0.01	6.00E-01
regulation of adenylate cyclase activity (GO:0045761)	31	0	1.58	-	 < 0.01	2.05E-01
positive regulation of action potential (GO:0045760)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of macrophage antigen processing and presentation (GO:0002617)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macrophage antigen processing and presentation (GO:0002616)	1	0	.05	-	 < 0.01	9.50E-01
response to UV-B (GO:0010224)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation of action potential (GO:0045759)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of Toll signaling pathway (GO:0045751)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of DNA methylation (GO:0010216)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	4	0	.20	-	 < 0.01	8.15E-01
regulation of dendritic cell antigen processing and presentation (GO:0002604)	11	0	.56	-	 < 0.01	5.70E-01
regulation of hexokinase activity (GO:1903299)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	5	0	.26	-	 < 0.01	7.75E-01
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	27	0	1.38	-	 < 0.01	2.52E-01
regulation of glutamate secretion, neurotransmission (GO:1903294)	3	0	.15	-	 < 0.01	8.58E-01
protein localization to Golgi membrane (GO:1903292)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	11	0	.56	-	 < 0.01	5.70E-01
arginine catabolic process to proline (GO:0019493)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	28	0	1.43	-	 < 0.01	2.39E-01
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of calcium:sodium antiporter activity (GO:1903281)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of calcium:sodium antiporter activity (GO:1903280)	1	0	.05	-	 < 0.01	9.50E-01
respiratory burst (GO:0045730)	17	0	.87	-	 < 0.01	4.19E-01
forebrain dorsal/ventral pattern formation (GO:0021798)	7	0	.36	-	 < 0.01	6.99E-01
forebrain anterior/posterior pattern specification (GO:0021797)	3	0	.15	-	 < 0.01	8.58E-01
chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.05	-	 < 0.01	9.50E-01
regulation of calcium:sodium antiporter activity (GO:1903279)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of sodium ion export across plasma membrane (GO:1903278)	4	0	.20	-	 < 0.01	8.15E-01
respiratory burst after phagocytosis (GO:0045728)	2	0	.10	-	 < 0.01	9.03E-01
beta-alanine biosynthetic process (GO:0019483)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sodium ion export across plasma membrane (GO:1903276)	4	0	.20	-	 < 0.01	8.15E-01
beta-alanine metabolic process (GO:0019482)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of integrin biosynthetic process (GO:0045726)	3	0	.15	-	 < 0.01	8.58E-01
L-alanine catabolic process, by transamination (GO:0019481)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of gluconeogenesis (GO:0045722)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of integrin biosynthetic process (GO:0045720)	2	0	.10	-	 < 0.01	9.03E-01
postganglionic parasympathetic fiber development (GO:0021784)	2	0	.10	-	 < 0.01	9.03E-01
preganglionic parasympathetic fiber development (GO:0021783)	15	0	.77	-	 < 0.01	4.65E-01
D-amino acid catabolic process (GO:0019478)	2	0	.10	-	 < 0.01	9.03E-01
glial cell fate commitment (GO:0021781)	14	0	.72	-	 < 0.01	4.89E-01
L-lysine catabolic process (GO:0019477)	4	0	.20	-	 < 0.01	8.15E-01
glial cell fate specification (GO:0021780)	5	0	.26	-	 < 0.01	7.75E-01
L-lysine catabolic process to acetyl-CoA (GO:0019474)	4	0	.20	-	 < 0.01	8.15E-01
oligodendrocyte cell fate commitment (GO:0021779)	5	0	.26	-	 < 0.01	7.75E-01
oligodendrocyte cell fate specification (GO:0021778)	5	0	.26	-	 < 0.01	7.75E-01
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	2	0	.10	-	 < 0.01	9.03E-01
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	2	0	.10	-	 < 0.01	9.03E-01
striatal medium spiny neuron differentiation (GO:0021773)	4	0	.20	-	 < 0.01	8.15E-01
lateral geniculate nucleus development (GO:0021771)	1	0	.05	-	 < 0.01	9.50E-01
exon-exon junction complex disassembly (GO:1903259)	1	0	.05	-	 < 0.01	9.50E-01
glycine decarboxylation via glycine cleavage system (GO:0019464)	3	0	.15	-	 < 0.01	8.58E-01
multi-ciliated epithelial cell differentiation (GO:1903251)	8	0	.41	-	 < 0.01	6.65E-01
posterior midgut development (GO:0007497)	2	0	.10	-	 < 0.01	9.03E-01
visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495)	1	0	.05	-	 < 0.01	9.50E-01
midgut development (GO:0007494)	13	0	.66	-	 < 0.01	5.15E-01
endodermal cell fate determination (GO:0007493)	2	0	.10	-	 < 0.01	9.03E-01
orbitofrontal cortex development (GO:0021769)	4	0	.20	-	 < 0.01	8.15E-01
nucleus accumbens development (GO:0021768)	1	0	.05	-	 < 0.01	9.50E-01
mammillary body development (GO:0021767)	2	0	.10	-	 < 0.01	9.03E-01
amygdala development (GO:0021764)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of citrulline biosynthetic process (GO:1903249)	1	0	.05	-	 < 0.01	9.50E-01
regulation of citrulline biosynthetic process (GO:1903248)	1	0	.05	-	 < 0.01	9.50E-01
L-cysteine catabolic process to taurine (GO:0019452)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	8	0	.41	-	 < 0.01	6.65E-01
globus pallidus development (GO:0021759)	4	0	.20	-	 < 0.01	8.15E-01
putamen development (GO:0021758)	1	0	.05	-	 < 0.01	9.50E-01
caudate nucleus development (GO:0021757)	1	0	.05	-	 < 0.01	9.50E-01
pronephric duct morphogenesis (GO:0039023)	1	0	.05	-	 < 0.01	9.50E-01
striatum development (GO:0021756)	19	0	.97	-	 < 0.01	3.79E-01
pronephric duct development (GO:0039022)	1	0	.05	-	 < 0.01	9.50E-01
facial nucleus development (GO:0021754)	1	0	.05	-	 < 0.01	9.50E-01
pronephric nephron tubule development (GO:0039020)	2	0	.10	-	 < 0.01	9.03E-01
L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.05	-	 < 0.01	9.50E-01
L-cysteine catabolic process (GO:0019448)	4	0	.20	-	 < 0.01	8.15E-01
vestibular nucleus development (GO:0021750)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of leukocyte tethering or rolling (GO:1903238)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of leukocyte tethering or rolling (GO:1903237)	4	0	.20	-	 < 0.01	8.15E-01
regulation of leukocyte tethering or rolling (GO:1903236)	14	0	.72	-	 < 0.01	4.89E-01
tryptophan catabolic process to acetyl-CoA (GO:0019442)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235)	1	0	.05	-	 < 0.01	9.50E-01
tryptophan catabolic process to kynurenine (GO:0019441)	5	0	.26	-	 < 0.01	7.75E-01
melanosome assembly (GO:1903232)	4	0	.20	-	 < 0.01	8.15E-01
pronephric nephron development (GO:0039019)	3	0	.15	-	 < 0.01	8.58E-01
pattern specification involved in pronephros development (GO:0039017)	2	0	.10	-	 < 0.01	9.03E-01
embryonic skeletal joint development (GO:0072498)	14	0	.72	-	 < 0.01	4.89E-01
principal sensory nucleus of trigeminal nerve development (GO:0021740)	2	0	.10	-	 < 0.01	9.03E-01
mesenchymal stem cell differentiation (GO:0072497)	3	0	.15	-	 < 0.01	8.58E-01
triglyceride catabolic process (GO:0019433)	25	0	1.28	-	 < 0.01	2.79E-01
triglyceride biosynthetic process (GO:0019432)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of endodermal cell differentiation (GO:1903225)	3	0	.15	-	 < 0.01	8.58E-01
regulation of endodermal cell differentiation (GO:1903224)	4	0	.20	-	 < 0.01	8.15E-01
removal of superoxide radicals (GO:0019430)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of oxidative stress-induced neuron death (GO:1903223)	7	0	.36	-	 < 0.01	6.99E-01
regulation of rhodopsin gene expression (GO:0007468)	4	0	.20	-	 < 0.01	8.15E-01
pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.05	-	 < 0.01	9.50E-01
pronephric nephron morphogenesis (GO:0039007)	1	0	.05	-	 < 0.01	9.50E-01
pronephric field specification (GO:0039003)	2	0	.10	-	 < 0.01	9.03E-01
midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.05	-	 < 0.01	9.50E-01
ammonium transmembrane transport (GO:0072488)	10	0	.51	-	 < 0.01	6.00E-01
acetyl-CoA biosynthetic process from acetate (GO:0019427)	2	0	.10	-	 < 0.01	9.03E-01
trigeminal sensory nucleus development (GO:0021730)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein targeting to mitochondrion (GO:1903215)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of the force of heart contraction by chemical signal (GO:0003099)	3	0	.15	-	 < 0.01	8.58E-01
renal sodium ion transport (GO:0003096)	7	0	.36	-	 < 0.01	6.99E-01
pressure natriuresis (GO:0003095)	3	0	.15	-	 < 0.01	8.58E-01
glomerular filtration (GO:0003094)	11	0	.56	-	 < 0.01	5.70E-01
regulation of glomerular filtration (GO:0003093)	11	0	.56	-	 < 0.01	5.70E-01
superior olivary nucleus maturation (GO:0021722)	2	0	.10	-	 < 0.01	9.03E-01
sulfide oxidation (GO:0019418)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	6	0	.31	-	 < 0.01	7.36E-01
regulation of hydrogen peroxide-induced neuron death (GO:1903207)	6	0	.31	-	 < 0.01	7.36E-01
acetate biosynthetic process (GO:0019413)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	17	0	.87	-	 < 0.01	4.19E-01
regulation of hydrogen peroxide-induced cell death (GO:1903205)	22	0	1.12	-	 < 0.01	3.25E-01
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.05	-	 < 0.01	9.50E-01
hindgut morphogenesis (GO:0007442)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of systemic arterial blood pressure (GO:0003084)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of renal output by angiotensin (GO:0003083)	1	0	.05	-	 < 0.01	9.50E-01
superior olivary nucleus development (GO:0021718)	2	0	.10	-	 < 0.01	9.03E-01
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	24	0	1.23	-	 < 0.01	2.93E-01
negative regulation of behavioral fear response (GO:2000986)	1	0	.05	-	 < 0.01	9.50E-01
hexitol catabolic process (GO:0019407)	1	0	.05	-	 < 0.01	9.50E-01
hexitol biosynthetic process (GO:0019406)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ATP citrate synthase activity (GO:2000984)	1	0	.05	-	 < 0.01	9.50E-01
alditol catabolic process (GO:0019405)	6	0	.31	-	 < 0.01	7.36E-01
regulation of ATP citrate synthase activity (GO:2000983)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of inner ear receptor cell differentiation (GO:2000982)	1	0	.05	-	 < 0.01	9.50E-01
galactitol metabolic process (GO:0019402)	1	0	.05	-	 < 0.01	9.50E-01
alditol biosynthetic process (GO:0019401)	6	0	.31	-	 < 0.01	7.36E-01
ectodermal digestive tract development (GO:0007439)	2	0	.10	-	 < 0.01	9.03E-01
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.05	-	 < 0.01	9.50E-01
cell-cell signaling involved in lung development (GO:0060495)	1	0	.05	-	 < 0.01	9.50E-01
lateral sprouting involved in lung morphogenesis (GO:0060490)	1	0	.05	-	 < 0.01	9.50E-01
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	5	0	.26	-	 < 0.01	7.75E-01
cerebellar granule cell differentiation (GO:0021707)	7	0	.36	-	 < 0.01	6.99E-01
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	24	0	1.23	-	 < 0.01	2.93E-01
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.05	-	 < 0.01	9.50E-01
locus ceruleus development (GO:0021703)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of forebrain neuron differentiation (GO:2000978)	3	0	.15	-	 < 0.01	8.58E-01
cerebellar Purkinje cell differentiation (GO:0021702)	13	0	.66	-	 < 0.01	5.15E-01
regulation of forebrain neuron differentiation (GO:2000977)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of detection of glucose (GO:2000971)	1	0	.05	-	 < 0.01	9.50E-01
regulation of detection of glucose (GO:2000970)	1	0	.05	-	 < 0.01	9.50E-01
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	1	0	.05	-	 < 0.01	9.50E-01
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	1	0	.05	-	 < 0.01	9.50E-01
club cell differentiation (GO:0060486)	4	0	.20	-	 < 0.01	8.15E-01
lung-associated mesenchyme development (GO:0060484)	8	0	.41	-	 < 0.01	6.65E-01
lobar bronchus development (GO:0060482)	5	0	.26	-	 < 0.01	7.75E-01
lobar bronchus epithelium development (GO:0060481)	4	0	.20	-	 < 0.01	8.15E-01
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.05	-	 < 0.01	9.50E-01
lung goblet cell differentiation (GO:0060480)	3	0	.15	-	 < 0.01	8.58E-01
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of heart rate by epinephrine (GO:0003065)	1	0	.05	-	 < 0.01	9.50E-01
regulation of heart rate by hormone (GO:0003064)	2	0	.10	-	 < 0.01	9.03E-01
regulation of heart rate by chemical signal (GO:0003062)	6	0	.31	-	 < 0.01	7.36E-01
protein deglutathionylation (GO:0080058)	1	0	.05	-	 < 0.01	9.50E-01
ventral midline development (GO:0007418)	5	0	.26	-	 < 0.01	7.75E-01
acrosomal vesicle exocytosis (GO:0060478)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of flagellated sperm motility involved in capacitation (GO:0060474)	3	0	.15	-	 < 0.01	8.58E-01
axonal fasciculation (GO:0007413)	21	0	1.07	-	 < 0.01	3.42E-01
axon target recognition (GO:0007412)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	0	.05	-	 < 0.01	9.50E-01
hormonal regulation of the force of heart contraction (GO:0003058)	1	0	.05	-	 < 0.01	9.50E-01
regulation of the force of heart contraction by chemical signal (GO:0003057)	6	0	.31	-	 < 0.01	7.36E-01
regulation of vascular associated smooth muscle contraction (GO:0003056)	8	0	.41	-	 < 0.01	6.65E-01
angiotensin-mediated drinking behavior (GO:0003051)	3	0	.15	-	 < 0.01	8.58E-01
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	2	0	.10	-	 < 0.01	9.03E-01
signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434)	1	0	.05	-	 < 0.01	9.50E-01
response to G1 DNA damage checkpoint signaling (GO:0072432)	1	0	.05	-	 < 0.01	9.50E-01
prevention of polyspermy (GO:0060468)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of fertilization (GO:0060467)	2	0	.10	-	 < 0.01	9.03E-01
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	6	0	.31	-	 < 0.01	7.36E-01
activation of meiosis involved in egg activation (GO:0060466)	1	0	.05	-	 < 0.01	9.50E-01
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	8	0	.41	-	 < 0.01	6.65E-01
pharynx development (GO:0060465)	3	0	.15	-	 < 0.01	8.58E-01
glial cell fate determination (GO:0007403)	1	0	.05	-	 < 0.01	9.50E-01
ganglion mother cell fate determination (GO:0007402)	2	0	.10	-	 < 0.01	9.03E-01
right lung morphogenesis (GO:0060461)	1	0	.05	-	 < 0.01	9.50E-01
neuroblast fate determination (GO:0007400)	1	0	.05	-	 < 0.01	9.50E-01
left lung morphogenesis (GO:0060460)	1	0	.05	-	 < 0.01	9.50E-01
signal transduction involved in intra-S DNA damage checkpoint (GO:0072428)	1	0	.05	-	 < 0.01	9.50E-01
response to nitrite (GO:0080033)	1	0	.05	-	 < 0.01	9.50E-01
detection of DNA damage stimulus involved in DNA damage checkpoint (GO:0072421)	1	0	.05	-	 < 0.01	9.50E-01
left lung development (GO:0060459)	2	0	.10	-	 < 0.01	9.03E-01
right lung development (GO:0060458)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of digestive system process (GO:0060457)	13	0	.66	-	 < 0.01	5.15E-01
somatic sex determination (GO:0018993)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of gastric acid secretion (GO:0060455)	5	0	.26	-	 < 0.01	7.75E-01
germ-line sex determination (GO:0018992)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of gastric acid secretion (GO:0060454)	2	0	.10	-	 < 0.01	9.03E-01
regulation of gastric acid secretion (GO:0060453)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of hindgut contraction (GO:0060450)	1	0	.05	-	 < 0.01	9.50E-01
detection of oxygen (GO:0003032)	5	0	.26	-	 < 0.01	7.75E-01
D-gluconate catabolic process (GO:0046177)	2	0	.10	-	 < 0.01	9.03E-01
aldonic acid catabolic process (GO:0046176)	2	0	.10	-	 < 0.01	9.03E-01
response to mitotic cell cycle checkpoint signaling (GO:0072414)	1	0	.05	-	 < 0.01	9.50E-01
bud elongation involved in lung branching (GO:0060449)	7	0	.36	-	 < 0.01	6.99E-01
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	2	0	.10	-	 < 0.01	9.03E-01
bud outgrowth involved in lung branching (GO:0060447)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial large ribosomal subunit assembly (GO:1902775)	3	0	.15	-	 < 0.01	8.58E-01
late endosome to lysosome transport (GO:1902774)	3	0	.15	-	 < 0.01	8.58E-01
branching involved in prostate gland morphogenesis (GO:0060442)	9	0	.46	-	 < 0.01	6.31E-01
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029)	1	0	.05	-	 < 0.01	9.50E-01
trachea formation (GO:0060440)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of choline O-acetyltransferase activity (GO:1902771)	1	0	.05	-	 < 0.01	9.50E-01
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027)	1	0	.05	-	 < 0.01	9.50E-01
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.05	-	 < 0.01	9.50E-01
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	3	0	.15	-	 < 0.01	8.58E-01
glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.10	-	 < 0.01	9.03E-01
glycerol-3-phosphate biosynthetic process (GO:0046167)	3	0	.15	-	 < 0.01	8.58E-01
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.10	-	 < 0.01	9.03E-01
heme a metabolic process (GO:0046160)	2	0	.10	-	 < 0.01	9.03E-01
trichloroethylene metabolic process (GO:0018979)	1	0	.05	-	 < 0.01	9.50E-01
triglyceride transport (GO:0034197)	4	0	.20	-	 < 0.01	8.15E-01
acylglycerol transport (GO:0034196)	4	0	.20	-	 < 0.01	8.15E-01
trachea morphogenesis (GO:0060439)	11	0	.56	-	 < 0.01	5.70E-01
regulation of choline O-acetyltransferase activity (GO:1902769)	1	0	.05	-	 < 0.01	9.50E-01
lung growth (GO:0060437)	6	0	.31	-	 < 0.01	7.36E-01
bronchiole morphogenesis (GO:0060436)	1	0	.05	-	 < 0.01	9.50E-01
bronchiole development (GO:0060435)	3	0	.15	-	 < 0.01	8.58E-01
skeletal muscle satellite cell migration (GO:1902766)	2	0	.10	-	 < 0.01	9.03E-01
bronchus morphogenesis (GO:0060434)	2	0	.10	-	 < 0.01	9.03E-01
lung pattern specification process (GO:0060432)	1	0	.05	-	 < 0.01	9.50E-01
primary lung bud formation (GO:0060431)	1	0	.05	-	 < 0.01	9.50E-01
lung saccule development (GO:0060430)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of chondrocyte development (GO:1902761)	1	0	.05	-	 < 0.01	9.50E-01
lymph circulation (GO:0003017)	2	0	.10	-	 < 0.01	9.03E-01
involuntary skeletal muscle contraction (GO:0003011)	3	0	.15	-	 < 0.01	8.58E-01
voluntary skeletal muscle contraction (GO:0003010)	2	0	.10	-	 < 0.01	9.03E-01
mRNA methylation (GO:0080009)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of sterol import (GO:2000911)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of sterol import (GO:2000910)	2	0	.10	-	 < 0.01	9.03E-01
thiocyanate metabolic process (GO:0018969)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	2	0	.10	-	 < 0.01	9.03E-01
lung connective tissue development (GO:0060427)	1	0	.05	-	 < 0.01	9.50E-01
propylene metabolic process (GO:0018964)	1	0	.05	-	 < 0.01	9.50E-01
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	6	0	.31	-	 < 0.01	7.36E-01
lung vasculature development (GO:0060426)	6	0	.31	-	 < 0.01	7.36E-01
4-nitrophenol metabolic process (GO:0018960)	1	0	.05	-	 < 0.01	9.50E-01
nuclear envelope organization (GO:0006998)	47	0	2.40	-	 < 0.01	9.03E-02
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	3	0	.15	-	 < 0.01	8.58E-01
pigment catabolic process (GO:0046149)	14	0	.72	-	 < 0.01	4.89E-01
regulation of sterol import (GO:2000909)	3	0	.15	-	 < 0.01	8.58E-01
D-alanine family amino acid metabolic process (GO:0046144)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lens fiber cell differentiation (GO:1902748)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of lens fiber cell differentiation (GO:1902747)	5	0	.26	-	 < 0.01	7.75E-01
regulation of lens fiber cell differentiation (GO:1902746)	9	0	.46	-	 < 0.01	6.31E-01
imidazole-containing compound catabolic process (GO:0052805)	6	0	.31	-	 < 0.01	7.36E-01
aorta smooth muscle tissue morphogenesis (GO:0060414)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of lamellipodium organization (GO:1902744)	5	0	.26	-	 < 0.01	7.75E-01
response to lipid hydroperoxide (GO:0006982)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of vitamin metabolic process (GO:0046137)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of vitamin metabolic process (GO:0046136)	4	0	.20	-	 < 0.01	8.15E-01
pyrimidine nucleoside catabolic process (GO:0046135)	21	0	1.07	-	 < 0.01	3.42E-01
pyrimidine nucleoside biosynthetic process (GO:0046134)	15	0	.77	-	 < 0.01	4.65E-01
pyrimidine ribonucleoside catabolic process (GO:0046133)	13	0	.66	-	 < 0.01	5.15E-01
pyrimidine ribonucleoside metabolic process (GO:0046131)	13	0	.66	-	 < 0.01	5.15E-01
purine ribonucleoside catabolic process (GO:0046130)	8	0	.41	-	 < 0.01	6.65E-01
toll-like receptor 10 signaling pathway (GO:0034166)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	4	0	.20	-	 < 0.01	8.15E-01
regulation of acetylcholine metabolic process (GO:0060408)	1	0	.05	-	 < 0.01	9.50E-01
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of penile erection (GO:0060407)	1	0	.05	-	 < 0.01	9.50E-01
toll-like receptor 9 signaling pathway (GO:0034162)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of penile erection (GO:0060406)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	3	0	.15	-	 < 0.01	8.58E-01
regulation of penile erection (GO:0060405)	7	0	.36	-	 < 0.01	6.99E-01
axonemal microtubule depolymerization (GO:0060404)	1	0	.05	-	 < 0.01	9.50E-01
calcium ion transport into cytosol (GO:0060402)	68	0	3.47	-	 < 0.01	3.08E-02
positive regulation of chondrocyte proliferation (GO:1902732)	5	0	.26	-	 < 0.01	7.75E-01
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of proteoglycan biosynthetic process (GO:1902730)	4	0	.20	-	 < 0.01	8.15E-01
purine ribonucleoside biosynthetic process (GO:0046129)	19	0	.97	-	 < 0.01	3.79E-01
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	5	0	.26	-	 < 0.01	7.75E-01
purine deoxyribonucleoside catabolic process (GO:0046124)	1	0	.05	-	 < 0.01	9.50E-01
purine deoxyribonucleoside metabolic process (GO:0046122)	2	0	.10	-	 < 0.01	9.03E-01
deoxyribonucleoside catabolic process (GO:0046121)	3	0	.15	-	 < 0.01	8.58E-01
deoxyribonucleoside biosynthetic process (GO:0046120)	2	0	.10	-	 < 0.01	9.03E-01
regulation of toll-like receptor 8 signaling pathway (GO:0034159)	3	0	.15	-	 < 0.01	8.58E-01
toll-like receptor 8 signaling pathway (GO:0034158)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of toll-like receptor 7 signaling pathway (GO:0034156)	1	0	.05	-	 < 0.01	9.50E-01
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	7	0	.36	-	 < 0.01	6.99E-01
toll-like receptor 7 signaling pathway (GO:0034154)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of proteoglycan biosynthetic process (GO:1902729)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	0	.10	-	 < 0.01	9.03E-01
toll-like receptor 6 signaling pathway (GO:0034150)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of satellite cell differentiation (GO:1902725)	4	0	.20	-	 < 0.01	8.15E-01
naphthalene metabolic process (GO:0018931)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of prolactin secretion (GO:1902722)	2	0	.10	-	 < 0.01	9.03E-01
nucleobase catabolic process (GO:0046113)	6	0	.31	-	 < 0.01	7.36E-01
nucleobase biosynthetic process (GO:0046112)	16	0	.82	-	 < 0.01	4.41E-01
xanthine biosynthetic process (GO:0046111)	1	0	.05	-	 < 0.01	9.50E-01
xanthine metabolic process (GO:0046110)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.05	-	 < 0.01	9.50E-01
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.05	-	 < 0.01	9.50E-01
toll-like receptor 5 signaling pathway (GO:0034146)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	8	0	.41	-	 < 0.01	6.65E-01
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	19	0	.97	-	 < 0.01	3.79E-01
toll-like receptor 4 signaling pathway (GO:0034142)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	3	0	.15	-	 < 0.01	8.58E-01
complement activation, classical pathway (GO:0006958)	33	0	1.69	-	 < 0.01	1.85E-01
complement activation, alternative pathway (GO:0006957)	13	0	.66	-	 < 0.01	5.15E-01
complement activation (GO:0006956)	47	0	2.40	-	 < 0.01	9.03E-02
acute-phase response (GO:0006953)	40	0	2.04	-	 < 0.01	1.29E-01
uridine metabolic process (GO:0046108)	2	0	.10	-	 < 0.01	9.03E-01
thymidine biosynthetic process (GO:0046105)	2	0	.10	-	 < 0.01	9.03E-01
thymidine metabolic process (GO:0046104)	5	0	.26	-	 < 0.01	7.75E-01
inosine biosynthetic process (GO:0046103)	3	0	.15	-	 < 0.01	8.58E-01
inosine metabolic process (GO:0046102)	4	0	.20	-	 < 0.01	8.15E-01
hypoxanthine biosynthetic process (GO:0046101)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590)	2	0	.10	-	 < 0.01	9.03E-01
hypoxanthine metabolic process (GO:0046100)	3	0	.15	-	 < 0.01	8.58E-01
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	9	0	.46	-	 < 0.01	6.31E-01
toll-like receptor 3 signaling pathway (GO:0034138)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	5	0	.26	-	 < 0.01	7.75E-01
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	11	0	.56	-	 < 0.01	5.70E-01
nitrobenzene metabolic process (GO:0018916)	3	0	.15	-	 < 0.01	8.58E-01
toll-like receptor 2 signaling pathway (GO:0034134)	5	0	.26	-	 < 0.01	7.75E-01
cell gliding (GO:0071976)	1	0	.05	-	 < 0.01	9.50E-01
toll-like receptor 1 signaling pathway (GO:0034130)	1	0	.05	-	 < 0.01	9.50E-01
extracellular exosome assembly (GO:0071971)	1	0	.05	-	 < 0.01	9.50E-01
benzene metabolic process (GO:0018910)	1	0	.05	-	 < 0.01	9.50E-01
induction by virus of host cell-cell fusion (GO:0006948)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587)	2	0	.10	-	 < 0.01	9.03E-01
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antigen processing and presentation of peptide antigen (GO:0002584)	4	0	.20	-	 < 0.01	8.15E-01
response to ozone (GO:0010193)	4	0	.20	-	 < 0.01	8.15E-01
regulation of antigen processing and presentation of peptide antigen (GO:0002583)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	0	.15	-	 < 0.01	8.58E-01
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	6	0	.31	-	 < 0.01	7.36E-01
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125)	2	0	.10	-	 < 0.01	9.03E-01
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	4	0	.20	-	 < 0.01	8.15E-01
fungal-type cell wall polysaccharide metabolic process (GO:0071966)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of toll-like receptor signaling pathway (GO:0034123)	25	0	1.28	-	 < 0.01	2.79E-01
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of erythrocyte aggregation (GO:0034120)	1	0	.05	-	 < 0.01	9.50E-01
mitotic sister chromatid cohesion, centromeric (GO:0071962)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	3	0	.15	-	 < 0.01	8.58E-01
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	2	0	.10	-	 < 0.01	9.03E-01
vitamin E biosynthetic process (GO:0010189)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of antigen processing and presentation (GO:0002579)	9	0	.46	-	 < 0.01	6.31E-01
substrate-dependent cell migration, cell extension (GO:0006930)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of antigen processing and presentation (GO:0002578)	9	0	.46	-	 < 0.01	6.31E-01
regulation of antigen processing and presentation (GO:0002577)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of cellular defense response (GO:0010186)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular defense response (GO:0010185)	1	0	.05	-	 < 0.01	9.50E-01
basophil chemotaxis (GO:0002575)	1	0	.05	-	 < 0.01	9.50E-01
sugar mediated signaling pathway (GO:0010182)	3	0	.15	-	 < 0.01	8.58E-01
pro-T cell differentiation (GO:0002572)	1	0	.05	-	 < 0.01	9.50E-01
regulation of erythrocyte aggregation (GO:0034118)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	16	0	.82	-	 < 0.01	4.41E-01
heterotypic cell-cell adhesion (GO:0034113)	35	0	1.79	-	 < 0.01	1.67E-01
recycling endosome to Golgi transport (GO:0071955)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of homotypic cell-cell adhesion (GO:0034112)	9	0	.46	-	 < 0.01	6.31E-01
chemokine (C-C motif) ligand 11 production (GO:0071954)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of homotypic cell-cell adhesion (GO:0034111)	15	0	.77	-	 < 0.01	4.65E-01
regulation of homotypic cell-cell adhesion (GO:0034110)	30	0	1.53	-	 < 0.01	2.16E-01
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.05	-	 < 0.01	9.50E-01
substrate-dependent cell migration (GO:0006929)	23	0	1.17	-	 < 0.01	3.09E-01
inflammatory cell apoptotic process (GO:0006925)	5	0	.26	-	 < 0.01	7.75E-01
activation-induced cell death of T cells (GO:0006924)	6	0	.31	-	 < 0.01	7.36E-01
somatic diversification of T cell receptor genes (GO:0002568)	5	0	.26	-	 < 0.01	7.75E-01
embryonic body morphogenesis (GO:0010172)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of tissue remodeling (GO:0034105)	11	0	.56	-	 < 0.01	5.70E-01
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of tissue remodeling (GO:0034104)	23	0	1.17	-	 < 0.01	3.09E-01
nitrogen cycle metabolic process (GO:0071941)	13	0	.66	-	 < 0.01	5.15E-01
phagocytosis, engulfment (GO:0006911)	37	0	1.89	-	 < 0.01	1.51E-01
phagocytosis, recognition (GO:0006910)	15	0	.77	-	 < 0.01	4.65E-01
wax metabolic process (GO:0010166)	3	0	.15	-	 < 0.01	8.58E-01
response to cesium ion (GO:0010164)	1	0	.05	-	 < 0.01	9.50E-01
serotonin secretion by platelet (GO:0002554)	3	0	.15	-	 < 0.01	8.58E-01
histamine secretion by mast cell (GO:0002553)	2	0	.10	-	 < 0.01	9.03E-01
mast cell chemotaxis (GO:0002551)	5	0	.26	-	 < 0.01	7.75E-01
formation of animal organ boundary (GO:0010160)	1	0	.05	-	 < 0.01	9.50E-01
vitamin A import (GO:0071939)	1	0	.05	-	 < 0.01	9.50E-01
vitamin A transport (GO:0071938)	1	0	.05	-	 < 0.01	9.50E-01
thiamine transmembrane transport (GO:0071934)	3	0	.15	-	 < 0.01	8.58E-01
replication fork reversal (GO:0071932)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	3	0	.15	-	 < 0.01	8.58E-01
specification of animal organ position (GO:0010159)	3	0	.15	-	 < 0.01	8.58E-01
monocyte chemotaxis (GO:0002548)	34	0	1.74	-	 < 0.01	1.76E-01
response to chlorate (GO:0010157)	2	0	.10	-	 < 0.01	9.03E-01
chronic inflammatory response (GO:0002544)	14	0	.72	-	 < 0.01	4.89E-01
Factor XII activation (GO:0002542)	2	0	.10	-	 < 0.01	9.03E-01
activation of plasma proteins involved in acute inflammatory response (GO:0002541)	1	0	.05	-	 < 0.01	9.50E-01
leukotriene production involved in inflammatory response (GO:0002540)	2	0	.10	-	 < 0.01	9.03E-01
alpha-tubulin acetylation (GO:0071929)	1	0	.05	-	 < 0.01	9.50E-01
endocannabinoid signaling pathway (GO:0071926)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cohesin loading (GO:0071922)	5	0	.26	-	 < 0.01	7.75E-01
cohesin loading (GO:0071921)	1	0	.05	-	 < 0.01	9.50E-01
arachidonic acid metabolite production involved in inflammatory response (GO:0002538)	2	0	.10	-	 < 0.01	9.03E-01
nitric oxide production involved in inflammatory response (GO:0002537)	2	0	.10	-	 < 0.01	9.03E-01
respiratory burst involved in inflammatory response (GO:0002536)	1	0	.05	-	 < 0.01	9.50E-01
cytokine production involved in inflammatory response (GO:0002534)	4	0	.20	-	 < 0.01	8.15E-01
production of molecular mediator involved in inflammatory response (GO:0002532)	19	0	.97	-	 < 0.01	3.79E-01
G-quadruplex DNA formation (GO:0071919)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of osteoclast differentiation (GO:0045671)	30	0	1.53	-	 < 0.01	2.16E-01
synchronous neurotransmitter secretion (GO:0071911)	1	0	.05	-	 < 0.01	9.50E-01
determination of liver left/right asymmetry (GO:0071910)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine ribonucleotide salvage (GO:0010138)	5	0	.26	-	 < 0.01	7.75E-01
leukocyte migration involved in inflammatory response (GO:0002523)	19	0	.97	-	 < 0.01	3.79E-01
leukocyte migration involved in immune response (GO:0002522)	2	0	.10	-	 < 0.01	9.03E-01
determination of stomach left/right asymmetry (GO:0071909)	1	0	.05	-	 < 0.01	9.50E-01
determination of intestine left/right asymmetry (GO:0071908)	1	0	.05	-	 < 0.01	9.50E-01
determination of digestive tract left/right asymmetry (GO:0071907)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of neutrophil differentiation (GO:0045660)	1	0	.05	-	 < 0.01	9.50E-01
neurofilament bundle assembly (GO:0033693)	3	0	.15	-	 < 0.01	8.58E-01
natural killer cell tolerance induction (GO:0002519)	3	0	.15	-	 < 0.01	8.58E-01
lymphocyte chemotaxis across high endothelial venule (GO:0002518)	1	0	.05	-	 < 0.01	9.50E-01
T cell tolerance induction (GO:0002517)	2	0	.10	-	 < 0.01	9.03E-01
phenylacetate catabolic process (GO:0010124)	2	0	.10	-	 < 0.01	9.03E-01
B cell tolerance induction (GO:0002514)	1	0	.05	-	 < 0.01	9.50E-01
tolerance induction to self antigen (GO:0002513)	5	0	.26	-	 < 0.01	7.75E-01
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neutrophil differentiation (GO:0045659)	2	0	.10	-	 < 0.01	9.03E-01
regulation of neutrophil differentiation (GO:0045658)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of monocyte differentiation (GO:0045656)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of megakaryocyte differentiation (GO:0045654)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of megakaryocyte differentiation (GO:0045653)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of macrophage differentiation (GO:0045651)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of macrophage differentiation (GO:0045650)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of osteoblast proliferation (GO:0033689)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of luteinizing hormone secretion (GO:0033686)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of luteinizing hormone secretion (GO:0033685)	3	0	.15	-	 < 0.01	8.58E-01
regulation of luteinizing hormone secretion (GO:0033684)	6	0	.31	-	 < 0.01	7.36E-01
central tolerance induction to self antigen (GO:0002509)	1	0	.05	-	 < 0.01	9.50E-01
central tolerance induction (GO:0002508)	2	0	.10	-	 < 0.01	9.03E-01
tolerance induction (GO:0002507)	15	0	.77	-	 < 0.01	4.65E-01
peptide antigen assembly with MHC class II protein complex (GO:0002503)	4	0	.20	-	 < 0.01	8.15E-01
peptide antigen assembly with MHC class I protein complex (GO:0002502)	2	0	.10	-	 < 0.01	9.03E-01
peptide antigen assembly with MHC protein complex (GO:0002501)	6	0	.31	-	 < 0.01	7.36E-01
regulation of macrophage differentiation (GO:0045649)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.05	-	 < 0.01	9.50E-01
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of eosinophil differentiation (GO:0045645)	2	0	.10	-	 < 0.01	9.03E-01
regulation of eosinophil differentiation (GO:0045643)	2	0	.10	-	 < 0.01	9.03E-01
glyoxal catabolic process (GO:1903190)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to iron ion starvation (GO:0010106)	1	0	.05	-	 < 0.01	9.50E-01
glyoxal metabolic process (GO:1903189)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of melanocyte differentiation (GO:0045636)	5	0	.26	-	 < 0.01	7.75E-01
glucuronoside catabolic process (GO:0019391)	3	0	.15	-	 < 0.01	8.58E-01
regulation of melanocyte differentiation (GO:0045634)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of mechanoreceptor differentiation (GO:0045633)	1	0	.05	-	 < 0.01	9.50E-01
regulation of SUMO transferase activity (GO:1903182)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dopamine biosynthetic process (GO:1903181)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of T-helper 2 cell differentiation (GO:0045630)	7	0	.36	-	 < 0.01	6.99E-01
cerebellar cortex maturation (GO:0021699)	3	0	.15	-	 < 0.01	8.58E-01
cerebellar cortex structural organization (GO:0021698)	2	0	.10	-	 < 0.01	9.03E-01
cerebellar cortex formation (GO:0021697)	24	0	1.23	-	 < 0.01	2.93E-01
cerebellar cortex morphogenesis (GO:0021696)	32	0	1.63	-	 < 0.01	1.95E-01
cerebellar cortex development (GO:0021695)	49	0	2.50	-	 < 0.01	8.15E-02
cerebellar Purkinje cell layer formation (GO:0021694)	13	0	.66	-	 < 0.01	5.15E-01
cerebellar Purkinje cell layer structural organization (GO:0021693)	2	0	.10	-	 < 0.01	9.03E-01
glucuronoside metabolic process (GO:0019389)	3	0	.15	-	 < 0.01	8.58E-01
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	16	0	.82	-	 < 0.01	4.41E-01
galactose catabolic process (GO:0019388)	8	0	.41	-	 < 0.01	6.65E-01
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.10	-	 < 0.01	9.03E-01
regulation of dopamine biosynthetic process (GO:1903179)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of T-helper 1 cell differentiation (GO:0045627)	6	0	.31	-	 < 0.01	7.36E-01
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of T-helper 1 cell differentiation (GO:0045626)	3	0	.15	-	 < 0.01	8.58E-01
regulation of T-helper 1 cell differentiation (GO:0045625)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of T-helper cell differentiation (GO:0045624)	21	0	1.07	-	 < 0.01	3.42E-01
fatty alcohol metabolic process (GO:1903173)	2	0	.10	-	 < 0.01	9.03E-01
cerebellar molecular layer formation (GO:0021688)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar molecular layer morphogenesis (GO:0021687)	2	0	.10	-	 < 0.01	9.03E-01
cerebellar granular layer maturation (GO:0021686)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar granular layer structural organization (GO:0021685)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar granular layer formation (GO:0021684)	7	0	.36	-	 < 0.01	6.99E-01
cerebellar granular layer morphogenesis (GO:0021683)	9	0	.46	-	 < 0.01	6.31E-01
cerebellar granular layer development (GO:0021681)	13	0	.66	-	 < 0.01	5.15E-01
glycolipid catabolic process (GO:0019377)	15	0	.77	-	 < 0.01	4.65E-01
cerebellar Purkinje cell layer development (GO:0021680)	26	0	1.33	-	 < 0.01	2.65E-01
galactolipid catabolic process (GO:0019376)	4	0	.20	-	 < 0.01	8.15E-01
galactolipid biosynthetic process (GO:0019375)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.05	-	 < 0.01	9.50E-01
galactolipid metabolic process (GO:0019374)	10	0	.51	-	 < 0.01	6.00E-01
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.05	-	 < 0.01	9.50E-01
response to polycyclic arene (GO:1903165)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar molecular layer development (GO:0021679)	3	0	.15	-	 < 0.01	8.58E-01
third ventricle development (GO:0021678)	5	0	.26	-	 < 0.01	7.75E-01
lysobisphosphatidic acid metabolic process (GO:2001311)	2	0	.10	-	 < 0.01	9.03E-01
fatty acid elongation, unsaturated fatty acid (GO:0019368)	7	0	.36	-	 < 0.01	6.99E-01
fatty acid elongation, saturated fatty acid (GO:0019367)	7	0	.36	-	 < 0.01	6.99E-01
lateral ventricle development (GO:0021670)	13	0	.66	-	 < 0.01	5.15E-01
pyridine nucleotide salvage (GO:0019365)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of inner ear auditory receptor cell differentiation (GO:0045609)	1	0	.05	-	 < 0.01	9.50E-01
pyridine nucleotide catabolic process (GO:0019364)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	6	0	.31	-	 < 0.01	7.36E-01
cell-cell adhesion mediated by integrin (GO:0033631)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cell adhesion mediated by integrin (GO:0033630)	21	0	1.07	-	 < 0.01	3.42E-01
lipoxin B4 biosynthetic process (GO:2001306)	1	0	.05	-	 < 0.01	9.50E-01
lipoxin B4 metabolic process (GO:2001304)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere 5 formation (GO:0021666)	1	0	.05	-	 < 0.01	9.50E-01
lipoxin A4 biosynthetic process (GO:2001303)	3	0	.15	-	 < 0.01	8.58E-01
rhombomere 5 structural organization (GO:0021665)	1	0	.05	-	 < 0.01	9.50E-01
lipoxin A4 metabolic process (GO:2001302)	4	0	.20	-	 < 0.01	8.15E-01
rhombomere 5 morphogenesis (GO:0021664)	1	0	.05	-	 < 0.01	9.50E-01
lipoxin biosynthetic process (GO:2001301)	7	0	.36	-	 < 0.01	6.99E-01
lipoxin metabolic process (GO:2001300)	8	0	.41	-	 < 0.01	6.65E-01
rhombomere 3 formation (GO:0021660)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of establishment of endothelial barrier (GO:1903142)	6	0	.31	-	 < 0.01	7.36E-01
posterior compartment specification (GO:0007388)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of establishment of endothelial barrier (GO:1903141)	2	0	.10	-	 < 0.01	9.03E-01
anterior compartment pattern formation (GO:0007387)	1	0	.05	-	 < 0.01	9.50E-01
cell adhesion mediated by integrin (GO:0033627)	24	0	1.23	-	 < 0.01	2.93E-01
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of integrin activation (GO:0033625)	11	0	.56	-	 < 0.01	5.70E-01
integrin activation (GO:0033622)	8	0	.41	-	 < 0.01	6.65E-01
rhombomere 3 structural organization (GO:0021659)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere 3 morphogenesis (GO:0021658)	2	0	.10	-	 < 0.01	9.03E-01
vestibulocochlear nerve formation (GO:0021650)	3	0	.15	-	 < 0.01	8.58E-01
transsulfuration (GO:0019346)	4	0	.20	-	 < 0.01	8.15E-01
cysteine biosynthetic process (GO:0019344)	2	0	.10	-	 < 0.01	9.03E-01
cysteine biosynthetic process via cystathionine (GO:0019343)	2	0	.10	-	 < 0.01	9.03E-01
dibenzo-p-dioxin catabolic process (GO:0019341)	1	0	.05	-	 < 0.01	9.50E-01
segment specification (GO:0007379)	16	0	.82	-	 < 0.01	4.41E-01
mononuclear cell differentiation (GO:1903131)	17	0	.87	-	 < 0.01	4.19E-01
ventral midline determination (GO:0007371)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	5	0	.26	-	 < 0.01	7.75E-01
vestibulocochlear nerve structural organization (GO:0021649)	2	0	.10	-	 < 0.01	9.03E-01
vestibulocochlear nerve morphogenesis (GO:0021648)	5	0	.26	-	 < 0.01	7.75E-01
vagus nerve morphogenesis (GO:0021644)	2	0	.10	-	 < 0.01	9.03E-01
trochlear nerve formation (GO:0021642)	1	0	.05	-	 < 0.01	9.50E-01
phenol-containing compound catabolic process (GO:0019336)	9	0	.46	-	 < 0.01	6.31E-01
detection of stimulus involved in cell cycle checkpoint (GO:0072394)	1	0	.05	-	 < 0.01	9.50E-01
microtubule anchoring at microtubule organizing center (GO:0072393)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of centriole-centriole cohesion (GO:1903126)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of thioredoxin peroxidase activity (GO:1903124)	1	0	.05	-	 < 0.01	9.50E-01
regulation of thioredoxin peroxidase activity (GO:1903123)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.05	-	 < 0.01	9.50E-01
chemokine receptor transport within lipid bilayer (GO:0033606)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of catecholamine secretion (GO:0033605)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of catecholamine secretion (GO:0033604)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of dopamine secretion (GO:0033603)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of dopamine secretion (GO:0033602)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	4	0	.20	-	 < 0.01	8.15E-01
trochlear nerve morphogenesis (GO:0021639)	1	0	.05	-	 < 0.01	9.50E-01
trigeminal nerve structural organization (GO:0021637)	5	0	.26	-	 < 0.01	7.75E-01
trigeminal nerve morphogenesis (GO:0021636)	5	0	.26	-	 < 0.01	7.75E-01
optic nerve structural organization (GO:0021633)	1	0	.05	-	 < 0.01	9.50E-01
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.05	-	 < 0.01	9.50E-01
optic nerve morphogenesis (GO:0021631)	5	0	.26	-	 < 0.01	7.75E-01
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.05	-	 < 0.01	9.50E-01
flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to actin cytoskeleton (GO:1903119)	1	0	.05	-	 < 0.01	9.50E-01
minus-end-directed organelle transport along microtubule (GO:0072385)	5	0	.26	-	 < 0.01	7.75E-01
urate homeostasis (GO:1903118)	1	0	.05	-	 < 0.01	9.50E-01
pentose catabolic process (GO:0019323)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of actin filament-based movement (GO:1903116)	1	0	.05	-	 < 0.01	9.50E-01
pentose biosynthetic process (GO:0019322)	4	0	.20	-	 < 0.01	8.15E-01
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.05	-	 < 0.01	9.50E-01
pentose metabolic process (GO:0019321)	11	0	.56	-	 < 0.01	5.70E-01
thorax and anterior abdomen determination (GO:0007356)	3	0	.15	-	 < 0.01	8.58E-01
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	4	0	.20	-	 < 0.01	8.15E-01
zygotic specification of dorsal/ventral axis (GO:0007352)	3	0	.15	-	 < 0.01	8.58E-01
olfactory nerve structural organization (GO:0021629)	1	0	.05	-	 < 0.01	9.50E-01
olfactory nerve morphogenesis (GO:0021627)	1	0	.05	-	 < 0.01	9.50E-01
central nervous system maturation (GO:0021626)	9	0	.46	-	 < 0.01	6.31E-01
oculomotor nerve formation (GO:0021623)	2	0	.10	-	 < 0.01	9.03E-01
oculomotor nerve morphogenesis (GO:0021622)	2	0	.10	-	 < 0.01	9.03E-01
blood coagulation, fibrin clot formation (GO:0072378)	27	0	1.38	-	 < 0.01	2.52E-01
amylopectin metabolic process (GO:2000896)	1	0	.05	-	 < 0.01	9.50E-01
fucose catabolic process (GO:0019317)	9	0	.46	-	 < 0.01	6.31E-01
blood coagulation, common pathway (GO:0072377)	1	0	.05	-	 < 0.01	9.50E-01
protein activation cascade (GO:0072376)	27	0	1.38	-	 < 0.01	2.52E-01
positive regulation of mitochondrial transcription (GO:1903109)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mitochondrial transcription (GO:1903108)	4	0	.20	-	 < 0.01	8.15E-01
inositol catabolic process (GO:0019310)	1	0	.05	-	 < 0.01	9.50E-01
cellularization (GO:0007349)	1	0	.05	-	 < 0.01	9.50E-01
1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.05	-	 < 0.01	9.50E-01
pronuclear fusion (GO:0007344)	1	0	.05	-	 < 0.01	9.50E-01
egg activation (GO:0007343)	5	0	.26	-	 < 0.01	7.75E-01
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	20	0	1.02	-	 < 0.01	3.60E-01
penetration of zona pellucida (GO:0007341)	7	0	.36	-	 < 0.01	6.99E-01
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.05	-	 < 0.01	9.50E-01
glossopharyngeal nerve morphogenesis (GO:0021615)	4	0	.20	-	 < 0.01	8.15E-01
facial nerve structural organization (GO:0021612)	9	0	.46	-	 < 0.01	6.31E-01
facial nerve morphogenesis (GO:0021610)	11	0	.56	-	 < 0.01	5.70E-01
D-ribose catabolic process (GO:0019303)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.15	-	 < 0.01	8.58E-01
regulation of growth hormone receptor signaling pathway (GO:0060398)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of SMAD protein signal transduction (GO:0060392)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of SMAD protein signal transduction (GO:0060391)	16	0	.82	-	 < 0.01	4.41E-01
regulation of SMAD protein signal transduction (GO:0060390)	28	0	1.43	-	 < 0.01	2.39E-01
cranial nerve structural organization (GO:0021604)	11	0	.56	-	 < 0.01	5.70E-01
cranial nerve formation (GO:0021603)	7	0	.36	-	 < 0.01	6.99E-01
cranial nerve morphogenesis (GO:0021602)	28	0	1.43	-	 < 0.01	2.39E-01
chromosome passenger complex localization to kinetochore (GO:0072356)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-T3 phosphorylation (GO:0072355)	1	0	.05	-	 < 0.01	9.50E-01
regulation of progesterone secretion (GO:2000870)	1	0	.05	-	 < 0.01	9.50E-01
synapse assembly involved in innervation (GO:0060386)	1	0	.05	-	 < 0.01	9.50E-01
axonogenesis involved in innervation (GO:0060385)	6	0	.31	-	 < 0.01	7.36E-01
innervation (GO:0060384)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation of DNA strand elongation (GO:0060383)	1	0	.05	-	 < 0.01	9.50E-01
regulation of DNA strand elongation (GO:0060382)	2	0	.10	-	 < 0.01	9.03E-01
sperm displacement (GO:0007321)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.05	-	 < 0.01	9.50E-01
insemination (GO:0007320)	12	0	.61	-	 < 0.01	5.42E-01
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of estradiol secretion (GO:2000866)	2	0	.10	-	 < 0.01	9.03E-01
regulation of estradiol secretion (GO:2000864)	3	0	.15	-	 < 0.01	8.58E-01
rescue of stalled ribosome (GO:0072344)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of aldosterone secretion (GO:2000860)	2	0	.10	-	 < 0.01	9.03E-01
cellular lactam catabolic process (GO:0072340)	1	0	.05	-	 < 0.01	9.50E-01
regulation of brood size (GO:0060378)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mast cell differentiation (GO:0060377)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mast cell differentiation (GO:0060376)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mast cell differentiation (GO:0060375)	3	0	.15	-	 < 0.01	8.58E-01
mast cell differentiation (GO:0060374)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	6	0	.31	-	 < 0.01	7.36E-01
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	5	0	.26	-	 < 0.01	7.75E-01
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	7	0	.36	-	 < 0.01	6.99E-01
susceptibility to T cell mediated cytotoxicity (GO:0060370)	2	0	.10	-	 < 0.01	9.03E-01
guanine biosynthetic process (GO:0046099)	1	0	.05	-	 < 0.01	9.50E-01
guanine metabolic process (GO:0046098)	3	0	.15	-	 < 0.01	8.58E-01
regulation of aldosterone secretion (GO:2000858)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of mineralocorticoid secretion (GO:2000857)	2	0	.10	-	 < 0.01	9.03E-01
cellular lactam metabolic process (GO:0072338)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mineralocorticoid secretion (GO:2000855)	6	0	.31	-	 < 0.01	7.36E-01
deoxycytidine metabolic process (GO:0046092)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of corticosterone secretion (GO:2000854)	3	0	.15	-	 < 0.01	8.58E-01
deoxyadenosine metabolic process (GO:0046090)	1	0	.05	-	 < 0.01	9.50E-01
regulation of corticosterone secretion (GO:2000852)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glucocorticoid secretion (GO:2000851)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	7	0	.36	-	 < 0.01	6.99E-01
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	12	0	.61	-	 < 0.01	5.42E-01
sagittal suture morphogenesis (GO:0060367)	1	0	.05	-	 < 0.01	9.50E-01
lambdoid suture morphogenesis (GO:0060366)	1	0	.05	-	 < 0.01	9.50E-01
frontal suture morphogenesis (GO:0060364)	4	0	.20	-	 < 0.01	8.15E-01
respiratory basal cell differentiation (GO:1902691)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of NAD metabolic process (GO:1902690)	1	0	.05	-	 < 0.01	9.50E-01
cytidine metabolic process (GO:0046087)	11	0	.56	-	 < 0.01	5.70E-01
adenosine biosynthetic process (GO:0046086)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of corticosteroid hormone secretion (GO:2000848)	8	0	.41	-	 < 0.01	6.65E-01
adenosine metabolic process (GO:0046085)	9	0	.46	-	 < 0.01	6.31E-01
adenine biosynthetic process (GO:0046084)	3	0	.15	-	 < 0.01	8.58E-01
adenine metabolic process (GO:0046083)	3	0	.15	-	 < 0.01	8.58E-01
dUTP catabolic process (GO:0046081)	1	0	.05	-	 < 0.01	9.50E-01
dUTP metabolic process (GO:0046080)	1	0	.05	-	 < 0.01	9.50E-01
response to ammonium ion (GO:0060359)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of NAD metabolic process (GO:1902689)	3	0	.15	-	 < 0.01	8.58E-01
regulation of NAD metabolic process (GO:1902688)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cell adhesion molecule production (GO:0060355)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of receptor localization to synapse (GO:1902685)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of receptor localization to synapse (GO:1902684)	1	0	.05	-	 < 0.01	9.50E-01
cell adhesion molecule production (GO:0060352)	3	0	.15	-	 < 0.01	8.58E-01
dUMP catabolic process (GO:0046079)	1	0	.05	-	 < 0.01	9.50E-01
dUMP metabolic process (GO:0046078)	3	0	.15	-	 < 0.01	8.58E-01
dUDP metabolic process (GO:0046077)	1	0	.05	-	 < 0.01	9.50E-01
dTTP metabolic process (GO:0046075)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of androgen secretion (GO:2000836)	1	0	.05	-	 < 0.01	9.50E-01
dTMP metabolic process (GO:0046073)	3	0	.15	-	 < 0.01	8.58E-01
dTDP metabolic process (GO:0046072)	1	0	.05	-	 < 0.01	9.50E-01
regulation of androgen secretion (GO:2000834)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of steroid hormone secretion (GO:2000833)	9	0	.46	-	 < 0.01	6.31E-01
dGTP metabolic process (GO:0046070)	4	0	.20	-	 < 0.01	8.15E-01
metanephric glomerular epithelial cell development (GO:0072313)	2	0	.10	-	 < 0.01	9.03E-01
metanephric glomerular epithelial cell differentiation (GO:0072312)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of parathyroid hormone secretion (GO:2000830)	1	0	.05	-	 < 0.01	9.50E-01
glomerular epithelial cell differentiation (GO:0072311)	20	0	1.02	-	 < 0.01	3.60E-01
glomerular epithelial cell development (GO:0072310)	12	0	.61	-	 < 0.01	5.42E-01
carbon tetrachloride metabolic process (GO:0018885)	1	0	.05	-	 < 0.01	9.50E-01
spleen trabecula formation (GO:0060345)	1	0	.05	-	 < 0.01	9.50E-01
cGMP catabolic process (GO:0046069)	4	0	.20	-	 < 0.01	8.15E-01
dGDP catabolic process (GO:0046067)	1	0	.05	-	 < 0.01	9.50E-01
dGDP metabolic process (GO:0046066)	2	0	.10	-	 < 0.01	9.03E-01
regulation of parathyroid hormone secretion (GO:2000828)	2	0	.10	-	 < 0.01	9.03E-01
dCTP metabolic process (GO:0046065)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial RNA surveillance (GO:2000827)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of androgen receptor activity (GO:2000825)	4	0	.20	-	 < 0.01	8.15E-01
dATP catabolic process (GO:0046061)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.10	-	 < 0.01	9.03E-01
dATP metabolic process (GO:0046060)	5	0	.26	-	 < 0.01	7.75E-01
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.05	-	 < 0.01	9.50E-01
regulation of grooming behavior (GO:2000821)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	2	0	.10	-	 < 0.01	9.03E-01
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of metanephric glomerulus development (GO:0072300)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of axon guidance (GO:1902669)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of axon guidance (GO:1902668)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	7	0	.36	-	 < 0.01	6.99E-01
benzoate metabolic process (GO:0018874)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	5	0	.26	-	 < 0.01	7.75E-01
regulation of maintenance of sister chromatid cohesion (GO:0034091)	6	0	.31	-	 < 0.01	7.36E-01
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	24	0	1.23	-	 < 0.01	2.93E-01
1-aminocyclopropane-1-carboxylate metabolic process (GO:0018871)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of response to interferon-gamma (GO:0060332)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of response to interferon-gamma (GO:0060331)	7	0	.36	-	 < 0.01	6.99E-01
regulation of response to interferon-gamma (GO:0060330)	24	0	1.23	-	 < 0.01	2.93E-01
positive regulation of glucose mediated signaling pathway (GO:1902661)	3	0	.15	-	 < 0.01	8.58E-01
dADP catabolic process (GO:0046057)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nucleotide-excision repair (GO:2000819)	3	0	.15	-	 < 0.01	8.58E-01
dADP metabolic process (GO:0046056)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of myoblast proliferation (GO:2000818)	2	0	.10	-	 < 0.01	9.03E-01
dGMP metabolic process (GO:0046054)	1	0	.05	-	 < 0.01	9.50E-01
dAMP metabolic process (GO:0046053)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.10	-	 < 0.01	9.03E-01
UTP metabolic process (GO:0046051)	8	0	.41	-	 < 0.01	6.65E-01
maintenance of mitotic sister chromatid cohesion (GO:0034088)	3	0	.15	-	 < 0.01	8.58E-01
establishment of mitotic sister chromatid cohesion (GO:0034087)	2	0	.10	-	 < 0.01	9.03E-01
maintenance of sister chromatid cohesion (GO:0034086)	3	0	.15	-	 < 0.01	8.58E-01
establishment of sister chromatid cohesion (GO:0034085)	3	0	.15	-	 < 0.01	8.58E-01
regulation of glucose mediated signaling pathway (GO:1902659)	3	0	.15	-	 < 0.01	8.58E-01
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	2	0	.10	-	 < 0.01	9.03E-01
calcium ion import into cytosol (GO:1902656)	17	0	.87	-	 < 0.01	4.19E-01
UMP metabolic process (GO:0046049)	10	0	.51	-	 < 0.01	6.00E-01
UDP metabolic process (GO:0046048)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of synaptic vesicle clustering (GO:2000809)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.05	-	 < 0.01	9.50E-01
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	1	0	.05	-	 < 0.01	9.50E-01
ITP metabolic process (GO:0046041)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800)	1	0	.05	-	 < 0.01	9.50E-01
primitive erythrocyte differentiation (GO:0060319)	2	0	.10	-	 < 0.01	9.03E-01
definitive erythrocyte differentiation (GO:0060318)	3	0	.15	-	 < 0.01	8.58E-01
tertiary alcohol biosynthetic process (GO:1902645)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of blood vessel remodeling (GO:0060313)	3	0	.15	-	 < 0.01	8.58E-01
tertiary alcohol metabolic process (GO:1902644)	12	0	.61	-	 < 0.01	5.42E-01
regulation of blood vessel remodeling (GO:0060312)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of elastin catabolic process (GO:0060311)	1	0	.05	-	 < 0.01	9.50E-01
regulation of elastin catabolic process (GO:0060310)	1	0	.05	-	 < 0.01	9.50E-01
cellular sodium ion homeostasis (GO:0006883)	17	0	.87	-	 < 0.01	4.19E-01
cellular zinc ion homeostasis (GO:0006882)	31	0	1.58	-	 < 0.01	2.05E-01
GMP catabolic process (GO:0046038)	1	0	.05	-	 < 0.01	9.50E-01
CTP metabolic process (GO:0046036)	10	0	.51	-	 < 0.01	6.00E-01
ADP catabolic process (GO:0046032)	1	0	.05	-	 < 0.01	9.50E-01
elastin catabolic process (GO:0060309)	3	0	.15	-	 < 0.01	8.58E-01
NAD-cap decapping (GO:0110155)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	18	0	.92	-	 < 0.01	3.99E-01
regulation of membrane repolarization (GO:0060306)	29	0	1.48	-	 < 0.01	2.27E-01
regulation of cell diameter (GO:0060305)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	6	0	.31	-	 < 0.01	7.36E-01
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of cytokine activity (GO:0060302)	2	0	.10	-	 < 0.01	9.03E-01
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cytokine activity (GO:0060301)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of membrane hyperpolarization (GO:1902632)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytokine activity (GO:0060300)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of membrane hyperpolarization (GO:1902631)	1	0	.05	-	 < 0.01	9.50E-01
cellular copper ion homeostasis (GO:0006878)	14	0	.72	-	 < 0.01	4.89E-01
regulation of membrane hyperpolarization (GO:1902630)	3	0	.15	-	 < 0.01	8.58E-01
cellular cadmium ion homeostasis (GO:0006876)	2	0	.10	-	 < 0.01	9.03E-01
endosomal vesicle fusion (GO:0034058)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of estrogen receptor binding (GO:0071899)	3	0	.15	-	 < 0.01	8.58E-01
regulation of estrogen receptor binding (GO:0071898)	3	0	.15	-	 < 0.01	8.58E-01
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	1	0	.05	-	 < 0.01	9.50E-01
BMP signaling pathway involved in nephric duct formation (GO:0071893)	1	0	.05	-	 < 0.01	9.50E-01
assembly of large subunit precursor of preribosome (GO:1902626)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of neutrophil migration (GO:1902624)	30	0	1.53	-	 < 0.01	2.16E-01
negative regulation of neutrophil migration (GO:1902623)	4	0	.20	-	 < 0.01	8.15E-01
regulation of neutrophil migration (GO:1902622)	41	0	2.09	-	 < 0.01	1.23E-01
glutamine transport (GO:0006868)	8	0	.41	-	 < 0.01	6.65E-01
asparagine transport (GO:0006867)	3	0	.15	-	 < 0.01	8.58E-01
pyrimidine nucleotide transport (GO:0006864)	2	0	.10	-	 < 0.01	9.03E-01
regulation of T cell homeostatic proliferation (GO:0046013)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	4	0	.20	-	 < 0.01	8.15E-01
macrophage apoptotic process (GO:0071888)	2	0	.10	-	 < 0.01	9.03E-01
Norrin signaling pathway (GO:0110135)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to fluoride (GO:1902618)	1	0	.05	-	 < 0.01	9.50E-01
response to fluoride (GO:1902617)	5	0	.26	-	 < 0.01	7.75E-01
acyl carnitine transmembrane transport (GO:1902616)	2	0	.10	-	 < 0.01	9.03E-01
phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)	1	0	.05	-	 < 0.01	9.50E-01
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613)	1	0	.05	-	 < 0.01	9.50E-01
regulation of anti-Mullerian hormone signaling pathway (GO:1902612)	1	0	.05	-	 < 0.01	9.50E-01
oligopeptide transport (GO:0006857)	10	0	.51	-	 < 0.01	6.00E-01
drug transmembrane transport (GO:0006855)	8	0	.41	-	 < 0.01	6.65E-01
mitochondrial pyruvate transmembrane transport (GO:0006850)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of activated T cell proliferation (GO:0046007)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	2	0	.10	-	 < 0.01	9.03E-01
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	2	0	.10	-	 < 0.01	9.03E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	0	.05	-	 < 0.01	9.50E-01
purine nucleoside bisphosphate catabolic process (GO:0034034)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to norepinephrine stimulus (GO:0071874)	2	0	.10	-	 < 0.01	9.03E-01
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	2	0	.10	-	 < 0.01	9.03E-01
ribonucleoside bisphosphate catabolic process (GO:0034031)	5	0	.26	-	 < 0.01	7.75E-01
response to norepinephrine (GO:0071873)	3	0	.15	-	 < 0.01	8.58E-01
heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.05	-	 < 0.01	9.50E-01
carnitine transmembrane transport (GO:1902603)	4	0	.20	-	 < 0.01	8.15E-01
pyruvate transport (GO:0006848)	5	0	.26	-	 < 0.01	7.75E-01
acyl carnitine transport (GO:0006844)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.05	-	 < 0.01	9.50E-01
tricarboxylic acid transport (GO:0006842)	3	0	.15	-	 < 0.01	8.58E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	8	0	.41	-	 < 0.01	6.65E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	8	0	.41	-	 < 0.01	6.65E-01
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	17	0	.87	-	 < 0.01	4.19E-01
specification of animal organ identity (GO:0010092)	17	0	.87	-	 < 0.01	4.19E-01
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of lipid transporter activity (GO:0110114)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lipid transporter activity (GO:0110113)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lipid transporter activity (GO:0110112)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cell proliferation in bone marrow (GO:0071864)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of animal organ morphogenesis (GO:0110111)	2	0	.10	-	 < 0.01	9.03E-01
response to silicon dioxide (GO:0034021)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cell proliferation in bone marrow (GO:0071863)	7	0	.36	-	 < 0.01	6.99E-01
serotonin transport (GO:0006837)	10	0	.51	-	 < 0.01	6.00E-01
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	3	0	.15	-	 < 0.01	8.58E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	6	0	.31	-	 < 0.01	7.36E-01
polarity specification of proximal/distal axis (GO:0010085)	2	0	.10	-	 < 0.01	9.03E-01
antigen processing and presentation via MHC class Ib (GO:0002475)	13	0	.66	-	 < 0.01	5.15E-01
plasmacytoid dendritic cell antigen processing and presentation (GO:0002470)	1	0	.05	-	 < 0.01	9.50E-01
mRNA alternative polyadenylation (GO:0110104)	3	0	.15	-	 < 0.01	8.58E-01
response to triglyceride (GO:0034014)	1	0	.05	-	 < 0.01	9.50E-01
fungal-type cell wall organization or biogenesis (GO:0071852)	1	0	.05	-	 < 0.01	9.50E-01
mitotic cell cycle arrest (GO:0071850)	16	0	.82	-	 < 0.01	4.41E-01
zinc ion transport (GO:0006829)	27	0	1.38	-	 < 0.01	2.52E-01
copper ion transport (GO:0006825)	16	0	.82	-	 < 0.01	4.41E-01
cobalt ion transport (GO:0006824)	6	0	.31	-	 < 0.01	7.36E-01
dendritic cell antigen processing and presentation (GO:0002468)	1	0	.05	-	 < 0.01	9.50E-01
peripheral tolerance induction (GO:0002465)	2	0	.10	-	 < 0.01	9.03E-01
tolerance induction dependent upon immune response (GO:0002461)	2	0	.10	-	 < 0.01	9.03E-01
zygote asymmetric cell division (GO:0010070)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848)	2	0	.10	-	 < 0.01	9.03E-01
TNFSF11-mediated signaling pathway (GO:0071847)	4	0	.20	-	 < 0.01	8.15E-01
actin filament debranching (GO:0071846)	2	0	.10	-	 < 0.01	9.03E-01
corpus callosum development (GO:0022038)	16	0	.82	-	 < 0.01	4.41E-01
potassium ion transport (GO:0006813)	155	0	7.92	-	 < 0.01	3.51E-04
peripheral T cell tolerance induction (GO:0002458)	1	0	.05	-	 < 0.01	9.50E-01
T cell antigen processing and presentation (GO:0002457)	3	0	.15	-	 < 0.01	8.58E-01
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	38	0	1.94	-	 < 0.01	1.43E-01
peripheral B cell tolerance induction (GO:0002451)	1	0	.05	-	 < 0.01	9.50E-01
apoptotic process in bone marrow cell (GO:0071839)	1	0	.05	-	 < 0.01	9.50E-01
cell proliferation in bone marrow (GO:0071838)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of regulatory T cell differentiation (GO:0045590)	5	0	.26	-	 < 0.01	7.75E-01
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.05	-	 < 0.01	9.50E-01
nitric oxide biosynthetic process (GO:0006809)	17	0	.87	-	 < 0.01	4.19E-01
regulation of nitrogen utilization (GO:0006808)	3	0	.15	-	 < 0.01	8.58E-01
malonyl-CoA catabolic process (GO:2001294)	1	0	.05	-	 < 0.01	9.50E-01
superoxide metabolic process (GO:0006801)	33	0	1.69	-	 < 0.01	1.85E-01
mast cell mediated immunity (GO:0002448)	18	0	.92	-	 < 0.01	3.99E-01
eosinophil mediated immunity (GO:0002447)	3	0	.15	-	 < 0.01	8.58E-01
serotonin secretion involved in inflammatory response (GO:0002442)	3	0	.15	-	 < 0.01	8.58E-01
histamine secretion involved in inflammatory response (GO:0002441)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of gamma-delta T cell differentiation (GO:0045588)	7	0	.36	-	 < 0.01	6.99E-01
regulation of gamma-delta T cell differentiation (GO:0045586)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of cytotoxic T cell differentiation (GO:0045585)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cytotoxic T cell differentiation (GO:0045584)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytotoxic T cell differentiation (GO:0045583)	3	0	.15	-	 < 0.01	8.58E-01
lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of caveolin-mediated endocytosis (GO:2001288)	4	0	.20	-	 < 0.01	8.15E-01
pallium cell proliferation in forebrain (GO:0022013)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of caveolin-mediated endocytosis (GO:2001287)	2	0	.10	-	 < 0.01	9.03E-01
subpallium cell proliferation in forebrain (GO:0022012)	1	0	.05	-	 < 0.01	9.50E-01
regulation of caveolin-mediated endocytosis (GO:2001286)	7	0	.36	-	 < 0.01	6.99E-01
chronic inflammatory response to antigenic stimulus (GO:0002439)	2	0	.10	-	 < 0.01	9.03E-01
response to mycotoxin (GO:0010046)	3	0	.15	-	 < 0.01	8.58E-01
immune complex clearance by monocytes and macrophages (GO:0002436)	1	0	.05	-	 < 0.01	9.50E-01
response to nickel cation (GO:0010045)	1	0	.05	-	 < 0.01	9.50E-01
immune complex clearance by erythrocytes (GO:0002435)	1	0	.05	-	 < 0.01	9.50E-01
response to aluminum ion (GO:0010044)	4	0	.20	-	 < 0.01	8.15E-01
immune complex clearance (GO:0002434)	3	0	.15	-	 < 0.01	8.58E-01
granuloma formation (GO:0002432)	2	0	.10	-	 < 0.01	9.03E-01
response to iron(III) ion (GO:0010041)	5	0	.26	-	 < 0.01	7.75E-01
response to iron(II) ion (GO:0010040)	4	0	.20	-	 < 0.01	8.15E-01
complement receptor mediated signaling pathway (GO:0002430)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of B cell differentiation (GO:0045578)	6	0	.31	-	 < 0.01	7.36E-01
basophil activation (GO:0045575)	3	0	.15	-	 < 0.01	8.58E-01
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	2	0	.10	-	 < 0.01	9.03E-01
central nervous system vasculogenesis (GO:0022009)	5	0	.26	-	 < 0.01	7.75E-01
convergent extension involved in neural plate elongation (GO:0022007)	2	0	.10	-	 < 0.01	9.03E-01
midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.05	-	 < 0.01	9.50E-01
response to iron ion (GO:0010039)	31	0	1.58	-	 < 0.01	2.05E-01
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	2	0	.10	-	 < 0.01	9.03E-01
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	7	0	.36	-	 < 0.01	6.99E-01
response to carbon dioxide (GO:0010037)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	5	0	.26	-	 < 0.01	7.75E-01
immunoglobulin production in mucosal tissue (GO:0002426)	1	0	.05	-	 < 0.01	9.50E-01
response to acetate (GO:0010034)	1	0	.05	-	 < 0.01	9.50E-01
T cell mediated immune response to tumor cell (GO:0002424)	1	0	.05	-	 < 0.01	9.50E-01
meiotic chromosome condensation (GO:0010032)	7	0	.36	-	 < 0.01	6.99E-01
potassium ion transmembrane transport (GO:0071805)	145	0	7.41	-	 < 0.01	5.88E-04
regulation of mammary gland epithelial cell proliferation (GO:0033599)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of podosome assembly (GO:0071803)	11	0	.56	-	 < 0.01	5.70E-01
mammary gland epithelial cell proliferation (GO:0033598)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of podosome assembly (GO:0071802)	1	0	.05	-	 < 0.01	9.50E-01
regulation of podosome assembly (GO:0071801)	15	0	.77	-	 < 0.01	4.65E-01
response to genistein (GO:0033595)	2	0	.10	-	 < 0.01	9.03E-01
response to hydroxyisoflavone (GO:0033594)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	6	0	.31	-	 < 0.01	7.36E-01
response to L-ascorbic acid (GO:0033591)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	17	0	.87	-	 < 0.01	4.19E-01
response to cobalamin (GO:0033590)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of C-C chemokine binding (GO:2001264)	1	0	.05	-	 < 0.01	9.50E-01
regulation of C-C chemokine binding (GO:2001263)	1	0	.05	-	 < 0.01	9.50E-01
T cell mediated cytotoxicity directed against tumor cell target (GO:0002419)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.05	-	 < 0.01	9.50E-01
immune response to tumor cell (GO:0002418)	4	0	.20	-	 < 0.01	8.15E-01
regulation of semaphorin-plexin signaling pathway (GO:2001260)	3	0	.15	-	 < 0.01	8.58E-01
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor (GO:0002416)	1	0	.05	-	 < 0.01	9.50E-01
wax biosynthetic process (GO:0010025)	3	0	.15	-	 < 0.01	8.58E-01
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415)	2	0	.10	-	 < 0.01	9.03E-01
immunoglobulin transcytosis in epithelial cells (GO:0002414)	3	0	.15	-	 < 0.01	8.58E-01
amylopectin biosynthetic process (GO:0010021)	1	0	.05	-	 < 0.01	9.50E-01
regulation of store-operated calcium entry (GO:2001256)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of histone H3-K36 trimethylation (GO:2001255)	2	0	.10	-	 < 0.01	9.03E-01
regulation of histone H3-K36 trimethylation (GO:2001253)	2	0	.10	-	 < 0.01	9.03E-01
myeloid dendritic cell chemotaxis (GO:0002408)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to meiotic spindle midzone (GO:1903096)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.15	-	 < 0.01	8.58E-01
protein glycosylation in endoplasmic reticulum (GO:0033577)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ammonia assimilation cycle (GO:2001248)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.05	-	 < 0.01	9.50E-01
siderophore biosynthetic process (GO:0019290)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082)	1	0	.05	-	 < 0.01	9.50E-01
regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080)	1	0	.05	-	 < 0.01	9.50E-01
DNA replication, Okazaki fragment processing (GO:0033567)	2	0	.10	-	 < 0.01	9.03E-01
gamma-tubulin complex localization (GO:0033566)	2	0	.10	-	 < 0.01	9.03E-01
anterior/posterior axon guidance (GO:0033564)	6	0	.31	-	 < 0.01	7.36E-01
dorsal/ventral axon guidance (GO:0033563)	3	0	.15	-	 < 0.01	8.58E-01
abducens nerve formation (GO:0021599)	2	0	.10	-	 < 0.01	9.03E-01
abducens nerve morphogenesis (GO:0021598)	2	0	.10	-	 < 0.01	9.03E-01
rhombomere structural organization (GO:0021595)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere formation (GO:0021594)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere morphogenesis (GO:0021593)	2	0	.10	-	 < 0.01	9.03E-01
fourth ventricle development (GO:0021592)	2	0	.10	-	 < 0.01	9.03E-01
ventricular system development (GO:0021591)	29	0	1.48	-	 < 0.01	2.27E-01
cerebellum maturation (GO:0021590)	4	0	.20	-	 < 0.01	8.15E-01
glycine betaine biosynthetic process from choline (GO:0019285)	2	0	.10	-	 < 0.01	9.03E-01
L-methionine salvage from S-adenosylmethionine (GO:0019284)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.05	-	 < 0.01	9.50E-01
regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of response to gamma radiation (GO:2001229)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to gamma radiation (GO:2001228)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of chloride transport (GO:2001226)	3	0	.15	-	 < 0.01	8.58E-01
cerebellum structural organization (GO:0021589)	2	0	.10	-	 < 0.01	9.03E-01
cerebellum formation (GO:0021588)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neuron migration (GO:2001224)	14	0	.72	-	 < 0.01	4.89E-01
cerebellum morphogenesis (GO:0021587)	39	0	1.99	-	 < 0.01	1.36E-01
negative regulation of neuron migration (GO:2001223)	11	0	.56	-	 < 0.01	5.70E-01
pons maturation (GO:0021586)	3	0	.15	-	 < 0.01	8.58E-01
regulation of neuron migration (GO:2001222)	42	0	2.15	-	 < 0.01	1.17E-01
UDP-N-acetylgalactosamine metabolic process (GO:0019276)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of protein lipidation (GO:1903061)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of protein lipidation (GO:1903060)	2	0	.10	-	 < 0.01	9.03E-01
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	14	0	.72	-	 < 0.01	4.89E-01
hindbrain maturation (GO:0021578)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of vasculogenesis (GO:2001214)	11	0	.56	-	 < 0.01	5.70E-01
hindbrain structural organization (GO:0021577)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of vasculogenesis (GO:2001213)	2	0	.10	-	 < 0.01	9.03E-01
hindbrain formation (GO:0021576)	1	0	.05	-	 < 0.01	9.50E-01
regulation of vasculogenesis (GO:2001212)	16	0	.82	-	 < 0.01	4.41E-01
hindbrain morphogenesis (GO:0021575)	42	0	2.15	-	 < 0.01	1.17E-01
rhombomere 6 development (GO:0021572)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere 5 development (GO:0021571)	3	0	.15	-	 < 0.01	8.58E-01
rhombomere 4 development (GO:0021570)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein lipidation (GO:1903059)	7	0	.36	-	 < 0.01	6.99E-01
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	2	0	.10	-	 < 0.01	9.03E-01
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.10	-	 < 0.01	9.03E-01
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	1	0	.05	-	 < 0.01	9.50E-01
glycine biosynthetic process from serine (GO:0019264)	2	0	.10	-	 < 0.01	9.03E-01
regulation of melanosome organization (GO:1903056)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	6	0	.31	-	 < 0.01	7.36E-01
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	2	0	.10	-	 < 0.01	9.03E-01
regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	5	0	.26	-	 < 0.01	7.75E-01
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	15	0	.77	-	 < 0.01	4.65E-01
regulation of systemic arterial blood pressure by hormone (GO:0001990)	37	0	1.89	-	 < 0.01	1.51E-01
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	8	0	.41	-	 < 0.01	6.65E-01
sperm individualization (GO:0007291)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transcription elongation by RNA polymerase I (GO:2001208)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription elongation from RNA polymerase I promoter (GO:2001207)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of osteoclast development (GO:2001206)	5	0	.26	-	 < 0.01	7.75E-01
rhombomere 3 development (GO:0021569)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of osteoclast development (GO:2001205)	5	0	.26	-	 < 0.01	7.75E-01
rhombomere 2 development (GO:0021568)	2	0	.10	-	 < 0.01	9.03E-01
regulation of osteoclast development (GO:2001204)	12	0	.61	-	 < 0.01	5.42E-01
hypoglossal nerve development (GO:0021566)	1	0	.05	-	 < 0.01	9.50E-01
vagus nerve development (GO:0021564)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dendritic cell differentiation (GO:2001200)	4	0	.20	-	 < 0.01	8.15E-01
glossopharyngeal nerve development (GO:0021563)	4	0	.20	-	 < 0.01	8.15E-01
vestibulocochlear nerve development (GO:0021562)	8	0	.41	-	 < 0.01	6.65E-01
facial nerve development (GO:0021561)	11	0	.56	-	 < 0.01	5.70E-01
abducens nerve development (GO:0021560)	2	0	.10	-	 < 0.01	9.03E-01
regulation of acetylcholine-gated cation channel activity (GO:1903048)	1	0	.05	-	 < 0.01	9.50E-01
glucose 1-phosphate metabolic process (GO:0019255)	2	0	.10	-	 < 0.01	9.03E-01
carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.15	-	 < 0.01	8.58E-01
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to membrane raft (GO:1903044)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of chondrocyte hypertrophy (GO:1903043)	1	0	.05	-	 < 0.01	9.50E-01
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	0	.05	-	 < 0.01	9.50E-01
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	2	0	.10	-	 < 0.01	9.03E-01
regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.05	-	 < 0.01	9.50E-01
sperm axoneme assembly (GO:0007288)	12	0	.61	-	 < 0.01	5.42E-01
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	1	0	.05	-	 < 0.01	9.50E-01
spermatogonial cell division (GO:0007284)	2	0	.10	-	 < 0.01	9.03E-01
histone H2B ubiquitination (GO:0033523)	10	0	.51	-	 < 0.01	6.00E-01
trigeminal nerve development (GO:0021559)	9	0	.46	-	 < 0.01	6.31E-01
trochlear nerve development (GO:0021558)	2	0	.10	-	 < 0.01	9.03E-01
oculomotor nerve development (GO:0021557)	3	0	.15	-	 < 0.01	8.58E-01
midbrain-hindbrain boundary morphogenesis (GO:0021555)	3	0	.15	-	 < 0.01	8.58E-01
optic nerve development (GO:0021554)	12	0	.61	-	 < 0.01	5.42E-01
olfactory nerve development (GO:0021553)	4	0	.20	-	 < 0.01	8.15E-01
central nervous system morphogenesis (GO:0021551)	2	0	.10	-	 < 0.01	9.03E-01
medulla oblongata development (GO:0021550)	2	0	.10	-	 < 0.01	9.03E-01
regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979)	1	0	.05	-	 < 0.01	9.50E-01
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	2	0	.10	-	 < 0.01	9.03E-01
lactate biosynthetic process from pyruvate (GO:0019244)	1	0	.05	-	 < 0.01	9.50E-01
renal system process involved in regulation of blood volume (GO:0001977)	16	0	.82	-	 < 0.01	4.41E-01
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	3	0	.15	-	 < 0.01	8.58E-01
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	12	0	.61	-	 < 0.01	5.42E-01
methylglyoxal biosynthetic process (GO:0019242)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of microtubule plus-end binding (GO:1903033)	2	0	.10	-	 < 0.01	9.03E-01
citrulline biosynthetic process (GO:0019240)	4	0	.20	-	 < 0.01	8.15E-01
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	7	0	.36	-	 < 0.01	6.99E-01
regulation of microtubule plus-end binding (GO:1903031)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of activation of membrane attack complex (GO:0001971)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of activation of membrane attack complex (GO:0001970)	2	0	.10	-	 < 0.01	9.03E-01
neuromuscular synaptic transmission (GO:0007274)	22	0	1.12	-	 < 0.01	3.25E-01
synaptic transmission, cholinergic (GO:0007271)	23	0	1.17	-	 < 0.01	3.09E-01
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.05	-	 < 0.01	9.50E-01
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512)	3	0	.15	-	 < 0.01	8.58E-01
midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.05	-	 < 0.01	9.50E-01
rhombomere development (GO:0021546)	7	0	.36	-	 < 0.01	6.99E-01
cranial nerve development (GO:0021545)	47	0	2.40	-	 < 0.01	9.03E-02
subpallium development (GO:0021544)	25	0	1.28	-	 < 0.01	2.79E-01
ammon gyrus development (GO:0021541)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric glomerulus development (GO:0072298)	3	0	.15	-	 < 0.01	8.58E-01
corpus callosum morphogenesis (GO:0021540)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of opsonization (GO:1903028)	2	0	.10	-	 < 0.01	9.03E-01
regulation of activation of membrane attack complex (GO:0001969)	4	0	.20	-	 < 0.01	8.15E-01
regulation of opsonization (GO:1903027)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	6	0	.31	-	 < 0.01	7.36E-01
thigmotaxis (GO:0001966)	2	0	.10	-	 < 0.01	9.03E-01
proprioception (GO:0019230)	4	0	.20	-	 < 0.01	8.15E-01
synaptic transmission, dopaminergic (GO:0001963)	14	0	.72	-	 < 0.01	4.89E-01
nitric oxide mediated signal transduction (GO:0007263)	21	0	1.07	-	 < 0.01	3.42E-01
floor plate morphogenesis (GO:0033505)	3	0	.15	-	 < 0.01	8.58E-01
floor plate development (GO:0033504)	10	0	.51	-	 < 0.01	6.00E-01
subthalamus development (GO:0021539)	1	0	.05	-	 < 0.01	9.50E-01
epithalamus development (GO:0021538)	3	0	.15	-	 < 0.01	8.58E-01
cell proliferation in hindbrain (GO:0021534)	8	0	.41	-	 < 0.01	6.65E-01
cell differentiation in hindbrain (GO:0021533)	22	0	1.12	-	 < 0.01	3.25E-01
neural tube patterning (GO:0021532)	35	0	1.79	-	 < 0.01	1.67E-01
metanephric nephron tubule formation (GO:0072289)	4	0	.20	-	 < 0.01	8.15E-01
neuronal action potential (GO:0019228)	28	0	1.43	-	 < 0.01	2.39E-01
neuronal action potential propagation (GO:0019227)	7	0	.36	-	 < 0.01	6.99E-01
spinal cord oligodendrocyte cell fate specification (GO:0021530)	3	0	.15	-	 < 0.01	8.58E-01
metanephric distal tubule morphogenesis (GO:0072287)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glycoprotein metabolic process (GO:1903019)	14	0	.72	-	 < 0.01	4.89E-01
transmission of nerve impulse (GO:0019226)	53	0	2.71	-	 < 0.01	6.64E-02
metanephric connecting tubule development (GO:0072286)	1	0	.05	-	 < 0.01	9.50E-01
mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of exo-alpha-sialidase activity (GO:1903017)	1	0	.05	-	 < 0.01	9.50E-01
metanephric S-shaped body morphogenesis (GO:0072284)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	0	.10	-	 < 0.01	9.03E-01
intramembranous ossification (GO:0001957)	6	0	.31	-	 < 0.01	7.36E-01
metanephric renal vesicle morphogenesis (GO:0072283)	11	0	.56	-	 < 0.01	5.70E-01
regulation of exo-alpha-sialidase activity (GO:1903015)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of neurotransmitter secretion (GO:0001956)	18	0	.92	-	 < 0.01	3.99E-01
blood vessel maturation (GO:0001955)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of bone development (GO:1903012)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of bone development (GO:1903011)	1	0	.05	-	 < 0.01	9.50E-01
JUN phosphorylation (GO:0007258)	4	0	.20	-	 < 0.01	8.15E-01
regulation of bone development (GO:1903010)	7	0	.36	-	 < 0.01	6.99E-01
intestinal D-glucose absorption (GO:0001951)	2	0	.10	-	 < 0.01	9.03E-01
spinal cord oligodendrocyte cell differentiation (GO:0021529)	5	0	.26	-	 < 0.01	7.75E-01
commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.05	-	 < 0.01	9.50E-01
spinal cord association neuron differentiation (GO:0021527)	14	0	.72	-	 < 0.01	4.89E-01
medial motor column neuron differentiation (GO:0021526)	2	0	.10	-	 < 0.01	9.03E-01
visceral motor neuron differentiation (GO:0021524)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.05	-	 < 0.01	9.50E-01
somatic motor neuron differentiation (GO:0021523)	6	0	.31	-	 < 0.01	7.36E-01
regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.05	-	 < 0.01	9.50E-01
spinal cord motor neuron differentiation (GO:0021522)	34	0	1.74	-	 < 0.01	1.76E-01
ventral spinal cord interneuron specification (GO:0021521)	8	0	.41	-	 < 0.01	6.65E-01
metanephric comma-shaped body morphogenesis (GO:0072278)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.05	-	 < 0.01	9.50E-01
spinal cord motor neuron cell fate specification (GO:0021520)	11	0	.56	-	 < 0.01	5.70E-01
metanephric glomerular capillary formation (GO:0072277)	3	0	.15	-	 < 0.01	8.58E-01
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	7	0	.36	-	 < 0.01	6.99E-01
metanephric glomerulus vasculature morphogenesis (GO:0072276)	3	0	.15	-	 < 0.01	8.58E-01
cell proliferation involved in heart valve development (GO:2000793)	1	0	.05	-	 < 0.01	9.50E-01
sebaceous gland cell differentiation (GO:0001949)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerulus morphogenesis (GO:0072275)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerular basement membrane development (GO:0072274)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein K63-linked deubiquitination (GO:1903006)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.10	-	 < 0.01	9.03E-01
proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein K63-linked deubiquitination (GO:1903004)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.05	-	 < 0.01	9.50E-01
xenobiotic glucuronidation (GO:0052697)	2	0	.10	-	 < 0.01	9.03E-01
cellular glucuronidation (GO:0052695)	9	0	.46	-	 < 0.01	6.31E-01
spinal cord association neuron specification (GO:0021519)	1	0	.05	-	 < 0.01	9.50E-01
ventral spinal cord development (GO:0021517)	46	0	2.35	-	 < 0.01	9.51E-02
dorsal spinal cord development (GO:0021516)	20	0	1.02	-	 < 0.01	3.60E-01
ventral spinal cord interneuron differentiation (GO:0021514)	14	0	.72	-	 < 0.01	4.89E-01
spinal cord dorsal/ventral patterning (GO:0021513)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of autophagosome assembly (GO:2000786)	9	0	.46	-	 < 0.01	6.31E-01
spinal cord patterning (GO:0021511)	20	0	1.02	-	 < 0.01	3.60E-01
pattern specification involved in metanephros development (GO:0072268)	4	0	.20	-	 < 0.01	8.15E-01
metanephric capsule specification (GO:0072267)	1	0	.05	-	 < 0.01	9.50E-01
metanephric capsule formation (GO:0072266)	1	0	.05	-	 < 0.01	9.50E-01
metanephric capsule morphogenesis (GO:0072265)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of sarcomere organization (GO:0060299)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of sarcomere organization (GO:0060298)	3	0	.15	-	 < 0.01	8.58E-01
regulation of sarcomere organization (GO:0060297)	6	0	.31	-	 < 0.01	7.36E-01
osmosensory signaling pathway (GO:0007231)	4	0	.20	-	 < 0.01	8.15E-01
transdifferentiation (GO:0060290)	7	0	.36	-	 < 0.01	6.99E-01
roof plate formation (GO:0021509)	1	0	.05	-	 < 0.01	9.50E-01
floor plate formation (GO:0021508)	2	0	.10	-	 < 0.01	9.03E-01
neural fold bending (GO:0021503)	1	0	.05	-	 < 0.01	9.50E-01
neural fold elevation formation (GO:0021502)	3	0	.15	-	 < 0.01	8.58E-01
metanephric interstitial fibroblast development (GO:0072259)	1	0	.05	-	 < 0.01	9.50E-01
prechordal plate formation (GO:0021501)	1	0	.05	-	 < 0.01	9.50E-01
metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-S10 phosphorylation involved in chromosome condensation (GO:2000775)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular senescence (GO:2000774)	11	0	.56	-	 < 0.01	5.70E-01
metanephric glomerular mesangial cell development (GO:0072255)	1	0	.05	-	 < 0.01	9.50E-01
regulation of exocyst assembly (GO:0001928)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerular mesangial cell differentiation (GO:0072254)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	1	0	.05	-	 < 0.01	9.50E-01
B-1 B cell differentiation (GO:0001923)	5	0	.26	-	 < 0.01	7.75E-01
B-1 B cell homeostasis (GO:0001922)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of hh target transcription factor activity (GO:0007228)	3	0	.15	-	 < 0.01	8.58E-01
signal transduction downstream of smoothened (GO:0007227)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of oocyte development (GO:0060283)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of oocyte development (GO:0060282)	2	0	.10	-	 < 0.01	9.03E-01
regulation of oocyte development (GO:0060281)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of ovulation (GO:0060280)	1	0	.05	-	 < 0.01	9.50E-01
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cytoplasmic translation (GO:2000767)	11	0	.56	-	 < 0.01	5.70E-01
metanephric glomerular visceral epithelial cell development (GO:0072249)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cytoplasmic translation (GO:2000766)	8	0	.41	-	 < 0.01	6.65E-01
metanephric glomerular visceral epithelial cell differentiation (GO:0072248)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cytoplasmic translation (GO:2000765)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerular epithelium development (GO:0072244)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of T cell mediated cytotoxicity (GO:0001916)	27	0	1.38	-	 < 0.01	2.52E-01
metanephric DCT cell differentiation (GO:0072240)	1	0	.05	-	 < 0.01	9.50E-01
T cell mediated cytotoxicity (GO:0001913)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of ovulation (GO:0060279)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	50	0	2.55	-	 < 0.01	7.75E-02
neuropeptide signaling pathway (GO:0007218)	98	0	5.01	-	 < 0.01	6.60E-03
regulation of ovulation (GO:0060278)	3	0	.15	-	 < 0.01	8.58E-01
tachykinin receptor signaling pathway (GO:0007217)	8	0	.41	-	 < 0.01	6.65E-01
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	15	0	.77	-	 < 0.01	4.65E-01
gamma-aminobutyric acid signaling pathway (GO:0007214)	25	0	1.28	-	 < 0.01	2.79E-01
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	18	0	.92	-	 < 0.01	3.99E-01
embryonic skeletal joint morphogenesis (GO:0060272)	11	0	.56	-	 < 0.01	5.70E-01
serotonin receptor signaling pathway (GO:0007210)	31	0	1.58	-	 < 0.01	2.05E-01
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	0	.05	-	 < 0.01	9.50E-01
metanephric glomerulus vasculature development (GO:0072239)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of sphingomyelin catabolic process (GO:2000755)	2	0	.10	-	 < 0.01	9.03E-01
metanephric proximal tubule development (GO:0072237)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sphingomyelin catabolic process (GO:2000754)	2	0	.10	-	 < 0.01	9.03E-01
metanephric loop of Henle development (GO:0072236)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.05	-	 < 0.01	9.50E-01
metanephric distal tubule development (GO:0072235)	7	0	.36	-	 < 0.01	6.99E-01
regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.05	-	 < 0.01	9.50E-01
killing by symbiont of host cells (GO:0001907)	3	0	.15	-	 < 0.01	8.58E-01
metanephric thick ascending limb development (GO:0072233)	2	0	.10	-	 < 0.01	9.03E-01
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of respiratory burst (GO:0060268)	5	0	.26	-	 < 0.01	7.75E-01
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway (GO:0007207)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of respiratory burst (GO:0060267)	7	0	.36	-	 < 0.01	6.99E-01
phospholipase C-activating G protein-coupled glutamate receptor signaling pathway (GO:0007206)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	0	.10	-	 < 0.01	9.03E-01
regulation of DNA replication origin binding (GO:1902595)	2	0	.10	-	 < 0.01	9.03E-01
regulation of respiratory burst involved in inflammatory response (GO:0060264)	5	0	.26	-	 < 0.01	7.75E-01
regulation of respiratory burst (GO:0060263)	15	0	.77	-	 < 0.01	4.65E-01
activation of phospholipase C activity (GO:0007202)	34	0	1.74	-	 < 0.01	1.76E-01
negative regulation of N-terminal protein palmitoylation (GO:0060262)	1	0	.05	-	 < 0.01	9.50E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	91	0	4.65	-	 < 0.01	9.46E-03
monoacylglycerol catabolic process (GO:0052651)	5	0	.26	-	 < 0.01	7.75E-01
metanephric proximal convoluted tubule development (GO:0072229)	1	0	.05	-	 < 0.01	9.50E-01
metanephric macula densa development (GO:0072227)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of anterior head development (GO:2000744)	2	0	.10	-	 < 0.01	9.03E-01
regulation of anterior head development (GO:2000742)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.20	-	 < 0.01	8.15E-01
metanephric glomerular mesangium development (GO:0072223)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	1	0	.05	-	 < 0.01	9.50E-01
metanephric distal convoluted tubule development (GO:0072221)	5	0	.26	-	 < 0.01	7.75E-01
regulation of feeding behavior (GO:0060259)	21	0	1.07	-	 < 0.01	3.42E-01
alditol phosphate metabolic process (GO:0052646)	10	0	.51	-	 < 0.01	6.00E-01
regulation of N-terminal protein palmitoylation (GO:0060254)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glial cell proliferation (GO:0060252)	15	0	.77	-	 < 0.01	4.65E-01
regulation of mesenchymal stem cell differentiation (GO:2000739)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of stem cell differentiation (GO:2000738)	18	0	.92	-	 < 0.01	3.99E-01
metanephric cortical collecting duct development (GO:0072219)	1	0	.05	-	 < 0.01	9.50E-01
metanephric ascending thin limb development (GO:0072218)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of metanephros development (GO:0072217)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of metanephros development (GO:0072216)	3	0	.15	-	 < 0.01	8.58E-01
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephros development (GO:0072215)	6	0	.31	-	 < 0.01	7.36E-01
metanephric cortex development (GO:0072214)	1	0	.05	-	 < 0.01	9.50E-01
metanephric capsule development (GO:0072213)	1	0	.05	-	 < 0.01	9.50E-01
regulation of termination of RNA polymerase I transcription (GO:2000730)	1	0	.05	-	 < 0.01	9.50E-01
regulation of calcium import into the mitochondrion (GO:0110097)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hippocampal neuron apoptotic process (GO:0110091)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of hippocampal neuron apoptotic process (GO:0110090)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cell growth involved in contact inhibition (GO:0060243)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of serine-type peptidase activity (GO:1902573)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of serine-type peptidase activity (GO:1902572)	5	0	.26	-	 < 0.01	7.75E-01
regulation of serine-type peptidase activity (GO:1902571)	6	0	.31	-	 < 0.01	7.36E-01
protein localization to nucleolus (GO:1902570)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardiac muscle cell differentiation (GO:2000727)	10	0	.51	-	 < 0.01	6.00E-01
metanephric mesangial cell differentiation (GO:0072209)	2	0	.10	-	 < 0.01	9.03E-01
metanephric smooth muscle tissue development (GO:0072208)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	2	0	.10	-	 < 0.01	9.03E-01
metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.05	-	 < 0.01	9.50E-01
metanephric collecting duct development (GO:0072205)	10	0	.51	-	 < 0.01	6.00E-01
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	3	0	.15	-	 < 0.01	8.58E-01
regulation of hippocampal neuron apoptotic process (GO:0110089)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721)	3	0	.15	-	 < 0.01	8.58E-01
cell proliferation involved in metanephros development (GO:0072203)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of mesenchymal cell proliferation (GO:0072201)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of activation of Janus kinase activity (GO:1902569)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of eosinophil activation (GO:1902567)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neutrophil activation (GO:1902565)	5	0	.26	-	 < 0.01	7.75E-01
neuroblast delamination (GO:0060234)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neutrophil activation (GO:1902564)	5	0	.26	-	 < 0.01	7.75E-01
regulation of neutrophil activation (GO:1902563)	13	0	.66	-	 < 0.01	5.15E-01
delamination (GO:0060232)	5	0	.26	-	 < 0.01	7.75E-01
vesicle-mediated intercellular transport (GO:0110077)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ferroptosis (GO:0110076)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ferroptosis (GO:0110075)	2	0	.10	-	 < 0.01	9.03E-01
3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of catalase activity (GO:1902553)	1	0	.05	-	 < 0.01	9.50E-01
retinal rod cell differentiation (GO:0060221)	14	0	.72	-	 < 0.01	4.89E-01
regulation of catalase activity (GO:1902551)	1	0	.05	-	 < 0.01	9.50E-01
polyphosphate catabolic process (GO:0006798)	4	0	.20	-	 < 0.01	8.15E-01
polyphosphate metabolic process (GO:0006797)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of dense core granule biogenesis (GO:2000707)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dense core granule biogenesis (GO:2000705)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.05	-	 < 0.01	9.50E-01
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.05	-	 < 0.01	9.50E-01
camera-type eye photoreceptor cell differentiation (GO:0060219)	26	0	1.33	-	 < 0.01	2.65E-01
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	12	0	.61	-	 < 0.01	5.42E-01
hemangioblast cell differentiation (GO:0060217)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of angiotensin-activated signaling pathway (GO:0110061)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.05	-	 < 0.01	9.50E-01
primitive hemopoiesis (GO:0060215)	6	0	.31	-	 < 0.01	7.36E-01
endocardium formation (GO:0060214)	4	0	.20	-	 < 0.01	8.15E-01
regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.15	-	 < 0.01	8.58E-01
heme oxidation (GO:0006788)	2	0	.10	-	 < 0.01	9.03E-01
porphyrin-containing compound catabolic process (GO:0006787)	14	0	.72	-	 < 0.01	4.89E-01
heme A biosynthetic process (GO:0006784)	2	0	.10	-	 < 0.01	9.03E-01
heme biosynthetic process (GO:0006783)	26	0	1.33	-	 < 0.01	2.65E-01
protoporphyrinogen IX biosynthetic process (GO:0006782)	9	0	.46	-	 < 0.01	6.31E-01
succinyl-CoA pathway (GO:0006781)	1	0	.05	-	 < 0.01	9.50E-01
uroporphyrinogen III biosynthetic process (GO:0006780)	2	0	.10	-	 < 0.01	9.03E-01
porphyrin-containing compound biosynthetic process (GO:0006779)	29	0	1.48	-	 < 0.01	2.27E-01
porphyrin-containing compound metabolic process (GO:0006778)	45	0	2.30	-	 < 0.01	1.00E-01
positive regulation of protein linear polyubiquitination (GO:1902530)	1	0	.05	-	 < 0.01	9.50E-01
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	6	0	.31	-	 < 0.01	7.36E-01
thiamine metabolic process (GO:0006772)	4	0	.20	-	 < 0.01	8.15E-01
riboflavin metabolic process (GO:0006771)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to prostaglandin D stimulus (GO:0071799)	3	0	.15	-	 < 0.01	8.58E-01
response to prostaglandin D (GO:0071798)	3	0	.15	-	 < 0.01	8.58E-01
regulation of protein linear polyubiquitination (GO:1902528)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein monoubiquitination (GO:1902527)	5	0	.26	-	 < 0.01	7.75E-01
regulation of protein monoubiquitination (GO:1902525)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of protein K63-linked ubiquitination (GO:1902523)	4	0	.20	-	 < 0.01	8.15E-01
endoplasmic reticulum tubular network formation (GO:0071787)	4	0	.20	-	 < 0.01	8.15E-01
endoplasmic reticulum tubular network organization (GO:0071786)	14	0	.72	-	 < 0.01	4.89E-01
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	11	0	.56	-	 < 0.01	5.70E-01
regulation of organelle transport along microtubule (GO:1902513)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of apoptotic DNA fragmentation (GO:1902512)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of apoptotic DNA fragmentation (GO:1902511)	2	0	.10	-	 < 0.01	9.03E-01
regulation of apoptotic DNA fragmentation (GO:1902510)	9	0	.46	-	 < 0.01	6.31E-01
glutathione catabolic process (GO:0006751)	5	0	.26	-	 < 0.01	7.75E-01
MHC class II protein complex assembly (GO:0002399)	4	0	.20	-	 < 0.01	8.15E-01
MHC class Ib protein complex assembly (GO:0002398)	1	0	.05	-	 < 0.01	9.50E-01
MHC class I protein complex assembly (GO:0002397)	3	0	.15	-	 < 0.01	8.58E-01
MHC protein complex assembly (GO:0002396)	7	0	.36	-	 < 0.01	6.99E-01
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	2	0	.10	-	 < 0.01	9.03E-01
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.05	-	 < 0.01	9.50E-01
DNA strand resection involved in replication fork processing (GO:0110025)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cardiac muscle myoblast proliferation (GO:0110022)	3	0	.15	-	 < 0.01	8.58E-01
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.05	-	 < 0.01	9.50E-01
FAD biosynthetic process (GO:0006747)	1	0	.05	-	 < 0.01	9.50E-01
NADP catabolic process (GO:0006742)	1	0	.05	-	 < 0.01	9.50E-01
NADP biosynthetic process (GO:0006741)	3	0	.15	-	 < 0.01	8.58E-01
NADPH regeneration (GO:0006740)	14	0	.72	-	 < 0.01	4.89E-01
immune response in gut-associated lymphoid tissue (GO:0002387)	2	0	.10	-	 < 0.01	9.03E-01
immune response in mucosal-associated lymphoid tissue (GO:0002386)	4	0	.20	-	 < 0.01	8.15E-01
mucosal immune response (GO:0002385)	26	0	1.33	-	 < 0.01	2.65E-01
hepatic immune response (GO:0002384)	2	0	.10	-	 < 0.01	9.03E-01
immune response in brain or nervous system (GO:0002383)	1	0	.05	-	 < 0.01	9.50E-01
immunoglobulin secretion involved in immune response (GO:0002380)	1	0	.05	-	 < 0.01	9.50E-01
nuclear inner membrane organization (GO:0071765)	1	0	.05	-	 < 0.01	9.50E-01
nuclear membrane organization (GO:0071763)	11	0	.56	-	 < 0.01	5.70E-01
NADP metabolic process (GO:0006739)	28	0	1.43	-	 < 0.01	2.39E-01
nicotinamide riboside catabolic process (GO:0006738)	1	0	.05	-	 < 0.01	9.50E-01
immunoglobulin biosynthetic process involved in immune response (GO:0002379)	1	0	.05	-	 < 0.01	9.50E-01
cytokine secretion involved in immune response (GO:0002374)	4	0	.20	-	 < 0.01	8.15E-01
dendritic cell cytokine production (GO:0002371)	1	0	.05	-	 < 0.01	9.50E-01
formin-nucleated actin cable organization (GO:0110009)	3	0	.15	-	 < 0.01	8.58E-01
triterpenoid metabolic process (GO:0006722)	2	0	.10	-	 < 0.01	9.03E-01
NK T cell lineage commitment (GO:0002364)	1	0	.05	-	 < 0.01	9.50E-01
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	2	0	.10	-	 < 0.01	9.03E-01
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	4	0	.20	-	 < 0.01	8.15E-01
sesquiterpenoid metabolic process (GO:0006714)	3	0	.15	-	 < 0.01	8.58E-01
estrogen catabolic process (GO:0006711)	1	0	.05	-	 < 0.01	9.50E-01
B cell homeostatic proliferation (GO:0002358)	2	0	.10	-	 < 0.01	9.03E-01
defense response to tumor cell (GO:0002357)	4	0	.20	-	 < 0.01	8.15E-01
detection of tumor cell (GO:0002355)	1	0	.05	-	 < 0.01	9.50E-01
plasma kallikrein-kinin cascade (GO:0002353)	3	0	.15	-	 < 0.01	8.58E-01
B cell negative selection (GO:0002352)	2	0	.10	-	 < 0.01	9.03E-01
serotonin production involved in inflammatory response (GO:0002351)	3	0	.15	-	 < 0.01	8.58E-01
transcriptional activation by promoter-enhancer looping (GO:0071733)	4	0	.20	-	 < 0.01	8.15E-01
cholesterol catabolic process (GO:0006707)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of dendritic cell differentiation (GO:2001199)	6	0	.31	-	 < 0.01	7.36E-01
regulation of dendritic cell differentiation (GO:2001198)	12	0	.61	-	 < 0.01	5.42E-01
mineralocorticoid biosynthetic process (GO:0006705)	6	0	.31	-	 < 0.01	7.36E-01
glucocorticoid biosynthetic process (GO:0006704)	12	0	.61	-	 < 0.01	5.42E-01
progesterone biosynthetic process (GO:0006701)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of gamma-delta T cell activation involved in immune response (GO:2001193)	1	0	.05	-	 < 0.01	9.50E-01
histamine production involved in inflammatory response (GO:0002349)	2	0	.10	-	 < 0.01	9.03E-01
regulation of gamma-delta T cell activation involved in immune response (GO:2001191)	1	0	.05	-	 < 0.01	9.50E-01
response to tumor cell (GO:0002347)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	3	0	.15	-	 < 0.01	8.58E-01
B cell affinity maturation (GO:0002344)	1	0	.05	-	 < 0.01	9.50E-01
peripheral B cell selection (GO:0002343)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to triacyl bacterial lipopeptide (GO:0071727)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to diacyl bacterial lipopeptide (GO:0071726)	4	0	.20	-	 < 0.01	8.15E-01
response to triacyl bacterial lipopeptide (GO:0071725)	3	0	.15	-	 < 0.01	8.58E-01
response to diacyl bacterial lipopeptide (GO:0071724)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	3	0	.15	-	 < 0.01	8.58E-01
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	6	0	.31	-	 < 0.01	7.36E-01
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	19	0	.97	-	 < 0.01	3.79E-01
B cell selection (GO:0002339)	3	0	.15	-	 < 0.01	8.58E-01
B-1a B cell differentiation (GO:0002337)	2	0	.10	-	 < 0.01	9.03E-01
B-1 B cell lineage commitment (GO:0002336)	1	0	.05	-	 < 0.01	9.50E-01
mature B cell differentiation (GO:0002335)	25	0	1.28	-	 < 0.01	2.79E-01
transitional one stage B cell differentiation (GO:0002333)	1	0	.05	-	 < 0.01	9.50E-01
transitional stage B cell differentiation (GO:0002332)	1	0	.05	-	 < 0.01	9.50E-01
pre-B cell allelic exclusion (GO:0002331)	3	0	.15	-	 < 0.01	8.58E-01
sodium-independent icosanoid transport (GO:0071718)	1	0	.05	-	 < 0.01	9.50E-01
leukotriene transport (GO:0071716)	2	0	.10	-	 < 0.01	9.03E-01
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173)	1	0	.05	-	 < 0.01	9.50E-01
pre-B cell differentiation (GO:0002329)	5	0	.26	-	 < 0.01	7.75E-01
pro-B cell differentiation (GO:0002328)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of ATP biosynthetic process (GO:2001171)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of ATP biosynthetic process (GO:2001170)	3	0	.15	-	 < 0.01	8.58E-01
natural killer cell activation involved in immune response (GO:0002323)	18	0	.92	-	 < 0.01	3.99E-01
B cell proliferation involved in immune response (GO:0002322)	6	0	.31	-	 < 0.01	7.36E-01
lymphoid progenitor cell differentiation (GO:0002320)	12	0	.61	-	 < 0.01	5.42E-01
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	1	0	.05	-	 < 0.01	9.50E-01
tumor necrosis factor superfamily cytokine production (GO:0071706)	9	0	.46	-	 < 0.01	6.31E-01
galactose catabolic process via UDP-galactose (GO:0033499)	3	0	.15	-	 < 0.01	8.58E-01
regulation of MAPK export from nucleus (GO:0071701)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of histone H2B ubiquitination (GO:2001168)	4	0	.20	-	 < 0.01	8.15E-01
regulation of histone H2B ubiquitination (GO:2001166)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.10	-	 < 0.01	9.03E-01
myeloid progenitor cell differentiation (GO:0002318)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.05	-	 < 0.01	9.50E-01
plasma cell differentiation (GO:0002317)	3	0	.15	-	 < 0.01	8.58E-01
regulation of histone H3-K79 methylation (GO:2001160)	3	0	.15	-	 < 0.01	8.58E-01
follicular B cell differentiation (GO:0002316)	1	0	.05	-	 < 0.01	9.50E-01
marginal zone B cell differentiation (GO:0002315)	8	0	.41	-	 < 0.01	6.65E-01
germinal center B cell differentiation (GO:0002314)	6	0	.31	-	 < 0.01	7.36E-01
mature B cell differentiation involved in immune response (GO:0002313)	19	0	.97	-	 < 0.01	3.79E-01
nitric oxide homeostasis (GO:0033484)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of renal water transport (GO:2001153)	1	0	.05	-	 < 0.01	9.50E-01
T cell proliferation involved in immune response (GO:0002309)	4	0	.20	-	 < 0.01	8.15E-01
regulation of renal water transport (GO:2001151)	1	0	.05	-	 < 0.01	9.50E-01
CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	2	0	.10	-	 < 0.01	9.03E-01
gamma-delta intraepithelial T cell differentiation (GO:0002304)	2	0	.10	-	 < 0.01	9.03E-01
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	1	0	.05	-	 < 0.01	9.50E-01
CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.05	-	 < 0.01	9.50E-01
S-methylmethionine metabolic process (GO:0033477)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.05	-	 < 0.01	9.50E-01
nicotinate transport (GO:2001142)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of phospholipid transport (GO:2001140)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of phospholipid transport (GO:2001139)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phospholipid transport (GO:2001138)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of endocytic recycling (GO:2001137)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of endocytic recycling (GO:2001136)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endocytic recycling (GO:2001135)	10	0	.51	-	 < 0.01	6.00E-01
specification of axis polarity (GO:0065001)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045425)	2	0	.10	-	 < 0.01	9.03E-01
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045423)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of translational frameshifting (GO:2001125)	1	0	.05	-	 < 0.01	9.50E-01
regulation of translational frameshifting (GO:2001124)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lens epithelial cell proliferation (GO:2001111)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cytolysis by symbiont of host cells (GO:0001899)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytolysis by symbiont of host cells (GO:0001898)	1	0	.05	-	 < 0.01	9.50E-01
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	2	0	.10	-	 < 0.01	9.03E-01
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	7	0	.36	-	 < 0.01	6.99E-01
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	8	0	.41	-	 < 0.01	6.65E-01
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196)	6	0	.31	-	 < 0.01	7.36E-01
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of adenylate cyclase activity (GO:0007194)	18	0	.92	-	 < 0.01	3.99E-01
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	11	0	.56	-	 < 0.01	5.70E-01
regulation of lens epithelial cell proliferation (GO:2001109)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	4	0	.20	-	 < 0.01	8.15E-01
endothelial cell morphogenesis (GO:0001886)	11	0	.56	-	 < 0.01	5.70E-01
receptor recycling (GO:0001881)	8	0	.41	-	 < 0.01	6.65E-01
Mullerian duct regression (GO:0001880)	4	0	.20	-	 < 0.01	8.15E-01
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	6	0	.31	-	 < 0.01	7.36E-01
SMAD protein complex assembly (GO:0007183)	7	0	.36	-	 < 0.01	6.99E-01
transforming growth factor beta receptor complex assembly (GO:0007181)	3	0	.15	-	 < 0.01	8.58E-01
response to yeast (GO:0001878)	10	0	.51	-	 < 0.01	6.00E-01
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	27	0	1.38	-	 < 0.01	2.52E-01
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	13	0	.66	-	 < 0.01	5.15E-01
signal complex assembly (GO:0007172)	8	0	.41	-	 < 0.01	6.65E-01
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	3	0	.15	-	 < 0.01	8.58E-01
mesenchymal cell proliferation involved in ureter development (GO:0072198)	1	0	.05	-	 < 0.01	9.50E-01
ureter morphogenesis (GO:0072197)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of complement activation, lectin pathway (GO:0001869)	2	0	.10	-	 < 0.01	9.03E-01
regulation of complement activation, lectin pathway (GO:0001868)	2	0	.10	-	 < 0.01	9.03E-01
kidney smooth muscle tissue development (GO:0072194)	2	0	.10	-	 < 0.01	9.03E-01
complement activation, lectin pathway (GO:0001867)	9	0	.46	-	 < 0.01	6.31E-01
ureter smooth muscle cell differentiation (GO:0072193)	3	0	.15	-	 < 0.01	8.58E-01
NK T cell proliferation (GO:0001866)	2	0	.10	-	 < 0.01	9.03E-01
ureter epithelial cell differentiation (GO:0072192)	1	0	.05	-	 < 0.01	9.50E-01
NK T cell differentiation (GO:0001865)	4	0	.20	-	 < 0.01	8.15E-01
ureter smooth muscle development (GO:0072191)	3	0	.15	-	 < 0.01	8.58E-01
ureter urothelium development (GO:0072190)	3	0	.15	-	 < 0.01	8.58E-01
calcium-independent cell-matrix adhesion (GO:0007161)	3	0	.15	-	 < 0.01	8.58E-01
ureter development (GO:0072189)	17	0	.87	-	 < 0.01	4.19E-01
metanephric cap morphogenesis (GO:0072186)	1	0	.05	-	 < 0.01	9.50E-01
metanephric cap development (GO:0072185)	1	0	.05	-	 < 0.01	9.50E-01
renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	2	0	.10	-	 < 0.01	9.03E-01
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	12	0	.61	-	 < 0.01	5.42E-01
mesonephric duct formation (GO:0072181)	2	0	.10	-	 < 0.01	9.03E-01
mesonephric duct morphogenesis (GO:0072180)	4	0	.20	-	 < 0.01	8.15E-01
neuron cell-cell adhesion (GO:0007158)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	4	0	.20	-	 < 0.01	8.15E-01
nephric duct formation (GO:0072179)	5	0	.26	-	 < 0.01	7.75E-01
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	16	0	.82	-	 < 0.01	4.41E-01
nephric duct morphogenesis (GO:0072178)	12	0	.61	-	 < 0.01	5.42E-01
mesonephric duct development (GO:0072177)	9	0	.46	-	 < 0.01	6.31E-01
nephric duct development (GO:0072176)	16	0	.82	-	 < 0.01	4.41E-01
metanephric tubule formation (GO:0072174)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.05	-	 < 0.01	9.50E-01
mesonephric tubule formation (GO:0072172)	8	0	.41	-	 < 0.01	6.65E-01
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844)	7	0	.36	-	 < 0.01	6.99E-01
neural fold formation (GO:0001842)	8	0	.41	-	 < 0.01	6.65E-01
female meiosis II (GO:0007147)	1	0	.05	-	 < 0.01	9.50E-01
neural plate development (GO:0001840)	9	0	.46	-	 < 0.01	6.31E-01
meiotic recombination nodule assembly (GO:0007146)	1	0	.05	-	 < 0.01	9.50E-01
male meiosis I (GO:0007141)	23	0	1.17	-	 < 0.01	3.09E-01
specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.05	-	 < 0.01	9.50E-01
specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular response to X-ray (GO:2000685)	1	0	.05	-	 < 0.01	9.50E-01
specification of mesonephric tubule identity (GO:0072167)	1	0	.05	-	 < 0.01	9.50E-01
posterior mesonephric tubule development (GO:0072166)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cellular response to X-ray (GO:2000683)	2	0	.10	-	 < 0.01	9.03E-01
neural plate morphogenesis (GO:0001839)	6	0	.31	-	 < 0.01	7.36E-01
anterior mesonephric tubule development (GO:0072165)	1	0	.05	-	 < 0.01	9.50E-01
release of cytochrome c from mitochondria (GO:0001836)	22	0	1.12	-	 < 0.01	3.25E-01
male somatic sex determination (GO:0019102)	1	0	.05	-	 < 0.01	9.50E-01
metanephric mesenchymal cell differentiation (GO:0072162)	5	0	.26	-	 < 0.01	7.75E-01
blastocyst hatching (GO:0001835)	23	0	1.17	-	 < 0.01	3.09E-01
female somatic sex determination (GO:0019101)	1	0	.05	-	 < 0.01	9.50E-01
mesenchymal cell differentiation involved in kidney development (GO:0072161)	7	0	.36	-	 < 0.01	6.99E-01
trophectodermal cell proliferation (GO:0001834)	2	0	.10	-	 < 0.01	9.03E-01
male germ-line sex determination (GO:0019100)	2	0	.10	-	 < 0.01	9.03E-01
trophectodermal cellular morphogenesis (GO:0001831)	2	0	.10	-	 < 0.01	9.03E-01
meiosis II (GO:0007135)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of lipase activity (GO:0060192)	15	0	.77	-	 < 0.01	4.65E-01
synaptonemal complex assembly (GO:0007130)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	5	0	.26	-	 < 0.01	7.75E-01
regulation of type B pancreatic cell apoptotic process (GO:2000674)	9	0	.46	-	 < 0.01	6.31E-01
distal tubule morphogenesis (GO:0072156)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of motor neuron apoptotic process (GO:2000672)	4	0	.20	-	 < 0.01	8.15E-01
inner cell mass cellular morphogenesis (GO:0001828)	2	0	.10	-	 < 0.01	9.03E-01
regulation of motor neuron apoptotic process (GO:2000671)	5	0	.26	-	 < 0.01	7.75E-01
inner cell mass cell fate commitment (GO:0001827)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dendritic cell apoptotic process (GO:2000670)	4	0	.20	-	 < 0.01	8.15E-01
inner cell mass cell differentiation (GO:0001826)	7	0	.36	-	 < 0.01	6.99E-01
histamine secretion (GO:0001821)	5	0	.26	-	 < 0.01	7.75E-01
serotonin secretion (GO:0001820)	3	0	.15	-	 < 0.01	8.58E-01
cell cycle switching (GO:0060184)	3	0	.15	-	 < 0.01	8.58E-01
apelin receptor signaling pathway (GO:0060183)	2	0	.10	-	 < 0.01	9.03E-01
female mating behavior (GO:0060180)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of dendritic cell apoptotic process (GO:2000669)	7	0	.36	-	 < 0.01	6.99E-01
regulation of dendritic cell apoptotic process (GO:2000668)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of interleukin-1-mediated signaling pathway (GO:2000661)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815)	1	0	.05	-	 < 0.01	9.50E-01
renal interstitial fibroblast development (GO:0072141)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antibody-dependent cellular cytotoxicity (GO:0001814)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antibody-dependent cellular cytotoxicity (GO:0001813)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of type I hypersensitivity (GO:0001812)	1	0	.05	-	 < 0.01	9.50E-01
regulation of exocyst localization (GO:0060178)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of type I hypersensitivity (GO:0001811)	1	0	.05	-	 < 0.01	9.50E-01
regulation of angiotensin metabolic process (GO:0060177)	2	0	.10	-	 < 0.01	9.03E-01
regulation of type I hypersensitivity (GO:0001810)	2	0	.10	-	 < 0.01	9.03E-01
limb bud formation (GO:0060174)	11	0	.56	-	 < 0.01	5.70E-01
endomitotic cell cycle (GO:0007113)	3	0	.15	-	 < 0.01	8.58E-01
ribonucleoprotein complex disassembly (GO:0032988)	5	0	.26	-	 < 0.01	7.75E-01
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.05	-	 < 0.01	9.50E-01
keratinocyte activation (GO:0032980)	1	0	.05	-	 < 0.01	9.50E-01
glomerular parietal epithelial cell differentiation (GO:0072139)	3	0	.15	-	 < 0.01	8.58E-01
regulation of apolipoprotein binding (GO:2000656)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.05	-	 < 0.01	9.50E-01
condensed mesenchymal cell proliferation (GO:0072137)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.05	-	 < 0.01	9.50E-01
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	3	0	.15	-	 < 0.01	8.58E-01
regulation of genetic imprinting (GO:2000653)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of type IV hypersensitivity (GO:0001809)	1	0	.05	-	 < 0.01	9.50E-01
kidney mesenchymal cell proliferation (GO:0072135)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of type IV hypersensitivity (GO:0001808)	2	0	.10	-	 < 0.01	9.03E-01
nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.10	-	 < 0.01	9.03E-01
regulation of type IV hypersensitivity (GO:0001807)	4	0	.20	-	 < 0.01	8.15E-01
metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of type III hypersensitivity (GO:0001805)	1	0	.05	-	 < 0.01	9.50E-01
kidney mesenchyme morphogenesis (GO:0072131)	3	0	.15	-	 < 0.01	8.58E-01
renal capsule specification (GO:0072130)	1	0	.05	-	 < 0.01	9.50E-01
regulation of type III hypersensitivity (GO:0001803)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein autoubiquitination (GO:1902499)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of adenosine receptor signaling pathway (GO:0060168)	3	0	.15	-	 < 0.01	8.58E-01
regulation of adenosine receptor signaling pathway (GO:0060167)	4	0	.20	-	 < 0.01	8.15E-01
olfactory pit development (GO:0060166)	3	0	.15	-	 < 0.01	8.58E-01
regulation of timing of subpallium neuron differentiation (GO:0060165)	1	0	.05	-	 < 0.01	9.50E-01
regulation of timing of neuron differentiation (GO:0060164)	3	0	.15	-	 < 0.01	8.58E-01
subpallium neuron fate commitment (GO:0060163)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dopamine receptor signaling pathway (GO:0060161)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of sperm capacitation (GO:1902491)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of dopamine receptor signaling pathway (GO:0060160)	4	0	.20	-	 < 0.01	8.15E-01
regulation of sperm capacitation (GO:1902490)	2	0	.10	-	 < 0.01	9.03E-01
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	4	0	.20	-	 < 0.01	8.15E-01
protein insertion into membrane from inner side (GO:0032978)	4	0	.20	-	 < 0.01	8.15E-01
release of matrix enzymes from mitochondria (GO:0032976)	1	0	.05	-	 < 0.01	9.50E-01
amino acid transmembrane export from vacuole (GO:0032974)	1	0	.05	-	 < 0.01	9.50E-01
regulation of muscle filament sliding speed (GO:0032972)	2	0	.10	-	 < 0.01	9.03E-01
regulation of muscle filament sliding (GO:0032971)	4	0	.20	-	 < 0.01	8.15E-01
renal capsule formation (GO:0072129)	1	0	.05	-	 < 0.01	9.50E-01
renal capsule morphogenesis (GO:0072128)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of receptor catabolic process (GO:2000645)	3	0	.15	-	 < 0.01	8.58E-01
renal capsule development (GO:0072127)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of early endosome to late endosome transport (GO:2000643)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of glomerular mesangial cell proliferation (GO:0072125)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.10	-	 < 0.01	9.03E-01
regulation of glomerular mesangial cell proliferation (GO:0072124)	9	0	.46	-	 < 0.01	6.31E-01
regulation of early endosome to late endosome transport (GO:2000641)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of SREBP signaling pathway (GO:2000640)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dopamine receptor signaling pathway (GO:0060159)	10	0	.51	-	 < 0.01	6.00E-01
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	8	0	.41	-	 < 0.01	6.65E-01
urinary bladder development (GO:0060157)	4	0	.20	-	 < 0.01	8.15E-01
platelet dense granule organization (GO:0060155)	7	0	.36	-	 < 0.01	6.99E-01
cytotoxic T cell pyroptotic process (GO:1902483)	2	0	.10	-	 < 0.01	9.03E-01
microtubule-based peroxisome localization (GO:0060152)	2	0	.10	-	 < 0.01	9.03E-01
peroxisome localization (GO:0060151)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to mitotic spindle (GO:1902480)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of collagen biosynthetic process (GO:0032967)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	6	0	.31	-	 < 0.01	7.36E-01
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of primary miRNA processing (GO:2000635)	3	0	.15	-	 < 0.01	8.58E-01
regulation of primary miRNA processing (GO:2000634)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of pre-miRNA processing (GO:2000632)	2	0	.10	-	 < 0.01	9.03E-01
pronephros morphogenesis (GO:0072114)	2	0	.10	-	 < 0.01	9.03E-01
regulation of pre-miRNA processing (GO:2000631)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of miRNA metabolic process (GO:2000630)	6	0	.31	-	 < 0.01	7.36E-01
glomerular visceral epithelial cell differentiation (GO:0072112)	19	0	.97	-	 < 0.01	3.79E-01
glomerular mesangial cell proliferation (GO:0072110)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of posttranscriptional gene silencing (GO:0060149)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of protein localization to synapse (GO:1902474)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	25	0	1.28	-	 < 0.01	2.79E-01
inositol trisphosphate biosynthetic process (GO:0032959)	2	0	.10	-	 < 0.01	9.03E-01
inositol trisphosphate metabolic process (GO:0032957)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cytokinetic process (GO:0032954)	3	0	.15	-	 < 0.01	8.58E-01
regulation of miRNA metabolic process (GO:2000628)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of miRNA catabolic process (GO:2000627)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.20	-	 < 0.01	8.15E-01
regulation of miRNA catabolic process (GO:2000625)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of ureteric bud formation (GO:0072107)	4	0	.20	-	 < 0.01	8.15E-01
regulation of ureteric bud formation (GO:0072106)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	4	0	.20	-	 < 0.01	8.15E-01
ureteric peristalsis (GO:0072105)	2	0	.10	-	 < 0.01	9.03E-01
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	4	0	.20	-	 < 0.01	8.15E-01
glomerular capillary formation (GO:0072104)	6	0	.31	-	 < 0.01	7.36E-01
glomerulus vasculature morphogenesis (GO:0072103)	6	0	.31	-	 < 0.01	7.36E-01
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101)	1	0	.05	-	 < 0.01	9.50E-01
specification of ureteric bud anterior/posterior symmetry (GO:0072100)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of apoptotic process by virus (GO:0060139)	2	0	.10	-	 < 0.01	9.03E-01
embryonic process involved in female pregnancy (GO:0060136)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of histone H3-K27 trimethylation (GO:1902466)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H3-K27 trimethylation (GO:1902464)	1	0	.05	-	 < 0.01	9.50E-01
somatotropin secreting cell development (GO:0060133)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to cell leading edge (GO:1902463)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mesenchymal stem cell proliferation (GO:1902460)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of histone H4-K16 acetylation (GO:2000619)	3	0	.15	-	 < 0.01	8.58E-01
secretion by tissue (GO:0032941)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of histone H3-K9 acetylation (GO:2000617)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of histone H3-K9 acetylation (GO:2000616)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H3-K9 acetylation (GO:2000615)	9	0	.46	-	 < 0.01	6.31E-01
regulation of thyroid-stimulating hormone secretion (GO:2000612)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of thyroid hormone generation (GO:2000611)	4	0	.20	-	 < 0.01	8.15E-01
somatotropin secreting cell differentiation (GO:0060126)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of growth hormone secretion (GO:0060125)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of stem cell population maintenance (GO:1902455)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of growth hormone secretion (GO:0060124)	8	0	.41	-	 < 0.01	6.65E-01
regulation of growth hormone secretion (GO:0060123)	12	0	.61	-	 < 0.01	5.42E-01
regulation of thyroid hormone generation (GO:2000609)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of superoxide anion generation (GO:0032930)	20	0	1.02	-	 < 0.01	3.60E-01
regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.05	-	 < 0.01	9.50E-01
vestibular receptor cell development (GO:0060118)	2	0	.10	-	 < 0.01	9.03E-01
vestibular receptor cell morphogenesis (GO:0060116)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	3	0	.15	-	 < 0.01	8.58E-01
vestibular receptor cell differentiation (GO:0060114)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	1	0	.05	-	 < 0.01	9.50E-01
generation of ovulation cycle rhythm (GO:0060112)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	1	0	.05	-	 < 0.01	9.50E-01
ganglioside catabolic process (GO:0006689)	7	0	.36	-	 < 0.01	6.99E-01
glycosphingolipid biosynthetic process (GO:0006688)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052501)	1	0	.05	-	 < 0.01	9.50E-01
sphingomyelin catabolic process (GO:0006685)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of superoxide anion generation (GO:0032929)	3	0	.15	-	 < 0.01	8.58E-01
regulation of superoxide anion generation (GO:0032928)	23	0	1.17	-	 < 0.01	3.09E-01
galactosylceramide catabolic process (GO:0006683)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of activin receptor signaling pathway (GO:0032927)	8	0	.41	-	 < 0.01	6.65E-01
galactosylceramide biosynthetic process (GO:0006682)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of activin receptor signaling pathway (GO:0032926)	10	0	.51	-	 < 0.01	6.00E-01
galactosylceramide metabolic process (GO:0006681)	9	0	.46	-	 < 0.01	6.31E-01
regulation of activin receptor signaling pathway (GO:0032925)	23	0	1.17	-	 < 0.01	3.09E-01
glucosylceramide catabolic process (GO:0006680)	3	0	.15	-	 < 0.01	8.58E-01
putrescine acetylation (GO:0032920)	1	0	.05	-	 < 0.01	9.50E-01
glucosylceramide biosynthetic process (GO:0006679)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of phagocytosis, engulfment (GO:0060101)	1	0	.05	-	 < 0.01	9.50E-01
glucosylceramide metabolic process (GO:0006678)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of amyloid-beta formation (GO:1902430)	12	0	.61	-	 < 0.01	5.42E-01
glycosylceramide metabolic process (GO:0006677)	15	0	.77	-	 < 0.01	4.65E-01
spermine acetylation (GO:0032919)	1	0	.05	-	 < 0.01	9.50E-01
spermidine acetylation (GO:0032918)	2	0	.10	-	 < 0.01	9.03E-01
polyamine acetylation (GO:0032917)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	0	.10	-	 < 0.01	9.03E-01
phytosphingosine metabolic process (GO:0006671)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transforming growth factor beta2 production (GO:0032915)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of transforming growth factor beta1 production (GO:0032914)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of transforming growth factor beta3 production (GO:0032913)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transforming growth factor beta2 production (GO:0032912)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of transforming growth factor beta1 production (GO:0032911)	6	0	.31	-	 < 0.01	7.36E-01
regulation of transforming growth factor beta3 production (GO:0032910)	4	0	.20	-	 < 0.01	8.15E-01
olfactory placode morphogenesis (GO:0071699)	3	0	.15	-	 < 0.01	8.58E-01
olfactory placode development (GO:0071698)	3	0	.15	-	 < 0.01	8.58E-01
ectodermal placode morphogenesis (GO:0071697)	12	0	.61	-	 < 0.01	5.42E-01
ectodermal placode development (GO:0071696)	13	0	.66	-	 < 0.01	5.15E-01
maintenance of protein location in extracellular region (GO:0071694)	6	0	.31	-	 < 0.01	7.36E-01
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	1	0	.05	-	 < 0.01	9.50E-01
protein transport within extracellular region (GO:0071693)	1	0	.05	-	 < 0.01	9.50E-01
cardiac muscle thin filament assembly (GO:0071691)	3	0	.15	-	 < 0.01	8.58E-01
sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.05	-	 < 0.01	9.50E-01
sphinganine-1-phosphate metabolic process (GO:0006668)	2	0	.10	-	 < 0.01	9.03E-01
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transforming growth factor beta2 production (GO:0032909)	8	0	.41	-	 < 0.01	6.65E-01
regulation of transforming growth factor beta1 production (GO:0032908)	12	0	.61	-	 < 0.01	5.42E-01
phosphatidylserine catabolic process (GO:0006660)	2	0	.10	-	 < 0.01	9.03E-01
nerve growth factor production (GO:0032902)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neurotrophin production (GO:0032901)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neurotrophin production (GO:0032900)	1	0	.05	-	 < 0.01	9.50E-01
striated muscle myosin thick filament assembly (GO:0071688)	3	0	.15	-	 < 0.01	8.58E-01
organism emergence from protective structure (GO:0071684)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of mRNA binding (GO:1902416)	6	0	.31	-	 < 0.01	7.36E-01
regulation of mRNA binding (GO:1902415)	7	0	.36	-	 < 0.01	6.99E-01
regulation of mitotic cytokinesis (GO:1902412)	6	0	.31	-	 < 0.01	7.36E-01
phosphatidylserine biosynthetic process (GO:0006659)	4	0	.20	-	 < 0.01	8.15E-01
diacylglycerol biosynthetic process (GO:0006651)	8	0	.41	-	 < 0.01	6.65E-01
alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.05	-	 < 0.01	9.50E-01
T-helper 1 cell lineage commitment (GO:0002296)	2	0	.10	-	 < 0.01	9.03E-01
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	4	0	.20	-	 < 0.01	8.15E-01
olfactory bulb axon guidance (GO:0071678)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mononuclear cell migration (GO:0071676)	8	0	.41	-	 < 0.01	6.65E-01
mononuclear cell migration (GO:0071674)	39	0	1.99	-	 < 0.01	1.36E-01
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	4	0	.20	-	 < 0.01	8.15E-01
regulation of smooth muscle cell chemotaxis (GO:0071671)	7	0	.36	-	 < 0.01	6.99E-01
smooth muscle cell chemotaxis (GO:0071670)	2	0	.10	-	 < 0.01	9.03E-01
phospholipid transfer to membrane (GO:0006649)	1	0	.05	-	 < 0.01	9.50E-01
phosphatidylethanolamine biosynthetic process (GO:0006646)	15	0	.77	-	 < 0.01	4.65E-01
triglyceride mobilization (GO:0006642)	3	0	.15	-	 < 0.01	8.58E-01
microglial cell activation involved in immune response (GO:0002282)	3	0	.15	-	 < 0.01	8.58E-01
macrophage activation involved in immune response (GO:0002281)	15	0	.77	-	 < 0.01	4.65E-01
monocyte activation involved in immune response (GO:0002280)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of granzyme B production (GO:0071663)	3	0	.15	-	 < 0.01	8.58E-01
regulation of granzyme B production (GO:0071661)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of IP-10 production (GO:0071660)	1	0	.05	-	 < 0.01	9.50E-01
tRNA demethylation (GO:1990983)	1	0	.05	-	 < 0.01	9.50E-01
mast cell activation involved in immune response (GO:0002279)	16	0	.82	-	 < 0.01	4.41E-01
eosinophil activation involved in immune response (GO:0002278)	3	0	.15	-	 < 0.01	8.58E-01
myeloid dendritic cell activation involved in immune response (GO:0002277)	3	0	.15	-	 < 0.01	8.58E-01
basophil activation involved in immune response (GO:0002276)	2	0	.10	-	 < 0.01	9.03E-01
plasmacytoid dendritic cell differentiation (GO:0002273)	1	0	.05	-	 < 0.01	9.50E-01
plasmacytoid dendritic cell activation (GO:0002270)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of IP-10 production (GO:0071659)	1	0	.05	-	 < 0.01	9.50E-01
regulation of IP-10 production (GO:0071658)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of granulocyte colony-stimulating factor production (GO:0071656)	1	0	.05	-	 < 0.01	9.50E-01
regulation of granulocyte colony-stimulating factor production (GO:0071655)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chemokine (C-C motif) ligand 1 production (GO:0071652)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	4	0	.20	-	 < 0.01	8.15E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.26	-	 < 0.01	7.75E-01
vacuolar protein processing (GO:0006624)	2	0	.10	-	 < 0.01	9.03E-01
protein retention in ER lumen (GO:0006621)	9	0	.46	-	 < 0.01	6.31E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	11	0	.56	-	 < 0.01	5.70E-01
follicular dendritic cell differentiation (GO:0002268)	1	0	.05	-	 < 0.01	9.50E-01
follicular dendritic cell activation (GO:0002266)	2	0	.10	-	 < 0.01	9.03E-01
astrocyte activation involved in immune response (GO:0002265)	4	0	.20	-	 < 0.01	8.15E-01
endothelial cell activation involved in immune response (GO:0002264)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	3	0	.15	-	 < 0.01	8.58E-01
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	5	0	.26	-	 < 0.01	7.75E-01
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.05	-	 < 0.01	9.50E-01
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	2	0	.10	-	 < 0.01	9.03E-01
modulation by host of RNA binding by virus (GO:1990968)	1	0	.05	-	 < 0.01	9.50E-01
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	8	0	.41	-	 < 0.01	6.65E-01
ATP generation from poly-ADP-D-ribose (GO:1990966)	4	0	.20	-	 < 0.01	8.15E-01
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	92	0	4.70	-	 < 0.01	8.98E-03
cotranslational protein targeting to membrane (GO:0006613)	96	0	4.90	-	 < 0.01	7.31E-03
establishment of blood-retinal barrier (GO:1990963)	1	0	.05	-	 < 0.01	9.50E-01
xenobiotic transport across blood-brain barrier (GO:1990962)	5	0	.26	-	 < 0.01	7.75E-01
ribosomal protein import into nucleus (GO:0006610)	4	0	.20	-	 < 0.01	8.15E-01
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	7	0	.36	-	 < 0.01	6.99E-01
kinin cascade (GO:0002254)	3	0	.15	-	 < 0.01	8.58E-01
organ or tissue specific immune response (GO:0002251)	30	0	1.53	-	 < 0.01	2.16E-01
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	5	0	.26	-	 < 0.01	7.75E-01
regulation of monocyte chemotactic protein-1 production (GO:0071637)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of transforming growth factor beta production (GO:0071635)	13	0	.66	-	 < 0.01	5.15E-01
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	2	0	.10	-	 < 0.01	9.03E-01
homogentisate metabolic process (GO:1901999)	1	0	.05	-	 < 0.01	9.50E-01
NLS-bearing protein import into nucleus (GO:0006607)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of meiotic cell cycle phase transition (GO:1901994)	3	0	.15	-	 < 0.01	8.58E-01
phosphocreatine metabolic process (GO:0006603)	3	0	.15	-	 < 0.01	8.58E-01
creatine biosynthetic process (GO:0006601)	2	0	.10	-	 < 0.01	9.03E-01
creatine metabolic process (GO:0006600)	6	0	.31	-	 < 0.01	7.36E-01
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	5	0	.26	-	 < 0.01	7.75E-01
wound healing involved in inflammatory response (GO:0002246)	6	0	.31	-	 < 0.01	7.36E-01
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.05	-	 < 0.01	9.50E-01
mastication (GO:0071626)	1	0	.05	-	 < 0.01	9.50E-01
vocalization behavior (GO:0071625)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of granulocyte chemotaxis (GO:0071624)	26	0	1.33	-	 < 0.01	2.65E-01
negative regulation of granulocyte chemotaxis (GO:0071623)	3	0	.15	-	 < 0.01	8.58E-01
regulation of granulocyte chemotaxis (GO:0071622)	47	0	2.40	-	 < 0.01	9.03E-02
granulocyte chemotaxis (GO:0071621)	80	0	4.09	-	 < 0.01	1.66E-02
response to ketamine (GO:1901986)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of inward rectifier potassium channel activity (GO:1901980)	2	0	.10	-	 < 0.01	9.03E-01
response to molecule of fungal origin (GO:0002238)	4	0	.20	-	 < 0.01	8.15E-01
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	6	0	.31	-	 < 0.01	7.36E-01
oxidative deethylation (GO:0071615)	1	0	.05	-	 < 0.01	9.50E-01
granulocyte colony-stimulating factor production (GO:0071611)	1	0	.05	-	 < 0.01	9.50E-01
regulation of inward rectifier potassium channel activity (GO:1901979)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of cell cycle checkpoint (GO:1901977)	5	0	.26	-	 < 0.01	7.75E-01
peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of metanephric ureteric bud development (GO:2001076)	2	0	.10	-	 < 0.01	9.03E-01
regulation of metanephric ureteric bud development (GO:2001074)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mitotic sister chromatid separation (GO:1901970)	13	0	.66	-	 < 0.01	5.15E-01
innate immune response in mucosa (GO:0002227)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of antimicrobial peptide production (GO:0002225)	5	0	.26	-	 < 0.01	7.75E-01
chemokine (C-C motif) ligand 5 production (GO:0071609)	1	0	.05	-	 < 0.01	9.50E-01
transforming growth factor beta production (GO:0071604)	1	0	.05	-	 < 0.01	9.50E-01
endothelial cell-cell adhesion (GO:0071603)	4	0	.20	-	 < 0.01	8.15E-01
phytosphingosine biosynthetic process (GO:0071602)	1	0	.05	-	 < 0.01	9.50E-01
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.05	-	 < 0.01	9.50E-01
otic vesicle morphogenesis (GO:0071600)	9	0	.46	-	 < 0.01	6.31E-01
calcium ion regulated lysosome exocytosis (GO:1990927)	2	0	.10	-	 < 0.01	9.03E-01
short-term synaptic potentiation (GO:1990926)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	2	0	.10	-	 < 0.01	9.03E-01
S-adenosyl-L-methionine transmembrane transport (GO:1901962)	1	0	.05	-	 < 0.01	9.50E-01
defense response to nematode (GO:0002215)	2	0	.10	-	 < 0.01	9.03E-01
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.05	-	 < 0.01	9.50E-01
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.05	-	 < 0.01	9.50E-01
putrescine biosynthetic process from ornithine (GO:0033387)	2	0	.10	-	 < 0.01	9.03E-01
geranylgeranyl diphosphate biosynthetic process (GO:0033386)	1	0	.05	-	 < 0.01	9.50E-01
geranylgeranyl diphosphate metabolic process (GO:0033385)	1	0	.05	-	 < 0.01	9.50E-01
double-strand break repair involved in meiotic recombination (GO:1990918)	7	0	.36	-	 < 0.01	6.99E-01
maintenance of granzyme B location in T cell secretory granule (GO:0033382)	1	0	.05	-	 < 0.01	9.50E-01
reactive nitrogen species metabolic process (GO:2001057)	23	0	1.17	-	 < 0.01	3.09E-01
granzyme B localization to T cell secretory granule (GO:0033380)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of anterograde dense core granule transport (GO:1901953)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mesenchymal cell apoptotic process (GO:2001055)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	10	0	.51	-	 < 0.01	6.00E-01
regulation of anterograde dense core granule transport (GO:1901951)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mesenchymal cell apoptotic process (GO:2001053)	12	0	.61	-	 < 0.01	5.42E-01
dense core granule transport (GO:1901950)	9	0	.46	-	 < 0.01	6.31E-01
response to hypobaric hypoxia (GO:1990910)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of tendon cell differentiation (GO:2001051)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of MHC class II biosynthetic process (GO:0045348)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of MHC class II biosynthetic process (GO:0045347)	6	0	.31	-	 < 0.01	7.36E-01
regulation of MHC class II biosynthetic process (GO:0045346)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of MHC class I biosynthetic process (GO:0045345)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.05	-	 < 0.01	9.50E-01
regulation of MHC class I biosynthetic process (GO:0045343)	8	0	.41	-	 < 0.01	6.65E-01
MHC class II biosynthetic process (GO:0045342)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of protease location in T cell secretory granule (GO:0033379)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of protein location in T cell secretory granule (GO:0033377)	1	0	.05	-	 < 0.01	9.50E-01
protease localization to T cell secretory granule (GO:0033375)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to T cell secretory granule (GO:0033374)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of protease location in mast cell secretory granule (GO:0033373)	1	0	.05	-	 < 0.01	9.50E-01
regulation of tendon cell differentiation (GO:2001049)	1	0	.05	-	 < 0.01	9.50E-01
T cell secretory granule organization (GO:0033371)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of protein location in mast cell secretory granule (GO:0033370)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of integrin-mediated signaling pathway (GO:2001046)	7	0	.36	-	 < 0.01	6.99E-01
protease localization to mast cell secretory granule (GO:0033368)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to mast cell secretory granule (GO:0033367)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to secretory granule (GO:0033366)	4	0	.20	-	 < 0.01	8.15E-01
mast cell secretory granule organization (GO:0033364)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cellular response to drug (GO:2001038)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of tongue muscle cell differentiation (GO:2001037)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tongue muscle cell differentiation (GO:2001035)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cellular glucuronidation (GO:2001031)	1	0	.05	-	 < 0.01	9.50E-01
transformation of host cell by virus (GO:0019087)	3	0	.15	-	 < 0.01	8.58E-01
late viral transcription (GO:0019086)	4	0	.20	-	 < 0.01	8.15E-01
early viral transcription (GO:0019085)	2	0	.10	-	 < 0.01	9.03E-01
carnitine biosynthetic process (GO:0045329)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cellular glucuronidation (GO:2001029)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of response to drug (GO:2001024)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to drug (GO:2001023)	4	0	.20	-	 < 0.01	8.15E-01
virus maturation (GO:0019075)	2	0	.10	-	 < 0.01	9.03E-01
viral RNA genome packaging (GO:0019074)	2	0	.10	-	 < 0.01	9.03E-01
viral genome packaging (GO:0019072)	2	0	.10	-	 < 0.01	9.03E-01
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of exoribonuclease activity (GO:1901919)	1	0	.05	-	 < 0.01	9.50E-01
regulation of exoribonuclease activity (GO:1901917)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of retrograde axon cargo transport (GO:2001019)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of collagen binding (GO:0033342)	1	0	.05	-	 < 0.01	9.50E-01
regulation of collagen binding (GO:0033341)	1	0	.05	-	 < 0.01	9.50E-01
regulation of retrograde axon cargo transport (GO:2001017)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of skeletal muscle cell differentiation (GO:2001015)	6	0	.31	-	 < 0.01	7.36E-01
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	4	0	.20	-	 < 0.01	8.15E-01
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	4	0	.20	-	 < 0.01	8.15E-01
mesenchymal cell differentiation involved in renal system development (GO:2001012)	7	0	.36	-	 < 0.01	6.99E-01
receptor-mediated endocytosis of virus by host cell (GO:0019065)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of type IIa hypersensitivity (GO:0001798)	3	0	.15	-	 < 0.01	8.58E-01
fusion of virus membrane with host plasma membrane (GO:0019064)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of type IIa hypersensitivity (GO:0001797)	1	0	.05	-	 < 0.01	9.50E-01
regulation of type IIa hypersensitivity (GO:0001796)	4	0	.20	-	 < 0.01	8.15E-01
uncoating of virus (GO:0019061)	1	0	.05	-	 < 0.01	9.50E-01
intracellular transport of viral protein in host cell (GO:0019060)	2	0	.10	-	 < 0.01	9.03E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	6	0	.31	-	 < 0.01	7.36E-01
diadenosine hexaphosphate catabolic process (GO:1901909)	4	0	.20	-	 < 0.01	8.15E-01
diadenosine hexaphosphate metabolic process (GO:1901908)	4	0	.20	-	 < 0.01	8.15E-01
diadenosine pentaphosphate catabolic process (GO:1901907)	4	0	.20	-	 < 0.01	8.15E-01
diadenosine pentaphosphate metabolic process (GO:1901906)	4	0	.20	-	 < 0.01	8.15E-01
modulation by virus of host transcription (GO:0019056)	1	0	.05	-	 < 0.01	9.50E-01
natural killer cell proliferation (GO:0001787)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host apoptotic process (GO:0019050)	3	0	.15	-	 < 0.01	8.58E-01
neutrophil apoptotic process (GO:0001781)	1	0	.05	-	 < 0.01	9.50E-01
neutrophil homeostasis (GO:0001780)	11	0	.56	-	 < 0.01	5.70E-01
mitotic nuclear envelope reassembly (GO:0007084)	3	0	.15	-	 < 0.01	8.58E-01
cerebrospinal fluid secretion (GO:0033326)	3	0	.15	-	 < 0.01	8.58E-01
UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.05	-	 < 0.01	9.50E-01
mitigation of host defenses by virus (GO:0019049)	2	0	.10	-	 < 0.01	9.03E-01
release from viral latency (GO:0019046)	3	0	.15	-	 < 0.01	8.58E-01
natural killer cell differentiation (GO:0001779)	10	0	.51	-	 < 0.01	6.00E-01
latent virus replication (GO:0019045)	3	0	.15	-	 < 0.01	8.58E-01
plasma membrane repair (GO:0001778)	11	0	.56	-	 < 0.01	5.70E-01
T cell homeostatic proliferation (GO:0001777)	1	0	.05	-	 < 0.01	9.50E-01
establishment of viral latency (GO:0019043)	10	0	.51	-	 < 0.01	6.00E-01
viral latency (GO:0019042)	12	0	.61	-	 < 0.01	5.42E-01
telomere maintenance via telomere trimming (GO:0090737)	9	0	.46	-	 < 0.01	6.31E-01
DNA repair complex assembly (GO:0090735)	6	0	.31	-	 < 0.01	7.36E-01
mitotic chromosome movement towards spindle pole (GO:0007079)	4	0	.20	-	 < 0.01	8.15E-01
immunological synapse formation (GO:0001771)	12	0	.61	-	 < 0.01	5.42E-01
mitotic nuclear envelope disassembly (GO:0007077)	11	0	.56	-	 < 0.01	5.70E-01
establishment of natural killer cell polarity (GO:0001770)	1	0	.05	-	 < 0.01	9.50E-01
UDP-D-xylose metabolic process (GO:0033319)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.05	-	 < 0.01	9.50E-01
meiotic spindle assembly checkpoint (GO:0033316)	1	0	.05	-	 < 0.01	9.50E-01
mitotic DNA replication checkpoint (GO:0033314)	9	0	.46	-	 < 0.01	6.31E-01
meiotic cell cycle checkpoint (GO:0033313)	6	0	.31	-	 < 0.01	7.36E-01
anterior/posterior pattern specification involved in ureteric bud development (GO:0072099)	1	0	.05	-	 < 0.01	9.50E-01
anterior/posterior pattern specification involved in kidney development (GO:0072098)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of branch elongation involved in ureteric bud branching (GO:0072096)	1	0	.05	-	 < 0.01	9.50E-01
regulation of branch elongation involved in ureteric bud branching (GO:0072095)	4	0	.20	-	 < 0.01	8.15E-01
establishment of T cell polarity (GO:0001768)	8	0	.41	-	 < 0.01	6.65E-01
establishment of lymphocyte polarity (GO:0001767)	9	0	.46	-	 < 0.01	6.31E-01
metanephric renal vesicle formation (GO:0072093)	4	0	.20	-	 < 0.01	8.15E-01
membrane raft polarization (GO:0001766)	3	0	.15	-	 < 0.01	8.58E-01
ureteric bud invasion (GO:0072092)	3	0	.15	-	 < 0.01	8.58E-01
membrane raft assembly (GO:0001765)	10	0	.51	-	 < 0.01	6.00E-01
female meiosis sister chromatid cohesion (GO:0007066)	1	0	.05	-	 < 0.01	9.50E-01
phytol metabolic process (GO:0033306)	2	0	.10	-	 < 0.01	9.03E-01
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.05	-	 < 0.01	9.50E-01
renal vesicle development (GO:0072087)	14	0	.72	-	 < 0.01	4.89E-01
specification of loop of Henle identity (GO:0072086)	4	0	.20	-	 < 0.01	8.15E-01
somite specification (GO:0001757)	5	0	.26	-	 < 0.01	7.75E-01
somitogenesis (GO:0001756)	60	0	3.06	-	 < 0.01	4.64E-02
specification of nephron tubule identity (GO:0072081)	5	0	.26	-	 < 0.01	7.75E-01
eye photoreceptor cell differentiation (GO:0001754)	45	0	2.30	-	 < 0.01	1.00E-01
immunological memory formation process (GO:0090715)	1	0	.05	-	 < 0.01	9.50E-01
immunological memory process (GO:0090713)	1	0	.05	-	 < 0.01	9.50E-01
spindle assembly involved in female meiosis I (GO:0007057)	2	0	.10	-	 < 0.01	9.03E-01
spindle assembly involved in female meiosis (GO:0007056)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of optic nerve formation (GO:2000597)	1	0	.05	-	 < 0.01	9.50E-01
nephron tubule formation (GO:0072079)	18	0	.92	-	 < 0.01	3.99E-01
regulation of optic nerve formation (GO:2000595)	1	0	.05	-	 < 0.01	9.50E-01
renal vesicle morphogenesis (GO:0072077)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.10	-	 < 0.01	9.03E-01
nephrogenic mesenchyme development (GO:0072076)	3	0	.15	-	 < 0.01	8.58E-01
metanephric mesenchyme development (GO:0072075)	14	0	.72	-	 < 0.01	4.89E-01
regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.10	-	 < 0.01	9.03E-01
kidney mesenchyme development (GO:0072074)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.05	-	 < 0.01	9.50E-01
kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.10	-	 < 0.01	9.03E-01
loop of Henle development (GO:0072070)	11	0	.56	-	 < 0.01	5.70E-01
optic placode formation (GO:0001743)	2	0	.10	-	 < 0.01	9.03E-01
lysosomal lumen acidification (GO:0007042)	9	0	.46	-	 < 0.01	6.31E-01
regulation of metanephric mesenchymal cell migration (GO:2000589)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	4	0	.20	-	 < 0.01	8.15E-01
DCT cell differentiation (GO:0072069)	1	0	.05	-	 < 0.01	9.50E-01
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.10	-	 < 0.01	9.03E-01
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	3	0	.15	-	 < 0.01	8.58E-01
inner medullary collecting duct development (GO:0072061)	3	0	.15	-	 < 0.01	8.58E-01
outer medullary collecting duct development (GO:0072060)	1	0	.05	-	 < 0.01	9.50E-01
protein catabolic process in the vacuole (GO:0007039)	8	0	.41	-	 < 0.01	6.65E-01
formation of cytoplasmic translation initiation complex (GO:0001732)	14	0	.72	-	 < 0.01	4.89E-01
mitotic cytokinesis checkpoint (GO:0044878)	3	0	.15	-	 < 0.01	8.58E-01
lipoprotein localization to membrane (GO:0044873)	1	0	.05	-	 < 0.01	9.50E-01
lipoprotein localization (GO:0044872)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	0	.10	-	 < 0.01	9.03E-01
modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	0	.10	-	 < 0.01	9.03E-01
cortical collecting duct development (GO:0072059)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of microtubule motor activity (GO:2000576)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of microtubule motor activity (GO:2000575)	1	0	.05	-	 < 0.01	9.50E-01
regulation of microtubule motor activity (GO:2000574)	9	0	.46	-	 < 0.01	6.31E-01
renal cortex development (GO:0072055)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.05	-	 < 0.01	9.50E-01
renal outer medulla development (GO:0072054)	2	0	.10	-	 < 0.01	9.03E-01
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.05	-	 < 0.01	9.50E-01
renal inner medulla development (GO:0072053)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of T-helper 2 cell activation (GO:2000570)	1	0	.05	-	 < 0.01	9.50E-01
juxtaglomerular apparatus development (GO:0072051)	2	0	.10	-	 < 0.01	9.03E-01
S-shaped body morphogenesis (GO:0072050)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	0	.10	-	 < 0.01	9.03E-01
relaxation of vascular associated smooth muscle (GO:0060087)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of microtubule depolymerization (GO:0007026)	25	0	1.28	-	 < 0.01	2.79E-01
modulation by host of viral molecular function (GO:0044868)	3	0	.15	-	 < 0.01	8.58E-01
circadian temperature homeostasis (GO:0060086)	2	0	.10	-	 < 0.01	9.03E-01
modulation by host of viral catalytic activity (GO:0044867)	2	0	.10	-	 < 0.01	9.03E-01
modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	0	.10	-	 < 0.01	9.03E-01
synaptic transmission involved in micturition (GO:0060084)	3	0	.15	-	 < 0.01	8.58E-01
post-chaperonin tubulin folding pathway (GO:0007023)	5	0	.26	-	 < 0.01	7.75E-01
smooth muscle contraction involved in micturition (GO:0060083)	3	0	.15	-	 < 0.01	8.58E-01
eye blink reflex (GO:0060082)	1	0	.05	-	 < 0.01	9.50E-01
tubulin complex assembly (GO:0007021)	9	0	.46	-	 < 0.01	6.31E-01
membrane hyperpolarization (GO:0060081)	9	0	.46	-	 < 0.01	6.31E-01
inhibitory postsynaptic potential (GO:0060080)	10	0	.51	-	 < 0.01	6.00E-01
protein transport into plasma membrane raft (GO:0044861)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to plasma membrane raft (GO:0044860)	4	0	.20	-	 < 0.01	8.15E-01
regulation of neurotrophin production (GO:0032899)	2	0	.10	-	 < 0.01	9.03E-01
neurotrophin production (GO:0032898)	2	0	.10	-	 < 0.01	9.03E-01
regulation of T-helper 2 cell activation (GO:2000569)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of memory T cell activation (GO:2000568)	2	0	.10	-	 < 0.01	9.03E-01
regulation of memory T cell activation (GO:2000567)	2	0	.10	-	 < 0.01	9.03E-01
comma-shaped body morphogenesis (GO:0072049)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	4	0	.20	-	 < 0.01	8.15E-01
urokinase plasminogen activator signaling pathway (GO:0038195)	2	0	.10	-	 < 0.01	9.03E-01
renal system pattern specification (GO:0072048)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000565)	1	0	.05	-	 < 0.01	9.50E-01
thyroid-stimulating hormone signaling pathway (GO:0038194)	2	0	.10	-	 < 0.01	9.03E-01
proximal/distal pattern formation involved in nephron development (GO:0072047)	5	0	.26	-	 < 0.01	7.75E-01
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	8	0	.41	-	 < 0.01	6.65E-01
thromboxane A2 signaling pathway (GO:0038193)	1	0	.05	-	 < 0.01	9.50E-01
establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	5	0	.26	-	 < 0.01	7.75E-01
gastric inhibitory peptide signaling pathway (GO:0038192)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	6	0	.31	-	 < 0.01	7.36E-01
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	9	0	.46	-	 < 0.01	6.31E-01
VEGF-activated neuropilin signaling pathway (GO:0038190)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of CD24 production (GO:2000560)	1	0	.05	-	 < 0.01	9.50E-01
endodermal cell fate specification (GO:0001714)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.20	-	 < 0.01	8.15E-01
ectodermal cell fate commitment (GO:0001712)	2	0	.10	-	 < 0.01	9.03E-01
plasma membrane raft organization (GO:0044857)	8	0	.41	-	 < 0.01	6.65E-01
regulation of resting membrane potential (GO:0060075)	9	0	.46	-	 < 0.01	6.31E-01
actin ubiquitination (GO:0007014)	1	0	.05	-	 < 0.01	9.50E-01
plasma membrane raft localization (GO:0044856)	1	0	.05	-	 < 0.01	9.50E-01
plasma membrane raft distribution (GO:0044855)	1	0	.05	-	 < 0.01	9.50E-01
micturition (GO:0060073)	8	0	.41	-	 < 0.01	6.65E-01
plasma membrane raft assembly (GO:0044854)	5	0	.26	-	 < 0.01	7.75E-01
regulation of vacuole fusion, non-autophagic (GO:0032889)	4	0	.20	-	 < 0.01	8.15E-01
regulation of mitotic spindle elongation (GO:0032888)	1	0	.05	-	 < 0.01	9.50E-01
regulation of spindle elongation (GO:0032887)	1	0	.05	-	 < 0.01	9.50E-01
neuropilin signaling pathway (GO:0038189)	4	0	.20	-	 < 0.01	8.15E-01
regulation of CD24 production (GO:2000559)	1	0	.05	-	 < 0.01	9.50E-01
cholecystokinin signaling pathway (GO:0038188)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	2	0	.10	-	 < 0.01	9.03E-01
regulation of immunoglobulin production in mucosal tissue (GO:2000557)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of T-helper 1 cell cytokine production (GO:2000556)	5	0	.26	-	 < 0.01	7.75E-01
intracellular bile acid receptor signaling pathway (GO:0038185)	1	0	.05	-	 < 0.01	9.50E-01
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	2	0	.10	-	 < 0.01	9.03E-01
cell surface bile acid receptor signaling pathway (GO:0038184)	1	0	.05	-	 < 0.01	9.50E-01
regulation of T-helper 1 cell cytokine production (GO:2000554)	5	0	.26	-	 < 0.01	7.75E-01
mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of T-helper 2 cell cytokine production (GO:2000552)	4	0	.20	-	 < 0.01	8.15E-01
renal vesicle induction (GO:0072034)	3	0	.15	-	 < 0.01	8.58E-01
regulation of T-helper 2 cell cytokine production (GO:2000551)	11	0	.56	-	 < 0.01	5.70E-01
nerve growth factor signaling pathway (GO:0038180)	12	0	.61	-	 < 0.01	5.42E-01
renal vesicle formation (GO:0072033)	6	0	.31	-	 < 0.01	7.36E-01
ectoderm formation (GO:0001705)	3	0	.15	-	 < 0.01	8.58E-01
vagina development (GO:0060068)	9	0	.46	-	 < 0.01	6.31E-01
estrous cycle (GO:0044849)	17	0	.87	-	 < 0.01	4.19E-01
cervix development (GO:0060067)	2	0	.10	-	 < 0.01	9.03E-01
oviduct development (GO:0060066)	3	0	.15	-	 < 0.01	8.58E-01
uterus development (GO:0060065)	23	0	1.17	-	 < 0.01	3.09E-01
Spemann organizer formation at the anterior end of the primitive streak (GO:0060064)	1	0	.05	-	 < 0.01	9.50E-01
Spemann organizer formation (GO:0060061)	4	0	.20	-	 < 0.01	8.15E-01
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	2	0	.10	-	 < 0.01	9.03E-01
regulation of establishment or maintenance of cell polarity (GO:0032878)	24	0	1.23	-	 < 0.01	2.93E-01
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of DNA endoreduplication (GO:0032876)	1	0	.05	-	 < 0.01	9.50E-01
regulation of DNA endoreduplication (GO:0032875)	4	0	.20	-	 < 0.01	8.15E-01
neurotrophin signaling pathway (GO:0038179)	28	0	1.43	-	 < 0.01	2.39E-01
positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.05	-	 < 0.01	9.50E-01
complement component C5a signaling pathway (GO:0038178)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of dendritic cell dendrite assembly (GO:2000548)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dendritic cell dendrite assembly (GO:2000547)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.05	-	 < 0.01	9.50E-01
connecting tubule development (GO:0072027)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	7	0	.36	-	 < 0.01	6.99E-01
granzyme-mediated programmed cell death signaling pathway (GO:0140507)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of gastrulation (GO:2000543)	6	0	.31	-	 < 0.01	7.36E-01
interleukin-33-mediated signaling pathway (GO:0038172)	3	0	.15	-	 < 0.01	8.58E-01
distal convoluted tubule development (GO:0072025)	5	0	.26	-	 < 0.01	7.75E-01
cannabinoid signaling pathway (GO:0038171)	6	0	.31	-	 < 0.01	7.36E-01
macula densa development (GO:0072024)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein geranylgeranylation (GO:2000541)	1	0	.05	-	 < 0.01	9.50E-01
somatostatin signaling pathway (GO:0038170)	5	0	.26	-	 < 0.01	7.75E-01
thick ascending limb development (GO:0072023)	2	0	.10	-	 < 0.01	9.03E-01
ascending thin limb development (GO:0072021)	4	0	.20	-	 < 0.01	8.15E-01
ceramide 1-phosphate transport (GO:1902389)	4	0	.20	-	 < 0.01	8.15E-01
mammary gland involution (GO:0060056)	5	0	.26	-	 < 0.01	7.75E-01
actomyosin contractile ring organization (GO:0044837)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	9	0	.46	-	 < 0.01	6.31E-01
neurofilament cytoskeleton organization (GO:0060052)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of protein glycosylation (GO:0060051)	1	0	.05	-	 < 0.01	9.50E-01
modulation by host of viral RNA genome replication (GO:0044830)	4	0	.20	-	 < 0.01	8.15E-01
somatostatin receptor signaling pathway (GO:0038169)	5	0	.26	-	 < 0.01	7.75E-01
regulation of protein geranylgeranylation (GO:2000539)	1	0	.05	-	 < 0.01	9.50E-01
epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of B cell chemotaxis (GO:2000538)	2	0	.10	-	 < 0.01	9.03E-01
epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167)	1	0	.05	-	 < 0.01	9.50E-01
regulation of B cell chemotaxis (GO:2000537)	2	0	.10	-	 < 0.01	9.03E-01
proximal convoluted tubule development (GO:0072019)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of entry of bacterium into host cell (GO:2000536)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of renal albumin absorption (GO:2000534)	1	0	.05	-	 < 0.01	9.50E-01
thrombopoietin-mediated signaling pathway (GO:0038163)	5	0	.26	-	 < 0.01	7.75E-01
glomerular parietal epithelial cell development (GO:0072016)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of renal albumin absorption (GO:2000533)	1	0	.05	-	 < 0.01	9.50E-01
erythropoietin-mediated signaling pathway (GO:0038162)	3	0	.15	-	 < 0.01	8.58E-01
glomerular visceral epithelial cell development (GO:0072015)	11	0	.56	-	 < 0.01	5.70E-01
regulation of renal albumin absorption (GO:2000532)	2	0	.10	-	 < 0.01	9.03E-01
proximal tubule development (GO:0072014)	5	0	.26	-	 < 0.01	7.75E-01
CXCL12-activated CXCR4 signaling pathway (GO:0038160)	1	0	.05	-	 < 0.01	9.50E-01
glomerular endothelium development (GO:0072011)	3	0	.15	-	 < 0.01	8.58E-01
glomerular epithelium development (GO:0072010)	23	0	1.17	-	 < 0.01	3.09E-01
VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation by host of viral genome replication (GO:0044828)	7	0	.36	-	 < 0.01	6.99E-01
regulation of acrosome reaction (GO:0060046)	15	0	.77	-	 < 0.01	4.65E-01
regulation of rRNA catabolic process (GO:1902374)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of tRNA catabolic process (GO:1902371)	2	0	.10	-	 < 0.01	9.03E-01
retinal bipolar neuron differentiation (GO:0060040)	5	0	.26	-	 < 0.01	7.75E-01
regulation of tRNA catabolic process (GO:1902370)	2	0	.10	-	 < 0.01	9.03E-01
meiotic telomere tethering at nuclear periphery (GO:0044821)	3	0	.15	-	 < 0.01	8.58E-01
C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myeloid dendritic cell chemotaxis (GO:2000529)	1	0	.05	-	 < 0.01	9.50E-01
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	2	0	.10	-	 < 0.01	9.03E-01
regulation of myeloid dendritic cell chemotaxis (GO:2000527)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-3-mediated signaling pathway (GO:0038156)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-23-mediated signaling pathway (GO:0038155)	9	0	.46	-	 < 0.01	6.31E-01
interleukin-11-mediated signaling pathway (GO:0038154)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of T cell costimulation (GO:2000524)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of immunological synapse formation (GO:2000522)	1	0	.05	-	 < 0.01	9.50E-01
kidney field specification (GO:0072004)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of immunological synapse formation (GO:2000521)	2	0	.10	-	 < 0.01	9.03E-01
kidney rudiment formation (GO:0072003)	3	0	.15	-	 < 0.01	8.58E-01
regulation of immunological synapse formation (GO:2000520)	3	0	.15	-	 < 0.01	8.58E-01
modulation by host of symbiont molecular function (GO:0052428)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	1	0	.05	-	 < 0.01	9.50E-01
notochord cell development (GO:0060035)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.05	-	 < 0.01	9.50E-01
notochord cell differentiation (GO:0060034)	1	0	.05	-	 < 0.01	9.50E-01
anatomical structure regression (GO:0060033)	16	0	.82	-	 < 0.01	4.41E-01
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.05	-	 < 0.01	9.50E-01
notochord regression (GO:0060032)	2	0	.10	-	 < 0.01	9.03E-01
melanocyte apoptotic process (GO:1902362)	1	0	.05	-	 < 0.01	9.50E-01
modulation by host of symbiont catalytic activity (GO:0052422)	3	0	.15	-	 < 0.01	8.58E-01
mediolateral intercalation (GO:0060031)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cellular pH reduction (GO:0032848)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.05	-	 < 0.01	9.50E-01
regulation of T-helper 1 cell activation (GO:2000517)	1	0	.05	-	 < 0.01	9.50E-01
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	34	0	1.74	-	 < 0.01	1.76E-01
macrophage colony-stimulating factor signaling pathway (GO:0038145)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of granzyme A production (GO:2000513)	1	0	.05	-	 < 0.01	9.50E-01
regulation of granzyme A production (GO:2000511)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dendritic cell chemotaxis (GO:2000510)	8	0	.41	-	 < 0.01	6.65E-01
convergent extension involved in organogenesis (GO:0060029)	5	0	.26	-	 < 0.01	7.75E-01
metabolism by host of substance in symbiont (GO:0052419)	1	0	.05	-	 < 0.01	9.50E-01
convergent extension involved in axis elongation (GO:0060028)	5	0	.26	-	 < 0.01	7.75E-01
sulfate transmembrane transport (GO:1902358)	15	0	.77	-	 < 0.01	4.65E-01
metabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052418)	1	0	.05	-	 < 0.01	9.50E-01
convergent extension involved in gastrulation (GO:0060027)	7	0	.36	-	 < 0.01	6.99E-01
metabolism by host of symbiont protein (GO:0052417)	1	0	.05	-	 < 0.01	9.50E-01
convergent extension (GO:0060026)	13	0	.66	-	 < 0.01	5.15E-01
oxaloacetate(2-) transmembrane transport (GO:1902356)	3	0	.15	-	 < 0.01	8.58E-01
metabolism by host of symbiont macromolecule (GO:0052416)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic activity (GO:0060025)	3	0	.15	-	 < 0.01	8.58E-01
G-quadruplex DNA unwinding (GO:0044806)	7	0	.36	-	 < 0.01	6.99E-01
hard palate development (GO:0060022)	6	0	.31	-	 < 0.01	7.36E-01
phosphagen metabolic process (GO:0006599)	3	0	.15	-	 < 0.01	8.58E-01
multi-organism membrane organization (GO:0044803)	10	0	.51	-	 < 0.01	6.00E-01
Bergmann glial cell differentiation (GO:0060020)	10	0	.51	-	 < 0.01	6.00E-01
spermine biosynthetic process (GO:0006597)	3	0	.15	-	 < 0.01	8.58E-01
multi-organism membrane fusion (GO:0044800)	7	0	.36	-	 < 0.01	6.99E-01
ornithine catabolic process (GO:0006593)	1	0	.05	-	 < 0.01	9.50E-01
ornithine biosynthetic process (GO:0006592)	1	0	.05	-	 < 0.01	9.50E-01
glomerular basement membrane development (GO:0032836)	11	0	.56	-	 < 0.01	5.70E-01
ornithine metabolic process (GO:0006591)	8	0	.41	-	 < 0.01	6.65E-01
thyroid hormone generation (GO:0006590)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of dendritic cell chemotaxis (GO:2000509)	1	0	.05	-	 < 0.01	9.50E-01
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)	2	0	.10	-	 < 0.01	9.03E-01
regulation of dendritic cell chemotaxis (GO:2000508)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of blood vessel remodeling (GO:2000504)	2	0	.10	-	 < 0.01	9.03E-01
ERBB2-ERBB3 signaling pathway (GO:0038133)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of natural killer cell chemotaxis (GO:2000502)	2	0	.10	-	 < 0.01	9.03E-01
ERBB4 signaling pathway (GO:0038130)	1	0	.05	-	 < 0.01	9.50E-01
radial glial cell differentiation (GO:0060019)	13	0	.66	-	 < 0.01	5.15E-01
response to chloroquine (GO:1902349)	1	0	.05	-	 < 0.01	9.50E-01
astrocyte fate commitment (GO:0060018)	4	0	.20	-	 < 0.01	8.15E-01
parathyroid gland development (GO:0060017)	7	0	.36	-	 < 0.01	6.99E-01
granulosa cell development (GO:0060016)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation by host of symbiont molecular function (GO:0052405)	5	0	.26	-	 < 0.01	7.75E-01
granulosa cell differentiation (GO:0060014)	2	0	.10	-	 < 0.01	9.03E-01
righting reflex (GO:0060013)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation by host of symbiont catalytic activity (GO:0052403)	2	0	.10	-	 < 0.01	9.03E-01
synaptic transmission, glycinergic (GO:0060012)	6	0	.31	-	 < 0.01	7.36E-01
octopamine biosynthetic process (GO:0006589)	2	0	.10	-	 < 0.01	9.03E-01
Sertoli cell proliferation (GO:0060011)	5	0	.26	-	 < 0.01	7.75E-01
Sertoli cell fate commitment (GO:0060010)	1	0	.05	-	 < 0.01	9.50E-01
indolalkylamine metabolic process (GO:0006586)	16	0	.82	-	 < 0.01	4.41E-01
dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.05	-	 < 0.01	9.50E-01
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	3	0	.15	-	 < 0.01	8.58E-01
melanin biosynthetic process from tyrosine (GO:0006583)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	3	0	.15	-	 < 0.01	8.58E-01
regulation of natural killer cell differentiation involved in immune response (GO:0032826)	4	0	.20	-	 < 0.01	8.15E-01
acetylcholine catabolic process (GO:0006581)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of natural killer cell differentiation (GO:0032825)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of natural killer cell differentiation (GO:0032824)	3	0	.15	-	 < 0.01	8.58E-01
regulation of natural killer cell differentiation (GO:0032823)	12	0	.61	-	 < 0.01	5.42E-01
ERBB3 signaling pathway (GO:0038129)	2	0	.10	-	 < 0.01	9.03E-01
toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)	4	0	.20	-	 < 0.01	8.15E-01
toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	6	0	.31	-	 < 0.01	7.36E-01
linear vestibuloocular reflex (GO:0060007)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	2	0	.10	-	 < 0.01	9.03E-01
vestibular reflex (GO:0060005)	4	0	.20	-	 < 0.01	8.15E-01
reflex (GO:0060004)	20	0	1.02	-	 < 0.01	3.60E-01
copper ion export (GO:0060003)	3	0	.15	-	 < 0.01	8.58E-01
amino-acid betaine catabolic process (GO:0006579)	3	0	.15	-	 < 0.01	8.58E-01
amino-acid betaine biosynthetic process (GO:0006578)	7	0	.36	-	 < 0.01	6.99E-01
amino-acid betaine metabolic process (GO:0006577)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of natural killer cell proliferation (GO:0032819)	7	0	.36	-	 < 0.01	6.99E-01
valine catabolic process (GO:0006574)	4	0	.20	-	 < 0.01	8.15E-01
valine metabolic process (GO:0006573)	7	0	.36	-	 < 0.01	6.99E-01
regulation of natural killer cell proliferation (GO:0032817)	9	0	.46	-	 < 0.01	6.31E-01
tyrosine catabolic process (GO:0006572)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of natural killer cell activation (GO:0032816)	20	0	1.02	-	 < 0.01	3.60E-01
tyrosine biosynthetic process (GO:0006571)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of natural killer cell activation (GO:0032815)	9	0	.46	-	 < 0.01	6.31E-01
tyrosine metabolic process (GO:0006570)	11	0	.56	-	 < 0.01	5.70E-01
regulation of natural killer cell activation (GO:0032814)	33	0	1.69	-	 < 0.01	1.85E-01
positive regulation of epinephrine secretion (GO:0032812)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of epinephrine secretion (GO:0032811)	4	0	.20	-	 < 0.01	8.15E-01
chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-21-mediated signaling pathway (GO:0038114)	8	0	.41	-	 < 0.01	6.65E-01
interleukin-9-mediated signaling pathway (GO:0038113)	9	0	.46	-	 < 0.01	6.31E-01
interleukin-8-mediated signaling pathway (GO:0038112)	2	0	.10	-	 < 0.01	9.03E-01
otic vesicle development (GO:0071599)	14	0	.72	-	 < 0.01	4.89E-01
tryptophan catabolic process (GO:0006569)	10	0	.51	-	 < 0.01	6.00E-01
tryptophan metabolic process (GO:0006568)	12	0	.61	-	 < 0.01	5.42E-01
threonine catabolic process (GO:0006567)	4	0	.20	-	 < 0.01	8.15E-01
threonine metabolic process (GO:0006566)	5	0	.26	-	 < 0.01	7.75E-01
L-serine catabolic process (GO:0006565)	4	0	.20	-	 < 0.01	8.15E-01
lacrimal gland development (GO:0032808)	7	0	.36	-	 < 0.01	6.99E-01
proline biosynthetic process (GO:0006561)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.10	-	 < 0.01	9.03E-01
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	6	0	.31	-	 < 0.01	7.36E-01
low-density lipoprotein particle receptor catabolic process (GO:0032802)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	0	.20	-	 < 0.01	8.15E-01
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	3	0	.15	-	 < 0.01	8.58E-01
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.05	-	 < 0.01	9.50E-01
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.05	-	 < 0.01	9.50E-01
CAAX-box protein processing (GO:0071586)	2	0	.10	-	 < 0.01	9.03E-01
detoxification of cadmium ion (GO:0071585)	1	0	.05	-	 < 0.01	9.50E-01
nuclear DNA replication termination (GO:1902317)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of zinc ion transmembrane transport (GO:0071583)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of zinc ion transport (GO:0071582)	1	0	.05	-	 < 0.01	9.50E-01
regulation of zinc ion transmembrane import (GO:0071581)	1	0	.05	-	 < 0.01	9.50E-01
regulation of zinc ion transmembrane transport (GO:0071580)	1	0	.05	-	 < 0.01	9.50E-01
regulation of copper ion transmembrane transport (GO:1902311)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of peptidyl-serine dephosphorylation (GO:1902310)	2	0	.10	-	 < 0.01	9.03E-01
S-adenosylmethioninamine biosynthetic process (GO:0006557)	1	0	.05	-	 < 0.01	9.50E-01
lysine catabolic process (GO:0006554)	11	0	.56	-	 < 0.01	5.70E-01
lysine metabolic process (GO:0006553)	12	0	.61	-	 < 0.01	5.42E-01
isoleucine catabolic process (GO:0006550)	4	0	.20	-	 < 0.01	8.15E-01
hepatocyte cell migration (GO:0002194)	1	0	.05	-	 < 0.01	9.50E-01
cap-dependent translational initiation (GO:0002191)	2	0	.10	-	 < 0.01	9.03E-01
regulation of zinc ion transport (GO:0071579)	2	0	.10	-	 < 0.01	9.03E-01
zinc ion import across plasma membrane (GO:0071578)	7	0	.36	-	 < 0.01	6.99E-01
zinc ion transmembrane transport (GO:0071577)	23	0	1.17	-	 < 0.01	3.09E-01
negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	2	0	.10	-	 < 0.01	9.03E-01
regulation of peptidyl-serine dephosphorylation (GO:1902308)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of sodium ion transmembrane transport (GO:1902306)	14	0	.72	-	 < 0.01	4.89E-01
isoleucine metabolic process (GO:0006549)	7	0	.36	-	 < 0.01	6.99E-01
histidine catabolic process (GO:0006548)	6	0	.31	-	 < 0.01	7.36E-01
glycine catabolic process (GO:0006546)	3	0	.15	-	 < 0.01	8.58E-01
glycine biosynthetic process (GO:0006545)	4	0	.20	-	 < 0.01	8.15E-01
glycine metabolic process (GO:0006544)	15	0	.77	-	 < 0.01	4.65E-01
glutamine catabolic process (GO:0006543)	3	0	.15	-	 < 0.01	8.58E-01
glutamate decarboxylation to succinate (GO:0006540)	1	0	.05	-	 < 0.01	9.50E-01
acetylcholine receptor signaling pathway (GO:0095500)	24	0	1.23	-	 < 0.01	2.93E-01
protein ufmylation (GO:0071569)	5	0	.26	-	 < 0.01	7.75E-01
glutamate catabolic process via 2-oxoglutarate (GO:0006539)	1	0	.05	-	 < 0.01	9.50E-01
cysteine biosynthetic process from serine (GO:0006535)	1	0	.05	-	 < 0.01	9.50E-01
aspartate catabolic process (GO:0006533)	4	0	.20	-	 < 0.01	8.15E-01
RNA acetylation (GO:1990884)	1	0	.05	-	 < 0.01	9.50E-01
aspartate biosynthetic process (GO:0006532)	3	0	.15	-	 < 0.01	8.58E-01
aspartate metabolic process (GO:0006531)	6	0	.31	-	 < 0.01	7.36E-01
rRNA acetylation (GO:1990882)	1	0	.05	-	 < 0.01	9.50E-01
asparagine catabolic process (GO:0006530)	1	0	.05	-	 < 0.01	9.50E-01
male germ cell proliferation (GO:0002176)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to paranode region of axon (GO:0002175)	5	0	.26	-	 < 0.01	7.75E-01
histone H3-K27 demethylation (GO:0071557)	5	0	.26	-	 < 0.01	7.75E-01
cell wall organization or biogenesis (GO:0071554)	4	0	.20	-	 < 0.01	8.15E-01
asparagine biosynthetic process (GO:0006529)	2	0	.10	-	 < 0.01	9.03E-01
arginine catabolic process (GO:0006527)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to gastrin (GO:1990878)	1	0	.05	-	 < 0.01	9.50E-01
arginine biosynthetic process (GO:0006526)	4	0	.20	-	 < 0.01	8.15E-01
lysophospholipid transport (GO:0051977)	2	0	.10	-	 < 0.01	9.03E-01
arginine metabolic process (GO:0006525)	16	0	.82	-	 < 0.01	4.41E-01
alanine catabolic process (GO:0006524)	5	0	.26	-	 < 0.01	7.75E-01
alanine metabolic process (GO:0006522)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cellular amino acid metabolic process (GO:0006521)	62	0	3.17	-	 < 0.01	4.19E-02
positive regulation of transmission of nerve impulse (GO:0051971)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of transmission of nerve impulse (GO:0051970)	6	0	.31	-	 < 0.01	7.36E-01
diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.05	-	 < 0.01	9.50E-01
diphosphoinositol polyphosphate metabolic process (GO:0071543)	4	0	.20	-	 < 0.01	8.15E-01
dopaminergic neuron differentiation (GO:0071542)	28	0	1.43	-	 < 0.01	2.39E-01
regulation of transmission of nerve impulse (GO:0051969)	16	0	.82	-	 < 0.01	4.41E-01
glycoprotein catabolic process (GO:0006516)	22	0	1.12	-	 < 0.01	3.25E-01
response to gastrin (GO:1990867)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of synapse assembly (GO:0051964)	8	0	.41	-	 < 0.01	6.65E-01
response to growth hormone-releasing hormone (GO:1990864)	1	0	.05	-	 < 0.01	9.50E-01
desmosome assembly (GO:0002159)	4	0	.20	-	 < 0.01	8.15E-01
osteoclast proliferation (GO:0002158)	4	0	.20	-	 < 0.01	8.15E-01
regulation of thyroid hormone mediated signaling pathway (GO:0002155)	4	0	.20	-	 < 0.01	8.15E-01
thyroid hormone mediated signaling pathway (GO:0002154)	3	0	.15	-	 < 0.01	8.58E-01
bile acid conjugation (GO:0002152)	1	0	.05	-	 < 0.01	9.50E-01
otolith mineralization (GO:0045299)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to centrosome (GO:0071539)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of relaxation of cardiac muscle (GO:1901899)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to endothelin (GO:1990859)	2	0	.10	-	 < 0.01	9.03E-01
GPI anchor release (GO:0006507)	1	0	.05	-	 < 0.01	9.50E-01
methotrexate transport (GO:0051958)	2	0	.10	-	 < 0.01	9.03E-01
regulation of relaxation of cardiac muscle (GO:1901897)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to lectin (GO:1990858)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of amino acid transport (GO:0051957)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of amine transport (GO:0051954)	37	0	1.89	-	 < 0.01	1.51E-01
C-terminal protein lipidation (GO:0006501)	6	0	.31	-	 < 0.01	7.36E-01
hypochlorous acid biosynthetic process (GO:0002149)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal protein palmitoylation (GO:0006500)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951)	1	0	.05	-	 < 0.01	9.50E-01
hypochlorous acid metabolic process (GO:0002148)	1	0	.05	-	 < 0.01	9.50E-01
tRNA wobble position uridine thiolation (GO:0002143)	4	0	.20	-	 < 0.01	8.15E-01
cementum mineralization (GO:0071529)	2	0	.10	-	 < 0.01	9.03E-01
tRNA re-export from nucleus (GO:0071528)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943)	1	0	.05	-	 < 0.01	9.50E-01
retinoic acid biosynthetic process (GO:0002138)	8	0	.41	-	 < 0.01	6.65E-01
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	8	0	.41	-	 < 0.01	6.65E-01
response to lectin (GO:1990840)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of imprinting at mating-type locus (GO:0071517)	1	0	.05	-	 < 0.01	9.50E-01
establishment of imprinting at mating-type locus (GO:0071516)	1	0	.05	-	 < 0.01	9.50E-01
genetic imprinting at mating-type locus (GO:0071515)	2	0	.10	-	 < 0.01	9.03E-01
response to endothelin (GO:1990839)	3	0	.15	-	 < 0.01	8.58E-01
L-glutamate import (GO:0051938)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of calcium ion binding (GO:1901877)	2	0	.10	-	 < 0.01	9.03E-01
catecholamine transport (GO:0051937)	14	0	.72	-	 < 0.01	4.89E-01
regulation of calcium ion binding (GO:1901876)	2	0	.10	-	 < 0.01	9.03E-01
glutamate reuptake (GO:0051935)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of post-translational protein modification (GO:1901874)	1	0	.05	-	 < 0.01	9.50E-01
catecholamine uptake involved in synaptic transmission (GO:0051934)	4	0	.20	-	 < 0.01	8.15E-01
regulation of post-translational protein modification (GO:1901873)	2	0	.10	-	 < 0.01	9.03E-01
response to odorant (GO:1990834)	3	0	.15	-	 < 0.01	8.58E-01
amino acid neurotransmitter reuptake (GO:0051933)	2	0	.10	-	 < 0.01	9.03E-01
synaptic transmission, GABAergic (GO:0051932)	14	0	.72	-	 < 0.01	4.89E-01
regulation of sensory perception (GO:0051931)	35	0	1.79	-	 < 0.01	1.67E-01
tRNA nucleoside ribose methylation (GO:0002128)	1	0	.05	-	 < 0.01	9.50E-01
regulation of sensory perception of pain (GO:0051930)	34	0	1.74	-	 < 0.01	1.76E-01
tRNA wobble base cytosine methylation (GO:0002127)	1	0	.05	-	 < 0.01	9.50E-01
maternal aggressive behavior (GO:0002125)	4	0	.20	-	 < 0.01	8.15E-01
inter-male aggressive behavior (GO:0002121)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to mycophenolic acid (GO:0071506)	2	0	.10	-	 < 0.01	9.03E-01
response to mycophenolic acid (GO:0071505)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to heparin (GO:0071504)	5	0	.26	-	 < 0.01	7.75E-01
secretion of lysosomal enzymes (GO:0033299)	4	0	.20	-	 < 0.01	8.15E-01
response to heparin (GO:0071503)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to temperature stimulus (GO:0071502)	5	0	.26	-	 < 0.01	7.75E-01
hepatocyte dedifferentiation (GO:1990828)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of muscle tissue development (GO:1901863)	20	0	1.02	-	 < 0.01	3.60E-01
sulfation (GO:0051923)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	1	0	.05	-	 < 0.01	9.50E-01
aggressive behavior (GO:0002118)	9	0	.46	-	 < 0.01	6.31E-01
store-operated calcium entry (GO:0002115)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of fibrinolysis (GO:0051919)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cellular respiration (GO:1901857)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cellular respiration (GO:1901856)	1	0	.05	-	 < 0.01	9.50E-01
induction of synaptic plasticity by chemical substance (GO:0051915)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of synaptic plasticity by chemical substance (GO:0051914)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic plasticity by chemical substance (GO:0051913)	1	0	.05	-	 < 0.01	9.50E-01
tRNA wobble cytosine modification (GO:0002101)	2	0	.10	-	 < 0.01	9.03E-01
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.05	-	 < 0.01	9.50E-01
cell proliferation in midbrain (GO:0033278)	6	0	.31	-	 < 0.01	7.36E-01
abortive mitotic cell cycle (GO:0033277)	2	0	.10	-	 < 0.01	9.03E-01
response to vitamin B2 (GO:0033274)	1	0	.05	-	 < 0.01	9.50E-01
endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846)	1	0	.05	-	 < 0.01	9.50E-01
establishment of pigment granule localization (GO:0051905)	22	0	1.12	-	 < 0.01	3.25E-01
pigment granule transport (GO:0051904)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of mitochondrial depolarization (GO:0051902)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of mitochondrial depolarization (GO:0051901)	9	0	.46	-	 < 0.01	6.31E-01
protein palmitoleylation (GO:0045234)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.05	-	 < 0.01	9.50E-01
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.05	-	 < 0.01	9.50E-01
external encapsulating structure organization (GO:0045229)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of CD4 production (GO:0045225)	1	0	.05	-	 < 0.01	9.50E-01
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.05	-	 < 0.01	9.50E-01
intermicrovillar adhesion (GO:0090675)	2	0	.10	-	 < 0.01	9.03E-01
regulation of CD4 production (GO:0045223)	1	0	.05	-	 < 0.01	9.50E-01
endothelial cell-matrix adhesion (GO:0090673)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of FasL production (GO:0045221)	1	0	.05	-	 < 0.01	9.50E-01
zeaxanthin biosynthetic process (GO:1901827)	1	0	.05	-	 < 0.01	9.50E-01
zeaxanthin metabolic process (GO:1901825)	1	0	.05	-	 < 0.01	9.50E-01
regulation of FasL production (GO:0045219)	1	0	.05	-	 < 0.01	9.50E-01
zonula adherens maintenance (GO:0045218)	2	0	.10	-	 < 0.01	9.03E-01
endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668)	1	0	.05	-	 < 0.01	9.50E-01
cell chemotaxis to vascular endothelial growth factor (GO:0090667)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter receptor metabolic process (GO:0045213)	3	0	.15	-	 < 0.01	8.58E-01
galanin-activated signaling pathway (GO:0090663)	2	0	.10	-	 < 0.01	9.03E-01
FasL biosynthetic process (GO:0045210)	1	0	.05	-	 < 0.01	9.50E-01
cerebrospinal fluid circulation (GO:0090660)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cellular amine catabolic process (GO:0033242)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular amine catabolic process (GO:0033241)	1	0	.05	-	 < 0.01	9.50E-01
MAPK phosphatase export from nucleus, leptomycin B sensitive (GO:0045209)	1	0	.05	-	 < 0.01	9.50E-01
MAPK phosphatase export from nucleus (GO:0045208)	1	0	.05	-	 < 0.01	9.50E-01
walking behavior (GO:0090659)	32	0	1.63	-	 < 0.01	1.95E-01
gastric acid secretion (GO:0001696)	5	0	.26	-	 < 0.01	7.75E-01
histamine catabolic process (GO:0001695)	1	0	.05	-	 < 0.01	9.50E-01
t-circle formation (GO:0090656)	9	0	.46	-	 < 0.01	6.31E-01
histamine biosynthetic process (GO:0001694)	2	0	.10	-	 < 0.01	9.03E-01
MAPK export from nucleus (GO:0045204)	2	0	.10	-	 < 0.01	9.03E-01
histamine metabolic process (GO:0001692)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cellular amine metabolic process (GO:0033239)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of protein sumoylation (GO:0033234)	8	0	.41	-	 < 0.01	6.65E-01
beta-glucoside catabolic process (GO:1901805)	2	0	.10	-	 < 0.01	9.03E-01
beta-glucoside metabolic process (GO:1901804)	2	0	.10	-	 < 0.01	9.03E-01
modulation of age-related behavioral decline (GO:0090647)	9	0	.46	-	 < 0.01	6.31E-01
tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.05	-	 < 0.01	9.50E-01
dsRNA transport (GO:0033227)	3	0	.15	-	 < 0.01	8.58E-01
reductive iron assimilation (GO:0033215)	1	0	.05	-	 < 0.01	9.50E-01
siderophore-dependent iron import into cell (GO:0033214)	1	0	.05	-	 < 0.01	9.50E-01
iron import into cell (GO:0033212)	7	0	.36	-	 < 0.01	6.99E-01
adiponectin-activated signaling pathway (GO:0033211)	7	0	.36	-	 < 0.01	6.99E-01
leptin-mediated signaling pathway (GO:0033210)	11	0	.56	-	 < 0.01	5.70E-01
conditioned taste aversion (GO:0001661)	5	0	.26	-	 < 0.01	7.75E-01
fever generation (GO:0001660)	3	0	.15	-	 < 0.01	8.58E-01
meiotic cytokinesis (GO:0033206)	7	0	.36	-	 < 0.01	6.99E-01
DNA clamp unloading (GO:0090618)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial mRNA processing (GO:0090615)	2	0	.10	-	 < 0.01	9.03E-01
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	5	0	.26	-	 < 0.01	7.75E-01
trans-Golgi network to recycling endosome transport (GO:0044795)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation by host of viral process (GO:0044793)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation by host of viral release from host cell (GO:0044791)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation by host of viral release from host cell (GO:0044790)	1	0	.05	-	 < 0.01	9.50E-01
cytoplasm protein quality control (GO:0140455)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of hepatic stellate cell activation (GO:2000491)	3	0	.15	-	 < 0.01	8.58E-01
protein targeting to Golgi apparatus (GO:0140450)	1	0	.05	-	 < 0.01	9.50E-01
modulation by host of viral release from host cell (GO:0044789)	5	0	.26	-	 < 0.01	7.75E-01
metaphase/anaphase transition of cell cycle (GO:0044784)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of glutamine transport (GO:2000487)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glutamine transport (GO:2000486)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutamine transport (GO:2000485)	2	0	.10	-	 < 0.01	9.03E-01
cytokine precursor processing (GO:0140447)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	9	0	.46	-	 < 0.01	6.31E-01
meiotic spindle checkpoint (GO:0044779)	1	0	.05	-	 < 0.01	9.50E-01
meiotic DNA integrity checkpoint (GO:0044778)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric glomerular visceral epithelial cell development (GO:2000477)	1	0	.05	-	 < 0.01	9.50E-01
regulation of opioid receptor signaling pathway (GO:2000474)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of hematopoietic stem cell migration (GO:2000473)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hematopoietic stem cell migration (GO:2000471)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of peroxidase activity (GO:2000470)	2	0	.10	-	 < 0.01	9.03E-01
multi-organism cellular process (GO:0044764)	16	0	.82	-	 < 0.01	4.41E-01
suppression of symbiont entry into host by host (GO:0052373)	1	0	.05	-	 < 0.01	9.50E-01
low-density lipoprotein receptor particle metabolic process (GO:0032799)	10	0	.51	-	 < 0.01	6.00E-01
uropod organization (GO:0032796)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of CREB transcription factor activity (GO:0032793)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of peroxidase activity (GO:2000469)	1	0	.05	-	 < 0.01	9.50E-01
regulation of peroxidase activity (GO:2000468)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glycogen (starch) synthase activity (GO:2000467)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of astrocyte chemotaxis (GO:2000464)	1	0	.05	-	 < 0.01	9.50E-01
nodal signaling pathway (GO:0038092)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	3	0	.15	-	 < 0.01	8.58E-01
catabolism by host of substance in symbiont (GO:0052364)	1	0	.05	-	 < 0.01	9.50E-01
catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363)	1	0	.05	-	 < 0.01	9.50E-01
catabolism by host of symbiont protein (GO:0052362)	1	0	.05	-	 < 0.01	9.50E-01
catabolism by organism of macromolecule in other organism involved in symbiotic interaction (GO:0052361)	1	0	.05	-	 < 0.01	9.50E-01
catabolism by host of symbiont macromolecule (GO:0052360)	1	0	.05	-	 < 0.01	9.50E-01
unsaturated monocarboxylic acid metabolic process (GO:0032789)	1	0	.05	-	 < 0.01	9.50E-01
saturated monocarboxylic acid metabolic process (GO:0032788)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA-templated transcription, elongation (GO:0032786)	21	0	1.07	-	 < 0.01	3.42E-01
bile acid secretion (GO:0032782)	4	0	.20	-	 < 0.01	8.15E-01
regulation of astrocyte chemotaxis (GO:2000458)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of ATPase activity (GO:0032780)	16	0	.82	-	 < 0.01	4.41E-01
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	2	0	.10	-	 < 0.01	9.03E-01
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	7	0	.36	-	 < 0.01	6.99E-01
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	0	.10	-	 < 0.01	9.03E-01
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.05	-	 < 0.01	9.50E-01
cell cycle DNA replication termination (GO:1902294)	1	0	.05	-	 < 0.01	9.50E-01
DNA methylation on cytosine (GO:0032776)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of monophenol monooxygenase activity (GO:0032773)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448)	2	0	.10	-	 < 0.01	9.03E-01
regulation of monophenol monooxygenase activity (GO:0032771)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	3	0	.15	-	 < 0.01	8.58E-01
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	12	0	.61	-	 < 0.01	5.42E-01
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	13	0	.66	-	 < 0.01	5.15E-01
neuron projection extension involved in neuron projection guidance (GO:1902284)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of primary amine oxidase activity (GO:1902283)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of monooxygenase activity (GO:0032769)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of mast cell cytokine production (GO:0032765)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of monocyte extravasation (GO:2000439)	3	0	.15	-	 < 0.01	8.58E-01
mast cell cytokine production (GO:0032762)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of monocyte extravasation (GO:2000438)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lymphotoxin A production (GO:0032761)	2	0	.10	-	 < 0.01	9.03E-01
regulation of monocyte extravasation (GO:2000437)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of protein neddylation (GO:2000436)	5	0	.26	-	 < 0.01	7.75E-01
collagen-activated signaling pathway (GO:0038065)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of protein neddylation (GO:2000435)	3	0	.15	-	 < 0.01	8.58E-01
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	12	0	.61	-	 < 0.01	5.42E-01
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	0	.05	-	 < 0.01	9.50E-01
nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	2	0	.10	-	 < 0.01	9.03E-01
DNA demethylation of male pronucleus (GO:0044727)	1	0	.05	-	 < 0.01	9.50E-01
chromatin reprogramming in the zygote (GO:0044725)	1	0	.05	-	 < 0.01	9.50E-01
(R)-carnitine transmembrane transport (GO:1902270)	1	0	.05	-	 < 0.01	9.50E-01
protein import into peroxisome matrix, substrate release (GO:0044721)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052330)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of TRAIL production (GO:0032759)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of interleukin-5 production (GO:0032754)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of interleukin-3 production (GO:0032752)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of apoptotic cell clearance (GO:2000427)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of apoptotic cell clearance (GO:2000426)	2	0	.10	-	 < 0.01	9.03E-01
regulation of apoptotic cell clearance (GO:2000425)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of eosinophil chemotaxis (GO:2000424)	2	0	.10	-	 < 0.01	9.03E-01
regulation of eosinophil chemotaxis (GO:2000422)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of polyamine transmembrane transport (GO:1902269)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of polyamine transmembrane transport (GO:1902268)	3	0	.15	-	 < 0.01	8.58E-01
regulation of polyamine transmembrane transport (GO:1902267)	4	0	.20	-	 < 0.01	8.15E-01
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of interleukin-23 production (GO:0032747)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of eosinophil migration (GO:2000418)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of interleukin-18 production (GO:0032741)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of interleukin-17 production (GO:0032740)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of fibronectin-dependent thymocyte migration (GO:2000415)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-5-mediated signaling pathway (GO:0038043)	2	0	.10	-	 < 0.01	9.03E-01
regulation of fibronectin-dependent thymocyte migration (GO:2000413)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of thymocyte migration (GO:2000412)	3	0	.15	-	 < 0.01	8.58E-01
cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041)	2	0	.10	-	 < 0.01	9.03E-01
regulation of thymocyte migration (GO:2000410)	4	0	.20	-	 < 0.01	8.15E-01
regulation of delayed rectifier potassium channel activity (GO:1902259)	18	0	.92	-	 < 0.01	3.99E-01
negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257)	2	0	.10	-	 < 0.01	9.03E-01
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	4	0	.20	-	 < 0.01	8.15E-01
phytoalexin metabolic process (GO:0052314)	2	0	.10	-	 < 0.01	9.03E-01
modulation of transcription in other organism involved in symbiotic interaction (GO:0052312)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of erythrocyte apoptotic process (GO:1902251)	1	0	.05	-	 < 0.01	9.50E-01
regulation of erythrocyte apoptotic process (GO:1902250)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-16 production (GO:0032739)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-15 production (GO:0032738)	1	0	.05	-	 < 0.01	9.50E-01
N-glycan processing (GO:0006491)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of T cell extravasation (GO:2000409)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of T cell extravasation (GO:2000408)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-1 alpha production (GO:0032730)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of T cell migration (GO:2000405)	6	0	.31	-	 < 0.01	7.36E-01
C-terminal protein methylation (GO:0006481)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	13	0	.66	-	 < 0.01	5.15E-01
N-terminal protein amino acid methylation (GO:0006480)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of connective tissue growth factor production (GO:0032723)	2	0	.10	-	 < 0.01	9.03E-01
epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of chemokine production (GO:0032722)	54	0	2.76	-	 < 0.01	6.31E-02
apolipoprotein A-I-mediated signaling pathway (GO:0038027)	5	0	.26	-	 < 0.01	7.75E-01
reelin-mediated signaling pathway (GO:0038026)	8	0	.41	-	 < 0.01	6.65E-01
insulin receptor recycling (GO:0038020)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.05	-	 < 0.01	9.50E-01
regulation of positive thymic T cell selection (GO:1902232)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	6	0	.31	-	 < 0.01	7.36E-01
peptidyl-tyrosine sulfation (GO:0006478)	2	0	.10	-	 < 0.01	9.03E-01
protein sulfation (GO:0006477)	8	0	.41	-	 < 0.01	6.65E-01
N-terminal protein amino acid acetylation (GO:0006474)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of interleukin-5 production (GO:0032714)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of interleukin-4 production (GO:0032713)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of interleukin-3 production (GO:0032712)	1	0	.05	-	 < 0.01	9.50E-01
insulin receptor internalization (GO:0038016)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	2	0	.10	-	 < 0.01	9.03E-01
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to UV-B (GO:0071493)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of acrosome reaction (GO:1902225)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to UV-A (GO:0071492)	9	0	.46	-	 < 0.01	6.31E-01
ketone body metabolic process (GO:1902224)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220)	1	0	.05	-	 < 0.01	9.50E-01
steroid hormone receptor complex assembly (GO:0006463)	1	0	.05	-	 < 0.01	9.50E-01
response to isoquinoline alkaloid (GO:0014072)	35	0	1.79	-	 < 0.01	1.67E-01
negative regulation of interleukin-23 production (GO:0032707)	2	0	.10	-	 < 0.01	9.03E-01
regulation of signal transduction by receptor internalization (GO:0038009)	1	0	.05	-	 < 0.01	9.50E-01
TRAF-mediated signal transduction (GO:0038008)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of interleukin-18 production (GO:0032701)	2	0	.10	-	 < 0.01	9.03E-01
netrin-activated signaling pathway (GO:0038007)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of interleukin-17 production (GO:0032700)	15	0	.77	-	 < 0.01	4.65E-01
endocrine signaling (GO:0038002)	1	0	.05	-	 < 0.01	9.50E-01
paracrine signaling (GO:0038001)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to high light intensity (GO:0071486)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-glutamic acid poly-ADP-ribosylation (GO:0018424)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to light intensity (GO:0071484)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to X-ray (GO:0071481)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of serotonin secretion (GO:0014064)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of serotonin secretion (GO:0014063)	5	0	.26	-	 < 0.01	7.75E-01
regulation of serotonin secretion (GO:0014062)	8	0	.41	-	 < 0.01	6.65E-01
regulation of norepinephrine secretion (GO:0014061)	15	0	.77	-	 < 0.01	4.65E-01
translational readthrough (GO:0006451)	8	0	.41	-	 < 0.01	6.65E-01
regulation of epinephrine secretion (GO:0014060)	6	0	.31	-	 < 0.01	7.36E-01
tRNA wobble uridine modification (GO:0002098)	15	0	.77	-	 < 0.01	4.65E-01
tRNA wobble base modification (GO:0002097)	18	0	.92	-	 < 0.01	3.99E-01
cellular hypotonic salinity response (GO:0071477)	2	0	.10	-	 < 0.01	9.03E-01
cellular hyperosmotic salinity response (GO:0071475)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to salt stress (GO:0071472)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dopamine secretion (GO:0014059)	34	0	1.74	-	 < 0.01	1.76E-01
C-terminal protein amino acid modification (GO:0018410)	12	0	.61	-	 < 0.01	5.42E-01
regulation of translational elongation (GO:0006448)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	1	0	.05	-	 < 0.01	9.50E-01
regulation of translational initiation by iron (GO:0006447)	3	0	.15	-	 < 0.01	8.58E-01
regulation of acetylcholine secretion, neurotransmission (GO:0014056)	3	0	.15	-	 < 0.01	8.58E-01
pancreas regeneration (GO:1990798)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	2	0	.10	-	 < 0.01	9.03E-01
regulation of gamma-aminobutyric acid secretion (GO:0014052)	6	0	.31	-	 < 0.01	7.36E-01
gamma-aminobutyric acid secretion (GO:0014051)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of glutamate secretion (GO:0014050)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of cardioblast differentiation (GO:0051892)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to glial cell derived neurotrophic factor (GO:1990792)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardioblast differentiation (GO:0051891)	6	0	.31	-	 < 0.01	7.36E-01
dorsal root ganglion development (GO:1990791)	7	0	.36	-	 < 0.01	6.99E-01
regulation of cardioblast differentiation (GO:0051890)	8	0	.41	-	 < 0.01	6.65E-01
response to glial cell derived neurotrophic factor (GO:1990790)	2	0	.10	-	 < 0.01	9.03E-01
regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	11	0	.56	-	 < 0.01	5.70E-01
diaphragm contraction (GO:0002086)	2	0	.10	-	 < 0.01	9.03E-01
protein depalmitoylation (GO:0002084)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to alkaline pH (GO:0071469)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to acidic pH (GO:0071468)	11	0	.56	-	 < 0.01	5.70E-01
cellular response to pH (GO:0071467)	21	0	1.07	-	 < 0.01	3.42E-01
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to hydrostatic pressure (GO:0071464)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to water stimulus (GO:0071462)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to redox state (GO:0071461)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of glutamate secretion (GO:0014049)	9	0	.46	-	 < 0.01	6.31E-01
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutamate secretion (GO:0014048)	15	0	.77	-	 < 0.01	4.65E-01
valyl-tRNA aminoacylation (GO:0006438)	2	0	.10	-	 < 0.01	9.03E-01
glutamate secretion (GO:0014047)	30	0	1.53	-	 < 0.01	2.16E-01
tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.10	-	 < 0.01	9.03E-01
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.10	-	 < 0.01	9.03E-01
establishment of endothelial blood-brain barrier (GO:0014045)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of hh target transcription factor activity (GO:1990787)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of timing of anagen (GO:0051886)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to dsDNA (GO:1990786)	1	0	.05	-	 < 0.01	9.50E-01
seryl-tRNA aminoacylation (GO:0006434)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of neuron maturation (GO:0014043)	3	0	.15	-	 < 0.01	8.58E-01
response to water-immersion restraint stress (GO:1990785)	3	0	.15	-	 < 0.01	8.58E-01
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.10	-	 < 0.01	9.03E-01
response to dsDNA (GO:1990784)	1	0	.05	-	 < 0.01	9.50E-01
killing of cells in other organism involved in symbiotic interaction (GO:0051883)	20	0	1.02	-	 < 0.01	3.60E-01
methionyl-tRNA aminoacylation (GO:0006431)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of Schwann cell differentiation (GO:0014040)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial depolarization (GO:0051882)	3	0	.15	-	 < 0.01	8.58E-01
lysyl-tRNA aminoacylation (GO:0006430)	1	0	.05	-	 < 0.01	9.50E-01
extraocular skeletal muscle development (GO:0002074)	2	0	.10	-	 < 0.01	9.03E-01
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	8	0	.41	-	 < 0.01	6.65E-01
glandular epithelial cell maturation (GO:0002071)	2	0	.10	-	 < 0.01	9.03E-01
epithelial cell maturation (GO:0002070)	14	0	.72	-	 < 0.01	4.89E-01
protein localization to chromosome, centromeric region (GO:0071459)	16	0	.82	-	 < 0.01	4.41E-01
cellular response to hyperoxia (GO:0071455)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to superoxide (GO:0071451)	15	0	.77	-	 < 0.01	4.65E-01
cellular response to oxygen radical (GO:0071450)	15	0	.77	-	 < 0.01	4.65E-01
regulation of Schwann cell differentiation (GO:0014038)	4	0	.20	-	 < 0.01	8.15E-01
isoleucyl-tRNA aminoacylation (GO:0006428)	1	0	.05	-	 < 0.01	9.50E-01
histidyl-tRNA aminoacylation (GO:0006427)	3	0	.15	-	 < 0.01	8.58E-01
neural crest cell fate specification (GO:0014036)	2	0	.10	-	 < 0.01	9.03E-01
lateral element assembly (GO:0051878)	1	0	.05	-	 < 0.01	9.50E-01
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.05	-	 < 0.01	9.50E-01
pigment granule aggregation in cell center (GO:0051877)	2	0	.10	-	 < 0.01	9.03E-01
neural crest cell fate commitment (GO:0014034)	4	0	.20	-	 < 0.01	8.15E-01
glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.10	-	 < 0.01	9.03E-01
pigment granule localization (GO:0051875)	24	0	1.23	-	 < 0.01	2.93E-01
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.10	-	 < 0.01	9.03E-01
tumor necrosis factor secretion (GO:1990774)	3	0	.15	-	 < 0.01	8.58E-01
aspartyl-tRNA aminoacylation (GO:0006422)	1	0	.05	-	 < 0.01	9.50E-01
killing by host of symbiont cells (GO:0051873)	18	0	.92	-	 < 0.01	3.99E-01
columnar/cuboidal epithelial cell maturation (GO:0002069)	6	0	.31	-	 < 0.01	7.36E-01
arginyl-tRNA aminoacylation (GO:0006420)	3	0	.15	-	 < 0.01	8.58E-01
clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.05	-	 < 0.01	9.50E-01
glandular epithelial cell development (GO:0002068)	18	0	.92	-	 < 0.01	3.99E-01
cellular response to lipid hydroperoxide (GO:0071449)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to hydroperoxide (GO:0071447)	8	0	.41	-	 < 0.01	6.65E-01
cellular response to pheromone (GO:0071444)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of histone H3-K14 acetylation (GO:0071442)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H3-K14 acetylation (GO:0071440)	4	0	.20	-	 < 0.01	8.15E-01
alanyl-tRNA aminoacylation (GO:0006419)	2	0	.10	-	 < 0.01	9.03E-01
notochord formation (GO:0014028)	4	0	.20	-	 < 0.01	8.15E-01
general adaptation syndrome, behavioral process (GO:0051867)	1	0	.05	-	 < 0.01	9.50E-01
general adaptation syndrome (GO:0051866)	2	0	.10	-	 < 0.01	9.03E-01
neural plate elongation (GO:0014022)	2	0	.10	-	 < 0.01	9.03E-01
myofibroblast contraction (GO:1990764)	1	0	.05	-	 < 0.01	9.50E-01
osteoblast fate commitment (GO:0002051)	4	0	.20	-	 < 0.01	8.15E-01
establishment of epithelial cell apical/basal polarity (GO:0045198)	16	0	.82	-	 < 0.01	4.41E-01
snRNA export from nucleus (GO:0006408)	2	0	.10	-	 < 0.01	9.03E-01
neuroblast fate commitment (GO:0014017)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of signal transduction by p53 class mediator (GO:1901798)	20	0	1.02	-	 < 0.01	3.60E-01
neuroblast differentiation (GO:0014016)	3	0	.15	-	 < 0.01	8.58E-01
mitotic sister chromatid biorientation (GO:1990758)	1	0	.05	-	 < 0.01	9.50E-01
RNA import into nucleus (GO:0006404)	3	0	.15	-	 < 0.01	8.58E-01
peripheral nervous system axon regeneration (GO:0014012)	6	0	.31	-	 < 0.01	7.36E-01
Schwann cell proliferation (GO:0014010)	2	0	.10	-	 < 0.01	9.03E-01
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	6	0	.31	-	 < 0.01	7.36E-01
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	7	0	.36	-	 < 0.01	6.99E-01
zonula adherens assembly (GO:0045186)	2	0	.10	-	 < 0.01	9.03E-01
malate transmembrane transport (GO:0071423)	3	0	.15	-	 < 0.01	8.58E-01
succinate transmembrane transport (GO:0071422)	5	0	.26	-	 < 0.01	7.75E-01
glial cell proliferation (GO:0014009)	17	0	.87	-	 < 0.01	4.19E-01
cellular response to histamine (GO:0071420)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of microglia differentiation (GO:0014008)	1	0	.05	-	 < 0.01	9.50E-01
regulation of microglia differentiation (GO:0014006)	1	0	.05	-	 < 0.01	9.50E-01
benzoyl-CoA metabolic process (GO:1901787)	1	0	.05	-	 < 0.01	9.50E-01
microglia development (GO:0014005)	3	0	.15	-	 < 0.01	8.58E-01
microglia differentiation (GO:0014004)	3	0	.15	-	 < 0.01	8.58E-01
astrocyte development (GO:0014002)	36	0	1.84	-	 < 0.01	1.59E-01
primary miRNA methylation (GO:1990744)	1	0	.05	-	 < 0.01	9.50E-01
protein sialylation (GO:1990743)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of L-glutamate import across plasma membrane (GO:0002038)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of L-glutamate import across plasma membrane (GO:0002037)	1	0	.05	-	 < 0.01	9.50E-01
brain renin-angiotensin system (GO:0002035)	5	0	.26	-	 < 0.01	7.75E-01
regulation of blood vessel diameter by renin-angiotensin (GO:0002034)	5	0	.26	-	 < 0.01	7.75E-01
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	1	0	.05	-	 < 0.01	9.50E-01
G protein-coupled receptor internalization (GO:0002031)	13	0	.66	-	 < 0.01	5.15E-01
cellular response to amine stimulus (GO:0071418)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to purine-containing compound (GO:0071415)	13	0	.66	-	 < 0.01	5.15E-01
cellular response to hydroxyisoflavone (GO:0071413)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to genistein (GO:0071412)	1	0	.05	-	 < 0.01	9.50E-01
cytolysis by host of symbiont cells (GO:0051838)	10	0	.51	-	 < 0.01	6.00E-01
response to manganese-induced endoplasmic reticulum stress (GO:1990737)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of synapse structural plasticity (GO:0051835)	4	0	.20	-	 < 0.01	8.15E-01
UV-damage excision repair, DNA incision (GO:1990731)	1	0	.05	-	 < 0.01	9.50E-01
reduction of food intake in response to dietary excess (GO:0002023)	4	0	.20	-	 < 0.01	8.15E-01
cell-cell signaling involved in cell fate commitment (GO:0045168)	3	0	.15	-	 < 0.01	8.58E-01
asymmetric protein localization involved in cell fate determination (GO:0045167)	1	0	.05	-	 < 0.01	9.50E-01
clustering of voltage-gated potassium channels (GO:0045163)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to triglyceride (GO:0071401)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to oleic acid (GO:0071400)	3	0	.15	-	 < 0.01	8.58E-01
response to hydroperoxide (GO:0033194)	18	0	.92	-	 < 0.01	3.99E-01
primary miRNA modification (GO:1990729)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synapse structural plasticity (GO:0051823)	9	0	.46	-	 < 0.01	6.31E-01
regulation of renal output by angiotensin (GO:0002019)	3	0	.15	-	 < 0.01	8.58E-01
renin-angiotensin regulation of aldosterone production (GO:0002018)	4	0	.20	-	 < 0.01	8.15E-01
regulation of blood volume by renal aldosterone (GO:0002017)	2	0	.10	-	 < 0.01	9.03E-01
regulation of blood volume by renin-angiotensin (GO:0002016)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of histone ubiquitination (GO:0033184)	5	0	.26	-	 < 0.01	7.75E-01
leukotriene A4 biosynthetic process (GO:1901753)	1	0	.05	-	 < 0.01	9.50E-01
xylulose biosynthetic process (GO:0005999)	2	0	.10	-	 < 0.01	9.03E-01
leukotriene A4 metabolic process (GO:1901751)	2	0	.10	-	 < 0.01	9.03E-01
xylulose catabolic process (GO:0005998)	1	0	.05	-	 < 0.01	9.50E-01
leukotriene D4 biosynthetic process (GO:1901750)	3	0	.15	-	 < 0.01	8.58E-01
xylulose metabolic process (GO:0005997)	4	0	.20	-	 < 0.01	8.15E-01
detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007)	1	0	.05	-	 < 0.01	9.50E-01
trehalose catabolic process (GO:0005993)	1	0	.05	-	 < 0.01	9.50E-01
angiotensin maturation (GO:0002003)	12	0	.61	-	 < 0.01	5.42E-01
regulation of angiotensin levels in blood (GO:0002002)	12	0	.61	-	 < 0.01	5.42E-01
trehalose metabolic process (GO:0005991)	2	0	.10	-	 < 0.01	9.03E-01
renin secretion into blood stream (GO:0002001)	2	0	.10	-	 < 0.01	9.03E-01
male anatomical structure morphogenesis (GO:0090598)	4	0	.20	-	 < 0.01	8.15E-01
meiotic sister chromatid segregation (GO:0045144)	9	0	.46	-	 < 0.01	6.31E-01
inflammatory response to wounding (GO:0090594)	7	0	.36	-	 < 0.01	6.99E-01
leukotriene D4 metabolic process (GO:1901748)	3	0	.15	-	 < 0.01	8.58E-01
presynaptic active zone organization (GO:1990709)	5	0	.26	-	 < 0.01	7.75E-01
conditioned place preference (GO:1990708)	3	0	.15	-	 < 0.01	8.58E-01
cholangiocyte proliferation (GO:1990705)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051803)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051802)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myoblast fusion (GO:1901741)	15	0	.77	-	 < 0.01	4.65E-01
cytolysis in other organism involved in symbiotic interaction (GO:0051801)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of myoblast fusion (GO:1901740)	2	0	.10	-	 < 0.01	9.03E-01
nucleolar chromatin organization (GO:1990700)	1	0	.05	-	 < 0.01	9.50E-01
sucrose biosynthetic process (GO:0005986)	2	0	.10	-	 < 0.01	9.03E-01
sucrose metabolic process (GO:0005985)	3	0	.15	-	 < 0.01	8.58E-01
development of secondary sexual characteristics (GO:0045136)	8	0	.41	-	 < 0.01	6.65E-01
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168)	1	0	.05	-	 < 0.01	9.50E-01
regulation of myoblast fusion (GO:1901739)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of platelet aggregation (GO:1901731)	3	0	.15	-	 < 0.01	8.58E-01
dsDNA loop formation (GO:0090579)	5	0	.26	-	 < 0.01	7.75E-01
T cell receptor V(D)J recombination (GO:0033153)	5	0	.26	-	 < 0.01	7.75E-01
NADPH oxidation (GO:0070995)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of histone deacetylase activity (GO:1901727)	6	0	.31	-	 < 0.01	7.36E-01
detection of oxidative stress (GO:0070994)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of histone deacetylase activity (GO:1901726)	2	0	.10	-	 < 0.01	9.03E-01
regulation of histone deacetylase activity (GO:1901725)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of cell proliferation involved in kidney development (GO:1901724)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of cell proliferation involved in kidney development (GO:1901723)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cell proliferation involved in kidney development (GO:1901722)	13	0	.66	-	 < 0.01	5.15E-01
azole transmembrane transport (GO:0045117)	12	0	.61	-	 < 0.01	5.42E-01
protein neddylation (GO:0045116)	12	0	.61	-	 < 0.01	5.42E-01
regulation of integrin biosynthetic process (GO:0045113)	5	0	.26	-	 < 0.01	7.75E-01
integrin biosynthetic process (GO:0045112)	1	0	.05	-	 < 0.01	9.50E-01
intermediate filament bundle assembly (GO:0045110)	7	0	.36	-	 < 0.01	6.99E-01
oxidative demethylation (GO:0070989)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	3	0	.15	-	 < 0.01	8.58E-01
L-asparagine biosynthetic process (GO:0070981)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	0	.05	-	 < 0.01	9.50E-01
establishment of endothelial intestinal barrier (GO:0090557)	11	0	.56	-	 < 0.01	5.70E-01
intermediate filament polymerization or depolymerization (GO:0045105)	1	0	.05	-	 < 0.01	9.50E-01
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	19	0	.97	-	 < 0.01	3.79E-01
protein K11-linked ubiquitination (GO:0070979)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation of glucokinase activity (GO:0033133)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of glucokinase activity (GO:0033132)	4	0	.20	-	 < 0.01	8.15E-01
mesenchymal cell differentiation involved in bone development (GO:1901706)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glucokinase activity (GO:0033131)	8	0	.41	-	 < 0.01	6.65E-01
protein localization to endoplasmic reticulum exit site (GO:0070973)	8	0	.41	-	 < 0.01	6.65E-01
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	1	0	.05	-	 < 0.01	9.50E-01
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	2	0	.10	-	 < 0.01	9.03E-01
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	29	0	1.48	-	 < 0.01	2.27E-01
positive regulation of histone phosphorylation (GO:0033129)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of histone phosphorylation (GO:0033128)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neutrophil mediated killing of fungus (GO:0070965)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neutrophil mediated killing of bacterium (GO:0070962)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	3	0	.15	-	 < 0.01	8.58E-01
medium-chain fatty acid transport (GO:0001579)	2	0	.10	-	 < 0.01	9.03E-01
globoside biosynthetic process (GO:0001576)	2	0	.10	-	 < 0.01	9.03E-01
globoside metabolic process (GO:0001575)	2	0	.10	-	 < 0.01	9.03E-01
ganglioside biosynthetic process (GO:0001574)	14	0	.72	-	 < 0.01	4.89E-01
ganglioside metabolic process (GO:0001573)	23	0	1.17	-	 < 0.01	3.09E-01
lactosylceramide biosynthetic process (GO:0001572)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neutrophil mediated killing of fungus (GO:0070953)	2	0	.10	-	 < 0.01	9.03E-01
regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951)	2	0	.10	-	 < 0.01	9.03E-01
regulation of neutrophil mediated killing of bacterium (GO:0070950)	2	0	.10	-	 < 0.01	9.03E-01
cell septum assembly (GO:0090529)	1	0	.05	-	 < 0.01	9.50E-01
antiviral innate immune response (GO:0140374)	9	0	.46	-	 < 0.01	6.31E-01
actin filament reorganization (GO:0090527)	9	0	.46	-	 < 0.01	6.31E-01
fatty acid alpha-oxidation (GO:0001561)	9	0	.46	-	 < 0.01	6.31E-01
vesicle tethering involved in exocytosis (GO:0090522)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell growth by extracellular stimulus (GO:0001560)	3	0	.15	-	 < 0.01	8.58E-01
glomerular visceral epithelial cell migration (GO:0090521)	5	0	.26	-	 < 0.01	7.75E-01
sphingolipid mediated signaling pathway (GO:0090520)	14	0	.72	-	 < 0.01	4.89E-01
regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	4	0	.20	-	 < 0.01	8.15E-01
regulation of neutrophil mediated cytotoxicity (GO:0070948)	6	0	.31	-	 < 0.01	7.36E-01
neutrophil-mediated killing of fungus (GO:0070947)	1	0	.05	-	 < 0.01	9.50E-01
neutrophil-mediated killing of gram-positive bacterium (GO:0070946)	1	0	.05	-	 < 0.01	9.50E-01
neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	3	0	.15	-	 < 0.01	8.58E-01
neutrophil-mediated killing of bacterium (GO:0070944)	5	0	.26	-	 < 0.01	7.75E-01
neutrophil-mediated killing of symbiont cell (GO:0070943)	5	0	.26	-	 < 0.01	7.75E-01
neutrophil mediated cytotoxicity (GO:0070942)	5	0	.26	-	 < 0.01	7.75E-01
oocyte growth (GO:0001555)	3	0	.15	-	 < 0.01	8.58E-01
luteolysis (GO:0001554)	7	0	.36	-	 < 0.01	6.99E-01
cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361)	1	0	.05	-	 < 0.01	9.50E-01
ovarian follicle atresia (GO:0001552)	2	0	.10	-	 < 0.01	9.03E-01
ovarian cumulus expansion (GO:0001550)	3	0	.15	-	 < 0.01	8.58E-01
tooth eruption (GO:0044691)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of lamellipodium morphogenesis (GO:2000394)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of lamellipodium morphogenesis (GO:2000393)	2	0	.10	-	 < 0.01	9.03E-01
regulation of lamellipodium morphogenesis (GO:2000392)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of neutrophil extravasation (GO:2000391)	7	0	.36	-	 < 0.01	6.99E-01
antral ovarian follicle growth (GO:0001547)	7	0	.36	-	 < 0.01	6.99E-01
preantral ovarian follicle growth (GO:0001546)	3	0	.15	-	 < 0.01	8.58E-01
lipid export from cell (GO:0140353)	8	0	.41	-	 < 0.01	6.65E-01
primary ovarian follicle growth (GO:0001545)	2	0	.10	-	 < 0.01	9.03E-01
initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.10	-	 < 0.01	9.03E-01
epiboly involved in wound healing (GO:0090505)	21	0	1.07	-	 < 0.01	3.42E-01
ovarian follicle rupture (GO:0001543)	1	0	.05	-	 < 0.01	9.50E-01
epiboly (GO:0090504)	22	0	1.12	-	 < 0.01	3.25E-01
ovulation from ovarian follicle (GO:0001542)	9	0	.46	-	 < 0.01	6.31E-01
endocardial cushion to mesenchymal transition (GO:0090500)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.05	-	 < 0.01	9.50E-01
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	25	0	1.28	-	 < 0.01	2.79E-01
regulation of neutrophil extravasation (GO:2000389)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of antral ovarian follicle growth (GO:2000388)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antral ovarian follicle growth (GO:2000387)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ovarian follicle development (GO:2000386)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of ectoderm development (GO:2000384)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ectoderm development (GO:2000383)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mesoderm development (GO:2000382)	1	0	.05	-	 < 0.01	9.50E-01
UV-damage excision repair (GO:0070914)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of oxygen metabolic process (GO:2000376)	2	0	.10	-	 < 0.01	9.03E-01
regulation of oxygen metabolic process (GO:2000374)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of clathrin-dependent endocytosis (GO:2000370)	5	0	.26	-	 < 0.01	7.75E-01
aminophospholipid translocation (GO:0140331)	5	0	.26	-	 < 0.01	7.75E-01
pseudouridine synthesis (GO:0001522)	17	0	.87	-	 < 0.01	4.19E-01
transepithelial L-ascorbic acid transport (GO:0070904)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial tRNA pseudouridine synthesis (GO:0070902)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial tRNA methylation (GO:0070901)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of interleukin-13 production (GO:0032696)	7	0	.36	-	 < 0.01	6.99E-01
mitochondrial tRNA modification (GO:0070900)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of interleukin-12 production (GO:0032695)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of interleukin-10 production (GO:0032693)	19	0	.97	-	 < 0.01	3.79E-01
regulation of clathrin-dependent endocytosis (GO:2000369)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of acrosomal vesicle exocytosis (GO:2000368)	2	0	.10	-	 < 0.01	9.03E-01
regulation of acrosomal vesicle exocytosis (GO:2000367)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of interleukin-1 alpha production (GO:0032690)	2	0	.10	-	 < 0.01	9.03E-01
lysophospholipid translocation (GO:0140329)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of prostaglandin-E synthase activity (GO:2000363)	3	0	.15	-	 < 0.01	8.58E-01
peptide amidation (GO:0001519)	2	0	.10	-	 < 0.01	9.03E-01
regulation of prostaglandin-E synthase activity (GO:2000361)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of binding of sperm to zona pellucida (GO:2000360)	4	0	.20	-	 < 0.01	8.15E-01
selenocysteine incorporation (GO:0001514)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation by symbiont of host autophagy (GO:0140321)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of interferon-gamma production (GO:0032689)	37	0	1.89	-	 < 0.01	1.51E-01
negative regulation of hepatocyte growth factor production (GO:0032686)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of connective tissue growth factor production (GO:0032683)	1	0	.05	-	 < 0.01	9.50E-01
regulation of binding of sperm to zona pellucida (GO:2000359)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of kidney smooth muscle cell differentiation (GO:2000358)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lymphotoxin A production (GO:0032681)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of kidney smooth muscle cell differentiation (GO:2000357)	1	0	.05	-	 < 0.01	9.50E-01
regulation of kidney smooth muscle cell differentiation (GO:2000356)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ovarian follicle development (GO:2000355)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ovarian follicle development (GO:2000354)	5	0	.26	-	 < 0.01	7.75E-01
acetylcholine catabolic process in synaptic cleft (GO:0001507)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of CD40 signaling pathway (GO:2000350)	1	0	.05	-	 < 0.01	9.50E-01
cartilage condensation (GO:0001502)	18	0	.92	-	 < 0.01	3.99E-01
histone H3-K4 dimethylation (GO:0044648)	5	0	.26	-	 < 0.01	7.75E-01
regulation of TRAIL production (GO:0032679)	2	0	.10	-	 < 0.01	9.03E-01
regulation of interleukin-5 production (GO:0032674)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of CD40 signaling pathway (GO:2000349)	2	0	.10	-	 < 0.01	9.03E-01
regulation of interleukin-3 production (GO:0032672)	2	0	.10	-	 < 0.01	9.03E-01
regulation of CD40 signaling pathway (GO:2000348)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of hepatocyte proliferation (GO:2000347)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of hepatocyte proliferation (GO:2000346)	4	0	.20	-	 < 0.01	8.15E-01
regulation of hepatocyte proliferation (GO:2000345)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of acrosome reaction (GO:2000344)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of viral release from host cell (GO:1902188)	15	0	.77	-	 < 0.01	4.65E-01
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-23 production (GO:0032667)	8	0	.41	-	 < 0.01	6.65E-01
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	5	0	.26	-	 < 0.01	7.75E-01
regulation of interleukin-18 production (GO:0032661)	7	0	.36	-	 < 0.01	6.99E-01
regulation of interleukin-17 production (GO:0032660)	31	0	1.58	-	 < 0.01	2.05E-01
positive regulation of blood microparticle formation (GO:2000334)	2	0	.10	-	 < 0.01	9.03E-01
regulation of blood microparticle formation (GO:2000332)	2	0	.10	-	 < 0.01	9.03E-01
regulation of terminal button organization (GO:2000331)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	4	0	.20	-	 < 0.01	8.15E-01
fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of keratinocyte apoptotic process (GO:1902174)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of keratinocyte apoptotic process (GO:1902173)	1	0	.05	-	 < 0.01	9.50E-01
regulation of keratinocyte apoptotic process (GO:1902172)	6	0	.31	-	 < 0.01	7.36E-01
regulation of interleukin-16 production (GO:0032659)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-15 production (GO:0032658)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	2	0	.10	-	 < 0.01	9.03E-01
regulation of T-helper 17 cell lineage commitment (GO:2000328)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of nuclear receptor transcription coactivator activity (GO:2000327)	3	0	.15	-	 < 0.01	8.58E-01
regulation of interleukin-1 alpha production (GO:0032650)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of nuclear receptor transcription coactivator activity (GO:2000326)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nuclear receptor transcription coactivator activity (GO:2000325)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of T-helper 17 cell differentiation (GO:2000321)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of T-helper 17 cell differentiation (GO:2000320)	10	0	.51	-	 < 0.01	6.00E-01
metabolism of macromolecule in other organism involved in symbiotic interaction (GO:0052229)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.05	-	 < 0.01	9.50E-01
catabolism of substance in other organism involved in symbiotic interaction (GO:0052227)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	3	0	.15	-	 < 0.01	8.58E-01
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hepatocyte growth factor production (GO:0032646)	1	0	.05	-	 < 0.01	9.50E-01
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	15	0	.77	-	 < 0.01	4.65E-01
regulation of connective tissue growth factor production (GO:0032643)	3	0	.15	-	 < 0.01	8.58E-01
regulation of T-helper 17 cell differentiation (GO:2000319)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of T-helper 17 type immune response (GO:2000318)	10	0	.51	-	 < 0.01	6.00E-01
lymphotoxin A production (GO:0032641)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of T-helper 17 type immune response (GO:2000317)	11	0	.56	-	 < 0.01	5.70E-01
tumor necrosis factor production (GO:0032640)	8	0	.41	-	 < 0.01	6.65E-01
regulation of T-helper 17 type immune response (GO:2000316)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	1	0	.05	-	 < 0.01	9.50E-01
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.10	-	 < 0.01	9.03E-01
regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.15	-	 < 0.01	8.58E-01
regulation of NMDA receptor activity (GO:2000310)	40	0	2.04	-	 < 0.01	1.29E-01
regulation of cyclic nucleotide-gated ion channel activity (GO:1902159)	2	0	.10	-	 < 0.01	9.03E-01
metabolism of substance in other organism involved in symbiotic interaction (GO:0052214)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to DNA damage checkpoint signaling (GO:1902153)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to DNA integrity checkpoint signaling (GO:1902151)	1	0	.05	-	 < 0.01	9.50E-01
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	5	0	.26	-	 < 0.01	7.75E-01
protein deadenylylation (GO:0044602)	1	0	.05	-	 < 0.01	9.50E-01
protein denucleotidylation (GO:0044601)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-8 production (GO:0032637)	8	0	.41	-	 < 0.01	6.65E-01
transcription initiation from mitochondrial promoter (GO:0006391)	4	0	.20	-	 < 0.01	8.15E-01
interleukin-6 production (GO:0032635)	11	0	.56	-	 < 0.01	5.70E-01
interleukin-5 production (GO:0032634)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309)	2	0	.10	-	 < 0.01	9.03E-01
interleukin-3 production (GO:0032632)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308)	1	0	.05	-	 < 0.01	9.50E-01
regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of ceramide biosynthetic process (GO:2000304)	11	0	.56	-	 < 0.01	5.70E-01
regulation of ceramide biosynthetic process (GO:2000303)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of synaptic vesicle exocytosis (GO:2000302)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301)	5	0	.26	-	 < 0.01	7.75E-01
regulation of response to cell cycle checkpoint signaling (GO:1902145)	1	0	.05	-	 < 0.01	9.50E-01
protein-pyridoxal-5-phosphate linkage (GO:0018352)	2	0	.10	-	 < 0.01	9.03E-01
modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204)	7	0	.36	-	 < 0.01	6.99E-01
induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703)	3	0	.15	-	 < 0.01	8.58E-01
protein esterification (GO:0018350)	1	0	.05	-	 < 0.01	9.50E-01
modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203)	4	0	.20	-	 < 0.01	8.15E-01
termination of RNA polymerase III transcription (GO:0006386)	1	0	.05	-	 < 0.01	9.50E-01
transcription initiation from RNA polymerase III promoter (GO:0006384)	8	0	.41	-	 < 0.01	6.65E-01
adenosine to inosine editing (GO:0006382)	8	0	.41	-	 < 0.01	6.65E-01
interleukin-21 production (GO:0032625)	2	0	.10	-	 < 0.01	9.03E-01
interleukin-2 production (GO:0032623)	10	0	.51	-	 < 0.01	6.00E-01
interleukin-18 production (GO:0032621)	2	0	.10	-	 < 0.01	9.03E-01
interleukin-17 production (GO:0032620)	5	0	.26	-	 < 0.01	7.75E-01
protein geranylgeranylation (GO:0018344)	6	0	.31	-	 < 0.01	7.36E-01
protein farnesylation (GO:0018343)	3	0	.15	-	 < 0.01	8.58E-01
protein prenylation (GO:0018342)	10	0	.51	-	 < 0.01	6.00E-01
interleukin-15 production (GO:0032618)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-13 production (GO:0032616)	3	0	.15	-	 < 0.01	8.58E-01
interleukin-12 production (GO:0032615)	2	0	.10	-	 < 0.01	9.03E-01
7-methylguanosine mRNA capping (GO:0006370)	31	0	1.58	-	 < 0.01	2.05E-01
interleukin-10 production (GO:0032613)	4	0	.20	-	 < 0.01	8.15E-01
interleukin-1 alpha production (GO:0032610)	1	0	.05	-	 < 0.01	9.50E-01
protein succinylation (GO:0018335)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to jasmonic acid stimulus (GO:0071395)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to progesterone stimulus (GO:0071393)	4	0	.20	-	 < 0.01	8.15E-01
cellular response to estrogen stimulus (GO:0071391)	14	0	.72	-	 < 0.01	4.89E-01
interferon-alpha production (GO:0032607)	3	0	.15	-	 < 0.01	8.58E-01
granulocyte macrophage colony-stimulating factor production (GO:0032604)	1	0	.05	-	 < 0.01	9.50E-01
fractalkine production (GO:0032603)	2	0	.10	-	 < 0.01	9.03E-01
chemokine production (GO:0032602)	10	0	.51	-	 < 0.01	6.00E-01
chemokine receptor transport out of membrane raft (GO:0032600)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to mineralocorticoid stimulus (GO:0071389)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to corticosterone stimulus (GO:0071386)	3	0	.15	-	 < 0.01	8.58E-01
enzyme active site formation via L-cysteine sulfinic acid (GO:0018323)	1	0	.05	-	 < 0.01	9.50E-01
protein tyrosinylation (GO:0018322)	1	0	.05	-	 < 0.01	9.50E-01
viral penetration into host nucleus (GO:0075732)	3	0	.15	-	 < 0.01	8.58E-01
protein C-linked glycosylation via tryptophan (GO:0018317)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	4	0	.20	-	 < 0.01	8.15E-01
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-serine ADP-ribosylation (GO:0018312)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	2	0	.10	-	 < 0.01	9.03E-01
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of hair follicle development (GO:0051799)	4	0	.20	-	 < 0.01	8.15E-01
DNA methylation-dependent heterochromatin assembly (GO:0006346)	5	0	.26	-	 < 0.01	7.75E-01
protein depalmitoleylation (GO:1990697)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of timing of catagen (GO:0051796)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of timing of catagen (GO:0051795)	3	0	.15	-	 < 0.01	8.58E-01
regulation of timing of catagen (GO:0051794)	4	0	.20	-	 < 0.01	8.15E-01
medium-chain fatty acid catabolic process (GO:0051793)	5	0	.26	-	 < 0.01	7.75E-01
medium-chain fatty acid biosynthetic process (GO:0051792)	6	0	.31	-	 < 0.01	7.36E-01
medium-chain fatty acid metabolic process (GO:0051791)	13	0	.66	-	 < 0.01	5.15E-01
short-chain fatty acid biosynthetic process (GO:0051790)	4	0	.20	-	 < 0.01	8.15E-01
enzyme active site formation (GO:0018307)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to exogenous dsRNA (GO:0071360)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation of cell division (GO:0051782)	14	0	.72	-	 < 0.01	4.89E-01
behavioral response to nutrient (GO:0051780)	1	0	.05	-	 < 0.01	9.50E-01
establishment of integrated proviral latency (GO:0075713)	8	0	.41	-	 < 0.01	6.65E-01
cellular response to interleukin-9 (GO:0071355)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to interleukin-18 (GO:0071351)	7	0	.36	-	 < 0.01	6.99E-01
histone H4-K16 deacetylation (GO:1990678)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to interleukin-11 (GO:0071348)	1	0	.05	-	 < 0.01	9.50E-01
diphosphate metabolic process (GO:0071344)	2	0	.10	-	 < 0.01	9.03E-01
transposition, DNA-mediated (GO:0006313)	2	0	.10	-	 < 0.01	9.03E-01
actin crosslink formation (GO:0051764)	14	0	.72	-	 < 0.01	4.89E-01
meiotic gene conversion (GO:0006311)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of hair follicle cell proliferation (GO:0071338)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hair follicle cell proliferation (GO:0071336)	1	0	.05	-	 < 0.01	9.50E-01
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	17	0	.87	-	 < 0.01	4.19E-01
cellular response to fructose stimulus (GO:0071332)	5	0	.26	-	 < 0.01	7.75E-01
apoptotic DNA fragmentation (GO:0006309)	14	0	.72	-	 < 0.01	4.89E-01
homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758)	1	0	.05	-	 < 0.01	9.50E-01
cannabinoid biosynthetic process (GO:1901696)	1	0	.05	-	 < 0.01	9.50E-01
meiotic sister chromatid cohesion, centromeric (GO:0051754)	4	0	.20	-	 < 0.01	8.15E-01
sebum secreting cell proliferation (GO:1990654)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to sucrose stimulus (GO:0071329)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to disaccharide stimulus (GO:0071324)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to cGMP (GO:0071321)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to prolactin (GO:1990646)	2	0	.10	-	 < 0.01	9.03E-01
arsenate ion transmembrane transport (GO:1901684)	1	0	.05	-	 < 0.01	9.50E-01
response to iron ion starvation (GO:1990641)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to isoquinoline alkaloid (GO:0071317)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to nicotine (GO:0071316)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to morphine (GO:0071315)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to cocaine (GO:0071314)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to caffeine (GO:0071313)	10	0	.51	-	 < 0.01	6.00E-01
nucleotide transmembrane transport (GO:1901679)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of histone H3-K27 acetylation (GO:1901676)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of histone H3-K27 acetylation (GO:1901675)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H3-K27 acetylation (GO:1901674)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of superoxide dismutase activity (GO:1901671)	4	0	.20	-	 < 0.01	8.15E-01
regulatory T cell differentiation (GO:0045066)	6	0	.31	-	 < 0.01	7.36E-01
cytotoxic T cell differentiation (GO:0045065)	1	0	.05	-	 < 0.01	9.50E-01
T-helper 2 cell differentiation (GO:0045064)	3	0	.15	-	 < 0.01	8.58E-01
T-helper 1 cell differentiation (GO:0045063)	8	0	.41	-	 < 0.01	6.65E-01
cellular response to vitamin K (GO:0071307)	2	0	.10	-	 < 0.01	9.03E-01
extrathymic T cell selection (GO:0045062)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to vitamin E (GO:0071306)	2	0	.10	-	 < 0.01	9.03E-01
negative thymic T cell selection (GO:0045060)	12	0	.61	-	 < 0.01	5.42E-01
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	3	0	.15	-	 < 0.01	8.58E-01
regulation of superoxide dismutase activity (GO:1901668)	4	0	.20	-	 < 0.01	8.15E-01
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of immature T cell proliferation in thymus (GO:0033092)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of immature T cell proliferation (GO:0033091)	5	0	.26	-	 < 0.01	7.75E-01
protein de-ADP-ribosylation (GO:0051725)	4	0	.20	-	 < 0.01	8.15E-01
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	3	0	.15	-	 < 0.01	8.58E-01
quinone catabolic process (GO:1901662)	5	0	.26	-	 < 0.01	7.75E-01
calcium ion export (GO:1901660)	8	0	.41	-	 < 0.01	6.65E-01
protein retention in Golgi apparatus (GO:0045053)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of T cell differentiation in thymus (GO:0033089)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of immature T cell proliferation in thymus (GO:0033088)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of immature T cell proliferation (GO:0033087)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of T cell differentiation in thymus (GO:0033085)	7	0	.36	-	 < 0.01	6.99E-01
glycosyl compound biosynthetic process (GO:1901659)	36	0	1.84	-	 < 0.01	1.59E-01
regulation of immature T cell proliferation in thymus (GO:0033084)	7	0	.36	-	 < 0.01	6.99E-01
glycosyl compound catabolic process (GO:1901658)	39	0	1.99	-	 < 0.01	1.36E-01
histone H3-K9 deacetylation (GO:1990619)	2	0	.10	-	 < 0.01	9.03E-01
regulation of immature T cell proliferation (GO:0033083)	9	0	.46	-	 < 0.01	6.31E-01
regulation of extrathymic T cell differentiation (GO:0033082)	2	0	.10	-	 < 0.01	9.03E-01
glycoside transport (GO:1901656)	3	0	.15	-	 < 0.01	8.58E-01
regulation of T cell differentiation in thymus (GO:0033081)	22	0	1.12	-	 < 0.01	3.25E-01
immature T cell proliferation in thymus (GO:0033080)	1	0	.05	-	 < 0.01	9.50E-01
cytolysis in other organism (GO:0051715)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of cytolysis in other organism (GO:0051713)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial membrane fusion (GO:1990613)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of killing of cells of other organism (GO:0051712)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of killing of cells of other organism (GO:0051711)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytolysis in other organism (GO:0051710)	1	0	.05	-	 < 0.01	9.50E-01
protein insertion into ER membrane (GO:0045048)	21	0	1.07	-	 < 0.01	3.42E-01
protein targeting to ER (GO:0045047)	106	0	5.41	-	 < 0.01	4.37E-03
dopamine uptake (GO:0090494)	9	0	.46	-	 < 0.01	6.31E-01
catecholamine uptake (GO:0090493)	9	0	.46	-	 < 0.01	6.31E-01
immature T cell proliferation (GO:0033079)	1	0	.05	-	 < 0.01	9.50E-01
extrathymic T cell differentiation (GO:0033078)	1	0	.05	-	 < 0.01	9.50E-01
isoquinoline alkaloid metabolic process (GO:0033076)	3	0	.15	-	 < 0.01	8.58E-01
regulation of killing of cells of other organism (GO:0051709)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of synoviocyte proliferation (GO:1901647)	2	0	.10	-	 < 0.01	9.03E-01
regulation of synoviocyte proliferation (GO:1901645)	2	0	.10	-	 < 0.01	9.03E-01
nucleoside transmembrane transport (GO:1901642)	7	0	.36	-	 < 0.01	6.99E-01
protein insertion into mitochondrial inner membrane (GO:0045039)	9	0	.46	-	 < 0.01	6.31E-01
purine nucleotide-sugar transmembrane transport (GO:0090480)	1	0	.05	-	 < 0.01	9.50E-01
XDP catabolic process (GO:1901639)	1	0	.05	-	 < 0.01	9.50E-01
plasma membrane fusion (GO:0045026)	22	0	1.12	-	 < 0.01	3.25E-01
G0 to G1 transition (GO:0045023)	2	0	.10	-	 < 0.01	9.03E-01
dibasic protein processing (GO:0090472)	1	0	.05	-	 < 0.01	9.50E-01
cellular pigmentation (GO:0033059)	47	0	2.40	-	 < 0.01	9.03E-02
directional locomotion (GO:0033058)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.05	-	 < 0.01	9.50E-01
RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.05	-	 < 0.01	9.50E-01
transcription preinitiation complex assembly (GO:0070897)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of transposon integration (GO:0070895)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transposon integration (GO:0070894)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to ergosterol (GO:1901625)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of lymphocyte chemotaxis (GO:1901624)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	6	0	.31	-	 < 0.01	7.36E-01
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of nitric oxide biosynthetic process (GO:0045019)	13	0	.66	-	 < 0.01	5.15E-01
mitochondrial magnesium ion transmembrane transport (GO:0045016)	1	0	.05	-	 < 0.01	9.50E-01
glutamate homeostasis (GO:0090461)	4	0	.20	-	 < 0.01	8.15E-01
platelet alpha granule organization (GO:0070889)	2	0	.10	-	 < 0.01	9.03E-01
regulation of proline transport (GO:0070881)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of vesicle transport along microtubule (GO:1901610)	3	0	.15	-	 < 0.01	8.58E-01
DNA deamination (GO:0045006)	13	0	.66	-	 < 0.01	5.15E-01
DNA replication proofreading (GO:0045004)	2	0	.10	-	 < 0.01	9.03E-01
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	9	0	.46	-	 < 0.01	6.31E-01
double-strand break repair via single-strand annealing (GO:0045002)	3	0	.15	-	 < 0.01	8.58E-01
polysaccharide localization (GO:0033037)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myeloid cell apoptotic process (GO:0033034)	8	0	.41	-	 < 0.01	6.65E-01
regulation of vesicle transport along microtubule (GO:1901608)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of myeloid cell apoptotic process (GO:0033033)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of neutrophil apoptotic process (GO:0033031)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of neutrophil apoptotic process (GO:0033030)	2	0	.10	-	 < 0.01	9.03E-01
endocytic iron import into cell (GO:0140298)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-glutamate ADP-deribosylation (GO:0140291)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-serine ADP-deribosylation (GO:0140290)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neutrophil apoptotic process (GO:0033029)	7	0	.36	-	 < 0.01	6.99E-01
myeloid cell apoptotic process (GO:0033028)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of mast cell apoptotic process (GO:0033026)	2	0	.10	-	 < 0.01	9.03E-01
heterochromatin organization involved in chromatin silencing (GO:0070868)	6	0	.31	-	 < 0.01	7.36E-01
regulation of mast cell apoptotic process (GO:0033025)	3	0	.15	-	 < 0.01	8.58E-01
mast cell homeostasis (GO:0033023)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	13	0	.66	-	 < 0.01	5.15E-01
protein mono-ADP-ribosylation (GO:0140289)	12	0	.61	-	 < 0.01	5.42E-01
endosome fission (GO:0140285)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of bile acid biosynthetic process (GO:0070858)	2	0	.10	-	 < 0.01	9.03E-01
tetrapyrrole catabolic process (GO:0033015)	14	0	.72	-	 < 0.01	4.89E-01
tetrapyrrole biosynthetic process (GO:0033014)	29	0	1.48	-	 < 0.01	2.27E-01
detection of endogenous biotic stimulus (GO:0090429)	1	0	.05	-	 < 0.01	9.50E-01
activation of meiosis (GO:0090427)	4	0	.20	-	 < 0.01	8.15E-01
acinar cell differentiation (GO:0090425)	1	0	.05	-	 < 0.01	9.50E-01
naphthalene-containing compound metabolic process (GO:0090420)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mast cell activation involved in immune response (GO:0033008)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of mast cell activation (GO:0033005)	21	0	1.07	-	 < 0.01	3.42E-01
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.05	-	 < 0.01	9.50E-01
polyubiquitinated protein transport (GO:0070844)	1	0	.05	-	 < 0.01	9.50E-01
misfolded protein transport (GO:0070843)	1	0	.05	-	 < 0.01	9.50E-01
aggresome assembly (GO:0070842)	4	0	.20	-	 < 0.01	8.15E-01
inclusion body assembly (GO:0070841)	6	0	.31	-	 < 0.01	7.36E-01
doxorubicin metabolic process (GO:0044598)	8	0	.41	-	 < 0.01	6.65E-01
daunorubicin metabolic process (GO:0044597)	8	0	.41	-	 < 0.01	6.65E-01
malonate catabolic process (GO:0090410)	1	0	.05	-	 < 0.01	9.50E-01
divalent metal ion export (GO:0070839)	9	0	.46	-	 < 0.01	6.31E-01
caveola assembly (GO:0070836)	4	0	.20	-	 < 0.01	8.15E-01
basement membrane assembly (GO:0070831)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	3	0	.15	-	 < 0.01	8.58E-01
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of synapse maturation (GO:2000297)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hydrogen peroxide catabolic process (GO:2000295)	4	0	.20	-	 < 0.01	8.15E-01
regulation of myotome development (GO:2000290)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199)	3	0	.15	-	 < 0.01	8.58E-01
oncogene-induced cell senescence (GO:0090402)	2	0	.10	-	 < 0.01	9.03E-01
heterochromatin maintenance (GO:0070829)	5	0	.26	-	 < 0.01	7.75E-01
chromatin maintenance (GO:0070827)	7	0	.36	-	 < 0.01	6.99E-01
butyryl-CoA catabolic process (GO:0044580)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myotome development (GO:2000287)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular amino acid biosynthetic process (GO:2000283)	1	0	.05	-	 < 0.01	9.50E-01
protein catabolic process at synapse (GO:0140246)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular amino acid biosynthetic process (GO:2000282)	3	0	.15	-	 < 0.01	8.58E-01
peripheral nervous system neuron axonogenesis (GO:0048936)	3	0	.15	-	 < 0.01	8.58E-01
peripheral nervous system neuron development (GO:0048935)	13	0	.66	-	 < 0.01	5.15E-01
peripheral nervous system neuron differentiation (GO:0048934)	13	0	.66	-	 < 0.01	5.15E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	9	0	.46	-	 < 0.01	6.31E-01
[2Fe-2S] cluster assembly (GO:0044571)	4	0	.20	-	 < 0.01	8.15E-01
hydrogen sulfide biosynthetic process (GO:0070814)	2	0	.10	-	 < 0.01	9.03E-01
hydrogen sulfide metabolic process (GO:0070813)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	2	0	.10	-	 < 0.01	9.03E-01
postsynaptic endocytosis (GO:0140239)	7	0	.36	-	 < 0.01	6.99E-01
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of fibroblast apoptotic process (GO:2000270)	7	0	.36	-	 < 0.01	6.99E-01
lateral line system development (GO:0048925)	1	0	.05	-	 < 0.01	9.50E-01
protein transport out of membrane raft (GO:0032599)	1	0	.05	-	 < 0.01	9.50E-01
B cell receptor transport into membrane raft (GO:0032597)	1	0	.05	-	 < 0.01	9.50E-01
protein transport into membrane raft (GO:0032596)	5	0	.26	-	 < 0.01	7.75E-01
B cell receptor transport within lipid bilayer (GO:0032595)	1	0	.05	-	 < 0.01	9.50E-01
protein transport within lipid bilayer (GO:0032594)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of blood coagulation, intrinsic pathway (GO:2000267)	5	0	.26	-	 < 0.01	7.75E-01
regulation of blood coagulation, intrinsic pathway (GO:2000266)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of blood coagulation, extrinsic pathway (GO:2000264)	4	0	.20	-	 < 0.01	8.15E-01
regulation of blood coagulation, extrinsic pathway (GO:2000263)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of blood coagulation, common pathway (GO:2000261)	1	0	.05	-	 < 0.01	9.50E-01
regulation of blood coagulation, common pathway (GO:2000260)	1	0	.05	-	 < 0.01	9.50E-01
relaxation of smooth muscle (GO:0044557)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of protein activation cascade (GO:2000258)	10	0	.51	-	 < 0.01	6.00E-01
ER-dependent peroxisome organization (GO:0032581)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein activation cascade (GO:2000257)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of male germ cell proliferation (GO:2000256)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of male germ cell proliferation (GO:2000255)	2	0	.10	-	 < 0.01	9.03E-01
regulation of male germ cell proliferation (GO:2000254)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of feeding behavior (GO:2000253)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of feeding behavior (GO:2000252)	5	0	.26	-	 < 0.01	7.75E-01
guanine nucleotide transport (GO:0001408)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of actin cytoskeleton reorganization (GO:2000251)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of long-chain fatty acid import into cell (GO:0140214)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of actin cytoskeleton reorganization (GO:2000250)	1	0	.05	-	 < 0.01	9.50E-01
NLRP3 inflammasome complex assembly (GO:0044546)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of flagellated sperm motility (GO:1902093)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation by symbiont of host apoptotic process (GO:0052151)	3	0	.15	-	 < 0.01	8.58E-01
regulation of actin cytoskeleton reorganization (GO:2000249)	41	0	2.09	-	 < 0.01	1.23E-01
response to vitamin K (GO:0032571)	4	0	.20	-	 < 0.01	8.15E-01
response to progesterone (GO:0032570)	48	0	2.45	-	 < 0.01	8.58E-02
tripeptide import across plasma membrane (GO:0140207)	1	0	.05	-	 < 0.01	9.50E-01
dipeptide import across plasma membrane (GO:0140206)	5	0	.26	-	 < 0.01	7.75E-01
oligopeptide import across plasma membrane (GO:0140205)	5	0	.26	-	 < 0.01	7.75E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate (GO:0140200)	1	0	.05	-	 < 0.01	9.50E-01
modulation by symbiont of host catalytic activity (GO:0052148)	1	0	.05	-	 < 0.01	9.50E-01
protein-FAD linkage (GO:0018293)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	5	0	.26	-	 < 0.01	7.75E-01
retrograde axonal protein transport (GO:0099642)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of apoptotic process in other organism (GO:0044533)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081)	2	0	.10	-	 < 0.01	9.03E-01
regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of rRNA processing (GO:2000234)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of rRNA processing (GO:2000233)	3	0	.15	-	 < 0.01	8.58E-01
regulation of rRNA processing (GO:2000232)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of pancreatic stellate cell proliferation (GO:2000231)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lateral motor column neuron migration (GO:1902078)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lateral motor column neuron migration (GO:1902076)	1	0	.05	-	 < 0.01	9.50E-01
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.10	-	 < 0.01	9.03E-01
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to postsynaptic specialization membrane (GO:0099633)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	0	.05	-	 < 0.01	9.50E-01
protein sulfhydration (GO:0044524)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of sphingolipid mediated signaling pathway (GO:1902070)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pancreatic stellate cell proliferation (GO:2000229)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of testosterone biosynthetic process (GO:2000225)	2	0	.10	-	 < 0.01	9.03E-01
regulation of testosterone biosynthetic process (GO:2000224)	3	0	.15	-	 < 0.01	8.58E-01
protein deamination (GO:0018277)	1	0	.05	-	 < 0.01	9.50E-01
isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter receptor diffusion trapping (GO:0099628)	8	0	.41	-	 < 0.01	6.65E-01
regulation of sphingolipid mediated signaling pathway (GO:1902068)	2	0	.10	-	 < 0.01	9.03E-01
ventricular cardiac muscle cell membrane repolarization (GO:0099625)	10	0	.51	-	 < 0.01	6.00E-01
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.05	-	 < 0.01	9.50E-01
atrial cardiac muscle cell membrane repolarization (GO:0099624)	5	0	.26	-	 < 0.01	7.75E-01
regulation of transcription from RNA polymerase II promoter involved in spermatogenesis (GO:1902064)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	21	0	1.07	-	 < 0.01	3.42E-01
cardiac muscle cell membrane repolarization (GO:0099622)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of glutamate metabolic process (GO:2000213)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glutamate metabolic process (GO:2000212)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutamate metabolic process (GO:2000211)	3	0	.15	-	 < 0.01	8.58E-01
isopeptide cross-linking (GO:0018262)	3	0	.15	-	 < 0.01	8.58E-01
protein localization to axon (GO:0099612)	11	0	.56	-	 < 0.01	5.70E-01
modulation of signal transduction in other organism (GO:0044501)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cell projection size (GO:0032536)	11	0	.56	-	 < 0.01	5.70E-01
pyrimidine dimer repair (GO:0006290)	9	0	.46	-	 < 0.01	6.31E-01
regulation of microvillus assembly (GO:0032534)	5	0	.26	-	 < 0.01	7.75E-01
regulation of microvillus length (GO:0032532)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.05	-	 < 0.01	9.50E-01
regulation of microvillus organization (GO:0032530)	11	0	.56	-	 < 0.01	5.70E-01
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ribosomal subunit export from nucleus (GO:2000200)	1	0	.05	-	 < 0.01	9.50E-01
regulation of action potential firing pattern (GO:0099608)	1	0	.05	-	 < 0.01	9.50E-01
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	0	.05	-	 < 0.01	9.50E-01
polyamine transmembrane transport (GO:1902047)	1	0	.05	-	 < 0.01	9.50E-01
microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Fas signaling pathway (GO:1902045)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Fas signaling pathway (GO:1902044)	3	0	.15	-	 < 0.01	8.58E-01
base-excision repair, DNA ligation (GO:0006288)	3	0	.15	-	 < 0.01	8.58E-01
base-excision repair, gap-filling (GO:0006287)	6	0	.31	-	 < 0.01	7.36E-01
base-excision repair, base-free sugar-phosphate removal (GO:0006286)	2	0	.10	-	 < 0.01	9.03E-01
microvillus organization (GO:0032528)	11	0	.56	-	 < 0.01	5.70E-01
somite rostral/caudal axis specification (GO:0032525)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of hematopoietic stem cell differentiation (GO:1902038)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	5	0	.26	-	 < 0.01	7.75E-01
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.05	-	 < 0.01	9.50E-01
DNA replication termination (GO:0006274)	1	0	.05	-	 < 0.01	9.50E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	16	0	.82	-	 < 0.01	4.41E-01
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to L-ascorbic acid (GO:0071298)	1	0	.05	-	 < 0.01	9.50E-01
tRNA exon ligation (GO:0000968)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to zinc ion (GO:0071294)	22	0	1.12	-	 < 0.01	3.25E-01
rRNA 5'-end processing (GO:0000967)	5	0	.26	-	 < 0.01	7.75E-01
L-histidine transport (GO:1902024)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial RNA 3'-end processing (GO:0000965)	5	0	.26	-	 < 0.01	7.75E-01
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	22	0	1.12	-	 < 0.01	3.25E-01
mitochondrial RNA 5'-end processing (GO:0000964)	3	0	.15	-	 < 0.01	8.58E-01
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	22	0	1.12	-	 < 0.01	3.25E-01
L-lysine transport (GO:1902022)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of cilium-dependent cell motility (GO:1902020)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	1	0	.05	-	 < 0.01	9.50E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	7	0	.36	-	 < 0.01	6.99E-01
regulation of mitochondrial RNA catabolic process (GO:0000960)	4	0	.20	-	 < 0.01	8.15E-01
DNA ligation (GO:0006266)	13	0	.66	-	 < 0.01	5.15E-01
DNA topological change (GO:0006265)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to mercury ion (GO:0071288)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to manganese ion (GO:0071287)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to magnesium ion (GO:0071286)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to lithium ion (GO:0071285)	14	0	.72	-	 < 0.01	4.89E-01
mitochondrial mRNA catabolic process (GO:0000958)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial RNA catabolic process (GO:0000957)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to iron(III) ion (GO:0071283)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to iron ion (GO:0071281)	10	0	.51	-	 < 0.01	6.00E-01
cellular response to copper ion (GO:0071280)	26	0	1.33	-	 < 0.01	2.65E-01
UDP-glucose catabolic process (GO:0006258)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	1	0	.05	-	 < 0.01	9.50E-01
UDP catabolic process (GO:0006256)	2	0	.10	-	 < 0.01	9.03E-01
dCTP catabolic process (GO:0006253)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to cobalt ion (GO:0071279)	4	0	.20	-	 < 0.01	8.15E-01
peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-tryptophan modification (GO:0018211)	5	0	.26	-	 < 0.01	7.75E-01
homogentisate catabolic process (GO:1902000)	1	0	.05	-	 < 0.01	9.50E-01
protein delipidation (GO:0051697)	1	0	.05	-	 < 0.01	9.50E-01
pointed-end actin filament capping (GO:0051694)	7	0	.36	-	 < 0.01	6.99E-01
CTP biosynthetic process (GO:0006241)	10	0	.51	-	 < 0.01	6.00E-01
cellular oligosaccharide catabolic process (GO:0051692)	2	0	.10	-	 < 0.01	9.03E-01
protein K69-linked ufmylation (GO:1990592)	4	0	.20	-	 < 0.01	8.15E-01
cellular oligosaccharide metabolic process (GO:0051691)	2	0	.10	-	 < 0.01	9.03E-01
L-methionine salvage (GO:0071267)	6	0	.31	-	 < 0.01	7.36E-01
peptidyl-methionine modification (GO:0018206)	11	0	.56	-	 < 0.01	5.70E-01
L-methionine biosynthetic process (GO:0071265)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-histidine modification (GO:0018202)	8	0	.41	-	 < 0.01	6.65E-01
regulation of translational initiation in response to starvation (GO:0071262)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-glycine modification (GO:0018201)	4	0	.20	-	 < 0.01	8.15E-01
dTTP biosynthetic process (GO:0006235)	3	0	.15	-	 < 0.01	8.58E-01
establishment of ER localization (GO:0051686)	1	0	.05	-	 < 0.01	9.50E-01
dTDP biosynthetic process (GO:0006233)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of Golgi location (GO:0051684)	3	0	.15	-	 < 0.01	8.58E-01
establishment of Golgi localization (GO:0051683)	7	0	.36	-	 < 0.01	6.99E-01
dTMP biosynthetic process (GO:0006231)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to magnetism (GO:0071259)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to gravity (GO:0071258)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to nitrite (GO:0071250)	1	0	.05	-	 < 0.01	9.50E-01
UTP biosynthetic process (GO:0006228)	7	0	.36	-	 < 0.01	6.99E-01
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.05	-	 < 0.01	9.50E-01
septin ring assembly (GO:0000921)	1	0	.05	-	 < 0.01	9.50E-01
dUDP biosynthetic process (GO:0006227)	1	0	.05	-	 < 0.01	9.50E-01
dUMP biosynthetic process (GO:0006226)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial L-ornithine transmembrane transport (GO:1990575)	3	0	.15	-	 < 0.01	8.58E-01
UMP biosynthetic process (GO:0006222)	10	0	.51	-	 < 0.01	6.00E-01
membrane disruption in other organism (GO:0051673)	8	0	.41	-	 < 0.01	6.65E-01
potassium ion import across plasma membrane (GO:1990573)	42	0	2.15	-	 < 0.01	1.17E-01
pyrimidine nucleotide biosynthetic process (GO:0006221)	26	0	1.33	-	 < 0.01	2.65E-01
transport of viral material towards nucleus (GO:0075606)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to chromate (GO:0071247)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to carbon monoxide (GO:0071245)	1	0	.05	-	 < 0.01	9.50E-01
division septum assembly (GO:0000917)	1	0	.05	-	 < 0.01	9.50E-01
actomyosin contractile ring contraction (GO:0000916)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to ammonium ion (GO:0071242)	3	0	.15	-	 < 0.01	8.58E-01
actomyosin contractile ring assembly (GO:0000915)	4	0	.20	-	 < 0.01	8.15E-01
glutamatergic neuron differentiation (GO:1905962)	5	0	.26	-	 < 0.01	7.75E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	4	0	.20	-	 < 0.01	8.15E-01
uridine catabolic process (GO:0006218)	2	0	.10	-	 < 0.01	9.03E-01
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	5	0	.26	-	 < 0.01	7.75E-01
cytidine catabolic process (GO:0006216)	11	0	.56	-	 < 0.01	5.70E-01
actin cortical patch localization (GO:0051666)	1	0	.05	-	 < 0.01	9.50E-01
thymidine catabolic process (GO:0006214)	1	0	.05	-	 < 0.01	9.50E-01
membrane raft localization (GO:0051665)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine nucleoside metabolic process (GO:0006213)	33	0	1.69	-	 < 0.01	1.85E-01
nuclear pore localization (GO:0051664)	1	0	.05	-	 < 0.01	9.50E-01
protein polyufmylation (GO:1990564)	4	0	.20	-	 < 0.01	8.15E-01
uracil catabolic process (GO:0006212)	2	0	.10	-	 < 0.01	9.03E-01
5-methylcytosine catabolic process (GO:0006211)	3	0	.15	-	 < 0.01	8.58E-01
thymine catabolic process (GO:0006210)	3	0	.15	-	 < 0.01	8.58E-01
maintenance of centrosome location (GO:0051661)	6	0	.31	-	 < 0.01	7.36E-01
regulation of cellular response to alcohol (GO:1905957)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of endothelial tube morphogenesis (GO:1905956)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to folic acid (GO:0071231)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.15	-	 < 0.01	8.58E-01
maintenance of mitochondrion location (GO:0051659)	2	0	.10	-	 < 0.01	9.03E-01
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine nucleobase metabolic process (GO:0006206)	14	0	.72	-	 < 0.01	4.89E-01
maintenance of organelle location (GO:0051657)	10	0	.51	-	 < 0.01	6.00E-01
response to capsazepine (GO:1901594)	1	0	.05	-	 < 0.01	9.50E-01
dGTP catabolic process (GO:0006203)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to tumor cell (GO:0071228)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to molecule of fungal origin (GO:0071226)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to muramyl dipeptide (GO:0071225)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to peptidoglycan (GO:0071224)	4	0	.20	-	 < 0.01	8.15E-01
regulation of response to calcium ion (GO:1905945)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to lipoteichoic acid (GO:0071223)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to bacterial lipopeptide (GO:0071221)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to bacterial lipoprotein (GO:0071220)	6	0	.31	-	 < 0.01	7.36E-01
mitochondrial NAD transmembrane transport (GO:1990549)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.05	-	 < 0.01	9.50E-01
Golgi localization (GO:0051645)	13	0	.66	-	 < 0.01	5.15E-01
mitochondrial ATP transmembrane transport (GO:1990544)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.05	-	 < 0.01	9.50E-01
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial manganese ion transmembrane transport (GO:1990540)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of germ cell proliferation (GO:1905938)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of germ cell proliferation (GO:1905937)	2	0	.10	-	 < 0.01	9.03E-01
regulation of germ cell proliferation (GO:1905936)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of cell fate determination (GO:1905934)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell fate determination (GO:1905933)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.10	-	 < 0.01	9.03E-01
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.15	-	 < 0.01	8.58E-01
fructose import across plasma membrane (GO:1990539)	1	0	.05	-	 < 0.01	9.50E-01
neuron projection maintenance (GO:1990535)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of invadopodium disassembly (GO:1905929)	1	0	.05	-	 < 0.01	9.50E-01
establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.05	-	 < 0.01	9.50E-01
regulation of invadopodium disassembly (GO:1905927)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to juxtaparanode region of axon (GO:0071205)	5	0	.26	-	 < 0.01	7.75E-01
fatty acid derivative catabolic process (GO:1901569)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of CoA-transferase activity (GO:1905920)	1	0	.05	-	 < 0.01	9.50E-01
epinephrine uptake (GO:0051625)	2	0	.10	-	 < 0.01	9.03E-01
bone regeneration (GO:1990523)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.05	-	 < 0.01	9.50E-01
response to benomyl (GO:1901561)	1	0	.05	-	 < 0.01	9.50E-01
norepinephrine uptake (GO:0051620)	6	0	.31	-	 < 0.01	7.36E-01
regulation of CoA-transferase activity (GO:1905918)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of calcium ion export across plasma membrane (GO:1905913)	1	0	.05	-	 < 0.01	9.50E-01
regulation of calcium ion export across plasma membrane (GO:1905912)	2	0	.10	-	 < 0.01	9.03E-01
response to metformin (GO:1901558)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine nucleotide import into mitochondrion (GO:1990519)	2	0	.10	-	 < 0.01	9.03E-01
response to fenofibrate (GO:1901557)	1	0	.05	-	 < 0.01	9.50E-01
histamine uptake (GO:0051615)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of endothelial cell development (GO:1901552)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of serotonin uptake (GO:0051612)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of endothelial cell development (GO:1901551)	2	0	.10	-	 < 0.01	9.03E-01
regulation of serotonin uptake (GO:0051611)	4	0	.20	-	 < 0.01	8.15E-01
piRNA biosynthetic process (GO:1990511)	4	0	.20	-	 < 0.01	8.15E-01
serotonin uptake (GO:0051610)	7	0	.36	-	 < 0.01	6.99E-01
replicative senescence (GO:0090399)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of amyloid fibril formation (GO:1905908)	4	0	.20	-	 < 0.01	8.15E-01
histamine transport (GO:0051608)	8	0	.41	-	 < 0.01	6.65E-01
response to raffinose (GO:1901545)	1	0	.05	-	 < 0.01	9.50E-01
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	0	.10	-	 < 0.01	9.03E-01
dense core granule exocytosis (GO:1990504)	6	0	.31	-	 < 0.01	7.36E-01
dense core granule maturation (GO:1990502)	3	0	.15	-	 < 0.01	8.58E-01
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.05	-	 < 0.01	9.50E-01
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.10	-	 < 0.01	9.03E-01
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.10	-	 < 0.01	9.03E-01
phagosome-lysosome docking (GO:0090384)	1	0	.05	-	 < 0.01	9.50E-01
regulation of heart induction (GO:0090381)	6	0	.31	-	 < 0.01	7.36E-01
changes to DNA methylation involved in embryo development (GO:1901538)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of DNA demethylation (GO:1901537)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of DNA demethylation (GO:1901536)	2	0	.10	-	 < 0.01	9.03E-01
regulation of DNA demethylation (GO:1901535)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of cholesterol efflux (GO:0090370)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of anion channel activity (GO:1901529)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of mitophagy (GO:1901526)	8	0	.41	-	 < 0.01	6.65E-01
icosanoid catabolic process (GO:1901523)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of mRNA modification (GO:0090366)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mRNA modification (GO:0090365)	1	0	.05	-	 < 0.01	9.50E-01
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	5	0	.26	-	 < 0.01	7.75E-01
response to biotin (GO:0070781)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tryptophan metabolic process (GO:0090357)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular organofluorine metabolic process (GO:0090350)	1	0	.05	-	 < 0.01	9.50E-01
D-aspartate import across plasma membrane (GO:0070779)	4	0	.20	-	 < 0.01	8.15E-01
D-aspartate transport (GO:0070777)	4	0	.20	-	 < 0.01	8.15E-01
regulation of endothelial tube morphogenesis (GO:1901509)	6	0	.31	-	 < 0.01	7.36E-01
ether catabolic process (GO:1901502)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140196)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular organohalogen metabolic process (GO:0090349)	1	0	.05	-	 < 0.01	9.50E-01
neuromast hair cell differentiation (GO:0048886)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular organofluorine metabolic process (GO:0090348)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular organohalogen metabolic process (GO:0090347)	1	0	.05	-	 < 0.01	9.50E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193)	1	0	.05	-	 < 0.01	9.50E-01
neuromast development (GO:0048884)	1	0	.05	-	 < 0.01	9.50E-01
cellular organofluorine metabolic process (GO:0090346)	1	0	.05	-	 < 0.01	9.50E-01
regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192)	2	0	.10	-	 < 0.01	9.03E-01
cellular organohalogen metabolic process (GO:0090345)	1	0	.05	-	 < 0.01	9.50E-01
lateral line development (GO:0048882)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cell aging (GO:0090343)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of secretion of lysosomal enzymes (GO:0090341)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.05	-	 < 0.01	9.50E-01
host-mediated regulation of intestinal microbiota composition (GO:0048874)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of platelet aggregation (GO:0090331)	12	0	.61	-	 < 0.01	5.42E-01
regulation of platelet aggregation (GO:0090330)	21	0	1.07	-	 < 0.01	3.42E-01
interleukin-35-mediated signaling pathway (GO:0070757)	11	0	.56	-	 < 0.01	5.70E-01
stem cell fate determination (GO:0048867)	3	0	.15	-	 < 0.01	8.58E-01
stem cell fate specification (GO:0048866)	4	0	.20	-	 < 0.01	8.15E-01
stem cell fate commitment (GO:0048865)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.05	-	 < 0.01	9.50E-01
regulation of locomotion involved in locomotory behavior (GO:0090325)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of oxidative phosphorylation (GO:0090324)	7	0	.36	-	 < 0.01	6.99E-01
regulation of superoxide metabolic process (GO:0090322)	31	0	1.58	-	 < 0.01	2.05E-01
positive regulation of chylomicron remnant clearance (GO:0090321)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chylomicron remnant clearance (GO:0090320)	1	0	.05	-	 < 0.01	9.50E-01
formation of anatomical boundary (GO:0048859)	5	0	.26	-	 < 0.01	7.75E-01
adenohypophysis morphogenesis (GO:0048855)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein targeting to membrane (GO:0090315)	5	0	.26	-	 < 0.01	7.75E-01
diencephalon morphogenesis (GO:0048852)	3	0	.15	-	 < 0.01	8.58E-01
hypophysis morphogenesis (GO:0048850)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of DNA methylation-dependent heterochromatin assembly (GO:0090310)	3	0	.15	-	 < 0.01	8.58E-01
histone H3-K27 methylation (GO:0070734)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ribonucleoprotein complex localization (GO:2000197)	6	0	.31	-	 < 0.01	7.36E-01
ammonium import across plasma membrane (GO:0140157)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309)	10	0	.51	-	 < 0.01	6.00E-01
axon extension involved in axon guidance (GO:0048846)	8	0	.41	-	 < 0.01	6.65E-01
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308)	14	0	.72	-	 < 0.01	4.89E-01
spindle assembly involved in meiosis (GO:0090306)	6	0	.31	-	 < 0.01	7.36E-01
otolith development (GO:0048840)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of neural crest formation (GO:0090301)	1	0	.05	-	 < 0.01	9.50E-01
cyclic nucleotide transport (GO:0070729)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter receptor internalization (GO:0099590)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of phosphate transmembrane transport (GO:2000187)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphate transmembrane transport (GO:2000185)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of progesterone biosynthetic process (GO:2000184)	2	0	.10	-	 < 0.01	9.03E-01
regulation of progesterone biosynthetic process (GO:2000182)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of androgen biosynthetic process (GO:2000180)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of postsynaptic cytosolic calcium concentration (GO:0099588)	1	0	.05	-	 < 0.01	9.50E-01
inorganic ion import across plasma membrane (GO:0099587)	82	0	4.19	-	 < 0.01	1.50E-02
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	1	0	.05	-	 < 0.01	9.50E-01
sodium-dependent organic cation transport (GO:0070715)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pro-T cell differentiation (GO:2000174)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of branching morphogenesis of a nerve (GO:2000173)	1	0	.05	-	 < 0.01	9.50E-01
regulation of branching morphogenesis of a nerve (GO:2000172)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of dendrite development (GO:2000171)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	3	0	.15	-	 < 0.01	8.58E-01
formation of extrachromosomal circular DNA (GO:0001325)	9	0	.46	-	 < 0.01	6.31E-01
age-dependent response to oxidative stress involved in chronological cell aging (GO:0001324)	2	0	.10	-	 < 0.01	9.03E-01
age-dependent general metabolic decline involved in chronological cell aging (GO:0001323)	2	0	.10	-	 < 0.01	9.03E-01
enucleate erythrocyte development (GO:0048822)	2	0	.10	-	 < 0.01	9.03E-01
hair follicle maturation (GO:0048820)	7	0	.36	-	 < 0.01	6.99E-01
regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	1	0	.05	-	 < 0.01	9.50E-01
detection of peptidoglycan (GO:0032499)	1	0	.05	-	 < 0.01	9.50E-01
detection of muramyl dipeptide (GO:0032498)	1	0	.05	-	 < 0.01	9.50E-01
detection of lipopolysaccharide (GO:0032497)	3	0	.15	-	 < 0.01	8.58E-01
response to bacterial lipoprotein (GO:0032493)	8	0	.41	-	 < 0.01	6.65E-01
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	8	0	.41	-	 < 0.01	6.65E-01
detection of molecule of fungal origin (GO:0032491)	1	0	.05	-	 < 0.01	9.50E-01
regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167)	1	0	.05	-	 < 0.01	9.50E-01
detection of molecule of bacterial origin (GO:0032490)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of hair follicle maturation (GO:0048817)	2	0	.10	-	 < 0.01	9.03E-01
age-dependent response to reactive oxygen species (GO:0001315)	1	0	.05	-	 < 0.01	9.50E-01
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	10	0	.51	-	 < 0.01	6.00E-01
modification of synaptic structure (GO:0099563)	8	0	.41	-	 < 0.01	6.65E-01
maintenance of postsynaptic density structure (GO:0099562)	7	0	.36	-	 < 0.01	6.99E-01
synaptic membrane adhesion (GO:0099560)	19	0	.97	-	 < 0.01	3.79E-01
regulation of Cdc42 protein signal transduction (GO:0032489)	7	0	.36	-	 < 0.01	6.99E-01
Cdc42 protein signal transduction (GO:0032488)	6	0	.31	-	 < 0.01	7.36E-01
regulation of Rap protein signal transduction (GO:0032487)	4	0	.20	-	 < 0.01	8.15E-01
regulation of Ral protein signal transduction (GO:0032485)	3	0	.15	-	 < 0.01	8.58E-01
regulation of Rab protein signal transduction (GO:0032483)	6	0	.31	-	 < 0.01	7.36E-01
Rab protein signal transduction (GO:0032482)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.10	-	 < 0.01	9.03E-01
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cilium-dependent cell motility (GO:2000155)	10	0	.51	-	 < 0.01	6.00E-01
male genitalia morphogenesis (GO:0048808)	4	0	.20	-	 < 0.01	8.15E-01
age-dependent response to oxidative stress (GO:0001306)	4	0	.20	-	 < 0.01	8.15E-01
extracellular vesicle biogenesis (GO:0140112)	7	0	.36	-	 < 0.01	6.99E-01
maintenance of synapse structure (GO:0099558)	16	0	.82	-	 < 0.01	4.41E-01
chronological cell aging (GO:0001300)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation by symbiont of host molecular function (GO:0052056)	2	0	.10	-	 < 0.01	9.03E-01
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	1	0	.05	-	 < 0.01	9.50E-01
modulation by symbiont of host molecular function (GO:0052055)	2	0	.10	-	 < 0.01	9.03E-01
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	1	0	.05	-	 < 0.01	9.50E-01
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation by symbiont of host catalytic activity (GO:0052053)	1	0	.05	-	 < 0.01	9.50E-01
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	3	0	.15	-	 < 0.01	8.58E-01
trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	2	0	.10	-	 < 0.01	9.03E-01
otolith formation (GO:0032475)	1	0	.05	-	 < 0.01	9.50E-01
otolith morphogenesis (GO:0032474)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of DNA-templated transcription, initiation (GO:2000143)	6	0	.31	-	 < 0.01	7.36E-01
interleukin-10-mediated signaling pathway (GO:0140105)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-glutamine modification (GO:0018199)	4	0	.20	-	 < 0.01	8.15E-01
peptidyl-cysteine modification (GO:0018198)	38	0	1.94	-	 < 0.01	1.43E-01
trans-synaptic signaling by nitric oxide (GO:0099548)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-alanine modification (GO:0018194)	1	0	.05	-	 < 0.01	9.50E-01
protein catabolic process, modulating synaptic transmission (GO:0099546)	1	0	.05	-	 < 0.01	9.50E-01
enzyme active site formation via cysteine modification to L-cysteine persulfide (GO:0018192)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-serine octanoylation (GO:0018191)	1	0	.05	-	 < 0.01	9.50E-01
trans-synaptic signaling by soluble gas (GO:0099543)	2	0	.10	-	 < 0.01	9.03E-01
protein octanoylation (GO:0018190)	1	0	.05	-	 < 0.01	9.50E-01
trans-synaptic signaling by endocannabinoid (GO:0099542)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation by symbiont of host programmed cell death (GO:0052042)	3	0	.15	-	 < 0.01	8.58E-01
trans-synaptic signaling by lipid (GO:0099541)	5	0	.26	-	 < 0.01	7.75E-01
trans-synaptic signaling by neuropeptide (GO:0099540)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cytokinesis (GO:0032466)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of protein homooligomerization (GO:0032464)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein homooligomerization (GO:0032463)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein homooligomerization (GO:0032462)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of protein oligomerization (GO:0032461)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein oligomerization (GO:0032460)	2	0	.10	-	 < 0.01	9.03E-01
synaptic signaling via neuropeptide (GO:0099538)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	3	0	.15	-	 < 0.01	8.58E-01
regulation of protein oligomerization (GO:0032459)	4	0	.20	-	 < 0.01	8.15E-01
slow endocytic recycling (GO:0032458)	1	0	.05	-	 < 0.01	9.50E-01
nerve growth factor processing (GO:0032455)	4	0	.20	-	 < 0.01	8.15E-01
regulation of endocannabinoid signaling pathway (GO:2000124)	3	0	.15	-	 < 0.01	8.58E-01
regulation of removal of superoxide radicals (GO:2000121)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of sodium-dependent phosphate transport (GO:2000120)	2	0	.10	-	 < 0.01	9.03E-01
protein depropionylation (GO:0106230)	2	0	.10	-	 < 0.01	9.03E-01
suppression by symbiont of host signal transduction pathway (GO:0052029)	1	0	.05	-	 < 0.01	9.50E-01
protein nucleotidylation (GO:0018175)	2	0	.10	-	 < 0.01	9.03E-01
postsynapse to nucleus signaling pathway (GO:0099527)	5	0	.26	-	 < 0.01	7.75E-01
modulation by symbiont of host signal transduction pathway (GO:0052027)	2	0	.10	-	 < 0.01	9.03E-01
presynapse to nucleus signaling pathway (GO:0099526)	2	0	.10	-	 < 0.01	9.03E-01
translocation of molecules into host (GO:0044417)	8	0	.41	-	 < 0.01	6.65E-01
modulation by symbiont of host transcription (GO:0052026)	1	0	.05	-	 < 0.01	9.50E-01
presynaptic dense core vesicle exocytosis (GO:0099525)	4	0	.20	-	 < 0.01	8.15E-01
peptidyl-cysteine oxidation (GO:0018171)	4	0	.20	-	 < 0.01	8.15E-01
protein urmylation (GO:0032447)	4	0	.20	-	 < 0.01	8.15E-01
fructose import (GO:0032445)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-lysine glutarylation (GO:0106227)	1	0	.05	-	 < 0.01	9.50E-01
regulation of establishment of cell polarity (GO:2000114)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of macrophage apoptotic process (GO:2000111)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of macrophage apoptotic process (GO:2000110)	5	0	.26	-	 < 0.01	7.75E-01
dense core granule cytoskeletal transport (GO:0099519)	9	0	.46	-	 < 0.01	6.31E-01
C-terminal protein-tyrosinylation (GO:0018166)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.05	-	 < 0.01	9.50E-01
cAMP catabolic process (GO:0006198)	9	0	.46	-	 < 0.01	6.31E-01
AMP catabolic process (GO:0006196)	2	0	.10	-	 < 0.01	9.03E-01
purine nucleotide catabolic process (GO:0006195)	42	0	2.15	-	 < 0.01	1.17E-01
melanosome organization (GO:0032438)	23	0	1.17	-	 < 0.01	3.09E-01
ITP catabolic process (GO:0006193)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macrophage apoptotic process (GO:2000109)	9	0	.46	-	 < 0.01	6.31E-01
activation of phospholipase A2 activity (GO:0032431)	3	0	.15	-	 < 0.01	8.58E-01
thermosensory behavior (GO:0040040)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of phospholipase A2 activity (GO:0032430)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of DNA-dependent DNA replication (GO:2000105)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mammary stem cell proliferation (GO:2000101)	1	0	.05	-	 < 0.01	9.50E-01
protein oxidation (GO:0018158)	13	0	.66	-	 < 0.01	5.15E-01
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	13	0	.66	-	 < 0.01	5.15E-01
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153)	2	0	.10	-	 < 0.01	9.03E-01
regulation of presynaptic membrane potential (GO:0099505)	5	0	.26	-	 < 0.01	7.75E-01
calcium-dependent activation of synaptic vesicle fusion (GO:0099502)	1	0	.05	-	 < 0.01	9.50E-01
dGDP biosynthetic process (GO:0006185)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phospholipase A2 activity (GO:0032429)	10	0	.51	-	 < 0.01	6.00E-01
polar body extrusion after meiotic divisions (GO:0040038)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	17	0	.87	-	 < 0.01	4.19E-01
GTP biosynthetic process (GO:0006183)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of mismatch repair (GO:0032425)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mismatch repair (GO:0032423)	4	0	.20	-	 < 0.01	8.15E-01
post-embryonic body morphogenesis (GO:0040032)	1	0	.05	-	 < 0.01	9.50E-01
regulation of molecular function, epigenetic (GO:0040030)	2	0	.10	-	 < 0.01	9.03E-01
peptide cross-linking (GO:0018149)	37	0	1.89	-	 < 0.01	1.51E-01
guanine salvage (GO:0006178)	1	0	.05	-	 < 0.01	9.50E-01
GMP biosynthetic process (GO:0006177)	3	0	.15	-	 < 0.01	8.58E-01
dATP biosynthetic process (GO:0006175)	1	0	.05	-	 < 0.01	9.50E-01
lysosome localization (GO:0032418)	39	0	1.99	-	 < 0.01	1.36E-01
dADP biosynthetic process (GO:0006173)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of sodium:proton antiporter activity (GO:0032417)	4	0	.20	-	 < 0.01	8.15E-01
ADP biosynthetic process (GO:0006172)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of sodium:proton antiporter activity (GO:0032416)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sodium:proton antiporter activity (GO:0032415)	6	0	.31	-	 < 0.01	7.36E-01
dAMP biosynthetic process (GO:0006170)	2	0	.10	-	 < 0.01	9.03E-01
adenine salvage (GO:0006168)	2	0	.10	-	 < 0.01	9.03E-01
AMP biosynthetic process (GO:0006167)	5	0	.26	-	 < 0.01	7.75E-01
purine ribonucleoside salvage (GO:0006166)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of embryonic development (GO:0040019)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of multicellular organism growth (GO:0040018)	35	0	1.79	-	 < 0.01	1.67E-01
embryonic cleavage (GO:0040016)	5	0	.26	-	 < 0.01	7.75E-01
melanosome transport (GO:0032402)	20	0	1.02	-	 < 0.01	3.60E-01
establishment of melanosome localization (GO:0032401)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of growth rate (GO:0040010)	3	0	.15	-	 < 0.01	8.58E-01
melanosome localization (GO:0032400)	23	0	1.17	-	 < 0.01	3.09E-01
peptidyl-cysteine methylation (GO:0018125)	3	0	.15	-	 < 0.01	8.58E-01
peptidyl-arginine ADP-ribosylation (GO:0018120)	4	0	.20	-	 < 0.01	8.15E-01
deoxyadenosine catabolic process (GO:0006157)	1	0	.05	-	 < 0.01	9.50E-01
adenosine catabolic process (GO:0006154)	3	0	.15	-	 < 0.01	8.58E-01
purine nucleoside catabolic process (GO:0006152)	8	0	.41	-	 < 0.01	6.65E-01
establishment of mitotic spindle localization (GO:0040001)	33	0	1.69	-	 < 0.01	1.85E-01
histone H2A-S1 phosphorylation (GO:0043990)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-cysteine S-nitrosylation (GO:0018119)	6	0	.31	-	 < 0.01	7.36E-01
protein adenylylation (GO:0018117)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cellular response to tunicamycin (GO:1905896)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to tunicamycin (GO:1905895)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to tunicamycin (GO:1905894)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cellular response to thapsigargin (GO:1905893)	1	0	.05	-	 < 0.01	9.50E-01
site-specific DNA replication termination at RTS1 barrier (GO:0071171)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to thapsigargin (GO:1905892)	1	0	.05	-	 < 0.01	9.50E-01
site-specific DNA replication termination (GO:0071170)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to thapsigargin (GO:1905891)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.05	-	 < 0.01	9.50E-01
inosine catabolic process (GO:0006148)	1	0	.05	-	 < 0.01	9.50E-01
response to hydrostatic pressure (GO:0051599)	7	0	.36	-	 < 0.01	6.99E-01
guanine catabolic process (GO:0006147)	1	0	.05	-	 < 0.01	9.50E-01
meiotic recombination checkpoint (GO:0051598)	2	0	.10	-	 < 0.01	9.03E-01
histone H3-S28 phosphorylation (GO:0043988)	2	0	.10	-	 < 0.01	9.03E-01
response to methylmercury (GO:0051597)	7	0	.36	-	 < 0.01	6.99E-01
purine nucleobase catabolic process (GO:0006145)	4	0	.20	-	 < 0.01	8.15E-01
histone H3-S10 phosphorylation (GO:0043987)	5	0	.26	-	 < 0.01	7.75E-01
methylglyoxal catabolic process (GO:0051596)	4	0	.20	-	 < 0.01	8.15E-01
response to methylglyoxal (GO:0051595)	3	0	.15	-	 < 0.01	8.58E-01
histone H4-R3 methylation (GO:0043985)	6	0	.31	-	 < 0.01	7.36E-01
detection of glucose (GO:0051594)	3	0	.15	-	 < 0.01	8.58E-01
histone H4-K16 acetylation (GO:0043984)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of neurotransmitter transport (GO:0051590)	22	0	1.12	-	 < 0.01	3.25E-01
histone H2B-K12 acetylation (GO:0043980)	1	0	.05	-	 < 0.01	9.50E-01
viral translational termination-reinitiation (GO:0075525)	5	0	.26	-	 < 0.01	7.75E-01
viral translational frameshifting (GO:0075523)	1	0	.05	-	 < 0.01	9.50E-01
microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521)	1	0	.05	-	 < 0.01	9.50E-01
establishment of protein localization to chromatin (GO:0071169)	4	0	.20	-	 < 0.01	8.15E-01
protein localization to chromatin (GO:0071168)	17	0	.87	-	 < 0.01	4.19E-01
protein C-linked glycosylation (GO:0018103)	5	0	.26	-	 < 0.01	7.75E-01
DNA replication preinitiation complex assembly (GO:0071163)	3	0	.15	-	 < 0.01	8.58E-01
protein citrullination (GO:0018101)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of neurotransmitter transport (GO:0051589)	14	0	.72	-	 < 0.01	4.89E-01
histone H2B-K5 acetylation (GO:0043979)	1	0	.05	-	 < 0.01	9.50E-01
histone H2A-K5 acetylation (GO:0043977)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	8	0	.41	-	 < 0.01	6.65E-01
dopamine uptake involved in synaptic transmission (GO:0051583)	4	0	.20	-	 < 0.01	8.15E-01
histone H3-K4 acetylation (GO:0043973)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neurotransmitter uptake (GO:0051582)	4	0	.20	-	 < 0.01	8.15E-01
histone H3-K23 acetylation (GO:0043972)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of neurotransmitter uptake (GO:0051581)	3	0	.15	-	 < 0.01	8.58E-01
mRNA pseudouridine synthesis (GO:1990481)	5	0	.26	-	 < 0.01	7.75E-01
histone H3-K9 acetylation (GO:0043970)	2	0	.10	-	 < 0.01	9.03E-01
microtubule-dependent intracellular transport of viral material (GO:0075519)	1	0	.05	-	 < 0.01	9.50E-01
clathrin-dependent endocytosis of virus by host cell (GO:0075512)	1	0	.05	-	 < 0.01	9.50E-01
regulation of oogenesis (GO:1905879)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.05	-	 < 0.01	9.50E-01
regulation of postsynaptic density organization (GO:1905874)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein localization to cell leading edge (GO:1905871)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	5	0	.26	-	 < 0.01	7.75E-01
regulation of arginine metabolic process (GO:0000821)	4	0	.20	-	 < 0.01	8.15E-01
glycerophosphate shuttle (GO:0006127)	2	0	.10	-	 < 0.01	9.03E-01
histone H2B acetylation (GO:0043969)	4	0	.20	-	 < 0.01	8.15E-01
response to ultrasound (GO:1990478)	2	0	.10	-	 < 0.01	9.03E-01
regulation of glutamine family amino acid metabolic process (GO:0000820)	8	0	.41	-	 < 0.01	6.65E-01
histone H2A acetylation (GO:0043968)	16	0	.82	-	 < 0.01	4.41E-01
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of histone H3-K9 methylation (GO:0051574)	9	0	.46	-	 < 0.01	6.31E-01
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	10	0	.51	-	 < 0.01	6.00E-01
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of histone H3-K4 methylation (GO:0051572)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	40	0	2.04	-	 < 0.01	1.29E-01
negative regulation of fatty acid beta-oxidation (GO:0031999)	5	0	.26	-	 < 0.01	7.75E-01
endocytosis involved in viral entry into host cell (GO:0075509)	7	0	.36	-	 < 0.01	6.99E-01
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	1	0	.05	-	 < 0.01	9.50E-01
mRNA export from nucleus in response to heat stress (GO:0031990)	2	0	.10	-	 < 0.01	9.03E-01
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	5	0	.26	-	 < 0.01	7.75E-01
epididymis development (GO:1905867)	4	0	.20	-	 < 0.01	8.15E-01
invadopodium organization (GO:1905863)	1	0	.05	-	 < 0.01	9.50E-01
resolution of mitotic recombination intermediates (GO:0071140)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.05	-	 < 0.01	9.50E-01
acetaldehyde metabolic process (GO:0006117)	1	0	.05	-	 < 0.01	9.50E-01
NADH oxidation (GO:0006116)	3	0	.15	-	 < 0.01	8.58E-01
protein autosumoylation (GO:1990466)	1	0	.05	-	 < 0.01	9.50E-01
glycerol biosynthetic process (GO:0006114)	5	0	.26	-	 < 0.01	7.75E-01
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of cAMP-mediated signaling (GO:0043951)	23	0	1.17	-	 < 0.01	3.09E-01
mitochondrial calcium ion homeostasis (GO:0051560)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of cAMP-mediated signaling (GO:0043950)	19	0	.97	-	 < 0.01	3.79E-01
bombesin receptor signaling pathway (GO:0031989)	2	0	.10	-	 < 0.01	9.03E-01
resolution of recombination intermediates (GO:0071139)	2	0	.10	-	 < 0.01	9.03E-01
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of pentose-phosphate shunt (GO:1905856)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of heparan sulfate binding (GO:1905855)	1	0	.05	-	 < 0.01	9.50E-01
regulation of heparan sulfate binding (GO:1905853)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cAMP-mediated signaling (GO:0043949)	48	0	2.45	-	 < 0.01	8.58E-02
fumarate metabolic process (GO:0006106)	4	0	.20	-	 < 0.01	8.15E-01
succinate metabolic process (GO:0006105)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation by host of symbiont catalytic activity (GO:0043947)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	4	0	.20	-	 < 0.01	8.15E-01
succinyl-CoA metabolic process (GO:0006104)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0043946)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cysteine metabolic process (GO:1901494)	1	0	.05	-	 < 0.01	9.50E-01
2-oxoglutarate metabolic process (GO:0006103)	16	0	.82	-	 < 0.01	4.41E-01
isocitrate metabolic process (GO:0006102)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of lymphangiogenesis (GO:1901492)	2	0	.10	-	 < 0.01	9.03E-01
flavone metabolic process (GO:0051552)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of lymphangiogenesis (GO:1901491)	3	0	.15	-	 < 0.01	8.58E-01
regulation of lymphangiogenesis (GO:1901490)	5	0	.26	-	 < 0.01	7.75E-01
cellular stress response to acidic pH (GO:1990451)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to gamma radiation (GO:1905843)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of keratinocyte migration (GO:0051549)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of transcription factor catabolic process (GO:1901485)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of elastin biosynthetic process (GO:0051545)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription factor catabolic process (GO:1901483)	3	0	.15	-	 < 0.01	8.58E-01
regulation of elastin biosynthetic process (GO:0051543)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-threonine autophosphorylation (GO:1990443)	2	0	.10	-	 < 0.01	9.03E-01
elastin biosynthetic process (GO:0051542)	1	0	.05	-	 < 0.01	9.50E-01
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.05	-	 < 0.01	9.50E-01
ossification involved in bone remodeling (GO:0043932)	5	0	.26	-	 < 0.01	7.75E-01
elastin metabolic process (GO:0051541)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	4	0	.20	-	 < 0.01	8.15E-01
cellular response to pyrimidine ribonucleotide (GO:1905835)	1	0	.05	-	 < 0.01	9.50E-01
response to pyrimidine ribonucleotide (GO:1905834)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of spindle assembly (GO:1905832)	5	0	.26	-	 < 0.01	7.75E-01
histone biotinylation (GO:0071110)	1	0	.05	-	 < 0.01	9.50E-01
U6 2'-O-snRNA methylation (GO:1990438)	1	0	.05	-	 < 0.01	9.50E-01
snRNA 2'-O-methylation (GO:1990437)	1	0	.05	-	 < 0.01	9.50E-01
pyruvate transmembrane transport (GO:1901475)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation by host of viral transcription (GO:0043923)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation by host of viral transcription (GO:0043922)	13	0	.66	-	 < 0.01	5.15E-01
modulation by host of viral transcription (GO:0043921)	2	0	.10	-	 < 0.01	9.03E-01
mineralocorticoid receptor signaling pathway (GO:0031959)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein autophosphorylation (GO:0031953)	13	0	.66	-	 < 0.01	5.15E-01
regulation of prostaglandin catabolic process (GO:1905828)	1	0	.05	-	 < 0.01	9.50E-01
adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)	2	0	.10	-	 < 0.01	9.03E-01
response to interleukin-11 (GO:0071105)	1	0	.05	-	 < 0.01	9.50E-01
response to interleukin-9 (GO:0071104)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of chromosome separation (GO:1905820)	16	0	.82	-	 < 0.01	4.41E-01
miRNA transport (GO:1990428)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of tetrapyrrole biosynthetic process (GO:1901465)	1	0	.05	-	 < 0.01	9.50E-01
mitotic recombination-dependent replication fork processing (GO:1990426)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tetrapyrrole biosynthetic process (GO:1901463)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of chromatin silencing at telomere (GO:0031940)	1	0	.05	-	 < 0.01	9.50E-01
response to insulin-like growth factor stimulus (GO:1990418)	2	0	.10	-	 < 0.01	9.03E-01
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	8	0	.41	-	 < 0.01	6.65E-01
adrenomedullin receptor signaling pathway (GO:1990410)	4	0	.20	-	 < 0.01	8.15E-01
regulation of chromatin silencing at telomere (GO:0031938)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of chromatin silencing (GO:0031936)	6	0	.31	-	 < 0.01	7.36E-01
regulation of neural crest formation (GO:0090299)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mitochondrial DNA replication (GO:0090298)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mitochondrial DNA replication (GO:0090297)	1	0	.05	-	 < 0.01	9.50E-01
mitochondria-nucleus signaling pathway (GO:0031930)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mitochondrial DNA replication (GO:0090296)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of synapse organization (GO:1905809)	13	0	.66	-	 < 0.01	5.15E-01
nitrogen catabolite activation of transcription (GO:0090294)	1	0	.05	-	 < 0.01	9.50E-01
nitrogen catabolite regulation of transcription (GO:0090293)	1	0	.05	-	 < 0.01	9.50E-01
nuclear matrix anchoring at nuclear membrane (GO:0090292)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of osteoclast proliferation (GO:0090291)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of osteoclast proliferation (GO:0090290)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cellular response to manganese ion (GO:1905802)	1	0	.05	-	 < 0.01	9.50E-01
calcitonin gene-related peptide receptor signaling pathway (GO:1990408)	3	0	.15	-	 < 0.01	8.58E-01
embryonic liver development (GO:1990402)	2	0	.10	-	 < 0.01	9.03E-01
embryonic lung development (GO:1990401)	2	0	.10	-	 < 0.01	9.03E-01
regulation of osteoclast proliferation (GO:0090289)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of protein glycosylation in Golgi (GO:0090285)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein glycosylation in Golgi (GO:0090284)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein glycosylation in Golgi (GO:0090283)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of synaptic plasticity (GO:0031914)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of somatostatin secretion (GO:0090274)	2	0	.10	-	 < 0.01	9.03E-01
regulation of somatostatin secretion (GO:0090273)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of fibroblast growth factor production (GO:0090272)	3	0	.15	-	 < 0.01	8.58E-01
response to benzene (GO:1901423)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	2	0	.10	-	 < 0.01	9.03E-01
regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of inclusion body assembly (GO:0090261)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	2	0	.10	-	 < 0.01	9.03E-01
regulation of response to alcohol (GO:1901419)	1	0	.05	-	 < 0.01	9.50E-01
seminal clot liquefaction (GO:0070684)	1	0	.05	-	 < 0.01	9.50E-01
proteasome regulatory particle assembly (GO:0070682)	3	0	.15	-	 < 0.01	8.58E-01
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	2	0	.10	-	 < 0.01	9.03E-01
regulation of retinal ganglion cell axon guidance (GO:0090259)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of mitochondrial fission (GO:0090258)	4	0	.20	-	 < 0.01	8.15E-01
pronephros development (GO:0048793)	8	0	.41	-	 < 0.01	6.65E-01
spontaneous exocytosis of neurotransmitter (GO:0048792)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of presynaptic active zone structure (GO:0048790)	3	0	.15	-	 < 0.01	8.58E-01
protein localization involved in establishment of planar polarity (GO:0090251)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	1	0	.05	-	 < 0.01	9.50E-01
intralumenal vesicle formation (GO:0070676)	2	0	.10	-	 < 0.01	9.03E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	3	0	.15	-	 < 0.01	8.58E-01
response to interleukin-18 (GO:0070673)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of tetrapyrrole metabolic process (GO:1901403)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tetrapyrrole metabolic process (GO:1901401)	4	0	.20	-	 < 0.01	8.15E-01
cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell motility involved in somitogenic axis elongation (GO:0090249)	2	0	.10	-	 < 0.01	9.03E-01
convergent extension involved in somitogenesis (GO:0090246)	1	0	.05	-	 < 0.01	9.50E-01
axis elongation involved in somitogenesis (GO:0090245)	4	0	.20	-	 < 0.01	8.15E-01
Wnt signaling pathway involved in somitogenesis (GO:0090244)	5	0	.26	-	 < 0.01	7.75E-01
retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mast cell proliferation (GO:0070668)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mast cell proliferation (GO:0070667)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mast cell proliferation (GO:0070666)	4	0	.20	-	 < 0.01	8.15E-01
mast cell proliferation (GO:0070662)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of arachidonic acid secretion (GO:0090238)	7	0	.36	-	 < 0.01	6.99E-01
regulation of arachidonic acid secretion (GO:0090237)	9	0	.46	-	 < 0.01	6.31E-01
erythrophore differentiation (GO:0048773)	1	0	.05	-	 < 0.01	9.50E-01
regulation of kinetochore assembly (GO:0090234)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of spindle checkpoint (GO:0090233)	1	0	.05	-	 < 0.01	9.50E-01
sarcomerogenesis (GO:0048769)	3	0	.15	-	 < 0.01	8.58E-01
cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.05	-	 < 0.01	9.50E-01
regulation of microtubule nucleation by Ran protein signal transduction (GO:0090226)	1	0	.05	-	 < 0.01	9.50E-01
centrosome-templated microtubule nucleation (GO:0090222)	2	0	.10	-	 < 0.01	9.03E-01
formin-nucleated actin cable assembly (GO:0070649)	3	0	.15	-	 < 0.01	8.58E-01
vitamin D3 metabolic process (GO:0070640)	5	0	.26	-	 < 0.01	7.75E-01
peptidyl-lysine butyrylation (GO:0140067)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-lysine crotonylation (GO:0140066)	1	0	.05	-	 < 0.01	9.50E-01
pigment granule maturation (GO:0048757)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of lipid kinase activity (GO:0090218)	39	0	1.99	-	 < 0.01	1.36E-01
branching morphogenesis of a nerve (GO:0048755)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216)	1	0	.05	-	 < 0.01	9.50E-01
pigment granule organization (GO:0048753)	24	0	1.23	-	 < 0.01	2.93E-01
regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215)	1	0	.05	-	 < 0.01	9.50E-01
semicircular canal morphogenesis (GO:0048752)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of establishment of blood-brain barrier (GO:0090212)	2	0	.10	-	 < 0.01	9.03E-01
regulation of establishment of blood-brain barrier (GO:0090210)	3	0	.15	-	 < 0.01	8.58E-01
pyridine nucleoside catabolic process (GO:0070638)	1	0	.05	-	 < 0.01	9.50E-01
pyridine nucleoside metabolic process (GO:0070637)	1	0	.05	-	 < 0.01	9.50E-01
transepithelial ammonium transport (GO:0070634)	3	0	.15	-	 < 0.01	8.58E-01
transepithelial transport (GO:0070633)	25	0	1.28	-	 < 0.01	2.79E-01
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	0	.10	-	 < 0.01	9.03E-01
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	9	0	.46	-	 < 0.01	6.31E-01
dendrite arborization (GO:0140059)	6	0	.31	-	 < 0.01	7.36E-01
neuron projection arborization (GO:0140058)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of skeletal muscle fiber development (GO:0048743)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of endocardial cushion to mesenchymal transition (GO:0140051)	1	0	.05	-	 < 0.01	9.50E-01
gene looping (GO:0090202)	4	0	.20	-	 < 0.01	8.15E-01
glucose import in response to insulin stimulus (GO:0044381)	4	0	.20	-	 < 0.01	8.15E-01
zymogen granule exocytosis (GO:0070625)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endocardial cushion to mesenchymal transition (GO:0140049)	1	0	.05	-	 < 0.01	9.50E-01
cardiac muscle fiber development (GO:0048739)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)	1	0	.05	-	 < 0.01	9.50E-01
sebaceous gland development (GO:0048733)	7	0	.36	-	 < 0.01	6.99E-01
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.05	-	 < 0.01	9.50E-01
regulation of peroxisome size (GO:0044375)	3	0	.15	-	 < 0.01	8.58E-01
regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of type B pancreatic cell development (GO:2000078)	3	0	.15	-	 < 0.01	8.58E-01
cell-cell adhesion in response to extracellular stimulus (GO:0140039)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of molecular function in other organism (GO:0044362)	7	0	.36	-	 < 0.01	6.99E-01
regulation of centromeric sister chromatid cohesion (GO:0070602)	3	0	.15	-	 < 0.01	8.58E-01
centromeric sister chromatid cohesion (GO:0070601)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ureter smooth muscle cell differentiation (GO:2000063)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ureter smooth muscle cell differentiation (GO:2000062)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ureter smooth muscle cell differentiation (GO:2000061)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial ADP transmembrane transport (GO:0140021)	5	0	.26	-	 < 0.01	7.75E-01
modulation of molecular function in other organism (GO:0044359)	9	0	.46	-	 < 0.01	6.31E-01
regulation of rRNA stability (GO:0044357)	1	0	.05	-	 < 0.01	9.50E-01
clearance of foreign intracellular DNA (GO:0044355)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of intracellular cholesterol transport (GO:0032385)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of intracellular cholesterol transport (GO:0032384)	2	0	.10	-	 < 0.01	9.03E-01
regulation of intracellular cholesterol transport (GO:0032383)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of intracellular sterol transport (GO:0032382)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of intracellular sterol transport (GO:0032381)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intracellular sterol transport (GO:0032380)	8	0	.41	-	 < 0.01	6.65E-01
regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	15	0	.77	-	 < 0.01	4.65E-01
histone displacement (GO:0001207)	1	0	.05	-	 < 0.01	9.50E-01
embryonic skeletal system development (GO:0048706)	127	0	6.49	-	 < 0.01	1.49E-03
embryonic skeletal system morphogenesis (GO:0048704)	96	0	4.90	-	 < 0.01	7.31E-03
embryonic viscerocranium morphogenesis (GO:0048703)	11	0	.56	-	 < 0.01	5.70E-01
embryonic neurocranium morphogenesis (GO:0048702)	9	0	.46	-	 < 0.01	6.31E-01
embryonic cranial skeleton morphogenesis (GO:0048701)	47	0	2.40	-	 < 0.01	9.03E-02
fibroblast apoptotic process (GO:0044346)	3	0	.15	-	 < 0.01	8.58E-01
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	0	.05	-	 < 0.01	9.50E-01
sodium-dependent phosphate transport (GO:0044341)	3	0	.15	-	 < 0.01	8.58E-01
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of intracellular lipid transport (GO:0032379)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of intracellular lipid transport (GO:0032378)	2	0	.10	-	 < 0.01	9.03E-01
regulation of intracellular lipid transport (GO:0032377)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of cholesterol transport (GO:0032375)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of sterol transport (GO:0032372)	14	0	.72	-	 < 0.01	4.89E-01
L-aspartate import across plasma membrane (GO:0140009)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cardiac cell fate specification (GO:2000044)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cardiac cell fate specification (GO:2000043)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041)	2	0	.10	-	 < 0.01	9.03E-01
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	2	0	.10	-	 < 0.01	9.03E-01
protein polyglutamylation (GO:0018095)	11	0	.56	-	 < 0.01	5.70E-01
canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339)	2	0	.10	-	 < 0.01	9.03E-01
protein polyglycylation (GO:0018094)	1	0	.05	-	 < 0.01	9.50E-01
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	3	0	.15	-	 < 0.01	8.58E-01
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	3	0	.15	-	 < 0.01	8.58E-01
canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335)	2	0	.10	-	 < 0.01	9.03E-01
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.10	-	 < 0.01	9.03E-01
canonical Wnt signaling pathway involved in positive regulation of wound healing (GO:0044330)	1	0	.05	-	 < 0.01	9.50E-01
regulation of stem cell division (GO:2000035)	9	0	.46	-	 < 0.01	6.31E-01
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329)	1	0	.05	-	 < 0.01	9.50E-01
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription involved in anterior/posterior axis specification (GO:0044324)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of hormone metabolic process (GO:0032352)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of glycine import across plasma membrane (GO:1900924)	2	0	.10	-	 < 0.01	9.03E-01
regulation of glycine import across plasma membrane (GO:1900923)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cardiac muscle cell contraction (GO:0106135)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cardiac muscle cell contraction (GO:0106134)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.15	-	 < 0.01	8.58E-01
wound healing, spreading of cells (GO:0044319)	21	0	1.07	-	 < 0.01	3.42E-01
protein K27-linked ubiquitination (GO:0044314)	4	0	.20	-	 < 0.01	8.15E-01
protein K6-linked deubiquitination (GO:0044313)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of aldosterone biosynthetic process (GO:0032349)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of aldosterone metabolic process (GO:0032346)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of male gonad development (GO:2000019)	1	0	.05	-	 < 0.01	9.50E-01
aldosterone biosynthetic process (GO:0032342)	3	0	.15	-	 < 0.01	8.58E-01
aldosterone metabolic process (GO:0032341)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of determination of dorsal identity (GO:2000017)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of determination of dorsal identity (GO:2000016)	2	0	.10	-	 < 0.01	9.03E-01
regulation of determination of dorsal identity (GO:2000015)	4	0	.20	-	 < 0.01	8.15E-01
regulation of adaxial/abaxial pattern formation (GO:2000011)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.05	-	 < 0.01	9.50E-01
cytochrome c-heme linkage (GO:0018063)	1	0	.05	-	 < 0.01	9.50E-01
pentose-phosphate shunt (GO:0006098)	12	0	.61	-	 < 0.01	5.42E-01
glyoxylate cycle (GO:0006097)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein localization to cell surface (GO:2000009)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of chondrocyte differentiation (GO:0032331)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of DNA damage checkpoint (GO:2000002)	4	0	.20	-	 < 0.01	8.15E-01
peptidyl-lysine oxidation (GO:0018057)	5	0	.26	-	 < 0.01	7.75E-01
acetate metabolic process (GO:0006083)	2	0	.10	-	 < 0.01	9.03E-01
molybdopterin cofactor biosynthetic process (GO:0032324)	6	0	.31	-	 < 0.01	7.36E-01
ER-dependent peroxisome localization (GO:0106101)	1	0	.05	-	 < 0.01	9.50E-01
glycerol-3-phosphate metabolic process (GO:0006072)	8	0	.41	-	 < 0.01	6.65E-01
prostaglandin secretion (GO:0032310)	3	0	.15	-	 < 0.01	8.58E-01
protein amidation (GO:0018032)	1	0	.05	-	 < 0.01	9.50E-01
ethanol oxidation (GO:0006069)	12	0	.61	-	 < 0.01	5.42E-01
ethanol catabolic process (GO:0006068)	9	0	.46	-	 < 0.01	6.31E-01
ethanol metabolic process (GO:0006067)	18	0	.92	-	 < 0.01	3.99E-01
glucuronate catabolic process (GO:0006064)	5	0	.26	-	 < 0.01	7.75E-01
uronic acid metabolic process (GO:0006063)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of prostaglandin secretion (GO:0032307)	2	0	.10	-	 < 0.01	9.03E-01
sorbitol catabolic process (GO:0006062)	1	0	.05	-	 < 0.01	9.50E-01
sorbitol biosynthetic process (GO:0006061)	1	0	.05	-	 < 0.01	9.50E-01
sorbitol metabolic process (GO:0006060)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of icosanoid secretion (GO:0032304)	5	0	.26	-	 < 0.01	7.75E-01
peptidyl-lysine monomethylation (GO:0018026)	7	0	.36	-	 < 0.01	6.99E-01
peptidyl-histidine methylation (GO:0018021)	2	0	.10	-	 < 0.01	9.03E-01
hexitol metabolic process (GO:0006059)	3	0	.15	-	 < 0.01	8.58E-01
mannoprotein biosynthetic process (GO:0006057)	1	0	.05	-	 < 0.01	9.50E-01
mannoprotein metabolic process (GO:0006056)	1	0	.05	-	 < 0.01	9.50E-01
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.05	-	 < 0.01	9.50E-01
RNA 3' uridylation (GO:0071076)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to puromycin (GO:1905795)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.05	-	 < 0.01	9.50E-01
response to puromycin (GO:1905794)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phospholipid biosynthetic process (GO:0071072)	5	0	.26	-	 < 0.01	7.75E-01
protein localization to pericentriolar material (GO:1905793)	2	0	.10	-	 < 0.01	9.03E-01
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.05	-	 < 0.01	9.50E-01
UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.05	-	 < 0.01	9.50E-01
karyogamy (GO:0000741)	1	0	.05	-	 < 0.01	9.50E-01
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of stress fiber assembly (GO:0051497)	27	0	1.38	-	 < 0.01	2.52E-01
N-acetylglucosamine biosynthetic process (GO:0006045)	2	0	.10	-	 < 0.01	9.03E-01
glucosamine catabolic process (GO:0006043)	2	0	.10	-	 < 0.01	9.03E-01
glucosamine metabolic process (GO:0006041)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of filopodium assembly (GO:0051490)	3	0	.15	-	 < 0.01	8.58E-01
protein K33-linked ubiquitination (GO:1990390)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788)	1	0	.05	-	 < 0.01	9.50E-01
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787)	1	0	.05	-	 < 0.01	9.50E-01
DNA catabolic process, exonucleolytic (GO:0000738)	8	0	.41	-	 < 0.01	6.65E-01
peptidyl-lysine N6-acetylation (GO:0018003)	2	0	.10	-	 < 0.01	9.03E-01
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	1	0	.05	-	 < 0.01	9.50E-01
removal of nonhomologous ends (GO:0000735)	1	0	.05	-	 < 0.01	9.50E-01
DNA strand renaturation (GO:0000733)	7	0	.36	-	 < 0.01	6.99E-01
NMDA selective glutamate receptor signaling pathway (GO:0098989)	1	0	.05	-	 < 0.01	9.50E-01
strand displacement (GO:0000732)	1	0	.05	-	 < 0.01	9.50E-01
DNA recombinase assembly (GO:0000730)	6	0	.31	-	 < 0.01	7.36E-01
mitotic cleavage furrow ingression (GO:1990386)	1	0	.05	-	 < 0.01	9.50E-01
hyaloid vascular plexus regression (GO:1990384)	7	0	.36	-	 < 0.01	6.99E-01
chitin catabolic process (GO:0006032)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	31	0	1.58	-	 < 0.01	2.05E-01
chitin metabolic process (GO:0006030)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cytosolic calcium ion concentration (GO:0051481)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of exonuclease activity (GO:1905779)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA helicase activity (GO:1905776)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of DNA helicase activity (GO:1905775)	2	0	.10	-	 < 0.01	9.03E-01
regulation of DNA helicase activity (GO:1905774)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of mesodermal cell differentiation (GO:1905772)	2	0	.10	-	 < 0.01	9.03E-01
snoRNA polyadenylation (GO:0071050)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mesodermal cell differentiation (GO:1905771)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mesodermal cell differentiation (GO:1905770)	7	0	.36	-	 < 0.01	6.99E-01
lipid transport across blood-brain barrier (GO:1990379)	5	0	.26	-	 < 0.01	7.75E-01
inhibitory chemical synaptic transmission (GO:0098977)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	4	0	.20	-	 < 0.01	8.15E-01
anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.05	-	 < 0.01	9.50E-01
inositol biosynthetic process (GO:0006021)	3	0	.15	-	 < 0.01	8.58E-01
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	4	0	.20	-	 < 0.01	8.15E-01
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	8	0	.41	-	 < 0.01	6.65E-01
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.10	-	 < 0.01	9.03E-01
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.05	-	 < 0.01	9.50E-01
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.05	-	 < 0.01	9.50E-01
nuclear histone mRNA catabolic process (GO:0071045)	1	0	.05	-	 < 0.01	9.50E-01
histone mRNA catabolic process (GO:0071044)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	3	0	.15	-	 < 0.01	8.58E-01
CUT metabolic process (GO:0071043)	4	0	.20	-	 < 0.01	8.15E-01
regulation of protection from non-homologous end joining at telomere (GO:1905764)	3	0	.15	-	 < 0.01	8.58E-01
antisense RNA transcript catabolic process (GO:0071041)	1	0	.05	-	 < 0.01	9.50E-01
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	1	0	.05	-	 < 0.01	9.50E-01
meiotic DNA repair synthesis (GO:0000711)	2	0	.10	-	 < 0.01	9.03E-01
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	3	0	.15	-	 < 0.01	8.58E-01
meiotic mismatch repair (GO:0000710)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	3	0	.15	-	 < 0.01	8.58E-01
D-ribose metabolic process (GO:0006014)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cortisol secretion (GO:0051464)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cortisol secretion (GO:0051463)	1	0	.05	-	 < 0.01	9.50E-01
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	14	0	.72	-	 < 0.01	4.89E-01
UDP-glucose metabolic process (GO:0006011)	4	0	.20	-	 < 0.01	8.15E-01
regulation of cortisol secretion (GO:0051462)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of corticotropin secretion (GO:0051461)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of corticotropin secretion (GO:0051460)	1	0	.05	-	 < 0.01	9.50E-01
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	1	0	.05	-	 < 0.01	9.50E-01
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	1	0	.05	-	 < 0.01	9.50E-01
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	1	0	.05	-	 < 0.01	9.50E-01
CUT catabolic process (GO:0071034)	4	0	.20	-	 < 0.01	8.15E-01
meiotic DNA recombinase assembly (GO:0000707)	2	0	.10	-	 < 0.01	9.03E-01
meiotic DNA double-strand break processing (GO:0000706)	3	0	.15	-	 < 0.01	8.58E-01
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.10	-	 < 0.01	9.03E-01
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cardioblast cell fate specification (GO:0009997)	1	0	.05	-	 < 0.01	9.50E-01
regulation of corticotropin secretion (GO:0051459)	6	0	.31	-	 < 0.01	7.36E-01
retrograde axonal transport of mitochondrion (GO:0098958)	2	0	.10	-	 < 0.01	9.03E-01
regulation of transforming growth factor beta3 activation (GO:1901398)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell fate specification (GO:0009996)	5	0	.26	-	 < 0.01	7.75E-01
corticotropin secretion (GO:0051458)	1	0	.05	-	 < 0.01	9.50E-01
anterograde axonal transport of mitochondrion (GO:0098957)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of transforming growth factor beta1 activation (GO:1901394)	1	0	.05	-	 < 0.01	9.50E-01
fructose 2,6-bisphosphate metabolic process (GO:0006003)	4	0	.20	-	 < 0.01	8.15E-01
cellular water homeostasis (GO:0009992)	8	0	.41	-	 < 0.01	6.65E-01
intracellular pH elevation (GO:0051454)	6	0	.31	-	 < 0.01	7.36E-01
receptor diffusion trapping (GO:0098953)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of transforming growth factor beta1 activation (GO:1901393)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transforming growth factor beta1 activation (GO:1901392)	2	0	.10	-	 < 0.01	9.03E-01
fructose catabolic process (GO:0006001)	4	0	.20	-	 < 0.01	8.15E-01
fructose metabolic process (GO:0006000)	13	0	.66	-	 < 0.01	5.15E-01
myoblast migration (GO:0051451)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of transforming growth factor beta activation (GO:1901390)	1	0	.05	-	 < 0.01	9.50E-01
myoblast proliferation (GO:0051450)	4	0	.20	-	 < 0.01	8.15E-01
regulation of endosome to plasma membrane protein transport (GO:1905749)	4	0	.20	-	 < 0.01	8.15E-01
hard palate morphogenesis (GO:1905748)	1	0	.05	-	 < 0.01	9.50E-01
cytoplasmic RNA surveillance (GO:0071026)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of saliva secretion (GO:1905747)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transforming growth factor beta activation (GO:1901389)	2	0	.10	-	 < 0.01	9.03E-01
regulation of transforming growth factor beta activation (GO:1901388)	8	0	.41	-	 < 0.01	6.65E-01
gap junction-mediated intercellular transport (GO:1990349)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of voltage-gated calcium channel activity (GO:1901387)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of meiotic cell cycle (GO:0051447)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of chorionic trophoblast cell proliferation (GO:1901384)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	16	0	.82	-	 < 0.01	4.41E-01
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	2	0	.10	-	 < 0.01	9.03E-01
regulation of chorionic trophoblast cell proliferation (GO:1901382)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of L-proline import across plasma membrane (GO:1905737)	1	0	.05	-	 < 0.01	9.50E-01
regulation of L-proline import across plasma membrane (GO:1905735)	1	0	.05	-	 < 0.01	9.50E-01
dendritic transport of mitochondrion (GO:0098939)	2	0	.10	-	 < 0.01	9.03E-01
anterograde dendritic transport (GO:0098937)	6	0	.31	-	 < 0.01	7.36E-01
organic heteropentacyclic compound catabolic process (GO:1901377)	2	0	.10	-	 < 0.01	9.03E-01
organic heteropentacyclic compound metabolic process (GO:1901376)	3	0	.15	-	 < 0.01	8.58E-01
acetate ester transport (GO:1901374)	3	0	.15	-	 < 0.01	8.58E-01
cytidine deamination (GO:0009972)	11	0	.56	-	 < 0.01	5.70E-01
lipid hydroperoxide transport (GO:1901373)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to microtubule end (GO:1905725)	5	0	.26	-	 < 0.01	7.75E-01
response to magnetism (GO:0071000)	3	0	.15	-	 < 0.01	8.58E-01
presynaptic signal transduction (GO:0098928)	2	0	.10	-	 < 0.01	9.03E-01
postsynaptic signal transduction (GO:0098926)	29	0	1.48	-	 < 0.01	2.27E-01
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	1	0	.05	-	 < 0.01	9.50E-01
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	1	0	.05	-	 < 0.01	9.50E-01
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	2	0	.10	-	 < 0.01	9.03E-01
retrograde trans-synaptic signaling by lipid (GO:0098920)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to perinuclear region of cytoplasm (GO:1905719)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cornification (GO:1905716)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cornification (GO:1905715)	1	0	.05	-	 < 0.01	9.50E-01
response to phosphatidylethanolamine (GO:1905711)	1	0	.05	-	 < 0.01	9.50E-01
epidermal cell fate specification (GO:0009957)	3	0	.15	-	 < 0.01	8.58E-01
radial pattern formation (GO:0009956)	1	0	.05	-	 < 0.01	9.50E-01
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915)	10	0	.51	-	 < 0.01	6.00E-01
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	5	0	.26	-	 < 0.01	7.75E-01
response to cortisone (GO:0051413)	1	0	.05	-	 < 0.01	9.50E-01
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	0	.15	-	 < 0.01	8.58E-01
dorsal/ventral axis specification (GO:0009950)	11	0	.56	-	 < 0.01	5.70E-01
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	12	0	.61	-	 < 0.01	5.42E-01
regulation of atrial cardiac muscle cell action potential (GO:0098910)	3	0	.15	-	 < 0.01	8.58E-01
detoxification of nitrogen compound (GO:0051410)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of glomerulus development (GO:0090194)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glomerulus development (GO:0090193)	4	0	.20	-	 < 0.01	8.15E-01
regulation of glomerulus development (GO:0090192)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of inhibitory synapse assembly (GO:1905703)	1	0	.05	-	 < 0.01	9.50E-01
polarity specification of anterior/posterior axis (GO:0009949)	2	0	.10	-	 < 0.01	9.03E-01
regulation of neuronal action potential (GO:0098908)	5	0	.26	-	 < 0.01	7.75E-01
proximal/distal axis specification (GO:0009946)	4	0	.20	-	 < 0.01	8.15E-01
regulation of SA node cell action potential (GO:0098907)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Purkinje myocyte action potential (GO:0098906)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346)	1	0	.05	-	 < 0.01	9.50E-01
regulation of bundle of His cell action potential (GO:0098905)	2	0	.10	-	 < 0.01	9.03E-01
regulation of AV node cell action potential (GO:0098904)	3	0	.15	-	 < 0.01	8.58E-01
response to leptomycin B (GO:1901344)	2	0	.10	-	 < 0.01	9.03E-01
regulation of membrane repolarization during action potential (GO:0098903)	7	0	.36	-	 < 0.01	6.99E-01
regulation of membrane depolarization during action potential (GO:0098902)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of pancreatic juice secretion (GO:0090188)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of pancreatic juice secretion (GO:0090187)	2	0	.10	-	 < 0.01	9.03E-01
regulation of pancreatic juice secretion (GO:0090186)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of kidney development (GO:0090185)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of kidney development (GO:0090184)	10	0	.51	-	 < 0.01	6.00E-01
regulation of secretion of lysosomal enzymes (GO:0090182)	2	0	.10	-	 < 0.01	9.03E-01
thioester transport (GO:1901337)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of odontoblast differentiation (GO:1901331)	1	0	.05	-	 < 0.01	9.50E-01
establishment of planar polarity involved in neural tube closure (GO:0090177)	1	0	.05	-	 < 0.01	9.50E-01
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.15	-	 < 0.01	8.58E-01
microtubule cytoskeleton organization involved in homologous chromosome segregation (GO:0090172)	1	0	.05	-	 < 0.01	9.50E-01
chondrocyte morphogenesis (GO:0090171)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Golgi inheritance (GO:0090170)	4	0	.20	-	 < 0.01	8.15E-01
regulation of odontoblast differentiation (GO:1901329)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of heart induction (GO:1901321)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of heart induction (GO:1901320)	1	0	.05	-	 < 0.01	9.50E-01
Golgi reassembly (GO:0090168)	4	0	.20	-	 < 0.01	8.15E-01
Golgi disassembly (GO:0090166)	6	0	.31	-	 < 0.01	7.36E-01
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.10	-	 < 0.01	9.03E-01
Golgi ribbon formation (GO:0090161)	14	0	.72	-	 < 0.01	4.89E-01
Golgi to lysosome transport (GO:0090160)	8	0	.41	-	 < 0.01	6.65E-01
cellular component macromolecule biosynthetic process (GO:0070589)	1	0	.05	-	 < 0.01	9.50E-01
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of flagellated sperm motility (GO:1901318)	3	0	.15	-	 < 0.01	8.58E-01
regulation of flagellated sperm motility (GO:1901317)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of collateral sprouting in absence of injury (GO:0048697)	2	0	.10	-	 < 0.01	9.03E-01
regulation of collateral sprouting in absence of injury (GO:0048696)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of collateral sprouting of injured axon (GO:0048694)	1	0	.05	-	 < 0.01	9.50E-01
cellular sphingolipid homeostasis (GO:0090156)	5	0	.26	-	 < 0.01	7.75E-01
regulation of collateral sprouting of injured axon (GO:0048693)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of sphingolipid biosynthetic process (GO:0090155)	6	0	.31	-	 < 0.01	7.36E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of axon extension involved in regeneration (GO:0048692)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of sphingolipid biosynthetic process (GO:0090154)	11	0	.56	-	 < 0.01	5.70E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of axon extension involved in regeneration (GO:0048691)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sphingolipid biosynthetic process (GO:0090153)	18	0	.92	-	 < 0.01	3.99E-01
regulation of axon extension involved in regeneration (GO:0048690)	4	0	.20	-	 < 0.01	8.15E-01
cadmium ion transmembrane transport (GO:0070574)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of neuron projection regeneration (GO:0070572)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of lipid catabolic process (GO:0050995)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of sprouting of injured axon (GO:0048688)	2	0	.10	-	 < 0.01	9.03E-01
RNA polymerase I preinitiation complex assembly (GO:0001188)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of sprouting of injured axon (GO:0048687)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial membrane fission (GO:0090149)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sprouting of injured axon (GO:0048686)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685)	1	0	.05	-	 < 0.01	9.50E-01
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	0	.05	-	 < 0.01	9.50E-01
sprouting of injured axon (GO:0048682)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial nucleoid organization (GO:0090144)	1	0	.05	-	 < 0.01	9.50E-01
nucleoid organization (GO:0090143)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of axon regeneration (GO:0048680)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of mitochondrial fission (GO:0090141)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	0	.10	-	 < 0.01	9.03E-01
regulation of vitamin D receptor signaling pathway (GO:0070562)	7	0	.36	-	 < 0.01	6.99E-01
protein secretion by platelet (GO:0070560)	2	0	.10	-	 < 0.01	9.03E-01
detection of mechanical stimulus (GO:0050982)	49	0	2.50	-	 < 0.01	8.15E-02
axon extension involved in regeneration (GO:0048677)	1	0	.05	-	 < 0.01	9.50E-01
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	0	.05	-	 < 0.01	9.50E-01
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.05	-	 < 0.01	9.50E-01
actin filament branching (GO:0090135)	3	0	.15	-	 < 0.01	8.58E-01
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in mesendoderm migration (GO:0090134)	1	0	.05	-	 < 0.01	9.50E-01
transcription, RNA-templated (GO:0001172)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of collateral sprouting (GO:0048671)	9	0	.46	-	 < 0.01	6.31E-01
mesendoderm migration (GO:0090133)	1	0	.05	-	 < 0.01	9.50E-01
mesenchyme migration (GO:0090131)	5	0	.26	-	 < 0.01	7.75E-01
rDNA condensation (GO:0070550)	1	0	.05	-	 < 0.01	9.50E-01
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.10	-	 < 0.01	9.03E-01
sensory perception of touch (GO:0050975)	3	0	.15	-	 < 0.01	8.58E-01
detection of mechanical stimulus involved in sensory perception (GO:0050974)	31	0	1.58	-	 < 0.01	2.05E-01
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	1	0	.05	-	 < 0.01	9.50E-01
collateral sprouting in absence of injury (GO:0048669)	2	0	.10	-	 < 0.01	9.03E-01
collateral sprouting (GO:0048668)	8	0	.41	-	 < 0.01	6.65E-01
neuron fate specification (GO:0048665)	29	0	1.48	-	 < 0.01	2.27E-01
neuron fate determination (GO:0048664)	8	0	.41	-	 < 0.01	6.65E-01
protein-containing complex assembly involved in synapse maturation (GO:0090126)	1	0	.05	-	 < 0.01	9.50E-01
cholesterol ester hydrolysis involved in cholesterol transport (GO:0090122)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-K36 demethylation (GO:0070544)	8	0	.41	-	 < 0.01	6.65E-01
response to linoleic acid (GO:0070543)	2	0	.10	-	 < 0.01	9.03E-01
response to platinum ion (GO:0070541)	3	0	.15	-	 < 0.01	8.58E-01
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	3	0	.15	-	 < 0.01	8.58E-01
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	12	0	.61	-	 < 0.01	5.42E-01
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	18	0	.92	-	 < 0.01	3.99E-01
smooth muscle cell proliferation (GO:0048659)	3	0	.15	-	 < 0.01	8.58E-01
detection of light stimulus involved in sensory perception (GO:0050962)	18	0	.92	-	 < 0.01	3.99E-01
detection of temperature stimulus involved in sensory perception (GO:0050961)	19	0	.97	-	 < 0.01	3.79E-01
detection of temperature stimulus involved in thermoception (GO:0050960)	2	0	.10	-	 < 0.01	9.03E-01
vesicle-mediated cholesterol transport (GO:0090119)	2	0	.10	-	 < 0.01	9.03E-01
C-5 methylation of cytosine (GO:0090116)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	4	0	.20	-	 < 0.01	8.15E-01
histone H2A K63-linked deubiquitination (GO:0070537)	3	0	.15	-	 < 0.01	8.58E-01
histone H2A K63-linked ubiquitination (GO:0070535)	2	0	.10	-	 < 0.01	9.03E-01
equilibrioception (GO:0050957)	6	0	.31	-	 < 0.01	7.36E-01
thermoception (GO:0050955)	4	0	.20	-	 < 0.01	8.15E-01
sensory perception of temperature stimulus (GO:0050951)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	2	0	.10	-	 < 0.01	9.03E-01
regulation of high-density lipoprotein particle assembly (GO:0090107)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of skeletal muscle tissue development (GO:0048643)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of skeletal muscle tissue development (GO:0048642)	4	0	.20	-	 < 0.01	8.15E-01
pancreatic epsilon cell differentiation (GO:0090104)	1	0	.05	-	 < 0.01	9.50E-01
protein kinase C signaling (GO:0070528)	15	0	.77	-	 < 0.01	4.65E-01
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	14	0	.72	-	 < 0.01	4.89E-01
response to ceramide (GO:0106096)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of pigment cell differentiation (GO:0050942)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of muscle organ development (GO:0048636)	19	0	.97	-	 < 0.01	3.79E-01
glial cell projection elongation (GO:0106091)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of skeletal muscle tissue growth (GO:0048633)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.10	-	 < 0.01	9.03E-01
regulation of skeletal muscle tissue growth (GO:0048631)	5	0	.26	-	 < 0.01	7.75E-01
skeletal muscle tissue growth (GO:0048630)	3	0	.15	-	 < 0.01	8.58E-01
cell wall disruption in other organism (GO:0044278)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of histone H4-K20 methylation (GO:0070512)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H4-K20 methylation (GO:0070510)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pigment cell differentiation (GO:0050932)	8	0	.41	-	 < 0.01	6.65E-01
myoblast development (GO:0048627)	3	0	.15	-	 < 0.01	8.58E-01
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.05	-	 < 0.01	9.50E-01
glycerol ether catabolic process (GO:0044269)	2	0	.10	-	 < 0.01	9.03E-01
protein-DNA complex remodeling (GO:0001120)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of DNA-dependent DNA replication initiation (GO:0032298)	2	0	.10	-	 < 0.01	9.03E-01
induction of negative chemotaxis (GO:0050929)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of positive chemotaxis (GO:0050928)	1	0	.05	-	 < 0.01	9.50E-01
peripheral nervous system myelin formation (GO:0032290)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of negative chemotaxis (GO:0050925)	2	0	.10	-	 < 0.01	9.03E-01
histone succinylation (GO:0106077)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of negative chemotaxis (GO:0050924)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial RNA modification (GO:1900864)	8	0	.41	-	 < 0.01	6.65E-01
regulation of negative chemotaxis (GO:0050923)	4	0	.20	-	 < 0.01	8.15E-01
embryonic hindgut morphogenesis (GO:0048619)	3	0	.15	-	 < 0.01	8.58E-01
embryonic foregut morphogenesis (GO:0048617)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	5	0	.26	-	 < 0.01	7.75E-01
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	11	0	.56	-	 < 0.01	5.70E-01
embryonic ectodermal digestive tract morphogenesis (GO:0048613)	1	0	.05	-	 < 0.01	9.50E-01
transcription open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.05	-	 < 0.01	9.50E-01
DNA-templated transcription open complex formation (GO:0001112)	2	0	.10	-	 < 0.01	9.03E-01
embryonic ectodermal digestive tract development (GO:0048611)	2	0	.10	-	 < 0.01	9.03E-01
intestinal lipid catabolic process (GO:0044258)	2	0	.10	-	 < 0.01	9.03E-01
central nervous system myelin formation (GO:0032289)	4	0	.20	-	 < 0.01	8.15E-01
myelin assembly (GO:0032288)	17	0	.87	-	 < 0.01	4.19E-01
sensory perception of umami taste (GO:0050917)	4	0	.20	-	 < 0.01	8.15E-01
sensory perception of sweet taste (GO:0050916)	4	0	.20	-	 < 0.01	8.15E-01
sensory perception of sour taste (GO:0050915)	5	0	.26	-	 < 0.01	7.75E-01
sensory perception of bitter taste (GO:0050913)	34	0	1.74	-	 < 0.01	1.76E-01
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	33	0	1.69	-	 < 0.01	1.85E-01
regulation of cobalamin metabolic process (GO:0106064)	1	0	.05	-	 < 0.01	9.50E-01
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	102	0	5.21	-	 < 0.01	5.37E-03
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of exit from mitosis (GO:0001100)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of gonadotropin secretion (GO:0032278)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of gonadotropin secretion (GO:0032277)	8	0	.41	-	 < 0.01	6.65E-01
regulation of gonadotropin secretion (GO:0032276)	11	0	.56	-	 < 0.01	5.70E-01
detection of light stimulus involved in visual perception (GO:0050908)	18	0	.92	-	 < 0.01	3.99E-01
detection of chemical stimulus involved in sensory perception (GO:0050907)	138	0	7.05	-	 < 0.01	8.43E-04
detection of stimulus involved in sensory perception (GO:0050906)	199	0	10.16	-	 < 0.01	3.62E-05
leukocyte adhesive activation (GO:0050902)	2	0	.10	-	 < 0.01	9.03E-01
leukocyte tethering or rolling (GO:0050901)	19	0	.97	-	 < 0.01	3.79E-01
GMP salvage (GO:0032263)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine nucleotide salvage (GO:0032262)	5	0	.26	-	 < 0.01	7.75E-01
spermidine deacetylation (GO:0106048)	1	0	.05	-	 < 0.01	9.50E-01
polyamine deacetylation (GO:0106047)	1	0	.05	-	 < 0.01	9.50E-01
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.05	-	 < 0.01	9.50E-01
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.05	-	 < 0.01	9.50E-01
guanine deglycation (GO:0106044)	1	0	.05	-	 < 0.01	9.50E-01
regulation of GABA-A receptor activity (GO:0106040)	1	0	.05	-	 < 0.01	9.50E-01
dense core granule localization (GO:0032253)	9	0	.46	-	 < 0.01	6.31E-01
secretory granule localization (GO:0032252)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826)	1	0	.05	-	 < 0.01	9.50E-01
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	5	0	.26	-	 < 0.01	7.75E-01
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	4	0	.20	-	 < 0.01	8.15E-01
protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	2	0	.10	-	 < 0.01	9.03E-01
neuron projection fasciculation (GO:0106030)	21	0	1.07	-	 < 0.01	3.42E-01
CTP salvage (GO:0044211)	3	0	.15	-	 < 0.01	8.58E-01
'de novo' CTP biosynthetic process (GO:0044210)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of nucleoside transport (GO:0032244)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nucleoside transport (GO:0032243)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nucleoside transport (GO:0032242)	2	0	.10	-	 < 0.01	9.03E-01
neuron projection retraction (GO:0106028)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nucleobase-containing compound transport (GO:0032240)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of vesicle docking (GO:0106022)	1	0	.05	-	 < 0.01	9.50E-01
regulation of vesicle docking (GO:0106020)	3	0	.15	-	 < 0.01	8.58E-01
AMP salvage (GO:0044209)	2	0	.10	-	 < 0.01	9.03E-01
'de novo' AMP biosynthetic process (GO:0044208)	1	0	.05	-	 < 0.01	9.50E-01
UMP salvage (GO:0044206)	5	0	.26	-	 < 0.01	7.75E-01
'de novo' UMP biosynthetic process (GO:0044205)	4	0	.20	-	 < 0.01	8.15E-01
adenosine transport (GO:0032238)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of actin filament bundle assembly (GO:0032232)	29	0	1.48	-	 < 0.01	2.27E-01
positive regulation of inflammatory response to wounding (GO:0106016)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of inflammatory response to wounding (GO:0106015)	1	0	.05	-	 < 0.01	9.50E-01
regulation of inflammatory response to wounding (GO:0106014)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of synaptic transmission, GABAergic (GO:0032229)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of synaptic transmission, cholinergic (GO:0032224)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of synaptic transmission, cholinergic (GO:0032223)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic transmission, cholinergic (GO:0032222)	7	0	.36	-	 < 0.01	6.99E-01
RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	2	0	.10	-	 < 0.01	9.03E-01
tRNA (guanine-N7)-methylation (GO:0106004)	2	0	.10	-	 < 0.01	9.03E-01
intestinal hexose absorption (GO:0106001)	5	0	.26	-	 < 0.01	7.75E-01
riboflavin transport (GO:0032218)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of polysome binding (GO:1905698)	1	0	.05	-	 < 0.01	9.50E-01
regulation of polysome binding (GO:1905696)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphatidic acid biosynthetic process (GO:1905693)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nerve growth factor receptor activity (GO:0051394)	1	0	.05	-	 < 0.01	9.50E-01
tRNA acetylation (GO:0051391)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of diacylglycerol kinase activity (GO:1905689)	1	0	.05	-	 < 0.01	9.50E-01
regulation of diacylglycerol kinase activity (GO:1905687)	1	0	.05	-	 < 0.01	9.50E-01
regulation of plasma membrane repair (GO:1905684)	2	0	.10	-	 < 0.01	9.03E-01
inactivation of MAPKK activity (GO:0051389)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	4	0	.20	-	 < 0.01	8.15E-01
modification of dendritic spine (GO:0098886)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	14	0	.72	-	 < 0.01	4.89E-01
modification of postsynaptic actin cytoskeleton (GO:0098885)	3	0	.15	-	 < 0.01	8.58E-01
postsynaptic neurotransmitter receptor internalization (GO:0098884)	7	0	.36	-	 < 0.01	6.99E-01
synapse pruning (GO:0098883)	8	0	.41	-	 < 0.01	6.65E-01
maintenance of postsynaptic specialization structure (GO:0098880)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of adaptive immune memory response (GO:1905676)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of adaptive immune memory response (GO:1905675)	2	0	.10	-	 < 0.01	9.03E-01
regulation of adaptive immune memory response (GO:1905674)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of lysosome organization (GO:1905673)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lysosome organization (GO:1905671)	4	0	.20	-	 < 0.01	8.15E-01
action potential propagation (GO:0098870)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of protein localization to endosome (GO:1905668)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of calcium ion import across plasma membrane (GO:1905665)	3	0	.15	-	 < 0.01	8.58E-01
regulation of calcium ion import across plasma membrane (GO:1905664)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662)	1	0	.05	-	 < 0.01	9.50E-01
regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	3	0	.15	-	 < 0.01	8.58E-01
bone growth (GO:0098868)	28	0	1.43	-	 < 0.01	2.39E-01
intramembranous bone growth (GO:0098867)	1	0	.05	-	 < 0.01	9.50E-01
response to transition metal nanoparticle (GO:1990267)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to potassium ion starvation (GO:0051365)	2	0	.10	-	 < 0.01	9.03E-01
neutrophil migration (GO:1990266)	82	0	4.19	-	 < 0.01	1.50E-02
anti-Mullerian hormone signaling pathway (GO:1990262)	1	0	.05	-	 < 0.01	9.50E-01
pre-mRNA catabolic process (GO:1990261)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	5	0	.26	-	 < 0.01	7.75E-01
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	0	.05	-	 < 0.01	9.50E-01
histone glutamine methylation (GO:1990258)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296)	1	0	.05	-	 < 0.01	9.50E-01
proprioception involved in equilibrioception (GO:0051355)	1	0	.05	-	 < 0.01	9.50E-01
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	2	0	.10	-	 < 0.01	9.03E-01
signal clustering (GO:1990256)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ligase activity (GO:0051352)	1	0	.05	-	 < 0.01	9.50E-01
proline import across plasma membrane (GO:1905647)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of DNA methylation (GO:1905643)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of DNA methylation (GO:1905642)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lyase activity (GO:0051349)	23	0	1.17	-	 < 0.01	3.09E-01
post-embryonic animal morphogenesis (GO:0009886)	14	0	.72	-	 < 0.01	4.89E-01
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	1	0	.05	-	 < 0.01	9.50E-01
histone H2A-T120 phosphorylation (GO:1990245)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	3	0	.15	-	 < 0.01	8.58E-01
regulation of protein localization to chromatin (GO:1905634)	8	0	.41	-	 < 0.01	6.65E-01
folate transmembrane transport (GO:0098838)	6	0	.31	-	 < 0.01	7.36E-01
intestinal folate absorption (GO:0098829)	1	0	.05	-	 < 0.01	9.50E-01
modulation of inhibitory postsynaptic potential (GO:0098828)	6	0	.31	-	 < 0.01	7.36E-01
prophase (GO:0051324)	15	0	.77	-	 < 0.01	4.65E-01
peptidyl-cysteine modification to L-cysteine persulfide (GO:0098822)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mRNA cap binding (GO:1905612)	1	0	.05	-	 < 0.01	9.50E-01
G2 phase (GO:0051319)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mRNA cap binding (GO:1905610)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of macrophage colony-stimulating factor production (GO:1901257)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macrophage colony-stimulating factor production (GO:1901256)	5	0	.26	-	 < 0.01	7.75E-01
spontaneous synaptic transmission (GO:0098814)	7	0	.36	-	 < 0.01	6.99E-01
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of intracellular transport of viral material (GO:1901253)	2	0	.10	-	 < 0.01	9.03E-01
regulation of intracellular transport of viral material (GO:1901252)	3	0	.15	-	 < 0.01	8.58E-01
neurotransmitter reuptake (GO:0098810)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of lung goblet cell differentiation (GO:1901251)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	0	.05	-	 < 0.01	9.50E-01
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of presynapse assembly (GO:1905608)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of presynapse assembly (GO:1905607)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of extracellular matrix disassembly (GO:0090091)	7	0	.36	-	 < 0.01	6.99E-01
regulation of presynapse assembly (GO:1905606)	30	0	1.53	-	 < 0.01	2.16E-01
positive regulation of blood-brain barrier permeability (GO:1905605)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of blood-brain barrier permeability (GO:1905604)	3	0	.15	-	 < 0.01	8.58E-01
regulation of blood-brain barrier permeability (GO:1905603)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	2	0	.10	-	 < 0.01	9.03E-01
female meiosis chromosome separation (GO:0051309)	2	0	.10	-	 < 0.01	9.03E-01
regulation of lung goblet cell differentiation (GO:1901249)	1	0	.05	-	 < 0.01	9.50E-01
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	4	0	.20	-	 < 0.01	8.15E-01
male meiosis chromosome separation (GO:0051308)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lung ciliated cell differentiation (GO:1901248)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of lung ciliated cell differentiation (GO:1901247)	1	0	.05	-	 < 0.01	9.50E-01
mitotic sister chromatid separation (GO:0051306)	4	0	.20	-	 < 0.01	8.15E-01
regulation of lung ciliated cell differentiation (GO:1901246)	2	0	.10	-	 < 0.01	9.03E-01
chromosome movement towards spindle pole (GO:0051305)	7	0	.36	-	 < 0.01	6.99E-01
regulation of renal system process (GO:0098801)	33	0	1.69	-	 < 0.01	1.85E-01
negative regulation of protein deubiquitination (GO:0090086)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082)	4	0	.20	-	 < 0.01	8.15E-01
regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	5	0	.26	-	 < 0.01	7.75E-01
abscission (GO:0009838)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of convergent extension involved in axis elongation (GO:1901233)	1	0	.05	-	 < 0.01	9.50E-01
regulation of convergent extension involved in axis elongation (GO:1901232)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231)	1	0	.05	-	 < 0.01	9.50E-01
relaxation of skeletal muscle (GO:0090076)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein homodimerization activity (GO:0090074)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein homodimerization activity (GO:0090073)	1	0	.05	-	 < 0.01	9.50E-01
regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229)	1	0	.05	-	 < 0.01	9.50E-01
unidimensional cell growth (GO:0009826)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	0	.15	-	 < 0.01	8.58E-01
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227)	1	0	.05	-	 < 0.01	9.50E-01
thrombin-activated receptor signaling pathway (GO:0070493)	9	0	.46	-	 < 0.01	6.31E-01
alkaloid catabolic process (GO:0009822)	3	0	.15	-	 < 0.01	8.58E-01
alkaloid metabolic process (GO:0009820)	7	0	.36	-	 < 0.01	6.99E-01
regulation of thalamus size (GO:0090067)	1	0	.05	-	 < 0.01	9.50E-01
regulation of production of siRNA involved in RNA interference (GO:0090065)	2	0	.10	-	 < 0.01	9.03E-01
T cell aggregation (GO:0070489)	2	0	.10	-	 < 0.01	9.03E-01
neutrophil aggregation (GO:0070488)	2	0	.10	-	 < 0.01	9.03E-01
monocyte aggregation (GO:0070487)	3	0	.15	-	 < 0.01	8.58E-01
defense response to fungus, incompatible interaction (GO:0009817)	1	0	.05	-	 < 0.01	9.50E-01
defense response, incompatible interaction (GO:0009814)	1	0	.05	-	 < 0.01	9.50E-01
detection of hypoxia (GO:0070483)	2	0	.10	-	 < 0.01	9.03E-01
flavonoid metabolic process (GO:0009812)	5	0	.26	-	 < 0.01	7.75E-01
stilbene metabolic process (GO:0009810)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cardiac chamber formation (GO:1901211)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cardiac chamber formation (GO:1901210)	1	0	.05	-	 < 0.01	9.50E-01
post-embryonic camera-type eye morphogenesis (GO:0048597)	3	0	.15	-	 < 0.01	8.58E-01
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.05	-	 < 0.01	9.50E-01
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of heart looping (GO:1901208)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of uterine smooth muscle contraction (GO:0070474)	8	0	.41	-	 < 0.01	6.65E-01
regulation of heart looping (GO:1901207)	2	0	.10	-	 < 0.01	9.03E-01
coumarin metabolic process (GO:0009804)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of uterine smooth muscle contraction (GO:0070473)	1	0	.05	-	 < 0.01	9.50E-01
regulation of uterine smooth muscle contraction (GO:0070472)	10	0	.51	-	 < 0.01	6.00E-01
uterine smooth muscle contraction (GO:0070471)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.05	-	 < 0.01	9.50E-01
determination of affect (GO:0050894)	1	0	.05	-	 < 0.01	9.50E-01
sensory processing (GO:0050893)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of deacetylase activity (GO:0090045)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of tubulin deacetylation (GO:0090044)	1	0	.05	-	 < 0.01	9.50E-01
regulation of tubulin deacetylation (GO:0090043)	11	0	.56	-	 < 0.01	5.70E-01
nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080)	1	0	.05	-	 < 0.01	9.50E-01
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.05	-	 < 0.01	9.50E-01
thyroid-stimulating hormone secretion (GO:0070460)	2	0	.10	-	 < 0.01	9.03E-01
neuromuscular process controlling balance (GO:0050885)	48	0	2.45	-	 < 0.01	8.58E-02
neuromuscular process controlling posture (GO:0050884)	15	0	.77	-	 < 0.01	4.65E-01
musculoskeletal movement, spinal reflex action (GO:0050883)	3	0	.15	-	 < 0.01	8.58E-01
voluntary musculoskeletal movement (GO:0050882)	7	0	.36	-	 < 0.01	6.99E-01
nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein kinase C signaling (GO:0090038)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of protein kinase C signaling (GO:0090037)	10	0	.51	-	 < 0.01	6.00E-01
regulation of protein kinase C signaling (GO:0090036)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.05	-	 < 0.01	9.50E-01
long-day photoperiodism (GO:0048571)	1	0	.05	-	 < 0.01	9.50E-01
notochord morphogenesis (GO:0048570)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of steroid hormone biosynthetic process (GO:0090031)	3	0	.15	-	 < 0.01	8.58E-01
prolactin secretion (GO:0070459)	4	0	.20	-	 < 0.01	8.15E-01
cellular detoxification of nitrogen compound (GO:0070458)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of heme biosynthetic process (GO:0070455)	1	0	.05	-	 < 0.01	9.50E-01
regulation of heme biosynthetic process (GO:0070453)	3	0	.15	-	 < 0.01	8.58E-01
ectodermal digestive tract morphogenesis (GO:0048567)	1	0	.05	-	 < 0.01	9.50E-01
embryonic digestive tract development (GO:0048566)	33	0	1.69	-	 < 0.01	1.85E-01
negative regulation of monocyte chemotaxis (GO:0090027)	6	0	.31	-	 < 0.01	7.36E-01
post-embryonic animal organ morphogenesis (GO:0048563)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of neutrophil chemotaxis (GO:0090024)	3	0	.15	-	 < 0.01	8.58E-01
establishment of animal organ orientation (GO:0048561)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neutrophil chemotaxis (GO:0090023)	24	0	1.23	-	 < 0.01	2.93E-01
establishment of anatomical structure orientation (GO:0048560)	3	0	.15	-	 < 0.01	8.58E-01
regulation of neutrophil chemotaxis (GO:0090022)	30	0	1.53	-	 < 0.01	2.16E-01
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of T cell receptor signaling pathway (GO:0050862)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of B cell receptor signaling pathway (GO:0050861)	8	0	.41	-	 < 0.01	6.65E-01
embryonic digestive tract morphogenesis (GO:0048557)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of pinocytosis (GO:0048550)	5	0	.26	-	 < 0.01	7.75E-01
transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of B cell receptor signaling pathway (GO:0050859)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	23	0	1.17	-	 < 0.01	3.09E-01
regulation of B cell receptor signaling pathway (GO:0050855)	26	0	1.33	-	 < 0.01	2.65E-01
positive regulation of pinocytosis (GO:0048549)	8	0	.41	-	 < 0.01	6.65E-01
regulation of pinocytosis (GO:0048548)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	4	0	.20	-	 < 0.01	8.15E-01
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	2	0	.10	-	 < 0.01	9.03E-01
antibiotic metabolic process (GO:0016999)	2	0	.10	-	 < 0.01	9.03E-01
cell wall macromolecule catabolic process (GO:0016998)	2	0	.10	-	 < 0.01	9.03E-01
bone marrow development (GO:0048539)	7	0	.36	-	 < 0.01	6.99E-01
anatomical structure arrangement (GO:0048532)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of heterochromatin organization (GO:0120263)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of heterochromatin organization (GO:0120262)	5	0	.26	-	 < 0.01	7.75E-01
regulation of heterochromatin organization (GO:0120261)	19	0	.97	-	 < 0.01	3.79E-01
trehalose metabolism in response to stress (GO:0070413)	1	0	.05	-	 < 0.01	9.50E-01
defense response to fungus (GO:0050832)	41	0	2.09	-	 < 0.01	1.23E-01
negative regulation of behavior (GO:0048521)	12	0	.61	-	 < 0.01	5.42E-01
olefinic compound catabolic process (GO:0120256)	1	0	.05	-	 < 0.01	9.50E-01
carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.05	-	 < 0.01	9.50E-01
carbamoyl phosphate metabolic process (GO:0070408)	1	0	.05	-	 < 0.01	9.50E-01
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.05	-	 < 0.01	9.50E-01
hydrocarbon catabolic process (GO:0120253)	2	0	.10	-	 < 0.01	9.03E-01
transposition, RNA-mediated (GO:0032197)	2	0	.10	-	 < 0.01	9.03E-01
transposition (GO:0032196)	4	0	.20	-	 < 0.01	8.15E-01
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.05	-	 < 0.01	9.50E-01
defense response to Gram-negative bacterium (GO:0050829)	74	0	3.78	-	 < 0.01	2.26E-02
regulation of liquid surface tension (GO:0050828)	2	0	.10	-	 < 0.01	9.03E-01
peptide antigen stabilization (GO:0050823)	1	0	.05	-	 < 0.01	9.50E-01
peptide stabilization (GO:0050822)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-K14 acetylation (GO:0044154)	7	0	.36	-	 < 0.01	6.99E-01
septin cytoskeleton organization (GO:0032185)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of D-amino-acid oxidase activity (GO:1900758)	1	0	.05	-	 < 0.01	9.50E-01
regulation of D-amino-acid oxidase activity (GO:1900757)	1	0	.05	-	 < 0.01	9.50E-01
doxorubicin transport (GO:1900753)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of development of symbiont involved in interaction with host (GO:0044147)	1	0	.05	-	 < 0.01	9.50E-01
modulation of development of symbiont involved in interaction with host (GO:0044145)	1	0	.05	-	 < 0.01	9.50E-01
glutathione deglycation (GO:0036531)	1	0	.05	-	 < 0.01	9.50E-01
protein deglycation, methylglyoxal removal (GO:0036530)	1	0	.05	-	 < 0.01	9.50E-01
(R)-carnitine transport (GO:1900749)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	10	0	.51	-	 < 0.01	6.00E-01
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	20	0	1.02	-	 < 0.01	3.60E-01
protein localization to motile cilium (GO:0120229)	1	0	.05	-	 < 0.01	9.50E-01
protein deglycation, glyoxal removal (GO:0036529)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-lysine deglycation (GO:0036528)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-arginine deglycation (GO:0036527)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-cysteine deglycation (GO:0036526)	1	0	.05	-	 < 0.01	9.50E-01
protein deglycation (GO:0036525)	2	0	.10	-	 < 0.01	9.03E-01
larynx development (GO:0120224)	2	0	.10	-	 < 0.01	9.03E-01
larynx morphogenesis (GO:0120223)	2	0	.10	-	 < 0.01	9.03E-01
astrocyte-dopaminergic neuron signaling (GO:0036520)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	5	0	.26	-	 < 0.01	7.75E-01
chemorepulsion of dopaminergic neuron axon (GO:0036518)	2	0	.10	-	 < 0.01	9.03E-01
chemoattraction of serotonergic neuron axon (GO:0036517)	1	0	.05	-	 < 0.01	9.50E-01
serotonergic neuron axon guidance (GO:0036515)	3	0	.15	-	 < 0.01	8.58E-01
dopaminergic neuron axon guidance (GO:0036514)	4	0	.20	-	 < 0.01	8.15E-01
trimming of second mannose on A branch (GO:0036512)	2	0	.10	-	 < 0.01	9.03E-01
proacrosomal vesicle fusion (GO:0120211)	1	0	.05	-	 < 0.01	9.50E-01
trimming of first mannose on A branch (GO:0036511)	2	0	.10	-	 < 0.01	9.03E-01
trimming of terminal mannose on C branch (GO:0036510)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation by symbiont of entry into host (GO:0075294)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of uterine smooth muscle relaxation (GO:1900721)	1	0	.05	-	 < 0.01	9.50E-01
trimming of terminal mannose on B branch (GO:0036509)	2	0	.10	-	 < 0.01	9.03E-01
growth of symbiont in host (GO:0044117)	3	0	.15	-	 < 0.01	8.58E-01
maintenance of unfolded protein (GO:0036506)	2	0	.10	-	 < 0.01	9.03E-01
development involved in symbiotic interaction (GO:0044111)	1	0	.05	-	 < 0.01	9.50E-01
growth involved in symbiotic interaction (GO:0044110)	3	0	.15	-	 < 0.01	8.58E-01
regulation of uterine smooth muscle relaxation (GO:1900719)	1	0	.05	-	 < 0.01	9.50E-01
cellular alcohol biosynthetic process (GO:0044108)	4	0	.20	-	 < 0.01	8.15E-01
cellular alcohol metabolic process (GO:0044107)	4	0	.20	-	 < 0.01	8.15E-01
sequestering of zinc ion (GO:0032119)	4	0	.20	-	 < 0.01	8.15E-01
regulation of carbohydrate phosphatase activity (GO:0032113)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of response to nutrient levels (GO:0032109)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of response to nutrient levels (GO:0032108)	12	0	.61	-	 < 0.01	5.42E-01
regulation of response to nutrient levels (GO:0032107)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation of response to extracellular stimulus (GO:0032106)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of response to extracellular stimulus (GO:0032105)	12	0	.61	-	 < 0.01	5.42E-01
regulation of response to extracellular stimulus (GO:0032104)	25	0	1.28	-	 < 0.01	2.79E-01
positive regulation of appetite (GO:0032100)	4	0	.20	-	 < 0.01	8.15E-01
cell dedifferentiation (GO:0043697)	5	0	.26	-	 < 0.01	7.75E-01
dedifferentiation (GO:0043696)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of low-density lipoprotein particle receptor binding (GO:1905596)	1	0	.05	-	 < 0.01	9.50E-01
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.10	-	 < 0.01	9.03E-01
fibronectin fibril organization (GO:1905590)	1	0	.05	-	 < 0.01	9.50E-01
establishment of meiotic spindle orientation (GO:0051296)	1	0	.05	-	 < 0.01	9.50E-01
mRNA cleavage involved in gene silencing (GO:0098795)	1	0	.05	-	 < 0.01	9.50E-01
co-translational protein modification (GO:0043686)	2	0	.10	-	 < 0.01	9.03E-01
establishment of meiotic spindle localization (GO:0051295)	5	0	.26	-	 < 0.01	7.75E-01
xenophagy (GO:0098792)	4	0	.20	-	 < 0.01	8.15E-01
protein heterotetramerization (GO:0051290)	13	0	.66	-	 < 0.01	5.15E-01
induction of programmed cell death (GO:0012502)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.05	-	 < 0.01	9.50E-01
outer hair cell apoptotic process (GO:1905584)	1	0	.05	-	 < 0.01	9.50E-01
pre-mRNA cleavage required for polyadenylation (GO:0098789)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of ERBB3 signaling pathway (GO:1905580)	1	0	.05	-	 < 0.01	9.50E-01
mRNA cleavage involved in mRNA processing (GO:0098787)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of sequestering of calcium ion (GO:0051283)	42	0	2.15	-	 < 0.01	1.17E-01
exosomal secretion (GO:1990182)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial tRNA 3'-end processing (GO:1990180)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ERBB3 signaling pathway (GO:1905578)	1	0	.05	-	 < 0.01	9.50E-01
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	7	0	.36	-	 < 0.01	6.99E-01
protein localization to nucleoplasm (GO:1990173)	1	0	.05	-	 < 0.01	9.50E-01
G protein-coupled receptor catabolic process (GO:1990172)	1	0	.05	-	 < 0.01	9.50E-01
stress response to cadmium ion (GO:1990170)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of vascular endothelial cell proliferation (GO:1905563)	5	0	.26	-	 < 0.01	7.75E-01
stress response to copper ion (GO:1990169)	13	0	.66	-	 < 0.01	5.15E-01
protein K33-linked deubiquitination (GO:1990168)	4	0	.20	-	 < 0.01	8.15E-01
protein K27-linked deubiquitination (GO:1990167)	3	0	.15	-	 < 0.01	8.58E-01
protein localization to site of double-strand break (GO:1990166)	3	0	.15	-	 < 0.01	8.58E-01
recognition of apoptotic cell (GO:0043654)	6	0	.31	-	 < 0.01	7.36E-01
histone H2A phosphorylation (GO:1990164)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	8	0	.41	-	 < 0.01	6.65E-01
engulfment of apoptotic cell (GO:0043652)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation blood vessel branching (GO:1905555)	3	0	.15	-	 < 0.01	8.58E-01
regulation of blood vessel branching (GO:1905553)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to interleukin-8 (GO:0098759)	3	0	.15	-	 < 0.01	8.58E-01
response to interleukin-8 (GO:0098758)	3	0	.15	-	 < 0.01	8.58E-01
regulation of protein localization to endoplasmic reticulum (GO:1905550)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to interleukin-21 (GO:0098757)	8	0	.41	-	 < 0.01	6.65E-01
response to interleukin-21 (GO:0098756)	8	0	.41	-	 < 0.01	6.65E-01
regulation of mitotic cell cycle, embryonic (GO:0009794)	4	0	.20	-	 < 0.01	8.15E-01
mitotic spindle midzone assembly (GO:0051256)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.05	-	 < 0.01	9.50E-01
regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of subtelomeric heterochromatin assembly (GO:1905549)	1	0	.05	-	 < 0.01	9.50E-01
regulation of subtelomeric heterochromatin assembly (GO:1905547)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to phenylpropanoid (GO:1905546)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar neuron development (GO:0098749)	3	0	.15	-	 < 0.01	8.58E-01
regulation of L-arginine import across plasma membrane (GO:1905541)	1	0	.05	-	 < 0.01	9.50E-01
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ephrin receptor signaling pathway (GO:1901189)	1	0	.05	-	 < 0.01	9.50E-01
regulation of asymmetric cell division (GO:0009786)	4	0	.20	-	 < 0.01	8.15E-01
fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ephrin receptor signaling pathway (GO:1901187)	2	0	.10	-	 < 0.01	9.03E-01
cell aggregation (GO:0098743)	19	0	.97	-	 < 0.01	3.79E-01
maintenance of translational fidelity (GO:1990145)	2	0	.10	-	 < 0.01	9.03E-01
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	2	0	.10	-	 < 0.01	9.03E-01
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.05	-	 < 0.01	9.50E-01
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.05	-	 < 0.01	9.50E-01
ncRNA polyadenylation (GO:0043629)	1	0	.05	-	 < 0.01	9.50E-01
protein insertion into plasma membrane (GO:0098737)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of the force of heart contraction (GO:0098736)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of the force of heart contraction (GO:0098735)	5	0	.26	-	 < 0.01	7.75E-01
macromolecule depalmitoylation (GO:0098734)	11	0	.56	-	 < 0.01	5.70E-01
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.05	-	 < 0.01	9.50E-01
meiotic spindle elongation (GO:0051232)	1	0	.05	-	 < 0.01	9.50E-01
cortical microtubule organization (GO:0043622)	4	0	.20	-	 < 0.01	8.15E-01
spindle elongation (GO:0051231)	7	0	.36	-	 < 0.01	6.99E-01
spindle disassembly (GO:0051230)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of heat generation (GO:0031651)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of Golgi lumen acidification (GO:1905528)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Golgi lumen acidification (GO:1905526)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein autoubiquitination (GO:1905524)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage migration (GO:1905523)	26	0	1.33	-	 < 0.01	2.65E-01
negative regulation of macrophage migration (GO:1905522)	10	0	.51	-	 < 0.01	6.00E-01
regulation of macrophage migration (GO:1905521)	43	0	2.20	-	 < 0.01	1.11E-01
positive regulation of presynaptic active zone assembly (GO:1905520)	2	0	.10	-	 < 0.01	9.03E-01
mitotic spindle disassembly (GO:0051228)	2	0	.10	-	 < 0.01	9.03E-01
symmetric cell division (GO:0098725)	1	0	.05	-	 < 0.01	9.50E-01
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of trophoblast cell migration (GO:1901165)	5	0	.26	-	 < 0.01	7.75E-01
astrocyte cell migration (GO:0043615)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of trophoblast cell migration (GO:1901164)	6	0	.31	-	 < 0.01	7.36E-01
regulation of trophoblast cell migration (GO:1901163)	11	0	.56	-	 < 0.01	5.70E-01
primary amino compound biosynthetic process (GO:1901162)	4	0	.20	-	 < 0.01	8.15E-01
regulation of carbohydrate utilization (GO:0043610)	1	0	.05	-	 < 0.01	9.50E-01
messenger ribonucleoprotein complex assembly (GO:1990120)	3	0	.15	-	 < 0.01	8.58E-01
regulation of presynaptic active zone assembly (GO:1905518)	2	0	.10	-	 < 0.01	9.03E-01
macrophage migration (GO:1905517)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of fertilization (GO:1905516)	4	0	.20	-	 < 0.01	8.15E-01
non-motile cilium assembly (GO:1905515)	43	0	2.20	-	 < 0.01	1.11E-01
negative regulation of short-term synaptic potentiation (GO:1905513)	1	0	.05	-	 < 0.01	9.50E-01
regulation of short-term synaptic potentiation (GO:1905512)	1	0	.05	-	 < 0.01	9.50E-01
sodium ion import across plasma membrane (GO:0098719)	18	0	.92	-	 < 0.01	3.99E-01
hexose mediated signaling (GO:0009757)	3	0	.15	-	 < 0.01	8.58E-01
serine import across plasma membrane (GO:0098718)	1	0	.05	-	 < 0.01	9.50E-01
xylulose 5-phosphate biosynthetic process (GO:1901159)	5	0	.26	-	 < 0.01	7.75E-01
carbohydrate mediated signaling (GO:0009756)	5	0	.26	-	 < 0.01	7.75E-01
B cell receptor apoptotic signaling pathway (GO:1990117)	1	0	.05	-	 < 0.01	9.50E-01
response to jasmonic acid (GO:0009753)	3	0	.15	-	 < 0.01	8.58E-01
formamide metabolic process (GO:0043606)	3	0	.15	-	 < 0.01	8.58E-01
cellular amide catabolic process (GO:0043605)	3	0	.15	-	 < 0.01	8.58E-01
leucine import across plasma membrane (GO:0098713)	3	0	.15	-	 < 0.01	8.58E-01
L-glutamate import across plasma membrane (GO:0098712)	8	0	.41	-	 < 0.01	6.65E-01
RNA polymerase II core complex assembly (GO:1990114)	1	0	.05	-	 < 0.01	9.50E-01
iron ion import across plasma membrane (GO:0098711)	2	0	.10	-	 < 0.01	9.03E-01
nitrate catabolic process (GO:0043602)	1	0	.05	-	 < 0.01	9.50E-01
plasminogen activation (GO:0031639)	10	0	.51	-	 < 0.01	6.00E-01
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	4	0	.20	-	 < 0.01	8.15E-01
protein localization to microtubule organizing center (GO:1905508)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of motile cilium assembly (GO:1905505)	1	0	.05	-	 < 0.01	9.50E-01
regulation of motile cilium assembly (GO:1905503)	1	0	.05	-	 < 0.01	9.50E-01
release of sequestered calcium ion into cytosol (GO:0051209)	41	0	2.09	-	 < 0.01	1.23E-01
protein linear deubiquitination (GO:1990108)	2	0	.10	-	 < 0.01	9.03E-01
response to sucrose (GO:0009744)	8	0	.41	-	 < 0.01	6.65E-01
copper ion import across plasma membrane (GO:0098705)	1	0	.05	-	 < 0.01	9.50E-01
calcium ion import across plasma membrane (GO:0098703)	16	0	.82	-	 < 0.01	4.41E-01
insulin catabolic process (GO:1901143)	3	0	.15	-	 < 0.01	8.58E-01
insulin metabolic process (GO:1901142)	7	0	.36	-	 < 0.01	6.99E-01
neurotransmitter loading into synaptic vesicle (GO:0098700)	8	0	.41	-	 < 0.01	6.65E-01
detection of hexose stimulus (GO:0009732)	3	0	.15	-	 < 0.01	8.58E-01
detection of carbohydrate stimulus (GO:0009730)	3	0	.15	-	 < 0.01	8.58E-01
detection of endogenous stimulus (GO:0009726)	3	0	.15	-	 < 0.01	8.58E-01
gentamycin metabolic process (GO:1901128)	1	0	.05	-	 < 0.01	9.50E-01
response to lipoteichoic acid (GO:0070391)	9	0	.46	-	 < 0.01	6.31E-01
tRNA-guanine transglycosylation (GO:0101030)	3	0	.15	-	 < 0.01	8.58E-01
mitotic nuclear membrane organization (GO:0101024)	3	0	.15	-	 < 0.01	8.58E-01
Harderian gland development (GO:0070384)	4	0	.20	-	 < 0.01	8.15E-01
DNA cytosine deamination (GO:0070383)	9	0	.46	-	 < 0.01	6.31E-01
catechol-containing compound biosynthetic process (GO:0009713)	19	0	.97	-	 < 0.01	3.79E-01
synaptic vesicle membrane organization (GO:0048499)	4	0	.20	-	 < 0.01	8.15E-01
maintenance of animal organ identity (GO:0048496)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of ERK5 cascade (GO:0070378)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ERK5 cascade (GO:0070376)	2	0	.10	-	 < 0.01	9.03E-01
ERK5 cascade (GO:0070375)	2	0	.10	-	 < 0.01	9.03E-01
parasympathetic nervous system development (GO:0048486)	16	0	.82	-	 < 0.01	4.41E-01
enteric nervous system development (GO:0048484)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of hepatocyte differentiation (GO:0070368)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hepatocyte differentiation (GO:0070366)	2	0	.10	-	 < 0.01	9.03E-01
detoxification of mercury ion (GO:0050787)	2	0	.10	-	 < 0.01	9.03E-01
cocaine metabolic process (GO:0050783)	1	0	.05	-	 < 0.01	9.50E-01
replication fork protection (GO:0048478)	8	0	.41	-	 < 0.01	6.65E-01
actin polymerization-dependent cell motility (GO:0070358)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of white fat cell proliferation (GO:0070352)	2	0	.10	-	 < 0.01	9.03E-01
regulation of white fat cell proliferation (GO:0070350)	3	0	.15	-	 < 0.01	8.58E-01
RNA destabilization (GO:0050779)	34	0	1.74	-	 < 0.01	1.76E-01
regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of brown fat cell proliferation (GO:0070349)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.05	-	 < 0.01	9.50E-01
regulation of brown fat cell proliferation (GO:0070347)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of fat cell proliferation (GO:0070346)	4	0	.20	-	 < 0.01	8.15E-01
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.10	-	 < 0.01	9.03E-01
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.15	-	 < 0.01	8.58E-01
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	8	0	.41	-	 < 0.01	6.65E-01
detection of bacterial lipopeptide (GO:0070340)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of bile acid secretion (GO:0120189)	1	0	.05	-	 < 0.01	9.50E-01
regulation of bile acid secretion (GO:0120188)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of protein localization to chromatin (GO:0120187)	1	0	.05	-	 < 0.01	9.50E-01
ventral trunk neural crest cell migration (GO:0036486)	4	0	.20	-	 < 0.01	8.15E-01
response to bacterial lipopeptide (GO:0070339)	6	0	.31	-	 < 0.01	7.36E-01
trunk neural crest cell migration (GO:0036484)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of focal adhesion disassembly (GO:0120183)	6	0	.31	-	 < 0.01	7.36E-01
regulation of focal adhesion disassembly (GO:0120182)	6	0	.31	-	 < 0.01	7.36E-01
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of vacuole organization (GO:0044090)	11	0	.56	-	 < 0.01	5.70E-01
regulation of thymidylate synthase biosynthetic process (GO:0050758)	1	0	.05	-	 < 0.01	9.50E-01
chemokine metabolic process (GO:0050755)	2	0	.10	-	 < 0.01	9.03E-01
neuron death in response to oxidative stress (GO:0036475)	3	0	.15	-	 < 0.01	8.58E-01
cell death in response to hydrogen peroxide (GO:0036474)	4	0	.20	-	 < 0.01	8.15E-01
thyroid hormone transport (GO:0070327)	10	0	.51	-	 < 0.01	6.00E-01
trans-synaptic signaling by BDNF (GO:0099191)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to glyoxal (GO:0036471)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of lipoprotein metabolic process (GO:0050748)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of lipoprotein metabolic process (GO:0050747)	5	0	.26	-	 < 0.01	7.75E-01
regulation of lipoprotein metabolic process (GO:0050746)	14	0	.72	-	 < 0.01	4.89E-01
detection of cold stimulus involved in thermoception (GO:0120169)	1	0	.05	-	 < 0.01	9.50E-01
postsynaptic intermediate filament cytoskeleton organization (GO:0099185)	3	0	.15	-	 < 0.01	8.58E-01
trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of G0 to G1 transition (GO:0070318)	3	0	.15	-	 < 0.01	8.58E-01
zinc ion import into synaptic vesicle (GO:0099180)	1	0	.05	-	 < 0.01	9.50E-01
TRAIL-activated apoptotic signaling pathway (GO:0036462)	6	0	.31	-	 < 0.01	7.36E-01
G1 to G0 transition involved in cell differentiation (GO:0070315)	3	0	.15	-	 < 0.01	8.58E-01
G1 to G0 transition (GO:0070314)	8	0	.41	-	 < 0.01	6.65E-01
olefin metabolic process (GO:1900673)	3	0	.15	-	 < 0.01	8.58E-01
regulation of synaptic membrane adhesion (GO:0099179)	2	0	.10	-	 < 0.01	9.03E-01
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of collagen catabolic process (GO:0120158)	1	0	.05	-	 < 0.01	9.50E-01
regulation of presynapse organization (GO:0099174)	31	0	1.58	-	 < 0.01	2.05E-01
negative regulation of ERBB4 signaling pathway (GO:0120154)	1	0	.05	-	 < 0.01	9.50E-01
presynaptic modulation of chemical synaptic transmission (GO:0099171)	6	0	.31	-	 < 0.01	7.36E-01
regulation of excretion (GO:0044062)	22	0	1.12	-	 < 0.01	3.25E-01
response to cGMP (GO:0070305)	7	0	.36	-	 < 0.01	6.99E-01
cap mRNA methylation (GO:0036451)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of appetite (GO:0032099)	12	0	.61	-	 < 0.01	5.42E-01
regulation of appetite (GO:0032098)	22	0	1.12	-	 < 0.01	3.25E-01
positive regulation of response to food (GO:0032097)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of response to food (GO:0032096)	12	0	.61	-	 < 0.01	5.42E-01
regulation of response to food (GO:0032095)	18	0	.92	-	 < 0.01	3.99E-01
response to food (GO:0032094)	18	0	.92	-	 < 0.01	3.99E-01
synaptic signaling by nitric oxide (GO:0099163)	2	0	.10	-	 < 0.01	9.03E-01
translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.05	-	 < 0.01	9.50E-01
regulation of modification of postsynaptic structure (GO:0099159)	6	0	.31	-	 < 0.01	7.36E-01
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.05	-	 < 0.01	9.50E-01
cell-cell signaling via exosome (GO:0099156)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of lens transparency (GO:0036438)	4	0	.20	-	 < 0.01	8.15E-01
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	2	0	.10	-	 < 0.01	9.03E-01
regulation of postsynaptic density assembly (GO:0099151)	9	0	.46	-	 < 0.01	6.31E-01
regulation of postsynaptic specialization assembly (GO:0099150)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of deoxyribonuclease activity (GO:0032077)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.10	-	 < 0.01	9.03E-01
regulation of restriction endodeoxyribonuclease activity (GO:0032072)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic vesicle docking (GO:0099148)	1	0	.05	-	 < 0.01	9.50E-01
cell wall macromolecule biosynthetic process (GO:0044038)	1	0	.05	-	 < 0.01	9.50E-01
response to zinc ion starvation (GO:0120127)	2	0	.10	-	 < 0.01	9.03E-01
cell wall macromolecule metabolic process (GO:0044036)	4	0	.20	-	 < 0.01	8.15E-01
response to copper ion starvation (GO:0120126)	1	0	.05	-	 < 0.01	9.50E-01
multi-organism catabolic process (GO:0044035)	1	0	.05	-	 < 0.01	9.50E-01
multi-organism metabolic process (GO:0044033)	1	0	.05	-	 < 0.01	9.50E-01
hypomethylation of CpG island (GO:0044029)	2	0	.10	-	 < 0.01	9.03E-01
DNA hypomethylation (GO:0044028)	2	0	.10	-	 < 0.01	9.03E-01
hypermethylation of CpG island (GO:0044027)	2	0	.10	-	 < 0.01	9.03E-01
T cell meandering migration (GO:0120117)	1	0	.05	-	 < 0.01	9.50E-01
DNA hypermethylation (GO:0044026)	3	0	.15	-	 < 0.01	8.58E-01
tRNA stabilization (GO:0036416)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tRNA stability (GO:0036415)	2	0	.10	-	 < 0.01	9.03E-01
histone citrullination (GO:0036414)	4	0	.20	-	 < 0.01	8.15E-01
histone H3-R26 citrullination (GO:0036413)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of translational initiation in response to stress (GO:0032058)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of translation in response to stress (GO:0032056)	9	0	.46	-	 < 0.01	6.31E-01
ciliary basal body organization (GO:0032053)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of monocyte aggregation (GO:1900625)	3	0	.15	-	 < 0.01	8.58E-01
regulation of monocyte aggregation (GO:1900623)	3	0	.15	-	 < 0.01	8.58E-01
acetate ester biosynthetic process (GO:1900620)	3	0	.15	-	 < 0.01	8.58E-01
conversion of ds siRNA to ss siRNA (GO:0036404)	1	0	.05	-	 < 0.01	9.50E-01
acetate ester metabolic process (GO:1900619)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial DNA metabolic process (GO:0032042)	9	0	.46	-	 < 0.01	6.31E-01
box C/D snoRNA 3'-end processing (GO:0000494)	2	0	.10	-	 < 0.01	9.03E-01
box H/ACA snoRNP assembly (GO:0000493)	2	0	.10	-	 < 0.01	9.03E-01
box C/D snoRNP assembly (GO:0000492)	8	0	.41	-	 < 0.01	6.65E-01
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	10	0	.51	-	 < 0.01	6.00E-01
maturation of 5S rRNA (GO:0000481)	1	0	.05	-	 < 0.01	9.50E-01
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	7	0	.36	-	 < 0.01	6.99E-01
response to magnesium ion (GO:0032026)	17	0	.87	-	 < 0.01	4.19E-01
response to cobalt ion (GO:0032025)	10	0	.51	-	 < 0.01	6.00E-01
trypsinogen activation (GO:0032023)	1	0	.05	-	 < 0.01	9.50E-01
ISG15-protein conjugation (GO:0032020)	4	0	.20	-	 < 0.01	8.15E-01
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	13	0	.66	-	 < 0.01	5.15E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	13	0	.66	-	 < 0.01	5.15E-01
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ARF protein signal transduction (GO:0032012)	19	0	.97	-	 < 0.01	3.79E-01
7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)	1	0	.05	-	 < 0.01	9.50E-01
detection of muscle stretch (GO:0035995)	7	0	.36	-	 < 0.01	6.99E-01
response to muscle stretch (GO:0035994)	21	0	1.07	-	 < 0.01	3.42E-01
deltoid tuberosity development (GO:0035993)	1	0	.05	-	 < 0.01	9.50E-01
tendon formation (GO:0035992)	2	0	.10	-	 < 0.01	9.03E-01
tendon cell differentiation (GO:0035990)	2	0	.10	-	 < 0.01	9.03E-01
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	5	0	.26	-	 < 0.01	7.75E-01
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	3	0	.15	-	 < 0.01	8.58E-01
enzyme-directed rRNA 2'-O-methylation (GO:0000453)	1	0	.05	-	 < 0.01	9.50E-01
rRNA 2'-O-methylation (GO:0000451)	2	0	.10	-	 < 0.01	9.03E-01
tendon development (GO:0035989)	5	0	.26	-	 < 0.01	7.75E-01
chondrocyte proliferation (GO:0035988)	8	0	.41	-	 < 0.01	6.65E-01
senescence-associated heterochromatin focus assembly (GO:0035986)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to trichostatin A (GO:0035984)	3	0	.15	-	 < 0.01	8.58E-01
response to trichostatin A (GO:0035983)	3	0	.15	-	 < 0.01	8.58E-01
hemoglobin metabolic process (GO:0020027)	11	0	.56	-	 < 0.01	5.70E-01
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	1	0	.05	-	 < 0.01	9.50E-01
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of branching morphogenesis of a nerve (GO:1905492)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	7	0	.36	-	 < 0.01	6.99E-01
histone H2A-S139 phosphorylation (GO:0035978)	2	0	.10	-	 < 0.01	9.03E-01
tongue morphogenesis (GO:0043587)	9	0	.46	-	 < 0.01	6.31E-01
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	5	0	.26	-	 < 0.01	7.75E-01
regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694)	1	0	.05	-	 < 0.01	9.50E-01
nose morphogenesis (GO:0043585)	3	0	.15	-	 < 0.01	8.58E-01
regulation of synaptic vesicle cycle (GO:0098693)	5	0	.26	-	 < 0.01	7.75E-01
nose development (GO:0043584)	15	0	.77	-	 < 0.01	4.65E-01
calcium-dependent self proteolysis (GO:1990092)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of motor neuron migration (GO:1905485)	1	0	.05	-	 < 0.01	9.50E-01
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.05	-	 < 0.01	9.50E-01
regulation of motor neuron migration (GO:1905483)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	3	0	.15	-	 < 0.01	8.58E-01
prosthetic group metabolic process (GO:0051189)	6	0	.31	-	 < 0.01	7.36E-01
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	3	0	.15	-	 < 0.01	8.58E-01
nuclear matrix organization (GO:0043578)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to interleukin-13 (GO:0035963)	3	0	.15	-	 < 0.01	8.58E-01
response to interleukin-13 (GO:0035962)	4	0	.20	-	 < 0.01	8.15E-01
maintenance of DNA repeat elements (GO:0043570)	6	0	.31	-	 < 0.01	7.36E-01
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	4	0	.20	-	 < 0.01	8.15E-01
canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474)	1	0	.05	-	 < 0.01	9.50E-01
pexophagy (GO:0000425)	7	0	.36	-	 < 0.01	6.99E-01
cartilage homeostasis (GO:1990079)	3	0	.15	-	 < 0.01	8.58E-01
meiotic sister chromatid cohesion (GO:0051177)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of sulfur metabolic process (GO:0051176)	3	0	.15	-	 < 0.01	8.58E-01
polyuridylation-dependent mRNA catabolic process (GO:1990074)	1	0	.05	-	 < 0.01	9.50E-01
wybutosine biosynthetic process (GO:0031591)	2	0	.10	-	 < 0.01	9.03E-01
wybutosine metabolic process (GO:0031590)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of clathrin-coated pit assembly (GO:1905469)	1	0	.05	-	 < 0.01	9.50E-01
regulation of clathrin-coated pit assembly (GO:1905468)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of histone H3-K36 methylation (GO:0000416)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of DNA duplex unwinding (GO:1905464)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of histone H3-K36 methylation (GO:0000415)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of DNA duplex unwinding (GO:1905463)	3	0	.15	-	 < 0.01	8.58E-01
regulation of histone H3-K36 methylation (GO:0000414)	6	0	.31	-	 < 0.01	7.36E-01
regulation of DNA duplex unwinding (GO:1905462)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of transcription by galactose (GO:0000411)	1	0	.05	-	 < 0.01	9.50E-01
xylulose 5-phosphate metabolic process (GO:0051167)	5	0	.26	-	 < 0.01	7.75E-01
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	26	0	1.33	-	 < 0.01	2.65E-01
mitochondrial mRNA surveillance (GO:0035946)	1	0	.05	-	 < 0.01	9.50E-01
L-xylitol metabolic process (GO:0051164)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	35	0	1.79	-	 < 0.01	1.67E-01
L-xylitol catabolic process (GO:0051160)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	4	0	.20	-	 < 0.01	8.15E-01
activation of phospholipase D activity (GO:0031584)	6	0	.31	-	 < 0.01	7.36E-01
hemidesmosome assembly (GO:0031581)	12	0	.61	-	 < 0.01	5.42E-01
membrane raft distribution (GO:0031580)	5	0	.26	-	 < 0.01	7.75E-01
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	2	0	.10	-	 < 0.01	9.03E-01
regulation of transcription by galactose (GO:0000409)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	0	.05	-	 < 0.01	9.50E-01
regulation of myeloid progenitor cell differentiation (GO:1905453)	1	0	.05	-	 < 0.01	9.50E-01
phenylpropanoid metabolic process (GO:0009698)	5	0	.26	-	 < 0.01	7.75E-01
inorganic cation import across plasma membrane (GO:0098659)	82	0	4.19	-	 < 0.01	1.50E-02
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	5	0	.26	-	 < 0.01	7.75E-01
inorganic anion import across plasma membrane (GO:0098658)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of striated muscle cell differentiation (GO:0051155)	38	0	1.94	-	 < 0.01	1.43E-01
ethylene metabolic process (GO:0009692)	1	0	.05	-	 < 0.01	9.50E-01
molybdopterin cofactor metabolic process (GO:0043545)	6	0	.31	-	 < 0.01	7.36E-01
corticosterone secretion (GO:0035934)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of smooth muscle cell differentiation (GO:0051152)	12	0	.61	-	 < 0.01	5.42E-01
glucocorticoid secretion (GO:0035933)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of smooth muscle cell differentiation (GO:0051151)	16	0	.82	-	 < 0.01	4.41E-01
aldosterone secretion (GO:0035932)	1	0	.05	-	 < 0.01	9.50E-01
activation of protein kinase C activity (GO:1990051)	5	0	.26	-	 < 0.01	7.75E-01
mineralocorticoid secretion (GO:0035931)	1	0	.05	-	 < 0.01	9.50E-01
membrane raft organization (GO:0031579)	22	0	1.12	-	 < 0.01	3.25E-01
corticosteroid hormone secretion (GO:0035930)	3	0	.15	-	 < 0.01	8.58E-01
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of clathrin coat assembly (GO:1905445)	1	0	.05	-	 < 0.01	9.50E-01
regulation of clathrin coat assembly (GO:1905443)	1	0	.05	-	 < 0.01	9.50E-01
retrograde neuronal dense core vesicle transport (GO:1990049)	5	0	.26	-	 < 0.01	7.75E-01
steroid hormone secretion (GO:0035929)	5	0	.26	-	 < 0.01	7.75E-01
regulation of actin phosphorylation (GO:0043538)	1	0	.05	-	 < 0.01	9.50E-01
anterograde neuronal dense core vesicle transport (GO:1990048)	5	0	.26	-	 < 0.01	7.75E-01
rRNA import into mitochondrion (GO:0035928)	3	0	.15	-	 < 0.01	8.58E-01
benzylpenicillin metabolic process (GO:1901086)	1	0	.05	-	 < 0.01	9.50E-01
RNA import into mitochondrion (GO:0035927)	5	0	.26	-	 < 0.01	7.75E-01
stress-induced mitochondrial fusion (GO:1990046)	2	0	.10	-	 < 0.01	9.03E-01
induced systemic resistance (GO:0009682)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to lipid droplet (GO:1990044)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of NK T cell proliferation (GO:0051142)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of relaxation of smooth muscle (GO:1901082)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of NK T cell proliferation (GO:0051141)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.05	-	 < 0.01	9.50E-01
foramen ovale closure (GO:0035922)	2	0	.10	-	 < 0.01	9.03E-01
regulation of NK T cell proliferation (GO:0051140)	5	0	.26	-	 < 0.01	7.75E-01
regulation of relaxation of smooth muscle (GO:1901080)	2	0	.10	-	 < 0.01	9.03E-01
desmosome disassembly (GO:0035921)	1	0	.05	-	 < 0.01	9.50E-01
non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of histone H3-K4 trimethylation (GO:1905437)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone H3-K4 trimethylation (GO:1905435)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	0	.05	-	 < 0.01	9.50E-01
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of relaxation of muscle (GO:1901079)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to glycine (GO:1905430)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of relaxation of muscle (GO:1901078)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of engulfment of apoptotic cell (GO:1901076)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of NK T cell activation (GO:0051135)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of NK T cell activation (GO:0051134)	2	0	.10	-	 < 0.01	9.03E-01
regulation of engulfment of apoptotic cell (GO:1901074)	3	0	.15	-	 < 0.01	8.58E-01
pore formation in membrane of other organism (GO:0035915)	2	0	.10	-	 < 0.01	9.03E-01
regulation of NK T cell activation (GO:0051133)	9	0	.46	-	 < 0.01	6.31E-01
glucosamine-containing compound biosynthetic process (GO:1901073)	2	0	.10	-	 < 0.01	9.03E-01
calcium ion export across plasma membrane (GO:1990034)	5	0	.26	-	 < 0.01	7.75E-01
NK T cell activation (GO:0051132)	2	0	.10	-	 < 0.01	9.03E-01
glucosamine-containing compound catabolic process (GO:1901072)	9	0	.46	-	 < 0.01	6.31E-01
guanosine-containing compound biosynthetic process (GO:1901070)	10	0	.51	-	 < 0.01	6.00E-01
ascending aorta morphogenesis (GO:0035910)	4	0	.20	-	 < 0.01	8.15E-01
regulation of DNA-templated transcription, termination (GO:0031554)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	2	0	.10	-	 < 0.01	9.03E-01
response to glycine (GO:1905429)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	2	0	.10	-	 < 0.01	9.03E-01
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	2	0	.10	-	 < 0.01	9.03E-01
guanosine-containing compound catabolic process (GO:1901069)	2	0	.10	-	 < 0.01	9.03E-01
regulation of myosin II filament organization (GO:0043519)	1	0	.05	-	 < 0.01	9.50E-01
vasomotion (GO:1990029)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of actin nucleation (GO:0051126)	8	0	.41	-	 < 0.01	6.65E-01
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	30	0	1.53	-	 < 0.01	2.16E-01
descending aorta development (GO:0035906)	1	0	.05	-	 < 0.01	9.50E-01
ascending aorta development (GO:0035905)	5	0	.26	-	 < 0.01	7.75E-01
RNA polymerase II preinitiation complex assembly (GO:0051123)	10	0	.51	-	 < 0.01	6.00E-01
hepoxilin biosynthetic process (GO:0051122)	8	0	.41	-	 < 0.01	6.65E-01
hepoxilin metabolic process (GO:0051121)	8	0	.41	-	 < 0.01	6.65E-01
response to immobilization stress (GO:0035902)	29	0	1.48	-	 < 0.01	2.27E-01
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	1	0	.05	-	 < 0.01	9.50E-01
response to isolation stress (GO:0035900)	8	0	.41	-	 < 0.01	6.65E-01
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	3	0	.15	-	 < 0.01	8.58E-01
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of dense core granule exocytosis (GO:1905415)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of dense core granule exocytosis (GO:1905414)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dense core granule exocytosis (GO:1905413)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of JUN kinase activity (GO:0043508)	13	0	.66	-	 < 0.01	5.15E-01
response to salt stress (GO:0009651)	22	0	1.12	-	 < 0.01	3.25E-01
mitochondrial DNA repair (GO:0043504)	5	0	.26	-	 < 0.01	7.75E-01
sarcosine catabolic process (GO:1901053)	1	0	.05	-	 < 0.01	9.50E-01
UV protection (GO:0009650)	12	0	.61	-	 < 0.01	5.42E-01
skeletal muscle fiber adaptation (GO:0043503)	4	0	.20	-	 < 0.01	8.15E-01
sarcosine metabolic process (GO:1901052)	2	0	.10	-	 < 0.01	9.03E-01
skeletal muscle adaptation (GO:0043501)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of exit from mitosis (GO:0031536)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.10	-	 < 0.01	9.03E-01
regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mitotic cohesin loading (GO:1905406)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mitotic cohesin loading (GO:1905405)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	1	0	.05	-	 < 0.01	9.50E-01
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	2	0	.10	-	 < 0.01	9.03E-01
retinal cell apoptotic process (GO:1990009)	4	0	.20	-	 < 0.01	8.15E-01
response to high light intensity (GO:0009644)	2	0	.10	-	 < 0.01	9.03E-01
DNA ligation involved in DNA repair (GO:0051103)	9	0	.46	-	 < 0.01	6.31E-01
DNA ligation involved in DNA recombination (GO:0051102)	1	0	.05	-	 < 0.01	9.50E-01
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	6	0	.31	-	 < 0.01	7.36E-01
cold acclimation (GO:0009631)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of response to reactive oxygen species (GO:1901033)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of response to reactive oxygen species (GO:1901032)	17	0	.87	-	 < 0.01	4.19E-01
regulation of response to reactive oxygen species (GO:1901031)	30	0	1.53	-	 < 0.01	2.16E-01
response to gravity (GO:0009629)	9	0	.46	-	 < 0.01	6.31E-01
renal sodium ion absorption (GO:0070294)	5	0	.26	-	 < 0.01	7.75E-01
response to nematode (GO:0009624)	3	0	.15	-	 < 0.01	8.58E-01
ripoptosome assembly involved in necroptotic process (GO:1901026)	2	0	.10	-	 < 0.01	9.03E-01
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	7	0	.36	-	 < 0.01	6.99E-01
response to fungus (GO:0009620)	54	0	2.76	-	 < 0.01	6.31E-02
cell wall glycoprotein biosynthetic process (GO:0031506)	1	0	.05	-	 < 0.01	9.50E-01
axonemal dynein complex assembly (GO:0070286)	28	0	1.43	-	 < 0.01	2.39E-01
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	21	0	1.07	-	 < 0.01	3.42E-01
intermediate mesodermal cell differentiation (GO:0048392)	1	0	.05	-	 < 0.01	9.50E-01
intermediate mesoderm formation (GO:0048391)	1	0	.05	-	 < 0.01	9.50E-01
intermediate mesoderm morphogenesis (GO:0048390)	1	0	.05	-	 < 0.01	9.50E-01
response to symbiotic bacterium (GO:0009609)	5	0	.26	-	 < 0.01	7.75E-01
extracellular matrix constituent secretion (GO:0070278)	3	0	.15	-	 < 0.01	8.58E-01
response to symbiont (GO:0009608)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	21	0	1.07	-	 < 0.01	3.42E-01
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.05	-	 < 0.01	9.50E-01
ubiquinone-6 metabolic process (GO:1901004)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of fermentation (GO:1901003)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.05	-	 < 0.01	9.50E-01
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to salt stress (GO:1901000)	3	0	.15	-	 < 0.01	8.58E-01
intermediate mesoderm development (GO:0048389)	2	0	.10	-	 < 0.01	9.03E-01
endosomal lumen acidification (GO:0048388)	4	0	.20	-	 < 0.01	8.15E-01
mesendoderm development (GO:0048382)	4	0	.20	-	 < 0.01	8.15E-01
cornification (GO:0070268)	99	0	5.06	-	 < 0.01	6.27E-03
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.05	-	 < 0.01	9.50E-01
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.05	-	 < 0.01	9.50E-01
glycine import into mitochondrion (GO:1904983)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of defense response to virus by host (GO:0050689)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of endosome organization (GO:1904980)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of defense response to virus (GO:0050687)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of lateral mesodermal cell fate specification (GO:0048378)	2	0	.10	-	 < 0.01	9.03E-01
lateral mesodermal cell differentiation (GO:0048371)	1	0	.05	-	 < 0.01	9.50E-01
lateral mesoderm formation (GO:0048370)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mucus secretion (GO:0070257)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of mucus secretion (GO:0070256)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mucus secretion (GO:0070255)	9	0	.46	-	 < 0.01	6.31E-01
mucus secretion (GO:0070254)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to bleomycin (GO:1904976)	2	0	.10	-	 < 0.01	9.03E-01
somatostatin secretion (GO:0070253)	2	0	.10	-	 < 0.01	9.03E-01
response to bleomycin (GO:1904975)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of viral translation (GO:1904973)	1	0	.05	-	 < 0.01	9.50E-01
regulation of viral translation (GO:1904971)	1	0	.05	-	 < 0.01	9.50E-01
brush border assembly (GO:1904970)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of urothelial cell proliferation (GO:0050677)	1	0	.05	-	 < 0.01	9.50E-01
regulation of urothelial cell proliferation (GO:0050675)	1	0	.05	-	 < 0.01	9.50E-01
urothelial cell proliferation (GO:0050674)	1	0	.05	-	 < 0.01	9.50E-01
lateral mesoderm morphogenesis (GO:0048369)	2	0	.10	-	 < 0.01	9.03E-01
lateral mesoderm development (GO:0048368)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.05	-	 < 0.01	9.50E-01
regulation of natural killer cell apoptotic process (GO:0070247)	1	0	.05	-	 < 0.01	9.50E-01
regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of thymocyte apoptotic process (GO:0070245)	6	0	.31	-	 < 0.01	7.36E-01
thymocyte apoptotic process (GO:0070242)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of activated T cell autonomous cell death (GO:0070241)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cytochrome-c oxidase activity (GO:1904960)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of homocysteine metabolic process (GO:0050668)	1	0	.05	-	 < 0.01	9.50E-01
regulation of homocysteine metabolic process (GO:0050666)	2	0	.10	-	 < 0.01	9.03E-01
hydrogen peroxide biosynthetic process (GO:0050665)	10	0	.51	-	 < 0.01	6.00E-01
paraxial mesoderm structural organization (GO:0048352)	1	0	.05	-	 < 0.01	9.50E-01
pre-replicative complex assembly (GO:0036388)	7	0	.36	-	 < 0.01	6.99E-01
regulation of activated T cell autonomous cell death (GO:0070239)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytochrome-c oxidase activity (GO:1904959)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of activation-induced cell death of T cells (GO:0070236)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of T cell apoptotic process (GO:0070234)	14	0	.72	-	 < 0.01	4.89E-01
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	5	0	.26	-	 < 0.01	7.75E-01
planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation (GO:1904955)	1	0	.05	-	 < 0.01	9.50E-01
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954)	4	0	.20	-	 < 0.01	8.15E-01
T cell apoptotic process (GO:0070231)	17	0	.87	-	 < 0.01	4.19E-01
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953)	10	0	.51	-	 < 0.01	6.00E-01
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	2	0	.10	-	 < 0.01	9.03E-01
dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652)	1	0	.05	-	 < 0.01	9.50E-01
paraxial mesodermal cell fate commitment (GO:0048343)	2	0	.10	-	 < 0.01	9.03E-01
paraxial mesodermal cell differentiation (GO:0048342)	2	0	.10	-	 < 0.01	9.03E-01
paraxial mesoderm formation (GO:0048341)	8	0	.41	-	 < 0.01	6.65E-01
paraxial mesoderm morphogenesis (GO:0048340)	11	0	.56	-	 < 0.01	5.70E-01
cell adhesion involved in sprouting angiogenesis (GO:0120078)	1	0	.05	-	 < 0.01	9.50E-01
calcitriol biosynthetic process from calciol (GO:0036378)	4	0	.20	-	 < 0.01	8.15E-01
angiogenic sprout fusion (GO:0120077)	1	0	.05	-	 < 0.01	9.50E-01
sodium ion export across plasma membrane (GO:0036376)	14	0	.72	-	 < 0.01	4.89E-01
calcium export from the mitochondrion (GO:0099093)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	0	.05	-	 < 0.01	9.50E-01
midbrain dopaminergic neuron differentiation (GO:1904948)	12	0	.61	-	 < 0.01	5.42E-01
opsin transport (GO:0036372)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	0	.05	-	 < 0.01	9.50E-01
folate import into mitochondrion (GO:1904947)	1	0	.05	-	 < 0.01	9.50E-01
sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	4	0	.20	-	 < 0.01	8.15E-01
mesoderm structural organization (GO:0048338)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mesodermal cell fate specification (GO:0048337)	1	0	.05	-	 < 0.01	9.50E-01
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089)	1	0	.05	-	 < 0.01	9.50E-01
transcription factor catabolic process (GO:0036369)	2	0	.10	-	 < 0.01	9.03E-01
retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099083)	1	0	.05	-	 < 0.01	9.50E-01
retrograde trans-synaptic signaling by neuropeptide (GO:0099082)	1	0	.05	-	 < 0.01	9.50E-01
transforming growth factor beta activation (GO:0036363)	1	0	.05	-	 < 0.01	9.50E-01
planar cell polarity pathway involved in axon guidance (GO:1904938)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of gastric emptying (GO:0120061)	1	0	.05	-	 < 0.01	9.50E-01
regulation of gastric emptying (GO:0120060)	1	0	.05	-	 < 0.01	9.50E-01
interneuron migration (GO:1904936)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of cell proliferation in midbrain (GO:1904935)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell proliferation in midbrain (GO:1904934)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell proliferation in midbrain (GO:1904933)	2	0	.10	-	 < 0.01	9.03E-01
axial mesodermal cell fate specification (GO:0048327)	1	0	.05	-	 < 0.01	9.50E-01
axial mesodermal cell fate commitment (GO:0048322)	1	0	.05	-	 < 0.01	9.50E-01
axial mesodermal cell differentiation (GO:0048321)	1	0	.05	-	 < 0.01	9.50E-01
axial mesoderm formation (GO:0048320)	2	0	.10	-	 < 0.01	9.03E-01
renal potassium excretion (GO:0036359)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of small intestinal transit (GO:0120058)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrion-derived vesicle mediated transport (GO:0099075)	2	0	.10	-	 < 0.01	9.03E-01
regulation of small intestinal transit (GO:0120057)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrion to lysosome transport (GO:0099074)	2	0	.10	-	 < 0.01	9.03E-01
protein heterotrimerization (GO:0070208)	1	0	.05	-	 < 0.01	9.50E-01
histone H2A-K15 ubiquitination (GO:0036352)	1	0	.05	-	 < 0.01	9.50E-01
histone H2A-K13 ubiquitination (GO:0036351)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924)	1	0	.05	-	 < 0.01	9.50E-01
establishment of protein localization to telomere (GO:0070200)	7	0	.36	-	 < 0.01	6.99E-01
axial mesoderm morphogenesis (GO:0048319)	3	0	.15	-	 < 0.01	8.58E-01
axial mesoderm development (GO:0048318)	6	0	.31	-	 < 0.01	7.36E-01
Golgi inheritance (GO:0048313)	10	0	.51	-	 < 0.01	6.00E-01
snRNA (adenine-N6)-methylation (GO:0120049)	1	0	.05	-	 < 0.01	9.50E-01
stereocilium maintenance (GO:0120045)	1	0	.05	-	 < 0.01	9.50E-01
platelet maturation (GO:0036345)	1	0	.05	-	 < 0.01	9.50E-01
psychomotor behavior (GO:0036343)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of macrophage proliferation (GO:0120042)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage proliferation (GO:0120041)	5	0	.26	-	 < 0.01	7.75E-01
regulation of macrophage proliferation (GO:0120040)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of establishment of protein-containing complex localization to telomere (GO:1904914)	1	0	.05	-	 < 0.01	9.50E-01
regulation of establishment of protein-containing complex localization to telomere (GO:1904913)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.05	-	 < 0.01	9.50E-01
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.05	-	 < 0.01	9.50E-01
organelle inheritance (GO:0048308)	10	0	.51	-	 < 0.01	6.00E-01
immunoglobulin secretion (GO:0048305)	4	0	.20	-	 < 0.01	8.15E-01
Fas signaling pathway (GO:0036337)	2	0	.10	-	 < 0.01	9.03E-01
epidermal stem cell homeostasis (GO:0036334)	1	0	.05	-	 < 0.01	9.50E-01
hepatocyte homeostasis (GO:0036333)	1	0	.05	-	 < 0.01	9.50E-01
vesicle scission (GO:0099050)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.10	-	 < 0.01	9.03E-01
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.10	-	 < 0.01	9.03E-01
avascular cornea development in camera-type eye (GO:0036331)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	6	0	.31	-	 < 0.01	7.36E-01
ESCRT III complex assembly (GO:1904902)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of purine nucleotide metabolic process (GO:1900544)	44	0	2.25	-	 < 0.01	1.05E-01
clearance of foreign intracellular nucleic acids (GO:0099046)	1	0	.05	-	 < 0.01	9.50E-01
vesicle tethering to endoplasmic reticulum (GO:0099044)	2	0	.10	-	 < 0.01	9.03E-01
vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325)	1	0	.05	-	 < 0.01	9.50E-01
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	5	0	.26	-	 < 0.01	7.75E-01
vesicle tethering to Golgi (GO:0099041)	5	0	.26	-	 < 0.01	7.75E-01
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	1	0	.05	-	 < 0.01	9.50E-01
ceramide translocation (GO:0099040)	2	0	.10	-	 < 0.01	9.03E-01
ghrelin secretion (GO:0036321)	1	0	.05	-	 < 0.01	9.50E-01
palmitic acid biosynthetic process (GO:1900535)	1	0	.05	-	 < 0.01	9.50E-01
palmitic acid metabolic process (GO:1900533)	1	0	.05	-	 < 0.01	9.50E-01
sphingolipid translocation (GO:0099039)	4	0	.20	-	 < 0.01	8.15E-01
protein localization to M-band (GO:0036309)	1	0	.05	-	 < 0.01	9.50E-01
embryonic heart tube elongation (GO:0036306)	1	0	.05	-	 < 0.01	9.50E-01
ameloblast differentiation (GO:0036305)	1	0	.05	-	 < 0.01	9.50E-01
vesicle tethering (GO:0099022)	8	0	.41	-	 < 0.01	6.65E-01
umbilical cord morphogenesis (GO:0036304)	2	0	.10	-	 < 0.01	9.03E-01
atrioventricular canal development (GO:0036302)	7	0	.36	-	 < 0.01	6.99E-01
mRNA 5'-splice site recognition (GO:0000395)	3	0	.15	-	 < 0.01	8.58E-01
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.26	-	 < 0.01	7.75E-01
neuronal dense core vesicle exocytosis (GO:0099011)	4	0	.20	-	 < 0.01	8.15E-01
modification of postsynaptic structure (GO:0099010)	5	0	.26	-	 < 0.01	7.75E-01
modulation by symbiont of host autophagy (GO:0075071)	6	0	.31	-	 < 0.01	7.36E-01
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.05	-	 < 0.01	9.50E-01
calmodulin dependent kinase signaling pathway (GO:0099004)	4	0	.20	-	 < 0.01	8.15E-01
RNA exon ligation (GO:0000378)	1	0	.05	-	 < 0.01	9.50E-01
parathyroid hormone secretion (GO:0035898)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation by symbiont of host autophagy (GO:0075044)	6	0	.31	-	 < 0.01	7.36E-01
cis assembly of pre-catalytic spliceosome (GO:0000354)	2	0	.10	-	 < 0.01	9.03E-01
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein heterodimerization activity (GO:0043497)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein homodimerization activity (GO:0043496)	2	0	.10	-	 < 0.01	9.03E-01
enteroendocrine cell differentiation (GO:0035883)	20	0	1.02	-	 < 0.01	3.60E-01
amacrine cell differentiation (GO:0035881)	5	0	.26	-	 < 0.01	7.75E-01
embryonic nail plate morphogenesis (GO:0035880)	3	0	.15	-	 < 0.01	8.58E-01
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to flavonoid (GO:1905396)	1	0	.05	-	 < 0.01	9.50E-01
response to flavonoid (GO:1905395)	3	0	.15	-	 < 0.01	8.58E-01
learned vocalization behavior or vocal learning (GO:0098598)	8	0	.41	-	 < 0.01	6.65E-01
observational learning (GO:0098597)	8	0	.41	-	 < 0.01	6.65E-01
plasma membrane lactate transport (GO:0035879)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of helicase activity (GO:0051097)	5	0	.26	-	 < 0.01	7.75E-01
imitative learning (GO:0098596)	7	0	.36	-	 < 0.01	6.99E-01
nail development (GO:0035878)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of helicase activity (GO:0051096)	5	0	.26	-	 < 0.01	7.75E-01
regulation of helicase activity (GO:0051095)	10	0	.51	-	 < 0.01	6.00E-01
endosome to pigment granule transport (GO:0043485)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to copper ion starvation (GO:0035874)	1	0	.05	-	 < 0.01	9.50E-01
lactate transmembrane transport (GO:0035873)	7	0	.36	-	 < 0.01	6.99E-01
cellular pigment accumulation (GO:0043482)	11	0	.56	-	 < 0.01	5.70E-01
protein K11-linked deubiquitination (GO:0035871)	10	0	.51	-	 < 0.01	6.00E-01
protein deneddylation (GO:0000338)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of protein localization to presynapse (GO:1905386)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein localization to presynapse (GO:1905384)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.05	-	 < 0.01	9.50E-01
constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.05	-	 < 0.01	9.50E-01
chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.05	-	 < 0.01	9.50E-01
pigment accumulation (GO:0043476)	11	0	.56	-	 < 0.01	5.70E-01
learned vocalization behavior (GO:0098583)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to potassium ion (GO:0035865)	11	0	.56	-	 < 0.01	5.70E-01
innate vocalization behavior (GO:0098582)	1	0	.05	-	 < 0.01	9.50E-01
detection of external biotic stimulus (GO:0098581)	22	0	1.12	-	 < 0.01	3.25E-01
response to potassium ion (GO:0035864)	15	0	.77	-	 < 0.01	4.65E-01
nuclear envelope disassembly (GO:0051081)	15	0	.77	-	 < 0.01	4.65E-01
dITP catabolic process (GO:0035863)	1	0	.05	-	 < 0.01	9.50E-01
dITP metabolic process (GO:0035862)	1	0	.05	-	 < 0.01	9.50E-01
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	9	0	.46	-	 < 0.01	6.31E-01
ceramide phosphoethanolamine biosynthetic process (GO:1905373)	2	0	.10	-	 < 0.01	9.03E-01
ceramide phosphoethanolamine metabolic process (GO:1905371)	2	0	.10	-	 < 0.01	9.03E-01
re-entry into mitotic cell cycle (GO:0000320)	3	0	.15	-	 < 0.01	8.58E-01
regulation of fermentation (GO:0043465)	5	0	.26	-	 < 0.01	7.75E-01
eosinophil fate commitment (GO:0035854)	2	0	.10	-	 < 0.01	9.03E-01
chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.05	-	 < 0.01	9.50E-01
proton-transporting ATP synthase complex assembly (GO:0043461)	6	0	.31	-	 < 0.01	7.36E-01
horizontal cell localization (GO:0035852)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mating type switching (GO:0031494)	2	0	.10	-	 < 0.01	9.03E-01
regulation of endosomal vesicle fusion (GO:1905364)	1	0	.05	-	 < 0.01	9.50E-01
nephric duct elongation (GO:0035849)	1	0	.05	-	 < 0.01	9.50E-01
dihydrobiopterin metabolic process (GO:0051066)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cellular respiration (GO:0043457)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of pentose-phosphate shunt (GO:0043456)	3	0	.15	-	 < 0.01	8.58E-01
uterine epithelium development (GO:0035847)	1	0	.05	-	 < 0.01	9.50E-01
regulation of secondary metabolic process (GO:0043455)	11	0	.56	-	 < 0.01	5.70E-01
oviduct epithelium development (GO:0035846)	1	0	.05	-	 < 0.01	9.50E-01
photoreceptor cell outer segment organization (GO:0035845)	13	0	.66	-	 < 0.01	5.15E-01
protein localization to meiotic spindle (GO:1905359)	1	0	.05	-	 < 0.01	9.50E-01
spine apparatus assembly (GO:1905355)	1	0	.05	-	 < 0.01	9.50E-01
response to oxygen radical (GO:0000305)	19	0	.97	-	 < 0.01	3.79E-01
response to singlet oxygen (GO:0000304)	1	0	.05	-	 < 0.01	9.50E-01
response to superoxide (GO:0000303)	18	0	.92	-	 < 0.01	3.99E-01
detection of virus (GO:0009597)	6	0	.31	-	 < 0.01	7.36E-01
cellular alkene metabolic process (GO:0043449)	2	0	.10	-	 < 0.01	9.03E-01
detection of gravity (GO:0009590)	1	0	.05	-	 < 0.01	9.50E-01
ciliary transition zone assembly (GO:1905349)	1	0	.05	-	 < 0.01	9.50E-01
prostaglandin catabolic process (GO:1905344)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein localization to kinetochore (GO:1905342)	3	0	.15	-	 < 0.01	8.58E-01
N-terminal peptidyl-serine acetylation (GO:0017198)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein localization to kinetochore (GO:1905341)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein localization to kinetochore (GO:1905340)	3	0	.15	-	 < 0.01	8.58E-01
N-terminal peptidyl-methionine acetylation (GO:0017196)	7	0	.36	-	 < 0.01	6.99E-01
acetoacetic acid metabolic process (GO:0043438)	1	0	.05	-	 < 0.01	9.50E-01
detection of visible light (GO:0009584)	42	0	2.15	-	 < 0.01	1.17E-01
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	8	0	.41	-	 < 0.01	6.65E-01
detection of other organism (GO:0098543)	19	0	.97	-	 < 0.01	3.79E-01
response to corticotropin-releasing hormone (GO:0043435)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	0	.05	-	 < 0.01	9.50E-01
gene conversion (GO:0035822)	4	0	.20	-	 < 0.01	8.15E-01
nuclear envelope reassembly (GO:0031468)	11	0	.56	-	 < 0.01	5.70E-01
glycine betaine transport (GO:0031460)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of aggrephagy (GO:1905337)	3	0	.15	-	 < 0.01	8.58E-01
regulation of aggrephagy (GO:1905335)	3	0	.15	-	 < 0.01	8.58E-01
regulation of gastric motility (GO:1905333)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of morphogenesis of an epithelium (GO:1905331)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-lysine hydroxylation (GO:0017185)	7	0	.36	-	 < 0.01	6.99E-01
regulation of transcription involved in meiotic cell cycle (GO:0051037)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	6	0	.31	-	 < 0.01	7.36E-01
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	5	0	.26	-	 < 0.01	7.75E-01
peptidyl-diphthamide metabolic process (GO:0017182)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of renal sodium excretion (GO:0035815)	12	0	.61	-	 < 0.01	5.42E-01
histone H3-K27 trimethylation (GO:0098532)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of renal sodium excretion (GO:0035814)	4	0	.20	-	 < 0.01	8.15E-01
regulation of renal sodium excretion (GO:0035813)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of strand invasion (GO:0098530)	1	0	.05	-	 < 0.01	9.50E-01
snRNA transport (GO:0051030)	4	0	.20	-	 < 0.01	8.15E-01
renal sodium excretion (GO:0035812)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of urine volume (GO:0035811)	5	0	.26	-	 < 0.01	7.75E-01
anthranilate metabolic process (GO:0043420)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of urine volume (GO:0035810)	11	0	.56	-	 < 0.01	5.70E-01
glycine betaine biosynthetic process (GO:0031456)	2	0	.10	-	 < 0.01	9.03E-01
glycine betaine metabolic process (GO:0031455)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of heterochromatin assembly (GO:0031453)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of heterochromatin assembly (GO:0031452)	5	0	.26	-	 < 0.01	7.75E-01
tracheoesophageal septum formation (GO:1905327)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mesenchymal stem cell migration (GO:1905322)	3	0	.15	-	 < 0.01	8.58E-01
skeletal muscle fiber differentiation (GO:0098528)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mesenchymal stem cell migration (GO:1905320)	3	0	.15	-	 < 0.01	8.58E-01
regulation of urine volume (GO:0035809)	20	0	1.02	-	 < 0.01	3.60E-01
chiasma assembly (GO:0051026)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of skeletal muscle tissue regeneration (GO:0043417)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of immunoglobulin secretion (GO:0051025)	3	0	.15	-	 < 0.01	8.58E-01
egg coat formation (GO:0035803)	2	0	.10	-	 < 0.01	9.03E-01
adrenal cortex formation (GO:0035802)	2	0	.10	-	 < 0.01	9.03E-01
adrenal cortex development (GO:0035801)	3	0	.15	-	 < 0.01	8.58E-01
regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	2	0	.10	-	 < 0.01	9.03E-01
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	2	0	.10	-	 < 0.01	9.03E-01
regulation of heterochromatin assembly (GO:0031445)	19	0	.97	-	 < 0.01	3.79E-01
slow-twitch skeletal muscle fiber contraction (GO:0031444)	1	0	.05	-	 < 0.01	9.50E-01
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mRNA 3'-end processing (GO:0031442)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of mRNA 3'-end processing (GO:0031441)	9	0	.46	-	 < 0.01	6.31E-01
regulation of mRNA 3'-end processing (GO:0031440)	27	0	1.38	-	 < 0.01	2.52E-01
inferior endocardial cushion morphogenesis (GO:1905317)	1	0	.05	-	 < 0.01	9.50E-01
transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.15	-	 < 0.01	8.58E-01
microtubule severing (GO:0051013)	11	0	.56	-	 < 0.01	5.70E-01
glucocorticoid mediated signaling pathway (GO:0043402)	1	0	.05	-	 < 0.01	9.50E-01
cortisol secretion (GO:0043400)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mRNA cleavage (GO:0031439)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mRNA cleavage (GO:0031437)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cohesin loading (GO:1905309)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macropinocytosis (GO:1905303)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of macropinocytosis (GO:1905302)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macropinocytosis (GO:1905301)	3	0	.15	-	 < 0.01	8.58E-01
endothelial to hematopoietic transition (GO:0098508)	2	0	.10	-	 < 0.01	9.03E-01
polynucleotide 5' dephosphorylation (GO:0098507)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of lipoprotein lipase activity (GO:0051005)	6	0	.31	-	 < 0.01	7.36E-01
DNA dephosphorylation (GO:0098502)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of nitric-oxide synthase activity (GO:0051001)	7	0	.36	-	 < 0.01	6.99E-01
response to methotrexate (GO:0031427)	4	0	.20	-	 < 0.01	8.15E-01
establishment of protein localization to chromosome (GO:0070199)	11	0	.56	-	 < 0.01	5.70E-01
meiotic attachment of telomere to nuclear envelope (GO:0070197)	3	0	.15	-	 < 0.01	8.58E-01
synaptonemal complex disassembly (GO:0070194)	2	0	.10	-	 < 0.01	9.03E-01
synaptonemal complex organization (GO:0070193)	21	0	1.07	-	 < 0.01	3.42E-01
oxylipin biosynthetic process (GO:0031408)	3	0	.15	-	 < 0.01	8.58E-01
oxylipin metabolic process (GO:0031407)	4	0	.20	-	 < 0.01	8.15E-01
kynurenine metabolic process (GO:0070189)	11	0	.56	-	 < 0.01	5.70E-01
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	0	.20	-	 < 0.01	8.15E-01
isotype switching to IgA isotypes (GO:0048290)	1	0	.05	-	 < 0.01	9.50E-01
D-serine biosynthetic process (GO:0070179)	1	0	.05	-	 < 0.01	9.50E-01
D-serine metabolic process (GO:0070178)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of enamel mineralization (GO:0070175)	2	0	.10	-	 < 0.01	9.03E-01
regulation of enamel mineralization (GO:0070173)	4	0	.20	-	 < 0.01	8.15E-01
ESCRT complex assembly (GO:1904895)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of tooth mineralization (GO:0070172)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of tooth mineralization (GO:0070171)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tooth mineralization (GO:0070170)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of excitatory synapse assembly (GO:1904891)	2	0	.10	-	 < 0.01	9.03E-01
sequestering of actin monomers (GO:0042989)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	6	0	.31	-	 < 0.01	7.36E-01
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	13	0	.66	-	 < 0.01	5.15E-01
amyloid precursor protein biosynthetic process (GO:0042983)	1	0	.05	-	 < 0.01	9.50E-01
regulation of excitatory synapse assembly (GO:1904889)	11	0	.56	-	 < 0.01	5.70E-01
Wnt signalosome assembly (GO:1904887)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of adiponectin secretion (GO:0070165)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of adiponectin secretion (GO:0070164)	4	0	.20	-	 < 0.01	8.15E-01
regulation of adiponectin secretion (GO:0070163)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.10	-	 < 0.01	9.03E-01
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to hydrogen sulfide (GO:1904881)	2	0	.10	-	 < 0.01	9.03E-01
response to hydrogen sulfide (GO:1904880)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial threonyl-tRNA aminoacylation (GO:0070159)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of DNA ligase activity (GO:1904877)	1	0	.05	-	 < 0.01	9.50E-01
regulation of DNA ligase activity (GO:1904875)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.05	-	 < 0.01	9.50E-01
lactone transport (GO:0042969)	1	0	.05	-	 < 0.01	9.50E-01
clathrin coat assembly (GO:0048268)	13	0	.66	-	 < 0.01	5.15E-01
behavioral response to pain (GO:0048266)	14	0	.72	-	 < 0.01	4.89E-01
response to pain (GO:0048265)	28	0	1.43	-	 < 0.01	2.39E-01
determination of ventral identity (GO:0048264)	1	0	.05	-	 < 0.01	9.50E-01
determination of dorsal identity (GO:0048263)	5	0	.26	-	 < 0.01	7.75E-01
regulation of centriole-centriole cohesion (GO:0030997)	3	0	.15	-	 < 0.01	8.58E-01
determination of dorsal/ventral asymmetry (GO:0048262)	6	0	.31	-	 < 0.01	7.36E-01
recombinational interstrand cross-link repair (GO:0036298)	2	0	.10	-	 < 0.01	9.03E-01
DNA rewinding (GO:0036292)	2	0	.10	-	 < 0.01	9.03E-01
protein trans-autophosphorylation (GO:0036290)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	2	0	.10	-	 < 0.01	9.03E-01
synaptic vesicle budding (GO:0070142)	9	0	.46	-	 < 0.01	6.31E-01
regulation of beta-catenin-TCF complex assembly (GO:1904863)	2	0	.10	-	 < 0.01	9.03E-01
response to UV-A (GO:0070141)	12	0	.61	-	 < 0.01	5.42E-01
inhibitory synapse assembly (GO:1904862)	12	0	.61	-	 < 0.01	5.42E-01
lipoprotein transport (GO:0042953)	14	0	.72	-	 < 0.01	4.89E-01
snoRNA localization (GO:0048254)	4	0	.20	-	 < 0.01	8.15E-01
lauric acid metabolic process (GO:0048252)	1	0	.05	-	 < 0.01	9.50E-01
elastic fiber assembly (GO:0048251)	8	0	.41	-	 < 0.01	6.65E-01
iron import into the mitochondrion (GO:0048250)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-serine autophosphorylation (GO:0036289)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of mitochondrial translation (GO:0070130)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.05	-	 < 0.01	9.50E-01
glucoside transport (GO:0042946)	2	0	.10	-	 < 0.01	9.03E-01
lymphocyte chemotaxis (GO:0048247)	40	0	2.04	-	 < 0.01	1.29E-01
D-alanine transport (GO:0042941)	1	0	.05	-	 < 0.01	9.50E-01
macrophage chemotaxis (GO:0048246)	13	0	.66	-	 < 0.01	5.15E-01
eosinophil chemotaxis (GO:0048245)	15	0	.77	-	 < 0.01	4.65E-01
norepinephrine secretion (GO:0048243)	1	0	.05	-	 < 0.01	9.50E-01
epinephrine secretion (GO:0048242)	1	0	.05	-	 < 0.01	9.50E-01
epinephrine transport (GO:0048241)	4	0	.20	-	 < 0.01	8.15E-01
sperm capacitation (GO:0048240)	21	0	1.07	-	 < 0.01	3.42E-01
thiamine pyrophosphate transmembrane transport (GO:0030974)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	7	0	.36	-	 < 0.01	6.99E-01
mitochondrial translational initiation (GO:0070124)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to L-glutamine (GO:1904845)	3	0	.15	-	 < 0.01	8.58E-01
response to L-glutamine (GO:1904844)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to nitroglycerin (GO:1904843)	1	0	.05	-	 < 0.01	9.50E-01
Kupffer's vesicle development (GO:0070121)	1	0	.05	-	 < 0.01	9.50E-01
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	4	0	.20	-	 < 0.01	8.15E-01
response to nitroglycerin (GO:1904842)	2	0	.10	-	 < 0.01	9.03E-01
tripeptide transport (GO:0042939)	6	0	.31	-	 < 0.01	7.36E-01
dipeptide transport (GO:0042938)	5	0	.26	-	 < 0.01	7.75E-01
regulation of protein targeting to vacuolar membrane (GO:1900483)	1	0	.05	-	 < 0.01	9.50E-01
regulation of diacylglycerol biosynthetic process (GO:1900480)	1	0	.05	-	 < 0.01	9.50E-01
enterobactin transport (GO:0042930)	1	0	.05	-	 < 0.01	9.50E-01
swimming behavior (GO:0036269)	1	0	.05	-	 < 0.01	9.50E-01
swimming (GO:0036268)	1	0	.05	-	 < 0.01	9.50E-01
RNA (guanine-N7)-methylation (GO:0036265)	6	0	.31	-	 < 0.01	7.36E-01
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.05	-	 < 0.01	9.50E-01
RNA capping (GO:0036260)	32	0	1.63	-	 < 0.01	1.95E-01
dorsal root ganglion morphogenesis (GO:1904835)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)	1	0	.05	-	 < 0.01	9.50E-01
plasma membrane to endosome transport (GO:0048227)	8	0	.41	-	 < 0.01	6.65E-01
astral microtubule nucleation (GO:0030954)	1	0	.05	-	 < 0.01	9.50E-01
astral microtubule organization (GO:0030953)	11	0	.56	-	 < 0.01	5.70E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952)	6	0	.31	-	 < 0.01	7.36E-01
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	3	0	.15	-	 < 0.01	8.58E-01
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	3	0	.15	-	 < 0.01	8.58E-01
response to methylamine (GO:0036255)	1	0	.05	-	 < 0.01	9.50E-01
regulation of aortic smooth muscle cell differentiation (GO:1904829)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-27-mediated signaling pathway (GO:0070106)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	4	0	.20	-	 < 0.01	8.15E-01
peroxisome transport along microtubule (GO:0036250)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to microtubule plus-end (GO:1904825)	5	0	.26	-	 < 0.01	7.75E-01
purine nucleobase transmembrane transport (GO:1904823)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	7	0	.36	-	 < 0.01	6.99E-01
inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	1	0	.05	-	 < 0.01	9.50E-01
Golgi vesicle prefusion complex stabilization (GO:0048213)	2	0	.10	-	 < 0.01	9.03E-01
Golgi vesicle docking (GO:0048211)	2	0	.10	-	 < 0.01	9.03E-01
Golgi vesicle fusion to target membrane (GO:0048210)	4	0	.20	-	 < 0.01	8.15E-01
cellular response to menadione (GO:0036245)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	1	0	.05	-	 < 0.01	9.50E-01
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dense core granule transport (GO:1904811)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of long-term synaptic depression (GO:1900454)	6	0	.31	-	 < 0.01	7.36E-01
9-cis-retinoic acid metabolic process (GO:0042905)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of long-term synaptic depression (GO:1900453)	3	0	.15	-	 < 0.01	8.58E-01
9-cis-retinoic acid biosynthetic process (GO:0042904)	4	0	.20	-	 < 0.01	8.15E-01
regulation of long-term synaptic depression (GO:1900452)	14	0	.72	-	 < 0.01	4.89E-01
regulation of vesicle targeting, to, from or within Golgi (GO:0048209)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glutamate receptor signaling pathway (GO:1900451)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dense core granule transport (GO:1904809)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of protein oxidation (GO:1904808)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein oxidation (GO:1904806)	1	0	.05	-	 < 0.01	9.50E-01
regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutamate receptor signaling pathway (GO:1900449)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of neuron remodeling (GO:1904800)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to nuclear inner membrane (GO:0036228)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-serine acetylation (GO:0030920)	1	0	.05	-	 < 0.01	9.50E-01
midbrain-hindbrain boundary development (GO:0030917)	8	0	.41	-	 < 0.01	6.65E-01
otic vesicle formation (GO:0030916)	8	0	.41	-	 < 0.01	6.65E-01
paranodal junction assembly (GO:0030913)	6	0	.31	-	 < 0.01	7.36E-01
olfactory placode formation (GO:0030910)	3	0	.15	-	 < 0.01	8.58E-01
contractile ring contraction (GO:0036213)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of defense response to bacterium (GO:1900426)	8	0	.41	-	 < 0.01	6.65E-01
protein splicing (GO:0030908)	1	0	.05	-	 < 0.01	9.50E-01
notochord development (GO:0030903)	19	0	.97	-	 < 0.01	3.79E-01
spermine transport (GO:0000296)	2	0	.10	-	 < 0.01	9.03E-01
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	2	0	.10	-	 < 0.01	9.03E-01
peptidoglycan metabolic process (GO:0000270)	6	0	.31	-	 < 0.01	7.36E-01
ureter maturation (GO:0035799)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	3	0	.15	-	 < 0.01	8.58E-01
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	1	0	.05	-	 < 0.01	9.50E-01
allantoin catabolic process (GO:0000256)	1	0	.05	-	 < 0.01	9.50E-01
allantoin metabolic process (GO:0000255)	2	0	.10	-	 < 0.01	9.03E-01
metanephric mesenchymal cell migration (GO:0035789)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in metanephros development (GO:0035788)	1	0	.05	-	 < 0.01	9.50E-01
regulation of corticotropin-releasing hormone secretion (GO:0043397)	4	0	.20	-	 < 0.01	8.15E-01
cell migration involved in kidney development (GO:0035787)	1	0	.05	-	 < 0.01	9.50E-01
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	1	0	.05	-	 < 0.01	9.50E-01
mature natural killer cell chemotaxis (GO:0035782)	1	0	.05	-	 < 0.01	9.50E-01
CD86 biosynthetic process (GO:0035781)	2	0	.10	-	 < 0.01	9.03E-01
CD80 biosynthetic process (GO:0035780)	1	0	.05	-	 < 0.01	9.50E-01
spliceosomal tri-snRNP complex assembly (GO:0000244)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of CAMKK-AMPK signaling cascade (GO:1905291)	1	0	.05	-	 < 0.01	9.50E-01
mycotoxin catabolic process (GO:0043387)	2	0	.10	-	 < 0.01	9.03E-01
mycotoxin metabolic process (GO:0043385)	3	0	.15	-	 < 0.01	8.58E-01
negative T cell selection (GO:0043383)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of memory T cell differentiation (GO:0043382)	7	0	.36	-	 < 0.01	6.99E-01
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of memory T cell differentiation (GO:0043381)	2	0	.10	-	 < 0.01	9.03E-01
interleukin-13-mediated signaling pathway (GO:0035772)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-4-mediated signaling pathway (GO:0035771)	4	0	.20	-	 < 0.01	8.15E-01
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	3	0	.15	-	 < 0.01	8.58E-01
fibrous ring of heart morphogenesis (GO:1905285)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of retrograde transport, endosome to Golgi (GO:1905280)	1	0	.05	-	 < 0.01	9.50E-01
memory T cell differentiation (GO:0043379)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)	2	0	.10	-	 < 0.01	9.03E-01
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.05	-	 < 0.01	9.50E-01
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	7	0	.36	-	 < 0.01	6.99E-01
endothelial cell chemotaxis (GO:0035767)	11	0	.56	-	 < 0.01	5.70E-01
cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.05	-	 < 0.01	9.50E-01
CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	2	0	.10	-	 < 0.01	9.03E-01
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	29	0	1.48	-	 < 0.01	2.27E-01
regulation of retrograde transport, endosome to Golgi (GO:1905279)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of epithelial tube formation (GO:1905278)	8	0	.41	-	 < 0.01	6.65E-01
regulation of epithelial tube formation (GO:1905276)	8	0	.41	-	 < 0.01	6.65E-01
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)	1	0	.05	-	 < 0.01	9.50E-01
regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)	1	0	.05	-	 < 0.01	9.50E-01
mesangial cell-matrix adhesion (GO:0035759)	2	0	.10	-	 < 0.01	9.03E-01
beta selection (GO:0043366)	3	0	.15	-	 < 0.01	8.58E-01
B cell chemotaxis (GO:0035754)	6	0	.31	-	 < 0.01	7.36E-01
lysosomal lumen pH elevation (GO:0035752)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.10	-	 < 0.01	9.03E-01
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	2	0	.10	-	 < 0.01	9.03E-01
natural killer cell chemotaxis (GO:0035747)	3	0	.15	-	 < 0.01	8.58E-01
enucleate erythrocyte differentiation (GO:0043353)	7	0	.36	-	 < 0.01	6.99E-01
T-helper 1 cell cytokine production (GO:0035744)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.10	-	 < 0.01	9.03E-01
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.10	-	 < 0.01	9.03E-01
regulation of RNA binding transcription factor activity (GO:1905255)	1	0	.05	-	 < 0.01	9.50E-01
hepatic stellate cell activation (GO:0035733)	2	0	.10	-	 < 0.01	9.03E-01
nitric oxide storage (GO:0035732)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of aspartic-type peptidase activity (GO:1905246)	3	0	.15	-	 < 0.01	8.58E-01
regulation of modification of synaptic structure (GO:1905244)	10	0	.51	-	 < 0.01	6.00E-01
cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	2	0	.10	-	 < 0.01	9.03E-01
response to 3,3',5-triiodo-L-thyronine (GO:1905242)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	1	0	.05	-	 < 0.01	9.50E-01
common myeloid progenitor cell proliferation (GO:0035726)	6	0	.31	-	 < 0.01	7.36E-01
response to exogenous dsRNA (GO:0043330)	40	0	2.04	-	 < 0.01	1.29E-01
intraciliary anterograde transport (GO:0035720)	4	0	.20	-	 < 0.01	8.15E-01
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	1	0	.05	-	 < 0.01	9.50E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of natural killer cell degranulation (GO:0043323)	4	0	.20	-	 < 0.01	8.15E-01
response to nitrogen dioxide (GO:0035713)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of natural killer cell degranulation (GO:0043322)	1	0	.05	-	 < 0.01	9.50E-01
regulation of natural killer cell degranulation (GO:0043321)	4	0	.20	-	 < 0.01	8.15E-01
T-helper 2 cell activation (GO:0035712)	1	0	.05	-	 < 0.01	9.50E-01
natural killer cell degranulation (GO:0043320)	4	0	.20	-	 < 0.01	8.15E-01
T-helper 1 cell activation (GO:0035711)	4	0	.20	-	 < 0.01	8.15E-01
cellular response to thyrotropin-releasing hormone (GO:1905229)	1	0	.05	-	 < 0.01	9.50E-01
regulation of adhesion of symbiont to host epithelial cell (GO:1905226)	1	0	.05	-	 < 0.01	9.50E-01
response to thyrotropin-releasing hormone (GO:1905225)	2	0	.10	-	 < 0.01	9.03E-01
clathrin-coated pit assembly (GO:1905224)	2	0	.10	-	 < 0.01	9.03E-01
epicardium morphogenesis (GO:1905223)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of platelet formation (GO:1905221)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cytotoxic T cell degranulation (GO:0043318)	2	0	.10	-	 < 0.01	9.03E-01
memory T cell activation (GO:0035709)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cytotoxic T cell degranulation (GO:0043317)	2	0	.10	-	 < 0.01	9.03E-01
cytotoxic T cell degranulation (GO:0043316)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neutrophil degranulation (GO:0043315)	4	0	.20	-	 < 0.01	8.15E-01
T-helper 17 cell chemotaxis (GO:0035705)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neutrophil degranulation (GO:0043314)	2	0	.10	-	 < 0.01	9.03E-01
regulation of neutrophil degranulation (GO:0043313)	8	0	.41	-	 < 0.01	6.65E-01
helper T cell chemotaxis (GO:0035704)	1	0	.05	-	 < 0.01	9.50E-01
monocyte homeostasis (GO:0035702)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of eosinophil degranulation (GO:0043310)	1	0	.05	-	 < 0.01	9.50E-01
hematopoietic stem cell migration (GO:0035701)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cell killing (GO:0031343)	68	0	3.47	-	 < 0.01	3.08E-02
positive regulation of vesicle fusion (GO:0031340)	9	0	.46	-	 < 0.01	6.31E-01
regulation of platelet formation (GO:1905219)	1	0	.05	-	 < 0.01	9.50E-01
response to astaxanthin (GO:1905217)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of RNA binding (GO:1905216)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of RNA binding (GO:1905215)	1	0	.05	-	 < 0.01	9.50E-01
regulation of RNA binding (GO:1905214)	9	0	.46	-	 < 0.01	6.31E-01
eosinophil degranulation (GO:0043308)	3	0	.15	-	 < 0.01	8.58E-01
eosinophil activation (GO:0043307)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mast cell degranulation (GO:0043306)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of mast cell degranulation (GO:0043305)	7	0	.36	-	 < 0.01	6.99E-01
7-methylguanosine RNA capping (GO:0009452)	32	0	1.63	-	 < 0.01	1.95E-01
mast cell degranulation (GO:0043303)	16	0	.82	-	 < 0.01	4.41E-01
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of leukocyte degranulation (GO:0043301)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of vesicle fusion (GO:0031339)	5	0	.26	-	 < 0.01	7.75E-01
regulation of vesicle fusion (GO:0031338)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of sulfur amino acid metabolic process (GO:0031337)	1	0	.05	-	 < 0.01	9.50E-01
regulation of sulfur amino acid metabolic process (GO:0031335)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cardiocyte differentiation (GO:1905209)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of connective tissue replacement (GO:1905205)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of connective tissue replacement (GO:1905204)	1	0	.05	-	 < 0.01	9.50E-01
regulation of connective tissue replacement (GO:1905203)	4	0	.20	-	 < 0.01	8.15E-01
gamma-aminobutyric acid biosynthetic process (GO:0009449)	3	0	.15	-	 < 0.01	8.58E-01
gamma-aminobutyric acid metabolic process (GO:0009448)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	2	0	.10	-	 < 0.01	9.03E-01
pyruvate oxidation (GO:0009444)	1	0	.05	-	 < 0.01	9.50E-01
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.05	-	 < 0.01	9.50E-01
glycolate metabolic process (GO:0009441)	3	0	.15	-	 < 0.01	8.58E-01
cyanate catabolic process (GO:0009440)	1	0	.05	-	 < 0.01	9.50E-01
cyanate metabolic process (GO:0009439)	1	0	.05	-	 < 0.01	9.50E-01
methylglyoxal metabolic process (GO:0009438)	6	0	.31	-	 < 0.01	7.36E-01
carnitine metabolic process (GO:0009437)	12	0	.61	-	 < 0.01	5.42E-01
glyoxylate catabolic process (GO:0009436)	2	0	.10	-	 < 0.01	9.03E-01
regulation of chemokine-mediated signaling pathway (GO:0070099)	9	0	.46	-	 < 0.01	6.31E-01
mitochondrial outer membrane translocase complex assembly (GO:0070096)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of glucagon secretion (GO:0070094)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of glucagon secretion (GO:0070093)	4	0	.20	-	 < 0.01	8.15E-01
regulation of glucagon secretion (GO:0070092)	9	0	.46	-	 < 0.01	6.31E-01
glucagon secretion (GO:0070091)	1	0	.05	-	 < 0.01	9.50E-01
ubiquitin-dependent endocytosis (GO:0070086)	3	0	.15	-	 < 0.01	8.58E-01
protein initiator methionine removal (GO:0070084)	2	0	.10	-	 < 0.01	9.03E-01
response to water (GO:0009415)	19	0	.97	-	 < 0.01	3.79E-01
response to water deprivation (GO:0009414)	11	0	.56	-	 < 0.01	5.70E-01
histone H4-R3 demethylation (GO:0070079)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-R2 demethylation (GO:0070078)	1	0	.05	-	 < 0.01	9.50E-01
histone arginine demethylation (GO:0070077)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neuron remodeling (GO:1904799)	1	0	.05	-	 < 0.01	9.50E-01
toxin catabolic process (GO:0009407)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of core promoter binding (GO:1904797)	2	0	.10	-	 < 0.01	9.03E-01
tear secretion (GO:0070075)	2	0	.10	-	 < 0.01	9.03E-01
protein nitrosylation (GO:0017014)	6	0	.31	-	 < 0.01	7.36E-01
pathogenesis (GO:0009405)	1	0	.05	-	 < 0.01	9.50E-01
toxin biosynthetic process (GO:0009403)	1	0	.05	-	 < 0.01	9.50E-01
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	6	0	.31	-	 < 0.01	7.36E-01
proton-transporting two-sector ATPase complex assembly (GO:0070071)	13	0	.66	-	 < 0.01	5.15E-01
regulation of euchromatin binding (GO:1904793)	1	0	.05	-	 < 0.01	9.50E-01
proton-transporting V-type ATPase complex assembly (GO:0070070)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.05	-	 < 0.01	9.50E-01
regulation of shelterin complex assembly (GO:1904790)	1	0	.05	-	 < 0.01	9.50E-01
cysteine transport (GO:0042883)	2	0	.10	-	 < 0.01	9.03E-01
protein-tetrapyrrole linkage (GO:0017006)	1	0	.05	-	 < 0.01	9.50E-01
protein-heme linkage (GO:0017003)	1	0	.05	-	 < 0.01	9.50E-01
NLRP1 inflammasome complex assembly (GO:1904784)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of NMDA glutamate receptor activity (GO:1904783)	7	0	.36	-	 < 0.01	6.99E-01
'de novo' actin filament nucleation (GO:0070060)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of NMDA glutamate receptor activity (GO:1904782)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein localization to centrosome (GO:1904780)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of hepatocyte growth factor biosynthetic process (GO:0048178)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hepatocyte growth factor biosynthetic process (GO:0048176)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	0	.05	-	 < 0.01	9.50E-01
regulation of short-term neuronal synaptic plasticity (GO:0048172)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of protein localization to cell cortex (GO:1904778)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of protein localization to cell cortex (GO:1904777)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein localization to cell cortex (GO:1904776)	8	0	.41	-	 < 0.01	6.65E-01
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.05	-	 < 0.01	9.50E-01
neuron cellular homeostasis (GO:0070050)	28	0	1.43	-	 < 0.01	2.39E-01
response to tetrachloromethane (GO:1904772)	2	0	.10	-	 < 0.01	9.03E-01
antisense RNA metabolic process (GO:0042868)	1	0	.05	-	 < 0.01	9.50E-01
pyruvate biosynthetic process (GO:0042866)	4	0	.20	-	 < 0.01	8.15E-01
fused antrum stage (GO:0048165)	3	0	.15	-	 < 0.01	8.58E-01
multi-layer follicle stage (GO:0048162)	3	0	.15	-	 < 0.01	8.58E-01
primary follicle stage (GO:0048160)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of myofibroblast differentiation (GO:1904761)	3	0	.15	-	 < 0.01	8.58E-01
regulation of myofibroblast differentiation (GO:1904760)	4	0	.20	-	 < 0.01	8.15E-01
L-alanine catabolic process (GO:0042853)	4	0	.20	-	 < 0.01	8.15E-01
L-alanine metabolic process (GO:0042851)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of myeloid dendritic cell activation (GO:0030887)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of myeloid dendritic cell activation (GO:0030886)	3	0	.15	-	 < 0.01	8.58E-01
regulation of myeloid dendritic cell activation (GO:0030885)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of protein localization to nucleolus (GO:1904750)	1	0	.05	-	 < 0.01	9.50E-01
behavioral response to ethanol (GO:0048149)	9	0	.46	-	 < 0.01	6.31E-01
behavioral response to cocaine (GO:0048148)	13	0	.66	-	 < 0.01	5.15E-01
D-glucuronate catabolic process (GO:0042840)	1	0	.05	-	 < 0.01	9.50E-01
fibroblast proliferation (GO:0048144)	2	0	.10	-	 < 0.01	9.03E-01
astrocyte activation (GO:0048143)	17	0	.87	-	 < 0.01	4.19E-01
osteoclast maturation (GO:0036179)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of apoptotic process involved in development (GO:1904746)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of telomeric DNA binding (GO:1904744)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.10	-	 < 0.01	9.03E-01
regulation of telomeric DNA binding (GO:1904742)	4	0	.20	-	 < 0.01	8.15E-01
protein arginylation (GO:0016598)	1	0	.05	-	 < 0.01	9.50E-01
D-glucuronate metabolic process (GO:0042839)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of polarized epithelial cell differentiation (GO:0030862)	1	0	.05	-	 < 0.01	9.50E-01
regulation of polarized epithelial cell differentiation (GO:0030860)	2	0	.10	-	 < 0.01	9.03E-01
cell-abiotic substrate adhesion (GO:0036164)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of electron transfer activity (GO:1904734)	2	0	.10	-	 < 0.01	9.03E-01
regulation of electron transfer activity (GO:1904732)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of intestinal lipid absorption (GO:1904730)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	4	0	.20	-	 < 0.01	8.15E-01
regulation of secondary metabolite biosynthetic process (GO:1900376)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of viral transcription (GO:0050434)	38	0	1.94	-	 < 0.01	1.43E-01
regulation of catecholamine secretion (GO:0050433)	53	0	2.71	-	 < 0.01	6.64E-02
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	5	0	.26	-	 < 0.01	7.75E-01
catecholamine secretion (GO:0050432)	2	0	.10	-	 < 0.01	9.03E-01
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.10	-	 < 0.01	9.03E-01
pyridoxal phosphate metabolic process (GO:0042822)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of RNA interference (GO:1900370)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of granulocyte differentiation (GO:0030854)	8	0	.41	-	 < 0.01	6.65E-01
inner dynein arm assembly (GO:0036159)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of granulocyte differentiation (GO:0030853)	10	0	.51	-	 < 0.01	6.00E-01
outer dynein arm assembly (GO:0036158)	15	0	.77	-	 < 0.01	4.65E-01
regulation of granulocyte differentiation (GO:0030852)	17	0	.87	-	 < 0.01	4.19E-01
acylglycerol acyl-chain remodeling (GO:0036155)	5	0	.26	-	 < 0.01	7.75E-01
triglyceride acyl-chain remodeling (GO:0036153)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of RNA interference (GO:1900369)	2	0	.10	-	 < 0.01	9.03E-01
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	6	0	.31	-	 < 0.01	7.36E-01
regulation of RNA interference (GO:1900368)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mRNA polyadenylation (GO:1900365)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of mRNA polyadenylation (GO:1900364)	8	0	.41	-	 < 0.01	6.65E-01
regulation of mRNA polyadenylation (GO:1900363)	16	0	.82	-	 < 0.01	4.41E-01
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of intermediate filament depolymerization (GO:0030844)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intermediate filament depolymerization (GO:0030842)	1	0	.05	-	 < 0.01	9.50E-01
dendritic cell homeostasis (GO:0036145)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of chaperone-mediated autophagy (GO:1904715)	3	0	.15	-	 < 0.01	8.58E-01
regulation of chaperone-mediated autophagy (GO:1904714)	8	0	.41	-	 < 0.01	6.65E-01
regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of granulosa cell apoptotic process (GO:1904710)	1	0	.05	-	 < 0.01	9.50E-01
protein import into peroxisome matrix, translocation (GO:0016561)	3	0	.15	-	 < 0.01	8.58E-01
protein import into peroxisome matrix, docking (GO:0016560)	4	0	.20	-	 < 0.01	8.15E-01
establishment of body hair planar orientation (GO:0048105)	3	0	.15	-	 < 0.01	8.58E-01
establishment of body hair or bristle planar orientation (GO:0048104)	3	0	.15	-	 < 0.01	8.58E-01
autophagic cell death (GO:0048102)	7	0	.36	-	 < 0.01	6.99E-01
regulation of granulosa cell apoptotic process (GO:1904708)	2	0	.10	-	 < 0.01	9.03E-01
peroxisome fission (GO:0016559)	10	0	.51	-	 < 0.01	6.00E-01
protein import into peroxisome matrix (GO:0016558)	13	0	.66	-	 < 0.01	5.15E-01
peroxisome membrane biogenesis (GO:0016557)	4	0	.20	-	 < 0.01	8.15E-01
mRNA modification (GO:0016556)	22	0	1.12	-	 < 0.01	3.25E-01
cytidine to uridine editing (GO:0016554)	11	0	.56	-	 < 0.01	5.70E-01
base conversion or substitution editing (GO:0016553)	19	0	.97	-	 < 0.01	3.79E-01
cellular response to platelet-derived growth factor stimulus (GO:0036120)	20	0	1.02	-	 < 0.01	3.60E-01
regulation of cardiac endothelial to mesenchymal transition (GO:0061999)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of nucleotide biosynthetic process (GO:0030810)	22	0	1.12	-	 < 0.01	3.25E-01
long-chain fatty-acyl-CoA catabolic process (GO:0036116)	1	0	.05	-	 < 0.01	9.50E-01
fatty-acyl-CoA catabolic process (GO:0036115)	3	0	.15	-	 < 0.01	8.58E-01
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	2	0	.10	-	 < 0.01	9.03E-01
very long-chain fatty-acyl-CoA catabolic process (GO:0036113)	1	0	.05	-	 < 0.01	9.50E-01
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	4	0	.20	-	 < 0.01	8.15E-01
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	2	0	.10	-	 < 0.01	9.03E-01
intein-mediated protein splicing (GO:0016539)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of transcription by glucose (GO:0061986)	1	0	.05	-	 < 0.01	9.50E-01
meiosis II cell cycle process (GO:0061983)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of nucleotide biosynthetic process (GO:0030809)	5	0	.26	-	 < 0.01	7.75E-01
alpha-linolenic acid metabolic process (GO:0036109)	13	0	.66	-	 < 0.01	5.15E-01
leukotriene B4 metabolic process (GO:0036102)	6	0	.31	-	 < 0.01	7.36E-01
leukotriene B4 catabolic process (GO:0036101)	5	0	.26	-	 < 0.01	7.75E-01
leukotriene catabolic process (GO:0036100)	5	0	.26	-	 < 0.01	7.75E-01
perichondral bone morphogenesis (GO:0061974)	1	0	.05	-	 < 0.01	9.50E-01
membrane bone morphogenesis (GO:0061973)	1	0	.05	-	 < 0.01	9.50E-01
establishment of left/right asymmetry (GO:0061966)	1	0	.05	-	 < 0.01	9.50E-01
inactivation of MAPK activity (GO:0000188)	25	0	1.28	-	 < 0.01	2.79E-01
inactivation of MAPK activity involved in osmosensory signaling pathway (GO:0000173)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein K48-linked ubiquitination (GO:0061944)	2	0	.10	-	 < 0.01	9.03E-01
phosphorelay signal transduction system (GO:0000160)	1	0	.05	-	 < 0.01	9.50E-01
monocyte extravasation (GO:0035696)	5	0	.26	-	 < 0.01	7.75E-01
mitophagy by induced vacuole formation (GO:0035695)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial protein catabolic process (GO:0035694)	4	0	.20	-	 < 0.01	8.15E-01
macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.05	-	 < 0.01	9.50E-01
regulation of erythrocyte enucleation (GO:0061930)	1	0	.05	-	 < 0.01	9.50E-01
helper T cell diapedesis (GO:0035685)	2	0	.10	-	 < 0.01	9.03E-01
helper T cell extravasation (GO:0035684)	3	0	.15	-	 < 0.01	8.58E-01
memory T cell extravasation (GO:0035683)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-lysine propionylation (GO:0061921)	1	0	.05	-	 < 0.01	9.50E-01
manchette assembly (GO:1905198)	2	0	.10	-	 < 0.01	9.03E-01
neuromast hair cell development (GO:0035675)	1	0	.05	-	 < 0.01	9.50E-01
tricarboxylic acid transmembrane transport (GO:0035674)	1	0	.05	-	 < 0.01	9.50E-01
oligopeptide transmembrane transport (GO:0035672)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metaphase/anaphase transition of meiosis I (GO:1905186)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein serine/threonine phosphatase activity (GO:1905184)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein serine/threonine phosphatase activity (GO:1905183)	1	0	.05	-	 < 0.01	9.50E-01
establishment of mitotic spindle orientation (GO:0000132)	28	0	1.43	-	 < 0.01	2.39E-01
response to morphine (GO:0043278)	35	0	1.79	-	 < 0.01	1.67E-01
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	2	0	.10	-	 < 0.01	9.03E-01
apoptotic cell clearance (GO:0043277)	37	0	1.89	-	 < 0.01	1.51E-01
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	2	0	.10	-	 < 0.01	9.03E-01
anoikis (GO:0043276)	11	0	.56	-	 < 0.01	5.70E-01
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.05	-	 < 0.01	9.50E-01
autophagosome-lysosome fusion (GO:0061909)	2	0	.10	-	 < 0.01	9.03E-01
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903)	3	0	.15	-	 < 0.01	8.58E-01
regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of cardiac muscle tissue regeneration (GO:1905179)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cardiac muscle tissue regeneration (GO:1905178)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	0	.05	-	 < 0.01	9.50E-01
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	0	.10	-	 < 0.01	9.03E-01
interleukin-18-mediated signaling pathway (GO:0035655)	7	0	.36	-	 < 0.01	6.99E-01
B cell costimulation (GO:0031296)	4	0	.20	-	 < 0.01	8.15E-01
Ran protein signal transduction (GO:0031291)	3	0	.15	-	 < 0.01	8.58E-01
retinal ganglion cell axon guidance (GO:0031290)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of lysosomal protein catabolic process (GO:1905166)	4	0	.20	-	 < 0.01	8.15E-01
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of phagosome maturation (GO:1905164)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phagosome maturation (GO:1905162)	3	0	.15	-	 < 0.01	8.58E-01
endosome to melanosome transport (GO:0035646)	9	0	.46	-	 < 0.01	6.31E-01
enteric smooth muscle cell differentiation (GO:0035645)	1	0	.05	-	 < 0.01	9.50E-01
phosphoanandamide dephosphorylation (GO:0035644)	1	0	.05	-	 < 0.01	9.50E-01
sodium-independent organic anion transport (GO:0043252)	15	0	.77	-	 < 0.01	4.65E-01
locomotory exploration behavior (GO:0035641)	14	0	.72	-	 < 0.01	4.89E-01
exploration behavior (GO:0035640)	27	0	1.38	-	 < 0.01	2.52E-01
positive regulation of guanylate cyclase activity (GO:0031284)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of guanylate cyclase activity (GO:0031283)	2	0	.10	-	 < 0.01	9.03E-01
regulation of guanylate cyclase activity (GO:0031282)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of cyclase activity (GO:0031281)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of cyclase activity (GO:0031280)	20	0	1.02	-	 < 0.01	3.60E-01
negative regulation of membrane invagination (GO:1905154)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of voltage-gated sodium channel activity (GO:1905152)	1	0	.05	-	 < 0.01	9.50E-01
FMN biosynthetic process (GO:0009398)	1	0	.05	-	 < 0.01	9.50E-01
sulfate assimilation (GO:0000103)	3	0	.15	-	 < 0.01	8.58E-01
folic acid-containing compound catabolic process (GO:0009397)	3	0	.15	-	 < 0.01	8.58E-01
regulation of voltage-gated sodium channel activity (GO:1905150)	7	0	.36	-	 < 0.01	6.99E-01
folic acid-containing compound biosynthetic process (GO:0009396)	9	0	.46	-	 < 0.01	6.31E-01
sulfur amino acid transport (GO:0000101)	7	0	.36	-	 < 0.01	6.99E-01
multicellular organismal signaling (GO:0035637)	132	0	6.74	-	 < 0.01	1.15E-03
entry of bacterium into host cell (GO:0035635)	8	0	.41	-	 < 0.01	6.65E-01
response to stilbenoid (GO:0035634)	6	0	.31	-	 < 0.01	7.36E-01
regulation of cyclase activity (GO:0031279)	45	0	2.30	-	 < 0.01	1.00E-01
regulation of lateral pseudopodium assembly (GO:0031275)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of pseudopodium assembly (GO:0031274)	12	0	.61	-	 < 0.01	5.42E-01
regulation of pseudopodium assembly (GO:0031272)	13	0	.66	-	 < 0.01	5.15E-01
lysosomal protein catabolic process (GO:1905146)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to acetylcholine (GO:1905145)	26	0	1.33	-	 < 0.01	2.65E-01
response to acetylcholine (GO:1905144)	26	0	1.33	-	 < 0.01	2.65E-01
eukaryotic translation initiation factor 2 complex assembly (GO:1905143)	1	0	.05	-	 < 0.01	9.50E-01
translational attenuation (GO:0009386)	2	0	.10	-	 < 0.01	9.03E-01
receptor transactivation (GO:0035624)	5	0	.26	-	 < 0.01	7.75E-01
renal glucose absorption (GO:0035623)	1	0	.05	-	 < 0.01	9.50E-01
intrahepatic bile duct development (GO:0035622)	2	0	.10	-	 < 0.01	9.03E-01
ER to Golgi ceramide transport (GO:0035621)	2	0	.10	-	 < 0.01	9.03E-01
pseudopodium assembly (GO:0031269)	1	0	.05	-	 < 0.01	9.50E-01
pseudopodium organization (GO:0031268)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of meiotic chromosome separation (GO:1905134)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of meiotic chromosome separation (GO:1905133)	2	0	.10	-	 < 0.01	9.03E-01
regulation of meiotic chromosome separation (GO:1905132)	3	0	.15	-	 < 0.01	8.58E-01
stress granule disassembly (GO:0035617)	5	0	.26	-	 < 0.01	7.75E-01
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	3	0	.15	-	 < 0.01	8.58E-01
protein branching point deglutamylation (GO:0035611)	1	0	.05	-	 < 0.01	9.50E-01
protein side chain deglutamylation (GO:0035610)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.05	-	 < 0.01	9.50E-01
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glucosylceramidase activity (GO:1905123)	2	0	.10	-	 < 0.01	9.03E-01
C-terminal protein deglutamylation (GO:0035609)	3	0	.15	-	 < 0.01	8.58E-01
protein deglutamylation (GO:0035608)	6	0	.31	-	 < 0.01	7.36E-01
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	2	0	.10	-	 < 0.01	9.03E-01
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	0	.05	-	 < 0.01	9.50E-01
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	0	.05	-	 < 0.01	9.50E-01
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602)	1	0	.05	-	 < 0.01	9.50E-01
tRNA methylthiolation (GO:0035600)	2	0	.10	-	 < 0.01	9.03E-01
auditory behavior (GO:0031223)	11	0	.56	-	 < 0.01	5.70E-01
posttranslational protein targeting to membrane, translocation (GO:0031204)	7	0	.36	-	 < 0.01	6.99E-01
oligosaccharide catabolic process (GO:0009313)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of acinar cell proliferation (GO:1904699)	1	0	.05	-	 < 0.01	9.50E-01
regulation of acinar cell proliferation (GO:1904697)	1	0	.05	-	 < 0.01	9.50E-01
protein biotinylation (GO:0009305)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of vascular associated smooth muscle contraction (GO:1904695)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of vascular associated smooth muscle contraction (GO:1904694)	2	0	.10	-	 < 0.01	9.03E-01
midbrain morphogenesis (GO:1904693)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of type B pancreatic cell proliferation (GO:1904692)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of type B pancreatic cell proliferation (GO:1904691)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cytoplasmic translational initiation (GO:1904690)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of developmental pigmentation (GO:0048087)	9	0	.46	-	 < 0.01	6.31E-01
tRNA 3'-end processing (GO:0042780)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cytoplasmic translational initiation (GO:1904688)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of metalloendopeptidase activity (GO:1904685)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of metalloendopeptidase activity (GO:1904684)	4	0	.20	-	 < 0.01	8.15E-01
regulation of metalloendopeptidase activity (GO:1904683)	6	0	.31	-	 < 0.01	7.36E-01
response to 3-methylcholanthrene (GO:1904681)	1	0	.05	-	 < 0.01	9.50E-01
tRNA 3'-trailer cleavage (GO:0042779)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	12	0	.61	-	 < 0.01	5.42E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	72	0	3.68	-	 < 0.01	2.51E-02
plasma membrane ATP synthesis coupled electron transport (GO:0042774)	1	0	.05	-	 < 0.01	9.50E-01
ATP synthesis coupled electron transport (GO:0042773)	73	0	3.73	-	 < 0.01	2.38E-02
DNA damage response, signal transduction resulting in transcription (GO:0042772)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of eye pigmentation (GO:0048075)	1	0	.05	-	 < 0.01	9.50E-01
regulation of eye pigmentation (GO:0048073)	2	0	.10	-	 < 0.01	9.03E-01
regulation of developmental pigmentation (GO:0048070)	13	0	.66	-	 < 0.01	5.15E-01
myo-inositol import across plasma membrane (GO:1904679)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of somatic stem cell division (GO:1904677)	1	0	.05	-	 < 0.01	9.50E-01
regulation of somatic stem cell division (GO:1904675)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.20	-	 < 0.01	8.15E-01
nucleosome mobilization (GO:0042766)	4	0	.20	-	 < 0.01	8.15E-01
very long-chain fatty acid biosynthetic process (GO:0042761)	11	0	.56	-	 < 0.01	5.70E-01
very long-chain fatty acid catabolic process (GO:0042760)	6	0	.31	-	 < 0.01	7.36E-01
ATP export (GO:1904669)	2	0	.10	-	 < 0.01	9.03E-01
germ cell proliferation (GO:0036093)	1	0	.05	-	 < 0.01	9.50E-01
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of ubiquitin protein ligase activity (GO:1904667)	9	0	.46	-	 < 0.01	6.31E-01
cleavage furrow ingression (GO:0036090)	2	0	.10	-	 < 0.01	9.03E-01
drinking behavior (GO:0042756)	10	0	.51	-	 < 0.01	6.00E-01
eating behavior (GO:0042755)	26	0	1.33	-	 < 0.01	2.65E-01
post-embryonic eye morphogenesis (GO:0048050)	7	0	.36	-	 < 0.01	6.99E-01
D-serine catabolic process (GO:0036088)	1	0	.05	-	 < 0.01	9.50E-01
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.05	-	 < 0.01	9.50E-01
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	1	0	.05	-	 < 0.01	9.50E-01
hydrogen peroxide catabolic process (GO:0042744)	27	0	1.38	-	 < 0.01	2.52E-01
hydrogen peroxide metabolic process (GO:0042743)	40	0	2.04	-	 < 0.01	1.29E-01
regulation of fat cell apoptotic process (GO:1904649)	2	0	.10	-	 < 0.01	9.03E-01
direct ossification (GO:0036072)	6	0	.31	-	 < 0.01	7.36E-01
response to rotenone (GO:1904647)	1	0	.05	-	 < 0.01	9.50E-01
N-glycan fucosylation (GO:0036071)	2	0	.10	-	 < 0.01	9.03E-01
response to methionine (GO:1904640)	3	0	.15	-	 < 0.01	8.58E-01
D-xylose metabolic process (GO:0042732)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)	1	0	.05	-	 < 0.01	9.50E-01
fibrinolysis (GO:0042730)	20	0	1.02	-	 < 0.01	3.60E-01
heme O biosynthetic process (GO:0048034)	1	0	.05	-	 < 0.01	9.50E-01
heme o metabolic process (GO:0048033)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to resveratrol (GO:1904639)	1	0	.05	-	 < 0.01	9.50E-01
response to resveratrol (GO:1904638)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to ionomycin (GO:1904637)	5	0	.26	-	 < 0.01	7.75E-01
response to ionomycin (GO:1904636)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glomerular visceral epithelial cell apoptotic process (GO:1904635)	3	0	.15	-	 < 0.01	8.58E-01
slit diaphragm assembly (GO:0036060)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glomerular visceral epithelial cell apoptotic process (GO:1904633)	3	0	.15	-	 < 0.01	8.58E-01
farnesol catabolic process (GO:0016488)	2	0	.10	-	 < 0.01	9.03E-01
farnesol metabolic process (GO:0016487)	2	0	.10	-	 < 0.01	9.03E-01
response to glucoside (GO:1904631)	1	0	.05	-	 < 0.01	9.50E-01
peptide hormone processing (GO:0016486)	33	0	1.69	-	 < 0.01	1.85E-01
regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	2	0	.10	-	 < 0.01	9.03E-01
flavin-containing compound catabolic process (GO:0042728)	1	0	.05	-	 < 0.01	9.50E-01
flavin-containing compound biosynthetic process (GO:0042727)	2	0	.10	-	 < 0.01	9.03E-01
regulation of proteinase activated receptor activity (GO:1900276)	1	0	.05	-	 < 0.01	9.50E-01
flavin-containing compound metabolic process (GO:0042726)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of phospholipase C activity (GO:1900275)	2	0	.10	-	 < 0.01	9.03E-01
regulation of phospholipase C activity (GO:1900274)	48	0	2.45	-	 < 0.01	8.58E-02
negative regulation of transcription by RNA polymerase III (GO:0016480)	3	0	.15	-	 < 0.01	8.58E-01
thiamine-containing compound metabolic process (GO:0042723)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of long-term synaptic potentiation (GO:1900272)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of melanin biosynthetic process (GO:0048023)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of melanin biosynthetic process (GO:0048022)	4	0	.20	-	 < 0.01	8.15E-01
regulation of melanin biosynthetic process (GO:0048021)	11	0	.56	-	 < 0.01	5.70E-01
filtration diaphragm assembly (GO:0036058)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	5	0	.26	-	 < 0.01	7.75E-01
response to phorbol 13-acetate 12-myristate (GO:1904627)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of transcription by RNA polymerase I (GO:0016479)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to dimethyl sulfoxide (GO:1904620)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	9	0	.46	-	 < 0.01	6.31E-01
regulation of DNA-directed DNA polymerase activity (GO:1900262)	9	0	.46	-	 < 0.01	6.31E-01
sperm ejaculation (GO:0042713)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.05	-	 < 0.01	9.50E-01
Tie signaling pathway (GO:0048014)	4	0	.20	-	 < 0.01	8.15E-01
neurotrophin TRK receptor signaling pathway (GO:0048011)	20	0	1.02	-	 < 0.01	3.60E-01
peptidyl-lysine desuccinylation (GO:0036049)	2	0	.10	-	 < 0.01	9.03E-01
protein desuccinylation (GO:0036048)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-lysine demalonylation (GO:0036047)	1	0	.05	-	 < 0.01	9.50E-01
protein demalonylation (GO:0036046)	1	0	.05	-	 < 0.01	9.50E-01
response to dimethyl sulfoxide (GO:1904619)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of actin binding (GO:1904618)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of actin binding (GO:1904617)	1	0	.05	-	 < 0.01	9.50E-01
regulation of actin binding (GO:1904616)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	2	0	.10	-	 < 0.01	9.03E-01
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	4	0	.20	-	 < 0.01	8.15E-01
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.05	-	 < 0.01	9.50E-01
uterine wall breakdown (GO:0042704)	2	0	.10	-	 < 0.01	9.03E-01
insulin-like growth factor receptor signaling pathway (GO:0048009)	14	0	.72	-	 < 0.01	4.89E-01
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	6	0	.31	-	 < 0.01	7.36E-01
progesterone secretion (GO:0042701)	2	0	.10	-	 < 0.01	9.03E-01
antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)	5	0	.26	-	 < 0.01	7.75E-01
luteinizing hormone signaling pathway (GO:0042700)	2	0	.10	-	 < 0.01	9.03E-01
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	6	0	.31	-	 < 0.01	7.36E-01
CD8-positive, alpha-beta T cell activation (GO:0036037)	11	0	.56	-	 < 0.01	5.70E-01
sequestering of triglyceride (GO:0030730)	4	0	.20	-	 < 0.01	8.15E-01
osteoclast development (GO:0036035)	7	0	.36	-	 < 0.01	6.99E-01
recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cytoplasmic translational elongation (GO:1900248)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cytoplasmic translational elongation (GO:1900247)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of RIG-I signaling pathway (GO:1900246)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of MDA-5 signaling pathway (GO:1900245)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of synaptic vesicle endocytosis (GO:1900244)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of synaptic vesicle endocytosis (GO:1900243)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phenotypic switching (GO:1900240)	2	0	.10	-	 < 0.01	9.03E-01
embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.15	-	 < 0.01	8.58E-01
limb joint morphogenesis (GO:0036022)	3	0	.15	-	 < 0.01	8.58E-01
regulation of phenotypic switching (GO:1900239)	3	0	.15	-	 < 0.01	8.58E-01
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of Kit signaling pathway (GO:1900235)	2	0	.10	-	 < 0.01	9.03E-01
regulation of Kit signaling pathway (GO:1900234)	2	0	.10	-	 < 0.01	9.03E-01
germ-line stem cell population maintenance (GO:0030718)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to erythropoietin (GO:0036018)	6	0	.31	-	 < 0.01	7.36E-01
response to erythropoietin (GO:0036017)	7	0	.36	-	 < 0.01	6.99E-01
protein localization to endosome (GO:0036010)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	2	0	.10	-	 < 0.01	9.03E-01
regulation of single-species biofilm formation in or on host organism (GO:1900228)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of amyloid-beta clearance (GO:1900223)	8	0	.41	-	 < 0.01	6.65E-01
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.10	-	 < 0.01	9.03E-01
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.10	-	 < 0.01	9.03E-01
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of hepatic stellate cell migration (GO:0061871)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of hepatic stellate cell migration (GO:0061870)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cardiolipin metabolic process (GO:1900210)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hepatic stellate cell migration (GO:0061869)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cardiolipin metabolic process (GO:1900208)	4	0	.20	-	 < 0.01	8.15E-01
mitotic prophase (GO:0000088)	15	0	.77	-	 < 0.01	4.65E-01
mitotic G2 phase (GO:0000085)	3	0	.15	-	 < 0.01	8.58E-01
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neuroblast migration (GO:0061855)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neuroblast migration (GO:0061853)	1	0	.05	-	 < 0.01	9.50E-01
DNA replication checkpoint (GO:0000076)	15	0	.77	-	 < 0.01	4.65E-01
response to cholecystokinin (GO:0061847)	2	0	.10	-	 < 0.01	9.03E-01
neuropeptide processing (GO:0061837)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to tricellular tight junction (GO:0061833)	2	0	.10	-	 < 0.01	9.03E-01
argininosuccinate metabolic process (GO:0000053)	1	0	.05	-	 < 0.01	9.50E-01
citrulline metabolic process (GO:0000052)	7	0	.36	-	 < 0.01	6.99E-01
G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589)	13	0	.66	-	 < 0.01	5.15E-01
urea cycle (GO:0000050)	12	0	.61	-	 < 0.01	5.42E-01
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	7	0	.36	-	 < 0.01	6.99E-01
calcium-mediated signaling using extracellular calcium source (GO:0035585)	4	0	.20	-	 < 0.01	8.15E-01
calcium-mediated signaling using intracellular calcium source (GO:0035584)	21	0	1.07	-	 < 0.01	3.42E-01
sequestering of TGFbeta in extracellular matrix (GO:0035583)	3	0	.15	-	 < 0.01	8.58E-01
sequestering of BMP in extracellular matrix (GO:0035582)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	5	0	.26	-	 < 0.01	7.75E-01
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.05	-	 < 0.01	9.50E-01
telomeric DNA-containing double minutes formation (GO:0061819)	3	0	.15	-	 < 0.01	8.58E-01
histone H4-K20 demethylation (GO:0035574)	2	0	.10	-	 < 0.01	9.03E-01
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.05	-	 < 0.01	9.50E-01
vacuolar sequestering (GO:0043181)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.05	-	 < 0.01	9.50E-01
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	1	0	.05	-	 < 0.01	9.50E-01
electron transport coupled proton transport (GO:0015990)	1	0	.05	-	 < 0.01	9.50E-01
cell wall mannoprotein biosynthetic process (GO:0000032)	1	0	.05	-	 < 0.01	9.50E-01
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.05	-	 < 0.01	9.50E-01
regulation of metanephros size (GO:0035566)	2	0	.10	-	 < 0.01	9.03E-01
nucleoside salvage (GO:0043174)	15	0	.77	-	 < 0.01	4.65E-01
regulation of pronephros size (GO:0035565)	1	0	.05	-	 < 0.01	9.50E-01
regulation of kidney size (GO:0035564)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of chromatin binding (GO:0035563)	13	0	.66	-	 < 0.01	5.15E-01
peptide catabolic process (GO:0043171)	23	0	1.17	-	 < 0.01	3.09E-01
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	1	0	.05	-	 < 0.01	9.50E-01
ATP synthesis coupled proton transport (GO:0015986)	15	0	.77	-	 < 0.01	4.65E-01
energy coupled proton transport, down electrochemical gradient (GO:0015985)	15	0	.77	-	 < 0.01	4.65E-01
ribosomal small subunit assembly (GO:0000028)	16	0	.82	-	 < 0.01	4.41E-01
ribosomal large subunit assembly (GO:0000027)	26	0	1.33	-	 < 0.01	2.65E-01
positive regulation of tight junction disassembly (GO:1905075)	3	0	.15	-	 < 0.01	8.58E-01
regulation of tight junction disassembly (GO:1905073)	3	0	.15	-	 < 0.01	8.58E-01
mitotic spindle elongation (GO:0000022)	6	0	.31	-	 < 0.01	7.36E-01
D-alanine catabolic process (GO:0055130)	1	0	.05	-	 < 0.01	9.50E-01
cell envelope organization (GO:0043163)	2	0	.10	-	 < 0.01	9.03E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	21	0	1.07	-	 < 0.01	3.42E-01
oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.15	-	 < 0.01	8.58E-01
oxidative single-stranded DNA demethylation (GO:0035552)	2	0	.10	-	 < 0.01	9.03E-01
L-proline biosynthetic process (GO:0055129)	5	0	.26	-	 < 0.01	7.75E-01
allantois development (GO:1905069)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067)	1	0	.05	-	 < 0.01	9.50E-01
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	6	0	.31	-	 < 0.01	7.36E-01
alpha-glucoside transport (GO:0000017)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	8	0	.41	-	 < 0.01	6.65E-01
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.05	-	 < 0.01	9.50E-01
determination of left/right asymmetry in nervous system (GO:0035545)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of SNARE complex assembly (GO:0035544)	3	0	.15	-	 < 0.01	8.58E-01
induction of bacterial agglutination (GO:0043152)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.05	-	 < 0.01	9.50E-01
regulation of SNARE complex assembly (GO:0035542)	9	0	.46	-	 < 0.01	6.31E-01
diadenosine tetraphosphate biosynthetic process (GO:0015966)	3	0	.15	-	 < 0.01	8.58E-01
diadenosine tetraphosphate metabolic process (GO:0015965)	3	0	.15	-	 < 0.01	8.58E-01
diadenosine triphosphate catabolic process (GO:0015964)	1	0	.05	-	 < 0.01	9.50E-01
diadenosine triphosphate metabolic process (GO:0015962)	1	0	.05	-	 < 0.01	9.50E-01
diadenosine polyphosphate catabolic process (GO:0015961)	5	0	.26	-	 < 0.01	7.75E-01
diadenosine polyphosphate biosynthetic process (GO:0015960)	3	0	.15	-	 < 0.01	8.58E-01
epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of base-excision repair (GO:1905053)	1	0	.05	-	 < 0.01	9.50E-01
GDP-mannose biosynthetic process (GO:0009298)	4	0	.20	-	 < 0.01	8.15E-01
regulation of base-excision repair (GO:1905051)	1	0	.05	-	 < 0.01	9.50E-01
ingression involved in gastrulation with mouth forming second (GO:0055111)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of metallopeptidase activity (GO:1905050)	9	0	.46	-	 < 0.01	6.31E-01
peptide modification (GO:0031179)	2	0	.10	-	 < 0.01	9.03E-01
diadenosine polyphosphate metabolic process (GO:0015959)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of metallopeptidase activity (GO:1905049)	7	0	.36	-	 < 0.01	6.99E-01
regulation of metallopeptidase activity (GO:1905048)	16	0	.82	-	 < 0.01	4.41E-01
Golgi to transport vesicle transport (GO:0055108)	1	0	.05	-	 < 0.01	9.50E-01
Golgi to secretory granule transport (GO:0055107)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of epithelium regeneration (GO:1905042)	1	0	.05	-	 < 0.01	9.50E-01
regulation of epithelium regeneration (GO:1905041)	2	0	.10	-	 < 0.01	9.03E-01
otic placode development (GO:1905040)	1	0	.05	-	 < 0.01	9.50E-01
DNA replication, removal of RNA primer (GO:0043137)	4	0	.20	-	 < 0.01	8.15E-01
retrograde transport, plasma membrane to Golgi (GO:0035526)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hindgut contraction (GO:0043134)	2	0	.10	-	 < 0.01	9.03E-01
proline transmembrane transport (GO:0035524)	8	0	.41	-	 < 0.01	6.65E-01
NAD transport (GO:0043132)	3	0	.15	-	 < 0.01	8.58E-01
protein K29-linked deubiquitination (GO:0035523)	5	0	.26	-	 < 0.01	7.75E-01
monoubiquitinated histone H2A deubiquitination (GO:0035522)	4	0	.20	-	 < 0.01	8.15E-01
monoubiquitinated histone deubiquitination (GO:0035521)	4	0	.20	-	 < 0.01	8.15E-01
monoubiquitinated protein deubiquitination (GO:0035520)	9	0	.46	-	 < 0.01	6.31E-01
metallo-sulfur cluster assembly (GO:0031163)	21	0	1.07	-	 < 0.01	3.42E-01
phosphatidylinositol catabolic process (GO:0031161)	1	0	.05	-	 < 0.01	9.50E-01
formate metabolic process (GO:0015942)	5	0	.26	-	 < 0.01	7.75E-01
regulation of membrane lipid metabolic process (GO:1905038)	18	0	.92	-	 < 0.01	3.99E-01
positive regulation of antifungal innate immune response (GO:1905036)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of antifungal innate immune response (GO:1905035)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antifungal innate immune response (GO:1905034)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032)	1	0	.05	-	 < 0.01	9.50E-01
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128)	1	0	.05	-	 < 0.01	9.50E-01
protein K29-linked ubiquitination (GO:0035519)	5	0	.26	-	 < 0.01	7.75E-01
regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126)	1	0	.05	-	 < 0.01	9.50E-01
oxidative RNA demethylation (GO:0035513)	5	0	.26	-	 < 0.01	7.75E-01
oxidative DNA demethylation (GO:0035511)	6	0	.31	-	 < 0.01	7.36E-01
coenzyme A catabolic process (GO:0015938)	1	0	.05	-	 < 0.01	9.50E-01
coenzyme A biosynthetic process (GO:0015937)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025)	1	0	.05	-	 < 0.01	9.50E-01
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	3	0	.15	-	 < 0.01	8.58E-01
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of vascular permeability (GO:0043117)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of vascular permeability (GO:0043116)	17	0	.87	-	 < 0.01	4.19E-01
ribonucleotide catabolic process (GO:0009261)	31	0	1.58	-	 < 0.01	2.05E-01
positive regulation of myosin light chain kinase activity (GO:0035505)	2	0	.10	-	 < 0.01	9.03E-01
regulation of myosin light chain kinase activity (GO:0035504)	2	0	.10	-	 < 0.01	9.03E-01
replication fork arrest (GO:0043111)	4	0	.20	-	 < 0.01	8.15E-01
metanephric part of ureteric bud development (GO:0035502)	4	0	.20	-	 < 0.01	8.15E-01
lipopolysaccharide transport (GO:0015920)	2	0	.10	-	 < 0.01	9.03E-01
regulation of 'de novo' NAD biosynthetic process from tryptophan (GO:1905012)	1	0	.05	-	 < 0.01	9.50E-01
10-formyltetrahydrofolate catabolic process (GO:0009258)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.05	-	 < 0.01	9.50E-01
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.10	-	 < 0.01	9.03E-01
peptidoglycan catabolic process (GO:0009253)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.05	-	 < 0.01	9.50E-01
hypoxanthine salvage (GO:0043103)	2	0	.10	-	 < 0.01	9.03E-01
amino acid salvage (GO:0043102)	6	0	.31	-	 < 0.01	7.36E-01
aminophospholipid transport (GO:0015917)	7	0	.36	-	 < 0.01	6.99E-01
sister chromatid biorientation (GO:0031134)	3	0	.15	-	 < 0.01	8.58E-01
fatty-acyl-CoA transport (GO:0015916)	2	0	.10	-	 < 0.01	9.03E-01
regulation of axon diameter (GO:0031133)	5	0	.26	-	 < 0.01	7.75E-01
short-chain fatty acid import (GO:0015913)	1	0	.05	-	 < 0.01	9.50E-01
short-chain fatty acid transport (GO:0015912)	2	0	.10	-	 < 0.01	9.03E-01
long-chain fatty acid import into peroxisome (GO:0015910)	4	0	.20	-	 < 0.01	8.15E-01
regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	2	0	.10	-	 < 0.01	9.03E-01
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	6	0	.31	-	 < 0.01	7.36E-01
picolinic acid biosynthetic process (GO:1905004)	1	0	.05	-	 < 0.01	9.50E-01
picolinic acid metabolic process (GO:1905003)	1	0	.05	-	 < 0.01	9.50E-01
protein lipoylation (GO:0009249)	6	0	.31	-	 < 0.01	7.36E-01
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.05	-	 < 0.01	9.50E-01
inductive cell-cell signaling (GO:0031129)	1	0	.05	-	 < 0.01	9.50E-01
tetracycline transmembrane transport (GO:0015904)	1	0	.05	-	 < 0.01	9.50E-01
snRNA pseudouridine synthesis (GO:0031120)	3	0	.15	-	 < 0.01	8.58E-01
siderophore metabolic process (GO:0009237)	1	0	.05	-	 < 0.01	9.50E-01
menaquinone biosynthetic process (GO:0009234)	1	0	.05	-	 < 0.01	9.50E-01
menaquinone metabolic process (GO:0009233)	5	0	.26	-	 < 0.01	7.75E-01
riboflavin biosynthetic process (GO:0009231)	1	0	.05	-	 < 0.01	9.50E-01
tRNA pseudouridine synthesis (GO:0031119)	5	0	.26	-	 < 0.01	7.75E-01
rRNA pseudouridine synthesis (GO:0031118)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of microtubule depolymerization (GO:0031117)	4	0	.20	-	 < 0.01	8.15E-01
regulation of microtubule depolymerization (GO:0031114)	29	0	1.48	-	 < 0.01	2.27E-01
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.05	-	 < 0.01	9.50E-01
nucleotide-sugar catabolic process (GO:0009227)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine ribonucleotide catabolic process (GO:0009222)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	18	0	.92	-	 < 0.01	3.99E-01
septin ring organization (GO:0031106)	1	0	.05	-	 < 0.01	9.50E-01
dendrite regeneration (GO:0031104)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine ribonucleotide metabolic process (GO:0009218)	21	0	1.07	-	 < 0.01	3.42E-01
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	5	0	.26	-	 < 0.01	7.75E-01
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	1	0	.05	-	 < 0.01	9.50E-01
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	8	0	.41	-	 < 0.01	6.65E-01
cyclic nucleotide catabolic process (GO:0009214)	13	0	.66	-	 < 0.01	5.15E-01
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	3	0	.15	-	 < 0.01	8.58E-01
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	5	0	.26	-	 < 0.01	7.75E-01
follicle-stimulating hormone signaling pathway (GO:0042699)	4	0	.20	-	 < 0.01	8.15E-01
thelarche (GO:0042695)	5	0	.26	-	 < 0.01	7.75E-01
muscle cell fate specification (GO:0042694)	1	0	.05	-	 < 0.01	9.50E-01
muscle cell fate commitment (GO:0042693)	14	0	.72	-	 < 0.01	4.89E-01
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	11	0	.56	-	 < 0.01	5.70E-01
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	12	0	.61	-	 < 0.01	5.42E-01
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	1	0	.05	-	 < 0.01	9.50E-01
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	1	0	.05	-	 < 0.01	9.50E-01
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.05	-	 < 0.01	9.50E-01
ribonucleoside triphosphate catabolic process (GO:0009203)	1	0	.05	-	 < 0.01	9.50E-01
regulation of termination of RNA polymerase II transcription (GO:1904594)	1	0	.05	-	 < 0.01	9.50E-01
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of protein import (GO:1904590)	13	0	.66	-	 < 0.01	5.15E-01
regulation of cardioblast cell fate specification (GO:0042686)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to glycoprotein (GO:1904588)	1	0	.05	-	 < 0.01	9.50E-01
response to glycoprotein (GO:1904587)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to putrescine (GO:1904586)	2	0	.10	-	 < 0.01	9.03E-01
response to putrescine (GO:1904585)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of intracellular mRNA localization (GO:1904582)	3	0	.15	-	 < 0.01	8.58E-01
regulation of intracellular mRNA localization (GO:1904580)	3	0	.15	-	 < 0.01	8.58E-01
retinal cone cell differentiation (GO:0042670)	10	0	.51	-	 < 0.01	6.00E-01
cellular response to thapsigargin (GO:1904579)	2	0	.10	-	 < 0.01	9.03E-01
response to thapsigargin (GO:1904578)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to tunicamycin (GO:1904577)	1	0	.05	-	 < 0.01	9.50E-01
response to tunicamycin (GO:1904576)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of selenocysteine insertion sequence binding (GO:1904574)	1	0	.05	-	 < 0.01	9.50E-01
regulation of selenocysteine insertion sequence binding (GO:1904573)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mRNA binding (GO:1904572)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of selenocysteine incorporation (GO:1904570)	1	0	.05	-	 < 0.01	9.50E-01
regulation of inner ear auditory receptor cell fate specification (GO:0042669)	1	0	.05	-	 < 0.01	9.50E-01
auditory receptor cell fate determination (GO:0042668)	1	0	.05	-	 < 0.01	9.50E-01
auditory receptor cell fate specification (GO:0042667)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ectodermal cell fate specification (GO:0042666)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ectodermal cell fate specification (GO:0042665)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of endodermal cell fate specification (GO:0042664)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endodermal cell fate specification (GO:0042663)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mesodermal cell fate specification (GO:0042662)	3	0	.15	-	 < 0.01	8.58E-01
regulation of mesodermal cell fate specification (GO:0042661)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cell fate specification (GO:0042660)	2	0	.10	-	 < 0.01	9.03E-01
regulation of selenocysteine incorporation (GO:1904569)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to wortmannin (GO:1904568)	1	0	.05	-	 < 0.01	9.50E-01
response to wortmannin (GO:1904567)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	0	.05	-	 < 0.01	9.50E-01
platelet activating factor catabolic process (GO:0062234)	2	0	.10	-	 < 0.01	9.03E-01
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	1	0	.05	-	 < 0.01	9.50E-01
prostanoid catabolic process (GO:0062232)	1	0	.05	-	 < 0.01	9.50E-01
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cell fate specification (GO:0042659)	15	0	.77	-	 < 0.01	4.65E-01
mitigation of host immune response by virus (GO:0030683)	2	0	.10	-	 < 0.01	9.03E-01
L-alanine transmembrane transport (GO:1904557)	4	0	.20	-	 < 0.01	8.15E-01
L-tryptophan transmembrane transport (GO:1904556)	2	0	.10	-	 < 0.01	9.03E-01
L-proline transmembrane transport (GO:1904555)	2	0	.10	-	 < 0.01	9.03E-01
response to arachidonic acid (GO:1904550)	1	0	.05	-	 < 0.01	9.50E-01
membrane bending (GO:0097753)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of oocyte maturation (GO:1900194)	2	0	.10	-	 < 0.01	9.03E-01
regulation of DNA stability (GO:0097752)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of single-species biofilm formation (GO:1900191)	2	0	.10	-	 < 0.01	9.03E-01
endosome membrane tubulation (GO:0097750)	2	0	.10	-	 < 0.01	9.03E-01
regulation of single-species biofilm formation (GO:1900190)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of free ubiquitin chain polymerization (GO:1904544)	1	0	.05	-	 < 0.01	9.50E-01
regulation of free ubiquitin chain polymerization (GO:1904542)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of clathrin-dependent endocytosis (GO:1900186)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial tRNA 5'-end processing (GO:0097745)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of hair cycle (GO:0042636)	1	0	.05	-	 < 0.01	9.50E-01
urate salt excretion (GO:0097744)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of hair cycle (GO:0042635)	1	0	.05	-	 < 0.01	9.50E-01
de novo centriole assembly (GO:0097742)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to water deprivation (GO:0042631)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glycolytic process through fructose-6-phosphate (GO:1904538)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of actin filament binding (GO:1904531)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of actin filament binding (GO:1904530)	1	0	.05	-	 < 0.01	9.50E-01
mating plug formation (GO:0042628)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.10	-	 < 0.01	9.03E-01
extracellular exosome biogenesis (GO:0097734)	5	0	.26	-	 < 0.01	7.75E-01
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	5	0	.26	-	 < 0.01	7.75E-01
regulation of vitamin metabolic process (GO:0030656)	10	0	.51	-	 < 0.01	6.00E-01
beta-lactam antibiotic metabolic process (GO:0030653)	1	0	.05	-	 < 0.01	9.50E-01
regulation of actin filament binding (GO:1904529)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of microtubule binding (GO:1904528)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of microtubule binding (GO:1904527)	2	0	.10	-	 < 0.01	9.03E-01
regulation of microtubule binding (GO:1904526)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of glial cell-derived neurotrophic factor production (GO:1900168)	3	0	.15	-	 < 0.01	8.58E-01
regulation of glial cell-derived neurotrophic factor production (GO:1900166)	3	0	.15	-	 < 0.01	8.58E-01
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phospholipid scramblase activity (GO:1900161)	1	0	.05	-	 < 0.01	9.50E-01
aminoglycoside antibiotic metabolic process (GO:0030647)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of TORC2 signaling (GO:1904515)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of protein localization to basolateral plasma membrane (GO:1904510)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	3	0	.15	-	 < 0.01	8.58E-01
regulation of bone mineralization involved in bone maturation (GO:1900157)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of bone trabecula formation (GO:1900155)	2	0	.10	-	 < 0.01	9.03E-01
regulation of bone trabecula formation (GO:1900154)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	3	0	.15	-	 < 0.01	8.58E-01
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	16	0	.82	-	 < 0.01	4.41E-01
regulation of defense response to fungus (GO:1900150)	4	0	.20	-	 < 0.01	8.15E-01
polyketide metabolic process (GO:0030638)	8	0	.41	-	 < 0.01	6.65E-01
regulation of protein localization to basolateral plasma membrane (GO:1904508)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	4	0	.20	-	 < 0.01	8.15E-01
regulation of telomere maintenance in response to DNA damage (GO:1904505)	4	0	.20	-	 < 0.01	8.15E-01
connective tissue replacement (GO:0097709)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of chromatin-mediated maintenance of transcription (GO:1904501)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of Schwann cell migration (GO:1900149)	2	0	.10	-	 < 0.01	9.03E-01
regulation of Schwann cell migration (GO:1900147)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.10	-	 < 0.01	9.03E-01
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of oligodendrocyte apoptotic process (GO:1900143)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	1	0	.05	-	 < 0.01	9.50E-01
regulation of oligodendrocyte apoptotic process (GO:1900141)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of arachidonic acid secretion (GO:1900139)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of phospholipase A2 activity (GO:1900138)	2	0	.10	-	 < 0.01	9.03E-01
meiotic chromosome movement towards spindle pole (GO:0016344)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of renin secretion into blood stream (GO:1900135)	2	0	.10	-	 < 0.01	9.03E-01
secretory granule maturation (GO:0061792)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of renin secretion into blood stream (GO:1900134)	1	0	.05	-	 < 0.01	9.50E-01
regulation of renin secretion into blood stream (GO:1900133)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of lipid binding (GO:1900131)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lipid binding (GO:1900130)	1	0	.05	-	 < 0.01	9.50E-01
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	41	0	2.09	-	 < 0.01	1.23E-01
dense core granule priming (GO:0061789)	3	0	.15	-	 < 0.01	8.58E-01
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of hyaluronan biosynthetic process (GO:1900127)	4	0	.20	-	 < 0.01	8.15E-01
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hyaluronan biosynthetic process (GO:1900126)	4	0	.20	-	 < 0.01	8.15E-01
morphogenesis of follicular epithelium (GO:0016333)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hyaluronan biosynthetic process (GO:1900125)	8	0	.41	-	 < 0.01	6.65E-01
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	1	0	.05	-	 < 0.01	9.50E-01
vesicle fusion with vesicle (GO:0061782)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of receptor binding (GO:1900122)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of DNA repair by transcription from RNA polymerase II promoter (GO:0100026)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of execution phase of apoptosis (GO:1900118)	9	0	.46	-	 < 0.01	6.31E-01
neuron remodeling (GO:0016322)	12	0	.61	-	 < 0.01	5.42E-01
xenobiotic transport across blood-nerve barrier (GO:0061772)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of histone H3-K9 trimethylation (GO:1900114)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of histone H3-K9 trimethylation (GO:1900113)	5	0	.26	-	 < 0.01	7.75E-01
endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.10	-	 < 0.01	9.03E-01
regulation of histone H3-K9 trimethylation (GO:1900112)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of histone H3-K9 dimethylation (GO:1900111)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of histone H3-K9 dimethylation (GO:1900110)	2	0	.10	-	 < 0.01	9.03E-01
regulation of histone H3-K9 dimethylation (GO:1900109)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of lung blood pressure (GO:0061767)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nodal signaling pathway (GO:1900108)	3	0	.15	-	 < 0.01	8.58E-01
regulation of nodal signaling pathway (GO:1900107)	6	0	.31	-	 < 0.01	7.36E-01
regulation of heart induction by canonical Wnt signaling pathway (GO:0100012)	1	0	.05	-	 < 0.01	9.50E-01
multivesicular body-lysosome fusion (GO:0061763)	2	0	.10	-	 < 0.01	9.03E-01
CAMKK-AMPK signaling cascade (GO:0061762)	3	0	.15	-	 < 0.01	8.58E-01
antifungal innate immune response (GO:0061760)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of plasma cell differentiation (GO:1900100)	3	0	.15	-	 < 0.01	8.58E-01
low-density lipoprotein particle mediated signaling (GO:0055096)	3	0	.15	-	 < 0.01	8.58E-01
lipoprotein particle mediated signaling (GO:0055095)	3	0	.15	-	 < 0.01	8.58E-01
response to hyperoxia (GO:0055093)	22	0	1.12	-	 < 0.01	3.25E-01
leukocyte adhesion to arterial endothelial cell (GO:0061757)	1	0	.05	-	 < 0.01	9.50E-01
leukocyte adhesion to vascular endothelial cell (GO:0061756)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of protein kinase activity by protein phosphorylation (GO:0100002)	1	0	.05	-	 < 0.01	9.50E-01
regulation of skeletal muscle contraction by action potential (GO:0100001)	1	0	.05	-	 < 0.01	9.50E-01
substrate localization to autophagosome (GO:0061753)	1	0	.05	-	 < 0.01	9.50E-01
fatty acid homeostasis (GO:0055089)	14	0	.72	-	 < 0.01	4.89E-01
motor behavior (GO:0061744)	10	0	.51	-	 < 0.01	6.00E-01
motor learning (GO:0061743)	6	0	.31	-	 < 0.01	7.36E-01
sodium ion homeostasis (GO:0055078)	35	0	1.79	-	 < 0.01	1.67E-01
potassium ion homeostasis (GO:0055075)	29	0	1.48	-	 < 0.01	2.27E-01
cadmium ion homeostasis (GO:0055073)	3	0	.15	-	 < 0.01	8.58E-01
manganese ion homeostasis (GO:0055071)	3	0	.15	-	 < 0.01	8.58E-01
copper ion homeostasis (GO:0055070)	17	0	.87	-	 < 0.01	4.19E-01
carnosine biosynthetic process (GO:0035499)	1	0	.05	-	 < 0.01	9.50E-01
carnosine metabolic process (GO:0035498)	1	0	.05	-	 < 0.01	9.50E-01
protein lipidation involved in autophagosome assembly (GO:0061739)	3	0	.15	-	 < 0.01	8.58E-01
SNARE complex disassembly (GO:0035494)	3	0	.15	-	 < 0.01	8.58E-01
leukotriene signaling pathway (GO:0061737)	5	0	.26	-	 < 0.01	7.75E-01
engulfment of target by autophagosome (GO:0061736)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	0	.05	-	 < 0.01	9.50E-01
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	4	0	.20	-	 < 0.01	8.15E-01
regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	0	.05	-	 < 0.01	9.50E-01
zinc ion homeostasis (GO:0055069)	33	0	1.69	-	 < 0.01	1.85E-01
pyrimidine nucleoside salvage (GO:0043097)	10	0	.51	-	 < 0.01	6.00E-01
purine nucleobase salvage (GO:0043096)	3	0	.15	-	 < 0.01	8.58E-01
regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.05	-	 < 0.01	9.50E-01
gastric emptying (GO:0035483)	2	0	.10	-	 < 0.01	9.03E-01
methylglyoxal catabolic process to lactate (GO:0061727)	4	0	.20	-	 < 0.01	8.15E-01
gastric motility (GO:0035482)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	4	0	.20	-	 < 0.01	8.15E-01
regulation of Notch signaling pathway involved in heart induction (GO:0035480)	4	0	.20	-	 < 0.01	8.15E-01
glycophagy (GO:0061723)	2	0	.10	-	 < 0.01	9.03E-01
penile erection (GO:0043084)	3	0	.15	-	 < 0.01	8.58E-01
miRNA 2'-O-methylation (GO:0061715)	1	0	.05	-	 < 0.01	9.50E-01
anterior neural tube closure (GO:0061713)	1	0	.05	-	 < 0.01	9.50E-01
drug transport (GO:0015893)	10	0	.51	-	 < 0.01	6.00E-01
siderophore transport (GO:0015891)	3	0	.15	-	 < 0.01	8.58E-01
anastral spindle assembly (GO:0055048)	1	0	.05	-	 < 0.01	9.50E-01
determination of pancreatic left/right asymmetry (GO:0035469)	5	0	.26	-	 < 0.01	7.75E-01
cobalamin transport (GO:0015889)	7	0	.36	-	 < 0.01	6.99E-01
thiamine transport (GO:0015888)	4	0	.20	-	 < 0.01	8.15E-01
folic acid transport (GO:0015884)	8	0	.41	-	 < 0.01	6.65E-01
FAD transport (GO:0015883)	2	0	.10	-	 < 0.01	9.03E-01
L-ascorbic acid transmembrane transport (GO:0015882)	2	0	.10	-	 < 0.01	9.03E-01
creatine transmembrane transport (GO:0015881)	3	0	.15	-	 < 0.01	8.58E-01
coenzyme A transport (GO:0015880)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to interferon-beta (GO:0035458)	20	0	1.02	-	 < 0.01	3.60E-01
response to interferon-beta (GO:0035456)	29	0	1.48	-	 < 0.01	2.27E-01
intercellular bridge organization (GO:0043063)	1	0	.05	-	 < 0.01	9.50E-01
carnitine transport (GO:0015879)	4	0	.20	-	 < 0.01	8.15E-01
acetyl-CoA transport (GO:0015876)	1	0	.05	-	 < 0.01	9.50E-01
norepinephrine transport (GO:0015874)	7	0	.36	-	 < 0.01	6.99E-01
dopamine transport (GO:0015872)	12	0	.61	-	 < 0.01	5.42E-01
choline transport (GO:0015871)	7	0	.36	-	 < 0.01	6.99E-01
acetylcholine transport (GO:0015870)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cardiac muscle tissue development (GO:0055026)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardiac muscle tissue development (GO:0055025)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cardiac muscle tissue development (GO:0055024)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.05	-	 < 0.01	9.50E-01
borate transmembrane transport (GO:0035445)	1	0	.05	-	 < 0.01	9.50E-01
nickel cation transmembrane transport (GO:0035444)	1	0	.05	-	 < 0.01	9.50E-01
tripeptide transmembrane transport (GO:0035443)	5	0	.26	-	 < 0.01	7.75E-01
dipeptide transmembrane transport (GO:0035442)	5	0	.26	-	 < 0.01	7.75E-01
cell migration involved in vasculogenesis (GO:0035441)	4	0	.20	-	 < 0.01	8.15E-01
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	5	0	.26	-	 < 0.01	7.75E-01
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	7	0	.36	-	 < 0.01	6.99E-01
ADP transport (GO:0015866)	7	0	.36	-	 < 0.01	6.99E-01
pyrimidine nucleoside transport (GO:0015864)	5	0	.26	-	 < 0.01	7.75E-01
uridine transport (GO:0015862)	5	0	.26	-	 < 0.01	7.75E-01
cytidine transport (GO:0015861)	1	0	.05	-	 < 0.01	9.50E-01
purine nucleoside transmembrane transport (GO:0015860)	4	0	.20	-	 < 0.01	8.15E-01
regulation of cardiac muscle fiber development (GO:0055018)	1	0	.05	-	 < 0.01	9.50E-01
ventricular cardiac muscle cell development (GO:0055015)	11	0	.56	-	 < 0.01	5.70E-01
atrial cardiac muscle cell development (GO:0055014)	2	0	.10	-	 < 0.01	9.03E-01
ventricular cardiac muscle cell differentiation (GO:0055012)	17	0	.87	-	 < 0.01	4.19E-01
atrial cardiac muscle cell differentiation (GO:0055011)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	1	0	.05	-	 < 0.01	9.50E-01
otic placode formation (GO:0043049)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	1	0	.05	-	 < 0.01	9.50E-01
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	2	0	.10	-	 < 0.01	9.03E-01
DNA methylation involved in embryo development (GO:0043045)	6	0	.31	-	 < 0.01	7.36E-01
deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.05	-	 < 0.01	9.50E-01
ribonucleoside diphosphate catabolic process (GO:0009191)	7	0	.36	-	 < 0.01	6.99E-01
copper ion transmembrane transport (GO:0035434)	6	0	.31	-	 < 0.01	7.36E-01
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.05	-	 < 0.01	9.50E-01
nucleoside transport (GO:0015858)	7	0	.36	-	 < 0.01	6.99E-01
pyrimidine nucleobase transport (GO:0015855)	5	0	.26	-	 < 0.01	7.75E-01
guanine transport (GO:0015854)	1	0	.05	-	 < 0.01	9.50E-01
atrial cardiac muscle tissue morphogenesis (GO:0055009)	6	0	.31	-	 < 0.01	7.36E-01
ventricular cardiac myofibril assembly (GO:0055005)	3	0	.15	-	 < 0.01	8.58E-01
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	3	0	.15	-	 < 0.01	8.58E-01
ribonucleoside diphosphate biosynthetic process (GO:0009188)	6	0	.31	-	 < 0.01	7.36E-01
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	4	0	.20	-	 < 0.01	8.15E-01
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.05	-	 < 0.01	9.50E-01
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	2	0	.10	-	 < 0.01	9.03E-01
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	3	0	.15	-	 < 0.01	8.58E-01
autocrine signaling (GO:0035425)	8	0	.41	-	 < 0.01	6.65E-01
purine ribonucleoside diphosphate catabolic process (GO:0009181)	4	0	.20	-	 < 0.01	8.15E-01
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of histone deacetylation (GO:0031064)	5	0	.26	-	 < 0.01	7.75E-01
polyamine transport (GO:0015846)	2	0	.10	-	 < 0.01	9.03E-01
monoamine transport (GO:0015844)	20	0	1.02	-	 < 0.01	3.60E-01
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	4	0	.20	-	 < 0.01	8.15E-01
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	4	0	.20	-	 < 0.01	8.15E-01
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	5	0	.26	-	 < 0.01	7.75E-01
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	10	0	.51	-	 < 0.01	6.00E-01
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	10	0	.51	-	 < 0.01	6.00E-01
purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171)	2	0	.10	-	 < 0.01	9.03E-01
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	3	0	.15	-	 < 0.01	8.58E-01
amino-acid betaine transport (GO:0015838)	6	0	.31	-	 < 0.01	7.36E-01
amine transport (GO:0015837)	8	0	.41	-	 < 0.01	6.65E-01
peptidoglycan transport (GO:0015835)	3	0	.15	-	 < 0.01	8.58E-01
chromosome breakage (GO:0031052)	2	0	.10	-	 < 0.01	9.03E-01
purine ribonucleoside monophosphate catabolic process (GO:0009169)	3	0	.15	-	 < 0.01	8.58E-01
histone H3-Y41 phosphorylation (GO:0035409)	1	0	.05	-	 < 0.01	9.50E-01
nucleoside catabolic process (GO:0009164)	30	0	1.53	-	 < 0.01	2.16E-01
histone H3-T6 phosphorylation (GO:0035408)	2	0	.10	-	 < 0.01	9.03E-01
nucleoside biosynthetic process (GO:0009163)	34	0	1.74	-	 < 0.01	1.76E-01
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	11	0	.56	-	 < 0.01	5.70E-01
histone-tyrosine phosphorylation (GO:0035406)	1	0	.05	-	 < 0.01	9.50E-01
histone-serine phosphorylation (GO:0035404)	11	0	.56	-	 < 0.01	5.70E-01
regulation of fusion of sperm to egg plasma membrane (GO:0043012)	1	0	.05	-	 < 0.01	9.50E-01
programmed DNA elimination (GO:0031049)	2	0	.10	-	 < 0.01	9.03E-01
heterochromatin assembly by small RNA (GO:0031048)	2	0	.10	-	 < 0.01	9.03E-01
valine transport (GO:0015829)	1	0	.05	-	 < 0.01	9.50E-01
tryptophan transport (GO:0015827)	5	0	.26	-	 < 0.01	7.75E-01
threonine transport (GO:0015826)	1	0	.05	-	 < 0.01	9.50E-01
proline transport (GO:0015824)	10	0	.51	-	 < 0.01	6.00E-01
phenylalanine transport (GO:0015823)	2	0	.10	-	 < 0.01	9.03E-01
ornithine transport (GO:0015822)	7	0	.36	-	 < 0.01	6.99E-01
methionine transport (GO:0015821)	1	0	.05	-	 < 0.01	9.50E-01
leucine transport (GO:0015820)	6	0	.31	-	 < 0.01	7.36E-01
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	2	0	.10	-	 < 0.01	9.03E-01
ribonucleoside monophosphate catabolic process (GO:0009158)	3	0	.15	-	 < 0.01	8.58E-01
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	8	0	.41	-	 < 0.01	6.65E-01
purine deoxyribonucleotide catabolic process (GO:0009155)	6	0	.31	-	 < 0.01	7.36E-01
purine ribonucleotide catabolic process (GO:0009154)	29	0	1.48	-	 < 0.01	2.27E-01
maintenance of rDNA (GO:0043007)	2	0	.10	-	 < 0.01	9.03E-01
purine deoxyribonucleotide biosynthetic process (GO:0009153)	5	0	.26	-	 < 0.01	7.75E-01
activation of phospholipase A2 activity by calcium-mediated signaling (GO:0043006)	1	0	.05	-	 < 0.01	9.50E-01
purine deoxyribonucleotide metabolic process (GO:0009151)	11	0	.56	-	 < 0.01	5.70E-01
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.05	-	 < 0.01	9.50E-01
Golgi to plasma membrane CFTR protein transport (GO:0043000)	2	0	.10	-	 < 0.01	9.03E-01
lysine transport (GO:0015819)	1	0	.05	-	 < 0.01	9.50E-01
isoleucine transport (GO:0015818)	1	0	.05	-	 < 0.01	9.50E-01
histidine transport (GO:0015817)	2	0	.10	-	 < 0.01	9.03E-01
glycine transport (GO:0015816)	11	0	.56	-	 < 0.01	5.70E-01
myosin filament assembly (GO:0031034)	3	0	.15	-	 < 0.01	8.58E-01
myosin filament organization (GO:0031033)	3	0	.15	-	 < 0.01	8.58E-01
L-cystine transport (GO:0015811)	4	0	.20	-	 < 0.01	8.15E-01
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	14	0	.72	-	 < 0.01	4.89E-01
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	17	0	.87	-	 < 0.01	4.19E-01
purine nucleoside triphosphate catabolic process (GO:0009146)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.05	-	 < 0.01	9.50E-01
nucleoside triphosphate catabolic process (GO:0009143)	12	0	.61	-	 < 0.01	5.42E-01
pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	2	0	.10	-	 < 0.01	9.03E-01
L-alanine transport (GO:0015808)	10	0	.51	-	 < 0.01	6.00E-01
S-adenosyl-L-methionine transport (GO:0015805)	1	0	.05	-	 < 0.01	9.50E-01
nuclear migration along microfilament (GO:0031022)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	3	0	.15	-	 < 0.01	8.58E-01
purine nucleoside diphosphate catabolic process (GO:0009137)	4	0	.20	-	 < 0.01	8.15E-01
purine nucleoside diphosphate biosynthetic process (GO:0009136)	6	0	.31	-	 < 0.01	7.36E-01
nucleoside diphosphate catabolic process (GO:0009134)	12	0	.61	-	 < 0.01	5.42E-01
nucleoside diphosphate biosynthetic process (GO:0009133)	8	0	.41	-	 < 0.01	6.65E-01
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	1	0	.05	-	 < 0.01	9.50E-01
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	14	0	.72	-	 < 0.01	4.89E-01
endocrine pancreas development (GO:0031018)	39	0	1.99	-	 < 0.01	1.36E-01
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	15	0	.77	-	 < 0.01	4.65E-01
purine nucleoside monophosphate catabolic process (GO:0009128)	4	0	.20	-	 < 0.01	8.15E-01
peptide antigen transport (GO:0046968)	3	0	.15	-	 < 0.01	8.58E-01
nucleoside monophosphate catabolic process (GO:0009125)	6	0	.31	-	 < 0.01	7.36E-01
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	2	0	.10	-	 < 0.01	9.03E-01
deoxyribonucleoside metabolic process (GO:0009120)	8	0	.41	-	 < 0.01	6.65E-01
sensitization (GO:0046960)	2	0	.10	-	 < 0.01	9.03E-01
response to caffeine (GO:0031000)	17	0	.87	-	 < 0.01	4.19E-01
habituation (GO:0046959)	5	0	.26	-	 < 0.01	7.75E-01
R-loop disassembly (GO:0062176)	4	0	.20	-	 < 0.01	8.15E-01
nonassociative learning (GO:0046958)	7	0	.36	-	 < 0.01	6.99E-01
xanthine catabolic process (GO:0009115)	2	0	.10	-	 < 0.01	9.03E-01
purine nucleobase biosynthetic process (GO:0009113)	9	0	.46	-	 < 0.01	6.31E-01
brexanolone metabolic process (GO:0062173)	1	0	.05	-	 < 0.01	9.50E-01
vitamin catabolic process (GO:0009111)	12	0	.61	-	 < 0.01	5.42E-01
ketone body catabolic process (GO:0046952)	4	0	.20	-	 < 0.01	8.15E-01
ketone body biosynthetic process (GO:0046951)	8	0	.41	-	 < 0.01	6.65E-01
cellular ketone body metabolic process (GO:0046950)	10	0	.51	-	 < 0.01	6.00E-01
behavioral response to starvation (GO:0042595)	2	0	.10	-	 < 0.01	9.03E-01
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	7	0	.36	-	 < 0.01	6.99E-01
mitochondrial protein processing (GO:0034982)	11	0	.56	-	 < 0.01	5.70E-01
regulation of chromatin-mediated maintenance of transcription (GO:1904499)	1	0	.05	-	 < 0.01	9.50E-01
lipoate biosynthetic process (GO:0009107)	1	0	.05	-	 < 0.01	9.50E-01
lipoate metabolic process (GO:0009106)	1	0	.05	-	 < 0.01	9.50E-01
hydroxylysine biosynthetic process (GO:0046947)	2	0	.10	-	 < 0.01	9.03E-01
hydroxylysine metabolic process (GO:0046946)	2	0	.10	-	 < 0.01	9.03E-01
lipopolysaccharide catabolic process (GO:0009104)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to ciliary transition zone (GO:1904491)	8	0	.41	-	 < 0.01	6.65E-01
vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.05	-	 < 0.01	9.50E-01
telomere maintenance via base-excision repair (GO:0097698)	1	0	.05	-	 < 0.01	9.50E-01
establishment of protein-containing complex localization to telomere (GO:0097695)	2	0	.10	-	 < 0.01	9.03E-01
establishment of RNA localization to telomere (GO:0097694)	2	0	.10	-	 < 0.01	9.03E-01
histone H3-R26 methylation (GO:0034972)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-R17 methylation (GO:0034971)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-R2 methylation (GO:0034970)	1	0	.05	-	 < 0.01	9.50E-01
response to 17alpha-ethynylestradiol (GO:1904486)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to tetrahydrofolate (GO:1904482)	1	0	.05	-	 < 0.01	9.50E-01
response to tetrahydrofolate (GO:1904481)	1	0	.05	-	 < 0.01	9.50E-01
glutamate receptor clustering (GO:0097688)	4	0	.20	-	 < 0.01	8.15E-01
retinal metabolic process (GO:0042574)	13	0	.66	-	 < 0.01	5.15E-01
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	3	0	.15	-	 < 0.01	8.58E-01
double-strand break repair via classical nonhomologous end joining (GO:0097680)	6	0	.31	-	 < 0.01	7.36E-01
box C/D snoRNA processing (GO:0034963)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transport across blood-brain barrier (GO:0150200)	1	0	.05	-	 < 0.01	9.50E-01
detection of stimulus involved in sensory perception of pain (GO:0062149)	25	0	1.28	-	 < 0.01	2.79E-01
negative regulation of intestinal absorption (GO:1904479)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of neurotransmitter secretion (GO:0046929)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of Ras GTPase binding (GO:1904477)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Ras GTPase binding (GO:1904476)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Ras GTPase binding (GO:1904475)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of endothelin production (GO:1904472)	2	0	.10	-	 < 0.01	9.03E-01
regulation of endothelin production (GO:1904470)	2	0	.10	-	 < 0.01	9.03E-01
endothelin maturation (GO:0034959)	1	0	.05	-	 < 0.01	9.50E-01
pteridine-containing compound catabolic process (GO:0042560)	3	0	.15	-	 < 0.01	8.58E-01
neutrophil chemotaxis (GO:0030593)	73	0	3.73	-	 < 0.01	2.38E-02
DNA ADP-ribosylation (GO:0030592)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of matrix metallopeptidase secretion (GO:1904466)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of matrix metallopeptidase secretion (GO:1904465)	2	0	.10	-	 < 0.01	9.03E-01
regulation of matrix metallopeptidase secretion (GO:1904464)	6	0	.31	-	 < 0.01	7.36E-01
superoxide anion generation (GO:0042554)	14	0	.72	-	 < 0.01	4.89E-01
symbiont intracellular protein transport in host (GO:0030581)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neuronal action potential (GO:1904457)	1	0	.05	-	 < 0.01	9.50E-01
fatty acid primary amide metabolic process (GO:0062126)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of neuronal action potential (GO:1904456)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of aspartate secretion (GO:1904450)	2	0	.10	-	 < 0.01	9.03E-01
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of plasma cell differentiation (GO:1900099)	1	0	.05	-	 < 0.01	9.50E-01
regulation of plasma cell differentiation (GO:1900098)	4	0	.20	-	 < 0.01	8.15E-01
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.10	-	 < 0.01	9.03E-01
regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	1	0	.05	-	 < 0.01	9.50E-01
cell wall biogenesis (GO:0042546)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)	3	0	.15	-	 < 0.01	8.58E-01
protein N-linked glycosylation via arginine (GO:0042543)	1	0	.05	-	 < 0.01	9.50E-01
hemoglobin biosynthetic process (GO:0042541)	6	0	.31	-	 < 0.01	7.36E-01
collagen catabolic process (GO:0030574)	41	0	2.09	-	 < 0.01	1.23E-01
bile acid catabolic process (GO:0030573)	2	0	.10	-	 < 0.01	9.03E-01
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	4	0	.20	-	 < 0.01	8.15E-01
regulation of aspartate secretion (GO:1904448)	2	0	.10	-	 < 0.01	9.03E-01
folate import across plasma membrane (GO:1904447)	5	0	.26	-	 < 0.01	7.75E-01
response to auditory stimulus (GO:0010996)	23	0	1.17	-	 < 0.01	3.09E-01
free ubiquitin chain polymerization (GO:0010994)	5	0	.26	-	 < 0.01	7.75E-01
fatty acid primary amide biosynthetic process (GO:0062112)	1	0	.05	-	 < 0.01	9.50E-01
ubiquitin recycling (GO:0010992)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.05	-	 < 0.01	9.50E-01
zinc ion import into organelle (GO:0062111)	1	0	.05	-	 < 0.01	9.50E-01
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of iron ion import across plasma membrane (GO:1904440)	2	0	.10	-	 < 0.01	9.03E-01
amylin receptor signaling pathway (GO:0097647)	7	0	.36	-	 < 0.01	6.99E-01
hypotonic salinity response (GO:0042539)	2	0	.10	-	 < 0.01	9.03E-01
calcitonin family receptor signaling pathway (GO:0097646)	8	0	.41	-	 < 0.01	6.65E-01
hyperosmotic salinity response (GO:0042538)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085)	1	0	.05	-	 < 0.01	9.50E-01
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of arginine catabolic process (GO:1900082)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	12	0	.61	-	 < 0.01	5.42E-01
L-ornithine import across plasma membrane (GO:0097640)	1	0	.05	-	 < 0.01	9.50E-01
regulation of arginine catabolic process (GO:1900081)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	65	0	3.32	-	 < 0.01	3.59E-02
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.05	-	 < 0.01	9.50E-01
regulation of low-density lipoprotein particle clearance (GO:0010988)	13	0	.66	-	 < 0.01	5.15E-01
regulation of iron ion import across plasma membrane (GO:1904438)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of transferrin receptor binding (GO:1904437)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lipoprotein particle clearance (GO:0010986)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of lipoprotein particle clearance (GO:0010985)	10	0	.51	-	 < 0.01	6.00E-01
regulation of transferrin receptor binding (GO:1904435)	2	0	.10	-	 < 0.01	9.03E-01
regulation of lipoprotein particle clearance (GO:0010984)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of ferrous iron binding (GO:1904434)	2	0	.10	-	 < 0.01	9.03E-01
double-stranded RNA biosynthetic process (GO:0062103)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	2	0	.10	-	 < 0.01	9.03E-01
regulation of high-density lipoprotein particle clearance (GO:0010982)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ferrous iron binding (GO:1904432)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of t-circle formation (GO:1904431)	1	0	.05	-	 < 0.01	9.50E-01
L-lysine import across plasma membrane (GO:0097639)	1	0	.05	-	 < 0.01	9.50E-01
L-arginine import across plasma membrane (GO:0097638)	5	0	.26	-	 < 0.01	7.75E-01
regulation of arginine biosynthetic process (GO:1900079)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of tubulin deacetylation (GO:1904428)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of GTP binding (GO:1904426)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of GTP binding (GO:1904425)	3	0	.15	-	 < 0.01	8.58E-01
regulation of GTP binding (GO:1904424)	14	0	.72	-	 < 0.01	4.89E-01
regulation of cellular hyperosmotic salinity response (GO:1900069)	3	0	.15	-	 < 0.01	8.58E-01
potassium ion export across plasma membrane (GO:0097623)	11	0	.56	-	 < 0.01	5.70E-01
regulation of peroxisome organization (GO:1900063)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of ceramide biosynthetic process (GO:1900060)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of cardiac ventricle development (GO:1904414)	1	0	.05	-	 < 0.01	9.50E-01
O-glycan processing, core 3 (GO:0016269)	1	0	.05	-	 < 0.01	9.50E-01
regulation of L-arginine import (GO:0010963)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cardiac ventricle development (GO:1904412)	1	0	.05	-	 < 0.01	9.50E-01
O-glycan processing, core 1 (GO:0016267)	2	0	.10	-	 < 0.01	9.03E-01
pyrimidine-containing compound salvage (GO:0008655)	10	0	.51	-	 < 0.01	6.00E-01
lipopolysaccharide metabolic process (GO:0008653)	1	0	.05	-	 < 0.01	9.50E-01
selenocysteine catabolic process (GO:0016261)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of retinoic acid biosynthetic process (GO:1900054)	1	0	.05	-	 < 0.01	9.50E-01
selenocysteine biosynthetic process (GO:0016260)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of retinoic acid biosynthetic process (GO:1900053)	1	0	.05	-	 < 0.01	9.50E-01
regulation of retinoic acid biosynthetic process (GO:1900052)	2	0	.10	-	 < 0.01	9.03E-01
embryonic genitalia morphogenesis (GO:0030538)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of nitric oxide metabolic process (GO:1904406)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.15	-	 < 0.01	8.58E-01
selenocysteine metabolic process (GO:0016259)	5	0	.26	-	 < 0.01	7.75E-01
response to Thyroid stimulating hormone (GO:1904400)	1	0	.05	-	 < 0.01	9.50E-01
N-glycan processing to lysosome (GO:0016256)	1	0	.05	-	 < 0.01	9.50E-01
attachment of GPI anchor to protein (GO:0016255)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of intestinal phytosterol absorption (GO:0010949)	2	0	.10	-	 < 0.01	9.03E-01
peptidyl-lysine deglutarylation (GO:0061699)	2	0	.10	-	 < 0.01	9.03E-01
protein deglutarylation (GO:0061698)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cellular response to hypoxia (GO:1900039)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to hypoxia (GO:1900038)	7	0	.36	-	 < 0.01	6.99E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	7	0	.36	-	 < 0.01	6.99E-01
regulation of cellular response to hypoxia (GO:1900037)	12	0	.61	-	 < 0.01	5.42E-01
regulation of autophagosome size (GO:0016243)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular response to heat (GO:1900036)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to heat (GO:1900035)	1	0	.05	-	 < 0.01	9.50E-01
autophagosome membrane docking (GO:0016240)	3	0	.15	-	 < 0.01	8.58E-01
cytoplasmic microtubule depolymerization (GO:0010938)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of macrophage cytokine production (GO:0010936)	5	0	.26	-	 < 0.01	7.75E-01
regulation of macrophage cytokine production (GO:0010935)	15	0	.77	-	 < 0.01	4.65E-01
macrophage cytokine production (GO:0010934)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of macrophage tolerance induction (GO:0010933)	1	0	.05	-	 < 0.01	9.50E-01
regulation of macrophage tolerance induction (GO:0010932)	1	0	.05	-	 < 0.01	9.50E-01
hormone-mediated apoptotic signaling pathway (GO:0008628)	4	0	.20	-	 < 0.01	8.15E-01
detoxification of inorganic compound (GO:0061687)	15	0	.77	-	 < 0.01	4.65E-01
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of ruffle assembly (GO:1900029)	14	0	.72	-	 < 0.01	4.89E-01
granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ruffle assembly (GO:1900028)	6	0	.31	-	 < 0.01	7.36E-01
regulation of ruffle assembly (GO:1900027)	27	0	1.38	-	 < 0.01	2.52E-01
seminal vesicle morphogenesis (GO:0061682)	1	0	.05	-	 < 0.01	9.50E-01
regulation of D-erythro-sphingosine kinase activity (GO:1900022)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein kinase C activity (GO:1900020)	7	0	.36	-	 < 0.01	6.99E-01
inorganic diphosphate transport (GO:0030505)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of bone mineralization (GO:0030502)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.05	-	 < 0.01	9.50E-01
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.05	-	 < 0.01	9.50E-01
iron-sulfur cluster assembly (GO:0016226)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of protein kinase C activity (GO:1900019)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	1	0	.05	-	 < 0.01	9.50E-01
guanosine metabolic process (GO:0008617)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	20	0	1.02	-	 < 0.01	3.60E-01
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.05	-	 < 0.01	9.50E-01
regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.05	-	 < 0.01	9.50E-01
regulation of inositol phosphate biosynthetic process (GO:0010919)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of mitochondrial membrane potential (GO:0010918)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of mitochondrial membrane potential (GO:0010917)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	0	.20	-	 < 0.01	8.15E-01
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	0	.20	-	 < 0.01	8.15E-01
spontaneous neurotransmitter secretion (GO:0061669)	6	0	.31	-	 < 0.01	7.36E-01
mitochondrial ribosome assembly (GO:0061668)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of eating behavior (GO:1903999)	3	0	.15	-	 < 0.01	8.58E-01
regulation of eating behavior (GO:1903998)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dendrite development (GO:1900006)	15	0	.77	-	 < 0.01	4.65E-01
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of serine-type endopeptidase activity (GO:1900005)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of serine-type endopeptidase activity (GO:1900004)	5	0	.26	-	 < 0.01	7.75E-01
regulation of serine-type endopeptidase activity (GO:1900003)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.15	-	 < 0.01	8.58E-01
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of UDP-glucose catabolic process (GO:0010905)	1	0	.05	-	 < 0.01	9.50E-01
regulation of UDP-glucose catabolic process (GO:0010904)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	2	0	.10	-	 < 0.01	9.03E-01
regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	6	0	.31	-	 < 0.01	7.36E-01
iron ion export across plasma membrane (GO:1903988)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phosphatidylcholine catabolic process (GO:0010900)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of microglial cell activation (GO:1903980)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of glial cell migration (GO:1903977)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glial cell migration (GO:1903976)	3	0	.15	-	 < 0.01	8.58E-01
regulation of glial cell migration (GO:1903975)	15	0	.77	-	 < 0.01	4.65E-01
chemorepulsion of axon (GO:0061643)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974)	2	0	.10	-	 < 0.01	9.03E-01
chemoattraction of axon (GO:0061642)	4	0	.20	-	 < 0.01	8.15E-01
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of response to macrophage colony-stimulating factor (GO:1903971)	2	0	.10	-	 < 0.01	9.03E-01
helper T cell enhancement of adaptive immune response (GO:0035397)	1	0	.05	-	 < 0.01	9.50E-01
regulation of response to macrophage colony-stimulating factor (GO:1903969)	5	0	.26	-	 < 0.01	7.75E-01
monounsaturated fatty acid biosynthetic process (GO:1903966)	2	0	.10	-	 < 0.01	9.03E-01
monounsaturated fatty acid catabolic process (GO:1903965)	1	0	.05	-	 < 0.01	9.50E-01
monounsaturated fatty acid metabolic process (GO:1903964)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of anion transmembrane transport (GO:1903961)	12	0	.61	-	 < 0.01	5.42E-01
Roundabout signaling pathway (GO:0035385)	5	0	.26	-	 < 0.01	7.75E-01
sterol transmembrane transport (GO:0035382)	1	0	.05	-	 < 0.01	9.50E-01
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954)	1	0	.05	-	 < 0.01	9.50E-01
glycolytic process from galactose (GO:0061623)	1	0	.05	-	 < 0.01	9.50E-01
glycolytic process through glucose-1-phosphate (GO:0061622)	2	0	.10	-	 < 0.01	9.03E-01
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952)	1	0	.05	-	 < 0.01	9.50E-01
carbon dioxide transmembrane transport (GO:0035378)	2	0	.10	-	 < 0.01	9.03E-01
transepithelial water transport (GO:0035377)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.05	-	 < 0.01	9.50E-01
pri-miRNA transcription by RNA polymerase II (GO:0061614)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hepatocyte apoptotic process (GO:1903944)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hepatocyte apoptotic process (GO:1903943)	2	0	.10	-	 < 0.01	9.03E-01
myo-inositol transport (GO:0015798)	5	0	.26	-	 < 0.01	7.75E-01
mannose to fructose-6-phosphate metabolic process (GO:0061611)	1	0	.05	-	 < 0.01	9.50E-01
mannitol transport (GO:0015797)	1	0	.05	-	 < 0.01	9.50E-01
UDP-xylose transmembrane transport (GO:0015790)	1	0	.05	-	 < 0.01	9.50E-01
thymine transport (GO:0035364)	1	0	.05	-	 < 0.01	9.50E-01
regulation of TORC2 signaling (GO:1903939)	2	0	.10	-	 < 0.01	9.03E-01
response to acrylamide (GO:1903937)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	9	0	.46	-	 < 0.01	6.31E-01
UDP-N-acetylgalactosamine transmembrane transport (GO:0015789)	3	0	.15	-	 < 0.01	8.58E-01
UDP-glucuronic acid transmembrane transport (GO:0015787)	3	0	.15	-	 < 0.01	8.58E-01
UDP-glucose transmembrane transport (GO:0015786)	2	0	.10	-	 < 0.01	9.03E-01
GDP-fucose transmembrane transport (GO:0015783)	1	0	.05	-	 < 0.01	9.50E-01
CMP-N-acetylneuraminate transmembrane transport (GO:0015782)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	3	0	.15	-	 < 0.01	8.58E-01
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	14	0	.72	-	 < 0.01	4.89E-01
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	7	0	.36	-	 < 0.01	6.99E-01
cellular triglyceride homeostasis (GO:0035356)	7	0	.36	-	 < 0.01	6.99E-01
primary palate development (GO:1903929)	2	0	.10	-	 < 0.01	9.03E-01
NAD transmembrane transport (GO:0035352)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to bisphenol A (GO:1903926)	1	0	.05	-	 < 0.01	9.50E-01
response to bisphenol A (GO:1903925)	1	0	.05	-	 < 0.01	9.50E-01
FAD transmembrane transport (GO:0035350)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein processing in phagocytic vesicle (GO:1903921)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of actin filament severing (GO:1903920)	1	0	.05	-	 < 0.01	9.50E-01
polysaccharide transport (GO:0015774)	1	0	.05	-	 < 0.01	9.50E-01
oligosaccharide transport (GO:0015772)	3	0	.15	-	 < 0.01	8.58E-01
sucrose transport (GO:0015770)	3	0	.15	-	 < 0.01	8.58E-01
coenzyme A transmembrane transport (GO:0035349)	2	0	.10	-	 < 0.01	9.03E-01
hypoxanthine transport (GO:0035344)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of actin filament severing (GO:1903919)	2	0	.10	-	 < 0.01	9.03E-01
regulation of actin filament severing (GO:1903918)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917)	1	0	.05	-	 < 0.01	9.50E-01
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	2	0	.10	-	 < 0.01	9.03E-01
regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916)	1	0	.05	-	 < 0.01	9.50E-01
inosine transport (GO:0035340)	1	0	.05	-	 < 0.01	9.50E-01
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	5	0	.26	-	 < 0.01	7.75E-01
disaccharide transport (GO:0015766)	3	0	.15	-	 < 0.01	8.58E-01
regulation of the force of heart contraction by cardiac conduction (GO:0086092)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of receptor clustering (GO:1903910)	1	0	.05	-	 < 0.01	9.50E-01
regulation of heart rate by cardiac conduction (GO:0086091)	36	0	1.84	-	 < 0.01	1.59E-01
glucose-6-phosphate transport (GO:0015760)	6	0	.31	-	 < 0.01	7.36E-01
valine biosynthetic process (GO:0009099)	3	0	.15	-	 < 0.01	8.58E-01
leucine biosynthetic process (GO:0009098)	2	0	.10	-	 < 0.01	9.03E-01
isoleucine biosynthetic process (GO:0009097)	3	0	.15	-	 < 0.01	8.58E-01
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	1	0	.05	-	 < 0.01	9.50E-01
cysteine catabolic process (GO:0009093)	4	0	.20	-	 < 0.01	8.15E-01
homoserine metabolic process (GO:0009092)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of hippo signaling (GO:0035332)	4	0	.20	-	 < 0.01	8.15E-01
regulation of plasma membrane raft polarization (GO:1903906)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of establishment of T cell polarity (GO:1903905)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.05	-	 < 0.01	9.50E-01
regulation of establishment of T cell polarity (GO:1903903)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of viral life cycle (GO:1903902)	29	0	1.48	-	 < 0.01	2.27E-01
galactose transmembrane transport (GO:0015757)	2	0	.10	-	 < 0.01	9.03E-01
fucose transmembrane transport (GO:0015756)	2	0	.10	-	 < 0.01	9.03E-01
fructose transmembrane transport (GO:0015755)	4	0	.20	-	 < 0.01	8.15E-01
pentose transmembrane transport (GO:0015750)	2	0	.10	-	 < 0.01	9.03E-01
hippo signaling (GO:0035329)	27	0	1.38	-	 < 0.01	2.52E-01
lysine biosynthetic process (GO:0009085)	2	0	.10	-	 < 0.01	9.03E-01
branched-chain amino acid biosynthetic process (GO:0009082)	5	0	.26	-	 < 0.01	7.75E-01
pyruvate family amino acid catabolic process (GO:0009080)	5	0	.26	-	 < 0.01	7.75E-01
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	6	0	.31	-	 < 0.01	7.36E-01
urate transport (GO:0015747)	6	0	.31	-	 < 0.01	7.36E-01
citrate transport (GO:0015746)	3	0	.15	-	 < 0.01	8.58E-01
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.05	-	 < 0.01	9.50E-01
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	8	0	.41	-	 < 0.01	6.65E-01
succinate transport (GO:0015744)	5	0	.26	-	 < 0.01	7.75E-01
malate transport (GO:0015743)	3	0	.15	-	 < 0.01	8.58E-01
alpha-ketoglutarate transport (GO:0015742)	4	0	.20	-	 < 0.01	8.15E-01
pyruvate family amino acid metabolic process (GO:0009078)	5	0	.26	-	 < 0.01	7.75E-01
non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.05	-	 < 0.01	9.50E-01
serine family amino acid catabolic process (GO:0009071)	13	0	.66	-	 < 0.01	5.15E-01
wound healing, spreading of epidermal cells (GO:0035313)	10	0	.51	-	 < 0.01	6.00E-01
bundle of His cell to Purkinje myocyte communication (GO:0086069)	13	0	.66	-	 < 0.01	5.15E-01
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	6	0	.31	-	 < 0.01	7.36E-01
AV node cell to bundle of His cell communication (GO:0086067)	10	0	.51	-	 < 0.01	6.00E-01
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	12	0	.61	-	 < 0.01	5.42E-01
cell communication involved in cardiac conduction (GO:0086065)	40	0	2.04	-	 < 0.01	1.29E-01
sialic acid transport (GO:0015739)	5	0	.26	-	 < 0.01	7.75E-01
cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	15	0	.77	-	 < 0.01	4.65E-01
prostaglandin transport (GO:0015732)	6	0	.31	-	 < 0.01	7.36E-01
Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling (GO:0086055)	1	0	.05	-	 < 0.01	9.50E-01
oxaloacetate transport (GO:0015729)	3	0	.15	-	 < 0.01	8.58E-01
bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054)	1	0	.05	-	 < 0.01	9.50E-01
mevalonate transport (GO:0015728)	1	0	.05	-	 < 0.01	9.50E-01
AV node cell to bundle of His cell communication by electrical coupling (GO:0086053)	2	0	.10	-	 < 0.01	9.03E-01
lactate transport (GO:0015727)	7	0	.36	-	 < 0.01	6.99E-01
membrane repolarization during SA node cell action potential (GO:0086052)	1	0	.05	-	 < 0.01	9.50E-01
membrane repolarization during bundle of His cell action potential (GO:0086050)	1	0	.05	-	 < 0.01	9.50E-01
formate transport (GO:0015724)	1	0	.05	-	 < 0.01	9.50E-01
bilirubin transport (GO:0015723)	1	0	.05	-	 < 0.01	9.50E-01
regulation of phosphatidylserine metabolic process (GO:0150178)	1	0	.05	-	 < 0.01	9.50E-01
canalicular bile acid transport (GO:0015722)	4	0	.20	-	 < 0.01	8.15E-01
bile acid and bile salt transport (GO:0015721)	28	0	1.43	-	 < 0.01	2.39E-01
regulation of phosphatidylethanolamine metabolic process (GO:0150175)	1	0	.05	-	 < 0.01	9.50E-01
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	5	0	.26	-	 < 0.01	7.75E-01
pentose-phosphate shunt, oxidative branch (GO:0009051)	4	0	.20	-	 < 0.01	8.15E-01
membrane depolarization during bundle of His cell action potential (GO:0086048)	3	0	.15	-	 < 0.01	8.58E-01
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	3	0	.15	-	 < 0.01	8.58E-01
membrane depolarization during SA node cell action potential (GO:0086046)	4	0	.20	-	 < 0.01	8.15E-01
membrane depolarization during AV node cell action potential (GO:0086045)	5	0	.26	-	 < 0.01	7.75E-01
atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044)	1	0	.05	-	 < 0.01	9.50E-01
bundle of His cell action potential (GO:0086043)	5	0	.26	-	 < 0.01	7.75E-01
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	7	0	.36	-	 < 0.01	6.99E-01
hexose phosphate transport (GO:0015712)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of hormone biosynthetic process (GO:0046886)	8	0	.41	-	 < 0.01	6.65E-01
follicle-stimulating hormone secretion (GO:0046884)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	6	0	.31	-	 < 0.01	7.36E-01
regulation of follicle-stimulating hormone secretion (GO:0046880)	6	0	.31	-	 < 0.01	7.36E-01
thiosulfate transport (GO:0015709)	3	0	.15	-	 < 0.01	8.58E-01
nitrite transport (GO:0015707)	1	0	.05	-	 < 0.01	9.50E-01
nitrate transport (GO:0015706)	1	0	.05	-	 < 0.01	9.50E-01
iodide transport (GO:0015705)	4	0	.20	-	 < 0.01	8.15E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of saliva secretion (GO:0046878)	3	0	.15	-	 < 0.01	8.58E-01
regulation of saliva secretion (GO:0046877)	6	0	.31	-	 < 0.01	7.36E-01
stomach development (GO:0062094)	2	0	.10	-	 < 0.01	9.03E-01
quinolinate metabolic process (GO:0046874)	4	0	.20	-	 < 0.01	8.15E-01
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	5	0	.26	-	 < 0.01	7.75E-01
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	5	0	.26	-	 < 0.01	7.75E-01
AV node cell to bundle of His cell signaling (GO:0086027)	7	0	.36	-	 < 0.01	6.99E-01
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	11	0	.56	-	 < 0.01	5.70E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024)	1	0	.05	-	 < 0.01	9.50E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	4	0	.20	-	 < 0.01	8.15E-01
SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021)	2	0	.10	-	 < 0.01	9.03E-01
cell-cell junction disassembly (GO:0150147)	1	0	.05	-	 < 0.01	9.50E-01
cell junction disassembly (GO:0150146)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of CD80 production (GO:0150145)	1	0	.05	-	 < 0.01	9.50E-01
regulation of CD80 production (GO:0150143)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of CD86 production (GO:0150142)	1	0	.05	-	 < 0.01	9.50E-01
regulation of CD86 production (GO:0150140)	1	0	.05	-	 < 0.01	9.50E-01
terpenoid transport (GO:0046865)	2	0	.10	-	 < 0.01	9.03E-01
isoprenoid transport (GO:0046864)	2	0	.10	-	 < 0.01	9.03E-01
cell-cell signaling involved in cardiac conduction (GO:0086019)	24	0	1.23	-	 < 0.01	2.93E-01
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	7	0	.36	-	 < 0.01	6.99E-01
Purkinje myocyte action potential (GO:0086017)	3	0	.15	-	 < 0.01	8.58E-01
AV node cell action potential (GO:0086016)	7	0	.36	-	 < 0.01	6.99E-01
SA node cell action potential (GO:0086015)	7	0	.36	-	 < 0.01	6.99E-01
atrial cardiac muscle cell action potential (GO:0086014)	11	0	.56	-	 < 0.01	5.70E-01
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	17	0	.87	-	 < 0.01	4.19E-01
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	16	0	.82	-	 < 0.01	4.41E-01
membrane repolarization during action potential (GO:0086011)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of bone remodeling (GO:0046851)	18	0	.92	-	 < 0.01	3.99E-01
membrane repolarization (GO:0086009)	20	0	1.02	-	 < 0.01	3.60E-01
detection of diacyl bacterial lipopeptide (GO:0042496)	2	0	.10	-	 < 0.01	9.03E-01
ventricular cardiac muscle cell action potential (GO:0086005)	19	0	.97	-	 < 0.01	3.79E-01
detection of triacyl bacterial lipopeptide (GO:0042495)	2	0	.10	-	 < 0.01	9.03E-01
detection of bacterial lipoprotein (GO:0042494)	5	0	.26	-	 < 0.01	7.75E-01
cardiac muscle cell contraction (GO:0086003)	40	0	2.04	-	 < 0.01	1.29E-01
cardiac muscle cell action potential involved in contraction (GO:0086002)	35	0	1.79	-	 < 0.01	1.67E-01
gamma-delta T cell differentiation (GO:0042492)	5	0	.26	-	 < 0.01	7.75E-01
cardiac muscle cell action potential (GO:0086001)	46	0	2.35	-	 < 0.01	9.51E-02
positive regulation of interleukin-33 production (GO:0150129)	1	0	.05	-	 < 0.01	9.50E-01
regulation of interleukin-33 production (GO:0150127)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neuromuscular junction development (GO:1904398)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of neuromuscular junction development (GO:1904397)	1	0	.05	-	 < 0.01	9.50E-01
filopodium assembly (GO:0046847)	18	0	.92	-	 < 0.01	3.99E-01
regulation of neuromuscular junction development (GO:1904396)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	0	.05	-	 < 0.01	9.50E-01
response to ciliary neurotrophic factor (GO:1904391)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of odontogenesis of dentin-containing tooth (GO:0042488)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of odontogenesis (GO:0042483)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of eye photoreceptor cell development (GO:0042480)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cholesterol esterification (GO:0150110)	1	0	.05	-	 < 0.01	9.50E-01
rod bipolar cell differentiation (GO:1904389)	1	0	.05	-	 < 0.01	9.50E-01
glycolipid transport (GO:0046836)	7	0	.36	-	 < 0.01	6.99E-01
response to sodium phosphate (GO:1904383)	2	0	.10	-	 < 0.01	9.03E-01
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.10	-	 < 0.01	9.03E-01
Golgi apparatus mannose trimming (GO:1904381)	3	0	.15	-	 < 0.01	8.58E-01
regulation of eye photoreceptor cell development (GO:0042478)	2	0	.10	-	 < 0.01	9.03E-01
outer ear morphogenesis (GO:0042473)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of protein localization to cell-cell junction (GO:0150107)	1	0	.05	-	 < 0.01	9.50E-01
reactive gliosis (GO:0150103)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of monocyte activation (GO:0150102)	2	0	.10	-	 < 0.01	9.03E-01
protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379)	1	0	.05	-	 < 0.01	9.50E-01
maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein export from nucleus (GO:0046826)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044)	2	0	.10	-	 < 0.01	9.03E-01
response to kainic acid (GO:1904373)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of nucleocytoplasmic transport (GO:0046823)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.05	-	 < 0.01	9.50E-01
eye photoreceptor cell development (GO:0042462)	33	0	1.69	-	 < 0.01	1.85E-01
photoreceptor cell development (GO:0042461)	46	0	2.35	-	 < 0.01	9.51E-02
fatty acid elongation (GO:0030497)	11	0	.56	-	 < 0.01	5.70E-01
sensory perception of cold stimulus (GO:0062035)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mitotic sister chromatid segregation (GO:0062033)	2	0	.10	-	 < 0.01	9.03E-01
coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.05	-	 < 0.01	9.50E-01
receptor-mediated virion attachment to host cell (GO:0046813)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of stress granule assembly (GO:0062030)	1	0	.05	-	 < 0.01	9.50E-01
ribonucleoside biosynthetic process (GO:0042455)	19	0	.97	-	 < 0.01	3.79E-01
ribonucleoside catabolic process (GO:0042454)	21	0	1.07	-	 < 0.01	3.42E-01
purine nucleoside biosynthetic process (GO:0042451)	19	0	.97	-	 < 0.01	3.79E-01
arginine biosynthetic process via ornithine (GO:0042450)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of stress granule assembly (GO:0062029)	2	0	.10	-	 < 0.01	9.03E-01
regulation of stress granule assembly (GO:0062028)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	0	.05	-	 < 0.01	9.50E-01
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein catabolic process in the vacuole (GO:1904351)	4	0	.20	-	 < 0.01	8.15E-01
photoreceptor cell morphogenesis (GO:0008594)	4	0	.20	-	 < 0.01	8.15E-01
calcium ion transmembrane import into cytosol (GO:0097553)	60	0	3.06	-	 < 0.01	4.64E-02
regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.05	-	 < 0.01	9.50E-01
mitochondrial double-strand break repair (GO:0097551)	1	0	.05	-	 < 0.01	9.50E-01
nuclear migration along microtubule (GO:0030473)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of small intestine smooth muscle contraction (GO:1904349)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of triglyceride catabolic process (GO:0010898)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of triglyceride catabolic process (GO:0010897)	5	0	.26	-	 < 0.01	7.75E-01
regulation of small intestine smooth muscle contraction (GO:1904347)	3	0	.15	-	 < 0.01	8.58E-01
regulation of triglyceride catabolic process (GO:0010896)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of gastric mucosal blood circulation (GO:1904346)	2	0	.10	-	 < 0.01	9.03E-01
regulation of gastric mucosal blood circulation (GO:1904344)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of colon smooth muscle contraction (GO:1904343)	1	0	.05	-	 < 0.01	9.50E-01
axon midline choice point recognition (GO:0016199)	5	0	.26	-	 < 0.01	7.75E-01
axon choice point recognition (GO:0016198)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of sequestering of triglyceride (GO:0010891)	5	0	.26	-	 < 0.01	7.75E-01
regulation of colon smooth muscle contraction (GO:1904341)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of sequestering of triglyceride (GO:0010890)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of dopaminergic neuron differentiation (GO:1904340)	4	0	.20	-	 < 0.01	8.15E-01
indole-containing compound catabolic process (GO:0042436)	10	0	.51	-	 < 0.01	6.00E-01
indole-containing compound biosynthetic process (GO:0042435)	4	0	.20	-	 < 0.01	8.15E-01
synaptic vesicle uncoating (GO:0016191)	5	0	.26	-	 < 0.01	7.75E-01
regulation of synaptic growth at neuromuscular junction (GO:0008582)	5	0	.26	-	 < 0.01	7.75E-01
indole metabolic process (GO:0042431)	1	0	.05	-	 < 0.01	9.50E-01
regulation of sequestering of triglyceride (GO:0010889)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of cholesterol storage (GO:0010886)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of lipid storage (GO:0010884)	25	0	1.28	-	 < 0.01	2.79E-01
negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)	1	0	.05	-	 < 0.01	9.50E-01
regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)	1	0	.05	-	 < 0.01	9.50E-01
synaptic vesicle maturation (GO:0016188)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000)	1	0	.05	-	 < 0.01	9.50E-01
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	7	0	.36	-	 < 0.01	6.99E-01
thymus epithelium morphogenesis (GO:0097536)	2	0	.10	-	 < 0.01	9.03E-01
serotonin biosynthetic process (GO:0042427)	3	0	.15	-	 < 0.01	8.58E-01
lymphoid lineage cell migration into thymus (GO:0097535)	2	0	.10	-	 < 0.01	9.03E-01
choline catabolic process (GO:0042426)	6	0	.31	-	 < 0.01	7.36E-01
synaptic vesicle budding from endosome (GO:0016182)	1	0	.05	-	 < 0.01	9.50E-01
lymphoid lineage cell migration (GO:0097534)	2	0	.10	-	 < 0.01	9.03E-01
catecholamine catabolic process (GO:0042424)	7	0	.36	-	 < 0.01	6.99E-01
catecholamine biosynthetic process (GO:0042423)	19	0	.97	-	 < 0.01	3.79E-01
mast cell migration (GO:0097531)	6	0	.31	-	 < 0.01	7.36E-01
granulocyte migration (GO:0097530)	92	0	4.70	-	 < 0.01	8.98E-03
norepinephrine biosynthetic process (GO:0042421)	6	0	.31	-	 < 0.01	7.36E-01
dopamine catabolic process (GO:0042420)	6	0	.31	-	 < 0.01	7.36E-01
regulation of complement activation, alternative pathway (GO:0030451)	3	0	.15	-	 < 0.01	8.58E-01
regulation of complement activation, classical pathway (GO:0030450)	4	0	.20	-	 < 0.01	8.15E-01
cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.05	-	 < 0.01	9.50E-01
cholesterol storage (GO:0010878)	2	0	.10	-	 < 0.01	9.03E-01
regulation of myofibroblast contraction (GO:1904328)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to cytosolic proteasome complex (GO:1904327)	1	0	.05	-	 < 0.01	9.50E-01
lipid transport involved in lipid storage (GO:0010877)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cholesterol esterification (GO:0010873)	9	0	.46	-	 < 0.01	6.31E-01
regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323)	1	0	.05	-	 < 0.01	9.50E-01
myeloid leukocyte migration (GO:0097529)	118	0	6.03	-	 < 0.01	2.36E-03
epinephrine biosynthetic process (GO:0042418)	2	0	.10	-	 < 0.01	9.03E-01
dopamine metabolic process (GO:0042417)	26	0	1.33	-	 < 0.01	2.65E-01
dopamine biosynthetic process (GO:0042416)	10	0	.51	-	 < 0.01	6.00E-01
epinephrine metabolic process (GO:0042414)	3	0	.15	-	 < 0.01	8.58E-01
carnitine catabolic process (GO:0042413)	1	0	.05	-	 < 0.01	9.50E-01
taurine biosynthetic process (GO:0042412)	2	0	.10	-	 < 0.01	9.03E-01
regulation of complement activation (GO:0030449)	50	0	2.55	-	 < 0.01	7.75E-02
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317)	1	0	.05	-	 < 0.01	9.50E-01
response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of phospholipase C activity (GO:0010863)	46	0	2.35	-	 < 0.01	9.51E-02
response to methamphetamine hydrochloride (GO:1904313)	2	0	.10	-	 < 0.01	9.03E-01
cristae formation (GO:0042407)	22	0	1.12	-	 < 0.01	3.25E-01
thyroid hormone catabolic process (GO:0042404)	1	0	.05	-	 < 0.01	9.50E-01
thyroid hormone metabolic process (GO:0042403)	22	0	1.12	-	 < 0.01	3.25E-01
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.05	-	 < 0.01	9.50E-01
peristalsis (GO:0030432)	10	0	.51	-	 < 0.01	6.00E-01
response to desipramine (GO:1904307)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	5	0	.26	-	 < 0.01	7.75E-01
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of maternal process involved in parturition (GO:1904303)	1	0	.05	-	 < 0.01	9.50E-01
regulation of maternal process involved in parturition (GO:1904301)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcytosis (GO:1904300)	2	0	.10	-	 < 0.01	9.03E-01
sialylation (GO:0097503)	19	0	.97	-	 < 0.01	3.79E-01
stress response to metal ion (GO:0097501)	15	0	.77	-	 < 0.01	4.65E-01
receptor localization to non-motile cilium (GO:0097500)	2	0	.10	-	 < 0.01	9.03E-01
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	4	0	.20	-	 < 0.01	8.15E-01
defecation (GO:0030421)	1	0	.05	-	 < 0.01	9.50E-01
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chromatin disassembly (GO:0010848)	2	0	.10	-	 < 0.01	9.03E-01
regulation of chromatin assembly (GO:0010847)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of reciprocal meiotic recombination (GO:0010845)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	2	0	.10	-	 < 0.01	9.03E-01
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	3	0	.15	-	 < 0.01	8.58E-01
glycoside catabolic process (GO:0016139)	9	0	.46	-	 < 0.01	6.31E-01
glycoside metabolic process (GO:0016137)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of myotube differentiation (GO:0010831)	11	0	.56	-	 < 0.01	5.70E-01
brassinosteroid biosynthetic process (GO:0016132)	1	0	.05	-	 < 0.01	9.50E-01
intestinal epithelial cell migration (GO:0061582)	2	0	.10	-	 < 0.01	9.03E-01
brassinosteroid metabolic process (GO:0016131)	1	0	.05	-	 < 0.01	9.50E-01
colon epithelial cell migration (GO:0061580)	1	0	.05	-	 < 0.01	9.50E-01
DNA-templated viral transcription (GO:0039695)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glucose transmembrane transport (GO:0010829)	17	0	.87	-	 < 0.01	4.19E-01
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of centrosome duplication (GO:0010825)	3	0	.15	-	 < 0.01	8.58E-01
phytosteroid biosynthetic process (GO:0016129)	1	0	.05	-	 < 0.01	9.50E-01
phytosteroid metabolic process (GO:0016128)	1	0	.05	-	 < 0.01	9.50E-01
sterol catabolic process (GO:0016127)	11	0	.56	-	 < 0.01	5.70E-01
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	0	.15	-	 < 0.01	8.58E-01
xanthophyll biosynthetic process (GO:0016123)	1	0	.05	-	 < 0.01	9.50E-01
xanthophyll metabolic process (GO:0016122)	2	0	.10	-	 < 0.01	9.03E-01
carotene catabolic process (GO:0016121)	1	0	.05	-	 < 0.01	9.50E-01
negative stranded viral RNA replication (GO:0039689)	3	0	.15	-	 < 0.01	8.58E-01
T cell chemotaxis (GO:0010818)	13	0	.66	-	 < 0.01	5.15E-01
calcitonin catabolic process (GO:0010816)	1	0	.05	-	 < 0.01	9.50E-01
bradykinin catabolic process (GO:0010815)	5	0	.26	-	 < 0.01	7.75E-01
substance P catabolic process (GO:0010814)	1	0	.05	-	 < 0.01	9.50E-01
neuropeptide catabolic process (GO:0010813)	2	0	.10	-	 < 0.01	9.03E-01
carotene metabolic process (GO:0016119)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	4	0	.20	-	 < 0.01	8.15E-01
carotenoid biosynthetic process (GO:0016117)	1	0	.05	-	 < 0.01	9.50E-01
carotenoid metabolic process (GO:0016116)	2	0	.10	-	 < 0.01	9.03E-01
terpenoid catabolic process (GO:0016115)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	2	0	.10	-	 < 0.01	9.03E-01
regulation of ATF6-mediated unfolded protein response (GO:1903891)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of synaptic vesicle priming (GO:0010808)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic vesicle priming (GO:0010807)	6	0	.31	-	 < 0.01	7.36E-01
tetraterpenoid biosynthetic process (GO:0016109)	1	0	.05	-	 < 0.01	9.50E-01
tetraterpenoid metabolic process (GO:0016108)	2	0	.10	-	 < 0.01	9.03E-01
sesquiterpenoid catabolic process (GO:0016107)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.05	-	 < 0.01	9.50E-01
triterpenoid biosynthetic process (GO:0016104)	1	0	.05	-	 < 0.01	9.50E-01
diterpenoid catabolic process (GO:0016103)	4	0	.20	-	 < 0.01	8.15E-01
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.05	-	 < 0.01	9.50E-01
diterpenoid biosynthetic process (GO:0016102)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.05	-	 < 0.01	9.50E-01
ganglion morphogenesis (GO:0061552)	2	0	.10	-	 < 0.01	9.03E-01
trigeminal ganglion development (GO:0061551)	5	0	.26	-	 < 0.01	7.75E-01
cranial ganglion development (GO:0061550)	6	0	.31	-	 < 0.01	7.36E-01
regulation of interleukin-17-mediated signaling pathway (GO:1903881)	1	0	.05	-	 < 0.01	9.50E-01
membrane fusion involved in viral entry into host cell (GO:0039663)	7	0	.36	-	 < 0.01	6.99E-01
sympathetic ganglion development (GO:0061549)	8	0	.41	-	 < 0.01	6.65E-01
ganglion development (GO:0061548)	15	0	.77	-	 < 0.01	4.65E-01
fusion of virus membrane with host endosome membrane (GO:0039654)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process (GO:0039650)	1	0	.05	-	 < 0.01	9.50E-01
glycine secretion, neurotransmission (GO:0061537)	1	0	.05	-	 < 0.01	9.50E-01
glycine secretion (GO:0061536)	1	0	.05	-	 < 0.01	9.50E-01
glutamate secretion, neurotransmission (GO:0061535)	1	0	.05	-	 < 0.01	9.50E-01
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	1	0	.05	-	 < 0.01	9.50E-01
trunk segmentation (GO:0035290)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of oxidative phosphorylation (GO:1903862)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of dendrite extension (GO:1903861)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of dendrite extension (GO:1903860)	1	0	.05	-	 < 0.01	9.50E-01
regulation of dendrite extension (GO:1903859)	22	0	1.12	-	 < 0.01	3.25E-01
brain segmentation (GO:0035284)	3	0	.15	-	 < 0.01	8.58E-01
central nervous system segmentation (GO:0035283)	3	0	.15	-	 < 0.01	8.58E-01
acetylcholine secretion (GO:0061526)	1	0	.05	-	 < 0.01	9.50E-01
hindgut development (GO:0061525)	8	0	.41	-	 < 0.01	6.65E-01
pre-miRNA export from nucleus (GO:0035281)	2	0	.10	-	 < 0.01	9.03E-01
cilium disassembly (GO:0061523)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cristae formation (GO:1903852)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cristae formation (GO:1903850)	4	0	.20	-	 < 0.01	8.15E-01
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	1	0	.05	-	 < 0.01	9.50E-01
macrophage homeostasis (GO:0061519)	1	0	.05	-	 < 0.01	9.50E-01
microglial cell proliferation (GO:0061518)	6	0	.31	-	 < 0.01	7.36E-01
macrophage proliferation (GO:0061517)	6	0	.31	-	 < 0.01	7.36E-01
interleukin-34-mediated signaling pathway (GO:0061514)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	3	0	.15	-	 < 0.01	8.58E-01
protein localization to cilium (GO:0061512)	47	0	2.40	-	 < 0.01	9.03E-02
cellular response to arsenite ion (GO:1903843)	5	0	.26	-	 < 0.01	7.75E-01
response to arsenite ion (GO:1903842)	5	0	.26	-	 < 0.01	7.75E-01
centriole elongation (GO:0061511)	2	0	.10	-	 < 0.01	9.03E-01
quaternary ammonium group transport (GO:0015697)	10	0	.51	-	 < 0.01	6.00E-01
cellular response to arsenite(3-) (GO:1903841)	2	0	.10	-	 < 0.01	9.03E-01
ammonium transport (GO:0015696)	10	0	.51	-	 < 0.01	6.00E-01
response to arsenite(3-) (GO:1903840)	2	0	.10	-	 < 0.01	9.03E-01
organic cation transport (GO:0015695)	32	0	1.63	-	 < 0.01	1.95E-01
mercury ion transport (GO:0015694)	1	0	.05	-	 < 0.01	9.50E-01
lead ion transport (GO:0015692)	1	0	.05	-	 < 0.01	9.50E-01
cadmium ion transport (GO:0015691)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.05	-	 < 0.01	9.50E-01
gonad morphogenesis (GO:0035262)	2	0	.10	-	 < 0.01	9.03E-01
external genitalia morphogenesis (GO:0035261)	2	0	.10	-	 < 0.01	9.03E-01
molybdate ion transport (GO:0015689)	1	0	.05	-	 < 0.01	9.50E-01
early endosome to recycling endosome transport (GO:0061502)	2	0	.10	-	 < 0.01	9.03E-01
protein maturation by copper ion transfer (GO:0015680)	2	0	.10	-	 < 0.01	9.03E-01
plasma membrane copper ion transport (GO:0015679)	1	0	.05	-	 < 0.01	9.50E-01
copper ion import (GO:0015677)	5	0	.26	-	 < 0.01	7.75E-01
vanadium ion transport (GO:0015676)	1	0	.05	-	 < 0.01	9.50E-01
nickel cation transport (GO:0015675)	1	0	.05	-	 < 0.01	9.50E-01
oxygen transport (GO:0015671)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of voltage-gated potassium channel activity (GO:1903818)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of voltage-gated potassium channel activity (GO:1903817)	11	0	.56	-	 < 0.01	5.70E-01
L-serine import across plasma membrane (GO:1903812)	1	0	.05	-	 < 0.01	9.50E-01
L-histidine import across plasma membrane (GO:1903810)	1	0	.05	-	 < 0.01	9.50E-01
ectopic germ cell programmed cell death (GO:0035234)	7	0	.36	-	 < 0.01	6.99E-01
L-isoleucine import across plasma membrane (GO:1903806)	1	0	.05	-	 < 0.01	9.50E-01
glycine import across plasma membrane (GO:1903804)	2	0	.10	-	 < 0.01	9.03E-01
L-glutamine import across plasma membrane (GO:1903803)	1	0	.05	-	 < 0.01	9.50E-01
L-leucine import across plasma membrane (GO:1903801)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.05	-	 < 0.01	9.50E-01
neuron-glial cell signaling (GO:0150099)	5	0	.26	-	 < 0.01	7.75E-01
glial cell-neuron signaling (GO:0150098)	4	0	.20	-	 < 0.01	8.15E-01
multiple spine synapse organization, single dendrite (GO:0150090)	1	0	.05	-	 < 0.01	9.50E-01
cell competition in a multicellular organism (GO:0035212)	1	0	.05	-	 < 0.01	9.50E-01
multiple spine synapse organization (GO:0150089)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neuroinflammatory response (GO:0150078)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of arginase activity (GO:0150072)	1	0	.05	-	 < 0.01	9.50E-01
regulation of arginase activity (GO:0150070)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of deacetylase activity (GO:0150066)	2	0	.10	-	 < 0.01	9.03E-01
regulation of deacetylase activity (GO:0150065)	12	0	.61	-	 < 0.01	5.42E-01
vertebrate eye-specific patterning (GO:0150064)	3	0	.15	-	 < 0.01	8.58E-01
complement-mediated synapse pruning (GO:0150062)	3	0	.15	-	 < 0.01	8.58E-01
viral replication complex formation and maintenance (GO:0046786)	1	0	.05	-	 < 0.01	9.50E-01
viral mRNA export from host cell nucleus (GO:0046784)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of protein localization to lysosome (GO:0150033)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein localization to lysosome (GO:0150032)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein localization to lysosome (GO:0150031)	3	0	.15	-	 < 0.01	8.58E-01
phosphagen biosynthetic process (GO:0042396)	3	0	.15	-	 < 0.01	8.58E-01
oxidised low-density lipoprotein particle clearance (GO:0150024)	1	0	.05	-	 < 0.01	9.50E-01
basal dendrite arborization (GO:0150020)	3	0	.15	-	 < 0.01	8.58E-01
regulation of transcytosis (GO:1904298)	2	0	.10	-	 < 0.01	9.03E-01
viral capsid secondary envelopment (GO:0046745)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ERAD pathway (GO:1904293)	6	0	.31	-	 < 0.01	7.36E-01
protein localization to non-motile cilium (GO:0097499)	7	0	.36	-	 < 0.01	6.99E-01
endothelial tube lumen extension (GO:0097498)	2	0	.10	-	 < 0.01	9.03E-01
blood vessel endothelial cell delamination (GO:0097497)	1	0	.05	-	 < 0.01	9.50E-01
response to histamine (GO:0034776)	11	0	.56	-	 < 0.01	5.70E-01
glutathione transmembrane transport (GO:0034775)	4	0	.20	-	 < 0.01	8.15E-01
sympathetic neuron projection guidance (GO:0097491)	4	0	.20	-	 < 0.01	8.15E-01
sympathetic neuron projection extension (GO:0097490)	4	0	.20	-	 < 0.01	8.15E-01
basal dendrite morphogenesis (GO:0150019)	3	0	.15	-	 < 0.01	8.58E-01
basal dendrite development (GO:0150018)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282)	1	0	.05	-	 < 0.01	9.50E-01
basement membrane disassembly (GO:0034769)	3	0	.15	-	 < 0.01	8.58E-01
vitamin K catabolic process (GO:0042377)	4	0	.20	-	 < 0.01	8.15E-01
phylloquinone catabolic process (GO:0042376)	5	0	.26	-	 < 0.01	7.75E-01
phylloquinone metabolic process (GO:0042374)	5	0	.26	-	 < 0.01	7.75E-01
vitamin K metabolic process (GO:0042373)	8	0	.41	-	 < 0.01	6.65E-01
vitamin K biosynthetic process (GO:0042371)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of iron ion transmembrane transport (GO:0034761)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of iron ion transmembrane transport (GO:0034760)	3	0	.15	-	 < 0.01	8.58E-01
regulation of spontaneous synaptic transmission (GO:0150003)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation by virus of viral protein levels in host cell (GO:0046726)	3	0	.15	-	 < 0.01	8.58E-01
tricellular tight junction assembly (GO:1904274)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.10	-	 < 0.01	9.03E-01
L-alanine import across plasma membrane (GO:1904273)	3	0	.15	-	 < 0.01	8.58E-01
oxalic acid secretion (GO:0046724)	2	0	.10	-	 < 0.01	9.03E-01
L-proline import across plasma membrane (GO:1904271)	2	0	.10	-	 < 0.01	9.03E-01
lactic acid secretion (GO:0046722)	1	0	.05	-	 < 0.01	9.50E-01
pyroptosome complex assembly (GO:1904270)	1	0	.05	-	 < 0.01	9.50E-01
vitamin D catabolic process (GO:0042369)	3	0	.15	-	 < 0.01	8.58E-01
lateral motor column neuron migration (GO:0097477)	3	0	.15	-	 < 0.01	8.58E-01
vitamin D biosynthetic process (GO:0042368)	4	0	.20	-	 < 0.01	8.15E-01
spinal cord motor neuron migration (GO:0097476)	4	0	.20	-	 < 0.01	8.15E-01
regulation of iron ion transmembrane transport (GO:0034759)	5	0	.26	-	 < 0.01	7.75E-01
motor neuron migration (GO:0097475)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of iron ion transport (GO:0034758)	2	0	.10	-	 < 0.01	9.03E-01
retinal cone cell apoptotic process (GO:0097474)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of iron ion transport (GO:0034757)	3	0	.15	-	 < 0.01	8.58E-01
water-soluble vitamin catabolic process (GO:0042365)	1	0	.05	-	 < 0.01	9.50E-01
retinal rod cell apoptotic process (GO:0097473)	1	0	.05	-	 < 0.01	9.50E-01
regulation of iron ion transport (GO:0034756)	8	0	.41	-	 < 0.01	6.65E-01
iron ion transmembrane transport (GO:0034755)	12	0	.61	-	 < 0.01	5.42E-01
fat-soluble vitamin catabolic process (GO:0042363)	11	0	.56	-	 < 0.01	5.70E-01
fat-soluble vitamin biosynthetic process (GO:0042362)	6	0	.31	-	 < 0.01	7.36E-01
menaquinone catabolic process (GO:0042361)	4	0	.20	-	 < 0.01	8.15E-01
vitamin E metabolic process (GO:0042360)	4	0	.20	-	 < 0.01	8.15E-01
membrane disassembly (GO:0030397)	15	0	.77	-	 < 0.01	4.65E-01
fructoselysine metabolic process (GO:0030393)	1	0	.05	-	 < 0.01	9.50E-01
regulation by virus of viral protein levels in host cell (GO:0046719)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of Schwann cell chemotaxis (GO:1904268)	1	0	.05	-	 < 0.01	9.50E-01
acid secretion (GO:0046717)	19	0	.97	-	 < 0.01	3.79E-01
regulation of Schwann cell chemotaxis (GO:1904266)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of TORC1 signaling (GO:1904262)	10	0	.51	-	 < 0.01	6.00E-01
borate transport (GO:0046713)	1	0	.05	-	 < 0.01	9.50E-01
GDP catabolic process (GO:0046712)	1	0	.05	-	 < 0.01	9.50E-01
programmed cell death in response to reactive oxygen species (GO:0097468)	3	0	.15	-	 < 0.01	8.58E-01
GDP biosynthetic process (GO:0046711)	1	0	.05	-	 < 0.01	9.50E-01
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	5	0	.26	-	 < 0.01	7.75E-01
thiamine diphosphate metabolic process (GO:0042357)	2	0	.10	-	 < 0.01	9.03E-01
L-fucose catabolic process (GO:0042355)	9	0	.46	-	 < 0.01	6.31E-01
L-fucose metabolic process (GO:0042354)	9	0	.46	-	 < 0.01	6.31E-01
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	2	0	.10	-	 < 0.01	9.03E-01
GDP-L-fucose biosynthetic process (GO:0042350)	2	0	.10	-	 < 0.01	9.03E-01
fructosamine metabolic process (GO:0030389)	2	0	.10	-	 < 0.01	9.03E-01
sperm mitochondrion organization (GO:0030382)	2	0	.10	-	 < 0.01	9.03E-01
IDP catabolic process (GO:0046709)	2	0	.10	-	 < 0.01	9.03E-01
IDP metabolic process (GO:0046707)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of iron ion transmembrane transporter activity (GO:1904256)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of iron ion transmembrane transporter activity (GO:1904255)	1	0	.05	-	 < 0.01	9.50E-01
regulation of iron ion transmembrane transporter activity (GO:1904254)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of bile acid metabolic process (GO:1904252)	2	0	.10	-	 < 0.01	9.03E-01
keratan sulfate catabolic process (GO:0042340)	12	0	.61	-	 < 0.01	5.42E-01
regulation of multivesicular body size involved in endosome transport (GO:0010797)	1	0	.05	-	 < 0.01	9.50E-01
regulation of multivesicular body size (GO:0010796)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mRNA export from nucleus (GO:0010793)	5	0	.26	-	 < 0.01	7.75E-01
monoterpenoid metabolic process (GO:0016098)	6	0	.31	-	 < 0.01	7.36E-01
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-K79 methylation (GO:0034729)	1	0	.05	-	 < 0.01	9.50E-01
cuticle development (GO:0042335)	3	0	.15	-	 < 0.01	8.58E-01
histone H3-K4 demethylation, trimethyl-H3-K4-specific (GO:0034721)	5	0	.26	-	 < 0.01	7.75E-01
histone H3-K4 demethylation (GO:0034720)	9	0	.46	-	 < 0.01	6.31E-01
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	0	.15	-	 < 0.01	8.58E-01
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of aconitate hydratase activity (GO:1904234)	3	0	.15	-	 < 0.01	8.58E-01
regulation of aconitate hydratase activity (GO:1904232)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of succinate dehydrogenase activity (GO:1904231)	2	0	.10	-	 < 0.01	9.03E-01
synaptic vesicle priming (GO:0016082)	13	0	.66	-	 < 0.01	5.15E-01
synaptic vesicle docking (GO:0016081)	9	0	.46	-	 < 0.01	6.31E-01
synaptic vesicle targeting (GO:0016080)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	5	0	.26	-	 < 0.01	7.75E-01
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	4	0	.20	-	 < 0.01	8.15E-01
regulation of succinate dehydrogenase activity (GO:1904229)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	3	0	.15	-	 < 0.01	8.58E-01
snoRNA catabolic process (GO:0016077)	2	0	.10	-	 < 0.01	9.03E-01
protein maturation by iron-sulfur cluster transfer (GO:0097428)	11	0	.56	-	 < 0.01	5.70E-01
snRNA catabolic process (GO:0016076)	3	0	.15	-	 < 0.01	8.58E-01
regulation of serine C-palmitoyltransferase activity (GO:1904220)	4	0	.20	-	 < 0.01	8.15E-01
penicillin metabolic process (GO:0042316)	1	0	.05	-	 < 0.01	9.50E-01
liver regeneration (GO:0097421)	29	0	1.48	-	 < 0.01	2.27E-01
vasoconstriction (GO:0042310)	29	0	1.48	-	 < 0.01	2.27E-01
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	2	0	.10	-	 < 0.01	9.03E-01
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of fibroblast migration (GO:0010764)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of iodide transmembrane transport (GO:1904213)	1	0	.05	-	 < 0.01	9.50E-01
regulation of iodide transmembrane transport (GO:1904212)	1	0	.05	-	 < 0.01	9.50E-01
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of macrophage chemotaxis (GO:0010760)	7	0	.36	-	 < 0.01	6.99E-01
homoiothermy (GO:0042309)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein import into nucleus (GO:0042308)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of macrophage chemotaxis (GO:0010759)	18	0	.92	-	 < 0.01	3.99E-01
regulation of macrophage chemotaxis (GO:0010758)	30	0	1.53	-	 < 0.01	2.16E-01
negative regulation of plasminogen activation (GO:0010757)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of plasminogen activation (GO:0010756)	6	0	.31	-	 < 0.01	7.36E-01
regulation of plasminogen activation (GO:0010755)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cGMP-mediated signaling (GO:0010754)	6	0	.31	-	 < 0.01	7.36E-01
regulation of skeletal muscle hypertrophy (GO:1904204)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cGMP-mediated signaling (GO:0010753)	6	0	.31	-	 < 0.01	7.36E-01
regulation of cGMP-mediated signaling (GO:0010752)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of iodide transport (GO:1904202)	1	0	.05	-	 < 0.01	9.50E-01
regulation of iodide transport (GO:1904201)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	3	0	.15	-	 < 0.01	8.58E-01
rhodopsin mediated signaling pathway (GO:0016056)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	4	0	.20	-	 < 0.01	8.15E-01
iodide transmembrane transport (GO:1904200)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to raffinose (GO:0097403)	1	0	.05	-	 < 0.01	9.50E-01
neuroblast migration (GO:0097402)	1	0	.05	-	 < 0.01	9.50E-01
synaptic vesicle lumen acidification (GO:0097401)	1	0	.05	-	 < 0.01	9.50E-01
interleukin-17-mediated signaling pathway (GO:0097400)	9	0	.46	-	 < 0.01	6.31E-01
prenylcysteine metabolic process (GO:0030329)	2	0	.10	-	 < 0.01	9.03E-01
prenylcysteine catabolic process (GO:0030328)	2	0	.10	-	 < 0.01	9.03E-01
prenylated protein catabolic process (GO:0030327)	3	0	.15	-	 < 0.01	8.58E-01
stabilization of membrane potential (GO:0030322)	16	0	.82	-	 < 0.01	4.41E-01
transepithelial chloride transport (GO:0030321)	5	0	.26	-	 < 0.01	7.75E-01
regulation of nitric oxide mediated signal transduction (GO:0010749)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	18	0	.92	-	 < 0.01	3.99E-01
detection of temperature stimulus (GO:0016048)	22	0	1.12	-	 < 0.01	3.25E-01
detection of fungus (GO:0016046)	2	0	.10	-	 < 0.01	9.03E-01
detection of bacterium (GO:0016045)	17	0	.87	-	 < 0.01	4.19E-01
osteoclast differentiation (GO:0030316)	42	0	2.15	-	 < 0.01	1.17E-01
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	12	0	.61	-	 < 0.01	5.42E-01
protein kinase A signaling (GO:0010737)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of protein glutathionylation (GO:0010734)	2	0	.10	-	 < 0.01	9.03E-01
absorption of visible light (GO:0016038)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein glutathionylation (GO:0010732)	2	0	.10	-	 < 0.01	9.03E-01
light absorption (GO:0016037)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	4	0	.20	-	 < 0.01	8.15E-01
memory T cell proliferation (GO:0061485)	1	0	.05	-	 < 0.01	9.50E-01
hematopoietic stem cell homeostasis (GO:0061484)	5	0	.26	-	 < 0.01	7.75E-01
tRNA import into mitochondrion (GO:0016031)	2	0	.10	-	 < 0.01	9.03E-01
response to TNF agonist (GO:0061481)	1	0	.05	-	 < 0.01	9.50E-01
poly-N-acetyllactosamine metabolic process (GO:0030309)	13	0	.66	-	 < 0.01	5.15E-01
deoxynucleotide transport (GO:0030302)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	3	0	.15	-	 < 0.01	8.58E-01
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	5	0	.26	-	 < 0.01	7.75E-01
regulation of primitive erythrocyte differentiation (GO:0010725)	2	0	.10	-	 < 0.01	9.03E-01
regulation of definitive erythrocyte differentiation (GO:0010724)	3	0	.15	-	 < 0.01	8.58E-01
regulation of ferrochelatase activity (GO:0010722)	1	0	.05	-	 < 0.01	9.50E-01
response to anticoagulant (GO:0061476)	1	0	.05	-	 < 0.01	9.50E-01
T follicular helper cell differentiation (GO:0061470)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of extracellular matrix disassembly (GO:0010716)	4	0	.20	-	 < 0.01	8.15E-01
regulation of extracellular matrix disassembly (GO:0010715)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of collagen metabolic process (GO:0010714)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of type B pancreatic cell proliferation (GO:0061469)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of collagen catabolic process (GO:0010711)	1	0	.05	-	 < 0.01	9.50E-01
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	25	0	1.28	-	 < 0.01	2.79E-01
regulation of collagen catabolic process (GO:0010710)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of inorganic anion transmembrane transport (GO:1903797)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of inorganic anion transmembrane transport (GO:1903796)	2	0	.10	-	 < 0.01	9.03E-01
regulation of inorganic anion transmembrane transport (GO:1903795)	7	0	.36	-	 < 0.01	6.99E-01
guanine nucleotide transmembrane transport (GO:1903790)	2	0	.10	-	 < 0.01	9.03E-01
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.05	-	 < 0.01	9.50E-01
globoside biosynthetic process via lactosylceramide (GO:0010707)	1	0	.05	-	 < 0.01	9.50E-01
ganglioside biosynthetic process via lactosylceramide (GO:0010706)	4	0	.20	-	 < 0.01	8.15E-01
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of norepinephrine secretion (GO:0010701)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of norepinephrine secretion (GO:0010700)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of glutathione biosynthetic process (GO:1903788)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glutathione biosynthetic process (GO:1903786)	2	0	.10	-	 < 0.01	9.03E-01
suppression by virus of host STAT2 activity (GO:0039564)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host STAT1 activity (GO:0039563)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host STAT activity (GO:0039562)	1	0	.05	-	 < 0.01	9.50E-01
charged-tRNA amino acid modification (GO:0019988)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to vacuolar membrane (GO:1903778)	1	0	.05	-	 < 0.01	9.50E-01
endocardial cushion cell fate commitment (GO:0061445)	1	0	.05	-	 < 0.01	9.50E-01
regulation of DNA double-strand break processing (GO:1903775)	2	0	.10	-	 < 0.01	9.03E-01
endocardial cushion cell development (GO:0061444)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.15	-	 < 0.01	8.58E-01
endocardial cushion cell differentiation (GO:0061443)	2	0	.10	-	 < 0.01	9.03E-01
regulation of viral budding via host ESCRT complex (GO:1903772)	4	0	.20	-	 < 0.01	8.15E-01
renal artery morphogenesis (GO:0061441)	2	0	.10	-	 < 0.01	9.03E-01
kidney vasculature morphogenesis (GO:0061439)	8	0	.41	-	 < 0.01	6.65E-01
renal system vasculature morphogenesis (GO:0061438)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of potassium ion export across plasma membrane (GO:1903765)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	2	0	.10	-	 < 0.01	9.03E-01
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	3	0	.15	-	 < 0.01	8.58E-01
hatching (GO:0035188)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of SUMO transferase activity (GO:1903755)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of p38MAPK cascade (GO:1903753)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	3	0	.15	-	 < 0.01	8.58E-01
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of RIG-I signaling pathway (GO:0039536)	8	0	.41	-	 < 0.01	6.65E-01
regulation of RIG-I signaling pathway (GO:0039535)	18	0	.92	-	 < 0.01	3.99E-01
negative regulation of MDA-5 signaling pathway (GO:0039534)	3	0	.15	-	 < 0.01	8.58E-01
regulation of MDA-5 signaling pathway (GO:0039533)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	10	0	.51	-	 < 0.01	6.00E-01
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	20	0	1.02	-	 < 0.01	3.60E-01
MDA-5 signaling pathway (GO:0039530)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.05	-	 < 0.01	9.50E-01
regulation of anterograde synaptic vesicle transport (GO:1903742)	2	0	.10	-	 < 0.01	9.03E-01
modulation by virus of host apoptotic process (GO:0039526)	4	0	.20	-	 < 0.01	8.15E-01
suppression by virus of host autophagy (GO:0039521)	1	0	.05	-	 < 0.01	9.50E-01
induction by virus of host autophagy (GO:0039520)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	2	0	.10	-	 < 0.01	9.03E-01
modulation by virus of host autophagy (GO:0039519)	3	0	.15	-	 < 0.01	8.58E-01
modulation by virus of host catalytic activity (GO:0039516)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host JAK-STAT cascade (GO:0039514)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host catalytic activity (GO:0039513)	1	0	.05	-	 < 0.01	9.50E-01
regulation of plasma membrane organization (GO:1903729)	10	0	.51	-	 < 0.01	6.00E-01
cGMP-mediated signaling (GO:0019934)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of phospholipid metabolic process (GO:1903726)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of centriole elongation (GO:1903724)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of centriole elongation (GO:1903723)	1	0	.05	-	 < 0.01	9.50E-01
regulation of centriole elongation (GO:1903722)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of I-kappaB phosphorylation (GO:1903721)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of I-kappaB phosphorylation (GO:1903720)	1	0	.05	-	 < 0.01	9.50E-01
suppression by virus of host molecular function (GO:0039507)	2	0	.10	-	 < 0.01	9.03E-01
modulation by virus of host molecular function (GO:0039506)	2	0	.10	-	 < 0.01	9.03E-01
regulation of I-kappaB phosphorylation (GO:1903719)	6	0	.31	-	 < 0.01	7.36E-01
regulation of aerobic respiration (GO:1903715)	7	0	.36	-	 < 0.01	6.99E-01
isoleucine transmembrane transport (GO:1903714)	1	0	.05	-	 < 0.01	9.50E-01
asparagine transmembrane transport (GO:1903713)	1	0	.05	-	 < 0.01	9.50E-01
cysteine transmembrane transport (GO:1903712)	1	0	.05	-	 < 0.01	9.50E-01
spermine transmembrane transport (GO:1903710)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	3	0	.15	-	 < 0.01	8.58E-01
uterine gland development (GO:1903709)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of production of siRNA involved in RNA interference (GO:1903704)	1	0	.05	-	 < 0.01	9.50E-01
substantia propria of cornea development (GO:1903701)	1	0	.05	-	 < 0.01	9.50E-01
post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.05	-	 < 0.01	9.50E-01
post-embryonic limb morphogenesis (GO:0035127)	1	0	.05	-	 < 0.01	9.50E-01
post-embryonic appendage morphogenesis (GO:0035120)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994)	1	0	.05	-	 < 0.01	9.50E-01
lipid tube assembly involved in organelle fusion (GO:0060989)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in coronary angiogenesis (GO:0060981)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in coronary vasculogenesis (GO:0060980)	1	0	.05	-	 < 0.01	9.50E-01
operant conditioning (GO:0035106)	4	0	.20	-	 < 0.01	8.15E-01
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	3	0	.15	-	 < 0.01	8.58E-01
cardioblast migration to the midline involved in heart field formation (GO:0060975)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in heart formation (GO:0060974)	2	0	.10	-	 < 0.01	9.03E-01
embryonic heart tube left/right pattern formation (GO:0060971)	5	0	.26	-	 < 0.01	7.75E-01
sperm competition (GO:0046692)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of gene silencing (GO:0060969)	26	0	1.33	-	 < 0.01	2.65E-01
negative regulation of gene silencing by RNA (GO:0060967)	20	0	1.02	-	 < 0.01	3.60E-01
negative regulation of gene silencing by miRNA (GO:0060965)	19	0	.97	-	 < 0.01	3.79E-01
response to mercury ion (GO:0046689)	11	0	.56	-	 < 0.01	5.70E-01
response to copper ion (GO:0046688)	38	0	1.94	-	 < 0.01	1.43E-01
response to chromate (GO:0046687)	2	0	.10	-	 < 0.01	9.03E-01
response to pyrethroid (GO:0046684)	4	0	.20	-	 < 0.01	8.15E-01
response to DDT (GO:0046680)	1	0	.05	-	 < 0.01	9.50E-01
endocardial cell fate commitment (GO:0060957)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of retinal cell programmed cell death (GO:0046671)	2	0	.10	-	 < 0.01	9.03E-01
cardiac neuron differentiation (GO:0060945)	1	0	.05	-	 < 0.01	9.50E-01
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	2	0	.10	-	 < 0.01	9.03E-01
regulation of retinal cell programmed cell death (GO:0046668)	3	0	.15	-	 < 0.01	8.58E-01
retinal cell programmed cell death (GO:0046666)	2	0	.10	-	 < 0.01	9.03E-01
response to prostaglandin F (GO:0034696)	1	0	.05	-	 < 0.01	9.50E-01
epicardium-derived cardiac fibroblast cell development (GO:0060939)	3	0	.15	-	 < 0.01	8.58E-01
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	3	0	.15	-	 < 0.01	8.58E-01
cardiac fibroblast cell development (GO:0060936)	3	0	.15	-	 < 0.01	8.58E-01
cardiac fibroblast cell differentiation (GO:0060935)	3	0	.15	-	 < 0.01	8.58E-01
His-Purkinje system cell differentiation (GO:0060932)	2	0	.10	-	 < 0.01	9.03E-01
sinoatrial node cell development (GO:0060931)	2	0	.10	-	 < 0.01	9.03E-01
folic acid catabolic process (GO:0046657)	1	0	.05	-	 < 0.01	9.50E-01
tetrahydrofolate biosynthetic process (GO:0046654)	7	0	.36	-	 < 0.01	6.99E-01
vocal learning (GO:0042297)	7	0	.36	-	 < 0.01	6.99E-01
atrioventricular node cell fate commitment (GO:0060929)	1	0	.05	-	 < 0.01	9.50E-01
atrioventricular node cell development (GO:0060928)	2	0	.10	-	 < 0.01	9.03E-01
cardiac pacemaker cell fate commitment (GO:0060927)	1	0	.05	-	 < 0.01	9.50E-01
cardiac pacemaker cell development (GO:0060926)	4	0	.20	-	 < 0.01	8.15E-01
cardiac muscle cell fate commitment (GO:0060923)	6	0	.31	-	 < 0.01	7.36E-01
atrioventricular node cell differentiation (GO:0060922)	2	0	.10	-	 < 0.01	9.03E-01
sinoatrial node cell differentiation (GO:0060921)	3	0	.15	-	 < 0.01	8.58E-01
cardiac pacemaker cell differentiation (GO:0060920)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of granulosa cell proliferation (GO:1904197)	1	0	.05	-	 < 0.01	9.50E-01
regulation of granulosa cell proliferation (GO:1904195)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of gamma-delta T cell activation (GO:0046645)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of cholangiocyte apoptotic process (GO:1904193)	1	0	.05	-	 < 0.01	9.50E-01
regulation of gamma-delta T cell activation (GO:0046643)	11	0	.56	-	 < 0.01	5.70E-01
regulation of cholangiocyte apoptotic process (GO:1904192)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of alpha-beta T cell proliferation (GO:0046642)	9	0	.46	-	 < 0.01	6.31E-01
cellular response to interleukin-17 (GO:0097398)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of alpha-beta T cell proliferation (GO:0046641)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of alpha-beta T cell proliferation (GO:0046640)	31	0	1.58	-	 < 0.01	2.05E-01
response to interleukin-17 (GO:0097396)	9	0	.46	-	 < 0.01	6.31E-01
mesenchymal cell proliferation involved in lung development (GO:0060916)	3	0	.15	-	 < 0.01	8.58E-01
mesenchymal cell differentiation involved in lung development (GO:0060915)	2	0	.10	-	 < 0.01	9.03E-01
heart formation (GO:0060914)	15	0	.77	-	 < 0.01	4.65E-01
chemotaxis to arachidonic acid (GO:0034670)	1	0	.05	-	 < 0.01	9.50E-01
cardiac cell fate determination (GO:0060913)	4	0	.20	-	 < 0.01	8.15E-01
cardiac cell fate specification (GO:0060912)	1	0	.05	-	 < 0.01	9.50E-01
cardiac cell fate commitment (GO:0060911)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of transformation of host cell by virus (GO:1904188)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transformation of host cell by virus (GO:1904187)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	2	0	.10	-	 < 0.01	9.03E-01
alpha-beta T cell proliferation (GO:0046633)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of membrane depolarization (GO:1904181)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of membrane depolarization (GO:1904180)	7	0	.36	-	 < 0.01	6.99E-01
error-free postreplication DNA repair (GO:0042275)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of macrophage cytokine production (GO:0060907)	10	0	.51	-	 < 0.01	6.00E-01
dorsal spinal cord interneuron anterior axon guidance (GO:0097380)	1	0	.05	-	 < 0.01	9.50E-01
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	3	0	.15	-	 < 0.01	8.58E-01
protection from natural killer cell mediated cytotoxicity (GO:0042270)	6	0	.31	-	 < 0.01	7.36E-01
regulation of protein folding in endoplasmic reticulum (GO:0060904)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of meiosis I (GO:0060903)	1	0	.05	-	 < 0.01	9.50E-01
regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901)	1	0	.05	-	 < 0.01	9.50E-01
embryonic camera-type eye formation (GO:0060900)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of adipose tissue development (GO:1904179)	6	0	.31	-	 < 0.01	7.36E-01
gamma-delta T cell activation (GO:0046629)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of adipose tissue development (GO:1904178)	2	0	.10	-	 < 0.01	9.03E-01
regulation of adipose tissue development (GO:1904177)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of bleb assembly (GO:1904172)	2	0	.10	-	 < 0.01	9.03E-01
dorsal spinal cord interneuron posterior axon guidance (GO:0097379)	1	0	.05	-	 < 0.01	9.50E-01
regulation of bleb assembly (GO:1904170)	2	0	.10	-	 < 0.01	9.03E-01
dorsal spinal cord interneuron axon guidance (GO:0097378)	2	0	.10	-	 < 0.01	9.03E-01
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	39	0	1.99	-	 < 0.01	1.36E-01
spinal cord interneuron axon guidance (GO:0097377)	2	0	.10	-	 < 0.01	9.03E-01
interneuron axon guidance (GO:0097376)	3	0	.15	-	 < 0.01	8.58E-01
regulation of cytolysis (GO:0042268)	4	0	.20	-	 < 0.01	8.15E-01
sensory neuron axon guidance (GO:0097374)	3	0	.15	-	 < 0.01	8.58E-01
nucleobase-containing small molecule catabolic process (GO:0034656)	46	0	2.35	-	 < 0.01	9.51E-02
DNA protection (GO:0042262)	5	0	.26	-	 < 0.01	7.75E-01
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.05	-	 < 0.01	9.50E-01
retinoic acid catabolic process (GO:0034653)	4	0	.20	-	 < 0.01	8.15E-01
cortisol biosynthetic process (GO:0034651)	3	0	.15	-	 < 0.01	8.58E-01
cortisol metabolic process (GO:0034650)	4	0	.20	-	 < 0.01	8.15E-01
optic placode formation involved in camera-type eye formation (GO:0046619)	2	0	.10	-	 < 0.01	9.03E-01
drug export (GO:0046618)	2	0	.10	-	 < 0.01	9.03E-01
DNA synthesis involved in UV-damage excision repair (GO:1904161)	2	0	.10	-	 < 0.01	9.03E-01
mature ribosome assembly (GO:0042256)	6	0	.31	-	 < 0.01	7.36E-01
mitochondrion migration along actin filament (GO:0034642)	1	0	.05	-	 < 0.01	9.50E-01
axonemal central apparatus assembly (GO:1904158)	4	0	.20	-	 < 0.01	8.15E-01
DN3 thymocyte differentiation (GO:1904156)	1	0	.05	-	 < 0.01	9.50E-01
DN2 thymocyte differentiation (GO:1904155)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mitotic centrosome separation (GO:0046604)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of mitotic centrosome separation (GO:0046603)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mitotic centrosome separation (GO:0046602)	8	0	.41	-	 < 0.01	6.65E-01
UDP-glucosylation (GO:0097359)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of centriole replication (GO:0046601)	5	0	.26	-	 < 0.01	7.75E-01
establishment of planar polarity of embryonic epithelium (GO:0042249)	4	0	.20	-	 < 0.01	8.15E-01
establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to heterochromatin (GO:0097355)	1	0	.05	-	 < 0.01	9.50E-01
prenylation (GO:0097354)	10	0	.51	-	 < 0.01	6.00E-01
RNA repair (GO:0042245)	2	0	.10	-	 < 0.01	9.03E-01
autophagosome maturation (GO:0097352)	23	0	1.17	-	 < 0.01	3.09E-01
glutathione transport (GO:0034635)	5	0	.26	-	 < 0.01	7.75E-01
neutrophil clearance (GO:0097350)	5	0	.26	-	 < 0.01	7.75E-01
retinol transport (GO:0034633)	2	0	.10	-	 < 0.01	9.03E-01
regulation of microglial cell mediated cytotoxicity (GO:1904149)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of alkaline phosphatase activity (GO:0010694)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of microglial cell migration (GO:1904141)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of microglial cell migration (GO:1904140)	1	0	.05	-	 < 0.01	9.50E-01
'de novo' NAD biosynthetic process (GO:0034627)	6	0	.31	-	 < 0.01	7.36E-01
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	7	0	.36	-	 < 0.01	6.99E-01
ripoptosome assembly (GO:0097343)	2	0	.10	-	 < 0.01	9.03E-01
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	7	0	.36	-	 < 0.01	6.99E-01
nuclear fragmentation involved in apoptotic nuclear change (GO:0030264)	1	0	.05	-	 < 0.01	9.50E-01
regulation of microglial cell migration (GO:1904139)	8	0	.41	-	 < 0.01	6.65E-01
response to clozapine (GO:0097338)	3	0	.15	-	 < 0.01	8.58E-01
response to antipsychotic drug (GO:0097332)	2	0	.10	-	 < 0.01	9.03E-01
lipid glycosylation (GO:0030259)	10	0	.51	-	 < 0.01	6.00E-01
microglial cell migration (GO:1904124)	2	0	.10	-	 < 0.01	9.03E-01
response to antineoplastic agent (GO:0097327)	5	0	.26	-	 < 0.01	7.75E-01
1-aminocyclopropane-1-carboxylate biosynthetic process (GO:0042218)	1	0	.05	-	 < 0.01	9.50E-01
melanocyte adhesion (GO:0097326)	1	0	.05	-	 < 0.01	9.50E-01
melanocyte proliferation (GO:0097325)	3	0	.15	-	 < 0.01	8.58E-01
melanocyte migration (GO:0097324)	2	0	.10	-	 < 0.01	9.03E-01
B cell adhesion (GO:0097323)	2	0	.10	-	 < 0.01	9.03E-01
terpene metabolic process (GO:0042214)	2	0	.10	-	 < 0.01	9.03E-01
autophagy of peroxisome (GO:0030242)	11	0	.56	-	 < 0.01	5.70E-01
skeletal muscle myosin thick filament assembly (GO:0030241)	3	0	.15	-	 < 0.01	8.58E-01
skeletal muscle thin filament assembly (GO:0030240)	6	0	.31	-	 < 0.01	7.36E-01
ectodermal cell differentiation (GO:0010668)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	21	0	1.07	-	 < 0.01	3.42E-01
cellular response to vasopressin (GO:1904117)	3	0	.15	-	 < 0.01	8.58E-01
response to vasopressin (GO:1904116)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of striated muscle cell apoptotic process (GO:0010664)	25	0	1.28	-	 < 0.01	2.79E-01
L-histidine transmembrane transport (GO:0089709)	6	0	.31	-	 < 0.01	7.36E-01
L-histidine transmembrane export from vacuole (GO:0089708)	1	0	.05	-	 < 0.01	9.50E-01
germ cell migration (GO:0008354)	6	0	.31	-	 < 0.01	7.36E-01
cap2 mRNA methylation (GO:0097310)	1	0	.05	-	 < 0.01	9.50E-01
protein kinase D signaling (GO:0089700)	3	0	.15	-	 < 0.01	8.58E-01
female sex determination (GO:0030237)	2	0	.10	-	 < 0.01	9.03E-01
cardiac muscle cell apoptotic process (GO:0010659)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of cholesterol import (GO:1904109)	1	0	.05	-	 < 0.01	9.50E-01
striated muscle cell apoptotic process (GO:0010658)	6	0	.31	-	 < 0.01	7.36E-01
protein localization to ciliary inversin compartment (GO:1904108)	1	0	.05	-	 < 0.01	9.50E-01
muscle cell apoptotic process (GO:0010657)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of muscle cell apoptotic process (GO:0010656)	36	0	1.84	-	 < 0.01	1.59E-01
protein localization to microvillus (GO:1904106)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of convergent extension involved in gastrulation (GO:1904105)	2	0	.10	-	 < 0.01	9.03E-01
regulation of convergent extension involved in gastrulation (GO:1904103)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell communication by chemical coupling (GO:0010652)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antimicrobial humoral response (GO:0008348)	1	0	.05	-	 < 0.01	9.50E-01
cap1 mRNA methylation (GO:0097309)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell communication by electrical coupling (GO:0010650)	2	0	.10	-	 < 0.01	9.03E-01
adult locomotory behavior (GO:0008344)	77	0	3.93	-	 < 0.01	1.94E-02
adult feeding behavior (GO:0008343)	10	0	.51	-	 < 0.01	6.00E-01
determination of adult lifespan (GO:0008340)	18	0	.92	-	 < 0.01	3.99E-01
extracellular matrix disassembly (GO:0022617)	62	0	3.17	-	 < 0.01	4.19E-02
macrophage differentiation (GO:0030225)	24	0	1.23	-	 < 0.01	2.93E-01
monocyte differentiation (GO:0030224)	17	0	.87	-	 < 0.01	4.19E-01
membrane to membrane docking (GO:0022614)	5	0	.26	-	 < 0.01	7.75E-01
neutrophil differentiation (GO:0030223)	4	0	.20	-	 < 0.01	8.15E-01
eosinophil differentiation (GO:0030222)	3	0	.15	-	 < 0.01	8.58E-01
basophil differentiation (GO:0030221)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cell communication by chemical coupling (GO:0010645)	2	0	.10	-	 < 0.01	9.03E-01
cell communication by electrical coupling (GO:0010644)	20	0	1.02	-	 < 0.01	3.60E-01
cell communication by chemical coupling (GO:0010643)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	4	0	.20	-	 < 0.01	8.15E-01
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	23	0	1.17	-	 < 0.01	3.09E-01
mammalian oogenesis stage (GO:0022605)	7	0	.36	-	 < 0.01	6.99E-01
hyaluronan catabolic process (GO:0030214)	17	0	.87	-	 < 0.01	4.19E-01
heparin catabolic process (GO:0030211)	1	0	.05	-	 < 0.01	9.50E-01
heparin biosynthetic process (GO:0030210)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of mitochondrial fusion (GO:0010637)	8	0	.41	-	 < 0.01	6.65E-01
closure of optic fissure (GO:0061386)	2	0	.10	-	 < 0.01	9.03E-01
cell migration in diencephalon (GO:0061381)	1	0	.05	-	 < 0.01	9.50E-01
dermatan sulfate catabolic process (GO:0030209)	1	0	.05	-	 < 0.01	9.50E-01
chondroitin sulfate catabolic process (GO:0030207)	14	0	.72	-	 < 0.01	4.89E-01
heparin metabolic process (GO:0030202)	12	0	.61	-	 < 0.01	5.42E-01
heparan sulfate proteoglycan catabolic process (GO:0030200)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.05	-	 < 0.01	9.50E-01
programmed cell death involved in cell development (GO:0010623)	10	0	.51	-	 < 0.01	6.00E-01
inferior colliculus development (GO:0061379)	2	0	.10	-	 < 0.01	9.03E-01
corpora quadrigemina development (GO:0061378)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of transcription by transcription factor localization (GO:0010621)	3	0	.15	-	 < 0.01	8.58E-01
mammillothalamic axonal tract development (GO:0061374)	1	0	.05	-	 < 0.01	9.50E-01
mammillary axonal complex development (GO:0061373)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of cardiac muscle adaptation (GO:0010616)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of cardiac muscle adaptation (GO:0010615)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cardiac muscle hypertrophy (GO:0010613)	24	0	1.23	-	 < 0.01	2.93E-01
regulation of cardiac muscle adaptation (GO:0010612)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.05	-	 < 0.01	9.50E-01
behavioral response to formalin induced pain (GO:0061368)	2	0	.10	-	 < 0.01	9.03E-01
tarsal gland development (GO:1903699)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mRNA stability involved in response to stress (GO:0010610)	3	0	.15	-	 < 0.01	8.58E-01
behavioral response to chemical pain (GO:0061366)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of microvillus assembly (GO:1903697)	1	0	.05	-	 < 0.01	9.50E-01
apoptotic process involved in luteolysis (GO:0061364)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	4	0	.20	-	 < 0.01	8.15E-01
optic chiasma development (GO:0061360)	1	0	.05	-	 < 0.01	9.50E-01
mRNA localization resulting in posttranscriptional regulation of gene expression (GO:0010609)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	6	0	.31	-	 < 0.01	7.36E-01
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of Wnt protein secretion (GO:0061358)	1	0	.05	-	 < 0.01	9.50E-01
planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354)	1	0	.05	-	 < 0.01	9.50E-01
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350)	1	0	.05	-	 < 0.01	9.50E-01
planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.15	-	 < 0.01	8.58E-01
planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	17	0	.87	-	 < 0.01	4.19E-01
planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cap-independent translational initiation (GO:1903677)	3	0	.15	-	 < 0.01	8.58E-01
planar cell polarity pathway involved in heart morphogenesis (GO:0061346)	1	0	.05	-	 < 0.01	9.50E-01
antigen processing and presentation of endogenous antigen (GO:0019883)	24	0	1.23	-	 < 0.01	2.93E-01
positive regulation of cap-dependent translational initiation (GO:1903676)	1	0	.05	-	 < 0.01	9.50E-01
cell adhesion involved in heart morphogenesis (GO:0061343)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cap-dependent translational initiation (GO:1903674)	1	0	.05	-	 < 0.01	9.50E-01
mitotic cleavage furrow formation (GO:1903673)	1	0	.05	-	 < 0.01	9.50E-01
non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	1	0	.05	-	 < 0.01	9.50E-01
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.10	-	 < 0.01	9.03E-01
establishment or maintenance of monopolar cell polarity (GO:0061339)	23	0	1.17	-	 < 0.01	3.09E-01
behavioral response to nicotine (GO:0035095)	7	0	.36	-	 < 0.01	6.99E-01
cardiac conduction (GO:0061337)	90	0	4.60	-	 < 0.01	9.95E-03
spermatogenesis, exchange of chromosomal proteins (GO:0035093)	7	0	.36	-	 < 0.01	6.99E-01
sperm chromatin condensation (GO:0035092)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of complement-dependent cytotoxicity (GO:1903661)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of complement-dependent cytotoxicity (GO:1903660)	3	0	.15	-	 < 0.01	8.58E-01
establishment of apical/basal cell polarity (GO:0035089)	21	0	1.07	-	 < 0.01	3.42E-01
siRNA loading onto RISC involved in RNA interference (GO:0035087)	3	0	.15	-	 < 0.01	8.58E-01
regulation of complement-dependent cytotoxicity (GO:1903659)	7	0	.36	-	 < 0.01	6.99E-01
cell proliferation involved in outflow tract morphogenesis (GO:0061325)	1	0	.05	-	 < 0.01	9.50E-01
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	1	0	.05	-	 < 0.01	9.50E-01
cell proliferation involved in heart morphogenesis (GO:0061323)	1	0	.05	-	 < 0.01	9.50E-01
uracil metabolic process (GO:0019860)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cytoplasmic transport (GO:1903651)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of cytoplasmic transport (GO:1903650)	3	0	.15	-	 < 0.01	8.58E-01
thymine metabolic process (GO:0019859)	3	0	.15	-	 < 0.01	8.58E-01
cytosine metabolic process (GO:0019858)	2	0	.10	-	 < 0.01	9.03E-01
5-methylcytosine metabolic process (GO:0019857)	3	0	.15	-	 < 0.01	8.58E-01
renal filtration cell differentiation (GO:0061318)	19	0	.97	-	 < 0.01	3.79E-01
pyrimidine nucleobase biosynthetic process (GO:0019856)	7	0	.36	-	 < 0.01	6.99E-01
regulation of cytoplasmic transport (GO:1903649)	23	0	1.17	-	 < 0.01	3.09E-01
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317)	2	0	.10	-	 < 0.01	9.03E-01
canonical Wnt signaling pathway involved in heart development (GO:0061316)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of chaperone-mediated protein folding (GO:1903646)	2	0	.10	-	 < 0.01	9.03E-01
L-ascorbic acid biosynthetic process (GO:0019853)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	1	0	.05	-	 < 0.01	9.50E-01
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	5	0	.26	-	 < 0.01	7.75E-01
regulation of gastrin-induced gastric acid secretion (GO:1903639)	1	0	.05	-	 < 0.01	9.50E-01
cardiac neural crest cell development involved in heart development (GO:0061308)	8	0	.41	-	 < 0.01	6.65E-01
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	8	0	.41	-	 < 0.01	6.65E-01
nuclear speck organization (GO:0035063)	3	0	.15	-	 < 0.01	8.58E-01
retinal blood vessel morphogenesis (GO:0061304)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of leucine-tRNA ligase activity (GO:1903634)	1	0	.05	-	 < 0.01	9.50E-01
smooth muscle cell-matrix adhesion (GO:0061302)	2	0	.10	-	 < 0.01	9.03E-01
regulation of leucine-tRNA ligase activity (GO:1903633)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	1	0	.05	-	 < 0.01	9.50E-01
cerebellum vasculature morphogenesis (GO:0061301)	1	0	.05	-	 < 0.01	9.50E-01
cerebellum vasculature development (GO:0061300)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of aminoacyl-tRNA ligase activity (GO:1903631)	1	0	.05	-	 < 0.01	9.50E-01
regulation of aminoacyl-tRNA ligase activity (GO:1903630)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dUTP diphosphatase activity (GO:1903629)	1	0	.05	-	 < 0.01	9.50E-01
cytolysis (GO:0019835)	29	0	1.48	-	 < 0.01	2.27E-01
regulation of dUTP diphosphatase activity (GO:1903627)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA catabolic process (GO:1903626)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of DNA catabolic process (GO:1903625)	3	0	.15	-	 < 0.01	8.58E-01
regulation of DNA catabolic process (GO:1903624)	11	0	.56	-	 < 0.01	5.70E-01
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of transdifferentiation (GO:1903620)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transdifferentiation (GO:1903618)	1	0	.05	-	 < 0.01	9.50E-01
fertilization, exchange of chromosomal proteins (GO:0035042)	1	0	.05	-	 < 0.01	9.50E-01
sperm chromatin decondensation (GO:0035041)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein tyrosine phosphatase activity (GO:1903615)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of protein tyrosine phosphatase activity (GO:1903614)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein tyrosine phosphatase activity (GO:1903613)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of calcium-dependent ATPase activity (GO:1903612)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of calcium-dependent ATPase activity (GO:1903611)	1	0	.05	-	 < 0.01	9.50E-01
regulation of calcium-dependent ATPase activity (GO:1903610)	2	0	.10	-	 < 0.01	9.03E-01
male pronucleus assembly (GO:0035039)	2	0	.10	-	 < 0.01	9.03E-01
female pronucleus assembly (GO:0035038)	1	0	.05	-	 < 0.01	9.50E-01
sperm entry (GO:0035037)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to cytoplasmic stress granule (GO:1903608)	7	0	.36	-	 < 0.01	6.99E-01
leading edge cell differentiation (GO:0035026)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of Rho protein signal transduction (GO:0035025)	33	0	1.69	-	 < 0.01	1.85E-01
quinolinate biosynthetic process (GO:0019805)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of Rac protein signal transduction (GO:0035021)	3	0	.15	-	 < 0.01	8.58E-01
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	6	0	.31	-	 < 0.01	7.36E-01
neural plate regionalization (GO:0060897)	4	0	.20	-	 < 0.01	8.15E-01
neural plate pattern specification (GO:0060896)	6	0	.31	-	 < 0.01	7.36E-01
limb epidermis development (GO:0060887)	1	0	.05	-	 < 0.01	9.50E-01
neuronal signal transduction (GO:0023041)	5	0	.26	-	 < 0.01	7.75E-01
semicircular canal fusion (GO:0060879)	1	0	.05	-	 < 0.01	9.50E-01
CD40 signaling pathway (GO:0023035)	9	0	.46	-	 < 0.01	6.31E-01
semicircular canal formation (GO:0060876)	2	0	.10	-	 < 0.01	9.03E-01
lateral semicircular canal development (GO:0060875)	1	0	.05	-	 < 0.01	9.50E-01
anterior semicircular canal development (GO:0060873)	1	0	.05	-	 < 0.01	9.50E-01
semicircular canal development (GO:0060872)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of viral entry into host cell (GO:0046598)	12	0	.61	-	 < 0.01	5.42E-01
termination of signal transduction (GO:0023021)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of calcium-dependent cell-cell adhesion (GO:0046588)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.05	-	 < 0.01	9.50E-01
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	2	0	.10	-	 < 0.01	9.03E-01
signal transduction involved in regulation of gene expression (GO:0023019)	20	0	1.02	-	 < 0.01	3.60E-01
establishment of glial blood-brain barrier (GO:0060857)	2	0	.10	-	 < 0.01	9.03E-01
establishment of blood-brain barrier (GO:0060856)	10	0	.51	-	 < 0.01	6.00E-01
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription involved in cell fate commitment (GO:0060850)	13	0	.66	-	 < 0.01	5.15E-01
growth plate cartilage chondrocyte development (GO:0003431)	5	0	.26	-	 < 0.01	7.75E-01
growth plate cartilage chondrocyte growth (GO:0003430)	3	0	.15	-	 < 0.01	8.58E-01
regulation of transcription involved in lymphatic endothelial cell fate commitment (GO:0060849)	2	0	.10	-	 < 0.01	9.03E-01
endothelial cell fate specification (GO:0060847)	3	0	.15	-	 < 0.01	8.58E-01
blood vessel endothelial cell fate commitment (GO:0060846)	3	0	.15	-	 < 0.01	8.58E-01
arterial endothelial cell fate commitment (GO:0060844)	2	0	.10	-	 < 0.01	9.03E-01
growth plate cartilage chondrocyte morphogenesis (GO:0003429)	1	0	.05	-	 < 0.01	9.50E-01
growth plate cartilage morphogenesis (GO:0003422)	2	0	.10	-	 < 0.01	9.03E-01
growth plate cartilage axis specification (GO:0003421)	1	0	.05	-	 < 0.01	9.50E-01
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	1	0	.05	-	 < 0.01	9.50E-01
endothelial cell fate commitment (GO:0060839)	7	0	.36	-	 < 0.01	6.99E-01
lymphatic endothelial cell fate commitment (GO:0060838)	3	0	.15	-	 < 0.01	8.58E-01
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	7	0	.36	-	 < 0.01	6.99E-01
growth plate cartilage chondrocyte proliferation (GO:0003419)	2	0	.10	-	 < 0.01	9.03E-01
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	3	0	.15	-	 < 0.01	8.58E-01
growth plate cartilage chondrocyte differentiation (GO:0003418)	8	0	.41	-	 < 0.01	6.65E-01
growth plate cartilage development (GO:0003417)	16	0	.82	-	 < 0.01	4.41E-01
endochondral bone growth (GO:0003416)	24	0	1.23	-	 < 0.01	2.93E-01
chondrocyte hypertrophy (GO:0003415)	4	0	.20	-	 < 0.01	8.15E-01
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	1	0	.05	-	 < 0.01	9.50E-01
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.05	-	 < 0.01	9.50E-01
hydroxyproline transport (GO:0034589)	1	0	.05	-	 < 0.01	9.50E-01
halogenated hydrocarbon metabolic process (GO:0042197)	2	0	.10	-	 < 0.01	9.03E-01
chlorinated hydrocarbon metabolic process (GO:0042196)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	1	0	.05	-	 < 0.01	9.50E-01
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	1	0	.05	-	 < 0.01	9.50E-01
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825)	1	0	.05	-	 < 0.01	9.50E-01
inactivation of X chromosome by DNA methylation (GO:0060821)	1	0	.05	-	 < 0.01	9.50E-01
optic cup structural organization (GO:0003409)	1	0	.05	-	 < 0.01	9.50E-01
inactivation of X chromosome by heterochromatin assembly (GO:0060820)	1	0	.05	-	 < 0.01	9.50E-01
optic cup formation involved in camera-type eye development (GO:0003408)	3	0	.15	-	 < 0.01	8.58E-01
retinal pigment epithelium development (GO:0003406)	4	0	.20	-	 < 0.01	8.15E-01
optic vesicle morphogenesis (GO:0003404)	2	0	.10	-	 < 0.01	9.03E-01
planar cell polarity pathway involved in axis elongation (GO:0003402)	3	0	.15	-	 < 0.01	8.58E-01
retinal cone cell development (GO:0046549)	10	0	.51	-	 < 0.01	6.00E-01
axis elongation (GO:0003401)	24	0	1.23	-	 < 0.01	2.93E-01
retinal rod cell development (GO:0046548)	11	0	.56	-	 < 0.01	5.70E-01
regulation of COPII vesicle coating (GO:0003400)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of autophagic cell death (GO:1904093)	2	0	.10	-	 < 0.01	9.03E-01
development of secondary male sexual characteristics (GO:0046544)	1	0	.05	-	 < 0.01	9.50E-01
regulation of autophagic cell death (GO:1904092)	5	0	.26	-	 < 0.01	7.75E-01
development of secondary female sexual characteristics (GO:0046543)	6	0	.31	-	 < 0.01	7.36E-01
saliva secretion (GO:0046541)	5	0	.26	-	 < 0.01	7.75E-01
regulation of nucleus size (GO:0097298)	1	0	.05	-	 < 0.01	9.50E-01
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	4	0	.20	-	 < 0.01	8.15E-01
renal phosphate ion absorption (GO:0097291)	1	0	.05	-	 < 0.01	9.50E-01
ketone catabolic process (GO:0042182)	13	0	.66	-	 < 0.01	5.15E-01
inactivation of paternal X chromosome (GO:0060817)	1	0	.05	-	 < 0.01	9.50E-01
random inactivation of X chromosome (GO:0060816)	2	0	.10	-	 < 0.01	9.03E-01
photoreceptor cell differentiation (GO:0046530)	57	0	2.91	-	 < 0.01	5.41E-02
xenobiotic catabolic process (GO:0042178)	10	0	.51	-	 < 0.01	6.00E-01
hepatocyte apoptotic process (GO:0097284)	11	0	.56	-	 < 0.01	5.70E-01
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	2	0	.10	-	 < 0.01	9.03E-01
immune complex formation (GO:0097281)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification (GO:0060807)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	1	0	.05	-	 < 0.01	9.50E-01
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of trophectodermal cell proliferation (GO:1904075)	1	0	.05	-	 < 0.01	9.50E-01
regulation of trophectodermal cell proliferation (GO:1904073)	1	0	.05	-	 < 0.01	9.50E-01
presynaptic active zone assembly (GO:1904071)	3	0	.15	-	 < 0.01	8.58E-01
complement-dependent cytotoxicity (GO:0097278)	2	0	.10	-	 < 0.01	9.03E-01
sphingoid catabolic process (GO:0046521)	1	0	.05	-	 < 0.01	9.50E-01
cellular urea homeostasis (GO:0097277)	1	0	.05	-	 < 0.01	9.50E-01
cellular creatinine homeostasis (GO:0097276)	1	0	.05	-	 < 0.01	9.50E-01
heme metabolic process (GO:0042168)	40	0	2.04	-	 < 0.01	1.29E-01
cellular ammonium homeostasis (GO:0097275)	1	0	.05	-	 < 0.01	9.50E-01
heme catabolic process (GO:0042167)	14	0	.72	-	 < 0.01	4.89E-01
urea homeostasis (GO:0097274)	2	0	.10	-	 < 0.01	9.03E-01
creatinine homeostasis (GO:0097273)	2	0	.10	-	 < 0.01	9.03E-01
ammonium homeostasis (GO:0097272)	2	0	.10	-	 < 0.01	9.03E-01
ceramide catabolic process (GO:0046514)	16	0	.82	-	 < 0.01	4.41E-01
omega-hydroxylase P450 pathway (GO:0097267)	9	0	.46	-	 < 0.01	6.31E-01
self proteolysis (GO:0097264)	7	0	.36	-	 < 0.01	6.99E-01
melatonin biosynthetic process (GO:0030187)	1	0	.05	-	 < 0.01	9.50E-01
melatonin metabolic process (GO:0030186)	1	0	.05	-	 < 0.01	9.50E-01
nitric oxide transport (GO:0030185)	2	0	.10	-	 < 0.01	9.03E-01
regulation of locomotor rhythm (GO:1904059)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of sensory perception of pain (GO:1904058)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of sensory perception of pain (GO:1904057)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cholangiocyte proliferation (GO:1904056)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cholangiocyte proliferation (GO:1904054)	3	0	.15	-	 < 0.01	8.58E-01
uroporphyrinogen III metabolic process (GO:0046502)	2	0	.10	-	 < 0.01	9.03E-01
protoporphyrinogen IX metabolic process (GO:0046501)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.05	-	 < 0.01	9.50E-01
spermidine biosynthetic process (GO:0008295)	3	0	.15	-	 < 0.01	8.58E-01
strand invasion (GO:0042148)	3	0	.15	-	 < 0.01	8.58E-01
renal tubular secretion (GO:0097254)	1	0	.05	-	 < 0.01	9.50E-01
acetylcholine biosynthetic process (GO:0008292)	3	0	.15	-	 < 0.01	8.58E-01
acetylcholine metabolic process (GO:0008291)	5	0	.26	-	 < 0.01	7.75E-01
oligodendrocyte apoptotic process (GO:0097252)	2	0	.10	-	 < 0.01	9.03E-01
mitochondrial respirasome assembly (GO:0097250)	6	0	.31	-	 < 0.01	7.36E-01
late meiotic recombination nodule assembly (GO:0042140)	1	0	.05	-	 < 0.01	9.50E-01
regulation of DNA-dependent DNA replication initiation (GO:0030174)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	1	0	.05	-	 < 0.01	9.50E-01
regulation of spontaneous neurotransmitter secretion (GO:1904048)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to aldosterone (GO:1904045)	1	0	.05	-	 < 0.01	9.50E-01
response to aldosterone (GO:1904044)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of lamellipodium assembly (GO:0010593)	3	0	.15	-	 < 0.01	8.58E-01
meiotic DNA double-strand break formation (GO:0042138)	2	0	.10	-	 < 0.01	9.03E-01
sequestering of neurotransmitter (GO:0042137)	2	0	.10	-	 < 0.01	9.03E-01
neurotransmitter biosynthetic process (GO:0042136)	16	0	.82	-	 < 0.01	4.41E-01
neurotransmitter catabolic process (GO:0042135)	10	0	.51	-	 < 0.01	6.00E-01
hematopoietic stem cell migration to bone marrow (GO:0097241)	4	0	.20	-	 < 0.01	8.15E-01
neurotransmitter metabolic process (GO:0042133)	28	0	1.43	-	 < 0.01	2.39E-01
chromosome attachment to the nuclear envelope (GO:0097240)	3	0	.15	-	 < 0.01	8.58E-01
proteoglycan catabolic process (GO:0030167)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of iron export across plasma membrane (GO:1904039)	1	0	.05	-	 < 0.01	9.50E-01
regulation of iron export across plasma membrane (GO:1904038)	1	0	.05	-	 < 0.01	9.50E-01
glutamine secretion (GO:0010585)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to methylglyoxal (GO:0097238)	2	0	.10	-	 < 0.01	9.03E-01
nitrate metabolic process (GO:0042126)	4	0	.20	-	 < 0.01	8.15E-01
sulfate transport (GO:0008272)	16	0	.82	-	 < 0.01	4.41E-01
response to vitamin B6 (GO:0034516)	1	0	.05	-	 < 0.01	9.50E-01
pancreatic juice secretion (GO:0030157)	6	0	.31	-	 < 0.01	7.36E-01
protein import into mitochondrial matrix (GO:0030150)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of collagen fibril organization (GO:1904028)	2	0	.10	-	 < 0.01	9.03E-01
regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of collagen fibril organization (GO:1904027)	2	0	.10	-	 < 0.01	9.03E-01
regulation of collagen fibril organization (GO:1904026)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	3	0	.15	-	 < 0.01	8.58E-01
vascular endothelial growth factor production (GO:0010573)	7	0	.36	-	 < 0.01	6.99E-01
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of G protein-coupled receptor internalization (GO:1904022)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of G protein-coupled receptor internalization (GO:1904021)	2	0	.10	-	 < 0.01	9.03E-01
regulation of G protein-coupled receptor internalization (GO:1904020)	4	0	.20	-	 < 0.01	8.15E-01
endothelial cell activation (GO:0042118)	12	0	.61	-	 < 0.01	5.42E-01
monocyte activation (GO:0042117)	10	0	.51	-	 < 0.01	6.00E-01
mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to kinetochore (GO:0034501)	11	0	.56	-	 < 0.01	5.70E-01
sphingolipid catabolic process (GO:0030149)	27	0	1.38	-	 < 0.01	2.52E-01
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of glycoprotein biosynthetic process (GO:0010561)	11	0	.56	-	 < 0.01	5.70E-01
response to Aroclor 1254 (GO:1904010)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cytokine biosynthetic process (GO:0042108)	3	0	.15	-	 < 0.01	8.58E-01
cytokine metabolic process (GO:0042107)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of lysosomal membrane permeability (GO:0097214)	2	0	.10	-	 < 0.01	9.03E-01
regulation of lysosomal membrane permeability (GO:0097213)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of activated T cell proliferation (GO:0042104)	23	0	1.17	-	 < 0.01	3.09E-01
lysosomal membrane organization (GO:0097212)	4	0	.20	-	 < 0.01	8.15E-01
cellular response to gonadotropin-releasing hormone (GO:0097211)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of T cell proliferation (GO:0042102)	100	0	5.11	-	 < 0.01	5.96E-03
cellular response to monosodium glutamate (GO:1904009)	1	0	.05	-	 < 0.01	9.50E-01
tRNA threonylcarbamoyladenosine modification (GO:0002949)	3	0	.15	-	 < 0.01	8.58E-01
response to monosodium glutamate (GO:1904008)	2	0	.10	-	 < 0.01	9.03E-01
tRNA C5-cytosine methylation (GO:0002946)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of eating behavior (GO:1904000)	4	0	.20	-	 < 0.01	8.15E-01
tRNA N2-guanine methylation (GO:0002940)	1	0	.05	-	 < 0.01	9.50E-01
renal filtration (GO:0097205)	12	0	.61	-	 < 0.01	5.42E-01
smooth muscle cell migration (GO:0014909)	9	0	.46	-	 < 0.01	6.31E-01
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	5	0	.26	-	 < 0.01	7.75E-01
myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	3	0	.15	-	 < 0.01	8.58E-01
muscle hyperplasia (GO:0014900)	2	0	.10	-	 < 0.01	9.03E-01
retina vasculature morphogenesis in camera-type eye (GO:0061299)	10	0	.51	-	 < 0.01	6.00E-01
lipid hydroxylation (GO:0002933)	6	0	.31	-	 < 0.01	7.36E-01
trabecular meshwork development (GO:0002930)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of activation of Janus kinase activity (GO:0010536)	7	0	.36	-	 < 0.01	6.99E-01
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	5	0	.26	-	 < 0.01	7.75E-01
regulation of activation of Janus kinase activity (GO:0010533)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	7	0	.36	-	 < 0.01	6.99E-01
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	12	0	.61	-	 < 0.01	5.42E-01
opsonization (GO:0008228)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of humoral immune response (GO:0002922)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of humoral immune response (GO:0002921)	14	0	.72	-	 < 0.01	4.89E-01
regulation of humoral immune response (GO:0002920)	71	0	3.63	-	 < 0.01	2.64E-02
vasopressin secretion (GO:0030103)	2	0	.10	-	 < 0.01	9.03E-01
natural killer cell activation (GO:0030101)	46	0	2.35	-	 < 0.01	9.51E-02
negative regulation of transposition (GO:0010529)	19	0	.97	-	 < 0.01	3.79E-01
regulation of transposition (GO:0010528)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of transposition, RNA-mediated (GO:0010526)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transposition, RNA-mediated (GO:0010525)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of lymphocyte anergy (GO:0002913)	4	0	.20	-	 < 0.01	8.15E-01
regulation of lymphocyte anergy (GO:0002911)	7	0	.36	-	 < 0.01	6.99E-01
regulation of reciprocal meiotic recombination (GO:0010520)	4	0	.20	-	 < 0.01	8.15E-01
mineralocorticoid metabolic process (GO:0008212)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of phospholipase activity (GO:0010519)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of mature B cell apoptotic process (GO:0002906)	4	0	.20	-	 < 0.01	8.15E-01
regulation of mature B cell apoptotic process (GO:0002905)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.10	-	 < 0.01	9.03E-01
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of gap junction assembly (GO:1903598)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of gap junction assembly (GO:1903597)	2	0	.10	-	 < 0.01	9.03E-01
regulation of gap junction assembly (GO:1903596)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of histamine secretion by mast cell (GO:1903595)	4	0	.20	-	 < 0.01	8.15E-01
regulation of histamine secretion by mast cell (GO:1903593)	4	0	.20	-	 < 0.01	8.15E-01
polyamine homeostasis (GO:0010509)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	6	0	.31	-	 < 0.01	7.36E-01
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of histone deubiquitination (GO:1903586)	1	0	.05	-	 < 0.01	9.50E-01
regulation of histone deubiquitination (GO:1903584)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of ATP metabolic process (GO:1903580)	41	0	2.09	-	 < 0.01	1.23E-01
response to L-arginine (GO:1903576)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein kinase D signaling (GO:1903572)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein kinase D signaling (GO:1903570)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.05	-	 < 0.01	9.50E-01
regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of protein localization to cilium (GO:1903566)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of protein localization to cilium (GO:1903565)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein localization to cilium (GO:1903564)	7	0	.36	-	 < 0.01	6.99E-01
pattern specification involved in mesonephros development (GO:0061227)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mesonephros development (GO:0061218)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mesonephros development (GO:0061217)	5	0	.26	-	 < 0.01	7.75E-01
regulation of growth hormone activity (GO:1903547)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to photoreceptor outer segment (GO:1903546)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to butyrate (GO:1903545)	1	0	.05	-	 < 0.01	9.50E-01
response to butyrate (GO:1903544)	1	0	.05	-	 < 0.01	9.50E-01
regulation of isoprenoid metabolic process (GO:0019747)	3	0	.15	-	 < 0.01	8.58E-01
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	2	0	.10	-	 < 0.01	9.03E-01
paramesonephric duct development (GO:0061205)	4	0	.20	-	 < 0.01	8.15E-01
pentacyclic triterpenoid metabolic process (GO:0019742)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of membrane tubulation (GO:1903527)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of membrane tubulation (GO:1903526)	2	0	.10	-	 < 0.01	9.03E-01
antifungal humoral response (GO:0019732)	11	0	.56	-	 < 0.01	5.70E-01
regulation of membrane tubulation (GO:1903525)	6	0	.31	-	 < 0.01	7.36E-01
antibacterial humoral response (GO:0019731)	49	0	2.50	-	 < 0.01	8.15E-02
positive regulation of single strand break repair (GO:1903518)	2	0	.10	-	 < 0.01	9.03E-01
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	8	0	.41	-	 < 0.01	6.65E-01
Mo-molybdopterin cofactor metabolic process (GO:0019720)	6	0	.31	-	 < 0.01	7.36E-01
phytanic acid metabolic process (GO:1903512)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription involved in primary germ layer cell fate commitment (GO:0060796)	1	0	.05	-	 < 0.01	9.50E-01
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	13	0	.66	-	 < 0.01	5.15E-01
cellular response to benomyl (GO:0072755)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to leptomycin B (GO:0072750)	2	0	.10	-	 < 0.01	9.03E-01
hair follicle placode formation (GO:0060789)	5	0	.26	-	 < 0.01	7.75E-01
ectodermal placode formation (GO:0060788)	12	0	.61	-	 < 0.01	5.42E-01
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.05	-	 < 0.01	9.50E-01
mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782)	1	0	.05	-	 < 0.01	9.50E-01
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	2	0	.10	-	 < 0.01	9.03E-01
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	3	0	.15	-	 < 0.01	8.58E-01
lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.05	-	 < 0.01	9.50E-01
brainstem development (GO:0003360)	6	0	.31	-	 < 0.01	7.36E-01
planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775)	2	0	.10	-	 < 0.01	9.03E-01
noradrenergic neuron fate commitment (GO:0003359)	1	0	.05	-	 < 0.01	9.50E-01
noradrenergic neuron development (GO:0003358)	2	0	.10	-	 < 0.01	9.03E-01
noradrenergic neuron differentiation (GO:0003357)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cilium movement (GO:0003354)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cilium movement (GO:0003353)	11	0	.56	-	 < 0.01	5.70E-01
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.05	-	 < 0.01	9.50E-01
S-adenosylhomocysteine metabolic process (GO:0046498)	3	0	.15	-	 < 0.01	8.58E-01
pulmonary myocardium development (GO:0003350)	2	0	.10	-	 < 0.01	9.03E-01
nicotinamide riboside metabolic process (GO:0046495)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to diamide (GO:0072738)	2	0	.10	-	 < 0.01	9.03E-01
response to diamide (GO:0072737)	2	0	.10	-	 < 0.01	9.03E-01
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.05	-	 < 0.01	9.50E-01
cellular response to staurosporine (GO:0072734)	4	0	.20	-	 < 0.01	8.15E-01
response to staurosporine (GO:0072733)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	3	0	.15	-	 < 0.01	8.58E-01
epithelial cell proliferation involved in prostate gland development (GO:0060767)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of androgen receptor signaling pathway (GO:0060766)	15	0	.77	-	 < 0.01	4.65E-01
cell-cell signaling involved in mammary gland development (GO:0060764)	1	0	.05	-	 < 0.01	9.50E-01
mammary duct terminal end bud growth (GO:0060763)	4	0	.20	-	 < 0.01	8.15E-01
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	5	0	.26	-	 < 0.01	7.75E-01
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.05	-	 < 0.01	9.50E-01
septum transversum development (GO:0003343)	2	0	.10	-	 < 0.01	9.03E-01
proepicardium development (GO:0003342)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of mast cell chemotaxis (GO:0060755)	1	0	.05	-	 < 0.01	9.50E-01
branch elongation involved in mammary gland duct branching (GO:0060751)	5	0	.26	-	 < 0.01	7.75E-01
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	4	0	.20	-	 < 0.01	8.15E-01
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	7	0	.36	-	 < 0.01	6.99E-01
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	8	0	.41	-	 < 0.01	6.65E-01
corneocyte desquamation (GO:0003336)	1	0	.05	-	 < 0.01	9.50E-01
corneocyte development (GO:0003335)	3	0	.15	-	 < 0.01	8.58E-01
glycosphingolipid catabolic process (GO:0046479)	13	0	.66	-	 < 0.01	5.15E-01
lactosylceramide metabolic process (GO:0046478)	1	0	.05	-	 < 0.01	9.50E-01
glycosylceramide catabolic process (GO:0046477)	6	0	.31	-	 < 0.01	7.36E-01
glycosylceramide biosynthetic process (GO:0046476)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to cisplatin (GO:0072719)	6	0	.31	-	 < 0.01	7.36E-01
response to cisplatin (GO:0072718)	8	0	.41	-	 < 0.01	6.65E-01
cellular response to actinomycin D (GO:0072717)	3	0	.15	-	 < 0.01	8.58E-01
response to actinomycin D (GO:0072716)	3	0	.15	-	 < 0.01	8.58E-01
cellular response to selenite ion (GO:0072715)	1	0	.05	-	 < 0.01	9.50E-01
response to selenite ion (GO:0072714)	1	0	.05	-	 < 0.01	9.50E-01
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	0	.15	-	 < 0.01	8.58E-01
mammary gland branching involved in thelarche (GO:0060744)	5	0	.26	-	 < 0.01	7.75E-01
epithelial cell maturation involved in prostate gland development (GO:0060743)	2	0	.10	-	 < 0.01	9.03E-01
prostate gland stromal morphogenesis (GO:0060741)	3	0	.15	-	 < 0.01	8.58E-01
pancreatic PP cell fate commitment (GO:0003329)	2	0	.10	-	 < 0.01	9.03E-01
type B pancreatic cell fate commitment (GO:0003327)	1	0	.05	-	 < 0.01	9.50E-01
pancreatic A cell fate commitment (GO:0003326)	2	0	.10	-	 < 0.01	9.03E-01
type B pancreatic cell development (GO:0003323)	14	0	.72	-	 < 0.01	4.89E-01
pancreatic A cell development (GO:0003322)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	7	0	.36	-	 < 0.01	6.99E-01
membrane lipid catabolic process (GO:0046466)	32	0	1.63	-	 < 0.01	1.95E-01
acylglycerol catabolic process (GO:0046464)	33	0	1.69	-	 < 0.01	1.85E-01
cellular response to sodium dodecyl sulfate (GO:0072707)	1	0	.05	-	 < 0.01	9.50E-01
response to sodium dodecyl sulfate (GO:0072706)	1	0	.05	-	 < 0.01	9.50E-01
neutral lipid catabolic process (GO:0046461)	33	0	1.69	-	 < 0.01	1.85E-01
late endosome to Golgi transport (GO:0034499)	6	0	.31	-	 < 0.01	7.36E-01
cellular response to methyl methanesulfonate (GO:0072703)	1	0	.05	-	 < 0.01	9.50E-01
early endosome to Golgi transport (GO:0034498)	7	0	.36	-	 < 0.01	6.99E-01
response to methyl methanesulfonate (GO:0072702)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to phagophore assembly site (GO:0034497)	11	0	.56	-	 < 0.01	5.70E-01
mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739)	1	0	.05	-	 < 0.01	9.50E-01
epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738)	2	0	.10	-	 < 0.01	9.03E-01
prostate gland morphogenetic growth (GO:0060737)	4	0	.20	-	 < 0.01	8.15E-01
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	1	0	.05	-	 < 0.01	9.50E-01
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of intestinal epithelial structure maintenance (GO:0060731)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intestinal epithelial structure maintenance (GO:0060730)	2	0	.10	-	 < 0.01	9.03E-01
cell migration to the midline involved in heart development (GO:0003318)	1	0	.05	-	 < 0.01	9.50E-01
pancreatic PP cell differentiation (GO:0003312)	2	0	.10	-	 < 0.01	9.03E-01
short-chain fatty acid metabolic process (GO:0046459)	16	0	.82	-	 < 0.01	4.41E-01
pancreatic D cell differentiation (GO:0003311)	1	0	.05	-	 < 0.01	9.50E-01
pancreatic A cell differentiation (GO:0003310)	6	0	.31	-	 < 0.01	7.36E-01
hexadecanal metabolic process (GO:0046458)	1	0	.05	-	 < 0.01	9.50E-01
dihydrofolate metabolic process (GO:0046452)	3	0	.15	-	 < 0.01	8.58E-01
vacuolar transmembrane transport (GO:0034486)	2	0	.10	-	 < 0.01	9.03E-01
type B pancreatic cell differentiation (GO:0003309)	19	0	.97	-	 < 0.01	3.79E-01
Wnt signaling pathway involved in heart development (GO:0003306)	4	0	.20	-	 < 0.01	8.15E-01
physiological cardiac muscle hypertrophy (GO:0003301)	8	0	.41	-	 < 0.01	6.65E-01
creatinine metabolic process (GO:0046449)	1	0	.05	-	 < 0.01	9.50E-01
tropane alkaloid metabolic process (GO:0046448)	1	0	.05	-	 < 0.01	9.50E-01
FMN metabolic process (GO:0046444)	1	0	.05	-	 < 0.01	9.50E-01
FAD metabolic process (GO:0046443)	1	0	.05	-	 < 0.01	9.50E-01
histone H3-K36 trimethylation (GO:0097198)	3	0	.15	-	 < 0.01	8.58E-01
L-lysine metabolic process (GO:0046440)	4	0	.20	-	 < 0.01	8.15E-01
cytokine biosynthetic process (GO:0042089)	4	0	.20	-	 < 0.01	8.15E-01
T-helper 1 type immune response (GO:0042088)	17	0	.87	-	 < 0.01	4.19E-01
pilomotor reflex (GO:0097195)	3	0	.15	-	 < 0.01	8.58E-01
U6 snRNA 3'-end processing (GO:0034477)	2	0	.10	-	 < 0.01	9.03E-01
U2 snRNA 3'-end processing (GO:0034474)	1	0	.05	-	 < 0.01	9.50E-01
chorionic trophoblast cell differentiation (GO:0060718)	5	0	.26	-	 < 0.01	7.75E-01
smooth muscle hypertrophy (GO:0014895)	1	0	.05	-	 < 0.01	9.50E-01
striated muscle atrophy (GO:0014891)	8	0	.41	-	 < 0.01	6.65E-01
L-cysteine metabolic process (GO:0046439)	4	0	.20	-	 < 0.01	8.15E-01
D-amino acid biosynthetic process (GO:0046437)	1	0	.05	-	 < 0.01	9.50E-01
D-alanine metabolic process (GO:0046436)	1	0	.05	-	 < 0.01	9.50E-01
dentin mineralization (GO:0097188)	1	0	.05	-	 < 0.01	9.50E-01
dentinogenesis (GO:0097187)	7	0	.36	-	 < 0.01	6.99E-01
cellular response to azide (GO:0097185)	1	0	.05	-	 < 0.01	9.50E-01
response to azide (GO:0097184)	1	0	.05	-	 < 0.01	9.50E-01
cell migration involved in gastrulation (GO:0042074)	14	0	.72	-	 < 0.01	4.89E-01
response to carbon monoxide (GO:0034465)	4	0	.20	-	 < 0.01	8.15E-01
trophoblast giant cell differentiation (GO:0060707)	14	0	.72	-	 < 0.01	4.89E-01
90S preribosome assembly (GO:0034463)	1	0	.05	-	 < 0.01	9.50E-01
small-subunit processome assembly (GO:0034462)	3	0	.15	-	 < 0.01	8.58E-01
muscle atrophy (GO:0014889)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of endoribonuclease activity (GO:0060702)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of ribonuclease activity (GO:0060701)	2	0	.10	-	 < 0.01	9.03E-01
transition between slow and fast fiber (GO:0014886)	1	0	.05	-	 < 0.01	9.50E-01
regulation of catecholamine metabolic process (GO:0042069)	19	0	.97	-	 < 0.01	3.79E-01
epoxide metabolic process (GO:0097176)	5	0	.26	-	 < 0.01	7.75E-01
microtubule anchoring at centrosome (GO:0034454)	9	0	.46	-	 < 0.01	6.31E-01
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	3	0	.15	-	 < 0.01	8.58E-01
response to injury involved in regulation of muscle adaptation (GO:0014876)	1	0	.05	-	 < 0.01	9.50E-01
protein repair (GO:0030091)	7	0	.36	-	 < 0.01	6.99E-01
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	3	0	.15	-	 < 0.01	8.58E-01
D-amino acid metabolic process (GO:0046416)	3	0	.15	-	 < 0.01	8.58E-01
mesenchymal stem cell proliferation (GO:0097168)	1	0	.05	-	 < 0.01	9.50E-01
very-low-density lipoprotein particle clearance (GO:0034447)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.10	-	 < 0.01	9.03E-01
regulation of dopamine metabolic process (GO:0042053)	19	0	.97	-	 < 0.01	3.79E-01
regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of lipoprotein oxidation (GO:0034443)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lipoprotein oxidation (GO:0034442)	2	0	.10	-	 < 0.01	9.03E-01
plasma lipoprotein particle oxidation (GO:0034441)	1	0	.05	-	 < 0.01	9.50E-01
skeletal myofibril assembly (GO:0014866)	8	0	.41	-	 < 0.01	6.65E-01
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	2	0	.10	-	 < 0.01	9.03E-01
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.05	-	 < 0.01	9.50E-01
regulation of central B cell tolerance induction (GO:0002895)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of type II hypersensitivity (GO:0002894)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of type II hypersensitivity (GO:0002893)	1	0	.05	-	 < 0.01	9.50E-01
regulation of type II hypersensitivity (GO:0002892)	4	0	.20	-	 < 0.01	8.15E-01
fasciculation of motor neuron axon (GO:0097156)	2	0	.10	-	 < 0.01	9.03E-01
fasciculation of sensory neuron axon (GO:0097155)	3	0	.15	-	 < 0.01	8.58E-01
GABAergic neuron differentiation (GO:0097154)	13	0	.66	-	 < 0.01	5.15E-01
epithelial fluid transport (GO:0042045)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of inhibitory postsynaptic potential (GO:0097151)	6	0	.31	-	 < 0.01	7.36E-01
metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of skeletal muscle cell proliferation (GO:0014859)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of skeletal muscle cell proliferation (GO:0014858)	3	0	.15	-	 < 0.01	8.58E-01
skeletal muscle cell proliferation (GO:0014856)	1	0	.05	-	 < 0.01	9.50E-01
insulin secretion (GO:0030073)	37	0	1.89	-	 < 0.01	1.51E-01
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.05	-	 < 0.01	9.50E-01
insulin processing (GO:0030070)	3	0	.15	-	 < 0.01	8.58E-01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	1	0	.05	-	 < 0.01	9.50E-01
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	11	0	.56	-	 < 0.01	5.70E-01
intercellular transport (GO:0010496)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of hypersensitivity (GO:0002885)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of hypersensitivity (GO:0002884)	3	0	.15	-	 < 0.01	8.58E-01
regulation of hypersensitivity (GO:0002883)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	1	0	.05	-	 < 0.01	9.50E-01
peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cytokine biosynthetic process (GO:0042036)	5	0	.26	-	 < 0.01	7.75E-01
chemokine biosynthetic process (GO:0042033)	1	0	.05	-	 < 0.01	9.50E-01
post-translational protein acetylation (GO:0034421)	3	0	.15	-	 < 0.01	8.58E-01
ureter smooth muscle contraction (GO:0014849)	2	0	.10	-	 < 0.01	9.03E-01
urinary tract smooth muscle contraction (GO:0014848)	9	0	.46	-	 < 0.01	6.31E-01
esophagus smooth muscle contraction (GO:0014846)	2	0	.10	-	 < 0.01	9.03E-01
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	0	.05	-	 < 0.01	9.50E-01
skeletal muscle satellite cell proliferation (GO:0014841)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	0	.05	-	 < 0.01	9.50E-01
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875)	1	0	.05	-	 < 0.01	9.50E-01
regulation of chronic inflammatory response to antigenic stimulus (GO:0002874)	3	0	.15	-	 < 0.01	8.58E-01
urate biosynthetic process (GO:0034418)	2	0	.10	-	 < 0.01	9.03E-01
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	1	0	.05	-	 < 0.01	9.50E-01
DNA endoreduplication (GO:0042023)	1	0	.05	-	 < 0.01	9.50E-01
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.20	-	 < 0.01	8.15E-01
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	4	0	.20	-	 < 0.01	8.15E-01
urinary bladder smooth muscle contraction (GO:0014832)	7	0	.36	-	 < 0.01	6.99E-01
gastro-intestinal system smooth muscle contraction (GO:0014831)	6	0	.31	-	 < 0.01	7.36E-01
response to sulfur dioxide (GO:0010477)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	6	0	.31	-	 < 0.01	7.36E-01
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	6	0	.31	-	 < 0.01	7.36E-01
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.10	-	 < 0.01	9.03E-01
vascular associated smooth muscle contraction (GO:0014829)	15	0	.77	-	 < 0.01	4.65E-01
parallel actin filament bundle assembly (GO:0030046)	7	0	.36	-	 < 0.01	6.99E-01
intestine smooth muscle contraction (GO:0014827)	4	0	.20	-	 < 0.01	8.15E-01
vein smooth muscle contraction (GO:0014826)	3	0	.15	-	 < 0.01	8.58E-01
actin filament fragmentation (GO:0030043)	4	0	.20	-	 < 0.01	8.15E-01
artery smooth muscle contraction (GO:0014824)	9	0	.46	-	 < 0.01	6.31E-01
actin filament polymerization (GO:0030041)	31	0	1.58	-	 < 0.01	2.05E-01
detection of wounding (GO:0014822)	1	0	.05	-	 < 0.01	9.50E-01
phasic smooth muscle contraction (GO:0014821)	17	0	.87	-	 < 0.01	4.19E-01
tonic smooth muscle contraction (GO:0014820)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859)	2	0	.10	-	 < 0.01	9.03E-01
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)	2	0	.10	-	 < 0.01	9.03E-01
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854)	2	0	.10	-	 < 0.01	9.03E-01
postsynaptic density protein 95 clustering (GO:0097119)	6	0	.31	-	 < 0.01	7.36E-01
regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)	2	0	.10	-	 < 0.01	9.03E-01
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.05	-	 < 0.01	9.50E-01
guanylate kinase-associated protein clustering (GO:0097117)	2	0	.10	-	 < 0.01	9.03E-01
gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	4	0	.20	-	 < 0.01	8.15E-01
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.05	-	 < 0.01	9.50E-01
NMDA glutamate receptor clustering (GO:0097114)	5	0	.26	-	 < 0.01	7.75E-01
AMPA glutamate receptor clustering (GO:0097113)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of translational initiation by iron (GO:0045994)	2	0	.10	-	 < 0.01	9.03E-01
gamma-aminobutyric acid receptor clustering (GO:0097112)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of translational initiation by iron (GO:0045993)	1	0	.05	-	 < 0.01	9.50E-01
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of embryonic development (GO:0045992)	2	0	.10	-	 < 0.01	9.03E-01
translocation of peptides or proteins into host (GO:0042000)	1	0	.05	-	 < 0.01	9.50E-01
actin filament reorganization involved in cell cycle (GO:0030037)	1	0	.05	-	 < 0.01	9.50E-01
regulation of skeletal muscle contraction (GO:0014819)	13	0	.66	-	 < 0.01	5.15E-01
skeletal muscle satellite cell differentiation (GO:0014816)	4	0	.20	-	 < 0.01	8.15E-01
microvillar actin bundle assembly (GO:0030034)	1	0	.05	-	 < 0.01	9.50E-01
microvillus assembly (GO:0030033)	9	0	.46	-	 < 0.01	6.31E-01
skeletal muscle satellite cell commitment (GO:0014813)	1	0	.05	-	 < 0.01	9.50E-01
muscle cell migration (GO:0014812)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810)	1	0	.05	-	 < 0.01	9.50E-01
exit from mitosis (GO:0010458)	13	0	.66	-	 < 0.01	5.15E-01
regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.05	-	 < 0.01	9.50E-01
centriole-centriole cohesion (GO:0010457)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of cell fate commitment (GO:0010455)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of cell fate commitment (GO:0010454)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of tolerance induction to tumor cell (GO:0002845)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cell fate commitment (GO:0010453)	30	0	1.53	-	 < 0.01	2.16E-01
regulation of tolerance induction to tumor cell (GO:0002843)	1	0	.05	-	 < 0.01	9.50E-01
endothelial tip cell fate specification (GO:0097102)	2	0	.10	-	 < 0.01	9.03E-01
blood vessel endothelial cell fate specification (GO:0097101)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of nucleotide metabolic process (GO:0045981)	44	0	2.25	-	 < 0.01	1.05E-01
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	4	0	.20	-	 < 0.01	8.15E-01
protein maturation by protein folding (GO:0022417)	9	0	.46	-	 < 0.01	6.31E-01
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	7	0	.36	-	 < 0.01	6.99E-01
cellular manganese ion homeostasis (GO:0030026)	2	0	.10	-	 < 0.01	9.03E-01
smooth muscle hyperplasia (GO:0014806)	2	0	.10	-	 < 0.01	9.03E-01
smooth muscle adaptation (GO:0014805)	4	0	.20	-	 < 0.01	8.15E-01
response to acidic pH (GO:0010447)	23	0	1.17	-	 < 0.01	3.09E-01
negative regulation of immune response to tumor cell (GO:0002838)	2	0	.10	-	 < 0.01	9.03E-01
response to alkaline pH (GO:0010446)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of response to tumor cell (GO:0002835)	2	0	.10	-	 < 0.01	9.03E-01
fungiform papilla formation (GO:0061198)	3	0	.15	-	 < 0.01	8.58E-01
fungiform papilla morphogenesis (GO:0061197)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of type 2 immune response (GO:0002830)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	0	.10	-	 < 0.01	9.03E-01
taste bud development (GO:0061193)	2	0	.10	-	 < 0.01	9.03E-01
regulation of sclerotome development (GO:0061190)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of T-helper 1 type immune response (GO:0002826)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of sclerotome development (GO:0061189)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of ribosomal DNA heterochromatin assembly (GO:0061188)	2	0	.10	-	 < 0.01	9.03E-01
fatty acid omega-oxidation (GO:0010430)	5	0	.26	-	 < 0.01	7.75E-01
regulation of ribosomal DNA heterochromatin assembly (GO:0061187)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of dermatome development (GO:0061185)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of dermatome development (GO:0061184)	3	0	.15	-	 < 0.01	8.58E-01
regulation of dermatome development (GO:0061183)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of chondrocyte development (GO:0061182)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dopamine metabolic process (GO:0045964)	6	0	.31	-	 < 0.01	7.36E-01
regulation of chondrocyte development (GO:0061181)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of dopamine metabolic process (GO:0045963)	4	0	.20	-	 < 0.01	8.15E-01
cellular potassium ion homeostasis (GO:0030007)	14	0	.72	-	 < 0.01	4.89E-01
hydrogen peroxide-mediated programmed cell death (GO:0010421)	2	0	.10	-	 < 0.01	9.03E-01
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of complement activation, classical pathway (GO:0045959)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of complement activation, alternative pathway (GO:0045957)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation of hair follicle placode formation (GO:0061170)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mitotic recombination (GO:0045951)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of antibacterial peptide production (GO:0002803)	3	0	.15	-	 < 0.01	8.58E-01
regulation of hair follicle placode formation (GO:0061168)	1	0	.05	-	 < 0.01	9.50E-01
response to 11-deoxycorticosterone (GO:1903496)	1	0	.05	-	 < 0.01	9.50E-01
response to dehydroepiandrosterone (GO:1903494)	1	0	.05	-	 < 0.01	9.50E-01
establishment of monopolar cell polarity (GO:0061162)	23	0	1.17	-	 < 0.01	3.09E-01
response to acetylsalicylate (GO:1903492)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of mitotic cytokinesis (GO:1903490)	2	0	.10	-	 < 0.01	9.03E-01
3'-UTR-mediated mRNA destabilization (GO:0061158)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of lactation (GO:1903489)	2	0	.10	-	 < 0.01	9.03E-01
mRNA destabilization (GO:0061157)	31	0	1.58	-	 < 0.01	2.05E-01
choline metabolic process (GO:0019695)	9	0	.46	-	 < 0.01	6.31E-01
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	5	0	.26	-	 < 0.01	7.75E-01
alkanesulfonate metabolic process (GO:0019694)	7	0	.36	-	 < 0.01	6.99E-01
regulation of lactation (GO:1903487)	3	0	.15	-	 < 0.01	8.58E-01
pulmonary artery endothelial tube morphogenesis (GO:0061155)	1	0	.05	-	 < 0.01	9.50E-01
endothelial tube morphogenesis (GO:0061154)	13	0	.66	-	 < 0.01	5.15E-01
trachea gland development (GO:0061153)	2	0	.10	-	 < 0.01	9.03E-01
trachea submucosa development (GO:0061152)	2	0	.10	-	 < 0.01	9.03E-01
BMP signaling pathway involved in renal system segmentation (GO:0061151)	1	0	.05	-	 < 0.01	9.50E-01
renal system segmentation (GO:0061150)	1	0	.05	-	 < 0.01	9.50E-01
box C/D snoRNA metabolic process (GO:0033967)	2	0	.10	-	 < 0.01	9.03E-01
neural plate anterior/posterior regionalization (GO:0021999)	3	0	.15	-	 < 0.01	8.58E-01
neural plate mediolateral regionalization (GO:0021998)	1	0	.05	-	 < 0.01	9.50E-01
neural plate axis specification (GO:0021997)	2	0	.10	-	 < 0.01	9.03E-01
initiation of neural tube closure (GO:0021993)	1	0	.05	-	 < 0.01	9.50E-01
BMP signaling pathway involved in ureter morphogenesis (GO:0061149)	1	0	.05	-	 < 0.01	9.50E-01
Peyer's patch morphogenesis (GO:0061146)	3	0	.15	-	 < 0.01	8.58E-01
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	7	0	.36	-	 < 0.01	6.99E-01
alveolar secondary septum development (GO:0061144)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of female receptivity (GO:0045925)	3	0	.15	-	 < 0.01	8.58E-01
alveolar primary septum development (GO:0061143)	1	0	.05	-	 < 0.01	9.50E-01
regulation of female receptivity (GO:0045924)	8	0	.41	-	 < 0.01	6.65E-01
lung ciliated cell differentiation (GO:0061141)	1	0	.05	-	 < 0.01	9.50E-01
lung secretory cell differentiation (GO:0061140)	9	0	.46	-	 < 0.01	6.31E-01
olfactory cortex development (GO:0021989)	1	0	.05	-	 < 0.01	9.50E-01
habenula development (GO:0021986)	3	0	.15	-	 < 0.01	8.58E-01
neurohypophysis development (GO:0021985)	2	0	.10	-	 < 0.01	9.03E-01
NAD catabolic process (GO:0019677)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cytolysis (GO:0045919)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cytolysis (GO:0045918)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of complement activation (GO:0045917)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of complement activation (GO:0045916)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of mitotic cell cycle DNA replication (GO:1903465)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of catecholamine metabolic process (GO:0045915)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of catecholamine metabolic process (GO:0045914)	4	0	.20	-	 < 0.01	8.15E-01
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.05	-	 < 0.01	9.50E-01
hypothalamus cell differentiation (GO:0021979)	7	0	.36	-	 < 0.01	6.99E-01
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	0	.05	-	 < 0.01	9.50E-01
lactate catabolic process (GO:1903457)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of translational termination (GO:0045905)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of translational fidelity (GO:0045903)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of G1 to G0 transition (GO:1903452)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of translational elongation (GO:0045901)	3	0	.15	-	 < 0.01	8.58E-01
regulation of G1 to G0 transition (GO:1903450)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of translational elongation (GO:0045900)	5	0	.26	-	 < 0.01	7.75E-01
corticospinal neuron axon guidance (GO:0021966)	2	0	.10	-	 < 0.01	9.03E-01
spinal cord ventral commissure morphogenesis (GO:0021965)	3	0	.15	-	 < 0.01	8.58E-01
anterior commissure morphogenesis (GO:0021960)	5	0	.26	-	 < 0.01	7.75E-01
lung proximal/distal axis specification (GO:0061115)	1	0	.05	-	 < 0.01	9.50E-01
branching involved in pancreas morphogenesis (GO:0061114)	1	0	.05	-	 < 0.01	9.50E-01
protein transport from ciliary membrane to plasma membrane (GO:1903445)	2	0	.10	-	 < 0.01	9.03E-01
pancreas morphogenesis (GO:0061113)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of brown fat cell differentiation (GO:1903444)	1	0	.05	-	 < 0.01	9.50E-01
response to lipoic acid (GO:1903442)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to ciliary membrane (GO:1903441)	7	0	.36	-	 < 0.01	6.99E-01
corticospinal tract morphogenesis (GO:0021957)	7	0	.36	-	 < 0.01	6.99E-01
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.05	-	 < 0.01	9.50E-01
seminal vesicle epithelium development (GO:0061108)	1	0	.05	-	 < 0.01	9.50E-01
aerobic electron transport chain (GO:0019646)	16	0	.82	-	 < 0.01	4.41E-01
seminal vesicle development (GO:0061107)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mitotic cytokinetic process (GO:1903438)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.05	-	 < 0.01	9.50E-01
regulation of mitotic cytokinetic process (GO:1903436)	2	0	.10	-	 < 0.01	9.03E-01
regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.05	-	 < 0.01	9.50E-01
adrenal chromaffin cell differentiation (GO:0061104)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.05	-	 < 0.01	9.50E-01
carotid body glomus cell differentiation (GO:0061103)	1	0	.05	-	 < 0.01	9.50E-01
regulation of constitutive secretory pathway (GO:1903433)	2	0	.10	-	 < 0.01	9.03E-01
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640)	5	0	.26	-	 < 0.01	7.75E-01
stomach neuroendocrine cell differentiation (GO:0061102)	1	0	.05	-	 < 0.01	9.50E-01
lung neuroendocrine cell differentiation (GO:0061100)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cell maturation (GO:1903430)	6	0	.31	-	 < 0.01	7.36E-01
neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944)	1	0	.05	-	 < 0.01	9.50E-01
formation of radial glial scaffolds (GO:0021943)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	9	0	.46	-	 < 0.01	6.31E-01
protein localization to cell cortex (GO:0072697)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of synaptic vesicle recycling (GO:1903423)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of synaptic vesicle recycling (GO:1903422)	3	0	.15	-	 < 0.01	8.58E-01
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.05	-	 < 0.01	9.50E-01
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	5	0	.26	-	 < 0.01	7.75E-01
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	7	0	.36	-	 < 0.01	6.99E-01
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	11	0	.56	-	 < 0.01	5.70E-01
cerebellar granule cell precursor tangential migration (GO:0021935)	2	0	.10	-	 < 0.01	9.03E-01
hindbrain tangential cell migration (GO:0021934)	2	0	.10	-	 < 0.01	9.03E-01
radial glia guided migration of cerebellar granule cell (GO:0021933)	1	0	.05	-	 < 0.01	9.50E-01
urate catabolic process (GO:0019628)	1	0	.05	-	 < 0.01	9.50E-01
cerebellar granule cell precursor proliferation (GO:0021930)	7	0	.36	-	 < 0.01	6.99E-01
urea metabolic process (GO:0019627)	13	0	.66	-	 < 0.01	5.15E-01
short-chain fatty acid catabolic process (GO:0019626)	8	0	.41	-	 < 0.01	6.65E-01
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.05	-	 < 0.01	9.50E-01
T cell extravasation (GO:0072683)	8	0	.41	-	 < 0.01	6.65E-01
response to glycoside (GO:1903416)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to bile acid (GO:1903413)	5	0	.26	-	 < 0.01	7.75E-01
response to bile acid (GO:1903412)	5	0	.26	-	 < 0.01	7.75E-01
physiological muscle hypertrophy (GO:0003298)	8	0	.41	-	 < 0.01	6.65E-01
atrial ventricular junction remodeling (GO:0003294)	1	0	.05	-	 < 0.01	9.50E-01
cardiac septum cell differentiation (GO:0003292)	2	0	.10	-	 < 0.01	9.03E-01
atrial septum secundum morphogenesis (GO:0003290)	1	0	.05	-	 < 0.01	9.50E-01
cell proliferation in external granule layer (GO:0021924)	7	0	.36	-	 < 0.01	6.99E-01
thymocyte migration (GO:0072679)	2	0	.10	-	 < 0.01	9.03E-01
T cell migration (GO:0072678)	29	0	1.48	-	 < 0.01	2.27E-01
eosinophil migration (GO:0072677)	16	0	.82	-	 < 0.01	4.41E-01
regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification (GO:0021920)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of sodium:potassium-exchanging ATPase activity (GO:1903408)	2	0	.10	-	 < 0.01	9.03E-01
osteoclast fusion (GO:0072675)	6	0	.31	-	 < 0.01	7.36E-01
multinuclear osteoclast differentiation (GO:0072674)	8	0	.41	-	 < 0.01	6.65E-01
catechol-containing compound catabolic process (GO:0019614)	7	0	.36	-	 < 0.01	6.99E-01
regulation of sodium:potassium-exchanging ATPase activity (GO:1903406)	2	0	.10	-	 < 0.01	9.03E-01
lamellipodium morphogenesis (GO:0072673)	6	0	.31	-	 < 0.01	7.36E-01
neutrophil extravasation (GO:0072672)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of renal phosphate excretion (GO:1903403)	1	0	.05	-	 < 0.01	9.50E-01
regulation of renal phosphate excretion (GO:1903402)	1	0	.05	-	 < 0.01	9.50E-01
L-lysine transmembrane transport (GO:1903401)	4	0	.20	-	 < 0.01	8.15E-01
atrial septum primum morphogenesis (GO:0003289)	4	0	.20	-	 < 0.01	8.15E-01
septum secundum development (GO:0003285)	2	0	.10	-	 < 0.01	9.03E-01
septum primum development (GO:0003284)	5	0	.26	-	 < 0.01	7.75E-01
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment (GO:0021918)	1	0	.05	-	 < 0.01	9.50E-01
somatic motor neuron fate commitment (GO:0021917)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	3	0	.15	-	 < 0.01	8.58E-01
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification (GO:0021913)	3	0	.15	-	 < 0.01	8.58E-01
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification (GO:0021912)	2	0	.10	-	 < 0.01	9.03E-01
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	3	0	.15	-	 < 0.01	8.58E-01
2-oxobutyrate catabolic process (GO:0019606)	1	0	.05	-	 < 0.01	9.50E-01
butyrate metabolic process (GO:0019605)	2	0	.10	-	 < 0.01	9.03E-01
maintenance of protein location in plasma membrane (GO:0072660)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of phospholipid catabolic process (GO:0060697)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.05	-	 < 0.01	9.50E-01
regulation of cholesterol transporter activity (GO:0060694)	2	0	.10	-	 < 0.01	9.03E-01
optokinetic behavior (GO:0007634)	2	0	.10	-	 < 0.01	9.03E-01
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	9	0	.46	-	 < 0.01	6.31E-01
epithelial cell maturation involved in salivary gland development (GO:0060691)	1	0	.05	-	 < 0.01	9.50E-01
epithelial cell differentiation involved in salivary gland development (GO:0060690)	1	0	.05	-	 < 0.01	9.50E-01
apoptotic process involved in heart morphogenesis (GO:0003278)	2	0	.10	-	 < 0.01	9.03E-01
endocardial cushion fusion (GO:0003274)	4	0	.20	-	 < 0.01	8.15E-01
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271)	1	0	.05	-	 < 0.01	9.50E-01
forebrain-midbrain boundary formation (GO:0021905)	1	0	.05	-	 < 0.01	9.50E-01
dorsal/ventral neural tube patterning (GO:0021904)	18	0	.92	-	 < 0.01	3.99E-01
rostrocaudal neural tube patterning (GO:0021903)	11	0	.56	-	 < 0.01	5.70E-01
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	7	0	.36	-	 < 0.01	6.99E-01
maintenance of protein location in membrane (GO:0072658)	2	0	.10	-	 < 0.01	9.03E-01
cell differentiation involved in salivary gland development (GO:0060689)	3	0	.15	-	 < 0.01	8.58E-01
adult walking behavior (GO:0007628)	30	0	1.53	-	 < 0.01	2.16E-01
regulation of branching involved in prostate gland morphogenesis (GO:0060687)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of prostatic bud formation (GO:0060686)	4	0	.20	-	 < 0.01	8.15E-01
regulation of prostatic bud formation (GO:0060685)	6	0	.31	-	 < 0.01	7.36E-01
grooming behavior (GO:0007625)	12	0	.61	-	 < 0.01	5.42E-01
epithelial-mesenchymal cell signaling (GO:0060684)	6	0	.31	-	 < 0.01	7.36E-01
ultradian rhythm (GO:0007624)	2	0	.10	-	 < 0.01	9.03E-01
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.05	-	 < 0.01	9.50E-01
primary ureteric bud growth (GO:0060682)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of female receptivity (GO:0007621)	4	0	.20	-	 < 0.01	8.15E-01
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.05	-	 < 0.01	9.50E-01
copulation (GO:0007620)	15	0	.77	-	 < 0.01	4.65E-01
cardioblast migration (GO:0003260)	1	0	.05	-	 < 0.01	9.50E-01
courtship behavior (GO:0007619)	3	0	.15	-	 < 0.01	8.58E-01
dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678)	1	0	.05	-	 < 0.01	9.50E-01
ureteric bud elongation (GO:0060677)	6	0	.31	-	 < 0.01	7.36E-01
ureteric bud formation (GO:0060676)	4	0	.20	-	 < 0.01	8.15E-01
short-term memory (GO:0007614)	11	0	.56	-	 < 0.01	5.70E-01
epithelial cell morphogenesis involved in placental branching (GO:0060672)	3	0	.15	-	 < 0.01	8.58E-01
epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	3	0	.15	-	 < 0.01	8.58E-01
branching involved in labyrinthine layer morphogenesis (GO:0060670)	12	0	.61	-	 < 0.01	5.42E-01
cardioblast anterior-lateral migration (GO:0003259)	1	0	.05	-	 < 0.01	9.50E-01
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.05	-	 < 0.01	9.50E-01
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of phospholipid efflux (GO:1902999)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of neurofibrillary tangle assembly (GO:1902998)	2	0	.10	-	 < 0.01	9.03E-01
branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	0	.10	-	 < 0.01	9.03E-01
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neurofibrillary tangle assembly (GO:1902996)	3	0	.15	-	 < 0.01	8.58E-01
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	4	0	.20	-	 < 0.01	8.15E-01
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of phospholipid efflux (GO:1902995)	3	0	.15	-	 < 0.01	8.58E-01
phototransduction, visible light (GO:0007603)	17	0	.87	-	 < 0.01	4.19E-01
regulation of phospholipid efflux (GO:1902994)	3	0	.15	-	 < 0.01	8.58E-01
salivary gland cavitation (GO:0060662)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	14	0	.72	-	 < 0.01	4.89E-01
submandibular salivary gland formation (GO:0060661)	2	0	.10	-	 < 0.01	9.03E-01
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	0	.15	-	 < 0.01	8.58E-01
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.05	-	 < 0.01	9.50E-01
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	2	0	.10	-	 < 0.01	9.03E-01
deoxyribose phosphate biosynthetic process (GO:0046385)	11	0	.56	-	 < 0.01	5.70E-01
CMP-N-acetylneuraminate metabolic process (GO:0046381)	1	0	.05	-	 < 0.01	9.50E-01
N-acetylneuraminate biosynthetic process (GO:0046380)	1	0	.05	-	 < 0.01	9.50E-01
nipple morphogenesis (GO:0060658)	1	0	.05	-	 < 0.01	9.50E-01
neurofibrillary tangle assembly (GO:1902988)	1	0	.05	-	 < 0.01	9.50E-01
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.05	-	 < 0.01	9.50E-01
sinus venosus morphogenesis (GO:0003236)	1	0	.05	-	 < 0.01	9.50E-01
sinus venosus development (GO:0003235)	1	0	.05	-	 < 0.01	9.50E-01
fructose biosynthetic process (GO:0046370)	2	0	.10	-	 < 0.01	9.03E-01
mitotic DNA replication termination (GO:1902979)	1	0	.05	-	 < 0.01	9.50E-01
mammary gland bud morphogenesis (GO:0060648)	3	0	.15	-	 < 0.01	8.58E-01
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.05	-	 < 0.01	9.50E-01
mammary gland epithelial cell differentiation (GO:0060644)	17	0	.87	-	 < 0.01	4.19E-01
atrial cardiac muscle tissue development (GO:0003228)	7	0	.36	-	 < 0.01	6.99E-01
right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.05	-	 < 0.01	9.50E-01
ventricular compact myocardium morphogenesis (GO:0003223)	8	0	.41	-	 < 0.01	6.65E-01
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	3	0	.15	-	 < 0.01	8.58E-01
GDP-L-fucose metabolic process (GO:0046368)	3	0	.15	-	 < 0.01	8.58E-01
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	2	0	.10	-	 < 0.01	9.03E-01
2-oxobutyrate metabolic process (GO:0046361)	2	0	.10	-	 < 0.01	9.03E-01
2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.05	-	 < 0.01	9.50E-01
telomere tethering at nuclear periphery (GO:0034398)	3	0	.15	-	 < 0.01	8.58E-01
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	6	0	.31	-	 < 0.01	7.36E-01
regulation of smooth muscle cell apoptotic process (GO:0034391)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of protein localization to early endosome (GO:1902966)	9	0	.46	-	 < 0.01	6.31E-01
regulation of protein localization to early endosome (GO:1902965)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	2	0	.10	-	 < 0.01	9.03E-01
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	2	0	.10	-	 < 0.01	9.03E-01
regulation of meiosis I (GO:0060631)	1	0	.05	-	 < 0.01	9.50E-01
cardiac left ventricle formation (GO:0003218)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	2	0	.10	-	 < 0.01	9.03E-01
butyrate catabolic process (GO:0046359)	1	0	.05	-	 < 0.01	9.50E-01
acetyl-CoA catabolic process (GO:0046356)	2	0	.10	-	 < 0.01	9.03E-01
disaccharide catabolic process (GO:0046352)	1	0	.05	-	 < 0.01	9.50E-01
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	2	0	.10	-	 < 0.01	9.03E-01
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	5	0	.26	-	 < 0.01	7.75E-01
high-density lipoprotein particle assembly (GO:0034380)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.05	-	 < 0.01	9.50E-01
regulation of early endosome to recycling endosome transport (GO:1902954)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of cholesterol import (GO:0060621)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of dendritic spine maintenance (GO:1902952)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of dendritic spine maintenance (GO:1902951)	4	0	.20	-	 < 0.01	8.15E-01
regulation of cholesterol import (GO:0060620)	3	0	.15	-	 < 0.01	8.58E-01
regulation of dendritic spine maintenance (GO:1902950)	11	0	.56	-	 < 0.01	5.70E-01
diacylglycerol catabolic process (GO:0046340)	3	0	.15	-	 < 0.01	8.58E-01
synaptic vesicle clustering (GO:0097091)	6	0	.31	-	 < 0.01	7.36E-01
nipple development (GO:0060618)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of tau-protein kinase activity (GO:1902948)	3	0	.15	-	 < 0.01	8.58E-01
very-low-density lipoprotein particle remodeling (GO:0034372)	8	0	.41	-	 < 0.01	6.65E-01
chylomicron remodeling (GO:0034371)	9	0	.46	-	 < 0.01	6.31E-01
protein localization to early endosome (GO:1902946)	2	0	.10	-	 < 0.01	9.03E-01
mammary gland bud formation (GO:0060615)	2	0	.10	-	 < 0.01	9.03E-01
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	12	0	.61	-	 < 0.01	5.42E-01
fat pad development (GO:0060613)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of voltage-gated chloride channel activity (GO:1902943)	2	0	.10	-	 < 0.01	9.03E-01
mammary gland fat development (GO:0060611)	1	0	.05	-	 < 0.01	9.50E-01
regulation of voltage-gated chloride channel activity (GO:1902941)	2	0	.10	-	 < 0.01	9.03E-01
diacylglycerol metabolic process (GO:0046339)	22	0	1.12	-	 < 0.01	3.25E-01
octopamine metabolic process (GO:0046333)	2	0	.10	-	 < 0.01	9.03E-01
methyl-branched fatty acid metabolic process (GO:0097089)	3	0	.15	-	 < 0.01	8.58E-01
lateral inhibition (GO:0046331)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of intracellular calcium activated chloride channel activity (GO:1902939)	1	0	.05	-	 < 0.01	9.50E-01
regulation of intracellular calcium activated chloride channel activity (GO:1902938)	3	0	.15	-	 < 0.01	8.58E-01
plasma membrane selenite transport (GO:0097080)	1	0	.05	-	 < 0.01	9.50E-01
tube lumen cavitation (GO:0060605)	5	0	.26	-	 < 0.01	7.75E-01
branch elongation of an epithelium (GO:0060602)	16	0	.82	-	 < 0.01	4.41E-01
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	9	0	.46	-	 < 0.01	6.31E-01
glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of glucose import (GO:0046325)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of fatty acid oxidation (GO:0046322)	11	0	.56	-	 < 0.01	5.70E-01
NAD salvage (GO:0034355)	1	0	.05	-	 < 0.01	9.50E-01
'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	6	0	.31	-	 < 0.01	7.36E-01
ductus arteriosus closure (GO:0097070)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of glial cell apoptotic process (GO:0034352)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of glial cell apoptotic process (GO:0034351)	7	0	.36	-	 < 0.01	6.99E-01
regulation of glial cell apoptotic process (GO:0034350)	9	0	.46	-	 < 0.01	6.31E-01
negative regulation of glucosylceramide biosynthetic process (GO:0046318)	1	0	.05	-	 < 0.01	9.50E-01
regulation of glucosylceramide biosynthetic process (GO:0046317)	1	0	.05	-	 < 0.01	9.50E-01
phosphocreatine biosynthetic process (GO:0046314)	3	0	.15	-	 < 0.01	8.58E-01
glial cell apoptotic process (GO:0034349)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of type III interferon production (GO:0034346)	2	0	.10	-	 < 0.01	9.03E-01
regulation of type III interferon production (GO:0034344)	4	0	.20	-	 < 0.01	8.15E-01
response to type III interferon (GO:0034342)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of neuroepithelial cell differentiation (GO:1902913)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of melanosome transport (GO:1902910)	1	0	.05	-	 < 0.01	9.50E-01
alkanesulfonate biosynthetic process (GO:0046305)	2	0	.10	-	 < 0.01	9.03E-01
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	4	0	.20	-	 < 0.01	8.15E-01
agmatine biosynthetic process (GO:0097055)	1	0	.05	-	 < 0.01	9.50E-01
L-kynurenine catabolic process (GO:0097053)	3	0	.15	-	 < 0.01	8.58E-01
L-kynurenine metabolic process (GO:0097052)	7	0	.36	-	 < 0.01	6.99E-01
retrograde axonal transport (GO:0008090)	19	0	.97	-	 < 0.01	3.79E-01
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.15	-	 < 0.01	8.58E-01
regulation of melanosome transport (GO:1902908)	2	0	.10	-	 < 0.01	9.03E-01
type B pancreatic cell apoptotic process (GO:0097050)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of antibacterial peptide production (GO:0002787)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antibacterial peptide production (GO:0002786)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of antimicrobial peptide production (GO:0002785)	1	0	.05	-	 < 0.01	9.50E-01
regulation of antimicrobial peptide production (GO:0002784)	6	0	.31	-	 < 0.01	7.36E-01
motor neuron apoptotic process (GO:0097049)	3	0	.15	-	 < 0.01	8.58E-01
antibacterial peptide biosynthetic process (GO:0002780)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of muscle adaptation (GO:0014744)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of muscle hypertrophy (GO:0014742)	24	0	1.23	-	 < 0.01	2.93E-01
COP9 signalosome assembly (GO:0010387)	5	0	.26	-	 < 0.01	7.75E-01
antibacterial peptide production (GO:0002778)	2	0	.10	-	 < 0.01	9.03E-01
antimicrobial peptide biosynthetic process (GO:0002777)	1	0	.05	-	 < 0.01	9.50E-01
antimicrobial peptide production (GO:0002775)	2	0	.10	-	 < 0.01	9.03E-01
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	4	0	.20	-	 < 0.01	8.15E-01
cell wall polysaccharide metabolic process (GO:0010383)	1	0	.05	-	 < 0.01	9.50E-01
mesodermal cell migration (GO:0008078)	4	0	.20	-	 < 0.01	8.15E-01
protein linear polyubiquitination (GO:0097039)	3	0	.15	-	 < 0.01	8.58E-01
heme export (GO:0097037)	3	0	.15	-	 < 0.01	8.58E-01
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	6	0	.31	-	 < 0.01	7.36E-01
primary alcohol catabolic process (GO:0034310)	12	0	.61	-	 < 0.01	5.42E-01
positive regulation of muscle hyperplasia (GO:0014739)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of muscle atrophy (GO:0014737)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of muscle atrophy (GO:0014736)	2	0	.10	-	 < 0.01	9.03E-01
regulation of muscle atrophy (GO:0014735)	4	0	.20	-	 < 0.01	8.15E-01
skeletal muscle hypertrophy (GO:0014734)	1	0	.05	-	 < 0.01	9.50E-01
skeletal muscle atrophy (GO:0014732)	7	0	.36	-	 < 0.01	6.99E-01
natural killer cell inhibitory signaling pathway (GO:0002769)	1	0	.05	-	 < 0.01	9.50E-01
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	6	0	.31	-	 < 0.01	7.36E-01
immune response-inhibiting signal transduction (GO:0002765)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of myeloid leukocyte differentiation (GO:0002762)	50	0	2.55	-	 < 0.01	7.75E-02
mature conventional dendritic cell differentiation (GO:0097029)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of antimicrobial humoral response (GO:0002760)	6	0	.31	-	 < 0.01	7.36E-01
dendritic cell dendrite assembly (GO:0097026)	2	0	.10	-	 < 0.01	9.03E-01
establishment of blood-nerve barrier (GO:0008065)	4	0	.20	-	 < 0.01	8.15E-01
primary alcohol biosynthetic process (GO:0034309)	4	0	.20	-	 < 0.01	8.15E-01
regulation of the force of skeletal muscle contraction (GO:0014728)	2	0	.10	-	 < 0.01	9.03E-01
regulation of twitch skeletal muscle contraction (GO:0014724)	3	0	.15	-	 < 0.01	8.58E-01
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	5	0	.26	-	 < 0.01	7.75E-01
twitch skeletal muscle contraction (GO:0014721)	2	0	.10	-	 < 0.01	9.03E-01
regulation of antimicrobial humoral response (GO:0002759)	8	0	.41	-	 < 0.01	6.65E-01
cell surface pattern recognition receptor signaling pathway (GO:0002752)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of anion channel activity (GO:0010360)	2	0	.10	-	 < 0.01	9.03E-01
eye pigment granule organization (GO:0008057)	1	0	.05	-	 < 0.01	9.50E-01
renal protein absorption (GO:0097017)	1	0	.05	-	 < 0.01	9.50E-01
sensory organ boundary specification (GO:0008052)	1	0	.05	-	 < 0.01	9.50E-01
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	11	0	.56	-	 < 0.01	5.70E-01
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	11	0	.56	-	 < 0.01	5.70E-01
female courtship behavior (GO:0008050)	2	0	.10	-	 < 0.01	9.03E-01
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.10	-	 < 0.01	9.03E-01
skeletal muscle satellite cell activation (GO:0014719)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.10	-	 < 0.01	9.03E-01
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	3	0	.15	-	 < 0.01	8.58E-01
regulation of anion channel activity (GO:0010359)	8	0	.41	-	 < 0.01	6.65E-01
male courtship behavior (GO:0008049)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	1	0	.05	-	 < 0.01	9.50E-01
branchiomeric skeletal muscle development (GO:0014707)	3	0	.15	-	 < 0.01	8.58E-01
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737)	1	0	.05	-	 < 0.01	9.50E-01
regulation of plasmacytoid dendritic cell cytokine production (GO:0002736)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	6	0	.31	-	 < 0.01	7.36E-01
synaptic target recognition (GO:0008039)	1	0	.05	-	 < 0.01	9.50E-01
regulation of myeloid dendritic cell cytokine production (GO:0002733)	6	0	.31	-	 < 0.01	7.36E-01
positive regulation of dendritic cell cytokine production (GO:0002732)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of dendritic cell cytokine production (GO:0002731)	2	0	.10	-	 < 0.01	9.03E-01
regulation of dendritic cell cytokine production (GO:0002730)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of sister chromatid cohesion (GO:0045875)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of phospholipid translocation (GO:0061092)	3	0	.15	-	 < 0.01	8.58E-01
regulation of phospholipid translocation (GO:0061091)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of rhodopsin gene expression (GO:0045872)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of sequestering of zinc ion (GO:0061090)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	2	0	.10	-	 < 0.01	9.03E-01
protein K6-linked ubiquitination (GO:0085020)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of natural killer cell cytokine production (GO:0002729)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of natural killer cell cytokine production (GO:0002728)	2	0	.10	-	 < 0.01	9.03E-01
regulation of natural killer cell cytokine production (GO:0002727)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of T cell cytokine production (GO:0002726)	19	0	.97	-	 < 0.01	3.79E-01
negative regulation of T cell cytokine production (GO:0002725)	10	0	.51	-	 < 0.01	6.00E-01
regulation of T cell cytokine production (GO:0002724)	32	0	1.63	-	 < 0.01	1.95E-01
regulation of sequestering of zinc ion (GO:0061088)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of histone H3-K27 methylation (GO:0061087)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	14	0	.72	-	 < 0.01	4.89E-01
regulation of B cell cytokine production (GO:0002721)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of histone H3-K27 methylation (GO:0061086)	3	0	.15	-	 < 0.01	8.58E-01
regulation of histone H3-K27 methylation (GO:0061085)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of protein refolding (GO:0061084)	4	0	.20	-	 < 0.01	8.15E-01
regulation of protein refolding (GO:0061083)	4	0	.20	-	 < 0.01	8.15E-01
myeloid leukocyte cytokine production (GO:0061082)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	20	0	1.02	-	 < 0.01	3.60E-01
maintenance of symbiont-containing vacuole by host (GO:0085018)	1	0	.05	-	 < 0.01	9.50E-01
entry into host cell by a symbiont-containing vacuole (GO:0085017)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of natural killer cell mediated immunity (GO:0002717)	25	0	1.28	-	 < 0.01	2.79E-01
negative regulation of natural killer cell mediated immunity (GO:0002716)	17	0	.87	-	 < 0.01	4.19E-01
regulation of natural killer cell mediated immunity (GO:0002715)	41	0	2.09	-	 < 0.01	1.23E-01
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neural retina development (GO:0061074)	3	0	.15	-	 < 0.01	8.58E-01
ciliary body morphogenesis (GO:0061073)	4	0	.20	-	 < 0.01	8.15E-01
pH elevation (GO:0045852)	7	0	.36	-	 < 0.01	6.99E-01
regulation of hydrogen peroxide metabolic process (GO:0010310)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of nitrogen utilization (GO:0045848)	1	0	.05	-	 < 0.01	9.50E-01
protein localization to kinetochore involved in kinetochore assembly (GO:1903394)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of striated muscle tissue development (GO:0045844)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of adherens junction organization (GO:1903393)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of adherens junction organization (GO:1903392)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	13	0	.66	-	 < 0.01	5.15E-01
regulation of adherens junction organization (GO:1903391)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of mitotic nuclear division (GO:0045840)	35	0	1.79	-	 < 0.01	1.67E-01
positive regulation of membrane potential (GO:0045838)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of homophilic cell adhesion (GO:1903387)	1	0	.05	-	 < 0.01	9.50E-01
sclerotome development (GO:0061056)	3	0	.15	-	 < 0.01	8.58E-01
myotome development (GO:0061055)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of membrane potential (GO:0045837)	14	0	.72	-	 < 0.01	4.89E-01
regulation of homophilic cell adhesion (GO:1903385)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of meiotic nuclear division (GO:0045835)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.10	-	 < 0.01	9.03E-01
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	1	0	.05	-	 < 0.01	9.50E-01
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	1	0	.05	-	 < 0.01	9.50E-01
nucleoside bisphosphate catabolic process (GO:0033869)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of NAD(P)H oxidase activity (GO:0033864)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of NAD(P)H oxidase activity (GO:0033861)	2	0	.10	-	 < 0.01	9.03E-01
regulation of NAD(P)H oxidase activity (GO:0033860)	9	0	.46	-	 < 0.01	6.31E-01
commitment of multipotent stem cells to neuronal lineage in forebrain (GO:0021898)	3	0	.15	-	 < 0.01	8.58E-01
forebrain astrocyte development (GO:0021897)	2	0	.10	-	 < 0.01	9.03E-01
forebrain astrocyte differentiation (GO:0021896)	2	0	.10	-	 < 0.01	9.03E-01
cerebral cortex neuron differentiation (GO:0021895)	25	0	1.28	-	 < 0.01	2.79E-01
cerebral cortex GABAergic interneuron development (GO:0021894)	7	0	.36	-	 < 0.01	6.99E-01
cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	2	0	.10	-	 < 0.01	9.03E-01
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	11	0	.56	-	 < 0.01	5.70E-01
olfactory bulb interneuron development (GO:0021891)	7	0	.36	-	 < 0.01	6.99E-01
cell growth involved in cardiac muscle cell development (GO:0061049)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of branching involved in lung morphogenesis (GO:0061048)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	2	0	.10	-	 < 0.01	9.03E-01
glucuronate metabolic process (GO:0019585)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of branching involved in lung morphogenesis (GO:0061047)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of isoprenoid metabolic process (GO:0045828)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of isoprenoid metabolic process (GO:0045827)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of vascular wound healing (GO:0061044)	4	0	.20	-	 < 0.01	8.15E-01
facioacoustic ganglion development (GO:1903375)	3	0	.15	-	 < 0.01	8.58E-01
vascular wound healing (GO:0061042)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	3	0	.15	-	 < 0.01	8.58E-01
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	5	0	.26	-	 < 0.01	7.75E-01
female gonad morphogenesis (GO:0061040)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of glycolytic process (GO:0045821)	23	0	1.17	-	 < 0.01	3.09E-01
olfactory bulb interneuron differentiation (GO:0021889)	11	0	.56	-	 < 0.01	5.70E-01
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	4	0	.20	-	 < 0.01	8.15E-01
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	4	0	.20	-	 < 0.01	8.15E-01
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment (GO:0021882)	3	0	.15	-	 < 0.01	8.58E-01
uterus morphogenesis (GO:0061038)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cartilage development (GO:0061037)	28	0	1.43	-	 < 0.01	2.39E-01
positive regulation of glycogen catabolic process (GO:0045819)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of fear response (GO:1903366)	1	0	.05	-	 < 0.01	9.50E-01
olfactory bulb mitral cell layer development (GO:0061034)	2	0	.10	-	 < 0.01	9.03E-01
secretion by lung epithelial cell involved in lung growth (GO:0061033)	3	0	.15	-	 < 0.01	8.58E-01
visceral serous pericardium development (GO:0061032)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)	1	0	.05	-	 < 0.01	9.50E-01
endodermal digestive tract morphogenesis (GO:0061031)	2	0	.10	-	 < 0.01	9.03E-01
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	4	0	.20	-	 < 0.01	8.15E-01
forebrain neuron fate commitment (GO:0021877)	11	0	.56	-	 < 0.01	5.70E-01
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	1	0	.05	-	 < 0.01	9.50E-01
forebrain neuroblast division (GO:0021873)	6	0	.31	-	 < 0.01	7.36E-01
Cajal-Retzius cell differentiation (GO:0021870)	1	0	.05	-	 < 0.01	9.50E-01
regulation of Golgi organization (GO:1903358)	12	0	.61	-	 < 0.01	5.42E-01
umbilical cord development (GO:0061027)	2	0	.10	-	 < 0.01	9.03E-01
cardiac muscle tissue regeneration (GO:0061026)	3	0	.15	-	 < 0.01	8.58E-01
glycerol catabolic process (GO:0019563)	5	0	.26	-	 < 0.01	7.75E-01
regulation of nucleus organization (GO:1903353)	1	0	.05	-	 < 0.01	9.50E-01
L-ornithine transmembrane transport (GO:1903352)	6	0	.31	-	 < 0.01	7.36E-01
blood coagulation, extrinsic pathway (GO:0007598)	4	0	.20	-	 < 0.01	8.15E-01
blood coagulation, intrinsic pathway (GO:0007597)	17	0	.87	-	 < 0.01	4.19E-01
forebrain ventricular zone progenitor cell division (GO:0021869)	6	0	.31	-	 < 0.01	7.36E-01
forebrain radial glial cell differentiation (GO:0021861)	7	0	.36	-	 < 0.01	6.99E-01
histidine catabolic process to glutamate and formate (GO:0019557)	3	0	.15	-	 < 0.01	8.58E-01
histidine catabolic process to glutamate and formamide (GO:0019556)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of bicellular tight junction assembly (GO:1903348)	7	0	.36	-	 < 0.01	6.99E-01
hepatoblast differentiation (GO:0061017)	1	0	.05	-	 < 0.01	9.50E-01
snRNA import into nucleus (GO:0061015)	2	0	.10	-	 < 0.01	9.03E-01
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.10	-	 < 0.01	9.03E-01
glutamate catabolic process to aspartate (GO:0019550)	2	0	.10	-	 < 0.01	9.03E-01
excretion (GO:0007588)	42	0	2.15	-	 < 0.01	1.17E-01
gall bladder development (GO:0061010)	2	0	.10	-	 < 0.01	9.03E-01
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	3	0	.15	-	 < 0.01	8.58E-01
hypothalamus cell migration (GO:0021855)	4	0	.20	-	 < 0.01	8.15E-01
cerebral cortex GABAergic interneuron migration (GO:0021853)	6	0	.31	-	 < 0.01	7.36E-01
common bile duct development (GO:0061009)	5	0	.26	-	 < 0.01	7.75E-01
arginine catabolic process to ornithine (GO:0019547)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of vacuolar transport (GO:1903337)	2	0	.10	-	 < 0.01	9.03E-01
arginine catabolic process to glutamate (GO:0019544)	1	0	.05	-	 < 0.01	9.50E-01
propionate catabolic process (GO:0019543)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of vacuolar transport (GO:1903336)	2	0	.10	-	 < 0.01	9.03E-01
pattern specification involved in kidney development (GO:0061004)	9	0	.46	-	 < 0.01	6.31E-01
regulation of vacuolar transport (GO:1903335)	5	0	.26	-	 < 0.01	7.75E-01
propionate biosynthetic process (GO:0019542)	2	0	.10	-	 < 0.01	9.03E-01
propionate metabolic process (GO:0019541)	4	0	.20	-	 < 0.01	8.15E-01
nucleolar fragmentation (GO:0007576)	1	0	.05	-	 < 0.01	9.50E-01
age-dependent general metabolic decline (GO:0007571)	4	0	.20	-	 < 0.01	8.15E-01
neuroblast division in subventricular zone (GO:0021849)	3	0	.15	-	 < 0.01	8.58E-01
ventricular zone neuroblast division (GO:0021847)	3	0	.15	-	 < 0.01	8.58E-01
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	9	0	.46	-	 < 0.01	6.31E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	110	0	5.62	-	 < 0.01	3.56E-03
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	2	0	.10	-	 < 0.01	9.03E-01
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of tRNA metabolic process (GO:1903327)	2	0	.10	-	 < 0.01	9.03E-01
regulation of tRNA metabolic process (GO:1903326)	2	0	.10	-	 < 0.01	9.03E-01
oxygen metabolic process (GO:0072592)	3	0	.15	-	 < 0.01	8.58E-01
oxalate transport (GO:0019532)	10	0	.51	-	 < 0.01	6.00E-01
taurine metabolic process (GO:0019530)	7	0	.36	-	 < 0.01	6.99E-01
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	0	.10	-	 < 0.01	9.03E-01
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	1	0	.05	-	 < 0.01	9.50E-01
interneuron migration from the subpallium to the cortex (GO:0021830)	9	0	.46	-	 < 0.01	6.31E-01
pentitol catabolic process (GO:0019527)	1	0	.05	-	 < 0.01	9.50E-01
caveolin-mediated endocytosis (GO:0072584)	5	0	.26	-	 < 0.01	7.75E-01
D-gluconate metabolic process (GO:0019521)	2	0	.10	-	 < 0.01	9.03E-01
regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.05	-	 < 0.01	9.50E-01
aldonic acid metabolic process (GO:0019520)	2	0	.10	-	 < 0.01	9.03E-01
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	2	0	.10	-	 < 0.01	9.03E-01
tricuspid valve formation (GO:0003195)	2	0	.10	-	 < 0.01	9.03E-01
pulmonary valve formation (GO:0003193)	2	0	.10	-	 < 0.01	9.03E-01
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	3	0	.15	-	 < 0.01	8.58E-01
postnatal olfactory bulb interneuron migration (GO:0021827)	2	0	.10	-	 < 0.01	9.03E-01
substrate-independent telencephalic tangential migration (GO:0021826)	9	0	.46	-	 < 0.01	6.31E-01
substrate-dependent cerebral cortex tangential migration (GO:0021825)	2	0	.10	-	 < 0.01	9.03E-01
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	2	0	.10	-	 < 0.01	9.03E-01
glycine receptor clustering (GO:0072579)	1	0	.05	-	 < 0.01	9.50E-01
pentitol metabolic process (GO:0019519)	1	0	.05	-	 < 0.01	9.50E-01
neurotransmitter-gated ion channel clustering (GO:0072578)	10	0	.51	-	 < 0.01	6.00E-01
L-threonine catabolic process to glycine (GO:0019518)	4	0	.20	-	 < 0.01	8.15E-01
liver morphogenesis (GO:0072576)	8	0	.41	-	 < 0.01	6.65E-01
lactate oxidation (GO:0019516)	1	0	.05	-	 < 0.01	9.50E-01
response to phenylpropanoid (GO:0080184)	5	0	.26	-	 < 0.01	7.75E-01
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	7	0	.36	-	 < 0.01	6.99E-01
hepatocyte proliferation (GO:0072574)	7	0	.36	-	 < 0.01	6.99E-01
tolerance induction to lipopolysaccharide (GO:0072573)	2	0	.10	-	 < 0.01	9.03E-01
S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.05	-	 < 0.01	9.50E-01
regulation of pyruvate kinase activity (GO:1903302)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of hexokinase activity (GO:1903301)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of hexokinase activity (GO:1903300)	4	0	.20	-	 < 0.01	8.15E-01
primary sex determination, germ-line (GO:0007542)	2	0	.10	-	 < 0.01	9.03E-01
sinoatrial valve morphogenesis (GO:0003185)	1	0	.05	-	 < 0.01	9.50E-01
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	3	0	.15	-	 < 0.01	8.58E-01
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	1	0	.05	-	 < 0.01	9.50E-01
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	4	0	.20	-	 < 0.01	8.15E-01
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	6	0	.31	-	 < 0.01	7.36E-01
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.05	-	 < 0.01	9.50E-01
L-methionine salvage from methylthioadenosine (GO:0019509)	4	0	.20	-	 < 0.01	8.15E-01
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.10	-	 < 0.01	9.03E-01
hydrogen peroxide transmembrane transport (GO:0080170)	1	0	.05	-	 < 0.01	9.50E-01
type B pancreatic cell maturation (GO:0072560)	2	0	.10	-	 < 0.01	9.03E-01
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	2	0	.10	-	 < 0.01	9.03E-01
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	1	0	.05	-	 < 0.01	9.50E-01
mammary placode formation (GO:0060596)	3	0	.15	-	 < 0.01	8.58E-01
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	0	.10	-	 < 0.01	9.03E-01
mammary gland specification (GO:0060594)	3	0	.15	-	 < 0.01	8.58E-01
mammary gland formation (GO:0060592)	7	0	.36	-	 < 0.01	6.99E-01
chondroblast differentiation (GO:0060591)	4	0	.20	-	 < 0.01	8.15E-01
cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808)	1	0	.05	-	 < 0.01	9.50E-01
sinoatrial valve development (GO:0003172)	1	0	.05	-	 < 0.01	9.50E-01
initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806)	1	0	.05	-	 < 0.01	9.50E-01
cerebral cortex tangential migration (GO:0021800)	6	0	.31	-	 < 0.01	7.36E-01
regulation of nitric oxide metabolic process (GO:0080164)	1	0	.05	-	 < 0.01	9.50E-01
blood vessel lumenization (GO:0072554)	2	0	.10	-	 < 0.01	9.03E-01
regulation of protein serine/threonine phosphatase activity (GO:0080163)	1	0	.05	-	 < 0.01	9.50E-01
terminal button organization (GO:0072553)	2	0	.10	-	 < 0.01	9.03E-01
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.05	-	 < 0.01	9.50E-01
regulation of lipoprotein lipid oxidation (GO:0060587)	2	0	.10	-	 < 0.01	9.03E-01
multicellular organismal iron ion homeostasis (GO:0060586)	9	0	.46	-	 < 0.01	6.31E-01
somatic muscle development (GO:0007525)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	3	0	.15	-	 < 0.01	8.58E-01
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	3	0	.15	-	 < 0.01	8.58E-01
cell fate determination involved in pattern specification (GO:0060582)	1	0	.05	-	 < 0.01	9.50E-01
visceral muscle development (GO:0007522)	1	0	.05	-	 < 0.01	9.50E-01
cell fate commitment involved in pattern specification (GO:0060581)	12	0	.61	-	 < 0.01	5.42E-01
muscle cell fate determination (GO:0007521)	2	0	.10	-	 < 0.01	9.03E-01
ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.05	-	 < 0.01	9.50E-01
Purkinje myocyte differentiation (GO:0003168)	1	0	.05	-	 < 0.01	9.50E-01
atrioventricular bundle cell differentiation (GO:0003167)	1	0	.05	-	 < 0.01	9.50E-01
bundle of His development (GO:0003166)	4	0	.20	-	 < 0.01	8.15E-01
Purkinje myocyte development (GO:0003165)	2	0	.10	-	 < 0.01	9.03E-01
His-Purkinje system development (GO:0003164)	5	0	.26	-	 < 0.01	7.75E-01
sinoatrial node development (GO:0003163)	3	0	.15	-	 < 0.01	8.58E-01
ventral spinal cord interneuron fate commitment (GO:0060579)	12	0	.61	-	 < 0.01	5.42E-01
myoblast fate determination (GO:0007518)	2	0	.10	-	 < 0.01	9.03E-01
pulmonary vein morphogenesis (GO:0060577)	1	0	.05	-	 < 0.01	9.50E-01
intestinal epithelial cell development (GO:0060576)	13	0	.66	-	 < 0.01	5.15E-01
intestinal epithelial cell differentiation (GO:0060575)	22	0	1.12	-	 < 0.01	3.25E-01
intestinal epithelial cell maturation (GO:0060574)	4	0	.20	-	 < 0.01	8.15E-01
cell fate specification involved in pattern specification (GO:0060573)	8	0	.41	-	 < 0.01	6.65E-01
adult heart development (GO:0007512)	13	0	.66	-	 < 0.01	5.15E-01
morphogenesis of an endothelium (GO:0003159)	13	0	.66	-	 < 0.01	5.15E-01
muscular septum morphogenesis (GO:0003150)	4	0	.20	-	 < 0.01	8.15E-01
glycolate catabolic process (GO:0046296)	1	0	.05	-	 < 0.01	9.50E-01
glycolate biosynthetic process (GO:0046295)	1	0	.05	-	 < 0.01	9.50E-01
fibroblast activation (GO:0072537)	6	0	.31	-	 < 0.01	7.36E-01
amino acid homeostasis (GO:0080144)	4	0	.20	-	 < 0.01	8.15E-01
pyrimidine-containing compound transmembrane transport (GO:0072531)	12	0	.61	-	 < 0.01	5.42E-01
purine-containing compound transmembrane transport (GO:0072530)	19	0	.97	-	 < 0.01	3.79E-01
mesoderm migration involved in gastrulation (GO:0007509)	2	0	.10	-	 < 0.01	9.03E-01
regulation of postsynaptic density protein 95 clustering (GO:1902897)	3	0	.15	-	 < 0.01	8.58E-01
gonadal mesoderm development (GO:0007506)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of DNA-templated transcription, termination (GO:0060566)	1	0	.05	-	 < 0.01	9.50E-01
terminal web assembly (GO:1902896)	2	0	.10	-	 < 0.01	9.03E-01
mesodermal cell fate specification (GO:0007501)	6	0	.31	-	 < 0.01	7.36E-01
membranous septum morphogenesis (GO:0003149)	8	0	.41	-	 < 0.01	6.65E-01
neural crest cell migration involved in heart formation (GO:0003147)	1	0	.05	-	 < 0.01	9.50E-01
embryonic heart tube formation (GO:0003144)	1	0	.05	-	 < 0.01	9.50E-01
cardiogenic plate morphogenesis (GO:0003142)	1	0	.05	-	 < 0.01	9.50E-01
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine-containing compound biosynthetic process (GO:0072528)	35	0	1.79	-	 < 0.01	1.67E-01
pyridine-containing compound catabolic process (GO:0072526)	4	0	.20	-	 < 0.01	8.15E-01
purine-containing compound catabolic process (GO:0072523)	49	0	2.50	-	 < 0.01	8.15E-02
seminiferous tubule development (GO:0072520)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of vitamin D biosynthetic process (GO:0060557)	2	0	.10	-	 < 0.01	9.03E-01
regulation of vitamin D biosynthetic process (GO:0060556)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of response to oxidative stress (GO:1902884)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of response to oxidative stress (GO:1902883)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)	1	0	.05	-	 < 0.01	9.50E-01
regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)	1	0	.05	-	 < 0.01	9.50E-01
secondary heart field specification (GO:0003139)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)	1	0	.05	-	 < 0.01	9.50E-01
primary heart field specification (GO:0003138)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136)	1	0	.05	-	 < 0.01	9.50E-01
mesodermal-endodermal cell signaling (GO:0003131)	1	0	.05	-	 < 0.01	9.50E-01
proteasome core complex assembly (GO:0080129)	1	0	.05	-	 < 0.01	9.50E-01
stilbene catabolic process (GO:0046272)	1	0	.05	-	 < 0.01	9.50E-01
phenylpropanoid catabolic process (GO:0046271)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	4	0	.20	-	 < 0.01	8.15E-01
AMP transport (GO:0080121)	2	0	.10	-	 < 0.01	9.03E-01
CAAX-box protein maturation (GO:0080120)	2	0	.10	-	 < 0.01	9.03E-01
regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of necroptotic process (GO:0060546)	14	0	.72	-	 < 0.01	4.89E-01
regulation of strand invasion (GO:0060542)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of amacrine cell differentiation (GO:1902871)	2	0	.10	-	 < 0.01	9.03E-01
heart field specification (GO:0003128)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of amacrine cell differentiation (GO:1902870)	1	0	.05	-	 < 0.01	9.50E-01
detection of nodal flow (GO:0003127)	2	0	.10	-	 < 0.01	9.03E-01
DNA demethylation (GO:0080111)	19	0	.97	-	 < 0.01	3.79E-01
diaphragm development (GO:0060539)	9	0	.46	-	 < 0.01	6.31E-01
regulation of amacrine cell differentiation (GO:1902869)	3	0	.15	-	 < 0.01	8.58E-01
cartilage morphogenesis (GO:0060536)	12	0	.61	-	 < 0.01	5.42E-01
regulation of retina development in camera-type eye (GO:1902866)	1	0	.05	-	 < 0.01	9.50E-01
trachea cartilage morphogenesis (GO:0060535)	4	0	.20	-	 < 0.01	8.15E-01
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.05	-	 < 0.01	9.50E-01
detection of monosaccharide stimulus (GO:0034287)	3	0	.15	-	 < 0.01	8.58E-01
response to disaccharide (GO:0034285)	8	0	.41	-	 < 0.01	6.65E-01
propionyl-CoA catabolic process (GO:1902859)	1	0	.05	-	 < 0.01	9.50E-01
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	6	0	.31	-	 < 0.01	7.36E-01
propionyl-CoA metabolic process (GO:1902858)	2	0	.10	-	 < 0.01	9.03E-01
prostate glandular acinus morphogenesis (GO:0060526)	6	0	.31	-	 < 0.01	7.36E-01
prostate epithelial cord elongation (GO:0060523)	3	0	.15	-	 < 0.01	8.58E-01
activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glomerular filtration by angiotensin (GO:0003106)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of glomerular filtration (GO:0003105)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of glomerular filtration (GO:0003104)	4	0	.20	-	 < 0.01	8.15E-01
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	5	0	.26	-	 < 0.01	7.75E-01
terpene catabolic process (GO:0046247)	1	0	.05	-	 < 0.01	9.50E-01
kynurenic acid biosynthetic process (GO:0034276)	2	0	.10	-	 < 0.01	9.03E-01
kynurenic acid metabolic process (GO:0034275)	2	0	.10	-	 < 0.01	9.03E-01
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.05	-	 < 0.01	9.50E-01
regulation of neuronal signal transduction (GO:1902847)	1	0	.05	-	 < 0.01	9.50E-01
primary prostatic bud elongation (GO:0060516)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of netrin-activated signaling pathway (GO:1902842)	4	0	.20	-	 < 0.01	8.15E-01
type II pneumocyte differentiation (GO:0060510)	5	0	.26	-	 < 0.01	7.75E-01
regulation of netrin-activated signaling pathway (GO:1902841)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of autophagy in response to ER overload (GO:0034263)	1	0	.05	-	 < 0.01	9.50E-01
regulation of nuclear migration along microtubule (GO:1902838)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of proline import across plasma membrane (GO:1902836)	1	0	.05	-	 < 0.01	9.50E-01
bud dilation involved in lung branching (GO:0060503)	1	0	.05	-	 < 0.01	9.50E-01
regulation of proline import across plasma membrane (GO:1902834)	1	0	.05	-	 < 0.01	9.50E-01
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	5	0	.26	-	 < 0.01	7.75E-01
coumarin catabolic process (GO:0046226)	2	0	.10	-	 < 0.01	9.03E-01
aflatoxin catabolic process (GO:0046223)	2	0	.10	-	 < 0.01	9.03E-01
aflatoxin metabolic process (GO:0046222)	3	0	.15	-	 < 0.01	8.58E-01
regulation of urea metabolic process (GO:0034255)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of late endosome to lysosome transport (GO:1902824)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of late endosome to lysosome transport (GO:1902823)	2	0	.10	-	 < 0.01	9.03E-01
regulation of late endosome to lysosome transport (GO:1902822)	4	0	.20	-	 < 0.01	8.15E-01
indolalkylamine biosynthetic process (GO:0046219)	4	0	.20	-	 < 0.01	8.15E-01
indolalkylamine catabolic process (GO:0046218)	10	0	.51	-	 < 0.01	6.00E-01
nitric oxide catabolic process (GO:0046210)	1	0	.05	-	 < 0.01	9.50E-01
snoRNA splicing (GO:0034247)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of protein localization to microtubule (GO:1902817)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of macrophage fusion (GO:0034241)	4	0	.20	-	 < 0.01	8.15E-01
regulation of protein localization to microtubule (GO:1902816)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	3	0	.15	-	 < 0.01	8.58E-01
nitric oxide metabolic process (GO:0046209)	21	0	1.07	-	 < 0.01	3.42E-01
nor-spermidine metabolic process (GO:0046204)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of cellular extravasation (GO:0002693)	15	0	.77	-	 < 0.01	4.65E-01
regulation of macrophage fusion (GO:0034239)	4	0	.20	-	 < 0.01	8.15E-01
macrophage fusion (GO:0034238)	1	0	.05	-	 < 0.01	9.50E-01
regulation of skeletal muscle fiber differentiation (GO:1902809)	4	0	.20	-	 < 0.01	8.15E-01
islet amyloid polypeptide processing (GO:0034231)	1	0	.05	-	 < 0.01	9.50E-01
enkephalin processing (GO:0034230)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of synaptic vesicle transport (GO:1902805)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of synaptic vesicle transport (GO:1902804)	1	0	.05	-	 < 0.01	9.50E-01
regulation of synaptic vesicle transport (GO:1902803)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of leukocyte chemotaxis (GO:0002689)	19	0	.97	-	 < 0.01	3.79E-01
somatic recombination of T cell receptor gene segments (GO:0002681)	5	0	.26	-	 < 0.01	7.75E-01
tRNA thio-modification (GO:0034227)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to zinc ion starvation (GO:0034224)	2	0	.10	-	 < 0.01	9.03E-01
